PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, CW; Wu, TX; Shang, HC; Li, YP; Altman, DG; Moher, D; Bian, ZX				Cheng, Chung-wah; Wu, Tai-xiang; Shang, Hong-cai; Li, You-ping; Altman, Douglas G.; Moher, David; Bian, Zhao-xiang		CONSORT-CHM Formulas 2017 Grp	CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; INTERVENTIONS; JOURNALS	Chinese herbal medicine (CHM) formulas are the major components of traditional Chinese medicine (TCM) interventions. The general reporting quality of randomized controlled trials (RCTs) of CHM formulas is disappointing, although CONSORT (Consolidated Standards of Reporting Trials) Statement extensions for herbal medicinal interventions and acupuncture interventions are available. A group of TCM clinical experts, methodologists, epidemiologists, and editors has developed this CONSORT Extension for CHM Formulas (CONSORT-CHM Formulas 2017) through a comprehensive process, including publication of the draft version, solicitation of comments, revision, and finalization. The CONSORT 2010 Statement was extended by introducing the idea of TCM Pattern and the features of CHM formulas. One new checklist subitem, keywords, was added to facilitate indexing and data searching. Seven of the 25 CONSORT checklist items, namely title and abstract, background and objectives, participants, interventions, outcomes, generalizability, and interpretation, are now elaborated, and the explanation of harms specific to CHM formulas is revised. Illustrative examples and explanations are also provided. The group hopes that CONSORT-CHM Formulas 2017 can improve the reporting quality of RCTs of CHM formulas.	[Cheng, Chung-wah; Bian, Zhao-xiang] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China; [Wu, Tai-xiang] Sichuan Univ, Chinese Cochrane Ctr, West China Hosp, Chengdu 610041, Sichuan, Peoples R China; [Li, You-ping] Sichuan Univ, Chinese Evidence Based Med Ctr, Dept Clin Epidemiol, West China Hosp, Chengdu, Sichuan, Peoples R China; [Shang, Hong-cai] Beijing Univ Chinese Med, Key Lab Chinese Internal Med, Minist Educ & Beijing, Dongzhimen Hosp, Beijing, Peoples R China; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Moher, David] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Hong Kong Baptist University; Sichuan University; Sichuan University; Beijing University of Chinese Medicine; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute	Bian, ZX (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Chinese Med Clin Study Ctr, 3-F,Jockey Club Sch Chinese Med Bldg, Kowloon Tong, Hong Kong, Peoples R China.	bzxiang@hkbu.edu.hk	Moher, David/I-3408-2019; shang, hongcai/H-1257-2014	Moher, David/0000-0003-2434-4206; Shang, Hongcai/0000-0001-6628-354X	Hong Kong Hospital Authority, HKSAR [HA/09-10/01]; Cancer Research UK [16895] Funding Source: researchfish	Hong Kong Hospital Authority, HKSAR; Cancer Research UK(Cancer Research UK)	The development of CONSORT-CHM Formulas 2017 was funded in part from the Hong Kong Hospital Authority, HKSAR (HA/09-10/01).	Bensky D, 1993, CHINESE HERBAL MED M; Bensky D., 1990, CHINESE HERBAL MED F; Berle CA, 2010, J ALTERN COMPLEM MED, V16, P357, DOI 10.1089/acm.2009.0367; Bian Zhao-xiang, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P661, DOI 10.3736/jcim20080701; Bian Zhao-xiang, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P771, DOI 10.3736/jcim20080801; Bian Zhao-Xiang, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P130; Bian Zhaoxiang, 2011, Front Med, V5, P171, DOI 10.1007/s11684-011-0132-z; Chen K.J., 1982, J MED RES, V11, P24; Cheng Chung-Wah, 2008, Zhong Xi Yi Jie He Xue Bao, V6, P881, DOI 10.3736/jcim20080901; Chinese Pharmacopoeia Commission, 2010, PHARMACOPOEIA PEOPLE; Dagenais Simon, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P455, DOI 10.3736/jcim20060504; 郑颂华, 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P152; First Conference of Blood Stasis of Society of Integrated Traditional and Western Medicine, 1983, CHIN J INTEGR TRADIT, V3, P2; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; He J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-122; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Leung Kelvin S Y, 2006, Zhong Xi Yi Jie He Xue Bao, V4, P225; Liu Z., 2009, ESSENTIALS CHINESE M, V1; MacPherson H, 2010, ACUPUNCT MED, V28, P83, DOI 10.1136/aim.2009.001370; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shen ZY, 1983, ZHONG GUO ZHONG XI Y, V3, P117; [吴泰相 WU Taixiang], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P601; The State Administration of Traditional Chinese Medicine of the People's Republic of China, 1994, CRIT DIAGN THER EFF; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; Wang SQ, 2014, SHI JIE ZHONG YI YAO, V9, P1093; Watanabe K, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq067; WHO, 2014, WHO TRADITIONAL MED, P1; Wieland LS, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-51; World Health Organization Western Pacific Region, 2007, WHO INT STAND TERM T; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Zhu WF, 2008, DIFFERENTIATION PATT	37	181	225	4	54	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					112	121		10.7326/M16-2977	http://dx.doi.org/10.7326/M16-2977			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28654980				2022-12-28	WOS:000405573400017
J	Karron, RA; Black, RE				Karron, Ruth A.; Black, Robert E.			Determining the burden of respiratory syncytial virus disease: the known and the unknown	LANCET			English	Editorial Material							MORTALITY		[Karron, Ruth A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA; [Karron, Ruth A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Vaccine Initiat, Baltimore, MD USA; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore, MD 21205 USA.	rblack1@jhu.edu			Regeneron; National Institutes of Health [HHSN272200900010C]	Regeneron(Regeneron); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RB declares no competing interests. RAK has received a consulting fee from Regeneron for a Scientific Advisory Board meeting that was convened to discuss RSV F mAb REGN2222 and has received funding through National Institutes of Health contract HHSN272200900010C for research on live viral vaccines, including RSV vaccines.	[Anonymous], 1957, AM J HYG; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nunes MC, 2016, JAMA PEDIATR, V170, P840, DOI 10.1001/jamapediatrics.2016.0921; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Shi T, 2017, LANCET; Stein RT, 2017, PEDIATR PULM, V52, P556, DOI 10.1002/ppul.23570; Taylor S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009337	11	26	26	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					917	+		10.1016/S0140-6736(17)31476-9	http://dx.doi.org/10.1016/S0140-6736(17)31476-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FF2SE	28689665	hybrid			2022-12-28	WOS:000408746300005
J	Mundle, S; Bracken, H; Khedikar, V; Mulik, J; Faragher, B; Easterling, T; Leigh, S; Granby, P; Haycox, A; Turner, MA; Alfirevic, Z; Winikoff, B; Weeks, AD				Mundle, Shuchita; Bracken, Hillary; Khedikar, Vaishali; Mulik, Jayashree; Faragher, Brian; Easterling, Thomas; Leigh, Simon; Granby, Paul; Haycox, Alan; Turner, Mark A.; Alfirevic, Zarko; Winikoff, Beverly; Weeks, Andrew D.			Foley catheterisation versus oral misoprostol for induction of labour in hypertensive women in India (INFORM): a multicentre, open-label, randomised controlled trial	LANCET			English	Article							UNFAVORABLE CERVIX; MORTALITY; TERM	Background Between 62 000 and 77 000 women die annually from pre-eclampsia and eclampsia. Prompt delivery, preferably by the vaginal route, is vital for good maternal and neonatal outcomes. Two low-cost intervention-slow-dose oral misoprostol tablets and transcervical Foley catheterisation-are already used in low-resource settings. We aimed to compare the relative risks and benefits of these interventions. Methods We undertook this multicentre, open-label, randomised controlled trial in two public hospitals in Nagpur, India. Women (aged >= 18 years) who were at 20 weeks' gestation or later with a live fetus and required delivery as a result of pre-eclampsia or hypertension were randomly assigned (1: 1), via computer-generated block randomisation (block sizes of four, six, and eight) with concealment by use of opaque, sequentially numbered, sealed envelopes, to receive labour induction with either oral misoprostol 25 mu g every 2 h (maximum of 12 doses) or a transcervical Foley catheter (silicone, size 18 F with 30 mL balloon). Randomisation was stratified by study centre. The catheter remained in place until active labour started, the catheter fell out, or 12 h had elapsed. If the catheter did not fall out within 12 h, induction continued with artificial membrane rupture and oxytocin, administered through a micro-drip gravity infusion set. Fetal monitoring was by intermittent auscultation. The primary outcome was vaginal birth within 24 h. Due to the nature of the interventions, masking of participants, study investigators, and care providers to group allocation was not possible. We analysed by intention to treat. Findings Between Dec 20, 2013, and June 29, 2015, we randomly assigned 602 women to induction with misoprostol (n=302) or the Foley catheter (n=300; intention-to-treat population). Vaginal birth within 24 h was more common in women in the misoprostol group than in the Foley catheter group (172 [57.0%] vs 141 [47.0%] women; absolute risk difference 10.0%, 95% CI 2.0-17.9; p=0.0136). Rates of uterine hyperstimulation were low in both the misoprostol and Foley catheter groups (two [0.7%] vs one [0.3%] cases; absolute risk difference 0.3%, 95% CI -0.8 to 1.5; p=0.566) and neonatal deaths did not differ significantly between groups (six [2.0%] vs three [1.0%] neonatal deaths; 1.0, -1.04 to 2.97; p=0.322). 17 serious adverse events (3%) were reported during the study: one case of intrapartum convulsion and one case of disseminated intravascular coagulation (both in the Foley group); ten perinatal deaths, including two stillbirths (both in the Foley catheter group) and eight neonatal deaths (n=5 in the misoprostol group and n=3 in the Foley catheter group); and five of neonatal morbidity, comprising birth asphyxia (n=3), septicaemia (n=1), and neonatal convulsion (n= 1). Interpretation Oral misoprostol was more effective than transcervical Foley catheterisation for induction of labour in women with pre-eclampsia or hypertension. Future studies are required to assess whether oxytocin augmentation following misoprostol can be replaced by regular doses of oral misoprostol tablets.	[Mundle, Shuchita; Mulik, Jayashree] Govt Med Coll, Dept Obstet & Gynecol, Nagpur, Maharashtra, India; [Bracken, Hillary; Winikoff, Beverly] Gynu Hlth Projects, New York, NY USA; [Khedikar, Vaishali] Daga Mem Womens Govt Hosp, Nagpur, Maharashtra, India; [Faragher, Brian] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Med Stat Unit, Liverpool, Merseyside, England; [Easterling, Thomas] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Leigh, Simon; Granby, Paul; Haycox, Alan] Univ Liverpool, Management Sch, Liverpool, Merseyside, England; [Turner, Mark A.; Alfirevic, Zarko; Weeks, Andrew D.] Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine; University of Washington; University of Washington Seattle; University of Liverpool; University of Liverpool	Weeks, AD (corresponding author), Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Sanyu Res Unit, Liverpool L8 7SS, Merseyside, England.	aweeks@liverpool.ac.uk	Granby, Paul/AAJ-6149-2021	Turner, Mark/0000-0002-5299-8656; Weeks, Andrew/0000-0002-1909-337X; Leigh, Simon/0000-0002-6843-6447	Medical Research Council; Department for International Development; Wellcome Trust Joint Global Health Trials Scheme; MRC [G1100686] Funding Source: UKRI; Medical Research Council [G1100686] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; Wellcome Trust Joint Global Health Trials Scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council, Department for International Development, and Wellcome Trust Joint Global Health Trials Scheme.	Alfirevic Z, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD001338.PUB3; Alfirevic Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h217; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Bracken H, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-308; Chen W, 2015, BJOG, V123, P346; FLACK FC, 1974, BMJ-BRIT MED J, V3, P439, DOI 10.1136/bmj.3.5928.439; Jozwiak M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001233.pub2; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; Kundodyiwa TW, 2009, OBSTET GYNECOL, V113, P374, DOI 10.1097/AOG.0b013e3181945859; Lovold A, 2008, INT J GYNECOL OBSTET, V103, P276, DOI 10.1016/j.ijgo.2008.08.009; McMaster K, 2015, OBSTET GYNECOL, V126, P539, DOI 10.1097/AOG.0000000000001002; Owolabi A T, 2005, J Obstet Gynaecol, V25, P565, DOI 10.1080/01443610500231450; Pennell CE, 2009, BJOG-INT J OBSTET GY, V116, P1443, DOI 10.1111/j.1471-0528.2009.02279.x; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Tang OS, 2002, HUM REPROD, V17, P332, DOI 10.1093/humrep/17.2.332; ten Eikelder MLG, 2017, AM J PERINAT, V34, P138, DOI 10.1055/s-0036-1584523; ten Eikelder MLG, 2016, LANCET, V387, P1619, DOI 10.1016/S0140-6736(16)00084-2; WHO, 2011, WHO REC IND LAB; Yuen PM, 1996, AUST NZ J OBSTET GYN, V36, P291, DOI 10.1111/j.1479-828X.1996.tb02713.x	22	20	21	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					669	680		10.1016/S0140-6736(17)31367-3	http://dx.doi.org/10.1016/S0140-6736(17)31367-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD3TV	28668289				2022-12-28	WOS:000407456200023
J	Mohamed, S; Johnson, GR; Chen, P; Hicks, PB; Davis, LL; Yoon, J; Gleason, TC; Vertrees, JE; Weingart, K; Tal, I; Scrymgeour, A; Lawrence, DD; Planeta, B; Thase, ME; Huang, GD; Zisook, S				Mohamed, Somaia; Johnson, Gary R.; Chen, Peijun; Hicks, Paul B.; Davis, Lori L.; Yoon, Jean; Gleason, Theresa C.; Vertrees, Julia E.; Weingart, Kimberly; Tal, Ilanit; Scrymgeour, Alexandra; Lawrence, David D.; Planeta, Beata; Thase, Michael E.; Huang, Grant D.; Zisook, Sidney		VAST-D Investigators	Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment The VAST-D Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTPATIENTS; GUIDELINES; OUTCOMES; FAILURE; SSRIS; MOOD; SR	IMPORTANCE Less than one-third of patients with major depressive disorder (MDD) achieve remission with their first antidepressant. OBJECTIVE To determine the relative effectiveness and safety of 3 common alternate treatments for MDD. DESIGN, SETTING, AND PARTICIPANTS From December 2012 to May 2015, 1522 patients at 35 US Veterans Health Administration medical centers who were diagnosed with nonpsychotic MDD, unresponsive to at least 1 antidepressant course meeting minimal standards for treatment dose and duration, participated in the study. Patients were randomly assigned (1:1:1) to 1 of 3 treatments and evaluated for up to 36 weeks. INTERVENTIONS Switch to a different antidepressant, bupropion (switch group, n=511); augment current treatment with bupropion (augment-bupropion group, n=506); or augment with an atypical antipsychotic, aripiprazole (augment-aripiprazole group, n=505) for 12 weeks (acute treatment phase) and up to 36 weeks for longer-term follow-up (continuation phase). MAIN OUTCOMES AND MEASURES The primary outcome was remission during the acute treatment phase (16-item Quick Inventory of Depressive Symptomatology-Clinician Rated [QIDS-C-16] score <= 5 at 2 consecutive visits). Secondary outcomes included response (>= 50% reduction in QIDS-C-16 score or improvement on the Clinical Global Impression Improvement scale), relapse, and adverse effects. RESULTS Among 1522 randomized patients (mean age, 54.4 years; men, 1296 [85.2%]), 1137 (74.7%) completed the acute treatment phase. Remission rates at 12 weeks were 22.3% (n=114) for the switch group, 26.9% (n=136)for the augment-bupropion group, and 28.9% (n=146) for the augment-aripiprazole group. The augment-aripiprazole group exceeded the switch group in remission (relative risk [RR], 1.30 [95% CI, 1.05-1.60]; P=.02), but other remission comparisons were not significant. Response was greater for the augment-aripiprazole group (74.3%) than for either the switch group (62.4%; RR, 1.19 [95% CI, 1.09-1.29]) or the augment-bupropion group (65.6%; RR, 1.13 [95% CI, 1.04-1.23]). No significant treatment differences were observed for relapse. Anxiety was more frequent in the 2 bupropion groups (24.3% in the switch group [n=124] vs 16.6% in the augment-aripiprazole group [n=84]; and 22.5% in augment-bupropion group [n=114]). Adverse effects more frequent in the augment-aripiprazole group included somnolence, akathisia, and weight gain. CONCLUSIONS and Relevance Among a predominantly male population with major depressive disorder unresponsive to antidepressant treatment, augmentation with aripiprazole resulted in a statistically significant but only modestly increased likelihood of remission during 12 weeks of treatment compared with switching to bupropion monotherapy. Given the small effect size and adverse effects associated with aripiprazole, further analysis including cost-effectiveness is needed to understand the net utility of this approach.	[Mohamed, Somaia] VA Connecticut Healthcare Syst, Vet Affairs VA New England Mental Illness Res Edu, 950 Campbell Ave,Mailstop 182, West Haven, CT 06516 USA; [Mohamed, Somaia] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Johnson, Gary R.; Lawrence, David D.; Planeta, Beata] VA Connecticut Healthcare Syst, Cooperat Studies Program Coordinating Ctr, 950 Campbell Ave,Mailstop 182, West Haven, CT 06516 USA; [Chen, Peijun] Louis Stokes VA Med Ctr, Cleveland, OH USA; [Chen, Peijun] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Hicks, Paul B.] Cent Texas Vet Healthcare Syst, Temple, TX USA; [Hicks, Paul B.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Psychiat & Behav Sci, Temple, TX USA; [Davis, Lori L.] Tuscaloosa VA Med Ctr, Tuscaloosa, AL USA; [Davis, Lori L.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Yoon, Jean] VA Palo Alto, Hlth Econ Resource Ctr, Menlo Pk, CA USA; [Gleason, Theresa C.] Off Res & Dev, Dept Vet Affairs, Washington, DC USA; [Vertrees, Julia E.; Scrymgeour, Alexandra] Clin Res Pharm Coordinating Ctr, Cooperat Studies Program, Albuquerque, NM USA; [Weingart, Kimberly; Tal, Ilanit; Zisook, Sidney] VA San Diego Healthcare Syst, San Diego, CA USA; [Weingart, Kimberly; Zisook, Sidney] Univ Calif San Diego, San Diego, CA 92103 USA; [Thase, Michael E.] Philadelphia VA Med Ctr, Philadelphia, PA USA; [Huang, Grant D.] Off Res & Dev, Dept Vet Affairs, Cooperat Studies Program, Cent Off, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Mohamed, S (corresponding author), VA Connecticut Healthcare Syst, 950 Campbell Ave,Mailstop 182, West Haven, CT 06516 USA.	somaia.mohamed@va.gov	Hicks, Paul/AAW-7599-2021; Hicks, Paul/AAF-6121-2021	Hicks, Paul/0000-0002-3921-9056	Veterans Affairs Cooperative Studies Program of the Department of Veterans Affairs, Office of Research and Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Veterans Affairs Cooperative Studies Program of the Department of Veterans Affairs, Office of Research and Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Veterans Affairs Cooperative Studies Program of the Department of Veterans Affairs, Office of Research and Development, which participated in the design and oversaw the conduct of the study including data collection and management and analysis. Bristol-Myers Squibb provided aripiprazole for use in this study.	Adams JR, 2006, COMMUNITY MENT HLT J, V42, P87, DOI 10.1007/s10597-005-9005-8; American Psychiatric Association, 2010, PRACTICE GUIDELINE T, V3rd; Arbaizar B, 2009, GEN HOSP PSYCHIAT, V31, P478, DOI 10.1016/j.genhosppsych.2009.05.005; Barrett E, 2004, OBES RES, V12, P362; Center for Behavioral Health Statistics and Quality, KEY SUBST US MENT HL; Cleare A, 2015, J PSYCHOPHARMACOL, V29, P459, DOI 10.1177/0269881115581093; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Goldberg JF, 2015, DEPRESS ANXIETY, V32, P605, DOI 10.1002/da.22378; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Han C, 2015, J PSYCHIATR RES, V66-67, P84, DOI 10.1016/j.jpsychires.2015.04.020; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Israel JA, 2006, J PSYCHOPHARMACOL, V20, P5, DOI 10.1177/1359786806064306; Kennedy SH, 2016, CAN J PSYCHIAT, V61, P540, DOI 10.1177/0706743716659417; Kolovos S, 2017, J AFFECT DISORDERS, V210, P72, DOI 10.1016/j.jad.2016.12.013; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEVINE J, 1986, PSYCHOPHARMACOL BULL, V22, P343; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Management of MDD Working Group, CLIN PRACT GUID MAN; Mohamed S, 2015, PSYCHIAT RES, V229, P760, DOI 10.1016/j.psychres.2015.08.005; Mohamed S, 2009, J CLIN PSYCHIAT, V70, P906, DOI 10.4088/JCP.08m04450; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Trivedi MH, 2009, J CLIN PSYCHIAT, V70, P26, DOI 10.4088/JCP.8133su1c.04; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; Zisook S, 2016, J AFFECT DISORDERS, V206, P232, DOI 10.1016/j.jad.2016.07.023	30	82	83	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					132	145		10.1001/jama.2017.8036	http://dx.doi.org/10.1001/jama.2017.8036			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA1HS	28697253	Green Published			2022-12-28	WOS:000405190800015
J	Peschel, J				Peschel, Joseph			Why What Makes Us Curious	SCIENCE			English	Book Review												joe@josephpeschel.com						Livio M., 2017, WHY WHAT MAKES US CU	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		42	42		10.1126/science.aan4064	http://dx.doi.org/10.1126/science.aan4064			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684497				2022-12-28	WOS:000404854100042
J	Beagrie, RA; Pombo, A				Beagrie, Robert A.; Pombo, Ana			Continuous chromatin changes	NATURE			English	Editorial Material							HI-C; ORGANIZATION; CHROMOSOME; DOMAINS; RESOLUTION		[Beagrie, Robert A.] Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Pombo, Ana] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, D-13125 Berlin, Germany	University of Oxford; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Beagrie, RA (corresponding author), Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	robert.beagrie@ndcls.ox.ac.uk; ana.pombo@mdc-berlin.de	Pombo, Ana/A-1045-2010	Pombo, Ana/0000-0002-7493-6288; Beagrie, Robert/0000-0003-1076-5595	Medical Research Council [1116071] Funding Source: researchfish; MRC [MC_U120061476] Funding Source: UKRI; Medical Research Council [MC_U120061476] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Denker A, 2016, GENE DEV, V30, P1357, DOI 10.1101/gad.281964.116; Dileep V, 2015, GENOME RES, V25, P1104, DOI 10.1101/gr.183699.114; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Grand RS, 2014, NUCLEIC ACIDS RES, V42, P12585, DOI 10.1093/nar/gku965; Kubo N., 2017, PREPRINT AT BIORXIV; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Schwarzer W., 2016, PREPRINT AT BIORXIV; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	13	9	9	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					34	35		10.1038/547034a	http://dx.doi.org/10.1038/547034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FR7RV	28682328				2022-12-28	WOS:000419269500001
J	Kalinic, J				Kalinic, Jelena			Defend real science in the Balkans	NATURE			English	Letter												jkalinic10@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					32	32		10.1038/547032e	http://dx.doi.org/10.1038/547032e			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682330	Bronze			2022-12-28	WOS:000404839900022
J	Kumar, S; Sharma, VK				Kumar, Sunil; Sharma, Vijay K.			Unmasking Ptosis in Both Eyes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kumar, Sunil] Dhahran Eye Specialist Hosp, Dhahran, Saudi Arabia; [Sharma, Vijay K.] Natl Univ Hlth Syst, Singapore, Singapore	National University of Singapore	Sharma, VK (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.	drvijay@singnet.com.sg	sharma, Vijay K/A-6733-2009; sharma, Vijay/T-5286-2019	sharma, Vijay K/0000-0002-8976-5696; sharma, Vijay/0000-0002-8976-5696					0	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					E1	E1		10.1056/NEJMicm1611978	http://dx.doi.org/10.1056/NEJMicm1611978			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679097				2022-12-28	WOS:000404730000011
J	Lamb, S; Moore, JDP; Smith, E; Stern, T				Lamb, Simon; Moore, James D. P.; Smith, Euan; Stern, Tim			Episodic kinematics in continental rifts modulated by changes in mantle melt fraction	NATURE			English	Article							TAUPO VOLCANIC ZONE; PLATE-BOUNDARY ZONE; NEW-ZEALAND; NORTH-ISLAND; DEFORMATION; TOPOGRAPHY; DYNAMICS	Oceanic crust is created by the extraction of molten rock from underlying mantle at the seafloor 'spreading centres' found between diverging tectonic plates. Modelling studies have suggested that mantle melting can occur through decompression as the mantle flows upwards beneath spreading centres(1), but direct observation of this process is difficult beneath the oceans. Continental rifts, however-which are also associated with mantle melt production-are amenable to detailed measurements of their short-term kinematics using geodetic techniques. Here we show that such data can provide evidence for an upwelling mantle flow, as well as information on the dimensions and timescale of mantle melting. For North Island, New Zealand, around ten years of campaign and continuous GPS measurements in the continental rift system known as the Taupo volcanic zone reveal that it is extending at a rate of 6-15 millimetres per year. However, a roughly 70-kilometre-long segment of the rift axis is associated with strong horizontal contraction and rapid subsidence, and is flanked by regions of extension and uplift. These features fit a simple model that involves flexure of an elastic upper crust, which is pulled downwards or pushed upwards along the rift axis by a driving force located at a depth greater than 15 kilometres. We propose that flexure is caused by melt-induced episodic changes in the vertical flow forces that are generated by upwelling mantle beneath the rift axis, triggering a transient lower-crustal flow. A drop in the melt fraction owing to melt extraction raises the mantle flow viscosity and drives subsidence, whereas melt accumulation reduces viscosity and allows uplift-processes that are also likely to occur in oceanic spreading centres.	[Lamb, Simon; Smith, Euan; Stern, Tim] Victoria Univ Wellington, Inst Geophys, Wellington, New Zealand; [Moore, James D. P.] Nanyang Technol Univ, Earth Observ Singapore, Singapore, Singapore	Victoria University Wellington; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lamb, S (corresponding author), Victoria Univ Wellington, Inst Geophys, Wellington, New Zealand.	simon.lamb@vuw.ac.nz; earth@jamesdpmoore.com; Euan.Smith@vuw.ac.nz	Moore, James/AAV-2044-2020	Moore, James Daniel Paul/0000-0001-8912-2730	New Zealand Marsden Fund; Earthquake Commission; Victoria University of Wellington; National Research Foundation of Singapore at the Earth Observatory of Singapore [NRF-NRFF2013-04]	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Earthquake Commission; Victoria University of Wellington; National Research Foundation of Singapore at the Earth Observatory of Singapore	This paper is part of a wider project funded through the New Zealand Marsden Fund, the Earthquake Commission, and Victoria University of Wellington graduate scholarships. J.D.P.M. was supported by the National Research Foundation of Singapore (award NRF-NRFF2013-04) at the Earth Observatory of Singapore.	Altamimi Z, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008930; Bannister S., 2015, P WORLD GEOTH C, P19; Beavan J, 2016, NEW ZEAL J GEOL GEOP, V59, P5, DOI 10.1080/00288306.2015.1112817; Bertrand EA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050177; BIBBY HM, 1995, J VOLCANOL GEOTH RES, V68, P29, DOI 10.1016/0377-0273(95)00007-H; CHEN YS, 1990, J GEOPHYS RES-SOLID, V95, P17571, DOI 10.1029/JB095iB11p17571; Crameri F, 2012, GEOPHYS J INT, V189, P38, DOI 10.1111/j.1365-246X.2012.05388.x; Dimitrova LL, 2016, NEW ZEAL J GEOL GEOP, V59, P43, DOI 10.1080/00288306.2015.1127823; Hamling IJ, 2015, J GEOPHYS RES-SOL EA, V120, P4667, DOI 10.1002/2015JB012125; Hamling IJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600288; Heise W, 2016, J VOLCANOL GEOTH RES, V314, P39, DOI 10.1016/j.jvolgeores.2015.10.017; Heise W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043110; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; Lamb S, 2015, GEOPHYS J INT, V201, P552, DOI 10.1093/gji/ggv027; Lamb S, 2013, J GEOPHYS RES-SOL EA, V118, P3160, DOI 10.1002/jgrb.50221; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; MORGAN JP, 1987, J GEOPHYS RES-SOLID, V92, P12823, DOI 10.1029/JB092iB12p12823; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Ranalli G., 1995, RHEOLOGY EARTH; RIBE NM, 1988, J GEOPHYS RES-SOLID, V93, P429, DOI 10.1029/JB093iB01p00429; SCOTT DR, 1989, J GEOPHYS RES-SOLID, V94, P2973, DOI 10.1029/JB094iB03p02973; Smith EGC, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004652; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; STERN TA, 1987, EARTH PLANET SC LETT, V85, P265, DOI 10.1016/0012-821X(87)90037-9; Stern TA, 1992, BASIN RES, V4, P197, DOI DOI 10.1111/J.1365-2117.1992.TB00045.X; Stern T, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008337; TENBRINK U, 1991, GEOLOGY, V19, P397, DOI 10.1130/0091-7613(1991)019<0397:VSAPR>2.3.CO;2; Turcotte D. L., 1982, GEODYNAMICS APPL CON, DOI 10.1017/CBO9780511843877; WALCOTT RI, 1987, PHILOS T R SOC A, V321, P163, DOI 10.1098/rsta.1987.0009; WALCOTT RI, 1984, GEOPHYS J ROY ASTR S, V79, P613, DOI 10.1111/j.1365-246X.1984.tb02244.x; Wallace LM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003241; Watts A.B., 2001, ISOSTASY FLEXURE LIT; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; WILSON CJN, 1995, J VOLCANOL GEOTH RES, V68, P1, DOI 10.1016/0377-0273(95)00006-G	34	9	9	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					84	+		10.1038/nature22962	http://dx.doi.org/10.1038/nature22962			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682337	Green Accepted			2022-12-28	WOS:000404839900035
J	Lambert, D				Lambert, David			Wendy Patricia Holmes OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3225	10.1136/bmj.j3225	http://dx.doi.org/10.1136/bmj.j3225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676473				2022-12-28	WOS:000405322100008
J	Kehayas, V; Holtmaat, A				Kehayas, Vassilis; Holtmaat, Anthony			Rejuvenating brain plasticity	SCIENCE			English	Editorial Material							AUDITORY-CORTEX; NUCLEUS BASALIS; CRITICAL PERIOD; MEMORY; SYSTEM		[Kehayas, Vassilis; Holtmaat, Anthony] Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland	University of Geneva	Holtmaat, A (corresponding author), Univ Geneva, Dept Basic Neurosci, Geneva, Switzerland.	anthony.holtmaat@unige.ch	Kehayas, Vassilis/I-1154-2019	Kehayas, Vassilis/0000-0002-8759-2808; Holtmaat, Anthony/0000-0002-7577-0769	Swiss National Science Foundation [31003A-153448, CRSIII-154453]; International Foundation for Research in Paraplegia	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); International Foundation for Research in Paraplegia	Financial support to V.K. and A.H. is provided by the Swiss National Science Foundation (31003A-153448; CRSIII-154453) and the International Foundation for Research in Paraplegia.	Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Blundon JA, 2017, SCIENCE, V356, P1352, DOI 10.1126/science.aaf4612; Blundon JA, 2011, J NEUROSCI, V31, P16012, DOI 10.1523/JNEUROSCI.3281-11.2011; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kullmann DM, 2012, NEURON, V75, P951, DOI 10.1016/j.neuron.2012.07.030; Kuroda S, 2001, CHEM PHARM BULL, V49, P988, DOI 10.1248/cpb.49.988; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Nakahara H, 2004, P NATL ACAD SCI USA, V101, P7170, DOI 10.1073/pnas.0401196101; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	15	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1335	1336		10.1126/science.aan8374	http://dx.doi.org/10.1126/science.aan8374			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663458				2022-12-28	WOS:000404351500019
J	LaManna, JA; Mangan, SA; Alonso, A; Bourg, NA; Brockelman, WY; Bunyavejchewin, S; Chang, LW; Chiang, JM; Chuyong, GB; Clay, K; Condit, R; Cordell, S; Davies, SJ; Furniss, TJ; Giardina, CP; Gunatilleke, IAUN; Gunatilleke, CVS; He, FL; Howe, RW; Hubbell, SP; Hsieh, CF; Inman-Narahari, FM; Janik, D; Johnson, DJ; Kenfack, D; Korte, L; Kral, K; Larson, AJ; Lutz, JA; McMahon, SM; McShea, WJ; Memiaghe, HR; Nathalang, A; Novotny, V; Ong, PS; Orwig, DA; Ostertag, R; Parker, GG; Phillips, RP; Sack, L; Sun, IF; Tello, JS; Thomas, DW; Turner, BL; Diaz, DMV; Vrska, T; Weiblen, GD; Wolf, A; Yap, S; Myers, JA				LaManna, Joseph A.; Mangan, Scott A.; Alonso, Alfonso; Bourg, Norman A.; Brockelman, Warren Y.; Bunyavejchewin, Sarayudh; Chang, Li-Wan; Chiang, Jyh-Min; Chuyong, George B.; Clay, Keith; Condit, Richard; Cordell, Susan; Davies, Stuart J.; Furniss, Tucker J.; Giardina, Christian P.; Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri; He, Fangliang; Howe, Robert W.; Hubbell, Stephen P.; Hsieh, Chang-Fu; Inman-Narahari, Faith M.; Janik, David; Johnson, Daniel J.; Kenfack, David; Korte, Lisa; Kral, Kamil; Larson, Andrew J.; Lutz, James A.; McMahon, Sean M.; McShea, William J.; Memiaghe, Herve R.; Nathalang, Anuttara; Novotny, Vojtech; Ong, Perry S.; Orwig, David A.; Ostertag, Rebecca; Parker, Geoffrey G.; Phillips, Richard P.; Sack, Lawren; Sun, I-Fang; Tello, J. Sebastian; Thomas, Duncan W.; Turner, Benjamin L.; Diaz, Dilys M. Vela; Vrska, Tomas; Weiblen, George D.; Wolf, Amy; Yap, Sandra; Myers, Jonathan A.			Plant diversity increases with the strength of negative density dependence at the global scale	SCIENCE			English	Article							RELATIVE ABUNDANCE; PATHOGENS; COEXISTENCE; HERBIVORES; FEEDBACK; TREES	Theory predicts that higher biodiversity in the tropics is maintained by specialized interactions among plants and their natural enemies that result in conspecific negative density dependence (CNDD). By using more than 3000 species and nearly 2.4 million trees across 24 forest plots worldwide, we show that global patterns in tree species diversity reflect not only stronger CNDD at tropical versus temperate latitudes but also a latitudinal shift in the relationship between CNDD and species abundance. CNDD was stronger for rare species at tropical versus temperate latitudes, potentially causing the persistence of greater numbers of rare species in the tropics. Our study reveals fundamental differences in the nature of local-scale biotic interactions that contribute to the maintenance of species diversity across temperate and tropical communities.	[LaManna, Joseph A.; Myers, Jonathan A.] Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA; [LaManna, Joseph A.; Mangan, Scott A.; Diaz, Dilys M. Vela; Myers, Jonathan A.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Alonso, Alfonso; Korte, Lisa] Smithsonian Conservat Biol Inst, Natl Zool Pk, Ctr Conservat & Sustainabil, Washington, DC USA; [Bourg, Norman A.; McShea, William J.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Conservat Ecol Ctr, Front Royal, VA USA; [Bourg, Norman A.] US Geol Survey, Natl Res Program, Eastern Branch, 959 Natl Ctr, Reston, VA 22092 USA; [Brockelman, Warren Y.; Nathalang, Anuttara] Natl Sci & Technol Dev Agcy, BIOTEC, Ecol Lab, Sci Pk, Pathum Thani, Thailand; [Brockelman, Warren Y.] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand; [Bunyavejchewin, Sarayudh] Dept Natl Pk Wildlife & Plant Conservat, Res Off, Bangkok, Thailand; [Chang, Li-Wan] Taiwan Forestry Res Inst, Taipei 10066, Taiwan; [Chiang, Jyh-Min] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chuyong, George B.] Univ Buea, Dept Bot & Plant Physiol, Buea, Cameroon; [Clay, Keith; Phillips, Richard P.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Condit, Richard; Turner, Benjamin L.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Cordell, Susan; Giardina, Christian P.; Inman-Narahari, Faith M.] US Forest Serv, Inst Pacific Isl Forestry, USDA, Hilo, HI USA; [Davies, Stuart J.; Kenfack, David] Smithsonian Trop Res Inst, Forest Global Earth Observ, Ctr Trop Forest Sci, Panama City, Panama; [Davies, Stuart J.; Kenfack, David] Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Furniss, Tucker J.; Lutz, James A.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Gunatilleke, I. A. U. Nimal; Gunatilleke, C. V. Savitri] Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya, Sri Lanka; [He, Fangliang] SYSU, Joint Lab Biodivers Conservat, Sun Yat Sen Univ SYSU Univ Alberta, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Fangliang] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Howe, Robert W.; Wolf, Amy] Univ Wisconsin, Dept Nat & Appl Sci, Green Bay, WI 54302 USA; [Hubbell, Stephen P.; Sack, Lawren] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Hsieh, Chang-Fu] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Janik, David; Kral, Kamil; Vrska, Tomas] Silva Tarouca Res Inst, Dept Forest Ecol, Brno, Czech Republic; [Johnson, Daniel J.] Los Alamos Natl Lab, Los Alamos, NM USA; [Larson, Andrew J.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [McMahon, Sean M.] Smithsonian Environm Res Ctr, Forest Global Earth Observ, Ctr Trop Forest Sci, POB 28, Edgewater, MD 21037 USA; [McMahon, Sean M.; Parker, Geoffrey G.] Smithsonian Environm Res Ctr, Forest Ecol Grp, POB 28, Edgewater, MD 21037 USA; [Memiaghe, Herve R.] Ctr Natl Rech Sci & Technol, Inst Rech Ecol Trop, Libreville, Gabon; [Novotny, Vojtech] New Guinea Binatang Res Ctr, POB 604, Madang, Papua N Guinea; [Novotny, Vojtech] Acad Sci Czech Republ, Biol Ctr, Prague, Czech Republic; [Novotny, Vojtech] Univ South Bohemia, Fac Sci, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Ong, Perry S.] Univ Philippines Diliman, Inst Biol, Quezon City, Philippines; [Orwig, David A.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Ostertag, Rebecca] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Sun, I-Fang] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Tello, J. Sebastian] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, Pob 299, St Louis, MO 63166 USA; [Thomas, Duncan W.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA; [Weiblen, George D.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA; [Wolf, Amy] Univ Wisconsin, Dept Biol, Green Bay, WI 54302 USA; [Yap, Sandra] Far Eastern Univ Manila, Inst Arts & Sci, Manila, Philippines	Washington University (WUSTL); Washington University (WUSTL); Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Tunghai University; Indiana University System; Indiana University Bloomington; Smithsonian Institution; Smithsonian Tropical Research Institute; United States Department of Agriculture (USDA); United States Forest Service; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Utah System of Higher Education; Utah State University; University of Peradeniya; Sun Yat Sen University; University of Alberta; University of Wisconsin System; University of California System; University of California Los Angeles; National Taiwan University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana; Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Institution; Smithsonian Environmental Research Center; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of the Philippines System; University of the Philippines Diliman; Harvard University; University of Hawaii System; University Hawaii Hilo; National Dong Hwa University; Missouri Botanical Gardens; Washington State University; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; Far Eastern University	LaManna, JA (corresponding author), Washington Univ, Tyson Res Ctr, St Louis, MO 63130 USA.; LaManna, JA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	joe.a.lamanna@gmail.com	Sack, Lawren/A-5492-2008; Kral, Kamil/E-4415-2014; Phillips, Richard P/C-6429-2009; Janík, David/H-1334-2018; Bunyavejchewin, Sarayudh/P-1529-2017; Giardina, Christian P/C-3120-2011; Novotny, Vojtech/G-9434-2014; Ostertag, Rebecca/B-1756-2013; Johnson, Daniel J./L-4899-2019; Lutz, James/AAA-9574-2019; Díaz, Dilys M Vela/N-4481-2018; Turner, Benjamin L/E-5940-2011	Sack, Lawren/0000-0002-7009-7202; Phillips, Richard P/0000-0002-1345-4138; Janík, David/0000-0002-8271-7456; Bunyavejchewin, Sarayudh/0000-0002-1976-5041; Giardina, Christian P/0000-0002-3431-5073; Novotny, Vojtech/0000-0001-7918-8023; Johnson, Daniel J./0000-0002-8585-2143; Díaz, Dilys M Vela/0000-0002-5332-1305; Turner, Benjamin L/0000-0002-6585-0722; Orwig, David/0000-0001-7822-3560; Bourg, Norman/0000-0002-7443-1992; Alonso, Alfonso/0000-0001-6860-8432; McShea, William/0000-0002-8102-0200; Kenfack, David/0000-0001-8208-3388; Chiang, Jyh-Min/0000-0002-6293-1551; LaManna, Joseph/0000-0002-8229-7973; Furniss, Tucker/0000-0002-4376-1737; Ostertag, Rebecca/0000-0002-5747-3285; Lutz, James/0000-0002-2560-0710; Kral, Kamil/0000-0002-3848-2119; Ong, Perry/0000-0002-1597-1921; Tello, J. Sebastian/0000-0003-2539-6796	NSF [DEB-1545761, DEB-1256788, DEB-1557094, DEB-1257989]; Tyson Research Center; Direct For Biological Sciences [1237491] Funding Source: National Science Foundation; Division Of Environmental Biology [1545761] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Tyson Research Center; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank everyone involved in the collection of the vast quantity of data in the CTFS-ForestGEO network (see table S20 for site-specific acknowledgments). This work was carried out during the 2016 CTFS-ForestGEO Workshop in Hainan, China, and was supported by NSF grant DEB-1545761 to S.J.D. This work was also supported by NSF grants DEB-1256788 and -1557094 to J.A.M., NSF grant DEB-1257989 to S.A.M., and the Tyson Research Center. We thank K. Harms, R. Chisholm, T. Fung, members of the Myers Lab, and three anonymous reviewers for helpful comments and discussions. We declare no conflicts of interest. The data used in the primary analyses will be available at the Smithsonian Institution's CTFS-ForestGEO database portal: www.forestgeo.si.edu/group/Data/Access+the+data.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; LaManna JA, 2016, ECOL LETT, V19, P657, DOI 10.1111/ele.12603; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10017; Mack KML, 2014, J ECOL, V102, P1195, DOI 10.1111/1365-2745.12269; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Marden JH, 2017, MOL ECOL, V26, P2498, DOI 10.1111/mec.13999; Miranda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127260; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Ricklefs RE, 2016, P NATL ACAD SCI USA, V113, P674, DOI 10.1073/pnas.1523683113; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Terborgh JW, 2015, P NATL ACAD SCI USA, V112, P11415, DOI 10.1073/pnas.1501070112; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Yenni G, 2017, GLOBAL ECOL BIOGEOGR, V26, P513, DOI 10.1111/geb.12566; Yenni G, 2012, ECOLOGY, V93, P456, DOI 10.1890/11-1087.1; Zhu K, 2015, ECOLOGY, V96, P2319, DOI 10.1890/14-1780.1	30	167	173	21	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1389	1392		10.1126/science.aam5678	http://dx.doi.org/10.1126/science.aam5678			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663501				2022-12-28	WOS:000404351500039
J	Stanley, M				Stanley, Matthew			Priest of Nature The Religious Worlds of Isaac Newton	SCIENCE			English	Book Review									[Stanley, Matthew] NYU, Gallatin Sch Individualized Study, 550 1St Ave, New York, NY 10003 USA	New York University	Stanley, M (corresponding author), NYU, Gallatin Sch Individualized Study, 550 1St Ave, New York, NY 10003 USA.							Iliffe R., 2017, PRIEST NATURE RELIG	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1341	1341		10.1126/science.aan4659	http://dx.doi.org/10.1126/science.aan4659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663462				2022-12-28	WOS:000404351500023
J	Mandadapu, KK; Hurley, JH				Mandadapu, Kranthi K.; Hurley, James H.			Friction at the BAR Leads to Membrane Breakup	CELL			English	Editorial Material							DOMAINS; ENDOCYTOSIS; CURVATURE; FISSION	A long-standing question in cell biology is how endocytic vesicles and tubules detach from the plasma membrane in the absence of constriction by dynamin. In this issue of Cell, Simunovic et al. describe an elegant biophysical model in which friction between lipids and BAR-domain proteins drives the scission of elongating membrane tubules.	[Mandadapu, Kranthi K.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Mandadapu, Kranthi K.] Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA; [Hurley, James H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hurley, James H.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Hurley, James H.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Mandadapu, KK (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Mandadapu, KK (corresponding author), Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA.; Hurley, JH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Hurley, JH (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.; Hurley, JH (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	kranthi@berkeley.edu; jimhurley@berkeley.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110066] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM110066] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Lu R, 2016, J CELL SCI, V129, P1531, DOI 10.1242/jcs.182303; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Simunovic M, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.047; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106	10	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					14	16		10.1016/j.cell.2017.06.027	http://dx.doi.org/10.1016/j.cell.2017.06.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666116	Bronze			2022-12-28	WOS:000404358500006
J	Voelker, R				Voelker, Rebecca			Changing the Weight-loss Subject	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2477	2477		10.1001/jama.2017.7240	http://dx.doi.org/10.1001/jama.2017.7240			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655024				2022-12-28	WOS:000404106600011
J	[Anonymous]				[Anonymous]			Drug-Resistant Fungus Arrives in US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2477	2477		10.1001/jama.2017.7238	http://dx.doi.org/10.1001/jama.2017.7238			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655023				2022-12-28	WOS:000404106600010
J	Spottiswoode, CN				Spottiswoode, Claire N.			The most perfect thing, explained	SCIENCE			English	Editorial Material									[Spottiswoode, Claire N.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, ZA-7701 Rondebosch, South Africa; [Spottiswoode, Claire N.] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England	National Research Foundation - South Africa; University of Cape Town; University of Cambridge	Spottiswoode, CN (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst African Ornithol, ZA-7701 Rondebosch, South Africa.; Spottiswoode, CN (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	cns26@cam.ac.uk			Biotechnology and Biological Sciences Research Council [BB/J014109/1] Funding Source: researchfish; BBSRC [BB/J014109/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 1862, ATLANTIC MONTHLY, V10, P368; Birkhead T.R., 2016, MOST PERFECT THING I; GILL FB, 2007, ORNITHOLOGY; Iverson J. B., 1991, EGG INCUBATION ITS E, P101; Lovette IJ., 2016, HDB BIRD BIOL; Stoddard MC, 2017, SCIENCE, V356, P1249, DOI 10.1126/science.aaj1945	6	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1234	1235		10.1126/science.aan2517	http://dx.doi.org/10.1126/science.aan2517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642397				2022-12-28	WOS:000403881700020
J	Tsakmakidis, KL; Shen, L; Schulz, SA; Zheng, X; Upham, J; Deng, X; Altug, H; Vakakis, AF; Boyd, RW				Tsakmakidis, K. L.; Shen, L.; Schulz, S. A.; Zheng, X.; Upham, J.; Deng, X.; Altug, H.; Vakakis, A. F.; Boyd, R. W.			Breaking Lorentz reciprocity to overcome the time-bandwidth limit in physics and engineering	SCIENCE			English	Article							SURFACE MAGNETOPLASMONS; SLOW LIGHT; INVISIBILITY	A century-old tenet in physics and engineering asserts that any type of system, having bandwidth Delta omega, can interact with a wave over only a constrained time period Delta t inversely proportional to the bandwidth (Delta t-Delta w similar to 2 pi). This law severely limits the generic capabilities of all types of resonant and wave-guiding systems in photonics, cavity quantum electrodynamics and optomechanics, acoustics, continuum mechanics, and atomic and optical physics but is thought to be completely fundamental, arising from basic Fourier reciprocity. We propose that this "fundamental" limit can be overcome in systems where Lorentz reciprocity is broken. As a system becomes more asymmetric in its transport properties, the degree to which the limit can be surpassed becomes greater. By way of example, we theoretically demonstrate how, in an astutely designed magnetized semiconductor heterostructure, the above limit can be exceeded by orders of magnitude by using realistic material parameters. Our findings revise prevailing paradigms for linear, time-invariant resonant systems, challenging the doctrine that high-quality resonances must invariably be narrowband and providing the possibility of developing devices with unprecedentedly high time-bandwidth performance.	[Tsakmakidis, K. L.; Schulz, S. A.; Upham, J.; Boyd, R. W.] Univ Ottawa, Dept Phys, 25 Templeton St, Ottawa, ON K1N 6N5, Canada; [Shen, L.; Deng, X.] Nanchang Univ, Inst Space Sci & Technol, Nanchang 330031, Jiangxi, Peoples R China; [Zheng, X.] Zhejiang Univ, State Key Lab Modern Opt Instrumentat, Hangzhou 310027, Zhejiang, Peoples R China; [Altug, H.] Ecole Polytech Fed Lausanne, Bioengn Dept, CH-1015 Lausanne, Switzerland; [Vakakis, A. F.] Univ Illinois, Dept Mech Sci & Engn, 1206 West Green St, Urbana, IL 61801 USA; [Boyd, R. W.] Univ Rochester, Inst Opt, Rochester, NY 14627 USA; [Boyd, R. W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Schulz, S. A.] Cork Inst Technol, Ctr Adv Photon & Proc Anal, Cork, Ireland; [Schulz, S. A.] Tyndall Natl Inst, Cork, Ireland	University of Ottawa; Nanchang University; Zhejiang University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Illinois System; University of Illinois Urbana-Champaign; University of Rochester; University of Rochester; Cork Institute of Technology; University College Cork	Tsakmakidis, KL; Boyd, RW (corresponding author), Univ Ottawa, Dept Phys, 25 Templeton St, Ottawa, ON K1N 6N5, Canada.; Boyd, RW (corresponding author), Univ Rochester, Inst Opt, Rochester, NY 14627 USA.; Boyd, RW (corresponding author), Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA.	kostsakmakidis@gmail.com; rboyd@uottawa.ca	Tsakmakidis, Kosmas L./I-7651-2019; Vakakis, Alexander/AAZ-3410-2021	Tsakmakidis, Kosmas L./0000-0003-2141-1338; Vakakis, Alexander/0000-0002-3919-432X; Schulz, Sebastian/0000-0001-5169-0337; Boyd, Robert/0000-0002-1234-2265; Shen, Linfang/0000-0002-3602-515X	Eugen Lommel fellowship of the Max Planck Institute for the Science of Light (Erlangen); European Commission [FETOPEN-737071]; National Natural Science Foundation of China [61372005, 41331070]	Eugen Lommel fellowship of the Max Planck Institute for the Science of Light (Erlangen); European Commission(European CommissionEuropean Commission Joint Research Centre); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	K.L.T. gratefully acknowledges the support of the Eugen Lommel fellowship of the Max Planck Institute for the Science of Light (Erlangen) and R.W.B. the Canada Excellence Research Chairs Program. H.A. and K.L.T. supported by European Commission Horizon 2020 (grant no. FETOPEN-737071), ULTRA-CHIRAL Project. L.S. supported by National Natural Science Foundation of China grant no. 61372005 and key project grant no. 41331070.	Boyd RW, 2011, J OPT SOC AM B, V28, pA38, DOI 10.1364/JOSAB.28.000A38; Boyd RW, 2009, SCIENCE, V326, P1074, DOI 10.1126/science.1170885; Boyd RW, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023801; BRION JJ, 1972, PHYS REV LETT, V28, P1455, DOI 10.1103/PhysRevLett.28.1455; Dutra S. M., 2005, CAVITY QUANTUM ELECT, P34; GREEN EI, 1955, AM SCI, V43, P584; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Haus H. A., 1984, WAVES FIELDS OPTOELE; Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185; Johnson K. S., 1924, TRANSMISSION CIRCUIT; Ketterle W., 2014, 8 421 ATOMIC OPTICAL; Khanikaev AB, 2013, NAT MATER, V12, P233, DOI [10.1038/nmat3520, 10.1038/NMAT3520]; Khurgin JB, 2009, OPT SCI ENG-CRC, V140, P293; Khurgin JB, 2010, ADV OPT PHOTONICS, V2, P287, DOI 10.1364/AOP.2.000287; Leonhardt U, 2009, SCIENCE, V323, P110, DOI 10.1126/science.1166332; Lukin MD, 2001, NATURE, V413, P273, DOI 10.1038/35095000; Miller DAB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.203903; Milonni P. W., 2005, I PHYS SERIES OPTICS; Monticone F, 2016, OPTICA, V3, P718, DOI 10.1364/OPTICA.3.000718; Novotny L., 2012, PRINCIPLES NANOOPTIC; Pozar D, 2011, MICROWAVE ENG, V4th; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Rivas JG, 2005, OPT EXPRESS, V13, P847, DOI 10.1364/OPEX.13.000847; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Shen LF, 2015, OPT EXPRESS, V23, P950, DOI 10.1364/OE.23.000950; Siegman AE, 1986, LASERS, P105; Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939; VAHALA KJ, 2005, OPTICAL MICROCAVITIE; Wee WH, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.165503; Xu QF, 2007, NAT PHYS, V3, P406, DOI 10.1038/nphys600; Zhang R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.233602	33	144	147	7	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1260	1264		10.1126/science.aam6662	http://dx.doi.org/10.1126/science.aam6662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642432	Green Submitted, Green Accepted			2022-12-28	WOS:000403881700034
J	Fitzpatrick, MC; Singer, BH; Hotez, PJ; Galvani, AP				Fitzpatrick, Meagan C.; Singer, Burton H.; Hotez, Peter J.; Galvani, Alison P.			Saving lives efficiently across sectors: the need for a Congressional cost-effectiveness committee	LANCET			English	Editorial Material							HEALTH		[Fitzpatrick, Meagan C.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Singer, Burton H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA; [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Houston, TX 77030 USA; [Hotez, Peter J.] Rice Univ, James A Baker Inst Publ Policy 3, Ctr Hlth & Biosci, Houston, TX USA; [Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06510 USA; [Galvani, Alison P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University System of Maryland; University of Maryland Baltimore; State University System of Florida; University of Florida; Baylor College of Medicine; Baylor College of Medicine; Rice University; Yale University; Yale University	Galvani, AP (corresponding author), Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT 06510 USA.	alison.galvani@yale.edu	Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668	National Institutes of Health [4T32AI007524-19]; Notsew Orm Sands Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM105627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notsew Orm Sands Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MCF and APG gratefully acknowledge funding from the National Institutes of Health (4T32AI007524-19) and Notsew Orm Sands Foundation, respectively. The authors are also grateful for discussions with Charles Burnett 3rd.	Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743; [Anonymous], 2015, US TODAY; [Anonymous], 2013, HIV UK 2013 REPORT D; [Anonymous], 2014, RWAND GLOB AIDS RESP; CDC, 2014, MON SEL NAT HIV PREV; Choi SE, 2017, AM J PREV MED, V52, pE147, DOI 10.1016/j.amepre.2016.12.013; Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974; Gellman B, 2013, WASHINGTON POST 0606; Gould E., 2009, Environmental Health Perspectives, V117, P1162, DOI 10.1289/ehp.0800408; Hausken K, 2018, DEFENCE PEACE ECON, V29, P111, DOI 10.1080/10242694.2016.1158440; Hausken K, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-016-0139-x; Hausken K, 2016, RISK ANAL, V36, P711, DOI 10.1111/risa.12318; Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531; Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322; Li R, 2015, ANN INTERN MED, V163, P452, DOI 10.7326/M15-0469; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; Medlock J, 2017, P NATL ACAD SCI USA, V114, P4017, DOI 10.1073/pnas.1620788114; Murray CJL, 2010, NEW ENGL J MED, V362, P98, DOI 10.1056/NEJMp0910064; President's Task Force on Environmental Health Risks and Safety Risks to Children, 2000, EL CHILDH LEAD POIS; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Richard P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029665; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Slovic P., 2002, REGULATION TOXIC SUB, V2; Sunstein C.R., 2002, RISK REASON SAFETY L; United States Centers for Disease Control and Prevention, 2016, OV BUDG REQ; Webb M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6699; WHO, 2016, WORLD HLTH STAT 2016; Wiltz T, 2016, DECADES BAN LEAD PAI	28	7	7	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2410	2412		10.1016/S0140-6736(17)31440-X	http://dx.doi.org/10.1016/S0140-6736(17)31440-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FN6IX	28669643	Green Accepted			2022-12-28	WOS:000416118700026
J	Brusselle, G; Pavord, I				Brusselle, Guy; Pavord, Ian			Azithromycin in uncontrolled asthma	LANCET			English	Editorial Material							MACROLIDES		[Brusselle, Guy] Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium; [Brusselle, Guy] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Brusselle, Guy] Erasmus MC, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands; [Pavord, Ian] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England; [Pavord, Ian] Univ Oxford, Nuffield Dept Med, Oxford Resp BRC, Oxford, England	Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; University of Oxford	Brusselle, G (corresponding author), Ghent Univ Hosp, Dept Resp Med, B-9000 Ghent, Belgium.; Brusselle, G (corresponding author), Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.; Brusselle, G (corresponding author), Erasmus MC, Dept Resp Med, NL-3000 CA Rotterdam, Netherlands.	guy.brusselle@ugent.be		Brusselle, Guy/0000-0001-7021-8505	AstraZeneca; Boehringer Inglehiem; Aerocrine; Almirall; Novartis; Teva; GlaxoSmithKline; Boehringer Ingelheim; Napp; National Institute for Health Research [NF-SI-0510-10157] Funding Source: researchfish	AstraZeneca(AstraZeneca); Boehringer Inglehiem; Aerocrine; Almirall(Almirall); Novartis(Novartis); Teva(Teva Pharmaceutical Industries); GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Napp; National Institute for Health Research(National Institute for Health Research (NIHR))	GB has within the last 5 years received honoraria for lectures or advisory boards from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Sanofi, Teva, and Zambon. IP has within the last 5 years received speaker's honoraria for speaking at sponsored meetings from AstraZeneca, Boehringer Inglehiem, Aerocrine, Almirall, Novartis, Teva, and GlaxoSmithKline, and a payment for organising an educational event from AstraZeneca. IP has received honoraria for attending advisory panels with Almirall, Genentech, Regeneron, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Sharp Dohme, Schering-Plough, Novartis, Dey, Napp, Teva, Merck, and Respivert, and he has received sponsorship to attend international scientific meetings from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Teva, and Napp.	Albert RK, 2014, AM J RESP CRIT CARE, V189, P1173, DOI 10.1164/rccm.201402-0385CI; Beran D, 2015, LANCET RESP MED, V3, P159, DOI 10.1016/S2213-2600(15)00004-1; Brusselle GG, 2014, CURR OPIN PULM MED, V20, P95, DOI 10.1097/MCP.0000000000000017; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Gibson PG, 2017, LANCET; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Kew KM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002997.pub4; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Reiter J, 2013, ALLERGY, V68, P1040, DOI 10.1111/all.12199; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673	12	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					629	630		10.1016/S0140-6736(17)31547-7	http://dx.doi.org/10.1016/S0140-6736(17)31547-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28687412	Green Submitted			2022-12-28	WOS:000407456200005
J	Lindley, RI; Anderson, CS; Billot, L; Forster, A; Hackett, ML; Harvey, LA; Jan, S; Li, Q; Liu, HM; Langhorne, P; Maulik, PK; Murthy, GVS; Walker, MF; Pandian, JD; Alim, M; Felix, C; Gandhi, DBC; Syrigapu, A; Tugnawat, DK; Verma, SJ; Shamanna, BR; Hankey, G; Thrift, A; Bernhardt, J; Mehndiratta, MM; Jeyaseelan, L; Donnelly, P; Byrne, D; Steley, S; Santhosh, V; Chilappagari, S; Mysore, J; Roy, J; Padma, MV; John, L; Aaron, S; Borah, NC; Vijaya, P; Kaul, S; Khurana, D; Sylaja, PN; Halprashanth, DS; Madhusudhan, BK; Nambiar, V; Sureshbabu, S; Khanna, MC; Narang, GS; Chakraborty, D; Chakraborty, SS; Biswas, B; Kaura, S; Koundal, H; Singh, P; Andrias, A; Thambu, DS; Ramya, I; George, J; Prabhakar, AT; Kirubakaran, P; Anbalagan, P; Ghose, M; Bordoloi, K; Gohain, P; Reddy, NM; Reddy, KV; Rao, TNM; Alladi, S; Jalapu, VRR; Manchireddy, K; Rajan, A; Mehta, S; Katoch, C; Das, B; Jangir, A; Kaur, T; Sreedharan, S; Sivasambath, S; Dinesh, S; Shibi, BS; Thangaraj, A; Karunanithi, A; Sulaiman, SMS; Dehingia, K; Das, K; Nandini, C; Thomas, NJ; Dhanya, TS; Thomas, N; Krishna, R; Aneesh, V; Krishna, R; Khullar, S; Thouman, S; Sebastian, I				Lindley, Richard I.; Anderson, Craig S.; Billot, Laurent; Forster, Anne; Hackett, Maree L.; Harvey, Lisa A.; Jan, Stephen; Li, Qiang; Liu, Hueiming; Langhorne, Peter; Maulik, Pallab K.; Murthy, Gudlavalleti Venkata Satyanarayana; Walker, Marion F.; Pandian, Jeyaraj D.; Alim, M.; Felix, C.; Gandhi, D. B. C.; Syrigapu, A.; Tugnawat, D. K.; Verma, S. J.; Shamanna, B. R.; Hankey, G.; Thrift, A.; Bernhardt, J.; Mehndiratta, M. M.; Jeyaseelan, L.; Donnelly, P.; Byrne, D.; Steley, S.; Santhosh, V.; Chilappagari, S.; Mysore, J.; Roy, J.; Padma, M. V.; John, L.; Aaron, S.; Borah, N. C.; Vijaya, P.; Kaul, S.; Khurana, D.; Sylaja, P. N.; Halprashanth, D. S.; Madhusudhan, B. K.; Nambiar, V.; Sureshbabu, S.; Khanna, M. C.; Narang, G. S.; Chakraborty, D.; Chakraborty, S. S.; Biswas, B.; Kaura, S.; Koundal, H.; Singh, P.; Andrias, A.; Thambu, D. S.; Ramya, I.; George, J.; Prabhakar, A. T.; Kirubakaran, P.; Anbalagan, P.; Ghose, M.; Bordoloi, K.; Gohain, P.; Reddy, N. M.; Reddy, K. V.; Rao, T. N. M.; Alladi, S.; Jalapu, V. R. R.; Manchireddy, K.; Rajan, A.; Mehta, S.; Katoch, C.; Das, B.; Jangir, A.; Kaur, T.; Sreedharan, S.; Sivasambath, S.; Dinesh, S.; Shibi, B. S.; Thangaraj, A.; Karunanithi, A.; Sulaiman, S. M. S.; Dehingia, K.; Das, K.; Nandini, C.; Thomas, N. J.; Dhanya, T. S.; Thomas, N.; Krishna, R.; Aneesh, V.; Krishna, R.; Khullar, S.; Thouman, S.; Sebastian, I.		ATTEND Collaborative Grp	Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial	LANCET			English	Article							LOW-INCOME; CARE; CAREGIVERS; SERVICES; BURDEN; HEALTH	Background Most people with stroke in India have no access to organised rehabilitation services. The effectiveness of training family members to provide stroke rehabilitation is uncertain. Our primary objective was to determine whether family-led stroke rehabilitation, initiated in hospital and continued at home, would be superior to usual care in a low-resource setting. Methods The Family-led Rehabilitation after Stroke in India (ATTEND) trial was a prospectively randomised open trial with blinded end point done across 14 hospitals in India. Patients aged 18 years or older who had had a stroke within the past month, had residual disability and reasonable expectation of survival, and who had an informal family nominated caregiver were randomly assigned to intervention or usual care by site coordinators using a secure web based system with minimisation by site and stroke severity. The family members of participants in the intervention group received additional structured rehabilitation training-including information provision, joint goal setting, carer training, and task-specific training-that was started in hospital and continued at home for up to 2 months. The primary outcome was death or dependency at 6 months, defined by scores 3-6 on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]) as assessed by masked observers. Analyses were by intention to treat. This trial is registered with Clinical Trials Registry-India (CTRI/2013/04/003557), Australian New Zealand Clinical Trials Registry (ACTRN12613000078752), and Universal Trial Number (U1111-1138-6707). Findings Between Jan 13, 2014, and Feb 12, 2016, 1250 patients were randomly assigned to intervention (n=623) or control (n=627) groups. 33 patients were lost to follow-up (14 intervention, 19 control) and five patients withdrew (two intervention, three control). At 6 months, 285 (47%) of 607 patients in the intervention group and 287 (47%) of 605 controls were dead or dependent (odds ratio 0.98, 95% CI 0.78-1.23, p=0.87). 72 (12%) patients in the intervention group and 86 (14%) in the control group died (p=0.27), and we observed no difference in rehospitalisation (89 [14%] patients in the intervention group vs 82 [13%] in the control group; p=0.56). We also found no difference in total nonfatal events (112 events in 82 [13%] intervention patients vs 110 events in 79 [13%] control patients; p=0.80). Interpretation Although task shifting is an attractive solution for health-care sustainability, our results do not support investment in new stroke rehabilitation services that shift tasks to family caregivers, unless new evidence emerges. A future avenue of research should be to investigate the effects of task shifting to health-care assistants or team-based community care.	[Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Lindley, Richard I.] Univ Sydney, Sydney Med Sch, Westmead Hosp, Discipline Med, Sydney, NSW, Australia; [Anderson, Craig S.] Univ New South Wales, George Inst Global Hlth, Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Anderson, Craig S.] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Billot, Laurent; Hackett, Maree L.; Jan, Stephen] Univ New South Wales, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia; [Forster, Anne] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Hackett, Maree L.] Univ Cent Lancashire, Preston, Lancs, England; [Harvey, Lisa A.] Univ Sydney, Sydney, NSW, Australia; [Li, Qiang; Liu, Hueiming; Donnelly, P.; Byrne, D.; Steley, S.; Mysore, J.] George Inst Global Hlth, Sydney, NSW, Australia; [Langhorne, Peter] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Maulik, Pallab K.; Alim, M.; Felix, C.; Chilappagari, S.] George Inst Global Hlth India, Delhi, India; [Maulik, Pallab K.] Univ Oxford, George Inst Global Hlth, Oxford, England; [Murthy, Gudlavalleti Venkata Satyanarayana; Syrigapu, A.; Tugnawat, D. K.] Indian Inst Publ Hlth, Hyderabad, Andhra Pradesh, India; [Walker, Marion F.] Univ Nottingham, Nottingham, Notts, England; [Pandian, Jeyaraj D.; Gandhi, D. B. C.; Verma, S. J.] Christian Med Coll & Hosp Ludhiana, Ludhiana, Punjab, India; [Shamanna, B. R.] Univ Hyderabad, Hyderabad, Andhra Pradesh, India; [Hankey, G.] Univ Western Australia, Nedlands, WA, Australia; [Thrift, A.] Monash Univ, Melbourne, Vic, Australia; [Bernhardt, J.] Univ Melbourne, Melbourne, Vic, Australia; [Mehndiratta, M. M.] Janakpuri Super Special Hosp, New Delhi, India; [Jeyaseelan, L.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Santhosh, V.] George Inst Global Hlth, Bangalore, Karnataka, India; [Khanna, M. C.; Narang, G. S.] Christian Med Coll & Hosp, Ludhiana, Punjab, India; [Roy, J.; Chakraborty, D.; Chakraborty, S. S.; Biswas, B.] Apollo Gleneagles Hosp, Kolkata, W Bengal, India; [Padma, M. V.; Kaura, S.; Koundal, H.] All India Inst Med Sci, Delhi, India; [John, L.; Singh, P.; Andrias, A.] Baptist Christian Hosp, Tezpur, Assam, India; [Aaron, S.; Thambu, D. S.; Ramya, I.; George, J.; Prabhakar, A. T.; Kirubakaran, P.; Anbalagan, P.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Borah, N. C.; Ghose, M.; Bordoloi, K.; Gohain, P.] GNRC Hosp, Dispur, Assam, India; [Vijaya, P.; Reddy, N. M.; Reddy, K. V.; Rao, T. N. M.] Lalitha Super Specialty Hosp, Guntur, Andhra Pradesh, India; [Kaul, S.; Alladi, S.; Jalapu, V. R. R.; Manchireddy, K.; Rajan, A.] Nizam Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Khurana, D.; Mehta, S.; Katoch, C.; Das, B.; Jangir, A.; Kaur, T.] Postgrad Inst Med Educ & Res, Chandigarh, India; [Sylaja, P. N.; Sreedharan, S.; Sivasambath, S.; Dinesh, S.; Shibi, B. S.] Sree Chitra Tirunal Inst Med Sci & Technol, Thiruvananthapuram, Kerala, India; [Halprashanth, D. S.; Thangaraj, A.; Karunanithi, A.; Sulaiman, S. M. S.] Global Hosp, Madras, Tamil Nadu, India; [Madhusudhan, B. K.; Dehingia, K.; Das, K.; Nandini, C.; Thomas, N. J.] BGS Global Hosp, Bangalore, Karnataka, India; [Nambiar, V.; Dhanya, T. S.; Thomas, N.; Krishna, R.; Aneesh, V.; Krishna, R.] Amrita Inst Med Sci, Kochi, Kerala, India; [Sureshbabu, S.; Khullar, S.; Thouman, S.; Sebastian, I.] St Stephens Hosp, Delhi, India	George Institute for Global Health; University of Sydney; University of Sydney; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Leeds; University of Central Lancashire; University of Sydney; George Institute for Global Health; University of Sydney; University of Glasgow; University of Oxford; University of Nottingham; University of Hyderabad; University of Western Australia; Monash University; University of Melbourne; Christian Medical College & Hospital (CMCH) Vellore; All India Institute of Medical Sciences (AIIMS) New Delhi; Christian Medical College & Hospital (CMCH) Vellore; Nizam's Institute of Medical Sciences; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; St. Stephen's Hospital	Lindley, RI (corresponding author), George Inst Global Hlth, POB M201, Camperdown, NSW 2050, Australia.; Lindley, RI (corresponding author), Univ Sydney, POB M201, Camperdown, NSW 2050, Australia.	rlindley@georgeinstitute.org.au	Gandhi, Dorcas/AAO-3740-2021; Sebastian, Ivy/HDO-4802-2022; Hackett, Maree L/O-8752-2016; Jan, Stephen/AAG-3333-2021; Pandian, Jeyaraj Durai/AAV-5591-2020; Thrift, Amanda/I-6251-2012; Lindley, Richard/B-8148-2013; Hankey, Graeme J/H-4968-2014; Billot, Laurent/Y-1241-2019; Fazli, Ghazal/AAE-8320-2022; SREEDHARAN, SAPNA ERAT/AAF-7589-2021; Mohammed, Alim/L-2831-2018; Bernhardt, Julie/F-9538-2015	Hackett, Maree L/0000-0003-1211-9087; Thrift, Amanda/0000-0001-8533-4170; Lindley, Richard/0000-0002-0104-5679; Hankey, Graeme J/0000-0002-6044-7328; Billot, Laurent/0000-0002-4975-9793; SREEDHARAN, SAPNA ERAT/0000-0003-0633-4899; Mohammed, Alim/0000-0002-1802-2203; Pandian, Jeyaraj/0000-0003-0028-1968; Thouman, Dr. Singlai/0000-0003-4568-8059; Harvey, Lisa A/0000-0002-4365-0236; Maulik, Pallab Kumar/0000-0001-6835-6175; Jan, Stephen/0000-0003-2839-1405; Alladi, Suvarna/0000-0002-0372-9572; Forster, Anne/0000-0001-7466-4414; Bernhardt, Julie/0000-0002-2787-8484; Gandhi, Dorcas B C/0000-0002-9616-7870	National Health and Medical Research Council of Australia; National Institute for Health Research [NF-SI-0512-10092] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute for Health Research(National Institute for Health Research (NIHR))	The National Health and Medical Research Council of Australia.	Alim M, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1129-8; Billot L, 2017, INT J STROKE, V12, P208, DOI 10.1177/1747493016674956; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Dieleman JL, 2016, LANCET, V387, P2521, DOI 10.1016/S0140-6736(16)30167-2; Early Supported Discharge Trialists, 2012, COCHRANE DB SYST REV, V9; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Elmstahl S, 1996, ARCH PHYS MED REHAB, V77, P177, DOI 10.1016/S0003-9993(96)90164-1; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Forster A, 2013, LANCET, V382, P2069, DOI 10.1016/S0140-6736(13)61603-7; French B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006073.pub2; Govindarajan V, 2013, HARVARD BUS REV, V91, P117; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hassett L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012074; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Joshi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103754; Kalkonde YV, 2015, STROKE, V46, P1764, DOI 10.1161/STROKEAHA.115.008918; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Langhorne P, 2012, LANCET NEUROL, V11, P341, DOI 10.1016/S1474-4422(12)70024-8; LINDLEY RI, 1994, CEREBROVASC DIS, V4, P314, DOI 10.1159/000108501; Liu HM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012027; MAHONEY F I, 1965, Md State Med J, V14, P61; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nouri F., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; Pandian JD, 2015, INT J STROKE; Pandian JD, INCIDENCE SHORT TERM; Pandian JD, 2013, J STROKE, V15, P128, DOI 10.5853/jos.2013.15.3.128; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vloothuis JDM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011058.pub2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; World Health Organization, 2008, TASK SHIFT RAT RED T; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	75	76	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					588	599		10.1016/S0140-6736(17)31447-2	http://dx.doi.org/10.1016/S0140-6736(17)31447-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28666682	Green Accepted, Green Submitted			2022-12-28	WOS:000406855800023
J	Shipman, SL; Nivala, J; Macklis, JD; Church, GM				Shipman, Seth L. .; Nivala, Jeff; Macklis, Jeffrey D.; Church, George M.			CRISPR-Cas encoding of a digital movie into the genomes of a population of living bacteria	NATURE			English	Article							INFORMATION-STORAGE; DNA; ADAPTATION; GENERATION; RESISTANCE; IMMUNITY; ELEMENTS	DNA is an excellent medium for archiving data. Recent efforts have illustrated the potential for information storage in DNA using synthesized oligonucleotides assembled in vitro(1-6). A relatively unexplored avenue of information storage in DNA is the ability to write information into the genome of a living cell by the addition of nucleotides over time. Using the Cas1-Cas2 integrase, the CRISPR-Cas microbial immune system stores the nucleotide content of invading viruses to confer adaptive immunity(7). When harnessed, this system has the potential to write arbitrary information into the genome(8). Here we use the CRISPR-Cas system to encode the pixel values of black and white images and a short movie into the genomes of a population of living bacteria. In doing so, we push the technical limits of this information storage system and optimize strategies to minimize those limitations. We also uncover underlying principles of the CRISPR-Cas adaptation system, including sequence determinants of spacer acquisition that are relevant for understanding both the basic biology of bacterial adaptation and its technological applications. This work demonstrates that this system can capture and stably store practical amounts of real data within the genomes of populations of living cells.	[Shipman, Seth L. .; Nivala, Jeff; Church, George M.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Shipman, Seth L. .; Macklis, Jeffrey D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Shipman, Seth L. .; Macklis, Jeffrey D.] Harvard Univ, Harvard Stem Cell Inst, Bauer Lab 103, Cambridge, MA 02138 USA; [Shipman, Seth L. .; Nivala, Jeff; Church, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Church, GM (corresponding author), Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.; Church, GM (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Nivala, Jeff/0000-0002-8210-5417	National Institute of Mental Health [5R01MH103910]; National Human Genome Research Institute [5RM1HG008525]; Simons Foundation Autism Research Initiative [368485]; National Institute of Neurological Disorders and Stroke [5R01NS045523]; Paul G. Allen Frontiers Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550, RM1HG008525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000222] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Simons Foundation Autism Research Initiative; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Paul G. Allen Frontiers Group; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	S.L.S. is a Shurl and Kay Curci Foundation Fellow of the Life Sciences Research Foundation. The project was supported by grants from the National Institute of Mental Health (5R01MH103910), National Human Genome Research Institute (5RM1HG008525), and Simons Foundation Autism Research Initiative (368485) to G.M.C., the National Institute of Neurological Disorders and Stroke (5R01NS045523) to J.D.M and an Allen Distinguished Investigator Award from the Paul G. Allen Frontiers Group to J.D.M. We thank G. Kuznetsov for comments on the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Church GM, 2012, SCIENCE, V337, P1628, DOI 10.1126/science.1226355; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Erlich Y, 2017, SCIENCE, V355, P950, DOI 10.1126/science.aaj2038; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Hsiao V, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156663; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nunez JK, 2015, NATURE, V527, P535, DOI 10.1038/nature15760; O'Shea JP, 2013, NAT METHODS, V10, P1211, DOI [10.1038/NMETH.2646, 10.1038/nmeth.2646]; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sternberg SH, 2016, MOL CELL, V61, P797, DOI 10.1016/j.molcel.2016.01.030; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Weinberger AD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002475; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zhirnov V, 2016, NAT MATER, V15, P366, DOI 10.1038/nmat4594	30	165	186	19	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					345	+		10.1038/nature23017	http://dx.doi.org/10.1038/nature23017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28700573	Green Submitted, Green Accepted			2022-12-28	WOS:000405844900033
J	Politi, MC; Jones, KM; Philpott, SE				Politi, Mary C.; Jones, Katherine M.; Philpott, Sydney E.			The Role of Patient Engagement in Addressing Parents' Perceptions About Immunizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Politi, Mary C.; Philpott, Sydney E.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,CB 8100, St Louis, MO 63110 USA; [Jones, Katherine M.] Washington Univ, St Louis Childrens Hosp, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL)	Politi, MC (corresponding author), Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, 660 S Euclid Ave,CB 8100, St Louis, MO 63110 USA.	mpoliti@wustl.edu		Politi, Mary/0000-0001-9103-6495	Merck Sharp Doehme	Merck Sharp Doehme	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Politi reported receiving a grant and a speaker's fee from Merck Sharp & Doehme. No other disclosures were reported.	Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Connolly T, 2003, ORGAN BEHAV HUM DEC, V91, P186, DOI 10.1016/S0749-5978(03)00057-8; Edwards KM, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2146; Opel DJ, 2013, PEDIATRICS, V132, P1037, DOI 10.1542/peds.2013-2037; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Shelby A, 2013, HUM VACC IMMUNOTHER, V9, P1795, DOI 10.4161/hv.24828	7	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					237	238		10.1001/jama.2017.7168	http://dx.doi.org/10.1001/jama.2017.7168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA9OJ	28654974				2022-12-28	WOS:000405775000007
J	Ganmore, I; Achiron, A				Ganmore, Ithamar; Achiron, Anat			Cerebral Cavernous Malformations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ganmore, Ithamar; Achiron, Anat] Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel	Chaim Sheba Medical Center	Achiron, A (corresponding author), Sheba Med Ctr Tel Hashomer, Ramat Gan, Israel.	anat.achiron@sheba.health.gov.il							0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					71	71		10.1056/NEJMicm1613312	http://dx.doi.org/10.1056/NEJMicm1613312			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679101				2022-12-28	WOS:000404730000010
J	Ngu, STI; Bilsland, D				Ngu, Sze Ting Ivy; Bilsland, David			SPOT DIAGNOSIS A striking annular rash in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ngu, Sze Ting Ivy; Bilsland, David] Queen Elizabeth Univ Hosp, Alan Lyell Ctr Dermatol, Glasgow, Lanark, Scotland	Queen Elizabeth University Hospital (QEUH)	Ngu, STI (corresponding author), Queen Elizabeth Univ Hosp, Alan Lyell Ctr Dermatol, Glasgow, Lanark, Scotland.	ivy.ngu@nhs.net						ASBRINK E, 1985, ACTA DERM-VENEREOL, V65, P43; Lipsker D, 2002, BRIT J DERMATOL, V146, P872, DOI 10.1046/j.1365-2133.2002.04628.x; MUHLEMANN MF, 1986, LANCET, V1, P553; MUHLEMANN MF, 1984, BRIT J DERMATOL, V111, P335, DOI 10.1111/j.1365-2133.1984.tb04732.x; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2017	358								j2914	10.1136/bmj.j2914	http://dx.doi.org/10.1136/bmj.j2914			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DN	28679498				2022-12-28	WOS:000405322200003
J	Khan, KN; Ogden, CF; Sloan, CEL; Goodson, C				Khan, Nawab Khan; Ogden, Christian Frank; Sloan, Catherine E. L.; Goodson, Claire			Jonathan Gerwyn Evans OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3224	10.1136/bmj.j3224	http://dx.doi.org/10.1136/bmj.j3224			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676503				2022-12-28	WOS:000405322100007
J	Cao, Q; Tersoff, J; Farmer, DB; Zhu, Y; Han, SJ				Cao, Qing; Tersoff, Jerry; Farmer, Damon B.; Zhu, Yu; Han, Shu-Jen			Carbon nanotube transistors scaled to a 40-nanometer footprint	SCIENCE			English	Article								The International Technology Roadmap for Semiconductors challenges the device research community to reduce the transistor footprint containing all components to 40 nanometers within the next decade. We report on a p-channel transistor scaled to such an extremely small dimension. Built on one semiconducting carbon nanotube, it occupies less than half the space of leading silicon technologies, while delivering a significantly higher pitch-normalized current density-above 0.9 milliampere per micrometer at a low supply voltage of 0.5 volts with a subthreshold swing of 85millivolts per decade. Furthermore, we show transistors with the same small footprint built on actual high-density arrays of such nanotubes that deliver higher current than that of the best-competing silicon devices under the same overdrive, without any normalization. We achieve this using low-resistance end-bonded contacts, a high-purity semiconducting carbon nanotube source, and self-assembly to pack nanotubes into full surface-coverage aligned arrays.	[Cao, Qing; Tersoff, Jerry; Farmer, Damon B.; Zhu, Yu; Han, Shu-Jen] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Cao, Q (corresponding author), IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	qcao@us.ibm.com						Bangsaruntip S., 2013, 2013 IEEE INT ELECT, P1, DOI DOI 10.1109/IEDM.2013.6724667; Brady GJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601240; Cao Q, 2015, SCIENCE, V350, P68, DOI 10.1126/science.aac8006; Cao Q, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.024022; Cao Q, 2013, NAT NANOTECHNOL, V8, P180, DOI [10.1038/nnano.2012.257, 10.1038/NNANO.2012.257]; Chang J. B., 2011, 2011 IEEE Symposium on VLSI Technology. Digest of Technical Papers, P12; Deng J, 2007, IEEE T ELECTRON DEV, V54, P3186, DOI 10.1109/TED.2007.909030; Desai SB, 2016, SCIENCE, V354, P99, DOI 10.1126/science.aah4698; Farmer DB, 2006, NANO LETT, V6, P699, DOI 10.1021/nl052453d; Franklin AD, 2015, SCIENCE, V349, DOI 10.1126/science.aab2750; Franklin AD, 2013, NANO LETT, V13, P2490, DOI 10.1021/nl400544q; Franklin AD, 2012, ACS NANO, V6, P1109, DOI 10.1021/nn203516z; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Franklin AD, 2010, NAT NANOTECHNOL, V5, P858, DOI [10.1038/nnano.2010.220, 10.1038/NNANO.2010.220]; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Han S.J., 2013, IEDM; Hoffmann TY, 2010, SOLID STATE TECHNOL, V53, P20; Jan C.-H., 2015, VLSI, pT12, DOI DOI 10.1109/VLSIT.2015.7223683; LEE H, 2006, VLSI S, P58, DOI DOI 10.1109/VLSIT.2006.1705215; Leonard F, 2006, NANOTECHNOLOGY, V17, P2381, DOI 10.1088/0957-4484/17/9/051; Martinez-Blanco J, 2015, NAT PHYS, V11, P640, DOI [10.1038/nphys3385, 10.1038/NPHYS3385]; Park H, 2012, NAT NANOTECHNOL, V7, P787, DOI [10.1038/nnano.2012.189, 10.1038/NNANO.2012.189]; Qiu CG, 2017, SCIENCE, V355, P271, DOI 10.1126/science.aaj1628; Seo K.-I., 2014, P 2014 S VLSI TECHNO, P1; Shulaker M. M., 2014, IEDM; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Singh N, 2006, IEEE ELECTR DEVICE L, V27, P383, DOI 10.1109/LED.2006.873381; Tang JS, 2016, INT EL DEVICES MEET; Weber O., 2015, VLSI TECH S KYOT JAP, pT168, DOI DOI 10.1109/VLSIT.2015.7223664; Wu SY, 2016, INT EL DEVICES MEET; Xie R, 2016, INT EL DEVICES MEET	31	144	151	12	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1369	1372		10.1126/science.aan2476	http://dx.doi.org/10.1126/science.aan2476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663497				2022-12-28	WOS:000404351500033
J	Di, Q; Wang, Y; Zanobetti, A; Wang, Y; Koutrakis, P; Choirat, C; Dominici, F; Schwartz, JD				Di, Qian; Wang, Yan; Zanobetti, Antonella; Wang, Yun; Koutrakis, Petros; Choirat, Christine; Dominici, Francesca; Schwartz, Joel D.			Air Pollution and Mortality in the Medicare Population	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; CARDIOVASCULAR MORTALITY; OZONE EXPOSURE; FOLLOW-UP; 6 CITIES; PM2.5; HEALTH; ASSOCIATIONS; PARTICLES	BACKGROUND Studies have shown that long-term exposure to air pollution increases mortality. However, evidence is limited for air-pollution levels below the most recent National Ambient Air Quality Standards. Previous studies involved predominantly urban populations and did not have the statistical power to estimate the health effects in underrepresented groups. METHODS We constructed an open cohort of all Medicare beneficiaries (60,925,443 persons) in the continental United States from the years 2000 through 2012, with 460,310,521 person-years of follow-up. Annual averages of fine particulate matter (particles with a mass median aerodynamic diameter of less than 2.5 mu m [PM2.5]) and ozone were estimated according to the ZIP Code of residence for each enrollee with the use of previously validated prediction models. We estimated the risk of death associated with exposure to increases of 10 mu g per cubic meter for PM2.5 and 10 parts per billion (ppb) for ozone using a two-pollutant Cox proportionalhazards model that controlled for demographic characteristics, Medicaid eligibility, and area-level covariates. RESULTS Increases of 10 mu g per cubic meter in PM2.5 and of 10 ppb in ozone were associated with increases in all-cause mortality of 7.3% (95% confidence interval [CI], 7.1 to 7.5) and 1.1% (95% CI, 1.0 to 1.2), respectively. When the analysis was restricted to person-years with exposure to PM2.5 of less than 12 mu g per cubic meter and ozone of less than 50 ppb, the same increases in PM2.5 and ozone were associated with increases in the risk of death of 13.6% (95% CI, 13.1 to 14.1) and 1.0% (95% CI, 0.9 to 1.1), respectively. For PM2.5, the risk of death among men, blacks, and people with Medicaid eligibility was higher than that in the rest of the population. CONCLUSIONS In the entire Medicare population, there was significant evidence of adverse effects related to exposure to PM2.5 and ozone at concentrations below current national standards. This effect was most pronounced among self-identified racial minorities and people with low income. (Supported by the Health Effects Institute and others.)	[Di, Qian; Wang, Yan; Zanobetti, Antonella; Koutrakis, Petros; Schwartz, Joel D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Wang, Yun; Choirat, Christine; Dominici, Francesca] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Bldg 2,4th Flr,655 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Dominici, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Bldg 2,4th Flr,655 Huntington Ave, Boston, MA 02115 USA.	fdominic@hsph.harvard.edu		Choirat, Christine/0000-0002-3745-9718; Di, Qian/0000-0002-1584-4770	Health Effects Institute [4953-RFA14-3/16-4]; National Institutes of Health [R01 ES024332-01A1, ES-000002, ES024012, R01ES026217]; National Cancer Institute [R35CA197449]; Environmental Protection Agency [83587201-0, RD-83479801]; NATIONAL CANCER INSTITUTE [P01CA134294, R35CA197449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R21ES022585, R21ES024012, R01ES024332, R01ES026217, R01ES012054] Funding Source: NIH RePORTER	Health Effects Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants from the Health Effects Institute (4953-RFA14-3/16-4), the National Institutes of Health (R01 ES024332-01A1, ES-000002, ES024012, R01ES026217), the National Cancer Institute (R35CA197449), and the Environmental Protection Agency (83587201-0 and RD-83479801).	[Anonymous], 2015, REG IMP AN FIN REV N; [Anonymous], 2014, AMB OUTD AIR QUAL HL; Atkinson RW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009493; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Carey IM, 2013, AM J RESP CRIT CARE, V187, P1226, DOI 10.1164/rccm.201210-1758OC; Crouse DL, 2015, ENVIRON HEALTH PERSP, V123, P1180, DOI 10.1289/ehp.1409276; Crouse DL, 2012, ENVIRON HEALTH PERSP, V120, P708, DOI 10.1289/ehp.1104049; Di Q, 2017, J AIR WASTE MANAGE, V67, P39, DOI 10.1080/10962247.2016.1200159; Di Q, 2016, ENVIRON SCI TECHNOL, V50, P4712, DOI 10.1021/acs.est.5b06121; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Eftim SE, 2008, EPIDEMIOLOGY, V19, P209, DOI 10.1097/EDE.0b013e3181632c09; Hao YP, 2015, AM J RESP CRIT CARE, V192, P337, DOI 10.1164/rccm.201410-1852OC; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kioumourtzoglou MA, 2016, EPIDEMIOLOGY, V27, P221, DOI 10.1097/EDE.0000000000000422; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; LEE EW, 1992, NATO ADV SCI I E-APP, V211, P237; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Makar M, 2016, EPIDEMIOLOGY; Ostro B, 2015, ENVIRON HEALTH PERSP, V123, P549, DOI 10.1289/ehp.1408565; Pinault L, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0111-6; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Schwartz J, 2008, ENVIRON HEALTH PERSP, V116, P64, DOI 10.1289/ehp.9955; Shi LH, 2016, ENVIRON HEALTH PERSP, V124, P46, DOI 10.1289/ehp.1409111; Smith RL, 2009, INHAL TOXICOL, V21, P37, DOI 10.1080/08958370903161612; Spiegelman D, 2016, AM J PUBLIC HEALTH, V106, P1563, DOI 10.2105/AJPH.2016.303377; Thurston GD, 2016, ENVIRON HEALTH PERSP, V124, P484, DOI 10.1289/ehp.1509676; Turner MC, 2016, AM J RESP CRIT CARE, V193, P1134, DOI 10.1164/rccm.201508-1633OC; Wang Y, 2017, EPIDEMIOLOGY, V28, P207, DOI 10.1097/EDE.0000000000000614; Wang Y, 2016, ENVIRON HEALTH PERSP, V124, P1182, DOI 10.1289/ehp.1409671; Zanobetti A, 2008, AM J RESP CRIT CARE, V177, P184, DOI 10.1164/rccm.200706-823OC	34	743	754	18	325	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2513	2522		10.1056/NEJMoa1702747	http://dx.doi.org/10.1056/NEJMoa1702747			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657878	Green Accepted, Bronze			2022-12-28	WOS:000404259200005
J	Ford, AC; Lacy, BE; Talley, NJ				Ford, Alexander C.; Lacy, Brian E.; Talley, Nicholas J.			Irritable Bowel Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PLACEBO-CONTROLLED TRIAL; LOW FODMAP DIET; DOUBLE-BLIND; GENERAL-POPULATION; REDUCES SYMPTOMS; CELIAC-DISEASE; CLINICAL-TRIAL; RISK-FACTORS; CONSTIPATION; METAANALYSIS	The irritable bowel syndrome (IBS) is a chronic and sometimes disabling functional bowel disorder.(1,2) Traditionally, this functional diagnostic label has been applied when no obvious structural or biochemical abnormalities are found, but emerging evidence suggests that distinct pathophysiological disturbances may account for the symptoms and that IBS is unlikely to be one disease or merely a psychiatric (somatosensory) disorder.(2) The Rome IV criteria, 1 derived from a consensus process by a multinational group of experts in functional gastrointestinal disorders, constitute the current standard for diagnosing IBS. According to these criteria, IBS is diagnosed on the basis of recurrent abdominal pain related to defecation or in association with a change in stool frequency or form (Table 1). Bloating is a common accompanying symptom. Symptoms must be chronic, occurring at least once per week, on average, in the previous 3 months, with a duration of at least 6 months. IBS negatively affects quality of life and work productivity. It has been estimated that patients would give up 10 to 15 years of life expectancy for an instant cure of the disease.(3) The prevalence of IBS in the United States is between 7% and 16%, and the condition is most common in women and young people.(4) Direct costs associated with IBS in the United States have been estimated, conservatively, at more than $1 billion.(5) Thus, diagnosing IBS accurately, minimizing invasive investigations, and recommending effective treatment have an important role in efforts to reduce the societal and economic effects of the disease.	[Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds, W Yorkshire, England; [Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Sect Gastroenterol & Hepatol, Lebanon, NH 03766 USA; [Talley, Nicholas J.] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW, Australia; [Talley, Nicholas J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Talley, Nicholas J.] Karolinska Inst, Stockholm, Sweden	University of Leeds; Saint James's University Hospital; Dartmouth College; University of Newcastle; Mayo Clinic; Karolinska Institutet	Talley, NJ (corresponding author), Univ Newcastle, Hunter Med Res Inst, 1 Kookaburra Circuit, New Lambton Hts, NSW 2305, Australia.	nicholas.talley@newcastle.edu.au	Ford, Alexander/K-5491-2012	Ford, Alexander/0000-0001-6371-4359	GE Healthcare; Almirall; Ironwood; Covidien; Salix; Takeda; Rome Foundation; GI Therapies; Prometheus; Abbott; Janssen; Pfizer; Yuhan; CJ Healthcare; Ardelyx; Forest Laboratories; Furiex; Synergy; GI Care; Outpost Medicine; Samsung Bioepis; Allergan; Napo Pharmaceuticals; Commonwealth Laboratories; Adelphi Values; Mayo Clinic for questionnaires on bowel disease and dysphagia	GE Healthcare(General ElectricGE Healthcare); Almirall(Almirall); Ironwood; Covidien; Salix; Takeda(Takeda Pharmaceutical Company Ltd); Rome Foundation; GI Therapies; Prometheus; Abbott(Abbott Laboratories); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Yuhan; CJ Healthcare; Ardelyx; Forest Laboratories; Furiex; Synergy; GI Care; Outpost Medicine; Samsung Bioepis(Samsung); Allergan(AbbVieAllergan); Napo Pharmaceuticals; Commonwealth Laboratories; Adelphi Values; Mayo Clinic for questionnaires on bowel disease and dysphagia	Dr. Ford reports receiving grant support and consulting fees from GE Healthcare and Almirall. Dr. Lacy reports receiving fees for attending advisory board meetings from Ironwood, Covidien, and Salix; receiving uncompensated assistance with manuscript production from Allergan; and receiving consulting fees from Takeda. Dr. Talley reports receiving grant support and honoraria from Rome Foundation; receiving grant support and consulting fees from GI Therapies and having a potential financial interest in GI Therapies; receiving grant support from Prometheus, Abbott, and Janssen; receiving grant support to the Mayo Clinic from Pfizer and Salix; receiving consulting fees and honoraria from Yuhan; receiving consulting fees from CJ Healthcare, Ardelyx, Takeda, Forest Laboratories, Furiex, Synergy, GI Care, Outpost Medicine, and Samsung Bioepis; receiving fees for serving on an advisory board from Allergan and Napo Pharmaceuticals; receiving grant support and fees for serving on an advisory board from Commonwealth Laboratories; serving on an advisory board for Danone; receiving development fees from Adelphi Values; receiving licensing fees from the Mayo Clinic for questionnaires on bowel disease and dysphagia; and holding a patent on IBS biomarkers (US 12735358.91405/2710383) and a pending patent application for "Nanotechnology drug delivery EoE" (Nestec European Patent 12735358.9). No other potential conflict of interest relevant to this article was reported.	Acosta A, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.32; Andresen V, 2008, CLIN GASTROENTEROL H, V6, P545, DOI 10.1016/j.cgh.2007.12.015; Barba E, 2015, GASTROENTEROLOGY, V148, P732, DOI 10.1053/j.gastro.2014.12.006; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Begtrup LM, 2013, CLIN GASTROENTEROL H, V11, P956, DOI 10.1016/j.cgh.2012.12.038; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Beyder A, 2014, GASTROENTEROLOGY, V146, P1659, DOI 10.1053/j.gastro.2014.02.054; Bhattarai Y, 2017, AM J PHYSIOL-GASTR L, V312, pG52, DOI 10.1152/ajpgi.00338.2016; Biesiekierski JR, 2013, GASTROENTEROLOGY, V145, P320, DOI 10.1053/j.gastro.2013.04.051; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bohn L, 2015, GASTROENTEROLOGY, V149, P1399, DOI 10.1053/j.gastro.2015.07.054; Camilleri M, 2014, NEUROGASTROENT MOTIL, V26, P1677, DOI 10.1111/nmo.12421; Camilleri M, 2016, AM J PHYSIOL-GASTR L, V311, pG365, DOI 10.1152/ajpgi.00037.2016; Canavan C, 2014, ALIMENT PHARM THER, V40, P1023, DOI 10.1111/apt.12938; Canavan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106478; Cash BD, 2016, DIGEST DIS SCI, V61, P560, DOI 10.1007/s10620-015-3858-7; Chang L, 2006, AM J GASTROENTEROL, V101, P1069, DOI 10.1111/j.1572-0241.2006.00459.x; Chey WD, 2012, AM J GASTROENTEROL, V107, P1702, DOI 10.1038/ajg.2012.254; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; Drossman Douglas, 2014, Am J Gastroenterol Suppl, V2, P22, DOI 10.1038/ajgsup.2014.6; Dunlop SP, 2003, ALIMENT PHARM THER, V18, P77, DOI 10.1046/j.1365-2036.2003.01640.x; Ek WE, 2015, GUT, V64, P1774, DOI 10.1136/gutjnl-2014-307997; Eswaran SL, 2016, AM J GASTROENTEROL, V111, P1824, DOI 10.1038/ajg.2016.434; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Ford AC, 2010, ALIMENT PHARM THER, V32, P144, DOI 10.1111/j.1365-2036.2010.04328.x; Ford AC, 2014, AM J GASTROENTEROL, V109, pS2, DOI 10.1038/ajg.2014.187; Garsed K, 2014, GUT, V63, P1617, DOI 10.1136/gutjnl-2013-305989; Halmos EP, 2015, GUT, V64, P93, DOI 10.1136/gutjnl-2014-307264; Halmos EP, 2014, GASTROENTEROLOGY, V146, P67, DOI [10.1053/j.gastro.2013.09.046, 10.1053/j.gastro.2014.04.034]; Hamilton W, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2998; Henstrom M, 2016, GUT; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Hughes PA, 2014, BRAIN BEHAV IMMUN, V42, P191, DOI 10.1016/j.bbi.2014.07.001; Irvine AJ, 2017, AM J GASTROENTEROL, V112, P65, DOI 10.1038/ajg.2016.466; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Jones MP, 2017, CLIN GASTROENTEROL H; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Keely S, 2015, EUR J CLIN INVEST, V45, P1350, DOI 10.1111/eci.12548; Kennedy PJ, 2014, PSYCHOL MED, V44, P3123, DOI 10.1017/S003329171400052X; Koloski NA, 2015, NEUROGASTROENT MOTIL, V27, P1317, DOI 10.1111/nmo.12626; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Lam C, 2016, GUT, V65, P91, DOI 10.1136/gutjnl-2015-309122; Lembo A, 2016, GASTROENTEROLOGY, V151, P1113, DOI 10.1053/j.gastro.2016.08.003; Lembo AJ, 2016, NEW ENGL J MED, V374, P242, DOI 10.1056/NEJMoa1505180; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Madisch A, 2004, ALIMENT PHARM THER, V19, P271, DOI 10.1111/j.1365-2036.2004.01859.x; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; Peters SL, 2016, ALIMENT PHARM THER, V44, P447, DOI 10.1111/apt.13706; Pimentel M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126438; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Rao S, 2012, AM J GASTROENTEROL, V107, P1714, DOI 10.1038/ajg.2012.255; Rao SSC, 2010, AM J GASTROENTEROL, V105, P890, DOI 10.1038/ajg.2010.53; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Saito YA, 2010, AM J GASTROENTEROL, V105, P170, DOI 10.1038/ajg.2009.577; Schmulson MJ, 2006, J PSYCHOSOM RES, V61, P461, DOI 10.1016/j.jpsychores.2006.02.011; Shanahan ER, 2016, ALIMENT PHARM THER, V43, P1186, DOI 10.1111/apt.13622; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058; Shim L, 2013, SCAND J GASTROENTERO, V48, P295, DOI 10.3109/00365521.2012.758767; Slattery SA, 2015, ALIMENT PHARM THER, V42, P3, DOI 10.1111/apt.13227; Song GH, 2005, GUT, V54, P1402, DOI 10.1136/gut.2004.062034; Sood R, 2015, ALIMENT PHARM THER, V42, P491, DOI 10.1111/apt.13283; Spiegel BMR, 2005, GASTROINTEST ENDOSC, V62, P892, DOI 10.1016/j.gie.2005.08.016; Spiegel BMR, 2010, AM J GASTROENTEROL, V105, P848, DOI 10.1038/ajg.2010.47; Sweetser S, 2009, AM J PHYSIOL-GASTR L, V296, pG1299, DOI 10.1152/ajpgi.00011.2009; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Tornblom H, 2015, NEUROGASTROENT MOTIL, V27, P455, DOI 10.1111/nmo.12509; van Rheenen PF, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3369; Vicario M, 2015, GUT, V64, P1379, DOI 10.1136/gutjnl-2013-306236; Walker MM, 2015, HUM PATHOL, V46, P277, DOI 10.1016/j.humpath.2014.10.026; Wouters MM, 2016, GUT, V65, P1279, DOI 10.1136/gutjnl-2015-309460; Wouters MM, 2016, GASTROENTEROLOGY, V150, P875, DOI 10.1053/j.gastro.2015.12.034; Zheng L, 2015, CLIN GASTROENTEROL H, V13, P1285, DOI 10.1016/j.cgh.2015.01.015	76	314	348	6	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2566	2578		10.1056/NEJMra1607547	http://dx.doi.org/10.1056/NEJMra1607547			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657875				2022-12-28	WOS:000404259200010
J	Lenart, A; Vaupel, JW				Lenart, Adam; Vaupel, James W.			Questionable evidence for a limit to human lifespan	NATURE			English	Letter									[Lenart, Adam; Vaupel, James W.] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark; [Lenart, Adam; Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	University of Southern Denmark; Max Planck Society	Vaupel, JW (corresponding author), Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark.; Vaupel, JW (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	jwv@demogr.mpg.de		Vaupel, James/0000-0003-0783-3905				Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Maier H, 2010, DEMOGR RES MONOGR, P1, DOI 10.1007/978-3-642-11520-2; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366	6	32	37	3	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E13	E14		10.1038/nature22790	http://dx.doi.org/10.1038/nature22790			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658239				2022-12-28	WOS:000404332000007
J	Lin, L; Rodrigues, FSLM; Kary, C; Contet, A; Logan, M; Baxter, RHG; Wood, W; Baehrecke, EH				Lin, Lin; Rodrigues, Frederico S. L. M.; Kary, Christina; Contet, Alicia; Logan, Mary; Baxter, Richard H. G.; Wood, Will; Baehrecke, Eric H.			Complement-Related Regulates Autophagy in Neighboring Cells	CELL			English	Article							ENGULFMENT RECEPTOR DRAPER; CORPSE ENGULFMENT; APOPTOTIC CELLS; SACCHAROMYCES-CEREVISIAE; DROSOPHILA; DEATH; PATHWAY; MUTANTS; PHAGOCYTOSIS; INFLAMMATION	Autophagy degrades cytoplasmic components and is important for development and human health. Although autophagy is known to be influenced by systemic intercellular signals, the proteins that control autophagy are largely thought to function within individual cells. Here, we report that Drosophila macroglobulin complement-related (Mcr), a complement ortholog, plays an essential role during developmental cell death and inflammation by influencing autophagy in neighboring cells. This function of Mcr involves the immune receptor Draper, suggesting a relationship between autophagy and the control of inflammation. Interestingly, Mcr function in epithelial cells is required for macrophage autophagy and migration to epithelial wounds, a Draper-dependent process. This study reveals, unexpectedly, that complement-related from one cell regulates autophagy in neighboring cells via an ancient immune signaling program.	[Lin, Lin; Kary, Christina; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Lin, Lin] Carnegie Inst Sci, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA; [Rodrigues, Frederico S. L. M.; Wood, Will] Univ Bristol, Fac Biomed Sci, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England; [Contet, Alicia; Baxter, Richard H. G.] Yale Univ, Dept Chem & Mol Biophys & Biochem, New Haven, CT 06520 USA; [Logan, Mary] Oregon Hlth & Sci Univ, Dept Neurol, Jungers Ctr Neurosci Res, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Kary, Christina] Nat Cell Biol, One New York Plaza, New York, NY 10004 USA	University of Massachusetts System; University of Massachusetts Worcester; Carnegie Institution for Science; University of Bristol; Yale University; Oregon Health & Science University	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	eric.baehrecke@umassmed.edu	Baxter, Richard/F-3027-2013; Wood, William/A-4939-2012	Baxter, Richard/0000-0001-5140-1726; Wood, William/0000-0001-5485-0236; Kary, Christina/0000-0002-2586-4185	 [R01GM079431]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431, R01GM114358] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Fortier, M. Freeman, S. Hall, G. Juhasz, Y. Nakanishi, D. Schafer, M. Sieber, A. Spradling, R. Ward, the Baehrecke laboratory, the Bloomington Stock Center, the Vienna Drosophila Resource Center, and the Developmental Studies Hybridoma Bank for flies, antibodies, advice, and technical support. This work was supported by R01GM079431 to E.H.B.	Anding AL, 2015, CELL DEATH DIFFER, V22, P457, DOI 10.1038/cdd.2014.174; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Evans IR, 2015, CURR BIOL, V25, P1606, DOI 10.1016/j.cub.2015.04.037; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hall S, 2014, DEVELOPMENT, V141, P889, DOI 10.1242/dev.102152; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Iram T, 2016, J NEUROSCI, V36, P5185, DOI 10.1523/JNEUROSCI.3850-15.2016; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Lee CY, 2001, DEVELOPMENT, V128, P1443; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; McPhee CK, 2010, NATURE, V465, P1093, DOI 10.1038/nature09127; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nelson C, 2014, MOL CELL, V56, P376, DOI 10.1016/j.molcel.2014.09.011; Nezis IP, 2008, J CELL BIOL, V180, P1065, DOI 10.1083/jcb.200711108; Pompon J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002255; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Tracy K, 2016, EMBO REP, V17, P110, DOI 10.15252/embr.201541283; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Weavers H, 2016, CELL, V165, P1658, DOI 10.1016/j.cell.2016.04.049; Williams Marni, 2014, Biophysical Reviews, V6, P261, DOI 10.1007/s12551-014-0142-6; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8; Ziegenfuss JS, 2008, NATURE, V453, P935, DOI 10.1038/nature06901	50	38	38	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					158	+		10.1016/j.cell.2017.06.018	http://dx.doi.org/10.1016/j.cell.2017.06.018			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666117	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000404358500017
J	Marciniak, T; Serebruany, V				Marciniak, Tom; Serebruany, Victor			Are drug regulators really too slow?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Serebruany, Victor] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University		thomas.a.marciniak@gmail.com	Goto, Shinya/AAU-6045-2020	Goto, Shinya/0000-0002-6821-1504				Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Carpenter D, 2008, NEW ENGL J MED, V358, P1354, DOI 10.1056/NEJMsa0706341; Doshi P, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1691; Downing NS, 2017, NEW ENGL J MED, V376, P1386, DOI 10.1056/NEJMc1700103; Downing NS, 2012, NEW ENGL J MED, V366, P2284, DOI 10.1056/NEJMsa1200223; EMA, 2016, EMA ANN REP 2015; FDA, 2012, MED REV AP; FDA, 2011, MED REV TIC; FDA, 2015, MED REV CANGR; FDA, 2015, FY 2015 PERF REP; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Hwang TJ, 2016, JAMA INTERN MED, V176, P1826, DOI 10.1001/jamainternmed.2016.6008; Kesselheim AS, 2017, JAMA-J AM MED ASSOC, V317, P581, DOI 10.1001/jama.2016.20640; Tabarrok A, 2014, FDA REPORT CARD WIDE; Zuckerman DM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6122	16	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2017	357								j2867	10.1136/bmj.j2867	http://dx.doi.org/10.1136/bmj.j2867			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AY	28663232				2022-12-28	WOS:000404725100003
J	Cusimano, MD; Casey, J; Jing, RW; Solarski, M; Techar, K; Zhang, SD				Cusimano, Michael D.; Casey, Julia; Jing, Ruiwei; Solarski, Michael; Techar, Kristina; Zhang, Shudong			Assessment of Head Collision Events During the 2014 FIFA World Cup Tournament	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							VIDEO ANALYSIS; FOOTBALL		[Cusimano, Michael D.; Casey, Julia; Jing, Ruiwei; Solarski, Michael; Techar, Kristina; Zhang, Shudong] St Michaels Hosp, Dept Neurosurg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Cusimano, MD (corresponding author), Univ Toronto, St Michaels Hosp, Dept Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.ca	Cusimano, Michael/GWR-1025-2022; Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Casey, Julia/0000-0002-3946-9805	Canadian Institutes of Health research [TIR-103946]; Ontario Neurotrauma Foundation	Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation	This research was supported by the Canadian Institutes of Health research strategic team grant TIR-103946 in applied injury research and the Ontario Neurotrauma Foundation.	Bjorneboe J, 2014, BRIT J SPORT MED, V48, P774, DOI 10.1136/bjsports-2012-091856; Cusimano M, CLIN J SPORT MED; Gardner A, 2015, NEUROLOGY S, V84; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699	6	15	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2548	2549		10.1001/jama.2017.6204	http://dx.doi.org/10.1001/jama.2017.6204			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655000	Green Published, Bronze			2022-12-28	WOS:000404106600026
J	Leslie, M				Leslie, Mitch			A division of labor in cells' protein factories	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1218	1219		10.1126/science.356.6344.1218	http://dx.doi.org/10.1126/science.356.6344.1218			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642386				2022-12-28	WOS:000403881700009
J	Gronemeyer, LL; Baltzer, A; Broekaert, S; Schrick, L; Moller, L; Nitsche, A; Mossner, R; Schon, MP; Buhl, T				Groenemeyer, Lisa-Lena; Baltzer, Anne; Broekaert, Sigrid; Schrick, Livia; Moeller, Lars; Nitsche, Andreas; Moessner, Rotraut; Schoen, Michael P.; Buhl, Timo			Generalised cowpox virus infection	LANCET			English	Editorial Material									[Groenemeyer, Lisa-Lena; Baltzer, Anne; Broekaert, Sigrid; Moessner, Rotraut; Schoen, Michael P.; Buhl, Timo] Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, D-37099 Gottingen, Germany; [Schrick, Livia; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens 1, Berlin, Germany; [Schrick, Livia; Nitsche, Andreas] Robert Koch Inst, German Consultant Lab Poxviruses, Berlin, Germany; [Moeller, Lars] Robert Koch Inst, Ctr Biol Threats & Special Pathogens 4, Adv Light & Electron Microscopy, Berlin, Germany; [Schoen, Michael P.; Buhl, Timo] Univ Med Ctr Gottingen, Lower Saxony Inst Occupat Dermatol, Gottingen, Germany; [Schoen, Michael P.; Buhl, Timo] Univ Osnabruck, Osnabruck, Germany	University of Gottingen; Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; University of Gottingen; University Osnabruck	Buhl, T (corresponding author), Univ Med Ctr Gottingen, Dept Dermatol Venereol & Allergol, D-37099 Gottingen, Germany.	timo.buhl@med.uni-goettingen.de	Buhl, Timo/AFP-7298-2022	Nitsche, Andreas/0000-0001-8185-3176					0	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 14	2017	390	10104					1769	1769		10.1016/S0140-6736(17)31428-9	http://dx.doi.org/10.1016/S0140-6736(17)31428-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ6GB	28669644				2022-12-28	WOS:000412853100029
J	Park, SY; Freedman, ND; Haiman, CA; Le Marchand, L; Wilkens, LR; Setiawan, VW				Park, Song-Yi; Freedman, Neal D.; Haiman, Christopher A.; Le Marchand, Loic; Wilkens, Lynne R.; Setiawan, Veronica Wendy			Association of Coffee Consumption With Total and Cause-Specific Mortality Among Nonwhite Populations	ANNALS OF INTERNAL MEDICINE			English	Article							TYPE-2 DIABETES-MELLITUS; ALL-CAUSE; CARDIOVASCULAR-DISEASE; MULTIETHNIC COHORT; DRINKING; METAANALYSIS; CANCER; RISK; CONFOUNDERS; SMOKING	Background: Coffee consumption has been associated with reduced risk for death in prospective cohort studies; however, data in nonwhites are sparse. Objective: To examine the association of coffee consumption with risk for total and cause-specific death. Design: The MEC (Multiethnic Cohort), a prospective population-based cohort study established between 1993 and 1996. Setting: Hawaii and Los Angeles, California. Participants: 185 855 African Americans, Native Hawaiians, Japanese Americans, Latinos, and whites aged 45 to 75 years at recruitment. Measurements: Outcomes were total and cause-specific mortality between 1993 and 2012. Coffee intake was assessed at baseline by means of a validated food-frequency questionnaire. Results: 58 397 participants died during 3 195 484 personyears of follow-up (average follow-up, 16.2 years). Compared with drinking no coffee, coffee consumption was associated with lower total mortality after adjustment for smoking and other potential confounders (1 cup per day: hazard ratio [HR], 0.88 [95% CI, 0.85 to 0.91]; 2 to 3 cups per day: HR, 0.82 [CI, 0.79 to 0.86]; >= 4 cups per day: HR, 0.82 [CI, 0.78 to 0.87]; P for trend < 0.001). Trends were similar between caffeinated and decaffeinated coffee. Significant inverse associations were observed in 4 ethnic groups; the association in Native Hawaiians did not reach statistical significance. Inverse associations were also seen in never-smokers, younger participants (< 55 years), and those who had not previously reported a chronic disease. Among examined end points, inverse associations were observed for deaths due to heart disease, cancer, respiratory disease, stroke, diabetes, and kidney disease. Limitation: Unmeasured confounding and measurement error, although sensitivity analysis suggested that neither was likely to affect results. Conclusion: Higher consumption of coffee was associated with lower risk for death in African Americans, Japanese Americans, Latinos, and whites.	[Le Marchand, Loic] Univ Hawaii, Canc Ctr, 701 Ilalo St,Room 530, Honolulu, HI 96813 USA; NCI, Bethesda, MD 20892 USA; Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Setiawan, Veronica Wendy] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, 1450 Biggy St,Room 1517G, Los Angeles, CA 90033 USA; [Park, Song-Yi] Univ Hawaii, 701 Ilalo St, Honolulu, HI 96813 USA; [Freedman, Neal D.] NCI, 9609 Med Ctr Dr, Rockville, MD 20850 USA; [Haiman, Christopher A.] Univ Southern Calif, 1450 Biggy St,Room 1504, Los Angeles, CA 90033 USA; [Wilkens, Lynne R.] Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA	Cancer Research Center of Hawaii; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; University of Southern California; University of Hawaii System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System	Setiawan, VW (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Prevent Med, 1450 Biggy St,Room 1517G, Los Angeles, CA 90033 USA.	spark@cc.hawaii.edu; vsetiawa@med.usc.edu	Freedman, Neal David/B-9741-2015	Freedman, Neal David/0000-0003-0074-1098; Setiawan, Veronica/0000-0001-9239-5692	National Cancer Institute	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020; Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526; Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Grosso G, 2017, PUBLIC HEALTH NUTR, V20, P82, DOI [10.1017/s1368980016001749, 10.1017/S1368980016001749]; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814; Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Liu JX, 2013, MAYO CLIN PROC, V88, P1066, DOI 10.1016/j.mayocp.2013.06.020; Lof M, 2015, EUR J EPIDEMIOL, V30, P1027, DOI 10.1007/s10654-015-0052-3; LOFTFIELD E, 2015, CIRCULATION, V182, P1010, DOI DOI 10.1161/CIRCULATI0NAHA.115.017341; Loftfield E, 2016, J NUTR, V146, P1762, DOI 10.3945/jn.116.233940; Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T; MAKUCH RW, 1982, J CHRON DIS, V35, P437, DOI 10.1016/0021-9681(82)90058-3; Malerba S, 2013, EUR J EPIDEMIOL, V28, P527, DOI 10.1007/s10654-013-9834-7; Martini D, 2016, MOLECULES, V21, DOI 10.3390/molecules21080979; National Center for Health Statistics. Health United States, 2015, DHHS PUBLICATION, V2016-1232; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304; Saaksjarvi K, 2008, EUR J CLIN NUTR, V62, P908, DOI 10.1038/sj.ejcn.1602788; Saito E, 2015, AM J CLIN NUTR, V101, P1029, DOI 10.3945/ajcn.114.104273; Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005; Stram DO, 2000, AM J EPIDEMIOL, V151, P358, DOI 10.1093/oxfordjournals.aje.a010214; Therneau TM, 2000, MODELING SURVIVAL DA; U.S. Department of Health and Human Services and U.S. Department of Agriculture, 2015, HHS PUBL; Wadhawan M, 2016, J CLIN EXP HEPATOL, V6, P40, DOI 10.1016/j.jceh.2016.02.003; Zhao YM, 2015, PUBLIC HEALTH NUTR, V18, P1282, DOI 10.1017/S1368980014001438	33	139	143	5	58	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					228	+		10.7326/M16-2472	http://dx.doi.org/10.7326/M16-2472			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28693036	Green Accepted			2022-12-28	WOS:000407797500011
J	Kazlauskiene, M; Kostiuk, G; Venclovas, C; Tamulaitis, G; Siksnys, V				Kazlauskiene, Migle; Kostiuk, Georgij; Venclovas, Ceslovas; Tamulaitis, Gintautas; Siksnys, Virginijus			A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems	SCIENCE			English	Article							CRYSTAL-STRUCTURE; EFFECTOR COMPLEX; DNA CLEAVAGE; RNA; IMMUNITY; PROTEIN; RECOGNITION; ENDORIBONUCLEASE; SUPERFAMILY; DEGRADATION	Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally active DNA and its transcripts by the Csm effector complex. The Cas10 subunit of the complex contains an HD nuclease domain that is responsible for DNA degradation and two Palm domains with elusive functions. In addition, Csm6, a ribonuclease that is not part of the complex, is also required to provide full immunity. We show here that target RNA binding by the Csm effector complex of Streptococcus thermophilus triggers Cas10 to synthesize cyclic oligoadenylates (cA(n); n = 2 to 6) by means of the Palm domains. Acting as signaling molecules, cyclic oligoadenylates bind Csm6 to activate its nonspecific RNA degradation. This cyclic oligoadenylate-based signaling pathway coordinates different components of CRISPR-Cas to prevent phage infection and propagation.	[Kazlauskiene, Migle; Kostiuk, Georgij; Venclovas, Ceslovas; Tamulaitis, Gintautas; Siksnys, Virginijus] Vilnius Univ, Inst Biotechnol, Sauletekio Ave 7, LT-10257 Vilnius, Lithuania	Vilnius University	Tamulaitis, G; Siksnys, V (corresponding author), Vilnius Univ, Inst Biotechnol, Sauletekio Ave 7, LT-10257 Vilnius, Lithuania.	tamulaitis@ibt.lt; siksnys@ibt.lt	Venclovas, Česlovas/AAO-9966-2020; Tamulaitis, Gintautas/U-9601-2017	Venclovas, Česlovas/0000-0002-4215-0213; Tamulaitis, Gintautas/0000-0002-2259-3033; Kazlauskiene, Migle/0000-0003-2329-0410; Kostiuk, Georgij/0000-0003-1059-9419	Research Council of Lithuania [APP-3/2016]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	We thank A. Ruksenaite and L. Taujenis (Thermofisher Scientific) for help with HPLC-MS experiments; A. Silanskas for HPLC purification of adenylates; P. Moller Martensen (Aarhus University) for a kind gift of pOAS1 and pPDE12 plasmids; P. Horvath (DuPont) for a kind gift of S. thermophilus DGCC8004 strain and discussions; and S. E. Halford for critical reading of the manuscript. G.T. acknowledges support from the Research Council of Lithuania (grant APP-3/2016). M.K., G.K., G.T., and V.S. are inventors on patent applications related to the work described in this manuscript: V.S., M.K., and G.T. on international patent application PCT/IB2015/056756 submitted by Vilnius University, which covers the StCsm complex and its use for directed RNA cleavage, and V.S., M.K., G.K., and G.T. on U.S. provisional patent application 62/512868 submitted by Vilnius University, which covers production of cyclic oligoadenylates and their use as allosteric regulators. Expression plasmids used in this work are available from G.T., M.K., or V.S. under a material transfer agreement with Vilnius University.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Cocozaki AI, 2012, STRUCTURE, V20, P545, DOI 10.1016/j.str.2012.01.018; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; FUJIMOTO M, 1974, AGR BIOL CHEM TOKYO, V38, P1555, DOI 10.1080/00021369.1974.10861384; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Kazlauskiene M, 2016, MOL CELL, V62, P295, DOI 10.1016/j.molcel.2016.03.024; Koonin EV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600186; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Liu TY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170552; Makarova KS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00102; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Opoku-Temeng C, 2016, CHEM COMMUN, V52, P9327, DOI 10.1039/c6cc03439j; Osawa T, 2013, J MOL BIOL, V425, P3811, DOI 10.1016/j.jmb.2013.03.042; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; SCHMIDT A, 1979, P NATL ACAD SCI USA, V76, P4788, DOI 10.1073/pnas.76.10.4788; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Tamulaitis G, 2017, TRENDS MICROBIOL, V25, P49, DOI 10.1016/j.tim.2016.09.012; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Yan XF, 2015, RNA BIOL, V12, P749, DOI 10.1080/15476286.2015.1051300; Zhu X, 2012, FEBS LETT, V586, P939, DOI 10.1016/j.febslet.2012.02.036	28	212	232	9	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2017	357	6351					605	+		10.1126/science.aao0100	http://dx.doi.org/10.1126/science.aao0100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD1VM	28663439				2022-12-28	WOS:000407324800044
J	Reinhart, K; Daniels, R; Kissoon, N; Machado, FR; Schachter, RD; Finfer, S				Reinhart, Konrad; Daniels, Ron; Kissoon, Niranjan; Machado, Flavia R.; Schachter, Raymond D.; Finfer, Simon			Recognizing Sepsis as a Global Health Priority - A WHO Resolution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reinhart, Konrad] Jena Univ Hosp, Jena, Germany; [Daniels, Ron] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat Emergency Med & Crit Care, Vancouver, BC, Canada; [Schachter, Raymond D.] Synergy Business Lawyers, Vancouver, BC, Canada; [Machado, Flavia R.] Univ Fed Sao Paulo, Dept Anesthesiol Pain & Intens Care Med, Sao Paulo, Brazil; [Finfer, Simon] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia	Friedrich Schiller University of Jena; Heart of England NHS Foundation Trust; University of British Columbia; Universidade Federal de Sao Paulo (UNIFESP); George Institute for Global Health; University of New South Wales Sydney; University of Sydney	Reinhart, K (corresponding author), Jena Univ Hosp, Jena, Germany.		Kissoon, Niranjan/AAC-6140-2021	Finfer, Simon/0000-0002-2785-5864; Kissoon, Niranjan/0000-0001-8847-9973				[Anonymous], 2017, WHA AD RES SEPS; [Anonymous], 2013, TIM ACT SEV SEPS RAP; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; National Confidential Enquiry into Patient Outcome and Death, 2015, JUST SAY SEPS REV PR	4	515	579	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					414	417		10.1056/NEJMp1707170	http://dx.doi.org/10.1056/NEJMp1707170			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC3NW	28658587	Bronze			2022-12-28	WOS:000406747100003
J	Redberg, RF; Jacoby, AF; Sharfstein, JM				Redberg, Rita F.; Jacoby, Alison F.; Sharfstein, Joshua M.			Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYSTERECTOMY; SURGERY; WOMEN		[Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Jacoby, Alison F.] Univ Calif San Francisco, Dept Obstretr & Gynecol, San Francisco, CA 94143 USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room W1033D, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu						Bazzi A, 2016, AM J OBSTET GYNECOL, V214, pS463, DOI 10.1016/j.ajog.2016.01.024; Broder MS, 2000, OBSTET GYNECOL, V95, P199, DOI 10.1016/S0029-7844(99)00519-0; Ekerhovd E, 2001, AM J OBSTET GYNECOL, V184, P48, DOI 10.1067/mob.2001.108330; Levitz J, 2014, WALL STREET J; Moore BJ., TRENDS HYSTERECTOMIE; Ong MBH, URGENT FDA ACTION TU; Parker W, 2016, J MINIM INVAS GYN, V23, P303, DOI 10.1016/j.jmig.2015.12.012; Pritts EA, 2015, GYNECOL SURG, V12, P165, DOI 10.1007/s10397-015-0894-4; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Wright JD, 2016, JAMA-J AM MED ASSOC, V316, P877, DOI 10.1001/jama.2016.9432	10	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					325	326		10.1001/jama.2017.7704	http://dx.doi.org/10.1001/jama.2017.7704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28662227				2022-12-28	WOS:000406296700006
J	Ott, PA; Hu, ZT; Keskin, DB; Shukla, SA; Sun, J; Bozym, DJ; Zhang, WD; Luoma, A; Giobbie-Hurder, A; Peter, L; Chen, C; Olive, O; Carter, TA; Li, SQ; Lieb, DJ; Eisenhaure, T; Gjini, E; Stevens, J; Lane, WJ; Javeri, I; Nellaiappan, K; Salazar, AM; Daley, H; Seaman, M; Buchbinder, EI; Yoon, CH; Harden, M; Lennon, N; Gabriel, S; Rodig, SJ; Barouch, DH; Aster, JC; Getz, G; Wucherpfennig, K; Neuberg, D; Ritz, J; Lander, ES; Fritsch, EF; Hacohen, N; Wu, CJ				Ott, Patrick A.; Hu, Zhuting; Keskin, Derin B.; Shukla, Sachet A.; Sun, Jing; Bozym, David J.; Zhang, Wandi; Luoma, Adrienne; Giobbie-Hurder, Anita; Peter, Lauren; Chen, Christina; Olive, Oriol; Carter, Todd A.; Li, Shuqiang; Lieb, David J.; Eisenhaure, Thomas; Gjini, Evisa; Stevens, Jonathan; Lane, William J.; Javeri, Indu; Nellaiappan, Kaliappanadar; Salazar, Andres M.; Daley, Heather; Seaman, Michael; Buchbinder, Elizabeth I.; Yoon, Charles H.; Harden, Maegan; Lennon, Niall; Gabriel, Stacey; Rodig, Scott J.; Barouch, Dan H.; Aster, Jon C.; Getz, Gad; Wucherpfennig, Kai; Neuberg, Donna; Ritz, Jerome; Lander, Eric S.; Fritsch, Edward F.; Hacohen, Nir; Wu, Catherine J.			An immunogenic personal neoantigen vaccine for patients with melanoma	NATURE			English	Article							CD4(+) T-CELLS; SEQUENCING DATA; CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; EXPRESSION; PREDICTION; MOLECULES; EPITOPES; ANTIGENS; PEPTIDE	Effective anti-tumour immunity in humans has been associated with the presence of T cells directed at cancer neoantigens(1), a class of HLA-bound peptides that arise from tumour-specific mutations. They are highly immunogenic because they are not present in normal tissues and hence bypass central thymic tolerance. Although neoantigens were long-envisioned as optimal targets for an anti-tumour immune response(2), their systematic discovery and evaluation only became feasible with the recent availability of massively parallel sequencing for detection of all coding mutations within tumours, and of machine learning approaches to reliably predict those mutated peptides with high-affinity binding of autologous human leukocyte antigen (HLA) molecules. We hypothesized that vaccination with neoantigens can both expand pre-existing neoantigen-specific T-cell populations and induce a broader repertoire of new T-cell specificities in cancer patients, tipping the intra-tumoural balance in favour of enhanced tumour control. Here we demonstrate the feasibility, safety, and immunogenicity of a vaccine that targets up to 20 predicted personal tumour neoantigens. Vaccine-induced polyfunctional CD4(+) and CD8(+) T cells targeted 58 (60%) and 15 (16%) of the 97 unique neoantigens used across patients, respectively. These T cells discriminated mutated from wild-type antigens, and in some cases directly recognized autologous tumour. Of six vaccinated patients, four had no recurrence at 25 months after vaccination, while two with recurrent disease were subsequently treated with anti-PD-1 (anti-programmed cell death-1) therapy and experienced complete tumour regression, with expansion of the repertoire of neoantigen-specific T cells. These data provide a strong rationale for further development of this approach, alone and in combination with checkpoint blockade or other immunotherapies.	[Ott, Patrick A.; Hu, Zhuting; Keskin, Derin B.; Shukla, Sachet A.; Sun, Jing; Bozym, David J.; Zhang, Wandi; Chen, Christina; Olive, Oriol; Daley, Heather; Buchbinder, Elizabeth I.; Ritz, Jerome; Fritsch, Edward F.; Wu, Catherine J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Ott, Patrick A.; Buchbinder, Elizabeth I.; Ritz, Jerome; Wu, Catherine J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; [Ott, Patrick A.; Keskin, Derin B.; Buchbinder, Elizabeth I.; Yoon, Charles H.; Barouch, Dan H.; Aster, Jon C.; Getz, Gad; Wucherpfennig, Kai; Ritz, Jerome; Lander, Eric S.; Hacohen, Nir; Wu, Catherine J.] Harvard Med Sch, Boston, MA 02215 USA; [Keskin, Derin B.; Shukla, Sachet A.; Carter, Todd A.; Li, Shuqiang; Lieb, David J.; Eisenhaure, Thomas; Harden, Maegan; Lennon, Niall; Gabriel, Stacey; Getz, Gad; Lander, Eric S.; Fritsch, Edward F.; Hacohen, Nir; Wu, Catherine J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Luoma, Adrienne; Wucherpfennig, Kai] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Giobbie-Hurder, Anita; Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Peter, Lauren; Seaman, Michael; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Peter, Lauren; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Gjini, Evisa; Rodig, Scott J.] Dana Farber Canc Inst, CIO, Boston, MA 02215 USA; [Stevens, Jonathan; Lane, William J.; Rodig, Scott J.; Aster, Jon C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA; [Javeri, Indu; Nellaiappan, Kaliappanadar] CuriRx Inc, Wilmington, MA 01887 USA; [Salazar, Andres M.] Oncovir Inc, 3203 Cleveland Ave NW, Washington, DC 20008 USA; [Yoon, Charles H.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02215 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02214 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02214 USA; [Fritsch, Edward F.] Neon Therapeut Inc, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Wu, CJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Harvard Med Sch, Boston, MA 02215 USA.; Wu, CJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	cwu@partners.org	Ritz, Jerome/C-7929-2009; Barouch, Dan/Y-3918-2019; Rodig, Scott/Y-3889-2019; Giobbie-Hurder, Anita/AAU-6193-2021	Ritz, Jerome/0000-0001-5526-4669; Peter, Lauren/0000-0002-2105-7503	Broad Institute SPARC program; National Institutes of Health [NCI-1RO1CA155010-02, NHLBI-5R01HL103532-03, NCI-SPORE-2P50CA101942-11A1, NCI-R50 RCA211482A]; Francis and Adele Kittredge Family Immuno-Oncology and Melanoma Research Fund; Faircloth Family Research Fund; DFCI Center for Cancer Immunotherapy Research fellowship; NATIONAL CANCER INSTITUTE [R50CA211482, P50CA101942, T32CA207021, R01CA155010] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103532] Funding Source: NIH RePORTER	Broad Institute SPARC program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Francis and Adele Kittredge Family Immuno-Oncology and Melanoma Research Fund; Faircloth Family Research Fund; DFCI Center for Cancer Immunotherapy Research fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Russell and the Dana-Farber Cancer Institute (DFCI) Center for Immuno-Oncology (CIO) staff; M. Copersino (Regulatory Affairs), B. Meyers, C. Harvey, and S. Bartel (Clinical Pharmacy); A. Lako (CIO), M. Bowden (Center for Molecular Oncologic Pathology); O. Sturtevant, H. Negre, S. Y. Kim, M. A. Kelley (Cell Manipulation Core Facility) and the Pasquarello Tissue Bank (all at DFCI); T. Bowman (DFHCC Specialized Histopathology Core Laboratory); the Broad Institute's Biological Samples, Genetic Analysis, and Genome Sequencing Platforms; S. Hodi, G. Dranoff, M. Rajasagi, U. Burkhardt, S. Sarkizova, J. Fan, and P. Bachireddy for discussions; J. Petricciani and M. Krane for regulatory advice; B. McDonough (CSBio) and S. Thorne (CuriRx) for peptide development. This research was made possible by a gift from the Blavatnik Family Foundation, and was supported by grants from the Broad Institute SPARC program and the National Institutes of Health (NCI-1RO1CA155010-02 (to C.J.W.), NHLBI-5R01HL103532-03 (to C.J.W.), NCI-SPORE-2P50CA101942-11A1 (to D.B.K.); NCI-R50 RCA211482A (to S. S.)), from the Francis and Adele Kittredge Family Immuno-Oncology and Melanoma Research Fund (to P. A. O.), the Faircloth Family Research Fund (to P. A. O.), and the DFCI Center for Cancer Immunotherapy Research fellowship (to Z.H.). C.J.W. is a scholar of the Leukemia and Lymphoma Society.	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Cai A, 2012, CLIN CANCER RES, V18, P5761, DOI 10.1158/1078-0432.CCR-12-1182; Call MJ, 2009, J IMMUNOL, V182, P6342, DOI 10.4049/jimmunol.0803464; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Haabeth OA, 2016, LEUKEMIA, V30, P1216, DOI 10.1038/leu.2015.278; Hacohen N, 2013, CANCER IMMUNOL RES, V1, P11, DOI 10.1158/2326-6066.CIR-13-0022; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Martin SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155189; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Prickett TD, 2016, CANCER IMMUNOL RES, V4, P669, DOI 10.1158/2326-6066.CIR-15-0215; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roemer MGM, 2016, CANCER IMMUNOL RES, V4, P910, DOI 10.1158/2326-6066.CIR-16-0201; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Stephen TL, 2017, IMMUNITY, V46, P51, DOI 10.1016/j.immuni.2016.12.015; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521	45	1438	1534	32	799	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					217	+		10.1038/nature22991	http://dx.doi.org/10.1038/nature22991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678778	Green Accepted			2022-12-28	WOS:000405314500039
J	Bohannon, J				Bohannon, John			THE CYBERSCIENTIST	SCIENCE			English	Editorial Material																			0	10	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		18	21		10.1126/science.357.6346.18	http://dx.doi.org/10.1126/science.357.6346.18			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684480				2022-12-28	WOS:000404854100014
J	Pennisi, E				Pennisi, Elizabeth			Combing the genome for the roots of autism	SCIENCE			English	Editorial Material																			0	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		25	25		10.1126/science.357.6346.25	http://dx.doi.org/10.1126/science.357.6346.25			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684485				2022-12-28	WOS:000404854100018
J	Aguado, LC; Schmid, S; May, J; Sabin, LR; Panis, M; Blanco-Melo, D; Shim, JV; Sachs, D; Cherry, S; Simon, AE; Levraud, JP; Tenoever, BR				Aguado, Lauren C.; Schmid, Sonja; May, Jared; Sabin, Leah R.; Panis, Maryline; Blanco-Melo, Daniel; Shim, Jaehee V.; Sachs, David; Cherry, Sara; Simon, Anne E.; Levraud, Jean-Pierre; tenOever, Benjamin R.			RNase III nucleases from diverse kingdoms serve as antiviral effectors	NATURE			English	Article							MAMMALIAN-CELLS; VIRUS GENOME; EVOLUTION; REPLICATION; DROSHA; MICROPROCESSOR; LOCALIZATION; ATTENUATION; INHIBITION; EXPRESSION	In contrast to the DNA-based viruses in prokaryotes, the emergence of eukaryotes provided the necessary compartmentalization and membranous environment for RNA viruses to flourish, creating the need for an RNA-targeting antiviral system(1,2). Present day eukaryotes employ at least two main defence strategies that emerged as a result of this viral shift, namely antiviral RNA interference and the interferon system(2). Here we demonstrate that Drosha and related RNase III ribonucleases from all three domains of life also elicit a unique RNA-targeting antiviral activity. Systemic evolution of ligands by exponential enrichment of this class of proteins illustrates the recognition of unbranched RNA stem loops. Biochemical analyses reveal that, in this context, Drosha functions as an antiviral clamp, conferring steric hindrance on the RNA-dependent RNA polymerases of diverse positive-stranded RNA viruses. We present evidence for cytoplasmic translocation of RNase III nucleases in response to virus in diverse eukaryotes including plants, arthropods, fish, and mammals. These data implicate RNase III recognition of viral RNA as an antiviral defence that is independent of, and possibly predates, other known eukaryotic antiviral systems.	[Aguado, Lauren C.; Schmid, Sonja; Panis, Maryline; Blanco-Melo, Daniel; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [May, Jared; Simon, Anne E.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Sabin, Leah R.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Shim, Jaehee V.] Icahn Sch Med Mt Sinai, Sch Med, Dept Pharm & Therapeut, New York, NY 10029 USA; [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Levraud, Jean-Pierre] CNRS, Inst Pasteur, Macrophages & Dev Immunite, UMR3738, 25-28 Rue Dr Roux, F-75724 Paris 15, France	Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland College Park; University of Pennsylvania; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tenoever, BR (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	Benjamin.tenOever@mssm.edu	May, Jared P./J-3060-2019; Simon, Anne E/B-8713-2014; Blanco-Melo, Daniel/AAG-3682-2020	May, Jared P./0000-0002-0671-5643; Simon, Anne E/0000-0001-6121-0704; Blanco-Melo, Daniel/0000-0002-0256-5019; Sachs, David/0000-0002-4445-2055; Schmid, Sonja/0000-0002-1946-5970; cherry, sara/0000-0003-3956-6610; Aguado, Lauren/0000-0002-0036-4803	Burroughs Wellcome Fund; National Institute of Allergy and Infectious Diseases (NIAID) [R01A1074951]; DIM Malinf, Conseil Regional d'Ile-de-France; American Heart Association [15PRE24930012]; National Science Foundation [MCB-1411836]; NIAID [R21AI117882, R01AI110575]; National Institute of General Medicine [F32 GM119235]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074951, R01AI110575, R21AI117882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM119235] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DIM Malinf, Conseil Regional d'Ile-de-France(Region Ile-de-France); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. K. Lim and A. G. Pletnev for Langat virus reagents, B. Lee for Sendai virus reagents, R. W. Hardy for SINV reagents, B. R. Cullen for NoDice cells, K. K. Conzelmann for BSR-T7 cells, and B. Ramratnam for pEGFP-Drosha. Recombinant IFN-beta was provided by the National Institute of Health's Biodefense and Emerging Infections Research Resources Repository (HuIFN-beta, NR-3080). This material is based upon work supported in part by the Burroughs Wellcome Fund, which provides support for both S.C. and B.R.T.S.C. is also supported by the National Institute of Allergy and Infectious Diseases (NIAID) (R01A1074951). J.P.L. is supported by the DIM Malinf, Conseil Regional d'Ile-de-France. L.C.A. is partly supported by the American Heart Association (15PRE24930012). A.E.S. is supported by National Science Foundation (MCB-1411836) and NIAID (R21AI117882). J.M. is supported by National Institute of General Medicine (F32 GM119235). B.R.T. is also supported by NIAID (R01AI110575).	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Manley James L, 2013, Cold Spring Harb Protoc, V2013, P156, DOI 10.1101/pdb.prot072934; McCormack J. C., 2006, CURRENT PROTOCOLS MI; Moy RH, 2014, CELL, V158, P764, DOI 10.1016/j.cell.2014.06.023; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Ossovskaya V, 2008, FEBS LETT, V582, P2402, DOI 10.1016/j.febslet.2008.06.004; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Perez JT, 2009, NAT BIOTECHNOL, V27, P572, DOI 10.1038/nbt.1542; Rio Donald C, 2014, Cold Spring Harb Protoc, V2014, P435, DOI 10.1101/pdb.prot080721; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Rupp JC, 2011, J VIROL, V85, P3449, DOI 10.1128/JVI.02058-10; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Sarkar D, 2008, P NATL ACAD SCI USA, V105, P17040, DOI 10.1073/pnas.0804956105; Sedano CD, 2014, CELL HOST MICROBE, V16, P257, DOI 10.1016/j.chom.2014.07.006; Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002; Shaffer SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075120; Shapiro JS, 2014, P NATL ACAD SCI USA, V111, P7108, DOI 10.1073/pnas.1319635111; Shapiro JS, 2012, RNA, V18, P1338, DOI 10.1261/rna.032268.112; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Shirako Y, 2003, J VIROL, V77, P2301, DOI 10.1128/JVI.77.4.2301-2309.2003; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; tenOever BR, 2016, CELL HOST MICROBE, V19, P142, DOI 10.1016/j.chom.2016.01.006; tenOever BR, 2013, NAT REV MICROBIOL, V11, P169, DOI 10.1038/nrmicro2971; Triboulet R, 2009, RNA, V15, P1005, DOI 10.1261/rna.1591709; Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061; Varble A, 2013, CELL HOST MICROBE, V14, P346, DOI 10.1016/j.chom.2013.08.007; Zhang FL, 2003, PLANT J, V35, P665, DOI 10.1046/j.1365-313X.2003.01837.x	39	35	36	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					114	+		10.1038/nature22990	http://dx.doi.org/10.1038/nature22990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658212	Green Accepted			2022-12-28	WOS:000404839900041
J	Oyston, J				Oyston, John			John Kenneth Oyston OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		OYSTON JK, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3215	10.1136/bmj.j3215	http://dx.doi.org/10.1136/bmj.j3215			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676536				2022-12-28	WOS:000405322100004
J	Servick, K				Servick, Kelly			Stem cell approach for cataracts challenged	SCIENCE			English	News Item																			0	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1318	1319		10.1126/science.356.6345.1318	http://dx.doi.org/10.1126/science.356.6345.1318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663449				2022-12-28	WOS:000404351500010
J	Stokstad, E				Stokstad, Erik			European bee study fuels debate over pesticide ban	SCIENCE			English	News Item																			0	8	9	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1321	1321		10.1126/science.356.6345.1321	http://dx.doi.org/10.1126/science.356.6345.1321			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663451				2022-12-28	WOS:000404351500012
J	Beumer, J; Clevers, H				Beumer, Joep; Clevers, Hans			How the Gut Feels, Smells, and Talks	CELL			English	Editorial Material							ENTEROENDOCRINE CELLS; DIFFERENTIATION; SEROTONIN	Gut-brain signaling plays a central role in a range of homeostatic processes, yet details of this cross-talk remain enigmatic. In this issue of Cell, Bellono and colleagues identify a variety of luminal stimuli acting on serotonin-secreting enteroendocrine cells and, for the first time, demonstrate a functional synaptic interaction with neurons.	[Beumer, Joep; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Beumer, Joep; Clevers, Hans] UMC Utrecht, Canc Genom Netherlands, NL-3584 GC Utrecht, Netherlands; [Clevers, Hans] Princess Maxima Ctr, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.; Clevers, H (corresponding author), UMC Utrecht, Canc Genom Netherlands, NL-3584 GC Utrecht, Netherlands.; Clevers, H (corresponding author), Princess Maxima Ctr, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu						Basak O, 2017, CELL STEM CELL, V20, P177, DOI 10.1016/j.stem.2016.11.001; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; Bohorquez DV, 2015, J CLIN INVEST, V125, P782, DOI 10.1172/JCI78361; Chang AJ, 2015, NATURE, V527, P240, DOI 10.1038/nature15721; Fothergill L.J., 2017, ENDOCRINOLOGY; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Grunddal KV, 2016, ENDOCRINOLOGY, V157, P176, DOI 10.1210/en.2015-1600; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408	10	14	14	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					10	11		10.1016/j.cell.2017.06.023	http://dx.doi.org/10.1016/j.cell.2017.06.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666112	Bronze			2022-12-28	WOS:000404358500004
J	Ghoneim, HE; Fan, YP; Moustaki, A; Abdelsamed, HA; Dash, P; Dogra, P; Carter, R; Awad, W; Neale, G; Thomas, PG; Ben Youngblood				Ghoneim, Hazem E.; Fan, Yiping; Moustaki, Ardiana; Abdelsamed, Hossam A.; Dash, Pradyot; Dogra, Pranay; Carter, Robert; Awad, Walid; Neale, Geoff; Thomas, Paul G.; Ben Youngblood			De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation	CELL			English	Article							DNA METHYLATION; VIRAL PERSISTENCE; VIRUS; DEMETHYLATION; INFECTION; PATTERNS; EFFECTOR; SUBSETS; ALPHA	Immune-checkpoint-blockade (ICB)-mediated rejuvenation of exhausted T cells has emerged as a promising approach for treating various cancers and chronic infections. However, T cells that become fully exhausted during prolonged antigen exposure remain refractory to ICB-mediated rejuvenation. We report that blocking de novo DNA methylation in activated CD8 T cells allows them to retain their effector functions despite chronic stimulation during a persistent viral infection. Whole-genome bisulfite sequencing of antigen-specific murine CD8 T cells at the effector and exhaustion stages of an immune response identified progressively acquired heritable de novo methylation programs that restrict T cell expansion and clonal diversity during PD-1 blockade treatment. Moreover, these exhaustion-associated DNA-methylation programs were acquired in tumor-infiltrating PD-1hi CD8 T cells, and approaches to reverse these programs improved T cell responses and tumor control during ICB. These data establish de novo DNA-methylation programming as a regulator of T cell exhaustion and barrier of ICB-mediated T cell rejuvenation.	[Ghoneim, Hazem E.; Moustaki, Ardiana; Abdelsamed, Hossam A.; Dash, Pradyot; Dogra, Pranay; Awad, Walid; Thomas, Paul G.; Ben Youngblood] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Fan, Yiping; Carter, Robert] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Neale, Geoff] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Ben Youngblood (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	benjamin.youngblood@stjude.org	Moustaki, Ardiana/AAL-5153-2020; Thomas, Paul G./H-1063-2018; Youngblood, Benjamin/N-2508-2018	Thomas, Paul G./0000-0001-7955-0256; Youngblood, Benjamin/0000-0002-1261-9957; Dogra, Pranay/0000-0003-2031-9855	National Institutes of Health [1R01AI114442]; ALSAC; SJCRH Garwood Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114442, R01AI107625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); SJCRH Garwood Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. Richard Cross and Greig Lennon in the St. Jude Flow Cytometry & Cell Sorting Shared Resource for cell sorting and the staff in the St. Jude Hartwell Center for all sequencing services. We also thank Dr. Angela McArthur at St. Jude for scientific editing and Dr. Rafick Sekaly for his critical comments. This work was supported by the National Institutes of Health grant 1R01AI114442 and ALSAC (to B.A.Y.) and the SJCRH Garwood Postdoctoral Fellowship (to A.M.).	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Dash P, 2015, METHODS MOL BIOL, V1343, P181, DOI 10.1007/978-1-4939-2963-4_15; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Foster BA, 1997, CANCER RES, V57, P3325; Ghoneim HE, 2016, TRENDS MOL MED, V22, P1000, DOI 10.1016/j.molmed.2016.10.002; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; MATLOUBIAN M, 1990, J EXP MED, V172, P1043, DOI 10.1084/jem.172.4.1043; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Scharer CD, 2013, J IMMUNOL, V191, P3419, DOI 10.4049/jimmunol.1301395; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Thomas PG, 2013, P NATL ACAD SCI USA, V110, P1839, DOI 10.1073/pnas.1222149110; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang L, 2015, CANCER IMMUNOL RES, V3, P1030, DOI 10.1158/2326-6066.CIR-15-0073; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu H, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv715; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Yu P, 2012, P NATL ACAD SCI USA, V109, P6187, DOI 10.1073/pnas.1203479109	37	383	394	8	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1								10.1016/j.cell.2017.06.007	http://dx.doi.org/10.1016/j.cell.2017.06.007			35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28648661	Bronze, Green Accepted			2022-12-28	WOS:000404358500016
J	Mukerji, SS; Gonzalez, RG; Gandhi, RT; Kraft, S				Mukerji, Shibani S.; Gonzalez, R. Gilberto; Gandhi, Rajesh T.; Kraft, Stefan			Case 20-2017: A 48-Year-Old Man with Weight Loss, Confusion, Skin Lesions, and Pancytopenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-INFECTION; IMMUNODEFICIENCY; SEIZURES		[Mukerji, Shibani S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Gandhi, Rajesh T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Kraft, Stefan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mukerji, Shibani S.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Gandhi, Rajesh T.] Harvard Med Sch, Dept Med, Boston, MA USA; [Kraft, Stefan] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mukerji, SS (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.; Mukerji, SS (corresponding author), Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA.		Mukerji, Shibani/T-2303-2019		Harvard University Center for AIDS Research [NIH P30 AI060354]; Centre for the Aids Programme of Research in South Africa; University of KwaZulu-Natal; South African HIV Clinicians Society; KwaZulu-Natal Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER	Harvard University Center for AIDS Research; Centre for the Aids Programme of Research in South Africa; University of KwaZulu-Natal; South African HIV Clinicians Society; KwaZulu-Natal Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This case was presented at the 10th Annual Workshop on Advanced Clinical Care-AIDS in Durban, South Africa, organized by Drs. Henry Sunpath and Mahomed-Yunus S. Moosa (Infectious Diseases Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal) and Dr. Rajesh T. Gandhi (Massachusetts General Hospital and the Ragon Institute) and sponsored by the Harvard University Center for AIDS Research (NIH P30 AI060354), the Centre for the Aids Programme of Research in South Africa, the University of KwaZulu-Natal, the South African HIV Clinicians Society, and the KwaZulu-Natal Department of Health.	Brew BJ, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0468-2; Crum-Cianflone NF, 2013, NEUROLOGY, V80, P371, DOI 10.1212/WNL.0b013e31827f0776; Gelman BB, 2015, CURR HIV-AIDS REP, V12, P272, DOI 10.1007/s11904-015-0266-8; Gheuens S, 2013, ANNU REV PATHOL-MECH, V8, P189, DOI 10.1146/annurev-pathol-020712-164018; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Hall HI, 2016, AIDS BEHAV, V20, P967, DOI 10.1007/s10461-015-1241-5; HOLTZMAN DM, 1989, AM J MED, V87, P173, DOI 10.1016/S0002-9343(89)80693-X; Hong A, 2003, PATHOLOGY, V35, P448, DOI 10.1080/00313020310001602657; Letendre Scott, 2011, Top Antivir Med, V19, P137; Lima MA, 2006, NEUROLOGY, V66, P262, DOI 10.1212/01.wnl.0000194227.16696.11; Newsome SD, 2011, NEUROLOGY, V76, P787, DOI 10.1212/WNL.0b013e31820e7b4e; Nightingale S, 2014, LANCET NEUROL, V13, P1139, DOI 10.1016/S1474-4422(14)70137-1; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Silverberg MJ, 2013, JNCI-J NATL CANCER I, V105, P350, DOI 10.1093/jnci/djs529; Spudich S, 2013, CURR HIV-AIDS REP, V10, P235, DOI 10.1007/s11904-013-0171-y; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]	18	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2580	2589		10.1056/NEJMcpc1616401	http://dx.doi.org/10.1056/NEJMcpc1616401			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657866	Green Accepted			2022-12-28	WOS:000404259200013
J	Lyon, J				Lyon, Jeff			Hunt for an HIV Vaccine Intensifies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2475	2475		10.1001/jama.2017.7352	http://dx.doi.org/10.1001/jama.2017.7352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28654994				2022-12-28	WOS:000404106600003
J	Ozdemir, V; Kickbusch, I; Coskun, Y				Ozdemir, Vural; Kickbusch, Ilona; Coskun, Yavuz			Rethinking the right to work for refugee Syrian healthcare professionals: a call for innovation in global governance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ozdemir, Vural] Innovat Global Governance Sci Technol & Hlth, Toronto, ON, Canada; [Ozdemir, Vural] Amrita Univ, Amrita Vishwa Vidyapeetham, Sch Biotechnol, Kollam, Kerala, India; [Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland; [Coskun, Yavuz] Gaziantep Univ, Fac Med, Gaziantep, Turkey	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri; Gaziantep University	Ozdemir, V (corresponding author), Innovat Global Governance Sci Technol & Hlth, Toronto, ON, Canada.; Ozdemir, V (corresponding author), Amrita Univ, Amrita Vishwa Vidyapeetham, Sch Biotechnol, Kollam, Kerala, India.	vural.ozdemir@alumni.utoronto.ca	Coşkun, M. Yavuz/AAI-8261-2020					[Anonymous], 2015, LANCET, V386, P1013, DOI 10.1016/S0140-6736(15)00190-7; Arie S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1552; Bourdieu P., 1992, INVITATION REFLEXIVE; Coskun MY, 2016, HURRIYET DAILY NEWS; Heisler M, 2015, NEW ENGL J MED, V373, P2489, DOI 10.1056/NEJMp1513512; Legrain P, 2016, REFUGEES WORK HUMANI; Mirchandani R, 2016, REFUGEES DISPLACEMEN; Ozdemir V, 2015, CURR PSYCHIAT PSYCHO, V357, P33; Ozdemir V., HDB RESPONS IN PRESS; Ozgenc M., 2016, HURRIYET NEWSPA 0429; Tatah L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168820; United Nations Department of Economic and Social Affairs Population Division, 2015, TRENDS INT MIGR STOC	12	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2017	357								j2710	10.1136/bmj.j2710	http://dx.doi.org/10.1136/bmj.j2710			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AQ	28655746				2022-12-28	WOS:000404724100001
J	Sokol, J				Sokol, Joshua			New haul of distant worlds casts doubt on Planet Nine	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1221	1221		10.1126/science.356.6344.1221	http://dx.doi.org/10.1126/science.356.6344.1221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642389				2022-12-28	WOS:000403881700012
J	Chowdhury, TA; Cheston, H; Claydon, A				Chowdhury, Tahseen A.; Cheston, Hannah; Claydon, Anne			ESSENTIALS Managing adults with diabetes in hospital during an acute illness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSULIN		[Chowdhury, Tahseen A.; Cheston, Hannah; Claydon, Anne] Barts Hlth NHS Trust, Royal London Hosp Whitechapel, Dept Diabet & Metab, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital	Chowdhury, TA (corresponding author), Barts Hlth NHS Trust, Royal London Hosp Whitechapel, Dept Diabet & Metab, London E1 1BB, England.	Tahseen.Chowdhury@bartshealth.nhs.uk						Bellolio MF, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005346.pub3; Dhatariya K, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f134; Evans NR, 2012, CLIN MED, V12, P137, DOI 10.7861/clinmedicine.12-2-137; George S, 2015, DIABETIC MED, V32, P706, DOI 10.1111/dme.12756; Inzucchi SE, 2006, NEW ENGL J MED, V355, P1903, DOI 10.1056/NEJMcp060094; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; Leicestershirediabetes.org.uk, ADV GIV PEOPL MAN IN; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Marik PE, 2016, INTENS CARE MED, V42, P1475, DOI 10.1007/s00134-016-4299-2; National Institute for Health and Care Excellence, TYP 2 DIAB AD MAN; Scott AR, 2015, DIABETIC MED, V32, P714, DOI 10.1111/dme.12757	11	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2551	10.1136/bmj.j2551	http://dx.doi.org/10.1136/bmj.j2551			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YZ	28642274				2022-12-28	WOS:000404210800001
J	Kleinert, S				Kleinert, Sabine			My Germany in 2017: a resilient country that is taking responsibility	LANCET			English	Editorial Material									[Kleinert, Sabine] The Lancet, London EC2Y 5AS, England		Kleinert, S (corresponding author), The Lancet, London EC2Y 5AS, England.	sabine.kleinert@lancet.com						[Anonymous], 2017, SUDDEUTSCHE ZEITUNG; Busse R, 2017, LANCET; Federal Government of Germany, 2017, GERM G20 PRES BEG; Federal Ministry for Family Affairs, 2017, AB Y20; G20 Germany, 2017, BERL DECL G20 HLTH M; Kickbusch I, 2017, LANCET	6	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					829	830		10.1016/S0140-6736(17)31658-6	http://dx.doi.org/10.1016/S0140-6736(17)31658-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28684021	Bronze			2022-12-28	WOS:000408330700007
J	Saini, SD; Waljee, AK				Saini, Sameer D.; Waljee, Akbar K.			Fool Me Thrice: The Evolving Story of Multiply Recurrent Clostridium difficile Infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							UNITED-STATES; BURDEN		VA Ann Arbor Ctr Clin Management Res, Ann Arbor, MI USA; Univ Michigan, Ann Arbor, MI 48109 USA; [Saini, Sameer D.; Waljee, Akbar K.] VA Ann Arbor Med Ctr, 2215 Fuller Rd 111D, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Saini, SD (corresponding author), VA Ann Arbor Med Ctr, 2215 Fuller Rd 111D, Ann Arbor, MI 48105 USA.	sdsaini@umich.edu	Waljee, Akbar K/G-2067-2010	Waljee, Akbar K/0000-0003-1964-8790	Veterans Affairs Health Services Research and Development Career Development Award [CDA 11-217]	Veterans Affairs Health Services Research and Development Career Development Award(US Department of Veterans Affairs)	Dr. Waljee's research is supported by a Veterans Affairs Health Services Research and Development Career Development Award (CDA 11-217).	Abou Chakra CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098400; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; D'Agostino RB, 2014, CLIN INFECT DIS, V58, P1386, DOI 10.1093/cid/ciu107; Desai K, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1610-3; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lessa FC, 2012, CLIN INFECT DIS, V55, pS65, DOI 10.1093/cid/cis319; Ma GK, 2017, ANN INTERN MED, V167, P152, DOI [10.7326/M16-2733, 10.7326/m16-2733]; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004	10	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					202	+		10.7326/M17-1565	http://dx.doi.org/10.7326/M17-1565			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28672286				2022-12-28	WOS:000406631400011
J	Iacaruso, MF; Gasler, IT; Hofer, SB				Iacaruso, M. Florencia; Gasler, Ioana T.; Hofer, Sonja B.			Synaptic organization of visual space in primary visual cortex	NATURE			English	Article							NEURONS IN-VIVO; STRIATE CORTEX; ORIENTATION SELECTIVITY; HORIZONTAL CONNECTIONS; FUNCTIONAL SPECIFICITY; NETWORKS; INPUTS; ARRANGEMENT; THALAMUS; CELLS	How a sensory stimulus is processed and perceived depends on the surrounding sensory scene. In the visual cortex, contextual signals can be conveyed by an extensive network of intra-and inter-areal excitatory connections that link neurons representing stimulus features separated in visual space(1-4). However, the connectional logic of visual contextual inputs remains unknown; it is not clear what information individual neurons receive from different parts of the visual field, nor how this input relates to the visual features that a neuron encodes, defined by its spatial receptive field. Here we determine the organization of excitatory synaptic inputs responding to different locations in the visual scene by mapping spatial receptive fields in dendritic spines of mouse visual cortex neurons using two-photon calcium imaging. We find that neurons receive functionally diverse inputs from extended regions of visual space. Inputs representing similar visual features from the same location in visual space are more likely to cluster on neighbouring spines. Inputs from visual field regions beyond the receptive field of the postsynaptic neuron often synapse on higher-order dendritic branches. These putative long-range inputs are more frequent and more likely to share the preference for oriented edges with the postsynaptic neuron when the receptive field of the input is spatially displaced along the axis of the receptive field orientation of the postsynaptic neuron. Therefore, the connectivity between neurons with displaced receptive fields obeys a specific rule, whereby they connect preferentially when their receptive fields are co-oriented and co-axially aligned. This organization of synaptic connectivity is ideally suited for the amplification of elongated edges, which are enriched in the visual environment, and thus provides a potential substrate for contour integration and object grouping.	[Iacaruso, M. Florencia; Gasler, Ioana T.; Hofer, Sonja B.] Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland; [Iacaruso, M. Florencia] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Basel; University of Oxford	Hofer, SB (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	sonja.hofer@unibas.ch		Hofer, Sonja/0000-0003-4921-8521	European Research Council; Biozentrum core funds	European Research Council(European Research Council (ERC)European Commission); Biozentrum core funds	We thank T. Mrsic-Flogel, P. Znamenskiy, D. Muir as well as members of the Hofer and Mrsic-Flogel laboratories for insightful comments and suggestions and J. Dahmen and L. Cossell for analysis code and advice. We thank the GENIE Program and Janelia Farm Research Campus of the Howard Hughes Medical Institute for making GCaMP6 material available. This work was supported by the European Research Council (SBH), and the Biozentrum core funds.	Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Chisum HJ, 2003, J NEUROSCI, V23, P2947; Cossell L, 2015, NATURE, V518, P399, DOI 10.1038/nature14182; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gilbert CD, 2013, NAT REV NEUROSCI, V14, P350, DOI 10.1038/nrn3476; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee WCA, 2016, NATURE, V532, P370, DOI 10.1038/nature17192; Leinweber M, 2014, JOVE-J VIS EXP, DOI 10.3791/50885; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Martin KAC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6252; Morgenstern NA, 2016, NAT NEUROSCI, V19, P1034, DOI 10.1038/nn.4339; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Roth MM, 2016, NAT NEUROSCI, V19, P299, DOI 10.1038/nn.4197; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; SCHWARZ C, 1991, J NEUROSCI, V11, P2995; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Sincich LC, 2001, J NEUROSCI, V21, P4416, DOI 10.1523/JNEUROSCI.21-12-04416.2001; Smith SL, 2013, NATURE, V503, P115, DOI 10.1038/nature12600; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Wilson DE, 2016, NAT NEUROSCI, V19, P1003, DOI 10.1038/nn.4323; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	37	87	87	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					449	+		10.1038/nature23019	http://dx.doi.org/10.1038/nature23019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28700575	Green Submitted, Green Accepted			2022-12-28	WOS:000406358300035
J	Service, RF				Service, Robert F.			Neural networks learn the art of chemical synthesis	SCIENCE			English	Editorial Material																			0	0	0	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		27	27		10.1126/science.357.6346.27	http://dx.doi.org/10.1126/science.357.6346.27			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684487				2022-12-28	WOS:000404854100020
J	Tam, C				Tam, Charmaine			Reprogramming my career	SCIENCE			English	Editorial Material									[Tam, Charmaine] Univ Sydney, Ctr Translat Data Sci, Sydney, NSW, Australia	University of Sydney	Tam, C (corresponding author), Univ Sydney, Ctr Translat Data Sci, Sydney, NSW, Australia.								0	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		102	102		10.1126/science.357.6346.102	http://dx.doi.org/10.1126/science.357.6346.102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684527				2022-12-28	WOS:000404854100043
J	Millenson, ML				Millenson, Michael L.			ESSAY When "patient centred" is no longer enough: the challenge of collaborative health: an essay by Michael L Millenson	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Millenson, Michael L.] Hlth Qual Advisors, Highland Pk, IL 60035 USA; [Millenson, Michael L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Millenson, ML (corresponding author), Hlth Qual Advisors, Highland Pk, IL 60035 USA.	mm@healthqualityadvisors.com			Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	I would like to thank the Robert Wood Johnson Foundation for its support of this research through a Pioneer grant.	Beatrice DF, 1998, HEALTH AFFAIR, V17, P236, DOI 10.1377/hlthaff.17.1.236; Blumenthal D, 2002, MILBANK Q, V80, P525, DOI 10.1111/1468-0009.00021; DeBronkart D, 2013, PATIENTS HELP PATIEN; Dix M, CURRENTCARE OFFERS B; Elwyn G, 2014, PATIENT EDUC COUNS, V97, P158, DOI 10.1016/j.pec.2014.07.027; European Commission, 2014, HEALTHC YOUR POCK UN; Freidson E., 1970, PROFESSION MED STUDY; Gartner Group, 2017, GARTN SAYS 8 4 BILL; Gerteis M., 1993, PATIENTS EYES UNDERS; Halfmann D, 2012, HEALTH-LONDON, V16, P186, DOI 10.1177/1363459311403947; Katz Jay, 2002, SILENT WORLD DOCTOR; Kutscher Beth, 2015, Mod Healthc, V45, P16; Lupton D., 2016, RES HDB DIG TRANSF, P85, DOI 10.4337/9781784717766.00011.; Marcus AD, 2015, WALL STREET J; Meeker M, 2017, INT TRENDS 2017 COD; Millenson ML, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4759; Millenson ML, 2014, J GEN INTERN MED, V29, P979, DOI 10.1007/s11606-014-2788-y; Monegain B., 2016, HEALTHCARE IT NEWS; Okun S, 2017, LEARN HEALTH SYST, V1, DOI 10.1002/lrh2.10028; Pennic J, 2016, BASEHEALTH TRIVITA L; Poushter J, 2016, SMARTPHONE OWNERSHIP; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Sarasohn-Kahn J, 2013, AM J PREV MED, V44, pS16, DOI 10.1016/j.amepre.2012.09.019; Society for Participatory Medicine, 2016, PAT OV BEL PARTN THE; Trojan A, 2017, PATIENT CTR MED, DOI [10.5772/66163, DOI 10.5772/66163]; Van den Bogaert S, 2017, SOC THEOR HEALTH, V15, P407, DOI 10.1057/s41285-017-0035-4; Walker J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7785	27	20	20	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2017	358								j3048	10.1136/bmj.j3048	http://dx.doi.org/10.1136/bmj.j3048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DN	28679500				2022-12-28	WOS:000405322200004
J	Lambertz, M				Lambertz, Markus			Taxonomy: retain scientific autonomy	NATURE			English	Letter									[Lambertz, Markus] Univ Bonn, Bonn, Germany	University of Bonn	Lambertz, M (corresponding author), Univ Bonn, Bonn, Germany.	lambertz@uni-bonn.deand	Lambertz, Markus/C-7328-2011	Lambertz, Markus/0000-0001-8348-9347				Kaiser Hinrich, 2013, Herpetological Review, V44, P8; Wagele H, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-25; 2017, NATURE, V546, P25	3	10	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					600	600		10.1038/546600b	http://dx.doi.org/10.1038/546600b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658242	Bronze			2022-12-28	WOS:000404332000029
J	Takeda, H				Takeda, Hiroyuki			Taxonomy: the IUBS responds	NATURE			English	Letter									[Takeda, Hiroyuki] Univ Tokyo, Tokyo, Japan	University of Tokyo	Takeda, H (corresponding author), Univ Tokyo, Tokyo, Japan.	nfomproix@iubs.org						2017, NATURE, V546, P25	1	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					600	600		10.1038/546600d	http://dx.doi.org/10.1038/546600d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658227	Bronze			2022-12-28	WOS:000404332000031
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: What might the Queen's speech mean for hospital doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Anandaciva S., 2017, NHS MYTH BUSTERS; Campbell D, 2016, GUARDIAN; Economist Intelligence Unit, 2016, VAL BAS HEALTHC UK A; Gray JAM, 2013, LANCET, V382, P200, DOI 10.1016/S0140-6736(13)61590-1; Gray M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j437; Ham C, 2017, ORG CARE NHS FRONT L; Ham C., 2014, REFORMING NHS HIERAR; Heneghan C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2973; Karakusevic S, 2016, UNDERSTANDING PATIEN; National Institute for Health Research, 2016, EV GETT IT RIGHT 1 T; Naylor C, 2015, ACUTE HOSP INTEGRATE; Royal College of Physicians, 2015, TEAMS WALLS VAL MED; Scottish Government, 2017, REAL REAL MED	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2017	357								j3077	10.1136/bmj.j3077	http://dx.doi.org/10.1136/bmj.j3077			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AQ	28655707	Bronze, Green Published			2022-12-28	WOS:000404724100004
J	Mara, MW; Hadt, RG; Reinhard, ME; Kroll, T; Lim, H; Hartsock, RW; Alonso-Mori, R; Chollet, M; Glownia, JM; Nelson, S; Sokaras, D; Kunnus, K; Hodgson, KO; Hedman, B; Bergmann, U; Gaffney, KJ; Solomon, EI				Mara, Michael W.; Hadt, Ryan G.; Reinhard, Marco Eli; Kroll, Thomas; Lim, Hyeongtaek; Hartsock, Robert W.; Alonso-Mori, Roberto; Chollet, Matthieu; Glownia, James M.; Nelson, Silke; Sokaras, Dimosthenis; Kunnus, Kristjan; Hodgson, Keith O.; Hedman, Britt; Bergmann, Uwe; Gaffney, Kelly J.; Solomon, Edward I.			Metalloprotein entatic control of ligand-metal bonds quantified by ultrafast x-ray spectroscopy	SCIENCE			English	Article							HEART CYTOCHROME-C; BLUE COPPER PROTEINS; HEME-PROTEINS; ACTIVE-SITE; TEMPERATURE-DEPENDENCE; AXIAL METHIONINE; RESONANCE RAMAN; DYNAMICS; CARDIOLIPIN; SCATTERING	The multifunctional protein cytochrome c (cyt c) plays key roles in electron transport and apoptosis, switching function by modulating bonding between a heme iron and the sulfur in a methionine residue. This Fe-S(Met) bond is too weak to persist in the absence of protein constraints. We ruptured the bond in ferrous cyt c using an optical laser pulse and monitored the bond reformation within the protein active site using ultrafast x-ray pulses from an x-ray free-electron laser, determining that the Fe-S(Met) bond enthalpy is similar to 4 kcal/mol stronger than in the absence of protein constraints. The 4 kcal/mol is comparable with calculations of stabilization effects in other systems, demonstrating how biological systems use an entatic state for modest yet accessible energetics to modulate chemical function.	[Mara, Michael W.; Hadt, Ryan G.; Lim, Hyeongtaek; Hodgson, Keith O.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Mara, Michael W.; Kroll, Thomas; Lim, Hyeongtaek; Sokaras, Dimosthenis; Hodgson, Keith O.; Hedman, Britt; Gaffney, Kelly J.; Solomon, Edward I.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA; [Reinhard, Marco Eli; Hartsock, Robert W.; Kunnus, Kristjan; Bergmann, Uwe; Gaffney, Kelly J.] Stanford Univ, PULSE Inst, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Alonso-Mori, Roberto; Chollet, Matthieu; Glownia, James M.; Nelson, Silke; Bergmann, Uwe] Stanford Univ, SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Mara, Michael W.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hadt, Ryan G.] Argonne Natl Lab, Chem Sci & Engn Div, 9700 S Cass Ave, Argonne, IL 60439 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Argonne National Laboratory	Solomon, EI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Solomon, EI (corresponding author), Stanford Univ, Stanford Synchrotron Radiat Lightsource, SLAC Natl Accelerator Lab, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	edward.solomon@stanford.edu	Gaffney, Kelly/AAG-7136-2020; Young, Michelle A/N-7228-2017; Gaffney, Kelly J/N-1597-2017; Sokaras, Dimosthenis/G-6037-2010; Kroll, Thomas/D-3636-2009; alonso mori, roberto/G-2638-2013	Gaffney, Kelly J/0000-0002-0525-6465; Sokaras, Dimosthenis/0000-0001-8117-1933; Solomon, Edward/0000-0003-0291-3199; Reinhard, Marco/0000-0001-7155-2011; Lim, Hyeongtaek/0000-0003-3470-8296; alonso mori, roberto/0000-0002-5357-0934; Kunnus, Kristjan/0000-0002-9777-2685	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Institute of General Medical Sciences of the National Institutes of Health [R01GM040392]; Atomic, Molecular, and Optical Sciences program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, DOE; Swiss National Science Foundation [158890]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040392, P41GM103393] Funding Source: NIH RePORTER	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Atomic, Molecular, and Optical Sciences program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, DOE; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Linac Coherent Light Source (LCLS) and the Stanford Synchrotron Radiation Lightsource (SSRL) of the SLAC National Accelerator Laboratory is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (P41GM103393). This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award R01GM040392 (E.I.S.). R.W.H., K.K., and K.J.G. acknowledge support from the Atomic, Molecular, and Optical Sciences program within the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, DOE. M.E.R. acknowledges the Swiss National Science Foundation, project 158890. H.L. acknowledges an Abbott Laboratories graduate fellowship. R.G.H. is currently an Enrico Fermi Fellow at Argonne National Laboratory. All data are reported in the main text, figures, and supplementary material.	ASHER SA, 1983, J AM CHEM SOC, V105, P7244, DOI 10.1021/ja00363a006; Benfatto M, 2005, PHYS SCRIPTA, VT115, P28; Benfatto M, 2001, J SYNCHROTRON RADIAT, V8, P1087, DOI 10.1107/S0909049501006422; Bram O, 2011, J PHYS CHEM B, V115, P13723, DOI 10.1021/jp207615u; Bressler C, 2009, SCIENCE, V323, P489, DOI 10.1126/science.1165733; Capdevila DA, 2015, BIOCHEMISTRY-US, V54, P7491, DOI 10.1021/acs.biochem.5b00922; Cheng MC, 1999, INORG CHEM, V38, P5703, DOI 10.1021/ic990395r; Cho HS, 2010, P NATL ACAD SCI USA, V107, P7281, DOI 10.1073/pnas.1002951107; Ghosh S, 2009, P NATL ACAD SCI USA, V106, P4969, DOI 10.1073/pnas.0900995106; Glatzel P, 2005, COORDIN CHEM REV, V249, P65, DOI 10.1016/j.ccr.2004.04.011; Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146; HENRY ER, 1986, P NATL ACAD SCI USA, V83, P8982, DOI 10.1073/pnas.83.23.8982; Howard DL, 2008, PHYS CHEM CHEM PHYS, V10, P4113, DOI 10.1039/b806165c; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kitagawa T, 1988, BIOL APPL RAMAN SPEC, V3, P97; Kroll T, 2014, J AM CHEM SOC, V136, P18087, DOI 10.1021/ja5100367; LI P, 1994, BIOPHYS J, V66, P430, DOI 10.1016/S0006-3495(94)80793-3; Liu J, 2014, CHEM REV, V114, P4366, DOI 10.1021/cr400479b; McClelland LJ, 2016, J AM CHEM SOC, V138, P16770, DOI 10.1021/jacs.6b10745; MOORE GR, 1980, EUR J BIOCHEM, V103, P513, DOI 10.1111/j.1432-1033.1980.tb05975.x; MOORE GR, 1980, EUR J BIOCHEM, V103, P523, DOI 10.1111/j.1432-1033.1980.tb05976.x; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Pandiscia LA, 2015, J PHYS CHEM B, V119, P12846, DOI 10.1021/acs.jpcb.5b07328; Pettigrew GW, 1987, CYTOCHROME C; RAPHAEL AL, 1989, PROTEINS, V6, P338, DOI 10.1002/prot.340060316; SCOTT RA, 1996, CYTOCHROME C; Serpas L, 2016, J PHYS CHEM B, V120, P12219, DOI 10.1021/acs.jpcb.6b05620; Snyder BER, 2016, NATURE, V536, P317, DOI 10.1038/nature19059; Solomon EI, 2011, COORDIN CHEM REV, V255, P774, DOI 10.1016/j.ccr.2010.12.008; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; Tezcan FA, 1998, J AM CHEM SOC, V120, P13383, DOI 10.1021/ja982536e; Tsai ML, 2013, P NATL ACAD SCI USA, V110, P14658, DOI 10.1073/pnas.1314242110; Tuominen EKJ, 2002, J BIOL CHEM, V277, P8822, DOI 10.1074/jbc.M200056200; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Yoon J, 2009, P NATL ACAD SCI USA, V106, P6585, DOI 10.1073/pnas.0902127106; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; ZHANG FL, 1994, BBA-BIOMEMBRANES, V1193, P219, DOI 10.1016/0005-2736(94)90156-2; Zhang WK, 2014, NATURE, V509, P345, DOI 10.1038/nature13252; Zhang Y, 2009, J PHYS CHEM B, V113, P825, DOI 10.1021/jp807499y	40	86	86	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1276	+		10.1126/science.aam6203	http://dx.doi.org/10.1126/science.aam6203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642436	Green Accepted			2022-12-28	WOS:000403881700038
J	Hoffmann, T; Glasziou, P; Beller, E; Goldacre, B; Chalmers, I				Hoffmann, Tammy; Glasziou, Paul; Beller, Elaine; Goldacre, Ben; Chalmers, Iain			Focus on sharing individual patient data distracts from other ways of improving trial transparency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REGISTRATION; GUIDANCE		[Hoffmann, Tammy; Glasziou, Paul; Beller, Elaine] Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Australia; [Goldacre, Ben] Univ Oxford, Ctr Evidence Based Med, Oxford, England; [Chalmers, Iain] James Lind Initiat, Oxford, England	Bond University; University of Oxford	Hoffmann, T (corresponding author), Bond Univ, Ctr Res Evidence Based Practice, Gold Coast, Australia.	thoffmann@bond.edu.au	Hoffmann, Tammy/E-8029-2010; Glasziou, Paul/A-7832-2008	Hoffmann, Tammy/0000-0001-5210-8548; Glasziou, Paul/0000-0001-7564-073X				Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Batelle Technology Partnership Practice, 2015, BIOPH IND SPONS CLIN; Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Dal-Re R, 2016, J CLIN EPIDEMIOL, V75, P100, DOI 10.1016/j.jclinepi.2016.01.017; Dal-Re R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1323; Dechartres A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0639-x; Doshi Peter, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002496; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Goldacre B, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1290-8; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hooft L, 2014, NETH J MED, V72, P349; Horton R, 2016, LANCET, V388, P1143, DOI 10.1016/S0140-6736(16)31638-5; Longo DL, 2016, NEW ENGL J MED, V374, P276, DOI 10.1056/NEJMe1516564; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mendel J, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4626; National Institutes of Health Department of Health and Human Services, 2016, Fed Regist, V81, P64981; Pfizer, 2009, DISCL CLIN TRAIL INF; Riveros C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001566; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Rosenbaum L, 2017, NEW ENGL J MED, V376, P2201, DOI 10.1056/NEJMp1704482; Strom BL, 2016, NEW ENGL J MED, V375, P1608, DOI 10.1056/NEJMp1610336; Taichman DB, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2372; Taichman DB, 2016, JAMA-J AM MED ASSOC, V315, P467, DOI 10.1001/jama.2015.18164; Tang E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0430-4; Vallance P, 2013, LANCET, V382, P1073, DOI 10.1016/S0140-6736(13)62001-2; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Weber WEJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3572; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785; Zarin DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001946	32	8	8	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2782	10.1136/bmj.j2782	http://dx.doi.org/10.1136/bmj.j2782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YZ	28642275	Green Submitted			2022-12-28	WOS:000404210800006
J	Vassy, JL; Christensen, KD; Schonman, EF; Blout, CL; Robinson, JO; Krier, JB; Diamond, PM; Lebo, M; Machini, K; Azzariti, DR; Dukhovny, D; Bates, DW; MacRae, CA; Murray, MF; Rehm, HL; McGuire, AL; Green, RC				Vassy, Jason L.; Christensen, Kurt D.; Schonman, Erica F.; Blout, Carrie L.; Robinson, Jill O.; Krier, Joel B.; Diamond, Pamela M.; Lebo, Matthew; Machini, Kalotina; Azzariti, Danielle R.; Dukhovny, Dmitry; Bates, David W.; MacRae, Calum A.; Murray, Michael F.; Rehm, Heidi L.; McGuire, Amy L.; Green, Robert C.		MedSeq Project	The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients A Pilot Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL GENETICS; AMERICAN-COLLEGE; EXOME; PARTICIPANTS; VARIANTS; RISKS; KEY	Background: Whole-genome sequencing (WGS) in asymptomatic adults might prevent disease but increase health care use without clinical value. Objective: To describe the effect on clinical care and outcomes of adding WGS to standardized family history assessment in primary care. Design: Pilot randomized trial. (ClinicalTrials.gov: NCT 01736566) Setting: Academic primary care practices. Participants: 9 primary care physicians (PCPs) and 100 generally healthy patients recruited at ages 40 to 65 years. Intervention: Patients were randomly assigned to receive a family history report alone (FH group) or in combination with an interpreted WGS report (FH + WGS group), which included monogenic disease risk (MDR) results (associated with Mendelian disorders), carrier variants, pharmacogenomic associations, and polygenic risk estimates for cardiometabolic traits. Each patient met with his or her PCP to discuss the report. Measurements: Clinical outcomes and health care use through 6 months were obtained from medical records and audio-recorded discussions between PCPs and patients. Patients' health behavior changes were surveyed 6 months after receiving results. A panel of clinician-geneticists rated the appropriateness of how PCPs managed MDR results. Results: Mean age was 55 years; 58% of patients were female. Eleven FH + WGS patients (22% [95% CI, 12% to 36%]) had new MDR results. Only 2 (4% [CI, 0.01% to 15%]) had evidence of the phenotypes predicted by an MDR result (fundus albipunctatus due to RDH5 and variegate porphyria due to PPOX). Primary care physicians recommended new clinical actions for 16% (CI, 8% to 30%) of FH patients and 34% (CI, 22% to 49%) of FH + WGS patients. Thirty percent (CI, 17% to 45%) and 41% (CI, 27% to 56%) of FH and FH + WGS patients, respectively, reported making a health behavior change after 6 months. Geneticists rated PCP management of 8 MDR results (73% [CI, 39% to 99%]) as appropriate and 2 results (18% [CI, 3% to 52%]) as inappropriate. Limitation: Limited sample size and ancestral and socioeconomic diversity. Conclusion: Adding WGS to primary care reveals new molecular findings of uncertain clinical utility. Nongeneticist providers may be able to manage WGS results appropriately, but WGS may prompt additional clinical actions of unclear value.	Harvard Med Sch, VA Boston Healthcare Syst, Brigham & Womens Hosp, Boston, MA USA; Partners HealthCare Personalized Med, Boston, MA USA; Baylor Coll Med, Houston, TX 77030 USA; UTHlth Sch Publ Hlth, Houston, TX USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Broad Inst MIT & Harvard, Cambridge, MA USA; Geisinger Hlth Syst, Danville, PA USA; [Vassy, Jason L.] 150 South Huntington Ave,152-G, Boston, MA 02130 USA; [Christensen, Kurt D.; Schonman, Erica F.; Blout, Carrie L.; Krier, Joel B.; Green, Robert C.] 41 Ave Louis Pasteur,Suite 301, Boston, MA 02115 USA; [Robinson, Jill O.; McGuire, Amy L.] 1 Baylor Plaza,Suite 310D, Houston, TX 77030 USA; [Diamond, Pamela M.] 7000 Fannin,UCT Suite 2614, Houston, TX 77030 USA; [Lebo, Matthew; Machini, Kalotina; Azzariti, Danielle R.; Rehm, Heidi L.] 65 Landsdowne St,Suite 350, Cambridge, MA 02139 USA; [Dukhovny, Dmitry] 707 SW Gaines St,Mail Code CDRC P, Portland, OR 97239 USA; [Bates, David W.] 1620 Tremont St,3rd Floor,BC3-2M, Boston, MA 02120 USA; [MacRae, Calum A.] Bldg Transformat Med 7016F,60 Fenwood Rd, Boston, MA 02115 USA; [Murray, Michael F.] 190 Welles St,Suite 128, Forty Ft, PA 18704 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Partners Healthcare System; Baylor College of Medicine; Oregon Health & Science University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Geisinger Health System	Vassy, JL (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave,152-G, Boston, MA 02115 USA.	jvassy@partners.org	Bates, David/AAE-7283-2019; Vassy, Jason L./AAC-8220-2019	Christensen, Kurt/0000-0003-4068-776X; Blout Zawatsky, Carrie/0000-0001-6328-0386; Lebo, Matthew/0000-0002-9733-5207; Kraft, Peter/0000-0002-4472-8103; Betting, Wendi/0000-0003-0894-8245; Vassy, Jason/0000-0001-6113-5564	National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100, UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007690, U01HG006500, K01HG009173, U01HG008685, U41HG006834] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health.	Beaudet AL, 2016, AM J MED GENET C, V172, P123, DOI 10.1002/ajmg.c.31487; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Cassa CA, 2013, HUM MUTAT, V34, P1216, DOI 10.1002/humu.22375; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Cuckle H, 2015, CLIN BIOCHEM, V48, P932, DOI 10.1016/j.clinbiochem.2015.02.011; DeSalvo KB, 2005, HEALTH SERV RES, V40, P1234, DOI 10.1111/j.1475-6773.2005.00404.x; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Feero WG, 2014, GENET MED, V16, P871, DOI 10.1038/gim.2014.67; Feero WG, 2013, JAMA-J AM MED ASSOC, V309, P1235, DOI 10.1001/jama.2013.113; Fitch K., 2001, RAND UCLA APPROPRIAT; Gagan J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0203-x; Green RC, 2016, AM J HUM GENET, V98, P1051, DOI 10.1016/j.ajhg.2016.04.011; Grosse SD, 2010, PUBLIC HEALTH GENOM, V13, P106, DOI 10.1159/000226594; Grosse SD, 2014, GENET MED, V16, P225, DOI 10.1038/gim.2013.158; Harrison Steven M, 2016, Curr Protoc Hum Genet, V89, DOI 10.1002/0471142905.hg0816s89; Hunter JE, 2016, GENET MED, V18, P1258, DOI 10.1038/gim.2016.40; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Khoury MJ, 2008, HEALTH AFFAIR, V27, P1600, DOI 10.1377/hlthaff.27.6.1600; Kohane IS, 2012, GENET MED, V14, P399, DOI 10.1038/gim.2011.68; Kong SW, 2015, GENET MED, V17, P536, DOI 10.1038/gim.2014.143; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; McLaughlin HM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0134-1; Nalichowski Ruth, 2006, AMIA Annu Symp Proc, P1044; Olfson E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135193; Prince AER, 2015, GENET MED, V17, P441, DOI 10.1038/gim.2014.129; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Relling MV, 2015, NATURE, V526, P343, DOI 10.1038/nature15817; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robinson JO, 2016, J EMPIR RES HUM RES, V11, P21, DOI 10.1177/1556264615624078; Salgado D, 2016, HUM MUTAT, V37, P1272, DOI 10.1002/humu.23110; Selkirk CG, 2013, GENET TEST MOL BIOMA, V17, P219, DOI 10.1089/gtmb.2012.0165; SNAITH RP, 1986, BMJ-BRIT MED J, V292, P344, DOI DOI 10.1136/BMJ.292.6516.344; Trinidad SB, 2015, AM J BIOETHICS, V15, P15, DOI 10.1080/15265161.2015.1039731; Vassy JL, 2015, PUBLIC HEALTH GENOM, V18, P123, DOI 10.1159/000370102; Vassy JL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-85; Watson M, 2015, GENET MED, V17, P505, DOI 10.1038/gim.2015.41; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	39	110	111	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					159	+		10.7326/M17-0188	http://dx.doi.org/10.7326/M17-0188			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28654958	Green Accepted			2022-12-28	WOS:000406631400006
J	Devi, S				Devi, Sharmila			Caring for health in occupied Palestinian territory	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					113	114		10.1016/S0140-6736(17)31767-1	http://dx.doi.org/10.1016/S0140-6736(17)31767-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28699581				2022-12-28	WOS:000404976600016
J	Avni, R; Nave, M; Barad, O; Baruch, K; Twardziok, SO; Gundlach, H; Hale, I; Mascher, M; Spannagl, M; Wiebe, K; Jordan, KW; Golan, G; Deek, J; Ben-Zvi, B; Ben-Zvi, G; Himmelbach, A; MacLachlan, RP; Sharpe, AG; Fritz, A; Ben-David, R; Budak, H; Fahima, T; Korol, A; Faris, JD; Hernandez, A; Mikel, MA; Levy, AA; Steffenson, B; Maccaferri, M; Tuberosa, R; Cattivelli, L; Faccioli, P; Ceriotti, A; Kashkush, K; Pourkheirandish, M; Komatsuda, T; Eilam, T; Sela, H; Sharon, A; Ohad, N; Chamovitz, DA; Mayer, KFX; Stein, N; Ronen, G; Peleg, Z; Pozniak, CJ; Akhunov, ED; Distelfeld, A				Avni, Raz; Nave, Moran; Barad, Omer; Baruch, Kobi; Twardziok, Sven O.; Gundlach, Heidrun; Hale, Iago; Mascher, Martin; Spannagl, Manuel; Wiebe, Krystalee; Jordan, Katherine W.; Golan, Guy; Deek, Jasline; Ben-Zvi, Batsheva; Ben-Zvi, Gil; Himmelbach, Axel; MacLachlan, Ron P.; Sharpe, Andrew G.; Fritz, Allan; Ben-David, Roi; Budak, Hikmet; Fahima, Tzion; Korol, Abraham; Faris, Justin D.; Hernandez, Alvaro; Mikel, Mark A.; Levy, Avraham A.; Steffenson, Brian; Maccaferri, Marco; Tuberosa, Roberto; Cattivelli, Luigi; Faccioli, Primetta; Ceriotti, Aldo; Kashkush, Khalil; Pourkheirandish, Mohammad; Komatsuda, Takao; Eilam, Tamar; Sela, Hanan; Sharon, Amir; Ohad, Nir; Chamovitz, Daniel A.; Mayer, Klaus F. X.; Stein, Nils; Ronen, Gil; Peleg, Zvi; Pozniak, Curtis J.; Akhunov, Eduard D.; Distelfeld, Assaf			Wild emmer genome architecture and diversity elucidate wheat evolution and domestication	SCIENCE			English	Article							GRAIN; SELECTION; REVEALS	Wheat (Triticum spp.) is one of the founder crops that likely drove the Neolithic transition to sedentary agrarian societies in the Fertile Crescent more than 10,000 years ago. Identifying genetic modifications underlying wheat's domestication requires knowledge about the genome of its allo-tetraploid progenitor, wild emmer (T. turgidum ssp. dicoccoides). We report a 10.1-gigabase assembly of the 14 chromosomes of wild tetraploid wheat, as well as analyses of gene content, genome architecture, and genetic diversity. With this fully assembled polyploid wheat genome, we identified the causal mutations in Brittle Rachis 1 (TtBtr1) genes controlling shattering, a key domestication trait. A study of genomic diversity among wild and domesticated accessions revealed genomic regions bearing the signature of selection under domestication. This reference assembly will serve as a resource for accelerating the genome-assisted improvement of modern wheat varieties.	[Avni, Raz; Nave, Moran; Deek, Jasline; Ben-Zvi, Batsheva; Sharon, Amir; Ohad, Nir; Chamovitz, Daniel A.; Distelfeld, Assaf] Tel Aviv Univ, Sch Plant Sci & Food Secur, Tel Aviv, Israel; [Barad, Omer; Baruch, Kobi; Ben-Zvi, Gil; Ronen, Gil] NRGene Ltd, Ness Ziona, Israel; [Twardziok, Sven O.; Gundlach, Heidrun; Spannagl, Manuel; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, Plant Genome & Syst Biol, Neuherberg, Germany; [Hale, Iago] Univ New Hampshire, Durham, NH 03824 USA; [Mascher, Martin; Himmelbach, Axel; Stein, Nils] Leibniz Inst Plant Genet & Crop Plant Res IPK, Ot Gatersleben, Stadt Seeland, Germany; [Mascher, Martin] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Wiebe, Krystalee; MacLachlan, Ron P.; Sharpe, Andrew G.; Pozniak, Curtis J.] Univ Saskatchewan, Saskatoon, SK, Canada; [Jordan, Katherine W.; Fritz, Allan; Akhunov, Eduard D.] Kansas State Univ, Manhattan, KS 66506 USA; [Golan, Guy; Peleg, Zvi] Hebrew Univ Jerusalem, Rehovot, Israel; [Sharpe, Andrew G.] Global Inst Food Secur, Saskatoon, SK, Canada; [Ben-David, Roi] ARO, Bet Dagan, Israel; [Budak, Hikmet] Montana State Univ, Bozeman, MT 59717 USA; [Fahima, Tzion; Korol, Abraham] Univ Haifa, Haifa, Israel; [Faris, Justin D.] USDA ARS, Fargo, ND USA; [Levy, Avraham A.] Weizmann Inst Sci, Rehovot, Israel; [Steffenson, Brian] Univ Minnesota, St Paul, MN 55108 USA; [Maccaferri, Marco; Tuberosa, Roberto] Univ Bologna, Bologna, Italy; [Cattivelli, Luigi; Faccioli, Primetta] Council Agr Res & Econ, Res Ctr Genom & Bioinformat, Fiorenzuola Darda, Italy; [Ceriotti, Aldo] CNR Natl Res Council, Inst Agr Biol & Biotechnol, Milan, Italy; [Kashkush, Khalil] Ben Gurion Univ Negev, Beer Sheva, Israel; [Pourkheirandish, Mohammad; Komatsuda, Takao] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Eilam, Tamar; Sela, Hanan; Sharon, Amir; Distelfeld, Assaf] Tel Aviv Univ, Inst Cereal Crops Improvement, Tel Aviv, Israel; [Mayer, Klaus F. X.] Tech Univ Munich, Sch Life Sci Weihenstephan, Munich, Germany; [Pourkheirandish, Mohammad] Univ Sydney, Plant Breeding Inst, Cobbitty, Australia	Tel Aviv University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System Of New Hampshire; University of New Hampshire; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Saskatchewan; Kansas State University; Hebrew University of Jerusalem; University of Saskatchewan; Montana State University System; Montana State University Bozeman; University of Haifa; United States Department of Agriculture (USDA); Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities; University of Bologna; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio Nazionale delle Ricerche (CNR); Ben Gurion University; National Institute of Agrobiological Sciences - Japan; Tel Aviv University; Technical University of Munich; University of Sydney	Distelfeld, A (corresponding author), Tel Aviv Univ, Sch Plant Sci & Food Secur, Tel Aviv, Israel.; Distelfeld, A (corresponding author), Tel Aviv Univ, Inst Cereal Crops Improvement, Tel Aviv, Israel.	adistel@tauex.tau.ac.il	Ceriotti, Aldo/A-1448-2016; Peleg, Zvi/P-3695-2019; Budak, Hikmet/S-5835-2017; Stein, Nils/F-7507-2017; cattivelli, luigi/AAE-7046-2020; Pourkheirandish, Mohammad/AAS-7002-2021; Mayer, Klaus FX/M-7941-2015; Distelfeld, Assaf/D-4951-2014; Chamovitz, Daniel/S-5021-2019; KASHKUSH, KHALIL/ABT-5599-2022; Budak, Hikmet/U-8517-2019	Ceriotti, Aldo/0000-0002-8230-8863; Peleg, Zvi/0000-0001-8063-1619; Budak, Hikmet/0000-0002-2556-2478; Stein, Nils/0000-0003-3011-8731; cattivelli, luigi/0000-0002-6067-4600; Pourkheirandish, Mohammad/0000-0003-4337-3600; Mayer, Klaus FX/0000-0001-6484-1077; Distelfeld, Assaf/0000-0003-1777-3053; Chamovitz, Daniel/0000-0002-2815-2909; KASHKUSH, KHALIL/0000-0001-7861-4959; Budak, Hikmet/0000-0002-2556-2478; Spannagl, Manuel/0000-0003-0701-7035; Avni, Raz/0000-0002-0801-5093; Golan, Guy/0000-0002-5255-393X; Fahima, Tzion/0000-0001-5555-0040; Akhunov, Eduard/0000-0002-0416-5211; Gundlach, Heidrun/0000-0002-6757-0943; Himmelbach, Axel/0000-0001-7338-0946; Hale, Iago/0000-0002-8558-7861; Ohad, Nir/0000-0002-7094-2939; Twardziok, Sven/0000-0002-0326-5704; Steffenson, Brian/0000-0001-7961-5363; Sela, Hanan/0000-0002-4218-4376; Faris, Justin/0000-0002-9653-3287; MACCAFERRI, MARCO/0000-0002-1935-3282	Israel Science Foundation [999/12, 1824/12, 322/15]; German-Israeli Foundation for Scientific Research and Development (GIF) grant [I-1212-315.13]; Integrated DNA Technologies, Inc. (IDT); United States-Israel Binational Science Foundation (BSF) [2013396, 2015409]; USDA NIFA (National Institute of Food and Agriculture) [2016-67013-24473]; German Ministry of Education and Research [0314000, 0315954, 031A536]; Genome Canada; Saskashewan Ministry of Agriculture and Western Grains Research Foundation (CTAG2 project); U.S. Agency for International Development Middle East Research and Cooperation [M34-037]; Italian Ministry of Education and Research Flagship InterOmics [PB05]; CREA-interomics projects; Manna Center Program for Food Safety and Security in Tel Aviv University; Montana Plant Sciences endowment; Lieberman-Okinow endowment at the University of Minnesota; Charles and Tillie Lubin Center for Plant Biotechnology at the Weizmann Institute; Genome Prairie	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation for Scientific Research and Development (GIF) grant; Integrated DNA Technologies, Inc. (IDT); United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); USDA NIFA (National Institute of Food and Agriculture); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Genome Canada(Genome Canada); Saskashewan Ministry of Agriculture and Western Grains Research Foundation (CTAG2 project); U.S. Agency for International Development Middle East Research and Cooperation(United States Agency for International Development (USAID)); Italian Ministry of Education and Research Flagship InterOmics; CREA-interomics projects; Manna Center Program for Food Safety and Security in Tel Aviv University; Montana Plant Sciences endowment; Lieberman-Okinow endowment at the University of Minnesota(University of Minnesota System); Charles and Tillie Lubin Center for Plant Biotechnology at the Weizmann Institute; Genome Prairie	Supported by Israel Science Foundation (grants 999/12, 1824/12, 322/15), the German-Israeli Foundation for Scientific Research and Development (GIF) grant I-1212-315.13, Integrated DNA Technologies, Inc. (IDT), the United States-Israel Binational Science Foundation (BSF grants 2013396 and 2015409), USDA NIFA (National Institute of Food and Agriculture) (grant 2016-67013-24473), German Ministry of Education and Research (grants 0314000, 0315954, 031A536), Genome Canada and Genome Prairie, Saskashewan Ministry of Agriculture and Western Grains Research Foundation (CTAG2 project), U.S. Agency for International Development Middle East Research and Cooperation (grant M34-037), Italian Ministry of Education and Research Flagship InterOmics (PB05), and CREA-interomics projects.r Additional support was funded from the Manna Center Program for Food Safety and Security in Tel Aviv University, Montana Plant Sciences endowment, the Lieberman-Okinow endowment at the University of Minnesota, and the Charles and Tillie Lubin Center for Plant Biotechnology at the Weizmann Institute. We thank O. Savin, I. Hamerman, A. Fiebig, and C. Wright. The WEW sequence (GenBank: LSYQ00000000) and all other WEW genomic resources can be accessed at http://wewseq.wixsite.com/consortium.	Abbo S, 2014, TRENDS PLANT SCI, V19, P351, DOI 10.1016/j.tplants.2013.12.002; Akhunov ED, 2007, MOL BIOL EVOL, V24, P539, DOI 10.1093/molbev/msl183; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; El Baidouri M, 2013, GENOME BIOL EVOL, V5, P954, DOI 10.1093/gbe/evt025; Golan G, 2015, J EXP BOT, V66, P5703, DOI 10.1093/jxb/erv249; Hirsch CN, 2016, PLANT CELL, V28, P2700, DOI 10.1105/tpc.16.00353; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Luo MC, 2007, THEOR APPL GENET, V114, P947, DOI 10.1007/s00122-006-0474-0; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Nave M, 2016, THEOR APPL GENET, V129, P1303, DOI 10.1007/s00122-016-2704-4; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Tanno K, 2006, SCIENCE, V311, P1886, DOI 10.1126/science.311.5769.1866a; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	24	463	485	14	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					93	96		10.1126/science.aan0032	http://dx.doi.org/10.1126/science.aan0032			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684525				2022-12-28	WOS:000416909500009
J	Hanna, R; Kreindler, G; Olken, BA				Hanna, Rema; Kreindler, Gabriel; Olken, Benjamin A.			Citywide effects of high-occupancy vehicle restrictions: Evidence from "three-in-one" in Jakarta	SCIENCE			English	Article								Widespread use of single-occupancy cars often leads to traffic congestion. Using anonymized traffic speed data from Android phones collected through Google Maps, we investigated whether high-occupancy vehicle (HOV) policies can combat congestion. We studied Jakarta's "three-in-one" policy, which required all private cars on two major roads to carry at least three passengers during peak hours. After the policy was abruptly abandoned in April 2016, delays rose from 2.1 to 3.1 minutes per kilometer (min/km) in the morning peak and from 2.8 to 5.3 min/km in the evening peak. The lifting of the policy led to worse traffic throughout the city, even on roads that had never been restricted or at times when restrictions had never been in place. In short, we find that HOV policies can greatly improve traffic conditions.	[Hanna, Rema] Harvard Univ, Harvard Kennedy Sch, 79 John F Kennedy St, Cambridge, MA 02138 USA; [Kreindler, Gabriel; Olken, Benjamin A.] MIT, Dept Econ, 50 Mem Dr, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Olken, BA (corresponding author), MIT, Dept Econ, 50 Mem Dr, Cambridge, MA 02142 USA.	bolken@mit.edu		/0000-0003-3847-7763	Australian Government's Department of Foreign Affairs and Trade	Australian Government's Department of Foreign Affairs and Trade(Australian Government)	We thank D. Acemoglu, M. Anderson, A. Banerjee, and M. Turner for helpful comments; A. Yansyah, Jakarta Transportation Agency (Dishub) for technical advice; and M. Fryar, Z. Hitzig, W. Perdhani, and F. Siregar for helpful assistance. This project was financially supported by the Australian Government's Department of Foreign Affairs and Trade. All views expressed in the paper are those of the authors alone, and do not necessarily reflect the views of any of the institutions or individuals acknowledged here. All data and programs are available at http://dx.doi.org/10.7910/DVN/48U7GP.	Anderson ML, 2014, AM ECON REV, V104, P2763, DOI 10.1257/aer.104.9.2763; Baker J., 2005, 3693 WORLD BANK; Dahlgren J, 1998, TRANSPORT RES A-POL, V32, P99, DOI 10.1016/S0965-8564(97)00021-9; Davis LW, 2008, J POLIT ECON, V116, P38, DOI 10.1086/529398; Fuhs C., 2002, 023922 TRANSP RES BO; Gallego F, 2013, J PUBLIC ECON, V107, P47, DOI 10.1016/j.jpubeco.2013.08.007; Geroliminis N, 2008, TRANSPORT RES B-METH, V42, P759, DOI 10.1016/j.trb.2008.02.002; Globe J., 2012, JAKARTA JOCKEYS FEEL; Indonesian Central Bureau of Statistics (BPS), 2015, SAT JAW BAR JUML PEN; Indonesian Central Bureau of Statistics (BPS), 2015, BANT PEND MEN JEN KE; Knittel CR, 2016, REV ECON STAT, V98, P350, DOI 10.1162/REST_a_00548; Kreindler G., 2016, DRIVING DELHI BEHAV; Kwon J, 2008, TRANSPORT RES C-EMER, V16, P98, DOI 10.1016/j.trc.2007.06.008; McKenzie B., 2011, AM COMMUNITY SURVEY, V15; Mochtar MZ, 2006, PRINCIPAL ISSUES IMP, V47, P31; Pereira R. H. M., 2013, 1813A IPEA; STEINBERG R, 1983, TRANSPORT SCI, V17, P301, DOI 10.1287/trsc.17.3.301; Transport for London, 2016, CONG CHARG IMP MON 4	18	26	26	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					89	+		10.1126/science.aan2747	http://dx.doi.org/10.1126/science.aan2747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5OK	28684524	Green Published			2022-12-28	WOS:000416909500008
J	Fischer, KR; Altorki, NK; Mittal, V; Gao, DC				Fischer, Kari R.; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng			Upholding a role for EMT in breast cancer metastasis Reply	NATURE			English	Letter							TO-MESENCHYMAL TRANSITION; DISSEMINATION		[Fischer, Kari R.; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Dept Cardiothorac Surg, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA; [Fischer, Kari R.; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Dept Cell & Dev Biol, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA; [Fischer, Kari R.; Altorki, Nasser K.; Mittal, Vivek; Gao, Dingcheng] Cornell Univ, Neuberger Berman Lung Canc Ctr, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA; [Fischer, Kari R.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA; [Fischer, Kari R.] New York Acad Sci, 250 Greenwich St, New York, NY 10007 USA	Cornell University; Cornell University; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Gao, DC (corresponding author), Cornell Univ, Dept Cardiothorac Surg, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.; Gao, DC (corresponding author), Cornell Univ, Dept Cell & Dev Biol, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.; Gao, DC (corresponding author), Cornell Univ, Neuberger Berman Lung Canc Ctr, Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	dig2009@med.cornell.edu	Gao, Dingcheng/P-5889-2019		NATIONAL CANCER INSTITUTE [R01CA205418] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA205418] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Ni T, 2016, NAT CELL BIOL, V18, P1221, DOI 10.1038/ncb3425; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Ye X, 2017, NATURE, V547, pE1, DOI 10.1038/nature22816; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	12	17	17	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					E5	E6		10.1038/nature22817	http://dx.doi.org/10.1038/nature22817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682327	Green Accepted			2022-12-28	WOS:000404839900002
J	Jani, SM; Nallamothu, BK; Cooper, LT; Smith, A; Fazel, R				Jani, Sandeep M.; Nallamothu, Brahmajee K.; Cooper, Leslie T.; Smith, Andrew; Fazel, Reza			Beating, Fast and Slow	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GIANT-CELL MYOCARDITIS; ENDOMYOCARDIAL BIOPSY; DIAGNOSIS; IMMUNOSUPPRESSION; RECURRENCE		[Jani, Sandeep M.] MedStar Washington Hosp Ctr, MedStar Heart & Vasc Inst, Washington, DC USA; [Nallamothu, Brahmajee K.] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Cooper, Leslie T.] Mayo Clin, Div Cardiol, Rochester, MN USA; [Smith, Andrew] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Fazel, Reza] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA	MedStar Washington Hospital Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Mayo Clinic; Emory University; Harvard University; Brigham & Women's Hospital	Fazel, R (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	rfazel@bwh.harvard.edu		Cooper, Leslie/0000-0003-1002-3313; Fazel, Reza/0000-0002-9102-6155				Cooper LT, 2012, HERZ, V37, P632, DOI 10.1007/s00059-012-3658-1; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Cooper LT, 2008, AM J CARDIOL, V102, P1535, DOI 10.1016/j.amjcard.2008.07.041; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Cooper LT, 2000, HERZ, V25, P291, DOI 10.1007/s000590050023; Davies RA, 2002, J HEART LUNG TRANSPL, V21, P674, DOI 10.1016/S1053-2498(02)00379-0; Eid SM, 2009, ARCH PATHOL LAB MED, V133, P138, DOI 10.1043/1543-2165-133.1.138; Heymans S, 2016, J AM COLL CARDIOL, V68, P2348, DOI 10.1016/j.jacc.2016.09.937; Kadkhodayan Ana, 2016, JACC Cardiovasc Imaging, V9, P603, DOI 10.1016/j.jcmg.2016.01.010; Kandolin R, 2013, CIRC-HEART FAIL, V6, P15, DOI 10.1161/CIRCHEARTFAILURE.112.969261; Maleszewski JJ, 2015, AM J CARDIOL, V115, P1733, DOI 10.1016/j.amjcard.2015.03.023; Okura Y, 2003, J AM COLL CARDIOL, V41, P322, DOI 10.1016/S0735-1097(02)02715-8; Scott RL, 2001, J HEART LUNG TRANSPL, V20, P375, DOI 10.1016/S1053-2498(00)00314-4; Shields RC, 2002, J CARD FAIL, V8, P74, DOI 10.1054/jcaf.2002.32196; Skouri HN, 2006, J AM COLL CARDIOL, V48, P2085, DOI 10.1016/j.jacc.2006.08.017	15	7	7	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					72	78		10.1056/NEJMcps1608688	http://dx.doi.org/10.1056/NEJMcps1608688			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679100				2022-12-28	WOS:000404730000012
J	Faccio, D				Faccio, Daniele			Plasmons that won't stick	SCIENCE			English	Editorial Material							INTERFERENCE; OPTICS		[Faccio, Daniele] Heriot Watt Univ, Inst Photon & Quantum Sci, Edinburgh EH14 7AS, Midlothian, Scotland	Heriot Watt University	Faccio, D (corresponding author), Heriot Watt Univ, Inst Photon & Quantum Sci, Edinburgh EH14 7AS, Midlothian, Scotland.	d.faccio@hw.ac.uk	Faccio, Daniele/K-5794-2018	Faccio, Daniele/0000-0001-8397-334X				Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Barnett SM, 1998, PHYS REV A, V57, P2134, DOI 10.1103/PhysRevA.57.2134; Falk AL, 2009, NAT PHYS, V5, P475, DOI 10.1038/NPHYS1284; Heeres RW, 2010, NANO LETT, V10, P661, DOI 10.1021/nl903761t; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jeffers J, 2000, J MOD OPTIC, V47, P1819, DOI 10.1080/09500340008232434; Roger T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.023601; Roger T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8031; Vest B, 2017, SCIENCE, V356, P1373, DOI 10.1126/science.aam9353; Zheludev NI, 2016, NAT NANOTECHNOL, V11, P16, DOI [10.1038/nnano.2015.302, 10.1038/NNANO.2015.302]	10	1	1	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1336	1337		10.1126/science.aan5756	http://dx.doi.org/10.1126/science.aan5756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663459				2022-12-28	WOS:000404351500020
J	Goodknight, J; Aspuru-Guzik, A				Goodknight, Joseph; Aspuru-Guzik, Alan			Taking six-dimensional spectra in finite time	SCIENCE			English	Editorial Material							ENERGY-TRANSFER; QUANTUM COHERENCE; SPECTROSCOPY; SYSTEMS		[Goodknight, Joseph; Aspuru-Guzik, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Aspuru-Guzik, A (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	alan@aspuru.com						Bylsma J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125322; Chan WL, 2012, J AM CHEM SOC, V134, P18295, DOI 10.1021/ja306271y; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Harel E, 2011, J PHYS CHEM A, V115, P3787, DOI 10.1021/jp107022f; Huh J, 2014, J AM CHEM SOC, V136, P2048, DOI 10.1021/ja412035q; Khalil M, 2003, J PHYS CHEM A, V107, P5258, DOI 10.1021/jp0219247; Scholes GD, 2017, NATURE, V543, P647, DOI 10.1038/nature21425; Spencer AP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14732; Tiwari V, 2013, P NATL ACAD SCI USA, V110, P1203, DOI 10.1073/pnas.1211157110; Yuen-Zhou J, 2011, P NATL ACAD SCI USA, V108, P17615, DOI 10.1073/pnas.1110642108; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050	11	0	0	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1333	1333		10.1126/science.aan2842	http://dx.doi.org/10.1126/science.aan2842			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663456	Green Submitted			2022-12-28	WOS:000404351500017
J	Kupferschmidt, K				Kupferschmidt, Kai			Cholera vaccine faces major test in Yemen	SCIENCE			English	News Item																			0	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1316	1317		10.1126/science.356.6345.1316	http://dx.doi.org/10.1126/science.356.6345.1316			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663447				2022-12-28	WOS:000404351500008
J	Pizer, WA				Pizer, William A.			What's the damage from climate change?	SCIENCE			English	Editorial Material									[Pizer, William A.] Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Pizer, William A.] Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA	Duke University; Duke University	Pizer, WA (corresponding author), Duke Univ, Sanford Sch Publ Policy, Durham, NC 27708 USA.; Pizer, WA (corresponding author), Duke Univ, Nicholas Inst Environm Policy Solut, Durham, NC 27708 USA.	william.pizer@duke.edu						[Anonymous], 1993, FED REG, V58, P51735; Barreca A, 2016, J POLIT ECON, V124, P105, DOI 10.1086/684582; Graham JD, 2007, REV ENV ECON POLICY, V1, P171, DOI 10.1093/reep/rem013; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Interagency Working Group on Social Cost of Carbon, 2010, 12866 US GOV INT WOR; Interagency Working Group on the Social Cost of Carbon United States Government, 2013, 12866 US GOV INT WOR; INTERAGENCY WORKING GRP. ON SOC. COST OF CARBON U.S. GOv'T, 2016, TECHN UPD SOC COST C, P17; Kelman S, 1981, Regulation, V5, P33; National Academies of Sciences Engineering and Medicine, 2017, VAL CLIM DAM UPD EST; Rose S., 2014, GOVERNANCE DIRECTION; Sunstein C. R., 2017, BLOOMBERG       0303; U.S. Office of Management and Budget, 2003, A4 US OFF MAN BUDG; 1978, FED REG, V43, P12661	13	3	4	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1330	1331		10.1126/science.aan5201	http://dx.doi.org/10.1126/science.aan5201			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663454				2022-12-28	WOS:000404351500015
J	Gupta, PC; Ram, J				Gupta, Parul C.; Ram, Jagat			Eye Injury from a Firecracker	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Parul C.; Ram, Jagat] Postgrad Inst Med Educ & Res, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Ram, J (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh, India.	drjagatram@gmail.com							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2579	2579		10.1056/NEJMicm1616104	http://dx.doi.org/10.1056/NEJMicm1616104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY8QE	28657877				2022-12-28	WOS:000404259200011
J	Simanshu, DK; Nissley, DV; McCormick, F				Simanshu, Dhirendra K.; Nissley, Dwight V.; McCormick, Frank			RAS Proteins and Their Regulators in Human Disease	CELL			English	Review							GAP-RELATED DOMAIN; ONCOGENIC K-RAS; N-RAS; NEUROFIBROMATOSIS TYPE-1; H-RAS; SIGNAL-TRANSDUCTION; MEMBRANE-BINDING; STRUCTURAL BASIS; NOONAN SYNDROME; SMALL MOLECULES	RAS proteins are binary switches, cycling between ON and OFF states during signal transduction. These switches are normally tightly controlled, but in RAS-related diseases, such as cancer, RASopathies, and many psychiatric disorders, mutations in the RAS genes or their regulators render RAS proteins persistently active. The structural basis of the switch and many of the pathways that RAS controls are well known, but the precise mechanisms by which RAS proteins function are less clear. All RAS biology occurs in membranes: a precise understanding of RAS' interaction with membranes is essential to understand RAS action and to intervene in RAS-driven diseases.	[Simanshu, Dhirendra K.; Nissley, Dwight V.; McCormick, Frank] NCI, RAS Initiat, Canc Res Technol Program, Frederick Natl Lab Canc Res,Leidos Biomed Res, Frederick, MD 21701 USA; [McCormick, Frank] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 3rd St, San Francisco, CA 94158 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	McCormick, F (corresponding author), NCI, RAS Initiat, Canc Res Technol Program, Frederick Natl Lab Canc Res,Leidos Biomed Res, Frederick, MD 21701 USA.; McCormick, F (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 3rd St, San Francisco, CA 94158 USA.	frank.mccormick@ucsf.edu		Simanshu, Dhirendra/0000-0002-9717-4618	federal funds from the National Cancer Institute, NIH [HHSN261200800001E]; Outstanding Investigator Award [5R35CA197709]; NATIONAL CANCER INSTITUTE [R35CA197709] Funding Source: NIH RePORTER	federal funds from the National Cancer Institute, NIH; Outstanding Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part with federal funds from the National Cancer Institute, NIH, under contract number HHSN261200800001E. In addition, this project was funded in part by the Outstanding Investigator Award to F.M. (5R35CA197709). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, and the mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; Aoki Y, 2016, J HUM GENET, V61, P33, DOI 10.1038/jhg.2015.114; Arafeh R, 2015, NAT GENET, V47, P1408, DOI 10.1038/ng.3427; BALLESTER R, 1987, J BIOL CHEM, V262, P2688; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bayrak-Toydemir P, 1993, GENEREVIEWS R; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Boyd KP, 2010, J AM ACAD DERMATOL, V63, P440, DOI 10.1016/j.jaad.2009.09.042; Brasil AS, 2010, ARQ BRAS ENDOCRINOL, V54, P717, DOI 10.1590/S0004-27302010000800009; Brasil AS, 2010, GENET TEST MOL BIOMA, V14, P425, DOI 10.1089/gtmb.2009.0192; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chang T, 2013, J CLIN INVEST, V123, P335, DOI 10.1172/JCI63193; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chio IIC, 2016, CELL, V166, P963, DOI 10.1016/j.cell.2016.06.056; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; de Bruin EC, 2014, CANCER DISCOV, V4, P606, DOI 10.1158/2159-8290.CD-13-0741; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Dunzendorfer-Matt T, 2016, P NATL ACAD SCI USA, V113, P7497, DOI 10.1073/pnas.1607298113; EASTON DF, 1993, AM J HUM GENET, V53, P305; Edkins S, 2006, CANCER BIOL THER, V5, P928, DOI 10.4161/cbt.5.8.3251; Ekvall S, 2011, AM J MED GENET A, V155A, P1217, DOI 10.1002/ajmg.a.33987; Erwin N, 2016, PHYS CHEM CHEM PHYS, V18, P8954, DOI 10.1039/c6cp00563b; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Fivaz M, 2005, J CELL BIOL, V170, P429, DOI 10.1083/jcb.200409157; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Garcia-Romero MT, 2016, PEDIATR DERMATOL, V33, P9, DOI 10.1111/pde.12673; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Gripp KW, 2016, AM J MED GENET A, V170, P2237, DOI 10.1002/ajmg.a.37781; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Higgins EM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91225; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Howard T.P., 2016, COLD SPRING HARB SYM; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Huntley C, 2015, GENE, V555, P63, DOI 10.1016/j.gene.2014.09.056; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; Jang H, 2016, FASEB J, V30, P1643, DOI 10.1096/fj.15-279091; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Jeyabalan N, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00032; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Keppler-Noreuil KM, 2016, AM J MED GENET C, V172, P402, DOI 10.1002/ajmg.c.31531; KOHL NE, 1995, NAT MED, V1, P792, DOI 10.1038/nm0895-792; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li HF, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0050-8; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Lobell RB, 2002, MOL CANCER THER, V1, P747; Lusk JB, 2017, CANCERS, V9, DOI 10.3390/cancers9020016; Maoz A, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMc1616637; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Mignot C, 2016, J MED GENET, V53, P511, DOI 10.1136/jmedgenet-2015-103451; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Morris SM, 2016, JAMA PSYCHIAT, V73, P1276, DOI 10.1001/jamapsychiatry.2016.2600; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Murillo MM, 2014, J CLIN INVEST, V124, P3601, DOI 10.1172/JCI74134; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Olsen SN, 2017, CANCER DISCOV, V7, P202, DOI 10.1158/2159-8290.CD-16-0520; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Ostrem JML, 2016, NAT REV DRUG DISCOV, V15, P771, DOI 10.1038/nrd.2016.139; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Paulson VA, 2017, THYROID, V27, P506, DOI 10.1089/thy.2016.0583; Powers S, 1992, Semin Cancer Biol, V3, P209; Prakash P., 2016, SMALL GTPASES AUG, P1; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prakash P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004469; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Raaijmakers JH, 2009, J BIOL CHEM, V284, P10995, DOI 10.1074/jbc.R800061200; Rauen KA, 2007, CLIN GENET, V71, P101, DOI 10.1111/j.1399-0004.2007.00743.x; Ritt DA, 2016, MOL CELL, V64, P875, DOI 10.1016/j.molcel.2016.10.029; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Rotblat B, 2004, MOL CELL BIOL, V24, P6799, DOI 10.1128/MCB.24.15.6799-6810.2004; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Shain AH, 2015, NAT GENET, V47, P1194, DOI 10.1038/ng.3382; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Stowe IB, 2012, GENE DEV, V26, P1421, DOI 10.1101/gad.190876.112; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Thiel C, 2009, AM J MED GENET A, V149A, P1263, DOI 10.1002/ajmg.a.32837; Tidyman WE, 2016, HUM MOL GENET, V25, pR123, DOI 10.1093/hmg/ddw191; To MD, 2013, ONCOGENE, V32, P4028, DOI 10.1038/onc.2012.404; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Ullrich M, 2017, MOL PSYCHIAT; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Vogel A, 2009, ANGEW CHEM INT EDIT, V48, P8784, DOI 10.1002/anie.200903396; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Weise K, 2011, J AM CHEM SOC, V133, P880, DOI 10.1021/ja107532q; Weise K, 2009, J AM CHEM SOC, V131, P1557, DOI 10.1021/ja808691r; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams VL, 2011, INT J DERMATOL, V50, P396, DOI 10.1111/j.1365-4632.2010.04822.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Xiong Y, 2017, ACS MED CHEM LETT, V8, P61, DOI 10.1021/acsmedchemlett.6b00373; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Young LC, 2013, MOL CELL, V52, P679, DOI 10.1016/j.molcel.2013.10.004; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zhang SY, 2017, ACS CHEM BIOL, V12, P1703, DOI 10.1021/acschembio.7b00165; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhu YG, 2016, ACS CHEM BIOL, V11, P943, DOI 10.1021/acschembio.5b00984; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	153	774	801	44	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					17	33		10.1016/j.cell.2017.06.009	http://dx.doi.org/10.1016/j.cell.2017.06.009			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666118	Green Accepted, Bronze			2022-12-28	WOS:000404358500007
J	Arie, S				Arie, Sophie			Cosmetic industry regulation is only skin deep	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Department of Health, 2013, REV REG COSM INT; Keynote, 2014, COSM SURG; Nuffield Council on Bioethics, 2017, COSM PROC ETH ISS	3	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2017	357								j3047	10.1136/bmj.j3047	http://dx.doi.org/10.1136/bmj.j3047			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AO	28652383				2022-12-28	WOS:000404723900004
J	Price, M				Price, Michael			Tallying the tropical toll on trees from lightning	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1222	1222		10.1126/science.356.6344.1222	http://dx.doi.org/10.1126/science.356.6344.1222			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642390				2022-12-28	WOS:000403881700013
J	Buscher, P; Cecchi, G; Jamonneau, V; Priotto, G				Buscher, Philippe; Cecchi, Giuliano; Jamonneau, Vincent; Priotto, Gerardo			Human African trypanosomiasis	LANCET			English	Review							EFLORNITHINE COMBINATION THERAPY; RAPID DIAGNOSTIC-TEST; SLEEPING-SICKNESS; BRUCEI-GAMBIENSE; CEREBROSPINAL-FLUID; PARASITIC INFECTIONS; ANIMAL RESERVOIRS; TSETSE-FLIES; RISK-FACTORS; SERODIAGNOSIS	Human African trypanosomiasis (sleeping sickness) is a parasitic infection that almost invariably progresses to death unless treated. Human African trypanosomiasis caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts over the past 15 years, the number of reported cases has fallen to an historically low level. Fewer than 3000 cases were reported in 2015, and the disease is targeted for elimination by WHO. Despite these recent successes, the disease is still endemic in parts of sub-Saharan Africa, where it is a considerable burden on rural communities, most notably in central Africa. Since patients are also reported from non-endemic countries, human African trypanosomiasis should be considered in differential diagnosis for travellers, tourists, migrants, and expatriates who have visited or lived in endemic areas. In the absence of a vaccine, disease control relies on case detection and treatment, and vector control. Available drugs are suboptimal, but ongoing clinical trials provide hope for safer and simpler treatments.	[Buscher, Philippe] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Cecchi, Giuliano] Food & Agr Org United Nat, Sub Reg Off Eastern Afr, Addis Ababa, Ethiopia; [Jamonneau, Vincent] Inst Rech Dev, UMR INTERTRYP, Montpellier, France; [Priotto, Gerardo] WHO, Control Neglected Trop Dis Innovat & Intensified, Geneva, Switzerland	Institute of Tropical Medicine (ITM); Food & Agriculture Organization of the United Nations (FAO); Institut de Recherche pour le Developpement (IRD); World Health Organization	Buscher, P (corresponding author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	pbuscher@itg.be	Büscher, Philippe/B-9956-2012; Jamonneau, Vincent/K-1124-2016; Priotto, Gerardo/AAS-9027-2021; Cecchi, Giuliano/AAG-6940-2020	Büscher, Philippe/0000-0002-1926-7472; Jamonneau, Vincent/0000-0001-8427-0769; Cecchi, Giuliano/0000-0002-6413-7298; Burri, Christian/0000-0001-5418-1984	Government of Italy [GTFS/RAF/474/ITA, GCP/RAF/502/ITA]	Government of Italy	The Food and Agriculture Organization of the United Nations' contribution to this study was provided in the framework of the Programme against African Trypanosomosis, and supported by the Government of Italy (FAO Project Improving food security in sub-Saharan Africa by supporting the progressive reduction of tsetsetransmitted trypanosomosis in the framework of the NEPAD, codes GTFS/RAF/474/ITA and GCP/RAF/502/ITA). From the Institute of Tropical Medicine, Antwerp, Belgium, we thank Jan Van Den Abbeele and Luc Verhelst for video 1, and Epco Hasker for video 2. The boundaries and names shown and the designations used on the maps presented in this paper do not imply the expression of any opinion on the part of FAO or WHO concerning the legal status of any country, territory, city, or area, of its authorities, or concerning the delimitation of its frontiers or boundaries. The views expressed in this paper are those of the authors and do not necessarily reflect the views of FAO or WHO.	ADAMS JH, 1986, NEUROPATH APPL NEURO, V12, P81, DOI 10.1111/j.1365-2990.1986.tb00682.x; Alirol E, 2013, CLIN INFECT DIS, V56, P195, DOI 10.1093/cid/cis886; Anderson NE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001211; Auty H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001828; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P777, DOI 10.2471/BLT.05.028399; Bisser S, 2000, T ROY SOC TROP MED H, V94, P225, DOI 10.1016/S0035-9203(00)90285-2; Bisser S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004608; BITONTI AJ, 1986, BIOCHEM PHARMACOL, V35, P351, DOI 10.1016/0006-2952(86)90539-3; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum JA, 2008, LANCET INFECT DIS, V8, P631, DOI 10.1016/S1473-3099(08)70230-5; Blum JA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000383; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Bucheton B, 2011, PARASITE IMMUNOL, V33, P438, DOI 10.1111/j.1365-3024.2011.01287.x; Buscher P, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000471; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Buscher P, 2015, EXPERT REV MOL DIAGN, V15, P607, DOI 10.1586/14737159.2015.1027195; Buscher P, 2014, LANCET GLOB HEALTH, V2, pE359, DOI 10.1016/S2214-109X(14)70203-7; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Camara O, 2014, TROP MED INT HEALTH, V19, P828, DOI 10.1111/tmi.12316; Capewell P, 2016, ELIFE, V5, DOI 10.7554/eLife.17716; Cecchi G, 2008, MED VET ENTOMOL, V22, P364, DOI 10.1111/j.1365-2915.2008.00747.x; Cecchi G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0898-y; Cecchi G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-39; Cecchi G, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-15; Chappuis F, 2005, CLIN INFECT DIS, V41, P748, DOI 10.1086/432576; Checchi F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000303; Checchi F, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000064; Checchi F, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-16; Cordon-Obras C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00765; Cordon-Obras C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000704; Courtin F, 2008, TROP MED INT HEALTH, V13, P334, DOI 10.1111/j.1365-3156.2008.02007.x; Courtin F, 2005, TROP MED INT HEALTH, V10, P340, DOI 10.1111/j.1365-3156.2005.01398.x; Courtin F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003727; De Kyvon MALC, 2016, EMERG INFECT DIS, V22, P935, DOI 10.3201/eid2205.160133; Deborggraeve S, 2008, DIAGN MICR INFEC DIS, V61, P428, DOI 10.1016/j.diagmicrobio.2008.03.006; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/ERM.12.72, 10.1586/erm.12.72]; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Diggle PJ, 1983, STAT ANAL SPACIAL PO; DUGGAN AJ, 1966, J TROP MED HYG, V69, P124; Food and Agriculture Organization of the United Nations, 2014, PROGR AFR TRYP PAAT; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Franco JAR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005585; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Franco JR, 2012, RES REP TROP MED, V3, P93, DOI 10.2147/RRTM.S34399; Fromentin H., 1963, ANN SOC BELG MED TR, V5, P797; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; Grebaut P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1479-4; GUEDEGBE B, 1992, ANN SOC BELG MED TR, V72, P113; Hasker E, 2015, TROP MED INT HEALTH, V20, P339; Hasker E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001950; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; HIRA PR, 1979, J HYG EPID MICROB IM, V23, P436; Hoare C, 1972, TRYPANOSOMES MAMMALS; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Ilboudo H, 2011, MICROBES INFECT, V13, P943, DOI 10.1016/j.micinf.2011.05.007; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Jamonneau V, 2014, LANCET GLOB HEALTH, V2, pE306, DOI 10.1016/S2214-109X(14)70226-8; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Kagbadouno MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001949; Kambire R, 2012, PARASITE, V19, P389, DOI 10.1051/parasite/2012194389; Kato CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118370; Koffi M, 2016, PARASITE, V23, DOI 10.1051/parasite/2016059; KOUCHNER G, 1979, B SOC PATHOL EXOT, V72, P131; Kristensson Krister, 2013, Handb Clin Neurol, V114, P11, DOI 10.1016/B978-0-444-53490-3.00002-9; Kuepfer I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001695; Kuepfer I, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000968; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Lejon V, 2002, TROP MED INT HEALTH, V7, P685, DOI 10.1046/j.1365-3156.2002.00917.x; Lejon V, 1998, ACTA TROP, V69, P151, DOI 10.1016/S0001-706X(97)00137-X; Lejon V, 2013, SLEEPING SICKNESS LE, P199; Lindner AK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000783; Lumbala C, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0013-9; Lutje V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006201.pub3; Lyons Maryinez, 1992, COLONIAL DIS SOCIAL; MacLean LM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000906; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P103; Magona JW, 2011, J VECTOR DIS, V48, P105; Miezan TW, 2000, T ROY SOC TROP MED H, V94, P293, DOI 10.1016/S0035-9203(00)90327-4; Migchelsen SJ, 2011, INT J INFECT DIS, V15, pE517, DOI 10.1016/j.ijid.2011.03.018; Mitashi PM, 2014, THESIS; Molyneux D H, 1973, Ann Soc Belg Med Trop, V53, P605; Mpandzou G, 2011, J NEUROL SCI, V305, P112, DOI 10.1016/j.jns.2011.03.002; Mpanya A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001467; Mpiana AB., 2015, INT J TROP DIS HLTH, V5, P190, DOI [10.9734/IJTDH/2015/14182, DOI 10.9734/IJTDH/2015/14182]; Mugnier MR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005784; Mulumba MA, 2005, CONGO MED, V4, P99; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; Ngoyi DM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002954; Ngoyi DM, 2013, TROP MED INT HEALTH, V18, P778, DOI 10.1111/tmi.12102; Njamnshi AK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001525; Njiokou F, 2010, PARASITE, V17, P61, DOI 10.1051/parasite/2010171061; Odiit M, 1997, E AFR MED J, V74, P792; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; Oscherwitz SL, 2003, J TRAVEL MED, V10, P141, DOI 10.2310/7060.2003.31743; Pays E, 2014, NAT REV MICROBIOL, V12, P575, DOI 10.1038/nrmicro3298; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; PEPIN J, 1994, T ROY SOC TROP MED H, V88, P447, DOI 10.1016/0035-9203(94)90430-8; Pepin J, 2000, B WORLD HEALTH ORGAN, V78, P1284; Pohlig G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004363; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Radwanska M, 2002, AM J TROP MED HYG, V67, P684, DOI 10.4269/ajtmh.2002.67.684; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Robays J, 2004, TROP MED INT HEALTH, V9, P869, DOI 10.1111/j.1365-3156.2004.01266.x; Rocha G, 2004, LANCET, V363, P247, DOI 10.1016/S0140-6736(03)15345-7; Rooney B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004271; Schmid C, 2005, J INFECT DIS, V191, P1922, DOI 10.1086/429929; Schmid C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001920; Seixas J., 2004, THESIS; Shaw APM, 2015, PREV VET MED, V122, P406, DOI 10.1016/j.prevetmed.2015.06.013; Shaw APM, 2013, PREV VET MED, V110, P290, DOI 10.1016/j.prevetmed.2012.12.014; Shereni W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1879-5; Simarro PP, 2012, PARASITOLOGY, V139, P842, DOI 10.1017/S0031182012000169; Simarro PP, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-57; Simarro PP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003785; Simarro PP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-4; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Simarro PP, 2012, J TRAVEL MED, V19, P44, DOI 10.1111/j.1708-8305.2011.00576.x; Simo G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1254-y; Solano P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00033; Sternberg JM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003373; Steverding D, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-3; Stijlemans B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00233; Sudarshi D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003349; Sullivan L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002976; Tarral A, 2014, CLIN PHARMACOKINET, V53, P565, DOI 10.1007/s40262-014-0136-3; Tiberti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040909; Truc P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002256; Urech K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001358; Vanhollebeke B, 2010, MOL MICROBIOL, V76, P806, DOI 10.1111/j.1365-2958.2010.07156.x; VANMARCK EAE, 1981, Z PARASITENKD, V64, P187; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Vreysen MJB, 2013, J INVERTEBR PATHOL, V112, pS15, DOI 10.1016/j.jip.2012.07.026; Wendo C, 2002, LANCET, V359, P239, DOI 10.1016/S0140-6736(02)07489-5; WHO, 2013, WHO TECH REP SER, V984, P1; *WHO, 1983, TRYP CONTR MAN; WHO, 2017, HUM AFR TRYP WHO COL; WHO/World Health Organization, 2017, HUM AFR TRYP EP SIT; Woo P. T. K., 1970, Acta trop., V27, P384; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	146	366	372	10	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2397	2409		10.1016/S0140-6736(17)31510-6	http://dx.doi.org/10.1016/S0140-6736(17)31510-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN6IX	28673422				2022-12-28	WOS:000416118700025
J	Elwyn, G; Barr, PJ; Castaldo, M				Elwyn, Glyn; Barr, Paul James; Castaldo, Mary			Can Patients Make Recordings of Medical Encounters? What Does the Law Say?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Elwyn, Glyn; Barr, Paul James; Castaldo, Mary] Dartmouth Inst Hlth Policy & Clin Practice, One Med Ctr Dr,Williamson Translat Res Bldg, Lebanon, NH 03756 USA	Dartmouth College	Elwyn, G (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, One Med Ctr Dr,Williamson Translat Res Bldg, Lebanon, NH 03756 USA.	glynelwyn@gmail.com	Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286				Barr PJ, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7735; Elwyn G, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008566; Elwyn G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2078; Rodriguez M, 2015, JAMA-J AM MED ASSOC, V313, P1615, DOI 10.1001/jama.2015.2424; Tsulukidze M, 2014, PATIENT EDUC COUNS, V95, P297, DOI 10.1016/j.pec.2014.02.007; Walker J, 2014, NEW ENGL J MED, V370, P6, DOI 10.1056/NEJMp1310132	6	21	21	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 8	2017	318	6					513	514		10.1001/jama.2017.7511	http://dx.doi.org/10.1001/jama.2017.7511			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC9KM	28692707				2022-12-28	WOS:000407160100009
J	Reis, F; Li, G; Dudy, L; Bauernfeind, M; Glass, S; Hanke, W; Thomale, R; Schafer, J; Claessen, R				Reis, F.; Li, G.; Dudy, L.; Bauernfeind, M.; Glass, S.; Hanke, W.; Thomale, R.; Schafer, J.; Claessen, R.			Bismuthene on a SiC substrate: A candidate for a high-temperature quantum spin Hall material	SCIENCE			English	Article							EPITAXIAL-GROWTH; SURFACE	Quantum spin Hall materials hold the promise of revolutionary devices with dissipationless spin currents but have required cryogenic temperatures owing to small energy gaps. Here we show theoretically that a room-temperature regime with a large energy gap may be achievable within a paradigm that exploits the atomic spin-orbit coupling. The concept is based on a substrate-supported monolayer of a high-atomic number element and is experimentally realized as a bismuth honeycomb lattice on top of the insulating silicon carbide substrate SiC(0001). Using scanning tunneling spectroscopy, we detect a gap of similar to 0.8 electron volt and conductive edge states consistent with theory. Our combined theoretical and experimental results demonstrate a concept for a quantum spin Hall wide-gap scenario, where the chemical potential resides in the global system gap, ensuring robust edge conductance.	[Reis, F.; Dudy, L.; Bauernfeind, M.; Glass, S.; Schafer, J.; Claessen, R.] Univ Wurzburg, Phys Inst, D-97074 Wurzburg, Germany; [Reis, F.; Dudy, L.; Bauernfeind, M.; Glass, S.; Schafer, J.; Claessen, R.] Univ Wurzburg, Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany; [Li, G.] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 201210, Peoples R China; [Li, G.; Hanke, W.; Thomale, R.] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; ShanghaiTech University; University of Wurzburg	Schafer, J (corresponding author), Univ Wurzburg, Phys Inst, D-97074 Wurzburg, Germany.; Schafer, J (corresponding author), Univ Wurzburg, Rontgen Res Ctr Complex Mat Syst, D-97074 Wurzburg, Germany.	joerg.schaefer@physik.uni-wuerzburg.de	Li, Gang/E-5004-2013; Claessen, Ralph/A-2045-2017	Li, Gang/0000-0002-0952-5909; Claessen, Ralph/0000-0003-3682-6325; Dudy, Lenart/0000-0002-4204-5405; Reis, Felix/0000-0002-4218-2477	Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center [SFB 1170, SPP 1666, SCHA1510/5]; European Research Council (ERC) through starting grant [ERC-StG-Thomale-336012]	Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center(German Research Foundation (DFG)); European Research Council (ERC) through starting grant	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the Collaborative Research Center SFB 1170 "ToCoTronics" in Wurzburg, the SPP 1666 Priority Program "Topological Insulators," and grant SCHA1510/5, as well as by the European Research Council (ERC) through starting grant ERC-StG-Thomale-336012 "Topolectrics." G.L. acknowledges the computing time granted at the Leibniz Supercomputing Centre (LRZ) in Munich. F.R. acknowledges many helpful discussions with M. R. Scholz and J. Aulbach. The authors declare no competing financial interests.	Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Drozdov IK, 2014, NAT PHYS, V10, P664, DOI [10.1038/NPHYS3048, 10.1038/nphys3048]; Hsu CH, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/2/025005; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Knez I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136603; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Konig M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021003; Kuzumaki T, 2010, SURF SCI, V604, P1044, DOI 10.1016/j.susc.2010.03.022; Lalmi B, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524215; Liu CC, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085431; Liu CC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076802; Liu Z, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.136805; Mariani E, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165402; Miwa RH, 2003, J PHYS-CONDENS MAT, V15, P2441, DOI 10.1088/0953-8984/15/17/302; Murakami S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.236805; Roth A, 2009, SCIENCE, V325, P294, DOI 10.1126/science.1174736; Sabater C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.176802; Takayama A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.066402; Vayrynen JI, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.216402; Vogt P, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.155501; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002; Wada M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.121310; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xu Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.136804; Yang F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.016801; Yao YG, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.041401; Zhang GF, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075114; Zhang L, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.256804; Zhou M, 2014, P NATL ACAD SCI USA, V111, P14378, DOI 10.1073/pnas.1409701111; Zhu FF, 2015, NAT MATER, V14, P1020, DOI [10.1038/nmat4384, 10.1038/NMAT4384]	31	557	560	40	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2017	357	6348								10.1126/science.aai8142	http://dx.doi.org/10.1126/science.aai8142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB1KF	28663438	Green Submitted			2022-12-28	WOS:000405901600037
J	Wunderink, RG; Waterer, G				Wunderink, Richard G.; Waterer, Grant			Advances in the causes and management of community acquired pneumonia in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CARE-ASSOCIATED PNEUMONIA; RESISTANT STAPHYLOCOCCUS-AUREUS; CHEST-X-RAY; INFECTIOUS-DISEASES-SOCIETY; PANTON-VALENTINE LEUKOCIDIN; BETA-LACTAM MONOTHERAPY; CRITICALLY-ILL PATIENTS; HOSPITALIZED-PATIENTS; ANTIBIOTIC-THERAPY; REQUIRING HOSPITALIZATION	Community acquired pneumonia remains a common cause of morbidity and mortality. Usually, the causal organism is not identified and treatment remains empiric. Recent computed tomography and magnetic resonance imaging studies have challenged the accuracy of the clinical diagnosis of pneumonia, and epidemiologic studies are changing our perspective of what causes community acquired pneumonia, especially the role of viral pathogens and the frequent finding of multiple pathogens. The past decade has seen increasing overuse of empiric coverage of meticillin resistant Staphylococcus aureus and antibiotic resistant Gram negative pathogens owing to inappropriate application of guidelines for healthcare associated pneumonia. Optimal treatment remains a matter for debate, especially in very sick patients, including the role of combination antibiotic therapy and corticosteroids. Pneumonia care bundles are being defined to improve outcomes. Increased recognition of both acute and long term cardiac complications is shifting our concept of pneumonia from an acute lung disease to a multisystem problem with adverse chronic health consequences.	[Wunderink, Richard G.; Waterer, Grant] Northwestern Univ, Feinberg Sch Med, Pulm & Crit Care, Chicago, IL 60611 USA; [Waterer, Grant] Univ Western Australia, Perth, WA, Australia	Northwestern University; Feinberg School of Medicine; University of Western Australia	Wunderink, RG (corresponding author), Northwestern Univ, Feinberg Sch Med, Pulm & Crit Care, Chicago, IL 60611 USA.	r-wunderink@northwestern.edu	Waterer, Grant/AAG-2385-2021		bioMerieux	bioMerieux	We have read and understood BMJ policy on declaration of interests and declare the following interests: RGW's institution received an investigator initiated grant from bioMerieux.	Ahn S, 2011, INFLUENZA OTHER RESP, V5, P398, DOI 10.1111/j.1750-2659.2011.00244.x; Alan M, 2015, J INTERN MED, V278, P174, DOI 10.1111/joim.12341; Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; Alfageme I, 2005, ARCH BRONCONEUMOL, V41, P272; Anderson R, 2017, J INFECTION, V74, P527, DOI 10.1016/j.jinf.2017.03.005; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Aukrust P, 2011, ANN MED, V43, P90, DOI 10.3109/07853890.2010.523711; Azmi S, 2016, INT J INFECT DIS, V49, P87, DOI 10.1016/j.ijid.2016.05.021; Baby N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02432-16, 10.1128/aac.02432-16]; Bellmann-Weiler R, 2010, J CLIN MICROBIOL, V48, P1915, DOI 10.1128/JCM.01348-09; Bello S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-123; Boersma F, 1999, INT J GERIATR PSYCH, V14, P748, DOI 10.1002/(SICI)1099-1166(199909)14:9<748::AID-GPS3>3.0.CO;2-H; Boersma WG, 2006, RESP MED, V100, P926, DOI 10.1016/j.rmed.2005.06.018; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Brown ML, 2012, J CLIN MICROBIOL, V50, P86, DOI 10.1128/JCM.05564-11; Brown RB, 2003, CHEST, V123, P1503, DOI 10.1378/chest.123.5.1503; Campbell SG, 2005, EMERG RADIOL, V11, P242, DOI 10.1007/s10140-005-0413-4; Cangemi R, 2014, J AM COLL CARDIOL, V64, P1917, DOI 10.1016/j.jacc.2014.07.985; Cao B, 2016, CRIT CARE MED, V44, pE318, DOI 10.1097/CCM.0000000000001616; Carr GE, 2012, CHEST, V141, P1528, DOI 10.1378/chest.11-1547; Carratala J, 1998, ARCH INTERN MED, V158, P868, DOI 10.1001/archinte.158.8.868; Carratala J, 2012, ARCH INTERN MED, V172, P922, DOI 10.1001/archinternmed.2012.1690; Chalmers JD, 2014, CLIN INFECT DIS, V58, P330, DOI 10.1093/cid/cit734; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chen JI, 2013, ANN PHARMACOTHER, V47, P9, DOI 10.1345/aph.1R322; Chen LP, 2015, WORLD J EMERG MED, V6, P172, DOI 10.5847/wjem.j.1920-8642.2015.03.002; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Cilloniz C, 2017, CHEST; Cilloniz C, 2015, AM J RESP CRIT CARE, V191, P1265, DOI 10.1164/rccm.201502-0212OC; Claessens YE, 2015, AM J RESP CRIT CARE, V192, P974, DOI 10.1164/rccm.201501-0017OC; Combes A, 2017, AM J RESP CRIT CARE, V195, P1161, DOI 10.1164/rccm.201701-0217CP; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Corrales-Medina VF, 2015, AM HEART J, V170, P306, DOI 10.1016/j.ahj.2015.04.028; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; Curtis JR, 2014, ARTHRIT CARE RES, V66, P990, DOI 10.1002/acr.22281; Defres S, 2009, EUR RESPIR J, V34, P1470, DOI 10.1183/09031936.00122309; Diaz MH, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw071; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; Dobler CC, 2013, RESPIROLOGY, V18, P923, DOI 10.1111/resp.12132; Eccles S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6722; Einarsson GG, 2016, THORAX, V71, P795, DOI 10.1136/thoraxjnl-2015-207235; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Ewig S, 2012, RESP MED, V106, P1309, DOI 10.1016/j.rmed.2012.07.002; Falcone M, 2016, INTENS CARE MED, V42, P301, DOI 10.1007/s00134-015-4139-9; Falcone M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001595; Fernandes L, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/12468.6147; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Garin N, 2014, JAMA INTERN MED, V174, P1894, DOI 10.1001/jamainternmed.2014.4887; Gattarello S, 2014, CHEST, V146, P22, DOI 10.1378/chest.13-1531; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Global Burden of Disease Study C, 2015, LANCET, V386, P743, DOI [10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4, 10.1016/s0140-6736(15)60692-4]; Grenier C, 2011, J ANTIMICROB CHEMOTH, V66, P1617, DOI 10.1093/jac/dkr176; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Gross AK, 2013, J THROMB THROMBOLYS, V35, P147, DOI 10.1007/s11239-012-0833-4; Guertler C, 2011, EUR RESPIR J, V37, P1439, DOI 10.1183/09031936.00121510; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; Hidron AI, 2009, LANCET INFECT DIS, V9, P384, DOI 10.1016/S1473-3099(09)70133-1; Holter JC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0803-5; Hopstaken RM, 2004, CLIN RADIOL, V59, P743, DOI 10.1016/j.crad.2004.01.011; Horita N, 2015, SCI REP-UK, V5, DOI 10.1038/srep14061; Ito A, 2016, RESPIROLOGY, V21, P1459, DOI 10.1111/resp.12846; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jose A, 2016, J PHYSIOTHER, V62, P96, DOI 10.1016/j.jphys.2016.02.014; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Khanna A, 2017, NEW ENGL J MED, V377, P419, DOI 10.1056/NEJMoa1704154; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Kruger S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-65; Kupfer JM, 2013, JAMA-J AM MED ASSOC, V309, P2213, DOI 10.1001/jama.2013.5009; Lilford R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2016; Lim HF, 2014, EUR RESPIR J, V43, P852, DOI 10.1183/09031936.00081713; Lim WS, 2016, THORAX, V71, P288, DOI 10.1136/thoraxjnl-2015-206834; Llamas-Alvarez AM, 2017, CHEST, V151, P374, DOI 10.1016/j.chest.2016.10.039; Lobo LJ, 2010, CHEST, V138, P130, DOI 10.1378/chest.09-1562; Long Wei, 2009, Zhonghua Nei Ke Za Zhi, V48, P216; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mandell LA, 2015, JAMA-J AM MED ASSOC, V314, P396, DOI 10.1001/jama.2015.3858; Mandell Lionel A., 2000, Clinical Infectious Diseases, V31, P383, DOI 10.1086/313959; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Maskell NA, 2006, AM J RESP CRIT CARE, V174, P817, DOI 10.1164/rccm.200601-074OC; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Menendez R, 2012, EUR RESPIR J, V39, P156, DOI 10.1183/09031936.00188710; Meterky ML, 2007, CHEST, V131, P466, DOI 10.1378/chest.06-1426; Metersky ML, 2016, RESPIROLOGY, V21, P157, DOI 10.1111/resp.12651; Metersky ML, 2012, CHEST, V142, P476, DOI 10.1378/chest.11-2393; Mitchell Susan L, 2009, N Engl J Med, V361, P1529, DOI 10.1056/NEJMoa0902234; Miyashita N, 2006, INTERNAL MED, V45, P419, DOI 10.2169/internalmedicine.45.1691; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mundy LM, 2003, CHEST, V124, P883, DOI 10.1378/chest.124.3.883; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Musher DM, 2014, J INFECT DIS, V209, P631, DOI 10.1093/infdis/jit579; Musher DM, 2013, J INFECTION, V67, P11, DOI 10.1016/j.jinf.2013.03.003; Nafae RM, 2013, EGYPT J CHEST DIS TU, V62, P439, DOI 10.1016/j.ejcdt.2013.03.009; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Neroladaki A, 2013, EUR RADIOL, V23, P360, DOI 10.1007/s00330-012-2627-7; Nie W, 2014, J ANTIMICROB CHEMOTH, V69, P1441, DOI 10.1093/jac/dku033; Ohana M, 2017, REV PNEUMOL CLIN, V73, P3, DOI 10.1016/j.pneumo.2016.09.007; Oz F, 2013, CORONARY ARTERY DIS, V24, P231, DOI 10.1097/MCA.0b013e32835d7610; Pereyre S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00974; Perry TW, 2011, AM J MED, V124, P244, DOI 10.1016/j.amjmed.2010.11.014; Pertel PE, 2008, CLIN INFECT DIS, V46, P1142, DOI 10.1086/533441; Pfister R, 2014, CRIT CARE, V18, DOI 10.1186/cc13760; Quan TP, 2016, THORAX, V71, P535, DOI 10.1136/thoraxjnl-2015-207688; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Qu J M, 2016, Zhonghua Jie He He Hu Xi Za Zhi, V39, P241, DOI 10.3760/cma.j.issn.1001-0939.2016.04.001; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Renaud B, 2007, CLIN MICROBIOL INFEC, V13, P923, DOI 10.1111/j.1469-0691.2007.01772.x; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rouha H, 2015, MABS-AUSTIN, V7, P243, DOI 10.4161/19420862.2014.985132; Rozenbaum MH, 2015, VACCINE, V33, P3193, DOI 10.1016/j.vaccine.2015.05.001; Sandvall B, 2013, CLIN INFECT DIS, V56, P1145, DOI 10.1093/cid/cis1207; Schappert Susan M, 2006, Vital Health Stat 13, P1; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Self WH, 2016, CHEST, V150, P819, DOI 10.1016/j.chest.2016.04.010; Self WH, 2016, CLIN INFECT DIS, V63, P300, DOI 10.1093/cid/ciw300; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Sharafkhaneh A, 2017, COPD, V14, P23, DOI 10.1080/15412555.2016.1220513; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shindo Y, 2011, INTERN EMERG MED, V6, P389, DOI 10.1007/s11739-011-0623-6; Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Simpson JCG, 2000, THORAX, V55, P1040, DOI 10.1136/thorax.55.12.1040; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Sligl WI, 2014, CRIT CARE MED, V42, P420, DOI 10.1097/CCM.0b013e3182a66b9b; Smith SB, 2014, JAMA INTERN MED, V174, P1837, DOI 10.1001/jamainternmed.2014.4344; Soto-Gomez N, 2013, AM J MED, V126, P43, DOI 10.1016/j.amjmed.2012.08.005; Storey RF, 2014, PLATELETS, V25, P517, DOI 10.3109/09537104.2013.842965; Syrjala H, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01303-2016; Taboada M, 2016, J ANTIMICROB CHEMOTH, V71, P862, DOI 10.1093/jac/dkv415; Takahashi K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-296; Tamura M, 2014, J INFECT CHEMOTHER, V20, P97, DOI 10.1016/j.jiac.2013.09.005; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Trevino SE, 2017, EUR J CLIN MICROBIOL, V36, P879, DOI 10.1007/s10096-016-2876-5; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vardakas KZ, 2008, CAN MED ASSOC J, V179, P1269, DOI 10.1503/cmaj.080358; Viasus D, 2016, J INFECTION, V72, P273, DOI 10.1016/j.jinf.2016.01.002; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; Vogeli A, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0502-4; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Webb BJ, 2015, RESP MED, V109, P1, DOI 10.1016/j.rmed.2014.10.017; Webb BJ, 2012, RESP MED, V106, P1606, DOI 10.1016/j.rmed.2012.08.003; Weingarten SR, 2002, ARCH INTERN MED, V162, P527, DOI 10.1001/archinte.162.5.527; Weiss K, 2002, CHEST, V122, P1102, DOI 10.1378/chest.122.3.1102; Welte T, 2015, RESP MED, V109, P758, DOI 10.1016/j.rmed.2015.03.008; Wiersinga WJ, 2012, NETH J MED, V70, P90; Wirz SA, 2016, EUR RESPIR J, V48, P1150, DOI 10.1183/13993003.00474-2016; Wu MH, 2013, INFLUENZA OTHER RESP, V7, P349, DOI 10.1111/j.1750-2659.2012.00386.x; Wunderink RG, 2015, JAMA-J AM MED ASSOC, V313, P673, DOI 10.1001/jama.2015.115; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1; Yang JW, 2015, CLIN MICROBIOL INFEC, V21, P956, DOI 10.1016/j.cmi.2015.06.022; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yu XQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01020-16, 10.1128/aac.01020-16]; Zingone F, 2016, ALIMENT PHARM THER, V44, P57, DOI 10.1111/apt.13652	161	95	102	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2017	358								j2471	10.1136/bmj.j2471	http://dx.doi.org/10.1136/bmj.j2471			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MO	28694251				2022-12-28	WOS:000405769900001
J	[Anonymous]				[Anonymous]			Retraction and republication-Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis pain: a network meta-analysis	LANCET			English	Editorial Material							CONTROLLED-TRIAL; CELECOXIB											Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; Boswell Diane J, 2008, Medscape J Med, V10, P259; da Costa BR, 2017, LANCET; da Costa BR, 2016, LANCET, V387, P2093, DOI 10.1016/S0140-6736(16)30002-2; Yocum D, 2000, ARCH INTERN MED, V160, P2947, DOI 10.1001/archinte.160.19.2947; Zhao SZ, 1999, PHARMACOTHERAPY, V19, P1269, DOI 10.1592/phco.19.16.1269.30879	6	2	2	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					109	109						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28699579	Bronze			2022-12-28	WOS:000404976600013
J	Hertzberg, J				Hertzberg, Jennifer			Ice-sheet history revealed by fossils	NATURE			English	Editorial Material							PINE ISLAND GLACIER; WEST ANTARCTICA; OCEAN	Microscopic fossils show that, from 10,400 to 7,500 years ago, upwelling of a water mass called Circumpolar Deep Water destabilized Antarctic ice shelves - a finding that advances our understanding of ice-sheet retreat. See Article p. 43	[Hertzberg, Jennifer] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA	University of Connecticut	Hertzberg, J (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	jennifer.hertzberg@uconn.edu		Hertzberg, Jennifer/0000-0001-6437-5977				Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Hillenbrand CD, 2017, NATURE, V547, P43, DOI 10.1038/nature22995; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Johnson JS, 2014, SCIENCE, V343, P999, DOI 10.1126/science.1247385; McGlone MS, 2010, NAT GEOSCI, V3, P622, DOI 10.1038/NGEO931; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140	9	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					35	36		10.1038/547035a	http://dx.doi.org/10.1038/547035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682325				2022-12-28	WOS:000404839900023
J	Ozen, A; Comrie, WA; Ardy, RC; Conde, CD; Dalgic, B; Beser, OF; Morawski, AR; Karakoc-Aydiner, E; Tutar, E; Baris, S; Ozcay, F; Serwas, NK; Zhang, Y; Matthews, HF; Pittaluga, S; Folio, LR; Aksu, AU; McElwee, JJ; Krolo, A; Kiykim, A; Baris, Z; Gulsan, M; Ogulur, I; Snapper, SB; Houwen, RHJ; Leavis, HL; Ertem, D; Kain, R; Sari, S; Erkan, T; Su, HC; Boztug, K; Lenardo, MJ				Ozen, Ahmet; Comrie, William A.; Ardy, Rico C.; Conde, Cecilia Dominguez; Dalgic, Buket; Beser, Omer F.; Morawski, Aaron R.; Karakoc-Aydiner, Elif; Tutar, Engin; Baris, Safa; Ozcay, Figen; Serwas, Nina K.; Zhang, Yu; Matthews, Helen F.; Pittaluga, Stefania; Folio, Les R.; Aksu, Aysel Unlusoy; McElwee, Joshua J.; Krolo, Ana; Kiykim, Ayca; Baris, Zeren; Gulsan, Meltem; Ogulur, Ismail; Snapper, Scott B.; Houwen, Roderick H. J.; Leavis, Helen L.; Ertem, Deniz; Kain, Renate; Sari, Sinan; Erkan, Tulay; Su, Helen C.; Boztug, Kaan; Lenardo, Michael J.			CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DECAY-ACCELERATING FACTOR; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; COMPLEMENT REGULATORY PROTEIN; INFLAMMATORY-BOWEL-DISEASE; HEMOLYTIC-UREMIC SYNDROME; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; CELL RESPONSES; INAB PHENOTYPE; T-CELLS; ACTIVATION	BACKGROUND Studies of monogenic gastrointestinal diseases have revealed molecular pathways critical to gut homeostasis and enabled the development of targeted therapies. METHODS We studied 11 patients with abdominal pain and diarrhea caused by early-onset protein-losing enteropathy with primary intestinal lymphangiectasia, edema due to hypoproteinemia, malabsorption, and less frequently, bowel inflammation, recurrent infections, and angiopathic thromboembolic disease; the disorder followed an autosomal recessive pattern of inheritance. Whole-exome sequencing was performed to identify gene variants. We evaluated the function of CD55 in patients' cells, which we confirmed by means of exogenous induction of expression of CD55. RESULTS We identified homozygous loss-of-function mutations in the gene encoding CD55 (decay-accelerating factor), which lead to loss of protein expression. Patients' T lymphocytes showed increased complement activation causing surface deposition of complement and the generation of soluble C5a. Costimulatory function and cytokine modulation by CD55 were defective. Genetic reconstitution of CD55 or treatment with a complement-inhibitory therapeutic antibody reversed abnormal complement activation. CONCLUSIONS CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal complement activation due to biallelic loss-of-function mutations in CD55. (Funded by the National Institute of Allergy and Infectious Diseases and others.)	[Ozen, Ahmet; Comrie, William A.; Morawski, Aaron R.; Matthews, Helen F.; Lenardo, Michael J.] NCI, Sect Mol Dev Immune Syst, Lab Immunol, Bethesda, MD 20892 USA; [Ozen, Ahmet; Comrie, William A.; Morawski, Aaron R.; Zhang, Yu; Matthews, Helen F.; Su, Helen C.; Lenardo, Michael J.] NCI, Clin Genom Program, Bethesda, MD 20892 USA; [Zhang, Yu; Su, Helen C.] NCI, Human Immunol Dis Sect, Lab Host Defenses, Bethesda, MD 20892 USA; [Pittaluga, Stefania] NCI, NIAID, Lab Pathol, Bethesda, MD 20892 USA; [Folio, Les R.] NIH, Clin Ctr, Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Ozen, Ahmet; Karakoc-Aydiner, Elif; Baris, Safa; Kiykim, Ayca; Ogulur, Ismail] Marmara Univ, Dept Pediat, Div Allergy & Immunol, Istanbul, Turkey; [Tutar, Engin; Ertem, Deniz] Marmara Univ, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Istanbul, Turkey; [Ozen, Ahmet; Karakoc-Aydiner, Elif; Baris, Safa; Kiykim, Ayca; Ogulur, Ismail] Istanbul Univ, Jeffrey Modell Diagnost Ctr Primary Immunodeficie, Cerrahpasa Fac Med, Ankara, Turkey; [Beser, Omer F.; Erkan, Tulay] Istanbul Univ Cerrahpasa, Fac Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Dalgic, Buket; Snapper, Scott B.] Gazi Univ, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Ozcay, Figen; Baris, Zeren; Gulsan, Meltem] Baskent Univ, Fac Med, Dept Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Aksu, Aysel Unlusoy] Dr Sami Ulus Childrens Hosp, Pediat Gastroenterol Clin, Ankara, Turkey; [Ardy, Rico C.; Conde, Cecilia Dominguez; Serwas, Nina K.; Krolo, Ana; Boztug, Kaan] Med Univ Vienna, Austrian Acad Sci, Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Vienna, Austria; [Ardy, Rico C.; Conde, Cecilia Dominguez; Serwas, Nina K.; Krolo, Ana; Boztug, Kaan] Med Univ Vienna, Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Kain, Renate] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Boztug, Kaan] Med Univ Vienna, St Anna Kinderspital & Childrens Canc Res Inst, Dept Pediat, Vienna, Austria; [McElwee, Joshua J.] Harvard Med Sch, Boston Childrens Hosp, Merck Res Labs, Boston, MA USA; [Snapper, Scott B.] Harvard Med Sch, Boston Childrens Hosp, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Houwen, Roderick H. J.] Wilhelmina Childrens Hosp, Univ Med Ctr, Dept Pediat Gastroenterol, Utrecht, Netherlands; [Leavis, Helen L.] Univ Med Ctr, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Marmara University; Marmara University; Istanbul University; Istanbul University - Cerrahpasa; Istanbul University - Cerrahpasa; Gazi University; Baskent University; Dr. Sami Ulus Education & Research Hospital; Austrian Academy of Sciences; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Saint Anna Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Merck & Company; Harvard University; Boston Children's Hospital; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	Boztug, K (corresponding author), Austrian Acad Sci, Ludwig Boltzmann Inst Rare & Undiagnosed Dis, Lazarettgasse 14 AKH BT 25-3, A-1090 Vienna, Austria.; Boztug, K (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14 AKH BT 25-3, A-1090 Vienna, Austria.; Lenardo, MJ (corresponding author), NIAID, Immune Syst Sect, Lab Immunol, Bldg 10-11D14,10 Ctr Dr,MSC 1892, Bethesda, MD 20892 USA.	kaan.boztug@rud.lbg.ac.-at; lenardo@nih.gov	Folio, Les R./AAO-5456-2021; Boztug, Kaan/AAM-4161-2021; Barış, Zeren/AAB-4153-2020; Beser, Omer Faruk/ABA-1156-2020; Sari, Sinan/AAP-5671-2021; ERTEM, DENIZ/C-2285-2015; Özçay, Figen/ABG-5684-2020; KIYKIM, Ayca/J-6400-2017; Kain, Renate/ACR-4709-2022; Ertan, Asli/AAE-6201-2021; Su, Helen C/H-9541-2015; Ertem, Deniz/AAK-7461-2020; Ogulur, Ismail/GYV-4415-2022; Baris, Safa/AAH-1932-2019; Ozen, Ahmet/R-6749-2017; Dominguez Conde, Cecilia/U-4890-2017	Boztug, Kaan/0000-0001-8387-9185; ERTEM, DENIZ/0000-0002-4427-0569; Özçay, Figen/0000-0002-5214-516X; KIYKIM, Ayca/0000-0001-5821-3963; Kain, Renate/0000-0002-2428-543X; Su, Helen C/0000-0002-5582-9110; Ertem, Deniz/0000-0002-4427-0569; Baris, Safa/0000-0002-4730-9422; Ozen, Ahmet/0000-0002-9065-1901; Morawski, Aaron/0000-0001-5995-0527; Ardy, Rico Chandra/0000-0003-4975-2177; unlusoy aksu, aysel/0000-0002-4550-0717; Serwas, Nina/0000-0003-2243-5446; Dominguez Conde, Cecilia/0000-0002-8684-4655; Comrie, William/0000-0003-1173-1127	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000769, ZIAAI000566, Z01AI000627, ZIAAI001059, ZIAAI000718, ZIAAI000565, ZIAAI000717, ZIAAI001187, ZIAAI000732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [FI2GM119979] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the National Institute of Allergy and Infectious Diseases and others.	Alders M, 2014, HUM GENET, V133, P1161, DOI 10.1007/s00439-014-1456-y; Alders M, 2009, NAT GENET, V41, P1272, DOI 10.1038/ng.484; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cofiell R, 2015, BLOOD, V125, P3253, DOI 10.1182/blood-2014-09-600411; DANIELS GL, 1982, TRANSFUSION, V22, P362, DOI 10.1046/j.1537-2995.1982.22583017458.x; Daniels GL, 1998, TRANSFUSION MED, V8, P141; Elkadri A, 2015, CELL MOL GASTROENTER, V1, P381, DOI 10.1016/j.jcmgh.2015.05.001; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Ham TH, 1939, J CLIN INVEST, V18, P657, DOI 10.1172/JCI101081; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Kurolap A, 2017, NEW ENGL J MED, V377, P87, DOI 10.1056/NEJMc1707173; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lin F, 2004, J IMMUNOL, V172, P3836, DOI 10.4049/jimmunol.172.6.3836; LIN RC, 1988, TRANSFUSION, V28, P427, DOI 10.1046/j.1537-2995.1988.28588337329.x; Liszewski MK, 2017, ANNU REV PATHOL-MECH, V12, P25, DOI 10.1146/annurev-pathol-012615-044145; Liu JN, 2005, J EXP MED, V201, P567, DOI 10.1084/jem.20040863; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Miwa T, 2007, AM J PATHOL, V170, P1258, DOI 10.2353/ajpath.2007.060601; Montes T, 2008, MOL IMMUNOL, V45, P2897, DOI 10.1016/j.molimm.2008.01.027; NAKANO Y, 1992, BIOCHIM BIOPHYS ACTA, V1116, P235, DOI 10.1016/0304-4165(92)90016-N; NICHOLSONWELLER A, 1985, NEW ENGL J MED, V312, P1091, DOI 10.1056/NEJM198504253121704; NICHOLSONWELLER A, 1983, P NATL ACAD SCI-BIOL, V80, P5066, DOI 10.1073/pnas.80.16.5066; Noris M, 2015, AM J KIDNEY DIS, V66, P359, DOI 10.1053/j.ajkd.2015.03.040; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Risitano AM, 2013, ADV EXP MED BIOL, V735, P155, DOI 10.1007/978-1-4614-4118-2_10; Salzer E, 2013, HAEMATOLOGICA, V98, P473, DOI 10.3324/haematol.2012.068791; Spendlove I, 2010, ADV EXP MED BIOL, V706, P138; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Thiel J, 2012, J ALLERGY CLIN IMMUN, V129, P801, DOI 10.1016/j.jaci.2011.09.027; Umar SB, 2010, AM J GASTROENTEROL, V105, P43, DOI 10.1038/ajg.2009.561; WALDMANN TA, 1961, GASTROENTEROLOGY, V41, P197; Yazer MH, 2006, TRANSFUSION, V46, P1537, DOI 10.1111/j.1537-2995.2006.00933.x; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	89	94	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					52	61		10.1056/NEJMoa1615887	http://dx.doi.org/10.1056/NEJMoa1615887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5CS	28657829	Green Accepted, Bronze			2022-12-28	WOS:000404730000008
J	Rheinbay, E; Parasuraman, P; Grimsby, J; Tiao, G; Engreitz, JM; Kim, J; Lawrence, MS; Taylor-Weiner, A; Rodriguez-Cuevas, S; Rosenberg, M; Hess, J; Stewart, C; Maruvka, YE; Stojanov, P; Cortes, ML; Seepo, S; Cibulskis, C; Tracy, A; Pugh, TJ; Lee, J; Zheng, ZL; Ellisen, LW; Iafrate, AJ; Boehm, JS; Gabriel, SB; Meyerson, M; Golub, TR; Baselga, J; Hidalgo-Miranda, A; Shioda, T; Bernards, A; Lander, ES; Getz, G				Rheinbay, Esther; Parasuraman, Prasanna; Grimsby, Jonna; Tiao, Grace; Engreitz, Jesse M.; Kim, Jaegil; Lawrence, Michael S.; Taylor-Weiner, Amaro; Rodriguez-Cuevas, Sergio; Rosenberg, Mara; Hess, Julian; Stewart, Chip; Maruvka, Yosef E.; Stojanov, Petar; Cortes, Maria L.; Seepo, Sara; Cibulskis, Carrie; Tracy, Adam; Pugh, Trevor J.; Lee, Jesse; Zheng, Zongli; Ellisen, Leif W.; Iafrate, A. John; Boehm, Jesse S.; Gabriel, Stacey B.; Meyerson, Matthew; Golub, Todd R.; Baselga, Jose; Hidalgo-Miranda, Alfredo; Shioda, Toshi; Bernards, Andre; Lander, Eric S.; Getz, Gad			Recurrent and functional regulatory mutations in breast cancer	NATURE			English	Article							ESTROGEN-RECEPTOR BINDING; TERT PROMOTER MUTATIONS; GENOME-WIDE ANALYSIS; SOMATIC MUTATIONS; LUMINAL SUBTYPE; EXPRESSION; FOXA1; LANDSCAPE; DISCOVERY; PROTEIN	Genomic analysis of tumours has led to the identification of hundreds of cancer genes on the basis of the presence of mutations in protein-coding regions. By contrast, much less is known about cancer-causing mutations in non-coding regions. Here we perform deep sequencing in 360 primary breast cancers and develop computational methods to identify significantly mutated promoters. Clear signals are found in the promoters of three genes. FOXA1, a known driver of hormone-receptor positive breast cancer, harbours a mutational hotspot in its promoter leading to overexpression through increased E2F binding. RMRP and NEAT1, two non-coding RNA genes, carry mutations that affect protein binding to their promoters and alter expression levels. Our study shows that promoter regions harbour recurrent mutations in cancer with functional consequences and that the mutations occur at similar frequencies as in coding regions. Power analyses indicate that more such regions remain to be discovered through deep sequencing of adequately sized cohorts of patients.	[Rheinbay, Esther; Grimsby, Jonna; Tiao, Grace; Engreitz, Jesse M.; Kim, Jaegil; Lawrence, Michael S.; Taylor-Weiner, Amaro; Rosenberg, Mara; Hess, Julian; Stewart, Chip; Maruvka, Yosef E.; Stojanov, Petar; Cortes, Maria L.; Seepo, Sara; Cibulskis, Carrie; Tracy, Adam; Boehm, Jesse S.; Gabriel, Stacey B.; Meyerson, Matthew; Golub, Todd R.; Lander, Eric S.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02124 USA; [Rheinbay, Esther; Parasuraman, Prasanna; Lawrence, Michael S.; Maruvka, Yosef E.; Lee, Jesse; Zheng, Zongli; Ellisen, Leif W.; Iafrate, A. John; Shioda, Toshi; Bernards, Andre; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rodriguez-Cuevas, Sergio] Inst Enfermedades Mama FUCAM AC, Mexico City 04980, DF, Mexico; [Pugh, Trevor J.] Univ Toronto, Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Pugh, Trevor J.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Ellisen, Leif W.; Meyerson, Matthew; Golub, Todd R.; Getz, Gad] Harvard Med Sch, Boston, MA 02115 USA; [Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Mexico City 14610, DF, Mexico; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Instituto Nacional de Medicina Genomica; Harvard University; Massachusetts General Hospital	Getz, G (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02124 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.; Getz, G (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Getz, G (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.	gadgetz@broadinstitute.org	Hidalgo-Miranda, Alfredo/B-2123-2010; Pugh, Trevor/Y-2535-2019; Ellisen, Leif W/AAA-6572-2022; Lawrence, Michael/AAC-8202-2020; Stojanov, Petar/GQI-4462-2022	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Pugh, Trevor/0000-0002-8073-5888; Ellisen, Leif W/0000-0003-0444-7910; Stojanov, Petar/0000-0001-7815-776X; Meyerson, Matthew/0000-0002-9133-8108; Rosenberg, Mara/0000-0001-6400-3161; Maruvka, Yosef/0000-0002-8918-9887	Carlos Slim Foundation in Mexico; Fannie and John Hertz Foundation; Massachusetts General Hospital; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Carlos Slim Foundation in Mexico; Fannie and John Hertz Foundation; Massachusetts General Hospital(General Electric); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the patients who contributed samples to this study. This study was a collaboration of the Broad Institute in Cambridge, Massachusetts, USA, and the National Institute of Genomic Medicine (INMEGEN) in Mexico City, Mexico. The work was conducted as part of the Slim Initiative in Genomic Medicine for the Americas (SIGMA), a project funded by the Carlos Slim Foundation in Mexico. We are grateful to S. Romero-Cordoba, R. Rebollar, and L. Alfaro-Ruiz for sample collection and processing. We thank the Broad Institute Genomics Platform and Target Accelerator for assistance; N. Dyson for assistance with E2F experiments; A. Kamburov and D. Rosebrock for computational help; M. Snyder, J. Reuter, and C. Cenik for discussion on TBC1D12; and S. Nik-Zainal for data access guidance. E.R., M. R., A.T.W., C. S., M. C., and J.S.B. were partly funded by SIGMA. J.M.E. was supported by the Fannie and John Hertz Foundation. P.P. and A.B were partly funded by the Massachusetts General Hospital startup funds of G.G. G.G. was partly funded by the Paul C. Zamecnick, MD, Chair in Oncology at Massachusetts General Hospital.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Araya CL, 2016, NAT GENET, V48, P117, DOI 10.1038/ng.3471; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Coser KR, 2009, P NATL ACAD SCI USA, V106, P14536, DOI 10.1073/pnas.0907560106; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Denchi EL, 2005, EMBO REP, V6, P661, DOI 10.1038/sj.embor.7400452; Dick FA, 2003, MOL CELL, V12, P639, DOI 10.1016/S1097-2765(03)00344-7; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Fu XY, 2016, P NATL ACAD SCI USA, V113, pE6600, DOI 10.1073/pnas.1612835113; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Getz G., 2006, BOOSTING PERMUTATION; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Geyer CJ, 2005, STAT SCI, V20, P358, DOI 10.1214/088342305000000340; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jeselsohn R, 2016, CLIN CANCER RES, V22, P5755, DOI 10.1158/1078-0432.CCR-16-0148; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lochovsky L, 2015, NUCLEIC ACIDS RES, V43, P8123, DOI 10.1093/nar/gkv803; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mehta RJ, 2012, BREAST CANCER RES TR, V131, P881, DOI 10.1007/s10549-011-1482-6; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pugh TJ, 2015, NATURE, V520, pE12, DOI 10.1038/nature14266; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; ROUTLEDGE RD, 1994, CAN J STAT, V22, P103, DOI 10.2307/3315826; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101	69	191	198	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					55	+		10.1038/nature22992	http://dx.doi.org/10.1038/nature22992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658208	Green Accepted, Green Submitted			2022-12-28	WOS:000404839900030
J	Mahony, C				Mahony, Chris			Sir Bernard Tomlinson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												chris.mahony@cjmedia.biz						TOMLINSON B, PUBLICATION LIST	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3249	10.1136/bmj.j3249	http://dx.doi.org/10.1136/bmj.j3249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676482				2022-12-28	WOS:000405322100012
J	Taieb, D; Sebag, F; Pacak, K				Taieb, David; Sebag, Frederic; Pacak, Karel			A Large Adrenal Tumor With Marked F-18-Fluorodeoxyglucose Uptake	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOMOGRAPHY; DIAGNOSIS; PREDICT		[Taieb, David] Aix Marseille Univ, La Timone Univ Hosp, Dept Nucl Med, CERIMED, Marseille, France; [Sebag, Frederic] Aix Marseille Univ, Concept Univ Hosp, Dept Endocrine Surg, Marseille, France; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, NIH, Bethesda, MD USA.; Pacak, K (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Med Neuroendocrinol, NIH, CRC, 10 Ctr Dr,MSC 1109,Bldg 10,Room 1E-3140, Bethesda, MD 20892 USA.	karel@mail.nih.gov	Taieb, Pr. David/M-5219-2017		Intramural NIH HHS [ZIA HD008735] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Berruti A, 2012, ANN ONCOL, V23, P131, DOI 10.1093/annonc/mds231; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Groussin L, 2009, J CLIN ENDOCR METAB, V94, P1713, DOI 10.1210/jc.2008-2302; Guerin C, 2017, J CLIN ENDOCR METAB, V102, P2465, DOI 10.1210/jc.2017-00254; Kim Y, 2016, JAMA SURG, V151, P365, DOI 10.1001/jamasurg.2015.4516; Libe R, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00045; Rashidi A, 2013, ANN HEMATOL, V92, P1583, DOI 10.1007/s00277-013-1812-3; Sturgeon C, 2006, J AM COLL SURGEONS, V202, P423, DOI 10.1016/j.jamcollsurg.2005.11.005; Tessonnier L, 2008, EUR J NUCL MED MOL I, V35, P2018, DOI 10.1007/s00259-008-0849-3	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					84	85		10.1001/jama.2017.6326	http://dx.doi.org/10.1001/jama.2017.6326			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672297	Green Accepted			2022-12-28	WOS:000404717700018
J	Kerr, JT				Kerr, Jeremy T.			A cocktail of toxins	SCIENCE			English	Editorial Material							EXPOSURE; BEES; IMPACTS; HEALTH; CORN		[Kerr, Jeremy T.] Univ Ottawa, Dept Biol, 30 Marie Curie, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Kerr, JT (corresponding author), Univ Ottawa, Dept Biol, 30 Marie Curie, Ottawa, ON K1N 6N5, Canada.	jkerr@uottawa.ca		Kerr, Jeremy/0000-0002-3972-7560	Natural Sciences and Engineering Research Council of Canada; University Research Chair in Macroecology and Conservation at the University of Ottawa	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University Research Chair in Macroecology and Conservation at the University of Ottawa	J.T.K. is supported by Discovery Grant and Discovery Accelerator funds from the Natural Sciences and Engineering Research Council of Canada and the University Research Chair in Macroecology and Conservation at the University of Ottawa.	Cutler GC, 2014, ECOTOXICOLOGY, V23, P1755, DOI 10.1007/s10646-014-1340-5; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; DeFries R, 2017, SCIENCE, V356, P265, DOI 10.1126/science.aal1950; Dicks L, 2013, NATURE, V494, P283, DOI 10.1038/494283a; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Potts SG., 2016, SECR INT SCI POL PLA; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; Woodcock BA, 2017, SCIENCE, V356, P1393, DOI 10.1126/science.aaa1190; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	12	11	11	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1331	1332		10.1126/science.aan6173	http://dx.doi.org/10.1126/science.aan6173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663455				2022-12-28	WOS:000404351500016
J	Dong, HR; Zeng, GM				Dong, Haoran; Zeng, Guangming			'Flammable ice' - extract with caution	NATURE			English	Letter									[Dong, Haoran; Zeng, Guangming] Hunan Univ, Changsha, Hunan, Peoples R China	Hunan University	Dong, HR (corresponding author), Hunan Univ, Changsha, Hunan, Peoples R China.	dongh@hnu.edu.cn						Dunn R, 2012, NATURE, V485, P578, DOI 10.1038/485578a	1	5	5	8	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					599	599		10.1038/546599a	http://dx.doi.org/10.1038/546599a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658237				2022-12-28	WOS:000404332000024
J	Wu, XK; Stener-Victorin, E; Kuang, HY; Ma, HL; Gao, JS; Xie, LZ; Hou, LH; Hu, ZX; Shao, XG; Ge, J; Zhang, JF; Xue, HY; Xu, XF; Liang, RN; Ma, HX; Yang, HW; Li, WL; Huang, DM; Sun, Y; Hao, CF; Du, SM; Yang, ZW; Wang, X; Yan, Y; Chen, XH; Fu, P; Ding, CF; Gao, YQ; Zhou, ZM; Wang, CC; Wu, TX; Liu, JP; Ng, EHY; Legro, RS; Zhang, HP				Wu, Xiao-Ke; Stener-Victorin, Elisabet; Kuang, Hong-Ying; Ma, Hong-Li; Gao, Jing-Shu; Xie, Liang-Zhen; Hou, Li-Hui; Hu, Zhen-Xing; Shao, Xiao-Guang; Ge, Jun; Zhang, Jin-Feng; Xue, Hui-Ying; Xu, Xiao-Feng; Liang, Rui-Ning; Ma, Hong-Xia; Yang, Hong-Wei; Li, Wei-Li; Huang, Dong-Mei; Sun, Yun; Hao, Cui-Fang; Du, Shao-Min; Yang, Zheng-Wang; Wang, Xin; Yan, Ying; Chen, Xiu-Hua; Fu, Ping; Ding, Cai-Fei; Gao, Ya-Qin; Zhou, Zhong-Ming; Wang, Chi Chiu; Wu, Tai-Xiang; Liu, Jian-Ping; Ng, Ernest H. Y.; Legro, Richard S.; Zhang, Heping		PCOSAct Study Grp	Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFERTILITY; MEDICINE; COMPLEMENTARY; HIRSUTISM; COMMUNITY; LETROZOLE; OVULATION; IMPACTS; COHORT	IMPORTANCE Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence. OBJECTIVE To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. DESIGN, SETTING, AND PARTICIPANTS A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1:1:1:1 ratio to 4 groups. INTERVENTIONS Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. MAIN OUTCOMES AND MEASURES The primary outcome was live birth. Secondary outcomes included adverse events. RESULTS Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea: 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising: 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). CONCLUSIONS AND RELEVANCE Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women.	[Wu, Xiao-Ke; Stener-Victorin, Elisabet; Kuang, Hong-Ying; Ma, Hong-Li; Gao, Jing-Shu; Xie, Liang-Zhen; Hou, Li-Hui; Legro, Richard S.] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin 150040, Peoples R China; [Wu, Xiao-Ke] World Federat Chinese Med Societies, Comm Reprod Med, Beijing, Peoples R China; [Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hu, Zhen-Xing] Xuzhou Maternal & Childrens Hosp, Outpatient Dept, Xuzhou, Peoples R China; [Shao, Xiao-Guang] Dalian Maternal & Childrens Ctr, Ctr Reprod Med, Dalian, Peoples R China; [Ge, Jun] Tanggu Dist Maternal & Childrens Hosp, Dept Infertil, Tianjin, Peoples R China; [Zhang, Jin-Feng] Shanxi Prov Hosp Chinese Med, Dept Obstet & Gynecol, Taiyuan, Peoples R China; Huaian Maternal & Childrens Hosp, Ctr Reprod Med, Huaian, Peoples R China; [Xu, Xiao-Feng] Suzhou City Hosp Chinese Med, Dept Gynecol, Suzhou, Peoples R China; [Liang, Rui-Ning] Jiangxi Univ Chinese Med, Hosp 2, Dept Gynecol, Nanchang, Jiangxi, Peoples R China; [Ma, Hong-Xia] Guangzhou Med Univ, Affiliated Hosp 1, Dept Chinese Med, Guangzhou, Guangdong, Peoples R China; [Yang, Hong-Wei] Liwan Dist Hosp Chinese Med, Dept Infertil, Guangzhou, Guangdong, Peoples R China; [Li, Wei-Li] Anhui Univ Chinese Med, Affiliated Hosp, Dept Obstet & Gynecol, Hefei, Peoples R China; [Huang, Dong-Mei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Integrated Tradit andWestern Med, Wuhan, Peoples R China; [Sun, Yun] Wenzhou City Hosp Chinese Med, Dept Gynecol, Wenzhou, Peoples R China; [Hao, Cui-Fang] Yuhuangding Hosp, Ctr Reprod Med, Yantai, Peoples R China; [Du, Shao-Min] Daqing Longnan Hosp, Dept Obstet & Gynecol, Daqing, Peoples R China; [Yang, Zheng-Wang] Hunan Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China; [Wang, Xin] Liaoning Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Shenyang, Peoples R China; [Yan, Ying] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Dept Gynecol, Tianjin, Peoples R China; [Chen, Xiu-Hua] Guangdong Prov Hosp Chinese Med, Dept Tradit Technol, Guangzhou, Guangdong, Peoples R China; [Fu, Ping] Hangzhou City Hosp Chinese Med, Dept Gynecol, Hangzhou, Zhejiang, Peoples R China; [Ding, Cai-Fei] Zhejiang Prov Hosp Integrat Med, Ctr Reprod Med, Hangzhou, Zhejiang, Peoples R China; [Gao, Ya-Qin] Daqing Oilfield Gen Hosp, Ctr Reprod Med, Daqing, Peoples R China; [Zhou, Zhong-Ming] Hubei Prov Hosp Chinese Med, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wu, Tai-Xiang] Chinese Clin Trial Registry, Shenzhen, Peoples R China; [Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Ng, Ernest H. Y.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Legro, Richard S.] Penn State Univ, Dept Obstet & Gynecol, Hershey, PA USA; [Zhang, Heping] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA	Heilongjiang University of Chinese Medicine; Karolinska Institutet; Jiangxi University of Traditional Chinese Medicine; Guangzhou Medical University; Anhui University of Chinese Medicine; Huazhong University of Science & Technology; Hunan University of Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Guangzhou University of Chinese Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Beijing University of Chinese Medicine; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University	Wu, XK (corresponding author), Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Obstet & Gynecol, Harbin 150040, Peoples R China.	xiaokewu2002@vip.sina.com	Stener-Victorin, Elisabet/W-6322-2018; Xie, Liangzhen/L-6087-2016; Wang, Ronald/C-6541-2014; Zhang, He/GXN-0028-2022; Liangzhen, Xie/AAR-4319-2020	Stener-Victorin, Elisabet/0000-0002-3424-1502; Xie, Liangzhen/0000-0003-1375-1666; Wang, Ronald/0000-0002-3928-7278; Liangzhen, Xie/0000-0003-1375-1666; Liu, Jianping/0000-0002-0320-061X; Hou, Lihui/0000-0003-0269-7801; Ng, Ernest/0000-0002-7688-4557; Legro, Richard/0000-0001-9927-7584	National Public Welfare Projects for Chinese Medicine [201107005, 200807002]; Heilongjiang Province Foundation for Outstanding Youths [JC200804]; Intervention for PCOS Based on Traditional Chinese Medicine Theory-TianGui Disorder [2011TD006]; First Affiliated Hospital, Heilongjiang University of Chinese Medicine from National Clinical Trial Base in Chinese Medicine Special Projects [JDZX2012036, 2015B009]; National Key Discipline of Chinese Medicine in Gynecology; Heilongjiang Province "Longjiang Scholar" Program; Chinese "Thousand Talents Plan" scholarship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; Novo Nordisk Fonden [NNF17OC0026724, NNF16OC0020744, NNF15OC0015902] Funding Source: researchfish	National Public Welfare Projects for Chinese Medicine; Heilongjiang Province Foundation for Outstanding Youths; Intervention for PCOS Based on Traditional Chinese Medicine Theory-TianGui Disorder; First Affiliated Hospital, Heilongjiang University of Chinese Medicine from National Clinical Trial Base in Chinese Medicine Special Projects; National Key Discipline of Chinese Medicine in Gynecology; Heilongjiang Province "Longjiang Scholar" Program; Chinese "Thousand Talents Plan" scholarship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants 201107005 and 200807002 from the National Public Welfare Projects for Chinese Medicine, JC200804 from the Heilongjiang Province Foundation for Outstanding Youths, 2011TD006 from the Intervention for PCOS Based on Traditional Chinese Medicine Theory-TianGui Disorder, and JDZX2012036 and 2015B009 from 2009 through 2016 at the First Affiliated Hospital, Heilongjiang University of Chinese Medicine from the National Clinical Trial Base in Chinese Medicine Special Projects, by the National Key Discipline of Chinese Medicine in Gynecology from 2009 through 2016, by the Heilongjiang Province "Longjiang Scholar" Program (Drs X.-K. Wu, Stener-Victorin, and Legro), and by the Chinese "Thousand Talents Plan" scholarship (Drs Legro and H. Zhang).	Birkeflet O, 2012, ACUPUNCT MED, V30, P12, DOI 10.1136/acupmed-2011-010089; Bovey M, 2010, FERTIL STERIL, V94, P2569, DOI 10.1016/j.fertnstert.2010.03.072; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2012, ZHONGHUA FU CHAN KE, V47, P74, DOI DOI 10.3760/CMA.J.ISSN.0529-567X.2012.01.022; Harbin Consensus Conference Workshop Group, 2014, FERTIL STERIL, V102, pe15; Hu M, 2015, P NATL ACAD SCI USA, V112, P14348, DOI 10.1073/pnas.1507514112; Jedel E, 2011, AM J PHYSIOL-ENDOC M, V300, pE37, DOI 10.1152/ajpendo.00495.2010; Johansson J, 2013, AM J PHYSIOL-ENDOC M, V304, pE934, DOI 10.1152/ajpendo.00039.2013; Kar Sujata, 2015, J Hum Reprod Sci, V8, P197, DOI 10.4103/0974-1208.170373; Kuang HY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/527303; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2006, FERTIL STERIL, V86, P914, DOI 10.1016/j.fertnstert.2006.03.037; Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218; Legro RS, 2014, FERTIL STERIL, V102, P952, DOI 10.1016/j.fertnstert.2014.08.002; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; Legro RS, 2012, CONTEMP CLIN TRIALS, V33, P470, DOI 10.1016/j.cct.2011.12.005; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Li R, 2012, EUR J OBSTET GYN R B, V163, P165, DOI 10.1016/j.ejogrb.2012.03.023; Li YA, 2011, FERTIL STERIL, V96, P452, DOI 10.1016/j.fertnstert.2011.05.072; Lim CED, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007689.pub4; MacPherson H, 2016, J ALTERN COMPLEM MED, V22, P101, DOI 10.1089/acm.2015.0184; Park JJ, 2010, J ALTERN COMPLEM MED, V16, P193, DOI 10.1089/acm.2008.0600; Pastore LM, 2011, J CLIN ENDOCR METAB, V96, P3143, DOI 10.1210/jc.2011-1126; Read SC, 2014, J ALTERN COMPLEM MED, V20, P686, DOI 10.1089/acm.2013.0329; Schlaff WD, 2011, FERTIL STERIL, V96, P15, DOI 10.1016/j.fertnstert.2011.05.069; Smith CA, 2014, COMPLEMENT THER MED, V22, P710, DOI 10.1016/j.ctim.2014.06.001; Smith JF, 2010, FERTIL STERIL, V93, P2169, DOI 10.1016/j.fertnstert.2010.02.054; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Tarlatzis BC, 2008, FERTIL STERIL, V89, P505, DOI 10.1016/j.fertnstert.2007.09.041; Wu XK, 2016, FERTIL STERIL, V106, P757, DOI 10.1016/j.fertnstert.2016.05.022; Wu XK, 2015, LANCET, V386, P70; Wu XK, 2016, Fertil Steril, V106, pe1; Zain MM, 2009, FERTIL STERIL, V91, P514, DOI 10.1016/j.fertnstert.2007.12.002; Zhao XM, 2011, FERTIL STERIL, V96, P792, DOI 10.1016/j.fertnstert.2011.06.040; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	35	99	132	10	144	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2502	2514		10.1001/jama.2017.7217	http://dx.doi.org/10.1001/jama.2017.7217			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655015	Green Published, Bronze			2022-12-28	WOS:000404106600020
J	Smith, FD; Esseltine, JL; Nygren, PJ; Veesler, D; Byrne, DP; Vonderach, M; Strashnov, I; Eyers, CE; Eyers, PA; Langeberg, LK; Scott, JD				Smith, F. Donelson; Esseltine, Jessica L.; Nygren, Patrick J.; Veesler, David; Byrne, Dominic P.; Vonderach, Matthias; Strashnov, Ilya; Eyers, Claire E.; Eyers, Patrick A.; Langeberg, Lorene K.; Scott, John D.			Local protein kinase A action proceeds through intact holoenzymes	SCIENCE			English	Article							MASS-SPECTROMETRY; SKELETAL-MUSCLE; CAMP; PHOSPHORYLATION; PKA; BAD; INHIBITION; ACTIVATION; SUBUNIT; COMPLEX	Hormones can transmit signals through adenosine 3',5'-monophosphate (cAMP) to precise intracellular locations. The fidelity of these responses relies on the activation of localized protein kinase A (PKA) holoenzymes. Association of PKA regulatory type II (RII) subunits with A-kinase-anchoring proteins (AKAPs) confers location, and catalytic (C) subunits phosphorylate substrates. Single-particle electron microscopy demonstrated that AKAP79 constrains RII-C subassemblies within 150 to 250 angstroms of its targets. Native mass spectrometry established that these macromolecular assemblies incorporated stoichiometric amounts of cAMP. Chemical-biology-and live cell-imaging techniques revealed that catalytically active PKA holoenzymes remained intact within the cytoplasm. These findings indicate that the parameters of anchored PKA holoenzyme action are much more restricted than originally anticipated.	[Smith, F. Donelson; Esseltine, Jessica L.; Nygren, Patrick J.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA; [Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Byrne, Dominic P.; Vonderach, Matthias; Eyers, Claire E.; Eyers, Patrick A.] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool L69 7ZB, Merseyside, England; [Strashnov, Ilya] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Esseltine, Jessica L.] Western Univ, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Liverpool; University of Manchester; Western University (University of Western Ontario)	Scott, JD (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA.	scottjdw@uw.edu	Veesler, David/HCH-3986-2022; Eyers, Claire/C-6291-2013	Nygren, Patrick/0000-0001-8688-9389; Strashnov, Ilya/0000-0001-6502-5530; Eyers, Claire/0000-0002-3223-5926; Eyers, Patrick/0000-0002-9220-2966	NIH [5R01DK105542, 4P01DK054441, 1R01GM120553]; U.K. Biotechnology and Biological Sciences Research Council [BB/L009501/1]; North West Cancer Research grant [CR1037]; Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool; Heart and Stroke Foundation of Canada; Biotechnology and Biological Sciences Research Council [BB/L009501/1] Funding Source: researchfish; Medical Research Council [G120/1030] Funding Source: researchfish; BBSRC [BB/L009501/1] Funding Source: UKRI; MRC [G120/1030] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, R01DK105542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, R01GM120553] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); North West Cancer Research grant; Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush for technical support, K.F. and N. Pollett for molecular biology and cell culture assistance, all members of the Scott Lab for critical discussions, T. Cooke for technical assistance with FRET microscopy, and M. Milnes for administrative support. This work was supported by the following grants from the NIH: 5R01DK105542 (J.D.S.), 4P01DK054441 (J.D.S.), 1R01GM120553 (D.V.); U.K. Biotechnology and Biological Sciences Research Council grant BB/L009501/1 (C.E.E.); North West Cancer Research grant CR1037 (P.A.E.); and Core funding from the Institute of Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool (C.E.E. and P.A.E.). J.L.E. is the recipient of the Heart and Stroke Foundation of Canada Postdoctoral Fellowship. F.D.S. and J.D.S. conceived of and supervised the project. F.D.S., J.L.E., P.J.N., D.P.B., M.V., C.E.E., P.A.E., and J.D.S. designed the experiments. F.D.S., J.L.E., P.J.N., D.P.B., M.V., C.E.E., and P.A.E. performed experiments. F.D.S., J.L.E., P.J.N., D.P.B., M.V., C.E.E., P.A.E., and J.D.S. analyzed the data. D.V. provided guidance and software for EM experiments. I.S. provided guidance and support for MS experiments with Thermo EMR. L.K.L. designed and prepared figures. F.D.S., L.K.L., and J.D.S. wrote the manuscript.	Byrne DP, 2016, BIOCHEM J, V473, P3159, DOI 10.1042/BCJ20160648; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Hehnly H, 2015, ELIFE, V4, DOI 10.7554/eLife.09384; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Jin SLC, 1998, J BIOL CHEM, V273, P19672, DOI 10.1074/jbc.273.31.19672; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lopez MS, 2014, METHOD ENZYMOL, V548, P189, DOI 10.1016/B978-0-12-397918-6.00008-2; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; POTTER RL, 1979, J BIOL CHEM, V254, P2413; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scott JD, 2013, ANNU REV PHARMACOL, V53, P187, DOI 10.1146/annurev-pharmtox-011112-140204; SILVER PJ, 1989, AM J CARDIOL, V63, pA2, DOI 10.1016/0002-9149(89)90384-6; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Virdee K, 2000, CURR BIOL, V10, pR883, DOI 10.1016/S0960-9822(00)00843-5; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	32	100	102	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1288	+		10.1126/science.aaj1669	http://dx.doi.org/10.1126/science.aaj1669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642438	Green Submitted, Green Accepted			2022-12-28	WOS:000403881700041
J	Zhang, JJ; Fiers, P; Witte, KA; Jackson, RW; Poggensee, KL; Atkeson, CG; Collins, SH				Zhang, Juanjuan; Fiers, Pieter; Witte, Kirby A.; Jackson, Rachel W.; Poggensee, Katherine L.; Atkeson, Christopher G.; Collins, Steven H.			Human-in-the-loop optimization of exoskeleton assistance during walking	SCIENCE			English	Article							ENERGETIC COST; ANKLE; PROSTHESIS; DESIGN; WORK; GAIT	Exoskeletons and active prostheses promise to enhance human mobility, but few have succeeded. Optimizing device characteristics on the basis of measured human performance could lead to improved designs. We have developed a method for identifying the exoskeleton assistance that minimizes human energy cost during walking. Optimized torque patterns from an exoskeleton worn on one ankle reduced metabolic energy consumption by 24.2 +/- 7.4% compared to no torque. The approach was effective with exoskeletons worn on one or both ankles, during a variety of walking conditions, during running, and when optimizing muscle activity. Finding a good generic assistance pattern, customizing it to individual needs, and helping users learn to take advantage of the device all contributed to improved economy. Optimization methods with these features can substantially improve performance.	[Zhang, Juanjuan; Fiers, Pieter; Witte, Kirby A.; Jackson, Rachel W.; Poggensee, Katherine L.; Collins, Steven H.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Zhang, Juanjuan] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Atkeson, Christopher G.; Collins, Steven H.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Carnegie Mellon University	Collins, SH (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.; Collins, SH (corresponding author), Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.	stevecollins@cmu.edu	Poggensee, Katherine/ABE-5992-2021	Poggensee, Katherine/0000-0002-1530-3800; Zhang, Juanjuan/0000-0002-3833-487X; Collins, Steve/0000-0002-3997-3374	National Science Foundation [IIS-1355716]; Graduate Research Fellowships [DGE-1252522]; Nike	National Science Foundation(National Science Foundation (NSF)); Graduate Research Fellowships; Nike	We thank V. Chiu and J. Caputo for thoughtful conversations on optimization approaches; T. Nguyen, A. Fatschel, P. Franks, and C. Morales for assistance with data collection and photography; H. Geyer for use of data collection equipment; Gordon Composites for donating materials; and M. Donelan, M. Lansberg, L. Lau, D. Lentink, K. Sreenath, M. Srinivasan, G. R. Tan, G. Torres-Oviedo, the reviewers, and others for editorial suggestions. This material is based on work supported by the National Science Foundation under grant IIS-1355716 to S.H.C. and Graduate Research Fellowships under grant DGE-1252522 to K.A.W., R.W.J., and K.L.P., and a grant from Nike to S.H.C. The data reported in this paper are provided as data S1, and code samples are provided as data S2. S.H.C., J.Z., and C.G.A. conceived the method; S.H.C. and J.Z. designed the main study; J.Z. conducted experiments and analyzed data for the main study; P.F., K.A.W., R.W.J., K.L.P., and S.H.C. conducted the single-subject studies, with P.F. leading the running study and K.L.P. leading the muscle activity study; S.H.C. and J.Z. drafted the manuscript; and all authors edited the manuscript. J.Z. and S.H.C. are inventors on patent applications 62/495,690 and 62/392,270 submitted by Carnegie Mellon University that respectively cover the online optimization approach and exoskeleton torque control approach used in this study. K.A.W., R.W.J., and S.H.C. are inventors on patent application 62/392,263 submitted by Carnegie Mellon University that covers the exoskeleton emulator used in this study.	ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Caputo JM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026225; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Cornwall W, 2015, SCIENCE, V350, P270, DOI 10.1126/science.350.6258.270; Farris DJ, 2013, J APPL PHYSIOL, V115, P579, DOI 10.1152/japplphysiol.00253.2013; Felt W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135342; Ferris Daniel P, 2005, Top Spinal Cord Inj Rehabil, V11, P34; Galle S, 2014, EUR J APPL PHYSIOL, V114, P2341, DOI 10.1007/s00421-014-2955-1; Gordon KE, 2007, J BIOMECH, V40, P2636, DOI 10.1016/j.jbiomech.2006.12.006; Hamaya M., PATTERN RECOGNIT LET, DOI [10.1016/j.patrec.2017.04.0072017, DOI 10.1016/J.PATREC.2017.04.0072017]; Handford ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep19983; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Hoogkamer W, 2016, MED SCI SPORT EXER, V48, P2175, DOI 10.1249/MSS.0000000000001012; Huang H, 2011, IEEE T BIO-MED ENG, V58, P2867, DOI 10.1109/TBME.2011.2161671; Ijspeert AJ, 2014, SCIENCE, V346, P196, DOI 10.1126/science.1254486; Jackson R. W., 2017, J EXP BIOL; Jackson RW, 2015, J APPL PHYSIOL, V119, P541, DOI 10.1152/japplphysiol.01133.2014; Kazerooni H, 2006, INT J ROBOT RES, V25, P561, DOI 10.1177/0278364906065505; Koller J. R., 2016, ROB SCI SYST 12 ANN; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Makin TR, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0014; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-151; Quesada RE, 2016, J BIOMECH, V49, P3452, DOI 10.1016/j.jbiomech.2016.09.015; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Reinkensmeyer DJ, 2006, J REHABIL RES DEV, V43, P657, DOI 10.1682/JRRD.2005.04.0073; Selinger JC, 2015, CURR BIOL, V25, P2452, DOI 10.1016/j.cub.2015.08.016; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Seo K, 2016, IEEE INT CONF ROBOT, P4628, DOI 10.1109/ICRA.2016.7487663; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Thatte N, 2016, IEEE T BIO-MED ENG, V63, P904, DOI 10.1109/TBME.2015.2472533; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417; van den Bogert AJ, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-17; van Dijk W, 2014, IEEE ROBOT AUTOM MAG, V21, P56, DOI 10.1109/MRA.2014.2360309; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Witte KA, 2015, IEEE INT CONF ROBOT, P1223, DOI 10.1109/ICRA.2015.7139347; Zelik KE, 2011, IEEE T NEUR SYS REH, V19, P411, DOI 10.1109/TNSRE.2011.2159018; Zhang J., 2017, BIOINSPIRED LEGGED L	41	398	409	62	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1280	1283		10.1126/science.aal5054	http://dx.doi.org/10.1126/science.aal5054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642437				2022-12-28	WOS:000403881700039
J	Baud, D; Gubler, DJ; Schaub, B; Lanteri, MC; Musso, D				Baud, David; Gubler, Duane J.; Schaub, Bruno; Lanteri, Marion C.; Musso, Didier			An update on Zika virus infection	LANCET			English	Review							GUILLAIN-BARRE-SYNDROME; PUBLIC-HEALTH EMERGENCY; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; CLINICAL MANAGEMENT; CROSS-REACTIVITY; FRENCH-POLYNESIA; DENGUE VIRUS; CASE SERIES; BLOOD	The epidemic history of Zika virus began in 2007, with its emergence in Yap Island in the western Pacific, followed in 2013-14 by a larger epidemic in French Polynesia, south Pacific, where the first severe complications and non-vectorborne transmission of the virus were reported. Zika virus emerged in Brazil in 2015 and was declared a national public health emergency after local researchers and physicians reported an increase in microcephaly cases. In 2016, WHO declared the recent cluster of microcephaly cases and other neurological disorders reported in Brazil a global public health emergency. Similar clusters of microcephaly cases were also observed retrospectively in French Polynesia in 2014. In 2015-16, Zika virus continued its spread to cause outbreaks in the Americas and the Pacific, and the first outbreaks were reported in continental USA, Africa, and southeast Asia. Non-vector-borne transmission was confirmed and Zika virus was established as a cause of severe neurological complications in fetuses, neonates, and adults. This Review focuses on important updates and gaps in the knowledge of Zika virus as of early 2017.	[Baud, David] Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofetal & Obstet Res Unit, Lausanne, Switzerland; [Gubler, Duane J.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Schaub, Bruno] CHU Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Maison Femme Mere & Enfant, Fort De France, Martinique, France; [Schaub, Bruno] CHU Martinique, Registre Malformat Antilles REMALAN, Maison Femme Mere & Enfant, Fort De France, Martinique, France; [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA; [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lanteri, Marion C.] Cerus Corp, Concord, CA USA; [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National University of Singapore; CHU Martinique; CHU Martinique; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Cerus Corporation	Baud, D (corresponding author), Univ Hosp, Dept Femme Mere Enfant, Obstet Serv, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.	david.baud@chuv.ch	Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016	Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496				Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168; American Association for Blood Banks, 2016, JOINT STAT FOOD DRUG; Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333; de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549; Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271; Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614; Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1; Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751; Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Castro MC, 2016, TRAVEL MED INFECT DI, V14, P384, DOI 10.1016/j.tmaid.2016.06.007; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148; Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2; de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3; Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020; Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254; Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9; Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657; Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102; Honein MA, 2011, JAMA-J AM MED ASSOC, V317, P59; Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2; Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA; Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677; Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387; Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269; Maria F Santa, TRANSFUSION IN PRESS; Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7; McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Musso D, 2017, ISBT SCI SERIES, V12, P254, DOI DOI 10.1111/voxs.12335; Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1; Musso D, 2016, TRANSFUSION, V56, P3143, DOI 10.1111/trf.13861; Musso D, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0551-8; Musso D, 2016, LANCET INFECT DIS, V16, P1108, DOI 10.1016/S1473-3099(16)30337-1; Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]; Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9; Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Paz-Bailey G., 2017, N ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJMOA1613108]; Penot P, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.3.30444; Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]; Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113; Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113; Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]; Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580; Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448; Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300; Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310; US Centers for Disease Control and Prevention, 2016, GUID US LAB TES ZIK; van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2; Vouga M, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30013-2; Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880; Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4; Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4; Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041; World Health Organization, 2017, SIT REP; World Health Organization (WHO), 2016, 5 M EM COMM INT HLTH; Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270	106	344	353	8	101	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 4	2017	390	10107					2099	2109		10.1016/S0140-6736(17)31450-2	http://dx.doi.org/10.1016/S0140-6736(17)31450-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FL5DD	28647173	Bronze			2022-12-28	WOS:000414250800027
J	Clark, J				Clark, Jocalyn			Ilona Kickbusch: global health reformer	LANCET			English	Biographical-Item														Clark, Jocalyn/0000-0002-8014-3989				KICKBUSCH I, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					835	835		10.1016/S0140-6736(17)31753-1	http://dx.doi.org/10.1016/S0140-6736(17)31753-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28684020				2022-12-28	WOS:000408330700011
J	Gibson, PG; Yang, IA; Upham, JW; Reynolds, PN; Hodge, S; James, AL; Jenkins, C; Peters, MJ; Marks, GB; Baraket, M; Powell, H; Taylor, SL; Leong, LEX; Rogers, GB; Simpson, JL				Gibson, Peter G.; Yang, Ian A.; Upham, John W.; Reynolds, Paul N.; Hodge, Sandra; James, Alan L.; Jenkins, Christine; Peters, Matthew J.; Marks, Guy B.; Baraket, Melissa; Powell, Heather; Taylor, Steven L.; Leong, Lex E. X.; Rogers, Geraint B.; Simpson, Jodie L.			Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							MACROLIDE ANTIBIOTICS; LONG-TERM; AIRWAY INFLAMMATION; CLARITHROMYCIN; QUESTIONNAIRE; METAANALYSIS; VALIDATION; THERAPY; DISEASE; BURDEN	Background Exacerbations of asthma cause a substantial global illness burden. Adults with uncontrolled persistent asthma despite maintenance treatment require additional therapy. Since macrolide antibiotics can be used to treat persistent asthma, we aimed to assess the efficacy and safety of oral azithromycin as add-on therapy in patients with uncontrolled persistent asthma on medium-to-high dose inhaled corticosteroids plus a long-acting bronchodilator. Methods We did a randomised, double-blind, placebo controlled parallel group trial to determine whether oral azithromycin decreases the frequency of asthma exacerbations in adults (>= 18 years) with symptomatic asthma despite current use of inhaled corticosteroid and long-acting bronchodilator, and who had no hearing impairment or abnormal prolongation of the corrected QT interval. Patients were randomly assigned (1: 1) to receive azithromycin 500 mg or placebo three times per week for 48 weeks. Patients were centrally allocated using concealed random allocation from a computer-generated random numbers table with permuted blocks of 4 or 6 and stratification for centre and past smoking. Primary efficacy endpoints were the rate of total (severe and moderate) asthma exacerbations over 48 weeks and asthma quality of life. Data were analysed on an intention-to-treat basis. Findings Between June 12, 2009, and Jan 31, 2015, 420 patients were randomly assigned (213 in the azithromycin group and 207 in the placebo group). Azithromycin reduced asthma exacerbations (1.07 per patient-year [95% CI 0.85-1.29]) compared with placebo (1.86 per patient-year [1.54-2.18]; incidence rate ratio [IRR] 0.59 [95% CI 0.47-0.74]; p<0.0001). The proportion of patients experiencing at least one asthma exacerbation was reduced by azithromycin treatment (127 [61%] patients in the placebo group vs 94 [44%] patients in the azithromycin group, p<0.0001). Azithromycin significantly improved asthma-related quality of life (adjusted mean difference, 0.36 [95% CI 0.21-0.52]; p=0.001). Diarrhoea was more common in azithromycin-treated patients (72 [34%] vs 39 [19%]; p=0.001). Interpretation Adults with persistent symptomatic asthma experience fewer asthma exacerbations and improved quality of life when treated with oral azithromycin for 48 weeks. Azithromycin might be a useful add-on therapy in persistent asthma.	[Gibson, Peter G.; Powell, Heather] Hunter Med Res Inst, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Gibson, Peter G.; Powell, Heather; Simpson, Jodie L.] Univ Newcastle, Prior Res Ctr Hlth Lungs, Newcastle, NSW, Australia; [Gibson, Peter G.; Marks, Guy B.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Yang, Ian A.; Upham, John W.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Yang, Ian A.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia; [Upham, John W.] Princess Alexandra Hosp, Dept Resp Med, Brisbane, Qld, Australia; [Reynolds, Paul N.; Hodge, Sandra] Royal Adelaide Hosp, Dept Thorac Med, Adelaide, SA, Australia; [Reynolds, Paul N.; Hodge, Sandra] Hanson Inst, Lung Res Lab, Adelaide, SA, Australia; [Reynolds, Paul N.; Hodge, Sandra] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Perth, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Jenkins, Christine] George Inst Global Hlth, Resp Trials, Sydney, NSW, Australia; [Peters, Matthew J.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Jenkins, Christine; Peters, Matthew J.] Concord Gen Hosp, Dept Thorac Med, Sydney, NSW, Australia; [Marks, Guy B.] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Baraket, Melissa] Univ New South Wales, Med Dept, Sydney, NSW, Australia; [Baraket, Melissa] Univ New South Wales, Med Fac, Ingham Inst Liverpool Hosp, Sydney, NSW, Australia; [Taylor, Steven L.; Leong, Lex E. X.; Rogers, Geraint B.] SAHMRI, Adelaide, SA, Australia; [Taylor, Steven L.; Leong, Lex E. X.; Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Microbiome Res Lab, Adelaide, SA, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Sydney; Woolcock Institute of Medical Research; University of Queensland; Prince Charles Hospital; Royal Adelaide Hospital; Hanson Institute; University of Adelaide; University of Western Australia; George Institute for Global Health; University of Sydney; Macquarie University; Concord Repatriation General Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Liverpool Hospital; University of New South Wales Sydney; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Gibson, PG (corresponding author), Hunter Med Res Inst, Lot 1 Kookaburra Circuit,Level 2,West Wing, New Lambton Hts, NSW 2305, Australia.	peter.gibson@hnehealth.nsw.gov.au	Leong, Lex/AAH-4211-2021; Yang, Ian A/B-9609-2008; Marks, Guy B./F-5058-2013; SIMPSON, JODIE LOUISE/G-7639-2013; Upham, John/F-4420-2010; Rogers, Geraint/AAD-1011-2020; Taylor, Steven/AAD-7827-2019; gibson, peter/G-6194-2014; Rogers, Geraint/N-1957-2013	Yang, Ian A/0000-0001-8338-1993; Marks, Guy B./0000-0002-8976-8053; SIMPSON, JODIE LOUISE/0000-0002-3626-680X; Upham, John/0000-0002-0017-3433; Taylor, Steven/0000-0003-4357-8243; Peters, Matthew/0000-0002-9649-8741; gibson, peter/0000-0001-5865-489X; Rogers, Geraint/0000-0003-4054-1947; Leong, Lex Ee Xiang/0000-0002-5073-2272	National Health and Medical Research Council of Australia; John Hunter Hospital Charitable Trust; National Health and Medical Research Council of Australia (NHMRC) [569246]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council of Australia, John Hunter Hospital Charitable Trust.; This study was funded by the National Health and Medical Research Council of Australia (NHMRC project identifier 569246) and the John Hunter Hospital Charitable trust. We thank the study participants, the clinical research officers, laboratory technicians, and statistical support that was provided throughout the conduct of this study.	Albert RK, 2014, AM J RESP CRIT CARE, V189, P1173, DOI 10.1164/rccm.201402-0385CI; Altenburg J, 2011, RESPIRATION, V81, P75, DOI 10.1159/000320320; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Calhoun WJ, 2014, J ALLER CL IMM-PRACT, V2, P193, DOI 10.1016/j.jaip.2013.11.013; Gielen V, 2010, EUR RESPIR J, V36, P646, DOI 10.1183/09031936.00095809; Haghi M, 2015, PHARM RES-DORDR, V32, P2144, DOI 10.1007/s11095-014-1605-y; Hahn DL, 2012, J AM BOARD FAM MED, V25, P442, DOI 10.3122/jabfm.2012.04.110309; Hua W, 2015, RESPIROLOGY, V20, P1055, DOI 10.1111/resp.12554; Ivanova JI, 2012, J ALLERGY CLIN IMMUN, V129, P1229, DOI 10.1016/j.jaci.2012.01.039; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Juniper EF, 1999, CHEST, V115, P1265, DOI 10.1378/chest.115.5.1265; Keene ON, 2007, PHARM STAT, V6, P89, DOI 10.1002/pst.250; Kew K, 2015, COCHRANE DB SYST REV, V15; Kew K, 2013, COCHRANE DB SYST REV, V16; Parnham MJ, 2014, PHARMACOL THERAPEUT, V143, P225, DOI 10.1016/j.pharmthera.2014.03.003; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Ratzinger F, 2014, SCI REP-UK, V4, DOI 10.1038/srep07438; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Reiter J, 2013, ALLERGY, V68, P1040, DOI 10.1111/all.12199; Richeldi L, 2005, COCHRANE DB SYST REV, V19; Rogers GB, 2014, LANCET RESP MED, V2, P988, DOI 10.1016/S2213-2600(14)70213-9; Rolfe FG, 1997, AM J RESP CELL MOL, V17, P243, DOI 10.1165/ajrcmb.17.2.2819; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Sutherland ER, 2010, J ALLERGY CLIN IMMUN, V126, P747, DOI 10.1016/j.jaci.2010.07.024; Tojima I, 2015, AURIS NASUS LARYNX, V42, P332, DOI 10.1016/j.anl.2015.02.003; Tong X, 2015, PULM PHARMACOL THER, V31, P99, DOI 10.1016/j.pupt.2014.09.005; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345	30	358	373	4	55	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					659	668		10.1016/S0140-6736(17)31281-3	http://dx.doi.org/10.1016/S0140-6736(17)31281-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD3TV	28687413				2022-12-28	WOS:000407456200022
J	Ibrahim, AM; Dimick, JB				Ibrahim, Andrew M.; Dimick, Justin B.			Monitoring Medical Devices Missed Warning Signs Within Existing Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ibrahim, Andrew M.; Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ibrahim, AM (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, 2800 Plymouth Ave,Bldg 10-G016, Ann Arbor, MI 48109 USA.	iandrew@umich.edu			Robert Wood Johnson Foundation; US Department of Veterans Affairs; National Institute on Aging [R01AG039434-04]; NATIONAL INSTITUTE ON AGING [R01AG039434] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Ibrahim acknowledges funding from the Robert Wood Johnson Foundation and the US Department of Veterans Affairs supporting his role as a Robert Wood Johnson Clinical Scholar. Dr Dimick acknowledges funding from the National Institute on Aging under award R01AG039434-04.	Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Ibrahim AM, JAMA SURG, DOI [10.1001/jamasurg.2017.1093, DOI 10.1001/JAMASURG.2017.1093]; KESSLER DA, 1993, JAMA-J AM MED ASSOC, V269, P2765, DOI 10.1001/jama.269.21.2765; Kuehn BM, 2016, JAMA-J AM MED ASSOC, V315, P1934, DOI 10.1001/jama.2016.2752; Murray P., 2016, PREVENTABLE TRAGEDIE; Obeid NR, 2017, ANN SURG, V265, P446, DOI 10.1097/SLA.0000000000002071; US Food and Drug Administration, 2011, LAP BAND SUMM SAF EF	7	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					327	328		10.1001/jama.2017.6584	http://dx.doi.org/10.1001/jama.2017.6584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28655037	Green Accepted			2022-12-28	WOS:000406296700007
J	Clark, LV; Pesola, F; Thomas, JM; Vergara-Williamson, M; Beynon, M; White, PD				Clark, Lucy V.; Pesola, Francesca; Thomas, Janice M.; Vergara-Williamson, Mario; Beynon, Michelle; White, Peter D.			Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial	LANCET			English	Article							VALIDITY; MODELS	Background Graded exercise therapy is an effective and safe treatment for chronic fatigue syndrome, but it is therapist intensive and availability is limited. We aimed to test the efficacy and safety of graded exercise delivered as guided self-help. Methods In this pragmatic randomised controlled trial, we recruited adult patients (18 years and older) who met the UK National Institute for Health and Care Excellence criteria for chronic fatigue syndrome from two secondary-care clinics in the UK. Patients were randomly assigned to receive specialist medical care (SMC) alone (control group) or SMC with additional guided graded exercise self-help (GES). Block randomisation (randomly varying block sizes) was done at the level of the individual with a computer-generated sequence and was stratified by centre, depression score, and severity of physical disability. Patients and physiotherapists were necessarily unmasked from intervention assignment; the statistician was masked from intervention assignment. SMC was delivered by specialist doctors but was not standardised; GES consisted of a self-help booklet describing a six-step graded exercise programme that would take roughly 12 weeks to complete, and up to four guidance sessions with a physiotherapist over 8 weeks (maximum 90 min in total). Primary outcomes were fatigue (measured by the Chalder Fatigue Questionnaire) and physical function (assessed by the Short Form-36 physical function subscale); both were self-rated by patients at 12 weeks after randomisation and analysed in all randomised patients with outcome data at follow-up (ie, by modified intention to treat). We recorded adverse events, including serious adverse reactions to trial interventions. We used multiple linear regression analysis to compare SMC with GES, adjusting for baseline and stratification factors. This trial is registered at ISRCTN, number ISRCTN22975026. Findings Between May 15, 2012, and Dec 24, 2014, we recruited 211 eligible patients, of whom 107 were assigned to the GES group and 104 to the control group. At 12 weeks, compared with the control group, mean fatigue score was 19.1 (SD 7.6) in the GES group and 22.9 (6.9) in the control group (adjusted difference -4.2 points, 95% CI -6.1 to -2.3, p<0.0001; effect size 0.53) and mean physical function score was 55.7 (23.3) in the GES group and 50.8 (25.3) in the control group (adjusted difference 6.3 points, 1.8 to 10.8, p=0.006; 0.20). No serious adverse reactions were recorded and other safety measures did not differ between the groups, after allowing for missing data. Interpretation GES is a safe intervention that might reduce fatigue and, to a lesser extent, physical disability for patients with chronic fatigue syndrome. These findings need confirmation and extension to other health-care settings. Funding UK National Institute for Health Research Research for Patient Benefit Programme and the Sue Estermann Fund. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license.	[Clark, Lucy V.; Beynon, Michelle; White, Peter D.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Psychiat, Charterhouse Sq, London EC1M 6BQ, England; [Pesola, Francesca] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England; [Thomas, Janice M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Vice Principal Hlth Off, London, England; [Vergara-Williamson, Mario] Kent & Medway Natl Hlth Serv & Social Care Partne, Chron Fatigue Syndrome Myalg Encephalopathy Serv, Maidstone, Kent, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London	Clark, LV (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Psychiat, Charterhouse Sq, London EC1M 6BQ, England.	l.clark@qmul.ac.uk		Clark, Lucy/0000-0001-7162-0512; Beynon, Michelle/0000-0002-2628-2187	UK National Institute for Health Research Research for Patient Benefit Programme; Sue Estermann Fund	UK National Institute for Health Research Research for Patient Benefit Programme; Sue Estermann Fund	UK National Institute for Health Research Research for Patient Benefit Programme and the Sue Estermann Fund.	Action for ME, 2008, ME 2008 WHAT PROGR; [Anonymous], 2014, ME TIM DEL IN FIND A; Baldwin SA, 2011, PSYCHOL METHODS, V16, P149, DOI 10.1037/a0023464; Cairns R, 2005, OCCUP MED-OXFORD, V55, P20, DOI 10.1093/occmed/kqi013; Chalder T, 1997, BRIT J HEALTH PSYCH, V2, P189, DOI 10.1111/j.2044-8287.1997.tb00535.x; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Clark L.V., 2011, GRADED EXERCISE THER; Clark LV, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5395; Collin SM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001417; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; First MB, 2002, STRUCTURED CLIN INTE; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Johnson DR, 2011, J MARRIAGE FAM, V73, P926, DOI 10.1111/j.1741-3737.2011.00861.x; Knoop H, 2008, BRIT J PSYCHIAT, V193, P340, DOI 10.1192/bjp.bp.108.051292; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Larun L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub4; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Tummers M, 2012, PSYCHOL MED, V42, P2205, DOI 10.1017/S0033291712000232; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	26	40	43	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					363	373		10.1016/S0140-6736(16)32589-2	http://dx.doi.org/10.1016/S0140-6736(16)32589-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28648402	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000405911300025
J	Aggarwal, A; Parai, MK; Shetty, N; Wallis, D; Woolhiser, L; Hastings, C; Dutta, NK; Galaviz, S; Dhakal, RC; Shrestha, R; Wakabayashi, S; Walpole, C; Matthews, D; Floyd, D; Scullion, P; Riley, J; Epemolu, O; Norval, S; Snavely, T; Robertson, GT; Rubin, EJ; Ioerger, TR; Sirgel, FA; van der Merwe, R; van Helden, PD; Keller, P; Bottger, EC; Karakousis, PC; Lenaerts, AJ; Sacchettini, JC				Aggarwal, Anup; Parai, Maloy K.; Shetty, Nishant; Wallis, Deeann; Woolhiser, Lisa; Hastings, Courtney; Dutta, Noton K.; Galaviz, Stacy; Dhakal, Ramesh C.; Shrestha, Rupesh; Wakabayashi, Shoko; Walpole, Chris; Matthews, David; Floyd, David; Scullion, Paul; Riley, Jennifer; Epemolu, Ola; Norval, Suzanne; Snavely, Thomas; Robertson, Gregory T.; Rubin, Eric J.; Ioerger, Thomas R.; Sirgel, Frik A.; van der Merwe, Ruben; van Helden, Paul D.; Keller, Peter; Bottger, Erik C.; Karakousis, Petros C.; Lenaerts, Anne J.; Sacchettini, James C.			Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13	CELL			English	Article							MYCOLIC ACID BIOSYNTHESIS; CATALASE-PEROXIDASE GENE; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID RESISTANCE; THIOESTERASE DOMAIN; CRYSTAL-STRUCTURE; QUINONE METHIDE; INHA; STRAIN; GENERATION	Widespread resistance to first-line TB drugs is a major problem that will likely only be resolved through the development of new drugs with novel mechanisms of action. We have used structure-guided methods to develop a lead molecule that targets the thioesterase activity of polyketide synthase Pks13, an essential enzyme that forms mycolic acids, required for the cell wall of Mycobacterium tuberculosis. Our lead, TAM16, is a benzofuran class inhibitor of Pks13 with highly potent in vitro bactericidal activity against drug-susceptible and drug-resistant clinical isolates of M. tuberculosis. In multiple mouse models of TB infection, TAM16 showed in vivo efficacy equal to the first-line TB drug isoniazid, both as a monotherapy and in combination therapy with rifampicin. TAM16 has excellent pharmacological and safety profiles, and the frequency of resistance for TAM16 is similar to 100-fold lower than INH, suggesting that it can be developed as a new antitubercular aimed at the acute infection.	[Aggarwal, Anup; Parai, Maloy K.; Shetty, Nishant; Wallis, Deeann; Galaviz, Stacy; Dhakal, Ramesh C.; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Woolhiser, Lisa; Hastings, Courtney; Robertson, Gregory T.; Lenaerts, Anne J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Dutta, Noton K.; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Ctr TB Res, Baltimore, MD 21205 USA; [Wakabayashi, Shoko; Rubin, Eric J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Walpole, Chris; Matthews, David; Floyd, David] SGC Toronto, Struct Guided Drug Discovery Coalit, Toronto, ON, Canada; [Scullion, Paul; Riley, Jennifer; Epemolu, Ola; Norval, Suzanne] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee, Scotland; [Snavely, Thomas; Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Sirgel, Frik A.; van der Merwe, Ruben; van Helden, Paul D.] Stellenbosch Univ, NRF Ctr Excellence Biomed TB Res, Tygerberg, South Africa; [Sirgel, Frik A.; van der Merwe, Ruben; van Helden, Paul D.] Stellenbosch Univ, South African MRC Ctr Mol & Cellular Biol, Div Mol Biol & Human Genet, Tygerberg, South Africa; [Keller, Peter; Bottger, Erik C.] Univ Zurich, Natl Ctr Mycobacteria, Inst Med Microbiol, Zurich, Switzerland	Texas A&M University System; Texas A&M University College Station; Colorado State University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; University of Dundee; Texas A&M University System; Texas A&M University College Station; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; University of Zurich	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	sacchett@tamu.edu	Böttger, Erik C./F-6175-2011; Karakousis, Petros Constantine/AAR-7899-2020; Robertson, Gregory T./E-1601-2017; Dutta, Noton K./K-5202-2012; Keller, Peter M/D-8675-2013; Parai, Maloy K/J-1393-2014; Lenaerts, Anne/F-1353-2017; Keller, Peter M/C-6876-2012; Shrestha, Rupesh/ABI-7761-2020	Robertson, Gregory T./0000-0001-7157-4034; Dutta, Noton K./0000-0002-5066-3342; Keller, Peter M/0000-0002-2890-5384; Keller, Peter M/0000-0002-2890-5384; Shrestha, Rupesh/0000-0002-6785-2932; Aggarwal, Anup/0000-0003-1937-964X	Bill and Melinda Gates Foundation [OPP1024055]; NIAID-NIH (TB Structural Genomics grant) [P01A1095208]; Welch foundation [A-0015]; Structure-guided Drug Discovery Coalition [OPP1032548]; NIH/NIAID IDIQ [HHSN272201000009I/HHSN27200001]; South African MRC; University of Zurich; NRF	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID-NIH (TB Structural Genomics grant); Welch foundation(The Welch Foundation); Structure-guided Drug Discovery Coalition; NIH/NIAID IDIQ; South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Zurich; NRF	This work was supported by grants from the Bill and Melinda Gates Foundation (OPP1024055), NIAID-NIH (TB Structural Genomics grant P01A1095208), Welch foundation (A-0015), and Structure-guided Drug Discovery Coalition (OPP1032548) to J.C.S.; the NIH/NIAID IDIQ Contract Task Order HHSN272201000009I/HHSN27200001 (Task A04) for the efficacy testing to A.J.L. The authors thank Midwest Center for Structural Genomics for providing LIC vectors; the staff at beamlines 19-ID and 23-ID of the Advanced Photon Source, Argonne National Laboratory for assistance during the X-ray data collection; scientists from AbbVie who provided in vitro safety data: M. Srikumaran, M.D. Kurnick, and G.M. Freiberg (hERG and enzyme/receptor assays) and J. Nicolette and A. Kondratiuk (Ames assay); K.D. Read from DDU for support and discussions. We also acknowledge the following for technical assistance: K. Loesch, W. Dong (HDF assays); H.L. Huang (MIC assays); A. Srivastava (genome sequencing of resistant mutants); L.M. Guthrie (PK studies); F. Zhou and M. K. Gupta (TAM16 purification); WuXi Apptec (TAM16 synthesis and purification); and S. Courtright (manuscript editing). E.C.B and P.K thank Rico Homke for expert technical assistance and the University of Zurich for continuous support. R.v.d.M., F. A. S., and P.D.v.H. thank the South African MRC and NRF for funding assistance. The authors declare no competing financial interests. J.C.S, A. A., and M.K.P. are listed as inventors on a patent relating to this work filed by Texas A&M University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barrero AF, 2006, TETRAHEDRON, V62, P6012, DOI 10.1016/j.tet.2006.04.004; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bellizzi JJ, 2000, P NATL ACAD SCI USA, V97, P4573, DOI 10.1073/pnas.080508097; BERNSTEIN J, 1952, AM REV TUBERC PULM, V65, P357; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhusal Y, 2005, INT J ANTIMICROB AG, V26, P292, DOI 10.1016/j.ijantimicag.2005.05.005; Bosne-David S, 2000, J ANTIMICROB CHEMOTH, V46, P391, DOI 10.1093/jac/46.3.391; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chopra T, 2009, METHOD ENZYMOL, V459, P259, DOI 10.1016/S0076-6879(09)04612-6; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Dutta NK, 2014, ANTIMICROB AGENTS CH, V58, P4048, DOI 10.1128/AAC.02981-14; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Guardia A, 2016, CHEMMEDCHEM, V11, P687, DOI 10.1002/cmdc.201600020; Guo XW, 2009, J AM CHEM SOC, V131, P17387, DOI 10.1021/ja907568j; Hayashi KI, 2008, BIOORGAN MED CHEM, V16, P5331, DOI 10.1016/j.bmc.2008.02.085; He SW, 2014, TETRAHEDRON LETT, V55, P2212, DOI 10.1016/j.tetlet.2014.02.051; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Johansson T, 2009, DRUG METAB DISPOS, V37, P571, DOI 10.1124/dmd.108.025171; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Larsen M.H., 2007, CURR PROTOC MICROBIO, V6; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Lechartier B, 2012, ANTIMICROB AGENTS CH, V56, P5790, DOI 10.1128/AAC.01476-12; Manjunatha UH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010597; Matsumoto J, 2005, TETRAHEDRON, V61, P5735, DOI 10.1016/j.tet.2005.04.037; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MONTI SA, 1970, J ORG CHEM, V35, P3764, DOI 10.1021/jo00836a041; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mothe SR, 2010, TETRAHEDRON LETT, V51, P2136, DOI 10.1016/j.tetlet.2010.02.066; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Newlander KA, 1997, J ORG CHEM, V62, P6726, DOI 10.1021/jo9620472; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan P, 2012, CURR TOP MED CHEM, V12, P672, DOI 10.2174/156802612799984535; Panda G, 2007, EUR J MED CHEM, V42, P410, DOI 10.1016/j.ejmech.2006.09.020; PETERSON GA, 1987, TETRAHEDRON LETT, V28, P1381, DOI 10.1016/S0040-4039(00)95932-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Quadri LEN, 2014, CRIT REV BIOCHEM MOL, V49, P179, DOI 10.3109/10409238.2014.896859; Richardson RD, 2007, MOL CANCER THER, V6, P2120, DOI 10.1158/1535-7163.MCT-07-0187; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Schmalhofer WA, 2010, ASSAY DRUG DEV TECHN, V8, P714, DOI 10.1089/adt.2010.0351; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Stokes RW, 1999, CELL IMMUNOL, V197, P1, DOI 10.1006/cimm.1999.1554; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Torres JN, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.42; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vilcheze C, 2000, J BACTERIOL, V182, P4059, DOI 10.1128/JB.182.14.4059-4067.2000; Vilcheze C., 2014, MICROBIOL SPECTR, V2, DOI DOI 10.1128/MICROBIOLSPEC.MGM2-0014-2013; WHO, 2014, GLOB TUB REP 2014; Wilson R, 2013, NAT CHEM BIOL, V9, P499, DOI 10.1038/nchembio.1277; Zhang W, 2011, P NATL ACAD SCI USA, V108, P15757, DOI 10.1073/pnas.1112334108; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; Zuniga ES, 2015, FUTURE MICROBIOL, V10, P217, DOI [10.2217/FMB.14.125, 10.2217/fmb.14.125]	67	94	100	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					249	+		10.1016/j.cell.2017.06.025	http://dx.doi.org/10.1016/j.cell.2017.06.025			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28669536	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000405493900006
J	Axelsson, KF; Nilsson, AG; Wedel, H; Lundh, D; Lorentzon, M				Axelsson, Kristian F.; Nilsson, Anna G.; Wedel, Hans; Lundh, Dan; Lorentzon, Mattias			Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; INDUCED OSTEOPOROSIS; INTERVENTION TRIAL; RANDOMIZED-TRIAL; RECOMMENDATIONS; EPIDEMIOLOGY; METAANALYSIS; OUTCOMES; WOMEN; VALIDATION	IMPORTANCE Oral glucocorticoid treatment increases fracture risk, and evidence is lacking regarding the efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids. OBJECTIVE To investigate whether alendronate treatment in older patients using oral prednisolone is associated with decreased hip fracture risk and adverse effects. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using a national database (N = 433 195) of patients aged 65 years or older undergoing a health evaluation (baseline) at Swedish health care facilities; 1802 patients who were prescribed alendronate after at least 3 months of oral prednisolone treatment (>= 5mg/d) were identified. Propensity score matching was used to select 1802 patients without alendronate use from 6076 patients taking prednisolone with the same dose and treatment time criteria. Follow-up occurred between January 2008 and December 2014. EXPOSURES Alendronate vs no alendronate use; no patients had previously taken alendronate at the time of prednisolone initiation. MAIN OUTCOMES AND MEASURES The primary outcome was incident hip fracture. RESULTS Of the 3604 included patients, the mean age was 79.9 (SD, 7.5) years, and 2524 (70%) were women. After a median follow-up of 1.32 years (interquartile range, 0.57-2.34 years), there were 27 hip fractures in the alendronate group and 73 in the no-alendronate group, corresponding to incidence rates of 9.5 (95% CI, 6.5-13.9) and 27.2 (95% CI, 21.6-34.2) fractures per 1000 person-years, with an absolute rate difference of -17.6 (95% CI, -24.8 to -10.4). The use of alendronate was associated with a lower risk of hip fracture in a multivariable-adjusted Cox model (hazard ratio, 0.35; 95% CI, 0.22-0.54). Alendronate treatment was not associated with increased risk of mild upper gastrointestinal tract symptoms (alendronate vs no alendronate, 15.6 [95% CI, 11.6-21.0] vs 12.9 [95% CI, 9.3-18.0] per 1000 person-years; P=.40) or peptic ulcers (10.9 [95% CI, 7.7-15.5] vs 11.4 [95% CI, 8.0-16.2] per 1000 person-years; P=.86). There were no cases of incident drug-induced osteonecrosis and only 1 case of femoral shaft fracture in each group. CONCLUSIONS AND RELEVANCE Among older patients using medium to high doses of prednisolone, alendronate treatment was associated with a significantly lower risk of hip fracture over a median of 1.32 years. Although the findings are limited by the observational study design and the small number of events, these results support the use of alendronate in this patient group.	[Axelsson, Kristian F.] Skaraborg Hosp, Dept Orthopaed Surg, Skovde, Sweden; [Axelsson, Kristian F.; Nilsson, Anna G.; Lorentzon, Mattias] Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Geriatr Med, Gothenburg, Sweden; [Nilsson, Anna G.] Sahlgrens Univ Hosp, Dept Endocrinol, Internal Med, Gothenburg, Sweden; [Wedel, Hans] Univ Gothenburg, Sahlgrenska Acad, Hlth Metr, Gothenburg, Sweden; [Lundh, Dan] Univ Skovde, Sch Biosci, Skovde, Sweden; [Lorentzon, Mattias] Sahlgrens Univ Hosp, Geriatr Med, Molndal, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of Skovde; Sahlgrenska University Hospital	Lorentzon, M (corresponding author), Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Med, Geriatr Med, Bldg K,Sixth Floor, S-43180 Molndal, Sweden.	mattias.lorentzon@medic.gu.se	Lorentzon, Mattias/W-7878-2019	Lorentzon, Mattias/0000-0003-0749-1431; Axelsson, Kristian/0000-0002-4118-6038	Research Fund at Skaraborg Hospital Skovde; Skaraborg Institute; Swedish Research Council; Sahlgrenska University Hospital; King Gustaf V's and Queen Victoria's Freemason Foundation	Research Fund at Skaraborg Hospital Skovde; Skaraborg Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital; King Gustaf V's and Queen Victoria's Freemason Foundation	This study was funded by the Research Fund at Skaraborg Hospital Skovde, the Skaraborg Institute, the Swedish Research Council, the ALF/LUA grant from the Sahlgrenska University Hospital, and King Gustaf V's and Queen Victoria's Freemason Foundation.	Abrahamsen B, 2009, OSTEOPOROSIS INT, V20, P1633, DOI 10.1007/s00198-009-0920-3; Allen CS, 2016, COCHRANE DB SYST REV, V10; Amiche MA, 2016, OSTEOPOROSIS INT, V27, P1989, DOI 10.1007/s00198-015-3476-4; Axelsson KF, 2016, OSTEOPOROSIS INT, V27, P3165, DOI 10.1007/s00198-016-3643-2; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Black DM, 2000, J CLIN ENDOCR METAB, V85, P4118, DOI 10.1210/jc.85.11.4118; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1174, DOI 10.1210/jc.2009-0852; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Curtis JR, 2012, ARTHRIT CARE RES, V64, P1855, DOI 10.1002/acr.21759; Duru N, 2013, ANN RHEUM DIS, V72, P1905, DOI 10.1136/annrheumdis-2013-203249; Dyer SM, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0332-0; Edvinsson J, 2015, QUAL MANAG HEALTH CA, V24, P96, DOI 10.1097/QMH.0000000000000058; Eisenberg DF, 2015, J MANAG CARE SPEC PH, V21, P56, DOI 10.18553/jmcp.2015.21.1.56; Grossman JM, 2010, ARTHRIT CARE RES, V62, P1515, DOI 10.1002/acr.20295; Harris H., 2016, PRACTICAL ASSESSMENT, V21, P4; Kallman U, 2014, ADV SKIN WOUND CARE, V27, P70, DOI 10.1097/01.ASW.0000439059.72199.41; Kanis JA, 2004, CALCIFIED TISSUE INT, V75, P90, DOI 10.1007/s00223-004-0287-6; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Mangram A, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-59; Natsui K, 2006, OSTEOPOROSIS INT, V17, P105, DOI 10.1007/s00198-005-1923-3; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Randolph J. J., 2014, PRACTICAL ASSESSMENT, V19, P1, DOI DOI 10.7275/N3PV-TX27; Rosengren BE, 2017, OSTEOPOROSIS INT, V28, P139, DOI 10.1007/s00198-016-3768-3; Vu T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003222; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; van Staa TP, 2000, QJM-MON J ASSOC PHYS, V93, P105, DOI 10.1093/qjmed/93.2.105; Wallander M, 2017, J BONE MINER RES, V32, P449, DOI 10.1002/jbmr.3002; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Wells GA, 2008, COCHRANE DB SYST REV	33	33	35	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					146	155		10.1001/jama.2017.8040	http://dx.doi.org/10.1001/jama.2017.8040			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697254	Green Published, Green Submitted			2022-12-28	WOS:000405190800016
J	Perkel, JM				Perkel, Jeffrey M.			SINGLE-CELL SEQUENCING MADE SIMPLE	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	13	13	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					125	126		10.1038/547125a	http://dx.doi.org/10.1038/547125a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682345	Bronze			2022-12-28	WOS:000404839900044
J	Zhao, XH; Liu, YM; Yang, X; Wang, SZ; Wang, SJ				Zhao, Xiu-he; Liu, Yi-ming; Yang, Xue; Wang, Shu-zhen; Wang, Sheng-jun			CASE REVIEW An older man with memory impairment and convulsions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Zhao, Xiu-he; Liu, Yi-ming; Yang, Xue; Wang, Shu-zhen; Wang, Sheng-jun] Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Peoples R China	Shandong University	Wang, SJ (corresponding author), Shandong Univ, Dept Neurol, Qilu Hosp, Jinan, Peoples R China.	qiluwangsj78@163.com						Boronat A, 2011, NEUROLOGY, V76, P795, DOI 10.1212/WNL.0b013e31820e7b8d; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; Dalmau J, 2017, NEUROLOGY, V88, P508, DOI 10.1212/WNL.0000000000003592; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99; Sarbu N, 2015, AUTOIMMUN REV, V14, P153, DOI 10.1016/j.autrev.2014.11.001; Scheid R, 2005, J NEUROL, V252, P1129, DOI 10.1007/s00415-005-0812-1; Schiess N, 2008, ANN NY ACAD SCI, V1142, P254, DOI 10.1196/annals.1444.018; Urbach H, 2006, NEURORADIOLOGY, V48, P380, DOI 10.1007/s00234-006-0069-0; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5	10	1	1	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2017	358								j2824	10.1136/bmj.j2824	http://dx.doi.org/10.1136/bmj.j2824			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DN	28679509	Green Published			2022-12-28	WOS:000405322200001
J	Hampton, T				Hampton, Tracy			Bench to Bedside and Back Again May Be Key to Clinical Breakthroughs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					16	17		10.1001/jama.2017.7276	http://dx.doi.org/10.1001/jama.2017.7276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672296				2022-12-28	WOS:000404717700002
J	Li, WT; Zhu, ZW; Chern, MS; Yin, JJ; Yang, C; Ran, L; Cheng, MP; He, M; Wang, K; Wang, J; Zhou, XG; Zhu, XB; Chen, ZX; Wang, JC; Zhao, W; Ma, BT; Qin, P; Chen, WL; Wang, YP; Liu, JL; Wang, WM; Wu, XJ; Li, P; Wang, JR; Zhu, LH; Li, SG; Chen, XW				Li, Weitao; Zhu, Ziwei; Chern, Mawsheng; Yin, Junjie; Yang, Chao; Ran, Li; Cheng, Mengping; He, Min; Wang, Kang; Wang, Jing; Zhou, Xiaogang; Zhu, Xiaobo; Chen, Zhixiong; Wang, Jichun; Zhao, Wen; Ma, Bingtian; Qin, Peng; Chen, Weilan; Wang, Yuping; Liu, Jiali; Wang, Wenming; Wu, Xianjun; Li, Ping; Wang, Jirui; Zhu, Lihuang; Li, Shigui; Chen, Xuewei			A Natural Allele of a Transcription Factor in Rice Confers Broad-Spectrum Blast Resistance	CELL			English	Article							MAGNAPORTHE-ORYZAE; DISEASE RESISTANCE; DURABLE RESISTANCE; INNATE IMMUNITY; NADPH OXIDASE; ARABIDOPSIS; PLANTS; GENE; PEROXIDASE; DEFENSE	Rice feeds half the world's population, and rice blast is often a destructive disease that results in significant crop loss. Non-race-specific resistance has been more effective in controlling crop diseases than race-specific resistance because of its broad spectrum and durability. Through a genome-wide association study, we report the identification of a natural allele of a C2H2-type transcription factor in rice that confers non-race-specific resistance to blast. A survey of 3,000 sequenced rice genomes reveals that this allele exists in 10% of rice, suggesting that this favorable trait has been selected through breeding. This allele causes a single nucleotide change in the promoter of the bsr-d1 gene, which results in reduced expression of the gene through the binding of the repressive MYB transcription factor and, consequently, an inhibition of H2O2 degradation and enhanced disease resistance. Our discovery highlights this novel allele as a strategy for breeding durable resistance in rice.	[Li, Weitao; Zhu, Ziwei; Yin, Junjie; Yang, Chao; Ran, Li; He, Min; Wang, Kang; Wang, Jing; Zhou, Xiaogang; Zhu, Xiaobo; Chen, Zhixiong; Wang, Jichun; Zhao, Wen; Ma, Bingtian; Qin, Peng; Chen, Weilan; Wang, Yuping; Liu, Jiali; Wang, Wenming; Wu, Xianjun; Li, Ping; Li, Shigui; Chen, Xuewei] Sichuan Agr Univ Wenjiang, Rice Res Inst, Key Lab Major Crop Dis, State Key Lab Hybrid Rice, Chengdu 611130, Sichuan, Peoples R China; [Li, Weitao; Zhu, Ziwei; Yin, Junjie; Yang, Chao; Ran, Li; He, Min; Wang, Kang; Wang, Jing; Zhou, Xiaogang; Zhu, Xiaobo; Chen, Zhixiong; Wang, Jichun; Zhao, Wen; Ma, Bingtian; Qin, Peng; Chen, Weilan; Wang, Yuping; Liu, Jiali; Wang, Wenming; Wu, Xianjun; Li, Ping; Li, Shigui; Chen, Xuewei] Sichuan Agr Univ Wenjiang, Collaborat Innovat Ctr Hybrid Rice Yangtze River, Chengdu 611130, Sichuan, Peoples R China; [Chern, Mawsheng] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Chern, Mawsheng] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Cheng, Mengping; Wang, Jirui] Sichuan Agr Univ, Triticeae Res Inst, Chengdu 611130, Sichuan, Peoples R China; [Zhao, Wen; Zhu, Lihuang] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Li, Weitao; Zhu, Ziwei; Chern, Mawsheng; Yin, Junjie; Yang, Chao; Ran, Li] Chinese Acad Sci, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Sichuan Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences	Chen, XW (corresponding author), Sichuan Agr Univ Wenjiang, Rice Res Inst, Key Lab Major Crop Dis, State Key Lab Hybrid Rice, Chengdu 611130, Sichuan, Peoples R China.; Chen, XW (corresponding author), Sichuan Agr Univ Wenjiang, Collaborat Innovat Ctr Hybrid Rice Yangtze River, Chengdu 611130, Sichuan, Peoples R China.	xwchen88@163.com	Wang, Wenming/G-3678-2012	Zhu, Xiaobo/0000-0002-6041-8586	National Science Foundation of China (NSFC) [31171622, 31571994]; Program for New Century Excellent Talents in University from the Ministry of Education in China [NECT-13-0920]; National Key Research and Development Program of China [2016YFD0100600]; Transgenic Projects from the Chinese Ministry of Agriculture (TPCMA) [2014ZX0800903B]; NSFC [31501627, 31601290, 31401351]; Key Project of Sichuan Education Department [15ZA0020]; DOE Joint BioEnergy Institute - U.S. Department of Energy [DE-AC02-05CH11231]; TPCMA [2016ZX08001002]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University from the Ministry of Education in China; National Key Research and Development Program of China; Transgenic Projects from the Chinese Ministry of Agriculture (TPCMA); NSFC(National Natural Science Foundation of China (NSFC)); Key Project of Sichuan Education Department; DOE Joint BioEnergy Institute - U.S. Department of Energy(United States Department of Energy (DOE)); TPCMA	We thank Dr. Yangwen Qian from Hangzhou Biogle Co., Ltd for assistance with gene transformation, and Mr. Zhongxu Chen from Triticeae Research Institute at Sichuan Agricultural University for SNP analysis. We thank the National Supercomputer Centre in Guangzhou houses (SUN YAT-SEN University) for granting CPU-time on the Tianhe-2, Navogene Company (Beijing, China) for analyzing ChIP-seq and Hangzhou Biogle Co., Ltd, for gene knockout constructions and transformations. X. C. was supported by the National Science Foundation of China (NSFC) (31171622 and 31571994), the Program for New Century Excellent Talents in University from the Ministry of Education in China (NECT-13-0920), the National Key Research and Development Program of China (2016YFD0100600), and Transgenic Projects from the Chinese Ministry of Agriculture (TPCMA) (2014ZX0800903B). W.L. was supported by the NSFC (31501627) and the Key Project of Sichuan Education Department (15ZA0020). Ma.C. was supported by the DOE Joint BioEnergy Institute funded by the U.S. Department of Energy (DE-AC02-05CH11231). J.Y. was supported by the NSFC (31601290). J.W. was supported by the NSFC (31401351). B.M. was supported by TPCMA (2016ZX08001002).	Bart R, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-13; Bhattacharjee S, 2011, SCIENCE, V334, P1405, DOI 10.1126/science.1211592; Bian JM, 2013, J GENET, V92, P281, DOI 10.1007/s12041-013-0267-6; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chen H, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0478-7; Chen LK, 2016, RICE, V9, P1, DOI 10.1186/s12284-016-0121-6; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chen XW, 2010, P NATL ACAD SCI USA, V107, P8029, DOI 10.1073/pnas.0912311107; Cheng HT, 2015, PLANT PHYSIOL, V167, P1087, DOI 10.1104/pp.114.256016; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Delannoy E, 2004, ACTA BOT GALLICA, V151, P353, DOI 10.1080/12538078.2004.10515440; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Gou JY, 2015, PLANT CELL, V27, P1755, DOI 10.1105/tpc.114.134296; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WT, 2016, MOL PLANT PATHOL, V17, P354, DOI 10.1111/mpp.12286; Liu DF, 2012, J EXP BOT, V63, P3899, DOI 10.1093/jxb/ers079; Liu JQ, 2016, PLANT PHYSIOL, V171, P1427, DOI 10.1104/pp.15.01921; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Nakano Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00288; Nishimura A, 2006, NAT PROTOC, V1, P2796, DOI 10.1038/nprot.2006.469; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Qiao Y, 2010, NEW PHYTOL, V185, P258, DOI 10.1111/j.1469-8137.2009.03047.x; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Seo E, 2015, BRIEF FUNCT GENOMICS, V14, P260, DOI 10.1093/bfgp/elv011; Takahashi H, 1997, PLANT J, V11, P993, DOI 10.1046/j.1365-313X.1997.11050993.x; Wang Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5768; Wang WM, 2009, PLANT CELL, V21, P2898, DOI 10.1105/tpc.109.067587; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Xu J, 2016, PLANT CELL, V28, P1144, DOI 10.1105/tpc.15.00871; Yin JJ, 2015, J GENET GENOMICS, V42, P511, DOI 10.1016/j.jgg.2015.05.005; Yokotani N, 2014, MOL PLANT MICROBE IN, V27, P1027, DOI 10.1094/MPMI-03-14-0065-R; Yoshioka K, 2001, J BIOL CHEM, V276, P35802, DOI 10.1074/jbc.M104079200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	261	310	39	282	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					114	+		10.1016/j.cell.2017.06.008	http://dx.doi.org/10.1016/j.cell.2017.06.008			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666113	Bronze			2022-12-28	WOS:000404358500014
J	Ho, LN; van Dijk, M; Chye, STJ; Messerschmidt, DM; Chng, SC; Ong, S; Yi, LK; Boussata, S; Goh, GHY; Afink, GB; Lim, CY; Dunn, NR; Solter, D; Knowles, BB; Reversade, B				Ho, Lena; van Dijk, Marie; Chye, Sam Tan Jian; Messerschmidt, Daniel M.; Chng, Serene C.; Ong, Sheena; Yi, Ling Ka; Boussata, Souad; Goh, Grace Hui-Yi; Afink, Gijs B.; Lim, Chin Yan; Dunn, N. Ray; Solter, Davor; Knowles, Barbara B.; Reversade, Bruno			ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice	SCIENCE			English	Article							GROWTH-FACTOR; EXPRESSION; RECEPTOR; TISSUE; CELLS; APJ	Preeclampsia (PE) is a gestational hypertensive syndrome affecting between 5 and 8% of all pregnancies. Although PE is the leading cause of fetal and maternal morbidity and mortality, its molecular etiology is still unclear. Here, we show that ELABELA (ELA), an endogenous ligand of the apelin receptor (APLNR, or APJ), is a circulating hormone secreted by the placenta. Elabela but not Apelin knockout pregnant mice exhibit PE-like symptoms, including proteinuria and elevated blood pressure due to defective placental angiogenesis. In mice, infusion of exogenous ELA normalizes hypertension, proteinuria, and birth weight. ELA, which is abundant in human placentas, increases the invasiveness of trophoblast-like cells, suggesting that it enhances placental development to prevent PE. The ELA-APLNR signaling axis may offer a new paradigm for the treatment of common pregnancy-related complications, including PE.	[Ho, Lena; Chye, Sam Tan Jian; Chng, Serene C.; Ong, Sheena; Goh, Grace Hui-Yi; Lim, Chin Yan; Dunn, N. Ray; Solter, Davor; Knowles, Barbara B.; Reversade, Bruno] ASTAR, Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore; [van Dijk, Marie; Boussata, Souad; Afink, Gijs B.; Reversade, Bruno] Acad Med Ctr, Reprod Biol Lab, Obstet & Gynaecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Messerschmidt, Daniel M.; Yi, Ling Ka; Reversade, Bruno] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Reversade, Bruno] Natl Univ Singapore, Dept Paediat, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Reversade, Bruno] Koc Univ, Med Genet Dept, Sch Med, TR-34010 Istanbul, Turkey	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Amsterdam; Academic Medical Center Amsterdam; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Koc University	Ho, LN; Reversade, B (corresponding author), ASTAR, Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.; Reversade, B (corresponding author), Acad Med Ctr, Reprod Biol Lab, Obstet & Gynaecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Reversade, B (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Reversade, B (corresponding author), Natl Univ Singapore, Dept Paediat, 1E Kent Ridge Rd, Singapore 119228, Singapore.; Reversade, B (corresponding author), Koc Univ, Med Genet Dept, Sch Med, TR-34010 Istanbul, Turkey.	lena.ho@reversade.com; bruno@reversade.com	Dunn, Norris Ray/W-5124-2019; Solter, Davor/Q-5476-2019; Afink, Gijs/AAB-2832-2021; Messerschmidt, Daniel Martin/W-7193-2019; Afink, Gijs/A-2025-2009	Afink, Gijs/0000-0002-2155-725X; Ho, Lena/0000-0002-9358-621X; Goh, Grace/0000-0001-5431-9939; van Dijk, Marie/0000-0003-1461-3441; REVERSADE, Bruno/0000-0002-4070-7997; Ong, Sheena/0000-0002-7569-7944; Lim, Chin Yan/0000-0002-1585-002X; Dunn, Norris Ray/0000-0002-6259-2975; Chng, Serene C/0000-0003-0500-8792; Messerschmidt, Daniel Martin/0000-0003-2022-4696	A*STAR Joint Council Organization; Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A*STAR, Singapore; Ferring Research Institute Innovation Grant; A*STAR Investigatorship, an EMBO	A*STAR Joint Council Organization(Agency for Science Technology & Research (A*STAR)); Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); Ferring Research Institute Innovation Grant(Ferring Pharmaceuticals); A*STAR Investigatorship, an EMBO	We thank T. Quertermous (Stanford University, USA) for sharing the Apln and Apj knockout mice; T. Veenboer (AMC, Netherlands) for assistance with human placenta samples; D. Kalicharan for technical assistance with electron microscopy; members of the Advanced Molecular Pathology Laboratory, Institute of Molecular and Cell Biology, for assistance with histopathology; the Institute of Medical Biology Microscopy Unit for assistance with imaging; and the Genome Institute of Singapore sequencing facility for assistance with RNA-seq. RNA-seq data are deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive under accession number PRJNA391361. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. The authors acknowledge financial support from the A*STAR Joint Council Organization (Young Researcher Collaborative Grant) and a Strategic Positioning Fund on Genetic Orphan Diseases from the Biomedical Research Council, A*STAR, Singapore. M.v.D. and S.B. are supported by a Ferring Research Institute Innovation Grant. B.R. is a fellow of the Branco Weiss Foundation, a recipient of the A*STAR Investigatorship, an EMBO Young Investigator, and an AAA fellow from AMC/VUmc. The authors declare no competing financial interests. B.R. and L.H. are inventors on patent application 10201605841S submitted by A*STAR, Singapore, which covers the use of ELABELA for the diagnosis and treatment of preeclampsia. The ELABELA-deficient mice and custom antibody are available from B.R. under a material transfer agreement with A*STAR, Singapore.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Adekola H, 2015, J MATERN-FETAL NEO M, V28, P1621, DOI 10.3109/14767058.2014.964676; Al-Ghafra A, 2006, MOL HUM REPROD, V12, P181, DOI 10.1093/molehr/gal016; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chang XW, 2015, INT J CLIN EXP PATHO, V8, P14733; Charo DN, 2009, AM J PHYSIOL-HEART C, V297, pH1904, DOI 10.1152/ajpheart.00686.2009; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hassan AS, 2010, GENE EXPR PATTERNS, V10, P127, DOI 10.1016/j.gep.2010.02.001; Hayman R, 1999, J SOC GYNECOL INVEST, V6, P3, DOI 10.1016/S1071-5576(98)00044-6; Helker CSM, 2015, ELIFE, V4, DOI 10.7554/eLife.06726; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Li MM, 2015, CELL STEM CELL, V16, P669, DOI 10.1016/j.stem.2015.04.002; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Schreiber CA, 2016, CURR GENE THER, V16, P349, DOI 10.2174/1566523217666161121111906; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; YAGEL S, 1988, J CELL PHYSIOL, V136, P455, DOI 10.1002/jcp.1041360309	30	124	140	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2017	357	6352					707	+		10.1126/science.aam6607	http://dx.doi.org/10.1126/science.aam6607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8SE	28663440				2022-12-28	WOS:000407793600040
J	Raven, A; Lu, WY; Man, TY; Ferreira-Gonzalez, S; O'Duibhir, E; Dwyer, BJ; Thomson, JP; Meehan, RR; Bogorad, R; Koteliansky, V; Kotelevtsev, Y; Ffrench-Constant, C; Boulter, L; Forbes, SJ				Raven, Alexander; Lu, Wei-Yu; Man, Tak Yung; Ferreira-Gonzalez, Sofia; O'Duibhir, Eoghan; Dwyer, Benjamin J.; Thomson, John P.; Meehan, Richard R.; Bogorad, Roman; Koteliansky, Victor; Kotelevtsev, Yuri; Ffrench-Constant, Charles; Boulter, Luke; Forbes, Stuart J.			Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration	NATURE			English	Article							HEPATIC PROGENITOR CELLS; INJURY; MICE; BETA-1-INTEGRIN; ACTIVATION; FIBROSIS; ABLATION; DISEASES; ORIGIN	After liver injury, regeneration occurs through self-replication of hepatocytes. In severe liver injury, hepatocyte proliferation is impaired-a feature of human chronic liver disease(1,2). It is unclear whether other liver cell types can regenerate hepatocytes(3-5). Here we use two independent systems to impair hepatocyte proliferation during liver injury to evaluate the contribution of non-hepatocytes to parenchymal regeneration. First, loss of beta 1-integrin in hepatocytes with liver injury triggered a ductular reaction of cholangiocyte origin, with approximately 25% of hepatocytes being derived from a non-hepatocyte origin. Second, cholangiocytes were lineage traced with concurrent inhibition of hepatocyte proliferation by beta 1-integrin knockdown or p21 overexpression, resulting in the significant emergence of cholangiocyte-derived hepatocytes. We describe a model of combined liver injury and inhibition of hepatocyte proliferation that causes physiologically significant levels of regeneration of functional hepatocytes from biliary cells.	[Raven, Alexander; Lu, Wei-Yu; Man, Tak Yung; Ferreira-Gonzalez, Sofia; O'Duibhir, Eoghan; Dwyer, Benjamin J.; Ffrench-Constant, Charles; Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland; [Thomson, John P.; Meehan, Richard R.; Boulter, Luke] Univ Edinburgh, MRC Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Bogorad, Roman] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Koteliansky, Victor; Kotelevtsev, Yuri] Skolkovo Inst Sci & Technol, Funct Genom & RNAi Therapy CREI, 3 Nobel St, Skolkovo 143026, Moscow Region, Russia	University of Edinburgh; University of Edinburgh; Massachusetts Institute of Technology (MIT); Skolkovo Institute of Science & Technology	Forbes, SJ (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Midlothian, Scotland.	stuart.forbes@ed.ac.uk	Lu, Wei-Yu/N-5884-2019; Ferreira-Gonzalez, Sofia/AAL-9189-2021; Kotelevtsev, Yuri V/R-1772-2016	Lu, Wei-Yu/0000-0002-0419-0257; Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Meehan, Richard/0000-0001-6471-6882; Kotelevtsev, Yuri/0000-0002-7255-7794; Forbes, Stuart/0000-0003-3715-2561; Raven, Alexander/0000-0003-4409-9543; Dwyer, Benjamin/0000-0003-2527-5417	UK Medical Research Council (MRC) [MC_PC_U127574433]; MRC [MR/L012766/1, MR/K017047/1]; UK Regenerative Medicine Platform [MR/K026666/1]; MRC [MR/K026666/1, MC_PC_U127574433, MR/K017047/1] Funding Source: UKRI; Medical Research Council [MR/L012766/1, 1356047, MR/K026666/1, 1802904, MC_PC_U127574433, G0700711B, MR/K017047/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Regenerative Medicine Platform; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank B. Vernay for assistance with microscopy, F. Rossi and C. Cryer with fluorescence-activated cell sorting (FACS), S. Werner for advice, and F. Mushinski for providing the p21 plasmid. Work in the laboratory of R.R.M. was supported by the UK Medical Research Council (MRC) (MC_PC_U127574433). This work was supported by the MRC (MR/L012766/1, MR/K017047/1) and the UK Regenerative Medicine Platform (MR/K026666/1).	Bird TG, 2008, CELL TISSUE RES, V331, P283, DOI 10.1007/s00441-007-0542-z; Bogorad RL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4869; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; He J., 2014, GASTROENTEROLOGY, V6, pe8, DOI DOI 10.1053/J.GASTR0.2013.11.045]; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; HUPPI K, 1994, ONCOGENE, V9, P3017; KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201; Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483; Liu Y, 2013, AM J PHYSIOL-GASTR L, V304, pG449, DOI 10.1152/ajpgi.00199.2012; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076; Michalopoulos GK, 2015, GASTROENTEROLOGY, V149, P876, DOI 10.1053/j.gastro.2015.08.004; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Petersen BE, 1998, HEPATOLOGY, V27, P1030, DOI 10.1002/hep.510270419; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Shin S, 2015, GASTROENTEROLOGY, V148, P192, DOI 10.1053/j.gastro.2014.09.039; Speicher T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4862; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112	27	275	283	8	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					350	+		10.1038/nature23015	http://dx.doi.org/10.1038/nature23015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28700576	Green Accepted, Green Published			2022-12-28	WOS:000405844900034
J	Bar-Gill, N; Retzker, A				Bar-Gill, Nir; Retzker, Alex			Observing chemical shifts from nanosamples	SCIENCE			English	Editorial Material							NUCLEAR-MAGNETIC-RESONANCE; SPECTROSCOPY; RESOLUTION; DIAMOND; SENSOR		[Bar-Gill, Nir] Hebrew Univ Jerusalem, Dept Appl Phys, Jerusalem, Israel; Hebrew Univ Jerusalem, Racah Inst Phys, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Bar-Gill, N (corresponding author), Hebrew Univ Jerusalem, Dept Appl Phys, Jerusalem, Israel.	bargill@phys.huji.ac.il						Aslam N, 2017, SCIENCE, V357, DOI 10.1126/science.aam8697; Boss JM, 2017, SCIENCE, V356, P837, DOI 10.1126/science.aam7009; Bucher D. B., 2017, ARXIV170508887QUANTP; Jelezko F, 2006, PHYS STATUS SOLIDI A, V203, P3207, DOI 10.1002/pssa.200671403; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Schmitt S, 2017, SCIENCE, V356, P832, DOI 10.1126/science.aam5532; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075	9	2	2	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		38	38		10.1126/science.aan6162	http://dx.doi.org/10.1126/science.aan6162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684494				2022-12-28	WOS:000404854100039
J	Hutson, M				Hutson, Matthew			How algorithms can analyze the mood of the masses	SCIENCE			English	Editorial Material																			0	15	15	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		23	23		10.1126/science.357.6346.23	http://dx.doi.org/10.1126/science.357.6346.23			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684484				2022-12-28	WOS:000404854100017
J	Markowitz, SD				Markowitz, Sanford D.			Cancer bypasses the lymph nodes	SCIENCE			English	Editorial Material							EVOLUTION; CLASSIFICATION; RESECTION		[Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Univ Hosp Cleveland, Seidman Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Markowitz, SD (corresponding author), Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA.; Markowitz, SD (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Markowitz, SD (corresponding author), Univ Hosp Cleveland, Seidman Canc Ctr, Cleveland, OH 44106 USA.	sxm10@cwru.edu			NATIONAL CANCER INSTITUTE [P50CA150964, U01CA152756, R35CA197442] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA152756, R35 CA197442, P50 CA150964] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; CHAPUIS PH, 1985, BRIT J SURG, V72, P698, DOI 10.1002/bjs.1800720909; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; JASS JR, 1987, LANCET, V1, P1303; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Libutti S. K., 2011, CANC PRINCIPLES PRAC, P768; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naxerova K, 2017, SCIENCE, V357, P55, DOI 10.1126/science.aai8515; Virchow R., 1863, KRANKHAFTEN GESCHWUL; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	15	5	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		35	36		10.1126/science.aan8299	http://dx.doi.org/10.1126/science.aan8299			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684492				2022-12-28	WOS:000404854100037
J	Pennisi, E				Pennisi, Elizabeth			BIOLOGY New technologies boost genome quality	SCIENCE			English	News Item																			0	11	12	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		10	11		10.1126/science.357.6346.10	http://dx.doi.org/10.1126/science.357.6346.10			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684474				2022-12-28	WOS:000404854100008
J	Woodcock, J; LaVange, LM				Woodcock, Janet; LaVange, Lisa M.			Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRIAL DESIGN; ADAPTIVE RANDOMIZATION; CLINICAL-TRIALS; PHASE-II; ERA	Master protocols come in different sizes and shapes but share many commonalities. All require increased planning efforts and coordination to satisfy the objectives of different stakeholders. Innovative design elements help ensure that maximum information is obtained from the research effort, and the infrastructure required for implementation increases data quality and trial efficiencies, as compared with those in stand-alone trials. If designed correctly, master protocols can last many years, even decades, with innovations from the laboratory translating quickly to clinical evaluation. As the targets for new drugs become more and more precise, there is no alternative but to move forward with these coordinated research efforts.	[Woodcock, Janet; LaVange, Lisa M.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	LaVange, LM (corresponding author), US FDA, Off Biostat, Off Translat Sci, Ctr Drug Evaluat & Res, 10903 New Hampshire Blvd, Silver Spring, MD 20993 USA.	lisa.lavange@fda.hhs.gov						[Anonymous], ANT PLATF DES; [Anonymous], STUD IN PROGR; ASCO Daily News, 2015, ASCO DAILY NEWS 0531; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Berry D, 2016, NEW ENGL J MED, V375, P1592, DOI 10.1056/NEJMc1609993; Berry DA, 2015, MOL ONCOL, V9, P951, DOI 10.1016/j.molonc.2015.02.011; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Berry SM, 2013, CLIN TRIALS, V10, P720, DOI 10.1177/1740774513497539; Catenacci DVT, 2015, MOL ONCOL, V9, P967, DOI 10.1016/j.molonc.2014.09.011; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Davis SM, 2003, SCHIZOPHRENIA BULL, V29, P73, DOI 10.1093/oxfordjournals.schbul.a006993; Dodd LE, 2016, J INFECT DIS, V213, P1906, DOI 10.1093/infdis/jiw061; Drazen JM, 2007, J ALLERGY CLIN IMMUN, V119, P28, DOI 10.1016/j.jaci.2006.06.011; Duke Margolis Center for Health Policy, 2016, PION STAT APPR ACC D; Esserman LJ, 2011, JAMA-J AM MED ASSOC, V306, P2608, DOI 10.1001/jama.2011.1837; Fridlyand J, 2013, NAT REV DRUG DISCOV, V12, P743, DOI 10.1038/nrd4101; Heinrich MC, 2008, CLIN CANCER RES, V14, P2717, DOI 10.1158/1078-0432.CCR-07-4575; Herbst R, 2012, FRIENDS CANC RES BRO; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Hey Spencer Phillips, 2015, Clin Trials, V12, P102, DOI 10.1177/1740774514563583; Hong FX, 2013, JNCI-J NATL CANCER I, V105, P1628, DOI 10.1093/jnci/djt265; Hunter DJ, 2015, NEW ENGL J MED, V373, P691, DOI 10.1056/NEJMp1508144; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; LaVange LM, 2014, INN BREAST CANC DRUG; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mullard A, 2014, NAT MED, V20, P3, DOI 10.1038/nm0114-3; National Institute on Aging, DOM INH ALZH NETW TR; Park JW, 2016, NEW ENGL J MED, V375, P11, DOI 10.1056/NEJMoa1513750; Redig AJ, 2015, J CLIN ONCOL, V33, P975, DOI 10.1200/JCO.2014.59.8433; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; Saville BR, 2016, CLIN TRIALS, V13, P358, DOI 10.1177/1740774515626362; Saville BR, 2014, CLIN TRIALS, V11, P485, DOI 10.1177/1740774514531352; Sridhara R, 2015, STAT BIOPHARM RES, V7, P348, DOI 10.1080/19466315.2015.1094673; Steuer CE, 2015, CLIN PHARMACOL THER, V97, P488, DOI 10.1002/cpt.88	37	452	468	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					62	70		10.1056/NEJMra1510062	http://dx.doi.org/10.1056/NEJMra1510062			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5CS	28679092	Bronze			2022-12-28	WOS:000404730000009
J	Webster, P				Webster, Paul			Drug shops as primary point of care-the case of Nigeria	LANCET			English	Editorial Material																			0	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					15	17		10.1016/S0140-6736(17)31722-1	http://dx.doi.org/10.1016/S0140-6736(17)31722-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677546				2022-12-28	WOS:000404396300012
J	Yuan, P				Yuan, Peng			Extraordinary and poor	SCIENCE			English	Editorial Material									[Yuan, Peng] Stanford Univ, Palo Alto, CA 94304 USA	Stanford University	Yuan, P (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.	SciCareerEditor@aaas.org		Yuan, Peng/0000-0003-4051-4447					0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1406	1406		10.1126/science.356.6345.1406	http://dx.doi.org/10.1126/science.356.6345.1406			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663505				2022-12-28	WOS:000404351500043
J	Wang, LM; Gao, P; Zhang, M; Huang, ZJ; Zhang, DD; Deng, Q; Li, YC; Zhao, ZP; Qin, XY; Jin, DY; Zhou, MG; Tang, X; Hu, YH; Wang, LH				Wang, Limin; Gao, Pei; Zhang, Mei; Huang, Zhengjing; Zhang, Dudan; Deng, Qian; Li, Yichong; Zhao, Zhenping; Qin, Xueying; Jin, Danyao; Zhou, Maigeng; Tang, Xun; Hu, Yonghua; Wang, Linhong			Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-PRESSURE; ADULTS; RISK; MORTALITY; MELLITUS; GLUCOSE; SYSTEM; DEATH; HAN	IMPORTANCE Previous studies have shown increasing prevalence of diabetes in China, which now has the world's largest diabetes epidemic. OBJECTIVES To estimate the recent prevalence and to investigate the ethnic variation of diabetes and prediabetes in the Chinese adult population. DESIGN, SETTING, AND PARTICIPANTS A nationally representative cross-sectional survey in 2013 in mainland China, which consisted of 170 287 participants. EXPOSURES Fasting plasma glucose and hemoglobin A(1c) levels were measured for all participants. A 2-hour oral glucose tolerance test was conducted for all participants without diagnosed diabetes. MAIN OUTCOMES AND MEASURES Primary outcomes were total diabetes and prediabetes defined according to the 2010 American Diabetes Association criteria. Awareness and treatment were also evaluated. Hemoglobin A(1c) concentration of less than 7.0% among treated diabetes patients was considered adequate glycemic control. Minority ethnic groups in China with at least 1000 participants (Tibetan, Zhuang, Manchu, Uyghur, and Muslim) were compared with Han participants. RESULTS Among the Chinese adult population, the estimated standardized prevalence of total diagnosed and undiagnosed diabetes was 10.9%(95% CI, 10.4%-11.5%); that of diagnosed diabetes, 4.0% (95% CI, 3.6%-4.3%); and that of prediabetes, 35.7%(95% CI, 34.1%-37.4%). Among persons with diabetes, 36.5%(95% CI, 34.3%-38.6%) were aware of their diagnosis and 32.2%(95% CI, 30.1%-34.2%) were treated; 49.2%(95% CI, 46.9%-51.5%) of patients treated had adequate glycemic control. Tibetan and Muslim Chinese had significantly lower crude prevalence of diabetes than Han participants (14.7% [95% CI, 14.6%-14.9%] for Han, 4.3%[95% CI, 3.5%-5.0%] for Tibetan, and 10.6%[95% CI, 9.3%-11.9%] for Muslim; P<.001 for Tibetan and Muslim compared with Han). In the multivariable logistic models, the adjusted odds ratios compared with Han participants were 0.42 (95% CI, 0.35-0.50) for diabetes and 0.77 (95% CI, 0.71-0.84) for prediabetes for Tibetan Chinese and 0.73 (95% CI, 0.63-0.85) for diabetes and 0.78 (95% CI, 0.71-0.86) for prediabetes in Muslim Chinese. CONCLUSIONS AND RELEVANCE Among adults in China, the estimated overall prevalence of diabetes was 10.9%, and that for prediabetes was 35.7%. Differences from previous estimates for 2010 may be due to an alternate method of measuring hemoglobin A(1c).	[Wang, Limin; Zhang, Mei; Huang, Zhengjing; Deng, Qian; Li, Yichong; Zhao, Zhenping; Zhou, Maigeng; Wang, Linhong] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron Noncommunicable Dis Control & Prev, Beijing 100050, Peoples R China; [Gao, Pei; Zhang, Dudan; Qin, Xueying; Jin, Danyao; Tang, Xun; Hu, Yonghua] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Peking University	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron Noncommunicable Dis Control & Prev, Beijing 100050, Peoples R China.; Hu, YH (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	yhhu@bjmu.edu.cn; linhong@chinawch.org.cn	Gao, Pei/AAF-3065-2019; wang, lili/HDL-7210-2022; wang, lin/GSE-3040-2022; Li, Yichong/A-3559-2019; TANG, Xun/L-8375-2013; Zhao, Zhenping/R-6323-2016; Zhou, Maigeng/HCH-7703-2022; Gao, Pei/R-4794-2018; wang, lin/HHM-2225-2022	Gao, Pei/0000-0001-8649-1290; Li, Yichong/0000-0003-3842-475X; TANG, Xun/0000-0002-6990-0168; Zhao, Zhenping/0000-0003-4227-3034; Gao, Pei/0000-0001-8649-1290; 	Chinese central government; National Natural Science Foundation of China [81473043, 81230066, 91546120]	Chinese central government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Chinese central government (key project of public health program) and the National Natural Science Foundation of China (grants 81473043, 81230066, and 91546120).	AAPOR-American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Bragg F, 2017, JAMA-J AM MED ASSOC, V317, P280, DOI 10.1001/jama.2016.19720; Chinese Diabetes Society, 2014, CHIN J DIABETES, V22, P42, DOI [10.3760/cma.j.issn.1674-2809.2014.07.004, DOI 10.3760/CMA.J.ISSN.1674-5809.2014.07.004, DOI 10.3760/CMA.J.ISSN.1674-2809.2014.07.004]; Faerch K, 2014, JAMA-J AM MED ASSOC, V311, P200, DOI 10.1001/jama.2013.283127; Feng Y, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-23; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Li YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27627; Lin YH, 2012, DIABETES TECHNOL THE, V14, P430, DOI 10.1089/dia.2011.0244; Liu LJ, 2001, HYPERTENS RES, V24, P315, DOI 10.1291/hypres.24.315; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Lu CW, 2014, JAMA-J AM MED ASSOC, V311, P199, DOI 10.1001/jama.2013.283124; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; National Collaborative Group of Diabetes Study, 1981, ZHONGHUA NEI KE ZA Z, V20, P678; Okumiya K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009728; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	24	1063	1504	29	267	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2515	2523		10.1001/jama.2017.7596	http://dx.doi.org/10.1001/jama.2017.7596			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655017	Green Published, Bronze			2022-12-28	WOS:000404106600021
J	Bren, KL; Raven, EL				Bren, Kara L.; Raven, Emma L.			Locked and loaded for apoptosis	SCIENCE			English	Editorial Material							CYTOCHROME-C; PROTEINS		[Bren, Kara L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Raven, Emma L.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England; [Raven, Emma L.] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester LE1 7RH, Leics, England	University of Rochester; University of Leicester; University of Leicester	Bren, KL (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	bren@chem.rochester.edu; emma.raven@le.ac.uk		Bren, Kara/0000-0002-8082-3634				Gray HB, 2000, J BIOL INORG CHEM, V5, P551, DOI 10.1007/s007750000146; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kleingardner JG, 2015, ACCOUNTS CHEM RES, V48, P1845, DOI 10.1021/acs.accounts.5b00106; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LO TP, 1995, BIOCHEMISTRY-US, V34, P5259, DOI 10.1021/bi00015a041; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Macmunn C. A., 1886, Philosophical Transactions, Vclxxvii, P267; Mara MW, 2017, SCIENCE, V356, P1276, DOI 10.1126/science.aam6203; McClelland LJ, 2016, J AM CHEM SOC, V138, P16770, DOI 10.1021/jacs.6b10745; Raven E. L., 2015, RSC METALLOBIOLOGY S; Rosell FI, 1998, J AM CHEM SOC, V120, P11234, DOI 10.1021/ja971756+	11	11	11	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1236	1236		10.1126/science.aan5587	http://dx.doi.org/10.1126/science.aan5587			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642398				2022-12-28	WOS:000403881700021
J	Nichols, ALA; Eichler, T; Latham, R; Zimmer, M				Nichols, Annika L. A.; Eichler, Tomas; Latham, Richard; Zimmer, Manuel			A global brain state underlies C. elegans sleep behavior	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; SOCIAL-BEHAVIOR; NEURONAL-ACTIVITY; CIRCUIT ACTIVITY; MOTOR CIRCUIT; QUIESCENCE; STRESS; REST; NEUROPEPTIDES	How the brain effectively switches between and maintains global states, such as sleep and wakefulness, is not yet understood. We used brainwide functional imaging at single-cell resolution to show that during the developmental stage of lethargus, the Caenorhabditis elegans brain is predisposed to global quiescence, characterized by systemic down-regulation of neuronal activity. Only a few specific neurons are exempt from this effect. In the absence of external arousing cues, this quiescent brain state arises by the convergence of neuronal activities toward a fixed-point attractor embedded in an otherwise dynamic neural state space. We observed efficient spontaneous and sensory-evoked exits from quiescence. Our data support the hypothesis that during global states such as sleep, neuronal networks are drawn to a baseline mode and can be effectively reactivated by signaling from arousing circuits.	[Nichols, Annika L. A.; Eichler, Tomas; Latham, Richard; Zimmer, Manuel] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zimmer, M (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria.	manuel.zimmer@imp.ac.at	Zimmer, Manuel/C-5275-2015; Eichler, Tomáš/I-9520-2018	Zimmer, Manuel/0000-0002-8072-787X; Eichler, Tomáš/0000-0003-0178-5148; Nichols, Annika/0000-0002-0388-904X	NIH Office of Research Infrastructure Programs [P40 OD010440]; European Community [281869]; Research Institute of Molecular Pathology (IMP); Simons Foundation [324958]; Boehringer Ingelheim Fonds; Boehringer Ingelheim	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Research Institute of Molecular Pathology (IMP); Simons Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Boehringer Ingelheim(Boehringer Ingelheim)	We thank L. Vosshall, H. Kaplan, and M. Andrione for critically reading the manuscript; members of the Zimmer laboratory for advice and discussion; M. Suplata and M. Sonntag for writing some scripts; G. Rath for IT support; and C. Bargmann for strains. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs grant P40 OD010440. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 281869 and the Research Institute of Molecular Pathology (IMP). M.Z. is supported by Simons Foundation grant 324958; T.E. was supported by a Ph.D. fellowship of the Boehringer Ingelheim Fonds. The IMP is funded by Boehringer Ingelheim. Author contributions: A.L.A.N. designed experiments, developed analytical methods, performed experiments, and analyzed data; T.E. designed and developed methods for lethargus population assays and performed initial behavioral experiments; R.L. performed aggregation assays; M.Z. designed experiments, developed analytical methods, and led the project; and A.L.A.N. and M.Z. wrote the manuscript. Raw data and codes are available upon reasonable request.	Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Busch KE, 2012, NAT NEUROSCI, V15, P581, DOI 10.1038/nn.3061; Bushey D, 2015, P NATL ACAD SCI USA, V112, P4785, DOI 10.1073/pnas.1419603112; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cho JY, 2014, CELL, V156, P249, DOI 10.1016/j.cell.2013.11.036; Choi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005359; Choi S, 2013, NEURON, V78, P869, DOI 10.1016/j.neuron.2013.04.002; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Finelli LA, 2000, NEUROSCIENCE, V101, P523, DOI 10.1016/S0306-4522(00)00409-7; Gendrel M, 2016, ELIFE, V5, DOI [10.7554/elife.17686, 10.7554/eLife.17686]; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; HALASZ P, 1979, ACTA PHYSIOL HUNG, V54, P1; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hill AJ, 2014, CURR BIOL, V24, P2399, DOI 10.1016/j.cub.2014.08.040; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Hums I, 2016, ELIFE, V5, DOI 10.7554/eLife.14116; Iwanir S, 2013, SLEEP, V36, P385, DOI 10.5665/sleep.2456; Jang H, 2017, P NATL ACAD SCI USA, V114, pE1263, DOI 10.1073/pnas.1621274114; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kawano T, 2011, NEURON, V72, P572, DOI 10.1016/j.neuron.2011.09.005; Krueger JM, 2008, NAT REV NEUROSCI, V9, P910, DOI 10.1038/nrn2521; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; Loomis A L, 1935, Science, V82, P198, DOI 10.1126/science.82.2122.198; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Monsalve GA, 2011, ESSENTIAL NEUROMODULATION, P415, DOI 10.1016/B978-0-12-381409-8.00019-X; MUKHAMETOV LM, 1977, BRAIN RES, V134, P581, DOI 10.1016/0006-8993(77)90835-6; Nagy S, 2014, ELIFE, V3, DOI 10.7554/eLife.04380; Nagy S, 2014, METHODS, V68, P500, DOI 10.1016/j.ymeth.2014.03.009; Nath RD, 2016, CURR BIOL, V26, P2446, DOI 10.1016/j.cub.2016.07.048; Nelson MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3846; Nelson MD, 2014, CURR BIOL, V24, P2406, DOI 10.1016/j.cub.2014.08.037; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pigarev IN, 1997, NEUROREPORT, V8, P2557, DOI 10.1097/00001756-199707280-00027; Potdar S, 2013, J NEUROGENET, V27, P23, DOI 10.3109/01677063.2013.791692; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schrodel T, 2013, NAT METHODS, V10, P1013, DOI [10.1038/NMETH.2637, 10.1038/nmeth.2637]; Schwarz Juliane, 2012, Worm, V1, P12, DOI 10.4161/worm.19499; Schwarz J, 2011, CURR BIOL, V21, pR983, DOI 10.1016/j.cub.2011.10.046; Shingai R, 2000, NEUROSCI RES, V38, P71, DOI 10.1016/S0168-0102(00)00148-6; Singh K, 2014, SLEEP, V37, P1439, DOI 10.5665/sleep.3990; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Suzuki A, 2013, P NATL ACAD SCI USA, V110, P10288, DOI 10.1073/pnas.1308295110; Tramm N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101162; Trojanowski NF, 2016, TRENDS NEUROSCI, V39, P54, DOI 10.1016/j.tins.2015.12.005; Turek M, 2016, ELIFE, V5, DOI 10.7554/eLife.12499; Turek M, 2013, CURR BIOL, V23, P2215, DOI 10.1016/j.cub.2013.09.028; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Watson BO, 2016, NEURON, V90, P839, DOI 10.1016/j.neuron.2016.03.036; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	66	86	86	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344							eaam6851	10.1126/science.aam6851	http://dx.doi.org/10.1126/science.aam6851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642382				2022-12-28	WOS:000403881700030
J	Luo, S; Tong, L				Luo, Shukun; Tong, Liang			Molecular mechanism for the regulation of yeast separase by securin (vol 542, pg 255, 2017)	NATURE			English	Correction													Luo, Shukun/AAT-8195-2021	Luo, Shukun/0000-0002-2766-3125	NIGMS NIH HHS [R35 GM118093] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118093] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Luo S, 2017, NATURE, V542, P255, DOI 10.1038/nature21061	1	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664								10.1038/nature23319	http://dx.doi.org/10.1038/nature23319			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28700574	Bronze			2022-12-28	WOS:000406358300042
J	Negredo, A; de la Calle-Prieto, F; Palencia-Herrejon, E; Mora-Rillo, M; Astray-Mochales, J; Sanchez-Seco, MP; Lopez, EB; Menarguez, J; Fernandez-Cruz, A; Sanchez-Artola, B; Keough-Delgado, E; de Arellano, ER; Lasala, F; Milla, J; Fraile, JL; Gavin, MO; de la Gandara, AM; Perez, LL; Diaz-Diaz, D; Lopez-Garcia, MA; Delgado-Jimenez, P; Martin-Quiros, A; Trigo, E; Figueira, JC; Manzanares, J; Rodriguez-Baena, E; Garcia-Comas, L; Rodriguez-Fraga, O; Garcia-Arenzana, N; Fernandez-Diaz, MV; Cornejo, VM; Emmerich, P; Schmidt-Chanasit, J; Arribas, JR				Negredo, A.; de la Calle-Prieto, F.; Palencia-Herrejon, E.; Mora-Rillo, M.; Astray-Mochales, J.; Sanchez-Seco, M. P.; Bermejo Lopez, E.; Menarguez, J.; Fernandez-Cruz, A.; Sanchez-Artola, B.; Keough-Delgado, E.; Ramirez de Arellano, E.; Lasala, F.; Milla, J.; Fraile, J. L.; Ordobas Gavin, M.; Martinez de la Gandara, A.; Lopez Perez, L.; Diaz-Diaz, D.; Lopez-Garcia, M. A.; Delgado-Jimenez, P.; Martin-Quiros, A.; Trigo, E.; Figueira, J. C.; Manzanares, J.; Rodriguez-Baena, E.; Garcia-Comas, L.; Rodriguez-Fraga, O.; Garcia-Arenzana, N.; Fernandez-Diaz, M. V.; Cornejo, V. M.; Emmerich, P.; Schmidt-Chanasit, J.; Arribas, J. R.		Crimean Congo Hemorrhagic Fever	Autochthonous Crimean-Congo Hemorrhagic Fever in Spain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MIGRATORY BIRDS; VIRUS; PATHOGENESIS; TICKS	Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed, viral, tickborne disease. In Europe, cases have been reported only in the southeastern part of the continent. We report two autochthonous cases in Spain. The index patient acquired the disease through a tick bite in the province of Avila - 300 km away from the province of Caceres, where viral RNA from ticks was amplified in 2010. The second patient was a nurse who became infected while caring for the index patient. Both were infected with the African 3 lineage of this virus. (Funded by Red de Investigacion Cooperativa en Enfermedades Tropicales [RICET] and Efficient Response to Highly Dangerous and Emerging Pathogens at EU [European Union] Level [EMERGE].)	[Negredo, A.; Sanchez-Seco, M. P.; Ramirez de Arellano, E.; Lasala, F.] Inst Salud Carlos III, Ctr Nacl Microbiol, Arbovirus & Imported Viral Dis Unit, Madrid, Spain; [Negredo, A.; Sanchez-Seco, M. P.; Ramirez de Arellano, E.; Lasala, F.] Red Invest Colaborativa Enfermedades Trop, Madrid, Spain; [de la Calle-Prieto, F.; Mora-Rillo, M.; Martin-Quiros, A.; Trigo, E.; Figueira, J. C.; Manzanares, J.; Rodriguez-Fraga, O.; Cornejo, V. M.; Arribas, J. R.] La Paz Univ Hosp, High Level Isolat Unit, Madrid, Spain; [Garcia-Arenzana, N.] La Paz Univ Hosp, Dept Prevent Med, Madrid, Spain; [Fernandez-Diaz, M. V.] La Paz Univ Hosp, Dept Occupat Hlth, Madrid, Spain; [Palencia-Herrejon, E.; Martinez de la Gandara, A.; Lopez Perez, L.; Diaz-Diaz, D.; Lopez-Garcia, M. A.] Infanta Leonor Univ Hosp, Intens Care Unit, Madrid, Spain; [Palencia-Herrejon, E.; Sanchez-Artola, B.] Infanta Leonor Univ Hosp, Dept Internal Med, Madrid, Spain; [Fraile, J. L.] Infanta Leonor Univ Hosp, Dept Emergency, Madrid, Spain; [Delgado-Jimenez, P.] Infanta Leonor Univ Hosp, Dept Occupat Hlth, Madrid, Spain; [Astray-Mochales, J.; Ordobas Gavin, M.; Rodriguez-Baena, E.; Garcia-Comas, L.] Autonomous Community Madrid, Epidemiol Area, Madrid, Spain; [Bermejo Lopez, E.; Keough-Delgado, E.] Gregorio Maranon Univ Gen Hosp, Intens Care Unit, Madrid, Spain; [Menarguez, J.; Milla, J.] Gregorio Maranon Univ Gen Hosp, Dept Pathol, Madrid, Spain; [Fernandez-Cruz, A.] Gregorio Maranon Univ Gen Hosp, Dept Clin Microbiol & Infect Dis, Madrid, Spain; [Menarguez, J.; Fernandez-Cruz, A.; Milla, J.] Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Emmerich, P.; Schmidt-Chanasit, J.] World Hlth Org, Collaborating Ctr Arbovirus & Hemorrhag Fever Ref, Bernhard Nocht Inst Trop Med, Hamburg, Germany	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario Infanta Leonor; Hospital Universitario Infanta Leonor; Hospital Universitario Infanta Leonor; Hospital Universitario Infanta Leonor; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Complutense University of Madrid; Bernhard Nocht Institut fur Tropenmedizin; World Health Organization	Arribas, JR (corresponding author), Hosp Univ La Paz, Idipaz, High Level Isolat Unit, Castellana 261, Madrid 28046, Spain.	joser.arribas@salud.madrid.org	Bouza, Emilio/D-8661-2014; Díaz-Díaz, Domingo/GSE-9681-2022; MENARGUEZ, JAVIER/ABC-7303-2020; Negredo, Ana/AAE-6155-2020; Cruz, Ana Fernández/L-2429-2019; Fraile, Lorenzo/A-1142-2009; Arribas, Jose/A-1595-2015; Mora-Rillo, Marta/E-8211-2015	Bouza, Emilio/0000-0001-6967-9267; MENARGUEZ, JAVIER/0000-0001-5318-9976; Negredo, Ana/0000-0001-7491-1032; Cruz, Ana Fernández/0000-0003-1189-1120; SANCHEZ-ARTOLA, BEATRIZ/0000-0002-6736-1092; Fraile, Lorenzo/0000-0002-8980-5862; Dominguez-Berjon, Maria Felicitas/0000-0003-3551-0660; Herrero Romero, Laura/0000-0002-0299-3574; Martin-Quiros, Alejandro/0000-0003-4630-7668; LASALA, FATIMA/0000-0001-8183-1866; Diaz Menendez, Marta/0000-0002-9427-5237; Arribas, Jose/0000-0002-7410-9450; SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704; Mora-Rillo, Marta/0000-0002-2735-5931; de la Calle-Prieto, Fernando/0000-0003-2544-3492	Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) [RD12/0018/0023]; EMERGE (Efficient Response to Highly Dangerous and Emerging Pathogens at EU [European Union] - EU Health Program [677066]	Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET); EMERGE (Efficient Response to Highly Dangerous and Emerging Pathogens at EU [European Union] - EU Health Program	Supported by Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET grant, RD12/0018/0023) and EMERGE (Efficient Response to Highly Dangerous and Emerging Pathogens at EU [European Union] Level), a joint action funded under the third EU Health Program (677066),.	Akinci E, 2016, ANTIVIR RES, V132, P233, DOI 10.1016/j.antiviral.2016.06.011; Aradaib IE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001159; Ardalan MR, 2006, NEPHROL DIAL TRANSPL, V21, P2304, DOI 10.1093/ndt/gfl248; Ascioglu S, 2011, J ANTIMICROB CHEMOTH, V66, P1215, DOI 10.1093/jac/dkr136; Barnwal B, 2016, J BIOL CHEM, V291, P582, DOI 10.1074/jbc.M115.667436; BASKERVILLE A, 1981, J CLIN PATHOL, V34, P871, DOI 10.1136/jcp.34.8.871; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Cevik MA, 2007, CLIN INFECT DIS, V45, pE96, DOI 10.1086/521244; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P743, DOI 10.1089/vbz.2011.0767; Estrada-Pena A, 2012, EMERG INFECT DIS, V18, P179, DOI 10.3201/eid1801.111040; Geisbert TW, 1998, ULTRASTRUCT PATHOL, V22, P3, DOI 10.3109/01913129809032253; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Jameson LJ, 2012, TICKS TICK-BORNE DIS, V3, P95, DOI 10.1016/j.ttbdis.2011.12.002; Leblebicioglu H, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.024; Leblebicioglu H, 2016, ANTIVIR RES, V133, P9, DOI 10.1016/j.antiviral.2016.07.010; Li Q, 2014, ELECTRON J DIFFER EQ; Palomar AM, 2013, EMERG INFECT DIS, V19, P260, DOI 10.3201/eid1902.121193; Papa A, 2015, ANTIVIR RES, V120, P57, DOI 10.1016/j.antiviral.2015.05.005; Shieh WJ, 2010, AM J TROP MED HYG, V83, P38, DOI 10.4269/ajtmh.2010.09-0463; The Secretary of the Expert Committee on the Selection and Use of Essential Medicines Policy Access and Rational Use Department of Medicines Policy and Standards World Health Organization, APPL INCL RIB WHO MO; Zaki SR, 1999, J INFECT DIS, V179, pS36, DOI 10.1086/514319	23	103	104	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					154	161		10.1056/NEJMoa1615162	http://dx.doi.org/10.1056/NEJMoa1615162			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700843	Green Published, Bronze			2022-12-28	WOS:000405282300009
J	Geddes, A				Geddes, Alasdair			Graham Ayliffe OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item								Recognised that antibiotic resistance was a "ticking time bomb" Alasdair Geddes professor of infection	[Geddes, Alasdair] Univ Birmingham, Infect, Birmingham, W Midlands, England	University of Birmingham	Geddes, A (corresponding author), Univ Birmingham, Infect, Birmingham, W Midlands, England.	a.m.geddes@bham.ac.uk						AYLIFFE G, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2017	358								j3333	10.1136/bmj.j3333	http://dx.doi.org/10.1136/bmj.j3333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MO	28694289				2022-12-28	WOS:000405769900009
J	Inoue, Y; Vy, TTP; Yoshida, K; Asano, H; Mitsuoka, C; Asuke, S; Anh, VL; Cumagun, CJR; Chuma, I; Terauchi, R; Kato, K; Mitchell, T; Valent, B; Farman, M; Tosa, Y				Inoue, Yoshihiro; Vy, Trinh T. P.; Yoshida, Kentaro; Asano, Hokuto; Mitsuoka, Chikako; Asuke, Soichiro; Anh, Vu L.; Cumagun, Christian J. R.; Chuma, Izumi; Terauchi, Ryohei; Kato, Kenji; Mitchell, Thomas; Valent, Barbara; Farman, Mark; Tosa, Yukio			Evolution of the wheat blast fungus through functional losses in a host specificity determinant	SCIENCE			English	Article							MAGNAPORTHE-GRISEA; PYRICULARIA-GRISEA; ORYZAE; BANGLADESH; CONTAINS; PATHOGEN	Wheat blast first emerged in Brazil in the mid-1980s and has recently caused heavy crop losses in Asia. Here we show how this devastating pathogen evolved in Brazil. Genetic analysis of host species determinants in the blast fungus resulted in the cloning of avirulence genes PWT3 and PWT4, whose gene products elicit defense in wheat cultivars containing the corresponding resistance genes Rwt3 and Rwt4. Studies on avirulence and resistance gene distributions, together with historical data on wheat cultivation in Brazil, suggest that wheat blast emerged due to widespread deployment of rwt3 wheat (susceptible to Lolium isolates), followed by the loss of function of PWT3. This implies that the rwt3 wheat served as a springboard for the host jump to common wheat.	[Inoue, Yoshihiro; Vy, Trinh T. P.; Yoshida, Kentaro; Asano, Hokuto; Asuke, Soichiro; Anh, Vu L.; Cumagun, Christian J. R.; Chuma, Izumi; Tosa, Yukio] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Yoshida, Kentaro; Mitsuoka, Chikako; Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Kitakami, Iwate 0240003, Japan; [Terauchi, Ryohei] Kyoto Univ, Grad Sch Agr, Kyoto 6170001, Japan; [Kato, Kenji] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan; [Mitchell, Thomas] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Valent, Barbara] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Farman, Mark] Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA; [Inoue, Yoshihiro] Kyoto Univ, Grad Sch Agr, Kyoto 6068224, Japan; [Cumagun, Christian J. R.] Univ Philippines Los Banos, Coll Agr, College Los Banos 4031, Laguna, Philippines	Kobe University; Iwate Biotechnology Research Center; Kyoto University; Okayama University; University System of Ohio; Ohio State University; Kansas State University; University of Kentucky; Kyoto University; University of the Philippines System; University of the Philippines Los Banos	Tosa, Y (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	tosayuki@kobe-u.ac.jp	Terauchi, Ryohei/Y-2992-2019	Terauchi, Ryohei/0000-0002-0095-4651; Inoue, Yoshihiro/0000-0002-0353-1726; Valent, Barbara/0000-0002-5088-3345; Yoshida, Kentaro/0000-0002-3614-1759; Cumagun, Christian/0000-0002-5676-657X	Japan Society for the Promotion of Science [26292025]; Agriculture and Food Research Initiative competitive grant from the U.S. Department of Agriculture National Institute of Food and Agriculture [2013-68004-20378]; Hatch project [KY012037, 1002523]; Grants-in-Aid for Scientific Research [26257409] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agriculture and Food Research Initiative competitive grant from the U.S. Department of Agriculture National Institute of Food and Agriculture; Hatch project(United States Department of Agriculture (USDA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Kamoun (The Sainsbury Laboratory), T. Wolpert (Oregon State University), A. S. Urashima (Federal University of Sao Carlos), Y. Takano (Kyoto University), and H. Nakayashiki and K. Ikeda (Kobe University) for comments on drafts of the manuscript and S. Liu (Kansas State University) for sharing PacBio sequence data for the complex transposon insertion. Nucleotide sequence data reported herein are available in the DNA Data Bank of Japan (DDBJ) Sequenced Read Archive under accession number DRA005349 and in the DDBJ, European Molecular Biology Laboratory, and GenBank databases under accession numbers LC202650 to LC202657, LC215053, LC215054, and LC229726. This project was supported by Japan Society for the Promotion of Science grant 26292025, the Agriculture and Food Research Initiative competitive grant 2013-68004-20378 from the U.S. Department of Agriculture National Institute of Food and Agriculture, and the Hatch project KY012037 under accession number 1002523. This is contribution number 17-356-J from the Kansas Agricultural Experiment Station and publication number 17-12-051 of the Kentucky Agricultural Experiment Station. The supplementary materials contain additional data.	Camargo C. E. O., 2001, WORLD WHEAT BOOK HIS, V1, P549; Farman M, 2017, PLANT DIS, V101, P684, DOI 10.1094/PDIS-05-16-0700-RE; Farman ML, 2002, PHYTOPATHOLOGY, V92, P245, DOI 10.1094/PHYTO.2002.92.3.245; Farman ML, 1996, MOL GEN GENET, V251, P675, DOI 10.1007/BF02174116; HAMER JE, 1989, P NATL ACAD SCI USA, V86, P9981, DOI 10.1073/pnas.86.24.9981; Islam MT, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0309-7; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; Nakayashiki H, 2001, NUCLEIC ACIDS RES, V29, P4106, DOI 10.1093/nar/29.20.4106; Oh HS, 2002, CAN J BOT, V80, P1088, DOI [10.1139/B02-101, 10.1139/b02-101]; Takabayashi N, 2002, PHYTOPATHOLOGY, V92, P1182, DOI 10.1094/PHYTO.2002.92.11.1182; Tosa Y, 2004, PHYTOPATHOLOGY, V94, P454, DOI 10.1094/PHYTO.2004.94.5.454; Vy TTP, 2014, J GEN PLANT PATHOL, V80, P59, DOI 10.1007/s10327-013-0478-y; Urashima A. S., 1994, THESIS; URASHIMA AS, 1993, PLANT DIS, V77, P1211, DOI 10.1094/PD-77-1211	15	137	141	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					80	82		10.1126/science.aam9654	http://dx.doi.org/10.1126/science.aam9654			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684523	Green Accepted			2022-12-28	WOS:000416909500006
J	Reda, S				Reda, Sherief			3D integration advances computing	NATURE			English	Editorial Material								Integrated circuits usually have only one layer of electronic devices, which limits their performance and functionality. A 3D integrated circuit that incorporates multiple device layers enables a wealth of applications. See Letter p.74	[Reda, Sherief] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Reda, Sherief] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA	Brown University; Brown University	Reda, S (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.; Reda, S (corresponding author), Brown Univ, Dept Comp Sci, Providence, RI 02912 USA.	sherief_reda@brown.edu						Batude P., 2011, P IEEE INT EL DEV M; Davis WR, 2005, IEEE DES TEST COMPUT, V22, P498, DOI 10.1109/MDT.2005.136; Golshani N., 2010, P IEEE 3D SYST INT C; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Or-Bach Z., 2016, CHIPS 2020, V2, P51; Patil N, 2009, IEEE T NANOTECHNOL, V8, P498, DOI 10.1109/TNANO.2009.2016562; Reda S, 2009, IEEE T VLSI SYST, V17, P1357, DOI 10.1109/TVLSI.2008.2003513; Shulaker MM, 2017, NATURE, V547, P74, DOI 10.1038/nature22994; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Young Yang Liauw, 2012, 2012 IEEE International Solid-State Circuits Conference (ISSCC), P406, DOI 10.1109/ISSCC.2012.6177067	10	9	9	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					38	40		10.1038/547038a	http://dx.doi.org/10.1038/547038a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682338				2022-12-28	WOS:000404839900025
J	Shear, MK; Muldberg, S; Periyakoil, V				Shear, M. Katherine; Muldberg, Stephanie; Periyakoil, Vyjeyanthi			PRACTICE POINTER Supporting patients who are bereaved	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shear, M. Katherine] Columbia Univ, Sch Social Work, Ctr Complicated Grief, New York, NY 10027 USA; [Periyakoil, Vyjeyanthi] Stanford Univ, Stanford Hosp, Palliat Care Educ & Training, Stanford, CA 94305 USA; [Periyakoil, Vyjeyanthi] Stanford Univ, Palliat Med Fellowship Program, Stanford Ethnogeriatr & Successful Aging Portal, Stanford, CA 94305 USA; [Periyakoil, Vyjeyanthi] Vet Affairs Palo Alto Hlth Care Syst, Palliat Care Serv, Palo Alto, CA USA	Columbia University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Shear, MK (corresponding author), Columbia Univ, Sch Social Work, Ctr Complicated Grief, New York, NY 10027 USA.	ks2394@columbia.edu			National Institute on Minority Health and Health Disparities [R25MD006857] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Boelen PA, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2016; Bourassa KJ, 2016, PSYCHOL SCI, V27, P270, DOI 10.1177/0956797615618968; Burden C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0800-8; Castelnovo A, 2015, J AFFECT DISORDERS, V186, P266, DOI 10.1016/j.jad.2015.07.032; Fhaili MNA, 2016, BRIT J GEN PRACT, V66, pE92, DOI 10.3399/bjgp16X683413; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Gray HM, 2011, PERS SOC PSYCHOL B, V37, P1438, DOI 10.1177/0146167211420167; Keyes KM, 2014, AM J PSYCHIAT, V171, P864, DOI 10.1176/appi.ajp.2014.13081132; Mikulincer M., 2014, MECH SOCIAL CONNECTI, DOI [10.1037/14250-000, DOI 10.1037/14250-000]; Monk TH, 2008, PSYCHIAT ANN, V38, P671, DOI 10.3928/00485713-20081001-06; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Shear MK, 2015, NEW ENGL J MED, V372, P153, DOI 10.1056/NEJMcp1315618; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; van den Berg GJ, 2011, J HEALTH ECON, V30, P774, DOI 10.1016/j.jhealeco.2011.05.011	14	14	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j2854	10.1136/bmj.j2854	http://dx.doi.org/10.1136/bmj.j2854			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA3DO	28684392	Green Published			2022-12-28	WOS:000405322300002
J	Shen, L; Jhund, PS; Petrie, MC; Claggett, BL; Barlera, S; Cleland, JGF; Dargie, HJ; Granger, CB; Kjekshus, J; Kober, L; Latini, R; Maggioni, AP; Packer, M; Pitt, B; Solomon, SD; Swedberg, K; Tavazzi, L; Wikstrand, J; Zannad, F; Zile, MR; McMurray, JJV				Shen, Li; Jhund, Pardeep S.; Petrie, Mark C.; Claggett, Brian L.; Barlera, Simona; Cleland, John G. F.; Dargie, Henry J.; Granger, Christopher B.; Kjekshus, John; Kober, Lars; Latini, Roberto; Maggioni, Aldo P.; Packer, Milton; Pitt, Bertram; Solomon, Scott D.; Swedberg, Karl; Tavazzi, Luigi; Wikstrand, John; Zannad, Faiez; Zile, Michael R.; McMurray, John J. V.			Declining Risk of Sudden Death in Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR SYSTOLIC DYSFUNCTION; CONVERTING-ENZYME INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; CARDIAC DEATH; MYOCARDIAL-INFARCTION; METAANALYSIS; CANDESARTAN; PREVENTION; MORTALITY	BACKGROUND The risk of sudden death has changed over time among patients with symptomatic heart failure and reduced ejection fraction with the sequential introduction of medications including angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, and mineralocorticoid-receptor antagonists. We sought to examine this trend in detail. METHODS We analyzed data from 40,195 patients who had heart failure with reduced ejection fraction and were enrolled in any of 12 clinical trials spanning the period from 1995 through 2014. Patients who had an implantable cardioverter-defibrillator at the time of trial enrollment were excluded. Weighted multivariable regression was used to examine trends in rates of sudden death over time. Adjusted hazard ratios for sudden death in each trial group were calculated with the use of Cox regression models. The cumulative incidence rates of sudden death were assessed at different time points after randomization and according to the length of time between the diagnosis of heart failure and randomization. RESULTS Sudden death was reported in 3583 patients. Such patients were older and were more often male, with an ischemic cause of heart failure and worse cardiac function, than those in whom sudden death did not occur. There was a 44% decline in the rate of sudden death across the trials (P = 0.03). The cumulative incidence of sudden death at 90 days after randomization was 2.4% in the earliest trial and 1.0% in the most recent trial. The rate of sudden death was not higher among patients with a recent diagnosis of heart failure than among those with a longer-standing diagnosis. CONCLUSIONS Rates of sudden death declined substantially over time among ambulatory patients with heart failure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consistent with a cumulative benefit of evidence-based medications on this cause of death. (Funded by the China Scholarship Council and the University of Glasgow.)	[Shen, Li; Jhund, Pardeep S.; Petrie, Mark C.; McMurray, John J. V.] Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Cleland, John G. F.] Univ Glasgow, Robertson Ctr Biostat & Clin Trials, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Petrie, Mark C.] Golden Jubilee Natl Hosp, Dept Cardiol, Glasgow, Lanark, Scotland; [Dargie, Henry J.] Glasgow Royal Infirm, Cardiol Dept, Glasgow, Lanark, Scotland; [Cleland, John G. F.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Claggett, Brian L.; Solomon, Scott D.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Claggett, Brian L.; Solomon, Scott D.] Harvard Med Sch, Boston, MA USA; [Barlera, Simona; Latini, Roberto] Ist Ric Farmacol Mario Negri, Ist Ricovero & Cura Carattere Sci, Dept Cardiovasc Res, Milan, Italy; [Maggioni, Aldo P.] Assoc Nazl Med Cardiol Osped, Res Ctr, Florence, Italy; [Tavazzi, Luigi] Maria Cecilia Hosp, Ettore Sansavini Hlth Sci Fdn, Grp Villa Maria Care & Res, Cotignola, Italy; [Granger, Christopher B.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Kjekshus, John] Univ Hosp, Rikshosp, Oslo, Norway; [Kober, Lars] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Packer, Milton] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX USA; [Pitt, Bertram] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Swedberg, Karl] Univ Gothenburg, Ctr Person Ctr Care, Gothenburg, Sweden; [Wikstrand, John] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Zannad, Faiez] Univ Lorraine, INSERM, Ctr Invest Clin 1433, Nancy, France; [Zannad, Faiez] CHU Nancy, Nancy, France; [Zile, Michael R.] Med Univ South Carolina, Charleston, SC 29425 USA; [Zile, Michael R.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	University of Glasgow; University of Glasgow; Golden Jubilee Hospital; University of Glasgow; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; IRCCS Ca Granda Ospedale Maggiore Policlinico; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO); Maria Cecilia Hospital; Duke University; University of Oslo; National Hospital Norway; Rigshospitalet; University of Copenhagen; Baylor University; Baylor University Medical Center; University of Michigan System; University of Michigan; University of Gothenburg; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	McMurray, JJV (corresponding author), Univ Glasgow, British Heart Fdn, Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	john.mcmurray@glasgow.ac.uk	Zannad, Faiez/K-4649-2019; Latini, Roberto/AAB-1410-2020; mcmurray, John/B-2467-2013; Jhund, Pardeep/GLS-9508-2022; Maggioni, Aldo Pietro/AAL-5334-2020; Cleland, John G./AAZ-4185-2020; Swedberg, Karl/B-2475-2008; Tavazzi, Luigi/ABD-5119-2020	Latini, Roberto/0000-0002-3729-4650; mcmurray, John/0000-0002-6317-3975; Jhund, Pardeep/0000-0003-4306-5317; Maggioni, Aldo Pietro/0000-0003-2764-6779; Cleland, John G./0000-0002-1471-7016; Tavazzi, Luigi/0000-0003-0336-8356; Kober, Lars/0000-0002-6635-1466; Zile, Michael/0000-0001-7076-221X; TAVAZZI, LUIGI/0000-0003-4448-5209	China Scholarship Council; University of Glasgow; National Institute for Health Research [NF-SI-0611-10227] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); University of Glasgow; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the China Scholarship Council and the University of Glasgow.	Al-Gobari M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-52; Bapoje SR, 2013, CIRC-HEART FAIL, V6, P166, DOI 10.1161/CIRCHEARTFAILURE.112.000003; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Betts TR, 2013, EUROPACE, V15, P813, DOI 10.1093/europace/eus427; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; Chung MK, 2010, J AM COLL CARDIOL, V56, P194, DOI 10.1016/j.jacc.2010.04.016; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Colucci WS, 2007, CIRCULATION, V116, P49, DOI 10.1161/CIRCULATIONAHA.106.666016; Cubbon RM, 2011, CIRC-HEART FAIL, V4, P396, DOI 10.1161/CIRCHEARTFAILURE.110.959882; Desai AS, 2015, EUR HEART J, V36, P1990, DOI 10.1093/eurheartj/ehv186; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P598, DOI 10.1016/S0735-1097(98)00609-3; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Eschalier R, 2015, CARDIOVASC DRUG THER, V29, P89, DOI 10.1007/s10557-015-6572-y; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fonarow GC, 2008, AM J CARDIOL, V102, P1524, DOI 10.1016/j.amjcard.2008.07.045; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; Hjalmarson A, 1999, LANCET, V353, P2001; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Kober L, 2016, NEW ENGL J MED, V375, P1221, DOI 10.1056/NEJMoa1608029; KONSTAM MA, 1993, CIRCULATION, V88, P2277, DOI 10.1161/01.CIR.88.5.2277; Lechat P, 1999, LANCET, V353, P9; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Remme WJ, 2004, CARDIOVASC DRUG THER, V18, P57, DOI 10.1023/B:CARD.0000025756.32499.6f; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Wong M, 2002, J AM COLL CARDIOL, V40, P970, DOI 10.1016/S0735-1097(02)02063-6; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zecchin M, 2012, AM J CARDIOL, V109, P729, DOI 10.1016/j.amjcard.2011.10.033	36	252	257	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					41	51		10.1056/NEJMoa1609758	http://dx.doi.org/10.1056/NEJMoa1609758			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5CS	28679089	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000404730000007
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Time for a truly independent NHS statistics authority	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2016, DOES THIS YEARS NHS; Campbell D, 2016, GUARDIAN; Ham C, 2017, ASSESSING CREDIBILIT; National Audit Office, 2016, HLTH SOC CAR INT; National Audit Office, 2016, HC18 SESS 2016 17	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2017	357								j3045	10.1136/bmj.j3045	http://dx.doi.org/10.1136/bmj.j3045			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AZ	28666978	Green Published, Bronze			2022-12-28	WOS:000404725200004
J	Gulland, A				Gulland, Anne			Sixty seconds on ... snakebite	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 27	2017	357								j3065	10.1136/bmj.j3065	http://dx.doi.org/10.1136/bmj.j3065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AQ	28655721				2022-12-28	WOS:000404724100003
J	Lyon, J				Lyon, Jeff			National Plan for COPD Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2475	2475		10.1001/jama.2017.7991	http://dx.doi.org/10.1001/jama.2017.7991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28654995				2022-12-28	WOS:000404106600004
J	Martinez-Sykora, J; De Pontieu, B; Hansteen, VH; van der Voort, LR; Carlsson, M; Pereira, TMD				Martinez-Sykora, J.; De Pontieu, B.; Hansteen, V. H.; van der Voort, L. Rouppe; Carlsson, M.; Pereira, T. M. D.			On the generation of solar spicules and Alfvenic waves	SCIENCE			English	Article							REGION; SIMULATION; CORONA; POWER	In the lower solar atmosphere, the chromosphere is permeated by jets known as spicules, in which plasma is propelled at speeds of 50 to 150 kilometers per second into the corona. The origin of the spicules is poorly understood, although they are expected to play a role in heating the million-degree corona and are associated with Alfvenic waves that help drive the solar wind. We compare magnetohydrodynamic simulations of spicules with observations from the Interface Region Imaging Spectrograph and the Swedish 1-m Solar Telescope. Spicules are shown to occur when magnetic tension is amplified and transported upward through interactions between ions and neutrals or ambipolar diffusion. The tension is impulsively released to drive flows, heat plasma (through ambipolar diffusion), and generate Alfvenic waves.	[Martinez-Sykora, J.] Bay Area Environm Res Inst, Petaluma, CA 94952 USA; [Martinez-Sykora, J.; De Pontieu, B.; Hansteen, V. H.] Lockheed Martin Solar & Astrophys Lab LMSAL, Palo Alto, CA 94304 USA; [De Pontieu, B.; Hansteen, V. H.; van der Voort, L. Rouppe; Carlsson, M.; Pereira, T. M. D.] Univ Oslo, Inst Theoret Astrophys, POB 1029, N-0315 Oslo, Norway	University of Oslo	Martinez-Sykora, J (corresponding author), Bay Area Environm Res Inst, Petaluma, CA 94952 USA.; Martinez-Sykora, J (corresponding author), Lockheed Martin Solar & Astrophys Lab LMSAL, Palo Alto, CA 94304 USA.	juanms@lmsal.com	; Pereira, Tiago/G-4079-2014	Rouppe van der Voort, Luc/0000-0003-2088-028X; Pereira, Tiago/0000-0003-4747-4329; Martinez-Sykora, Juan/0000-0002-0333-5717; De Pontieu, Bart/0000-0002-8370-952X; Carlsson, Mats/0000-0001-9218-3139	NASA; Research Council of Norway; European Research Council (ERC); European Space Agency; Norwegian Space Centre; NASA [NNX11AN98G, NNM12AB40P, NNH15ZDA001N-HSR, NNX16AG90G, NNM07AA01C, NNG09FA40C]; ERC under the European Union [291058]; Pleiades cluster through computing project from NASA's High-End Computing Program [s1061]; Research Council of Norway [170935/V30]	NASA(National Aeronautics & Space Administration (NASA)); Research Council of Norway(Research Council of Norway); European Research Council (ERC)(European Research Council (ERC)European Commission); European Space Agency(European Space AgencyEuropean Commission); Norwegian Space Centre; NASA(National Aeronautics & Space Administration (NASA)); ERC under the European Union; Pleiades cluster through computing project from NASA's High-End Computing Program; Research Council of Norway(Research Council of Norway)	This work is supported by NASA, the Research Council of Norway, and the European Research Council (ERC). IRIS is a NASA Small Explorer mission developed and operated by LMSAL with mission operations executed at NASA Ames Research Center and major contributions to downlink communications funded by the European Space Agency and the Norwegian Space Centre. The SST is operated on the island of La Palma by the Institute for Solar Physics of Stockholm University in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. We gratefully acknowledge support by NASA grants NNX11AN98G, NNM12AB40P, NNH15ZDA001N-HSR, and NNX16AG90G and NASA contracts NNM07AA01C (Hinode) and NNG09FA40C (IRIS). This research was supported by the Research Council of Norway and by the ERC under the European Union's Seventh Framework Programme (FP7/2007-2013; ERC grant agreement no. 291058). The simulations were run on clusters from the Notur project and the Pleiades cluster through computing project s1061 from NASA's High-End Computing Program. We thankfully acknowledge the computer and supercomputer resources of the Research Council of Norway through grant 170935/V30 and through grants of computing time from the Programme for Supercomputing. IRIS observations are archived at http://iris.lmsal.com/data.html; level 3 data including the SST and IRIS observations used for Fig. 4 are accessible at http://bit.ly/2mnGVYg. The simulation output and synthetic observables for models B and C are available at http://sdc.uio.no/search/simulations under the names en096014_gol and en096014_nongol, respectively. Executables for the Bifrost software and files necessary to run the simulations are available at http://iris.lmsal.com/bf/code.tar.bz2, source code for RH is at http://github.com/ITA-Solar/rh, (supplementary materials) and the optically thin radiation was calculated using the IRIS library of SolarSoft at www.lmsal.com/solarsoft/. Various items of documentation for these software and output files are available at http://iris.lmsal.com/modeling.html.	ACHESON DJ, 1979, SOL PHYS, V62, P23, DOI 10.1007/BF00150129; Antolin P, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/72; Carlsson M, 2016, ASTRON ASTROPHYS, V585, DOI 10.1051/0004-6361/201527226; De Pontieu B, 2007, SCIENCE, V318, P1574, DOI 10.1126/science.1151747; De Pontieu B, 2014, SOL PHYS, V289, P2733, DOI 10.1007/s11207-014-0485-y; De Pontieu B, 2012, ASTROPHYS J LETT, V752, DOI [10.1088/2041-8205/752/1/L12, 10.1088/2041-8205/752/1/L12L12]; De Pontieu B, 2011, SCIENCE, V331, P55, DOI 10.1126/science.1197738; De Pontieu B, 2007, PUBL ASTRON SOC JPN, V59, pS655, DOI 10.1093/pasj/59.sp3.S655; De Pontieu B, 2014, SCIENCE, V346, P315, DOI 10.1126/science.346.6207.315; De Pontieu B, 2009, ASTROPHYS J LETT, V701, pL1, DOI 10.1088/0004-637X/701/1/L1; Hansteen V, 2015, ASTROPHYS J, V811, DOI 10.1088/0004-637X/811/2/106; HOLLWEG JV, 1986, J GEOPHYS RES-SPACE, V91, P4111, DOI 10.1029/JA091iA04p04111; Klimchuk JA, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/60; Lites BW, 2008, ASTROPHYS J, V672, P1237, DOI 10.1086/522922; Martinez-Sykora J, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/66; Martinez-Sykora J, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/9; McIntosh SW, 2011, NATURE, V475, P477, DOI 10.1038/nature10235; Okamoto J., 2011, ASTROPHYS J, V736, pL24; Okamoto TJ, 2015, ASTROPHYS J, V809, DOI 10.1088/0004-637X/809/1/71; PARKER EN, 1989, SOL PHYS, V121, P271; Pereira TMD, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L15; Pereira TMD, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/18; Rouppe van der Voort L., 2009, ASTROPHYS J, V705, P272, DOI [10.1088/0004-637X/705/1/272, DOI 10.1088/0004-637X/705/1/272]; Scharmer GB, 2003, P SOC PHOTO-OPT INS, V4853, P341, DOI 10.1117/12.460377; Secchi A., 1878, STERNE GRUNDZUGE AST; Sekse DH, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/108; Tsiropoula G, 2012, SPACE SCI REV, V169, P181, DOI 10.1007/s11214-012-9920-2; van der Voort LR, 2015, ASTROPHYS J LETT, V799, DOI 10.1088/2041-8205/799/1/L3; Yokoyama T, 1996, PUBL ASTRON SOC JPN, V48, P353, DOI 10.1093/pasj/48.2.353	29	120	121	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1269	+		10.1126/science.aah5412	http://dx.doi.org/10.1126/science.aah5412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642434	Green Submitted			2022-12-28	WOS:000403881700036
J	Shi, T; McAllister, DA; O'Brien, KL; Simoes, EAF; Madhi, SA; Gessner, BD; Polack, FP; Balsells, E; Acacio, S; Aguayo, C; Alassani, I; Ali, A; Antonio, M; Awasthi, S; Awori, JO; Azziz-Baumgartner, E; Baggett, HC; Baillie, VL; Balmaseda, A; Barahona, A; Basnet, S; Bassat, Q; Basualdo, W; Bigogo, G; Bont, L; Breiman, RF; Brooks, WA; Broor, S; Bruce, N; Bruden, D; Buchy, P; Campbell, S; Carosone-Link, P; Chadha, M; Chipeta, J; Chou, M; Clara, W; Cohen, C; de Cuellar, E; Dang, DA; Dash-yandag, B; Deloria-Knoll, M; Dherani, M; Eap, T; Ebruke, BE; Echavarria, M; Emediato, CCDL; Fasce, RA; Feikin, DR; Feng, LZ; Gentile, A; Gordon, A; Goswami, D; Goyet, S; Groome, M; Halasa, N; Hirve, S; Homaira, N; Howie, SRC; Jara, J; Jroundi, I; Kartasasmita, CB; Khuri-Bulos, N; Kotloff, KL; Krishnan, A; Libster, R; Lopez, O; Lucero, MG; Lucion, F; Lupisan, SP; Marcone, DN; McCracken, JP; Mejia, M; Moisi, JC; Montgomery, JM; Moore, DP; Moraleda, C; Moyes, J; Munywoki, P; Mutyara, K; Nicol, MP; Nokes, DJ; Nymadawa, P; Oliveira, MTD; Oshitani, H; Pandey, N; Paranhos-Baccala, G; Phillips, LN; Picot, VS; Rahman, M; Rakoto-Andrianarivelo, M; Rasmussen, ZA; Rath, BA; Robinson, A; Romero, C; Russomando, G; Salimi, V; Sawatwong, P; Scheltema, N; Schweiger, B; Scott, JAG; Seidenberg, P; Shen, KL; Singleton, R; Sotomayor, V; Strand, TA; Sutanto, A; Sylla, M; Tapia, MD; Thamthitiwat, S; Thomas, ED; Tokarz, R; Turner, C; Venter, M; Waicharoen, S; Wang, JW; Watthanaworawit, W; Yoshida, LM; Yu, HJ; Zar, HJ; Campbell, H; Nair, H				Shi, Ting; McAllister, David A.; O'Brien, Katherine L.; Simoes, Eric A. F.; Madhi, Shabir A.; Gessner, Bradford D.; Polack, Fernando P.; Balsells, Evelyn; Acacio, Sozinho; Aguayo, Claudia; Alassani, Issifou; Ali, Asad; Antonio, Martin; Awasthi, Shally; Awori, Juliet O.; Azziz-Baumgartner, Eduardo; Baggett, Henry C.; Baillie, Vicky L.; Balmaseda, Angel; Barahona, Alfredo; Basnet, Sudha; Bassat, Quique; Basualdo, Wilma; Bigogo, Godfrey; Bont, Louis; Breiman, Robert F.; Brooks, W. Abdullah; Broor, Shobha; Bruce, Nigel; Bruden, Dana; Buchy, Philippe; Campbell, Stuart; Carosone-Link, Phyllis; Chadha, Mandeep; Chipeta, James; Chou, Monidarin; Clara, Wilfrido; Cohen, Cheryl; de Cuellar, Elizabeth; Duc-Anh Dang; Dash-yandag, Budragchaagiin; Deloria-Knoll, Maria; Dherani, Mukesh; Eap, Tekchheng; Ebruke, Bernard E.; Echavarria, Marcela; Lazaro Emediato, Carla Cecilia de Freitas; Fasce, Rodrigo A.; Feikin, Daniel R.; Feng, Luzhao; Gentile, Angela; Gordon, Aubree; Goswami, Doli; Goyet, Sophie; Groome, Michelle; Halasa, Natasha; Hirve, Siddhivinayak; Homaira, Nusrat; Howie, Stephen R. C.; Jara, Jorge; Jroundi, Imane; Kartasasmita, Cissy B.; Khuri-Bulos, Najwa; Kotloff, Karen L.; Krishnan, Anand; Libster, Romina; Lopez, Olga; Lucero, Marilla G.; Lucion, Florencia; Lupisan, Socorro P.; Marcone, Debora N.; McCracken, John P.; Mejia, Mario; Moisi, Jennifer C.; Montgomery, Joel M.; Moore, David P.; Moraleda, Cinta; Moyes, Jocelyn; Munywoki, Patrick; Mutyara, Kuswandewi; Nicol, Mark P.; Nokes, D. James; Nymadawa, Pagbajabyn; da Costa Oliveira, Maria Tereza; Oshitani, Histoshi; Pandey, Nitin; Paranhos-Baccala, Glaucia; Phillips, Lia N.; Picot, Valentina Sanchez; Rahman, Mustafizur; Rakoto-Andrianarivelo, Mala; Rasmussen, Zeba A.; Rath, Barbara A.; Robinson, Annick; Romero, Candice; Russomando, Graciela; Salimi, Vahid; Sawatwong, Pongpun; Scheltema, Nienke; Schweiger, Brunhilde; Scott, J. Anthony G.; Seidenberg, Phil; Shen, Kunling; Singleton, Rosalyn; Sotomayor, Viviana; Strand, Tor A.; Sutanto, Agustinus; Sylla, Mariam; Tapia, Milagritos D.; Thamthitiwat, Somsak; Thomas, Elizabeth D.; Tokarz, Rafal; Turner, Claudia; Venter, Marietjie; Waicharoen, Sunthareeya; Wang, Jianwei; Watthanaworawit, Wanitda; Yoshida, Lay-Myint; Yu, Hongjie; Zar, Heather J.; Campbell, Harry; Nair, Harish		RSV Global Epidemiology Network	Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study	LANCET			English	Article							RISK-FACTORS; PNEUMONIA; METAANALYSIS; MANAGEMENT; MORTALITY; INFANTS; COST; RSV	Background We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015. Methods We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity. Findings We estimated that globally in 2015, 33.1 million (uncertainty range [UR] 21.6-50.3) episodes of RSV-ALRI, resulted in about 3.2 million (2.7-3.8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1.4 million (UR 1.2-1.7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population. Interpretation Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and inhospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group.	[Shi, Ting; Balsells, Evelyn; Campbell, Stuart; Campbell, Harry; Nair, Harish] Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland; [McAllister, David A.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [O'Brien, Katherine L.; Brooks, W. Abdullah; Deloria-Knoll, Maria; Goswami, Doli] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD USA; [Simoes, Eric A. F.] Univ Colorado, Aurora, CO USA; [Madhi, Shabir A.; Baillie, Vicky L.; Groome, Michelle; Moore, David P.] Univ Witwatersrand, Sch Pathol, Med Res Council, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir A.; Groome, Michelle; Moore, David P.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa; [Gessner, Bradford D.; Moisi, Jennifer C.] Agence Med Prevent, Paris, France; [Polack, Fernando P.; Libster, Romina] Fdn INFANT, Buenos Aires, DF, Argentina; [Acacio, Sozinho; Bassat, Quique] CISM, Maputo, Mozambique; [Aguayo, Claudia; Sotomayor, Viviana] Minist Hlth Santiago, Epidemiol Dept, Santiago, Chile; [Alassani, Issifou] Minist Hlth, Lome, Togo; [Ali, Asad] Aga Khan Univ, Dept Pediat & Child Hlth, Karachi, Pakistan; [Antonio, Martin; Ebruke, Bernard E.; Howie, Stephen R. C.] Med Res Council Unit Gambia, Basse, Gambia; [Awasthi, Shally; Pandey, Nitin] King Georges Med Univ, Dept Pediat, Lucknow, Uttar Pradesh, India; [Awori, Juliet O.; Munywoki, Patrick; Nokes, D. James; Scott, J. Anthony G.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Azziz-Baumgartner, Eduardo; Brooks, W. Abdullah; Goswami, Doli; Homaira, Nusrat; Rahman, Mustafizur] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Azziz-Baumgartner, Eduardo; Feikin, Daniel R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Baggett, Henry C.; Sawatwong, Pongpun; Thamthitiwat, Somsak] Thailand Minist Publ Health US, Ctr Dis Control & Prevent Collaborat, Global Dis Detect Ctr, Nonthaburi, Thailand; [Baggett, Henry C.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA; [Balmaseda, Angel] Minist Hlth, Managua, Nicaragua; [Barahona, Alfredo] Hosp Materno Infantil Jose Domingo de Obaldia, Ciudad De David, Chiriqui, Panama; [Basnet, Sudha; Strand, Tor A.] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Basnet, Sudha] Tribhuvan Univ Inst Med, Dept Child Hlth, Kathmandu, Nepal; [Bassat, Quique; Jroundi, Imane; Moraleda, Cinta] Univ Barcelona, Hosp Clin, ISGlobal Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Bassat, Quique] ICREA, Pg Lluis Co 23, Barcelona 08010, Spain; [Basualdo, Wilma] Minis Salud Publ & Bienestar Social, Hosp Gen Peditr Ninos Acosta Nu, San Lorenzo, Paraguay; [Bigogo, Godfrey] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Bont, Louis; Scheltema, Nienke] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Breiman, Robert F.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Broor, Shobha; Krishnan, Anand] All India Inst Med Sci, New Delhi, India; [Bruce, Nigel; Dherani, Mukesh] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Bruden, Dana; Singleton, Rosalyn] Ctr Dis Control & Prevent, NCEZID, Arctic Invest Program, Anchorage, AK USA; [Buchy, Philippe; Goyet, Sophie] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Buchy, Philippe] GSK Vaccines Singapore, Singapore, Singapore; [Carosone-Link, Phyllis] Childrens Hosp Colorado, Dept Pediat Infect Dis, Aurora, CO USA; [Chadha, Mandeep] Natl Inst Virol, Pune, Maharashtra, India; [Chipeta, James] Univ Teaching Hosp, Lusaka, Zambia; [Chou, Monidarin] Univ Hlth Sci, Fac Pharm, Rodolphe Merieux Lab, Phnom Penh, Cambodia; [Clara, Wilfrido] Cent Amer Reg, Ctr Dis Control & Prevent, Guatemala City, Guatemala; [Cohen, Cheryl; Moyes, Jocelyn] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Cohen, Cheryl; Moyes, Jocelyn] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [de Cuellar, Elizabeth] Minist Hlth, Hosp San Juan de Dios Santa Ana, San Salvador, El Salvador; [Duc-Anh Dang] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Dash-yandag, Budragchaagiin] Bayanzurkh Dist Gen Hosp, Ulaanbaatar, Mongolia; [Eap, Tekchheng] Natl Pediat Hosp, Dept Pneumol, Phnom Penh, Cambodia; [Echavarria, Marcela; Marcone, Debora N.] CEMIC, Buenos Aires, DF, Argentina; [Lazaro Emediato, Carla Cecilia de Freitas; da Costa Oliveira, Maria Tereza] Hlth Secretariat City Belo Horizonte, Belo Horizonte, MG, Brazil; [Fasce, Rodrigo A.] Inst Publ Hlth, Santiago, Chile; [Feng, Luzhao; Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Gentile, Angela; Lucion, Florencia] Austral Univ, Dept Epidemiol, Buenos Aires, DF, Argentina; [Gentile, Angela; Lucion, Florencia] Ricardo Gutierrez Children Hosp, Buenos Aires, DF, Argentina; [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Halasa, Natasha; Libster, Romina] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hirve, Siddhivinayak] KEM Hosp Res Ctr, Pune, Maharashtra, India; [Homaira, Nusrat] Univ New South Wales, Fac Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Howie, Stephen R. C.] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Howie, Stephen R. C.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Jara, Jorge; McCracken, John P.] Univ Valle Guatemala, Ctr Hlth Studies, Guatemala City, Guatemala; [Jroundi, Imane] Univ Mohammed 5, Sch Med & Pharm Rabat, Unit Training & Res Publ Hlth, Rabat, Morocco; [Kartasasmita, Cissy B.; Mutyara, Kuswandewi] Univ Padjdjaran, Bandung, Indonesia; [Khuri-Bulos, Najwa] Univ Jordan, Amman, Jordan; [Kotloff, Karen L.; Tapia, Milagritos D.] Univ Maryland, Sch Med, Dept Pediat & Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Libster, Romina] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Lopez, Olga] Hosp Dr Ernesto Torres Galdames, Iquique, Chile; [Lucero, Marilla G.] Res Inst Trop Med, Muntinlupa, Philippines; [Lupisan, Socorro P.] Res Inst Trop Med, Dept Hlth, Muntinlupa, Philippines; [Mejia, Mario] Minist Publ Hlth & Social Welf, Guatemala City, Guatemala; [Montgomery, Joel M.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Nairobi, Kenya; [Munywoki, Patrick] Pwani Univ, Kilifi, Kenya; [Nicol, Mark P.] Univ Cape Town, Div Med Microbiol, Cape Town, South Africa; [Nicol, Mark P.] Natl Hlth Lab Serv, Cape Town, South Africa; [Nokes, D. James] Univ Warwick, Sch Life Sci, Warwick, England; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia; [Oshitani, Histoshi] Univ Grad Sch Med, Dept Virol, Sendai, Miyagi, Japan; [Paranhos-Baccala, Glaucia; Picot, Valentina Sanchez] UCBL1, ENS Lyon, Emerging Pathofens Lab, Fondat Merieux,CIRI,Inserm U1111,CNRS,UMR5308, Lyon, France; [Phillips, Lia N.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Rakoto-Andrianarivelo, Mala] CICM, Antananarivo, Madagascar; [Rasmussen, Zeba A.; Thomas, Elizabeth D.] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bethesda, MD USA; [Rath, Barbara A.] Charite, Med Ctr, Dept Pediat, Berlin, Germany; [Robinson, Annick] Hop Femme Mere Enfant, Antananarivo, Madagascar; [Romero, Candice] US Naval Med Res, Unit 6, Callao, Peru; [Russomando, Graciela] Univ Nacl Asunc, Inst Invest Ciencias Salud, Dept Biol Mol & Genet, Asuncion, Paraguay; [Salimi, Vahid] Univ Med Sci, Dept Virol, Sch Publ Hlth, Tehran, Iran; [Schweiger, Brunhilde] RKI, Berlin, Germany; [Scott, J. Anthony G.] London Sch Hyg & Trop Med, London, England; [Seidenberg, Phil] Univ New Mexico, Dept Emergency Med, Albuquerque, NM 87131 USA; [Shen, Kunling] Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children & Natl Key Discipline, Capital Med Univ,Minist Educ, Beijing, Peoples R China; [Singleton, Rosalyn] Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; [Strand, Tor A.] Innlandet Hosp Trust, Dept Res, Lillehammer, Norway; [Sutanto, Agustinus] Minist Hlth, Jakarta, Indonesia; [Sylla, Mariam] CHU Gabriel Toure, Bamako, Mali; [Tokarz, Rafal] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Turner, Claudia; Watthanaworawit, Wanitda] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Malaria Res Unit, Mae Sot, Thailand; [Venter, Marietjie] Univ Pretoria, Dept Med Virol, Ctr Viral Zoonosis, Pretoria, South Africa; [Waicharoen, Sunthareeya] Minist Publ Hlth, Dept Med Sci, Natl Inst Hlth, Nonthaburi, Thailand; [Wang, Jianwei] CAMS, MOH Key Lab Syst Biol Pathogens, Beijing, Peoples R China; [Wang, Jianwei] CAMS, Christophe Merieux Lab, IPB, CAMS Fdn Merieux, Beijing, Peoples R China; [Wang, Jianwei] PUMC, Beijing, Peoples R China; [Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki, Japan; [Zar, Heather J.] Red Cross War Mem Childrens Hosp, Dept Paediat & Child Heath, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, MRC Unit Child & Adolescent Hlth, Cape Town, South Africa; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India	University of Edinburgh; University of Glasgow; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; South African Medical Research Council; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; Agence de Medecine Preventive; Centro de Investigacao em Saude de Manhica; Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; King George's Medical University; Kenya Medical Research Institute; International Centre for Diarrhoeal Disease Research (ICDDR); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Bergen; Tribhuvan University; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; ICREA; Kenya Medical Research Institute; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Emory University; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Liverpool; Centers for Disease Control & Prevention - USA; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Children's Hospital Colorado; Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); University of Zambia; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institute of Hygiene & Epidemiology (NIHE); Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Chinese Center for Disease Control & Prevention; Austral University; Hospital de Ninos Doctor Ricardo Gutierrez; University of Michigan System; University of Michigan; Vanderbilt University; University of New South Wales Sydney; University of Auckland; University of Otago; Universidad del Valle de Guatemala; Mohammed V University in Rabat; University of Jordan; University System of Maryland; University of Maryland Baltimore; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Research Institute for Tropical Medicine - Philippines; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Pwani University; University of Cape Town; University of Warwick; Mongolian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Emory University; Rollins School Public Health; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Naval Medical Research Center (NMRC); Naval Medical Research Unit No. 6 (NAMRU-6); Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion; Tehran University of Medical Sciences; Robert Koch Institute; University of London; London School of Hygiene & Tropical Medicine; University of New Mexico; Capital Medical University; Alaska Native Tribal Health Consortium; Innlandet Hospital Trust; Ministry of Health - Indonesia; Columbia University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Pretoria; Ministry of Public Health - Thailand; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Nagasaki University; University of Cape Town; Public Health Foundation of India	Nair, H (corresponding author), Univ Edinburgh, Ctr Global Hlth Res, Usher Inst Populat Hlth Sci & Informat, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	harish.nair@ed.ac.uk	Marcone, Débora Natalia/Y-7539-2019; Broor, Shobha/AAX-4163-2021; Moore, David/AAU-7186-2020; Oshitani, Hitoshi/AAE-4349-2019; Wang, Jianwei/W-5916-2019; Krishnan, Anand/D-8537-2012; Murdoch, David/A-2012-2009; kotloff, karen l/E-7768-2012; Bassat, Quique/P-2341-2016; Groome, Michelle Jennifer/AAI-9967-2021; Nymadawa, Pagbajab/AAE-7344-2019; Echavarria, Marcela/AAQ-2897-2021; Venter, Marietjie/P-9604-2016; Ebruke, Bernard/AAX-7133-2020; Campbell, Harry/E-2959-2010; Wang, Jianwei/AAW-9499-2020; Gordon, Aubree/X-1113-2019; Yu, Hongjie/GZK-5351-2022; Nair, Harish/E-7431-2010; Nicol, Mark/W-4149-2019; Strand, Tor/D-9836-2016; Homaira, Nusrat/U-4526-2019; Zar, Heather/GZL-5350-2022; Brooks, W. Abdullah/AAD-3876-2021; Munywoki, Patrick K./GQP-4775-2022; Tavakoli, Forough/HHS-9853-2022; Bigogo, Godfrey/W-3591-2019; Moyes, Jocelyn/AAF-7882-2019	Marcone, Débora Natalia/0000-0003-4407-7280; Broor, Shobha/0000-0001-9679-4180; Moore, David/0000-0001-6091-1605; Krishnan, Anand/0000-0002-9173-7811; kotloff, karen l/0000-0003-1808-6431; Bassat, Quique/0000-0003-0875-7596; Groome, Michelle Jennifer/0000-0001-5893-3725; Nymadawa, Pagbajab/0000-0002-3189-2772; Echavarria, Marcela/0000-0001-6987-8397; Venter, Marietjie/0000-0003-2696-824X; Campbell, Harry/0000-0002-6169-6262; Wang, Jianwei/0000-0002-1116-4559; Gordon, Aubree/0000-0002-9352-7877; Nair, Harish/0000-0002-9432-9100; Nicol, Mark/0000-0002-1366-4805; Strand, Tor/0000-0002-4038-151X; Zar, Heather/0000-0002-9046-759X; Brooks, W. Abdullah/0000-0001-9871-5546; Munywoki, Patrick K./0000-0001-9419-7155; Deloria Knoll, Maria/0000-0001-9041-2671; Ali, Syed Asad/0000-0001-5274-7665; BUCHY, Philippe/0000-0003-1372-3008; Dherani, Mukesh/0000-0002-3055-9636; Cohen, Cheryl/0000-0003-0376-2302; O'Brien, Katherine/0000-0002-0164-4030; Homaira, Nusrat/0000-0003-3341-7964; YOSHIDA, LAYMYINT/0000-0002-7567-3248; Moraleda, Cinta/0000-0002-8335-903X; Goyet, Sophie/0000-0002-1835-4478; Salimi, Vahid/0000-0002-8541-7846; Baillie, Vicky Lynne/0000-0003-1327-9090; Shi, Ting/0000-0002-4101-4535	Bill AMP; Melinda Gates Foundation; MRC [MC_U190088478] Funding Source: UKRI; Medical Research Council [MC_U190088478] Funding Source: researchfish; Wellcome Trust [102975/Z/13/Z, 098532/B/12/Z] Funding Source: researchfish; National Center for Immunization and Respiratory Diseases (NCIRD) [U01IP001048] Funding Source: NIH RePORTER	Bill AMP; Melinda Gates Foundation(CGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The Bill & Melinda Gates Foundation.	August A., 2015, RSV F VACCINE PHASE; Bigogo G, 2010, INT J INFECT DIS, V14, pE967, DOI 10.1016/j.ijid.2010.05.016; Chan PWK, 2003, ACTA PAEDIATR, V92, P481, DOI 10.1111/j.1651-2227.2003.tb00582.x; Department of Child and Adolescent Health, 2005, HDB IMCI INT MAN CHI; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Griffin MP, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01714-16, 10.1128/aac.01714-16]; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mazur N, 2015, LANCET RESP MED, V3, P888, DOI 10.1016/S2213-2600(15)00255-6; Modjarrad K, 2016, VACCINE, V34, P190, DOI 10.1016/j.vaccine.2015.05.093; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Marcone DN, 2013, PEDIATR INFECT DIS J, V32, pE105, DOI 10.1097/INF.0b013e31827cd06f; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Ram PK, 2014, AM J TROP MED HYG, V90, P968, DOI 10.4269/ajtmh.13-0532; Reis AD, 2008, REV INST MED TROP SP, V50, P37, DOI 10.1590/S0036-46652008000100008; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Ruckwardt TJ, 2016, CURR OPIN VIROL, V16, P151, DOI 10.1016/j.coviro.2016.01.003; Shi T, 2015, J GLOB HEALTH, V5, P203, DOI 10.7189/jogh.05.020416; Shi T, 2015, J GLOB HEALTH, V5, P122, DOI 10.7189/jogh.05.010408; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Theodoratou E, 2014, LANCET INFECT DIS, V14, P1250, DOI 10.1016/S1473-3099(14)70990-9; UNICEF, 2014, THE STATE OF THE WOR; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Weinberger DM, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001776; World Health Organization, 2015, WHO PROD DEV VACC AD; Zhang SS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010408	32	1115	1166	8	116	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 2	2017	390	10098					946	958		10.1016/S0140-6736(17)30938-8	http://dx.doi.org/10.1016/S0140-6736(17)30938-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF2SE	28689664	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000408746300024
J	Grohe, H				Groehe, Hermann			Together today for a healthy tomorrow-Germany's role in global health	LANCET			English	Editorial Material									[Groehe, Hermann] German Fed Minist Hlth, D-53107 Bonn, Germany		Grohe, H (corresponding author), German Fed Minist Hlth, D-53107 Bonn, Germany.	Hermann.Groehe@bmg.bund.de						Busse R, 2017, LANCET; Group of 20, 2017, BERL DECL G20 HLTH M; Kickbusch I, 2017, LANCET	3	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					831	832		10.1016/S0140-6736(17)31617-3	http://dx.doi.org/10.1016/S0140-6736(17)31617-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28684023	Bronze			2022-12-28	WOS:000408330700008
J	Gordon, WJ; Fairhall, A; Landman, A				Gordon, William J.; Fairhall, Adam; Landman, Adam			Threats to Information Security - Public Health Implications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gordon, William J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Gordon, William J.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Landman, Adam] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Gordon, William J.; Landman, Adam] Harvard Med Sch, Boston, MA 02115 USA; [Fairhall, Adam; Landman, Adam] Partners Healthcare, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System	Gordon, WJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Gordon, WJ (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Gordon, WJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Cox J, 2016, HACKER ADVERTISES SL; Healthcare IT News HIMSS Analytics, 2016, HIMSS AN HEALTHC IT; ICS-CERT, 2015, HOSP SYMB INF SYST V; Nigrin DJ, 2014, NEW ENGL J MED, V371, P393, DOI 10.1056/NEJMp1407326; Ponemon Institute, 2016, 6 ANN BENCHM STUD PR	5	22	23	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2017	377	8					707	709		10.1056/NEJMp1707212	http://dx.doi.org/10.1056/NEJMp1707212			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FJ9IS	28700269				2022-12-28	WOS:000413090000002
J	Ozorowski, G; Pallesen, J; de Val, N; Lyumkis, D; Cottrell, CA; Torres, JL; Copps, J; Stanfield, RL; Cupo, A; Pugach, P; Moore, JP; Wilson, IA; Ward, AB				Ozorowski, Gabriel; Pallesen, Jesper; de Val, Natalia; Lyumkis, Dmitry; Cottrell, Christopher A.; Torres, Jonathan L.; Copps, Jeffrey; Stanfield, Robyn L.; Cupo, Albert; Pugach, Pavel; Moore, John P.; Wilson, Ian A.; Ward, Andrew B.			Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike	NATURE			English	Article							CRYO-EM STRUCTURE; GP120; ANTIBODIES; VACCINE; LEGINON; SYSTEM; IMAGES; CLASSIFICATION; NEUTRALIZATION; GLYCOPROTEIN	For many enveloped viruses, binding to a receptor(s) on a host cell acts as the first step in a series of events culminating in fusion with the host cell membrane and transfer of genetic material for replication(1,2). The envelope glycoprotein (Env) trimer on the surface of HIV is responsible for receptor binding and fusion. Although Env can tolerate a high degree of mutation in five variable regions (V1-V5), and also at N-linked glycosylation sites that contribute roughly half the mass of Env, the functional sites for recognition of receptor CD4 and co-receptor CXCR4/CCR5 are conserved and essential for viral fitness. Soluble SOSIP Env trimers are structural and antigenic mimics of the pre-fusion native, surface-presented Env(3,4), and are targets of broadly neutralizing antibodies. Thus, they are attractive immunogens for vaccine development(5-8). Here we present high-resolution cryo-electron microscopy structures of subtype B B41 SOSIP Env trimers in complex with CD4 and antibody 17b, or with antibody b12, at resolutions of 3.7 angstrom and 3.6 angstrom, respectively. We compare these to cryo-electron microscopy reconstructions of B41 SOSIP Env trimers with no ligand or in complex with either CD4 or the CD4-binding-site antibody PGV04 at 5.6 angstrom, 5.2 angstrom and 7.4 angstrom resolution, respectively. Consequently, we present the most complete description yet, to our knowledge, of the CD4-17b-induced intermediate and provide the molecular basis of the receptor-binding-induced conformational change required for HIV-1 entry into host cells. Both CD4 and b12 induce large, previously uncharacterized conformational rearrangements in the gp41 subunits, and the fusion peptide becomes buried in a newly formed pocket. These structures provide key details on the biological function of the type I viral fusion machine from HIV-1 as well as new templates for inhibitor design.	[Ozorowski, Gabriel; Pallesen, Jesper; de Val, Natalia; Cottrell, Christopher A.; Torres, Jonathan L.; Copps, Jeffrey; Stanfield, Robyn L.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Ozorowski, Gabriel; Pallesen, Jesper; de Val, Natalia; Cottrell, Christopher A.; Torres, Jonathan L.; Copps, Jeffrey; Stanfield, Robyn L.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Salk Inst Biol Studies, Lab Genet, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Lyumkis, Dmitry] Salk Inst Biol Studies, Helmsley Ctr Genom Med, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Cupo, Albert; Pugach, Pavel; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [de Val, Natalia] NanoImaging Serv, 11099 North Torrey Pines Rd,Suite 250, La Jolla, CA 92037 USA	International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Salk Institute; Salk Institute; Cornell University; Scripps Research Institute	Ward, AB (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.; Ward, AB (corresponding author), Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA.	andrew@scripps.edu	Ward, Andrew B/F-9203-2014; Stanfield, Robyn/AAH-3190-2019; Ozorowski, Gabriel/HCH-0634-2022; de Val, Natalia/AAF-4822-2019; Ward, Andrew/ABD-7728-2021; Cottrell, Christopher A/P-3514-2015	Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Cottrell, Christopher A/0000-0002-3364-3083; Torres, Jonathan/0000-0003-0137-8497; Pallesen, Jesper/0000-0002-3270-1587	Center for HIV/AIDS Vaccine Immunology and Immunogen [UM1AI100663]; NIH HIVRAD [P01 AI110657]; NIH [R56 AI084817, P50 GM103368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084817, P01AI110657, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM103368] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology and Immunogen; NIH HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery Grant UM1AI100663 (I.A.W., A.B.W.), NIH HIVRAD Grant P01 AI110657 (I.A.W., J.P.M., A.B.W.), NIH Grant R56 AI084817 (I.A.W.), and NIH Grant P50 GM103368 (D.L.). This is manuscript #29422 of The Scripps Research Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anastasopoulou CG, 2011, VIROLOGY, V413, P47, DOI 10.1016/j.virol.2010.12.052; Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Lindemann D, 2013, ADV EXP MED BIOL, V790, P128, DOI 10.1007/978-1-4614-7651-1_7; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Lutteke T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-69; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang JZ, 2008, J BIOL CHEM, V283, P32644, DOI 10.1074/jbc.M806099200; Webb B., 2002, CURRENT PROTOCOLS IN; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	53	149	150	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					360	+		10.1038/nature23010	http://dx.doi.org/10.1038/nature23010			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28700571	Green Accepted			2022-12-28	WOS:000405844900036
J	Knowland, D; Lilascharoen, V; Pacia, CP; Shin, S; Wang, EHJ; Lim, BK				Knowland, Daniel; Lilascharoen, Varoth; Pacia, Christopher Pham; Shin, Sora; Wang, Eric Hou-Jen; Lim, Byung Kook			Distinct Ventral Pallidal Neural Populations Mediate Separate Symptoms of Depression	CELL			English	Article							PARVALBUMIN-CONTAINING NEURONS; SOCIAL DEFEAT STRESS; DORSAL RAPHE NUCLEUS; DOPAMINE NEURONS; ANTIDEPRESSANT ACTION; LATERAL HABENULA; BASAL FOREBRAIN; TEGMENTAL AREA; GABA NEURONS; REWARD	Major depressive disorder (MDD) patients display a common but often variable set of symptoms making successful, sustained treatment difficult to achieve. Separate depressive symptoms may be encoded by differential changes in distinct circuits in the brain, yet how discrete circuits underlie behavioral subsets of depression and how they adapt in response to stress has not been addressed. We identify two discrete circuits of parvalbumin-positive (PV) neurons in the ventral pallidum (VP) projecting to either the lateral habenula or ventral tegmental area contributing to depression. We find that these populations undergo different electrophysiological adaptations in response to social defeat stress, which are normalized by antidepressant treatment. Furthermore, manipulation of each population mediates either social withdrawal or behavioral despair, but not both. We propose that distinct components of the VP PV circuit can subserve related, yet separate depressive-like phenotypes in mice, which could ultimately provide a platform for symptom-specific treatments of depression.	[Knowland, Daniel; Lim, Byung Kook] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA; [Knowland, Daniel; Lilascharoen, Varoth; Pacia, Christopher Pham; Shin, Sora; Lim, Byung Kook] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Wang, Eric Hou-Jen; Lim, Byung Kook] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Lim, BK (corresponding author), Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA.; Lim, BK (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA.; Lim, BK (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.	bklim@ucsd.edu		Pacia, Christopher/0000-0003-1645-9222; Lim, Byungkook/0000-0002-3766-5415	Klingenstein foundation; Searle scholar program (Kinship foundation) [Searle 15-SSP-229]; Whitehall foundation [2014-08-63]; NARSAD young investigator grant [24094]; NIH [MH107742, MH108594]; Anandamahidol Foundation Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108594, R01MH107742] Funding Source: NIH RePORTER	Klingenstein foundation(Klingenstein Philanthropies); Searle scholar program (Kinship foundation); Whitehall foundation; NARSAD young investigator grant(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anandamahidol Foundation Fellowship; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank X. Wang for technical assistance and H. Pribiag and the Lim laboratory for comments on manuscript. This work was supported by the Klingenstein foundation, Searle scholar program (Kinship foundation; Searle 15-SSP-229), the Whitehall foundation (2014-08-63), NARSAD young investigator grant (24094), and grants from NIH (MH107742 and MH108594). V.L. is also supported by Anandamahidol Foundation Fellowship.	Adachi M, 2017, NEUROPSYCHOPHARMACOL, V42, P886, DOI 10.1038/npp.2016.201; Bagot RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8062; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; BRAUER K, 1993, BRAIN RES, V631, P167, DOI 10.1016/0006-8993(93)91205-7; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cetin A, 2014, J NEUROPHYSIOL, V111, P2150, DOI 10.1152/jn.00495.2013; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Christoffel DJ, 2015, NAT NEUROSCI, V18, P962, DOI 10.1038/nn.4034; Creed M, 2016, NEURON, V92, P214, DOI 10.1016/j.neuron.2016.09.001; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Franklin TB, 2012, NEURON, V75, P747, DOI 10.1016/j.neuron.2012.08.016; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Gaykema RPA, 1997, BRAIN RES, V747, P173, DOI 10.1016/S0006-8993(96)01309-1; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; HABER SN, 1985, J COMP NEUROL, V235, P322, DOI 10.1002/cne.902350304; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; HEIMER L, 1982, TRENDS NEUROSCI, V5, P83, DOI 10.1016/0166-2236(82)90037-6; Kato S, 2011, HUM GENE THER, V22, P197, DOI 10.1089/hum.2009.179; Kim EJ, 2016, CELL REP, V15, P692, DOI 10.1016/j.celrep.2016.03.067; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; KUO H, 1992, J COMP NEUROL, V321, P626, DOI 10.1002/cne.903210409; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Mahn M, 2016, NAT NEUROSCI, V19, P554, DOI 10.1038/nn.4266; Murrough JW, 2011, PSYCHOPHARMACOLOGY, V213, P547, DOI 10.1007/s00213-010-1881-0; Neumaier JF, 1996, NEUROPSYCHOPHARMACOL, V15, P515, DOI 10.1016/S0893-133X(96)00095-4; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Pascoli V, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.017; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Root DH, 2015, PROG NEUROBIOL, V130, P29, DOI 10.1016/j.pneurobio.2015.03.005; Rothwell PE, 2014, CELL, V158, P198, DOI 10.1016/j.cell.2014.04.045; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Smith KS, 2009, BEHAV BRAIN RES, V196, P155, DOI 10.1016/j.bbr.2008.09.038; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Walsh JJ, 2014, NAT NEUROSCI, V17, P27, DOI 10.1038/nn.3591; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Yamanaka H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.112; Zahm DS, 1996, J COMP NEUROL, V364, P340, DOI 10.1002/(SICI)1096-9861(19960108)364:2<340::AID-CNE11>3.0.CO;2-T	45	135	136	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					284	+		10.1016/j.cell.2017.06.015	http://dx.doi.org/10.1016/j.cell.2017.06.015			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28689640	Green Accepted, Bronze			2022-12-28	WOS:000405493900009
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: An economist explains why healthcare can't be treated as a market	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				ARROW KJ, 1963, AM ECON REV, V53, P941; Weinstein MM, 2017, NY TIMES	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2017	358								j3223	10.1136/bmj.j3223	http://dx.doi.org/10.1136/bmj.j3223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MO	28694319	Bronze, Green Published			2022-12-28	WOS:000405769900003
J	Hillenbrand, CD; Smith, JA; Hodell, DA; Greaves, M; Poole, CR; Kender, S; Williams, M; Andersen, TJ; Jernas, PE; Elderfield, H; Klages, JP; Roberts, SJ; Gohl, K; Larter, RD; Kuhn, G				Hillenbrand, Claus-Dieter; Smith, James A.; Hodell, David A.; Greaves, Mervyn; Poole, Christopher R.; Kender, Sev; Williams, Mark; Andersen, Thorbjorn Joest; Jernas, Patrycja E.; Elderfield, Henry; Klages, Johann P.; Roberts, Stephen J.; Gohl, Karsten; Larter, Robert D.; Kuhn, Gerhard			West Antarctic Ice Sheet retreat driven by Holocene warm water incursions	NATURE			English	Article							AMUNDSEN SEA EMBAYMENT; PINE ISLAND GLACIER; BENTHIC FORAMINIFERAL B/CA; GROUNDING-LINE RETREAT; SOUTHERN-OCEAN; WEDDELL SEA; PLANKTONIC-FORAMINIFERA; CONTINENTAL-MARGIN; ATLANTIC SECTOR; SHELF HISTORY	Glaciological and oceanographic observations coupled with numerical models show that warm Circumpolar Deep Water (CDW) incursions onto the West Antarctic continental shelf cause melting of the undersides of floating ice shelves. Because these ice shelves buttress glaciers feeding into them, their ocean-induced thinning is driving Antarctic ice-sheet retreat today. Here we present a multi-proxy data based reconstruction of variability in CDW inflow to the Amundsen Sea sector, the most vulnerable part of the West Antarctic Ice Sheet, during the Holocene epoch (from 11.7 thousand years ago to the present). The chemical compositions of foraminifer shells and benthic foraminifer assemblages in marine sediments indicate that enhanced CDW upwelling, controlled by the latitudinal position of the Southern Hemisphere westerly winds, forced deglaciation of this sector from at least 10,400 years ago until 7,500 years ago-when an ice-shelf collapse may have caused rapid ice-sheet thinning further upstream-and since the 1940s. These results increase confidence in the predictive capability of current ice-sheet models.	[Hillenbrand, Claus-Dieter; Smith, James A.; Roberts, Stephen J.; Larter, Robert D.] British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England; [Hodell, David A.; Greaves, Mervyn; Elderfield, Henry] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Poole, Christopher R.; Williams, Mark] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Poole, Christopher R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Kender, Sev] Univ Exeter, Camborne Sch Mines, Penryn TR10 9FE, Cornwall, England; [Kender, Sev] British Geol Survey, Nottingham NG12 5GG, England; [Andersen, Thorbjorn Joest] Univ Copenhagen, Dept Geosci & Nat Resource Management, Ctr Permafrost CENPERM, DK-1350 Copenhagen K, Denmark; [Jernas, Patrycja E.] Arctic Univ Norway, Univ Tromso, Dept Geosci, N-9037 Tromso, Norway; [Klages, Johann P.; Gohl, Karsten; Kuhn, Gerhard] Alfred Wegener Inst, Dept Geosci, Helmholtz Zentrum Polar & Meeresforsch, Alten Hafen 26, D-27568 Bremerhaven, Germany	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge; University of Leicester; University of London; University College London; University of Exeter; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Copenhagen; UiT The Arctic University of Tromso; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Hillenbrand, CD (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	hilc@bas.ac.uk	; Andersen, Thorbjorn Joest/N-7560-2014; Williams, Mark/B-7590-2009; Kender, Sev/B-9409-2016	Hodell, David/0000-0001-8537-1588; Andersen, Thorbjorn Joest/0000-0001-5032-9945; Gohl, Karsten/0000-0002-9558-2116; Williams, Mark/0000-0002-7987-6069; Roberts, Stephen/0000-0003-3407-9127; Poole, Christopher R./0000-0003-1401-3307; Greaves, Mervyn/0000-0001-8014-8627; Klages, Johann Philipp/0000-0003-0968-1183; Jernas, Patrycja Ewa/0000-0002-9012-1804; Kender, Sev/0000-0003-4216-3214; Kuhn, Gerhard/0000-0001-6069-7485	Natural Environment Research Council (NERC); NERC [NE/M013081/1]; Helmholtz Association; European Research Council (ERC) [2010-NEWLOG ADG-267931 HE]; NERC [bas0100030, nigl010001, NE/J006513/1] Funding Source: UKRI; Natural Environment Research Council [nigl010001, bas0100030, NE/M013081/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Helmholtz Association(Helmholtz Association); European Research Council (ERC)(European Research Council (ERC)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study is part of the Polar Science for Planet Earth Programme of the British Antarctic Survey and the PACES II (Polar Regions and Coasts in the changing Earth System) programme of the Alfred-Wegener-Institut. It was funded by the Natural Environment Research Council (NERC), NERC grant NE/M013081/1 and the Helmholtz Association. This work was also funded (in part) by The European Research Council (ERC grant 2010-NEWLOG ADG-267931 HE). We thank the captain, crew, shipboard scientists and support staff participating in RV Polarstern expeditions ANT-XXIII/4 and ANT-XXVI/3, and are grateful to R. Downey, T. Williams, V. Peck, H. Blagbrough, R. Frohlking and S. Wiebe for their assistance. Furthermore, we thank D. Hodgson, D. Vaughan and P. Dutrieux for discussions, and S. Schmidtko for providing data.	Appleby PG, 2002, DEV PALEOENVIRON RES, V1, P171; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Barrett P. J., 2007, ANTARCTIC DATA SERIE, V25, P1; Berberich D., 1996, POLAR RES, V195, P1; Bergami C, 2009, MAR MICROPALEONTOL, V73, P37, DOI 10.1016/j.marmicro.2009.06.007; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; BOLTON BR, 1988, MAR GEOL, V84, P53, DOI 10.1016/0025-3227(88)90125-9; Bonn WJ, 1998, PALAEOGEOGR PALAEOCL, V139, P195, DOI 10.1016/S0031-0182(97)00144-2; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000039; CHARLES CD, 1990, NATO ADV SCI I C-MAT, V308, P519; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; de Villiers S, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000169; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; DELANGE GJ, 1992, MAR GEOL, V109, P171, DOI 10.1016/0025-3227(92)90227-9; Dixon DA, 2012, INT J CLIMATOL, V32, P1455, DOI 10.1002/joc.2371; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; Duplessy JC, 2007, SCIENCE, V316, P89, DOI 10.1126/science.1138582; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Elderfield H, 2012, SCIENCE, V337, P704, DOI 10.1126/science.1221294; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Fudge TJ, 2013, NATURE, V500, P440, DOI 10.1038/nature12376; Gohl K., 2007, REP POLAR MAR RES, V557, P1; Gohl K., 2010, REP POLAR MAR RES, V617, P1; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Golledge NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6107; Greaves M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001974; Hasenfratz AP, 2017, EARTH PLANET SC LETT, V457, P335, DOI 10.1016/j.epsl.2016.10.004; Hein J.R., 2014, TREATISE GEOCHEMISTR, V13, P273, DOI [DOI 10.1016/B978-0-08-095975-7.01111-6, 10.1016/B978-0-08-095975-7.01111-6]; Hein JR., 1999, HDB MARINE MINERAL D, P239; Henrich R., 1989, Proceedings of the Ocean Drilling Program Scientific Results, V104, P189, DOI 10.2973/odp.proc.sr.104.116.1989; Hillenbrand CD, 2009, QUATERNARY SCI REV, V28, P1147, DOI 10.1016/j.quascirev.2008.12.010; Hillenbrand CD, 2013, GEOLOGY, V41, P35, DOI 10.1130/G33469.1; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Ishman S. E., 2007, ONL P 10 ISAES 10; Ishman SE, 2003, ANTARCT RES SER, V79, P239; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Johnson JS, 2014, SCIENCE, V343, P999, DOI 10.1126/science.1247385; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; Kilfeather AA, 2011, GEOL SOC AM BULL, V123, P997, DOI 10.1130/B30282.1; Kirshner AE, 2012, QUATERNARY SCI REV, V38, P11, DOI 10.1016/j.quascirev.2012.01.017; Koffman BG, 2014, CLIM PAST, V10, P1125, DOI 10.5194/cp-10-1125-2014; Kohfeld KE, 1996, PALEOCEANOGRAPHY, V11, P679, DOI 10.1029/96PA02617; Kohfeld KE, 2000, PALEOCEANOGRAPHY, V15, P53, DOI 10.1029/1999PA900049; Larter RD, 2014, QUATERNARY SCI REV, V100, P55, DOI 10.1016/j.quascirev.2013.10.016; Mackensen A, 2004, SOUTH ATLANTIC IN THE LATE QUATERNARY: RECONSTRUCTION OF MATERIAL BUDGETS AND CURRENT SYSTEMS, P623; MACKENSEN A, 1990, MAR MICROPALEONTOL, V16, P241, DOI 10.1016/0377-8398(90)90006-8; Mackensen A, 2001, GLOBAL PLANET CHANGE, V30, P197, DOI 10.1016/S0921-8181(01)00102-3; Mackensen A, 2001, DEEP-SEA RES PT I, V48, P1401, DOI 10.1016/S0967-0637(00)00093-5; Mackensen A, 2000, MAR MICROPALEONTOL, V40, P233, DOI 10.1016/S0377-8398(00)00040-2; Mackensen A, 2012, EARTH PLANET SC LETT, V317, P20, DOI 10.1016/j.epsl.2011.11.030; McGlone MS, 2010, NAT GEOSCI, V3, P622, DOI 10.1038/NGEO931; Melis R, 2009, MAR MICROPALEONTOL, V70, P39, DOI 10.1016/j.marmicro.2008.10.003; Mikhalevich VI, 2004, MICROPALEONTOLOGY, V50, P179, DOI 10.2113/50.2.179; Misra S, 2014, GEOCHEM GEOPHY GEOSY, V15, P1617, DOI 10.1002/2013GC005049; Mouginot J, 2014, GEOPHYS RES LETT, V41, P1576, DOI 10.1002/2013GL059069; Murray J.W., 1971, ATLAS BRIT RECENT FO; Murray JW, 2000, J MICROPALAEONTOL, V19, P44, DOI 10.1144/jm.19.1.44; Murray JW, 2004, MAR MICROPALEONTOL, V53, P67, DOI 10.1016/j.marmicro.2004.04.001; Nicholls KW, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002302; Nurnberg CC, 1997, PALEOCEANOGRAPHY, V12, P594, DOI 10.1029/97PA01130; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Peck VL, 2015, QUATERNARY SCI REV, V119, P54, DOI 10.1016/j.quascirev.2015.04.002; Pena LD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002018; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Pollard D, 2016, GEOSCI MODEL DEV, V9, P1697, DOI 10.5194/gmd-9-1697-2016; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Poole C., 2012, THESIS; Pudsey CJ, 2006, QUATERNARY SCI REV, V25, P2357, DOI 10.1016/j.quascirev.2006.01.029; Randall-Goodwin E, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000065; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richter TO, 2006, GEOL SOC SPEC PUBL, V267, P39, DOI 10.1144/GSL.SP.2006.267.01.03; Rickaby REM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001762; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rosenthal Y, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000650; Schiebel Ralf, 2005, Palaeontologische Zeitschrift, V79, P135; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schweizer M, 2005, MAR MICROPALEONTOL, V57, P51, DOI 10.1016/j.marmicro.2005.07.001; Schweizer M, 2011, CR PALEVOL, V10, P95, DOI 10.1016/j.crpv.2011.01.003; Shevenell AE, 2011, NATURE, V470, P250, DOI 10.1038/nature09751; Smith JA, 2017, NATURE, V541, P77, DOI 10.1038/nature20136; Smith JA, 2014, GLOBAL PLANET CHANGE, V122, P224, DOI 10.1016/j.gloplacha.2014.07.015; Steig EJ, 2012, ANN GLACIOL, V53, P19, DOI 10.3189/2012AoG60A110; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; Sutterley TC, 2014, GEOPHYS RES LETT, V41, P8421, DOI 10.1002/2014GL061940; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Toscano MA, 2011, QUATERNARY SCI REV, V30, P3032, DOI 10.1016/j.quascirev.2011.07.018; VILKS G, 1975, Journal of Foraminiferal Research, V5, P313; Wahlin AK, 2013, J PHYS OCEANOGR, V43, P2054, DOI 10.1175/JPO-D-12-0157.1; Weltje GJ, 2008, EARTH PLANET SC LETT, V274, P423, DOI 10.1016/j.epsl.2008.07.054; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Yu JM, 2007, EARTH PLANET SC LETT, V258, P73, DOI 10.1016/j.epsl.2007.03.025; Yu JM, 2010, EARTH PLANET SC LETT, V293, P114, DOI 10.1016/j.epsl.2010.02.029; Yu JM, 2008, EARTH PLANET SC LETT, V276, P129, DOI 10.1016/j.epsl.2008.09.015	97	69	72	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					43	+		10.1038/nature22995	http://dx.doi.org/10.1038/nature22995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682333	Green Accepted, Green Submitted			2022-12-28	WOS:000404839900028
J	Zabala-Letona, A; Arruabarrena-Aristorena, A; Martin-Martin, N; Fernandez-Ruiz, S; Sutherland, JD; Clasquin, M; Tomas-Cortazar, J; Jimenez, J; Torres, I; Quang, P; Ximenez-Embun, P; Bago, R; Galde-Olano, AU; Oizaga-Iriarte, AL; Acasa-Viscasillas, IL; Nda, MU; Torrano, V; Cabrera, D; van Liempd, SM; Cendon, Y; Castro, E; Murray, S; Revandkar, A; Alimonti, A; Zhang, YN; Barnett, A; Lein, G; Pirman, D; Cortazar, AR; Arreal, L; Prudkin, L; Astobiza, I; Valcarcel-Jimenez, L; Zuniga-Garcia, P; Fernandez-Dominguez, I; Piva, M; Caro-Maldonado, A; Sanchez-Mosquera, P; Castillo-Martin, M; Serra, V; Beraza, N; Gentilella, A; Thomas, G; Azkargorta, M; Elortza, F; Farras, R; Olmos, D; Efeyan, A; Anguita, J; Munoz, J; Falcon-Perez, JM; Barrio, R; Macarulla, T; Mato, JM; Martinez-Chantar, ML; Cordon-Cardo, C; Aransay, AM; Marks, K; Baselga, J; Tabernero, J; Nuciforo, P; Manning, BD; Marjon, K; Carracedo, A				Zabala-Letona, Amaia; Arruabarrena-Aristorena, Amaia; Martin-Martin, Natalia; Fernandez-Ruiz, Sonia; Sutherland, James D.; Clasquin, Michelle; Tomas-Cortazar, Julen; Jimenez, Jose; Torres, Ines; Phong Quang; Ximenez-Embun, Pilar; Bago, Ruzica; Galde-Olano, Aitziber U.; Oizaga-Iriarte, Ana L.; Acasa-Viscasillas, Isabel L.; Nda, Miguel U.; Torrano, Veronica; Cabrera, Diana; van Liempd, Sebastiaan M.; Cendon, Ylenia; Castro, Elena; Murray, Stuart; Revandkar, Ajinkya; Alimonti, Andrea; Zhang, Yinan; Barnett, Amelia; Lein, Gina; Pirman, David; Cortazar, Ana R.; Arreal, Leire; Prudkin, Ludmila; Astobiza, Ianire; Valcarcel-Jimenez, Lorea; Zuniga-Garcia, Patricia; Fernandez-Dominguez, Itziar; Piva, Marco; Caro-Maldonado, Alfredo; Sanchez-Mosquera, Pilar; Castillo-Martin, Mireia; Serra, Violeta; Beraza, Naiara; Gentilella, Antonio; Thomas, George; Azkargorta, Mikel; Elortza, Felix; Farras, Rosa; Olmos, David; Efeyan, Alejo; Anguita, Juan; Munoz, Javier; Falcon-Perez, Juan M.; Barrio, Rosa; Macarulla, Teresa; Mato, Jose M.; Martinez-Chantar, Maria L.; Cordon-Cardo, Carlos; Aransay, Ana M.; Marks, Kevin; Baselga, Jose; Tabernero, Josep; Nuciforo, Paolo; Manning, Brendan D.; Marjon, Katya; Carracedo, Arkaitz			mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer	NATURE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; SOLID TUMORS; PHASE-I; BIOSYNTHESIS INHIBITOR; CELLULAR SENESCENCE; PTEN; PATHWAY; CELLS; GROWTH; LEADS	Activation of the PTEN-PI3K-mTORC1 pathway consolidates metabolic programs that sustain cancer cell growth and proliferation(1,2). Here we show that mechanistic target of rapamycin complex 1 (mTORC1) regulates polyamine dynamics, a metabolic route that is essential for oncogenicity. By using integrative metabolomics in a mouse model(3) and human biopsies(4) of prostate cancer, we identify alterations in tumours affecting the production of decarboxylated S-adenosylmethionine (dcSAM) and polyamine synthesis. Mechanistically, this metabolic rewiring stems from mTORC1-dependent regulation of S-adenosylmethionine decarboxylase 1 (AMD1) stability. This novel molecular regulation is validated in mouse and human cancer specimens. AMD1 is upregulated in human prostate cancer with activated mTORC1. Conversely, samples from a clinical trial with the mTORC1 inhibitor everolimus(5) exhibit a predominant decrease in AMD1 immunoreactivity that is associated with a decrease in proliferation, in line with the requirement of dcSAM production for oncogenicity. These findings provide fundamental information about the complex regulatory landscape controlled by mTORC1 to integrate and translate growth signals into an oncogenic metabolic program.	[Zabala-Letona, Amaia; Arruabarrena-Aristorena, Amaia; Martin-Martin, Natalia; Fernandez-Ruiz, Sonia; Sutherland, James D.; Tomas-Cortazar, Julen; Torrano, Veronica; Cabrera, Diana; van Liempd, Sebastiaan M.; Cortazar, Ana R.; Arreal, Leire; Astobiza, Ianire; Valcarcel-Jimenez, Lorea; Zuniga-Garcia, Patricia; Fernandez-Dominguez, Itziar; Piva, Marco; Caro-Maldonado, Alfredo; Sanchez-Mosquera, Pilar; Beraza, Naiara; Azkargorta, Mikel; Elortza, Felix; Anguita, Juan; Falcon-Perez, Juan M.; Barrio, Rosa; Mato, Jose M.; Martinez-Chantar, Maria L.; Aransay, Ana M.; Carracedo, Arkaitz] CIC bioGUNE, Bizkaia Technology Pk,801 Bldg, Derio 48160, Spain; [Zabala-Letona, Amaia; Martin-Martin, Natalia; Fernandez-Ruiz, Sonia; Macarulla, Teresa; Tabernero, Josep; Carracedo, Arkaitz] Inst Salud Carlos III, CIBERONC, C Monforte Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain; [Clasquin, Michelle; Phong Quang; Murray, Stuart; Barnett, Amelia; Lein, Gina; Pirman, David; Marjon, Katya] AGIOS Pharmaceut, Cambridge, MA 02139 USA; [Jimenez, Jose; Prudkin, Ludmila; Serra, Violeta; Macarulla, Teresa; Tabernero, Josep; Nuciforo, Paolo] Univ Autonoma Barcelona, VHIO, Barcelona 08035, Spain; [Torres, Ines] Univ Autonoma Barcelona, ValldHebron Hosp, Dept Pathol, Barcelona 08035, Spain; [Ximenez-Embun, Pilar; Cendon, Ylenia; Castro, Elena; Olmos, David; Efeyan, Alejo; Munoz, Javier] Spanish Natl Canc Res Ctr CNIO, Madrid 28029, Spain; [Bago, Ruzica] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dow St, Dundee DD1 5EH, Scotland; [Galde-Olano, Aitziber U.] Basurto Univ Hosp, Dept Pathol, Bilbao 48013, Spain; [Oizaga-Iriarte, Ana L.; Acasa-Viscasillas, Isabel L.; Nda, Miguel U.] Basurto Univ Hosp, Dept Urol, Bilbao 48013, Spain; [Cendon, Ylenia] Univ Autonoma Madrid, Sch Med, Madrid 28049, Spain; [Revandkar, Ajinkya; Alimonti, Andrea] IOR, CH-6500 Bellinzona, Switzerland; [Revandkar, Ajinkya; Alimonti, Andrea] Oncol Inst Southern Switzerland IOSI, CH-6500 Bellinzona, Switzerland; [Alimonti, Andrea] Univ Lausanne UNIL, Fac Biol & Med, CH-1011 Lausanne, Switzerland; [Zhang, Yinan; Manning, Brendan D.] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Castillo-Martin, Mireia; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Castillo-Martin, Mireia] Fundacao Champalimaud, Dept Pathol, P-1400038 Lisbon, Portugal; [Gentilella, Antonio; Thomas, George] Catalan Inst Oncol, ICO, Bellvitge Biomed Res Inst, IDIBELL,Lab Metab & Canc, Barcelona 08908, Spain; [Gentilella, Antonio] Univ Barcelona, Fac Pharm, Dept Biochem & Physiol, Barcelona 08028, Catalunya, Spain; [Azkargorta, Mikel; Elortza, Felix] Inst Salud Carlos III, Carlos Networked Prote Platform ProteoRed ISCIII, C Monforte Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain; [Elortza, Felix; Falcon-Perez, Juan M.; Mato, Jose M.; Martinez-Chantar, Maria L.; Aransay, Ana M.] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, C Monforte Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain; [Farras, Rosa] Ctr Invest Principe Felipe, Eduardo Primo Yufera 3, Valencia 46012, Spain; [Olmos, David] Hosp Univ Virgen de la Victoria & Reg Malaga, Med Oncol Dept, CNIO IBIMA Genitourinary Canc Unit, Malaga 29010, Spain; [Anguita, Juan; Falcon-Perez, Juan M.; Carracedo, Arkaitz] Ikerbasque, Basque Fdn Sci, Bilbao 48011, Spain; [Baselga, Jose] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Carracedo, Arkaitz] Univ Basque Country UPV EHU, Biochem & Mol Biol Dept, Bilbao 48940, Spain; [Beraza, Naiara] Inst Food Res, Gut Hlth & Food Safety Programme, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England	CIC bioGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; Agios Pharmaceuticals; Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Dundee; Basurto Hospital; Basurto Hospital; Autonomous University of Madrid; Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR); University of Lausanne; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai; Fundacao Champalimaud; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Prince Felipe Research Center; Basque Foundation for Science; Memorial Sloan Kettering Cancer Center; University of Basque Country; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Carracedo, A (corresponding author), CIC bioGUNE, Bizkaia Technology Pk,801 Bldg, Derio 48160, Spain.; Carracedo, A (corresponding author), Inst Salud Carlos III, CIBERONC, C Monforte Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain.; Carracedo, A (corresponding author), Ikerbasque, Basque Fdn Sci, Bilbao 48011, Spain.; Carracedo, A (corresponding author), Univ Basque Country UPV EHU, Biochem & Mol Biol Dept, Bilbao 48940, Spain.	acarracedo@cicbiogune.es	Olmos, David/L-5664-2015; Zabala, Amaia/AAA-4172-2019; Torrano Moya, Veronica/D-3285-2014; unda, miguel/AAP-8322-2021; Nuciforo, Paolo/Q-2885-2019; Fernández-Domínguez, Itziar/AAB-3478-2019; Piva, Marco/F-2748-2019; Elortza, Felix/ABG-4183-2020; Tabernero, Josep/AAG-5026-2019; Macarulla, Teresa/AAG-9230-2019; Valcarcel, Lorea/F-6747-2017; Carracedo, Arkaitz/F-7029-2011; unda, miguel/D-7532-2012; Efeyan, Alejo/J-8197-2016; Sutherland, James D/K-2686-2014; Arruabarrena-Aristorena, Amaia/N-1858-2015; García, Patricia Zúñiga/G-4756-2016; Anguita, Juan/D-5432-2011; Astobiza, Ianire/AAA-4265-2019; Castro, Elena/F-1492-2018; Azkargorta, Mikel/AAA-8047-2019; Munoz, Javier/I-4891-2012; MATO, JOSE/A-5187-2011; Arreal, Leire/AAA-4122-2019; Chantar, Maria Luz Martinez/F-5190-2011; Cortazar, Ana Rosa/AAA-4463-2019; Falcon-Perez, Juan M/F-5920-2011; Tomás-Cortázar, Julen/AAN-8237-2021; Serra, Violeta/AAG-8328-2019; Manning, Brendan/ABD-6528-2021; Gentilella, Antonio/AAA-9864-2020; Aransay, Ana M./F-8086-2011; Blanco, Leire/O-5114-2017; Farràs, Rosa/B-5180-2014; Barrio, Rosa/F-8712-2011; Arruabarrena-Aristorena, Amaia/K-6790-2019; van Liempd, Sebastiaan/K-5740-2014	Zabala, Amaia/0000-0003-2088-5195; unda, miguel/0000-0003-2849-9459; Tabernero, Josep/0000-0002-2495-8139; Valcarcel, Lorea/0000-0002-7309-9924; Carracedo, Arkaitz/0000-0001-5957-1260; unda, miguel/0000-0003-2849-9459; Efeyan, Alejo/0000-0002-3806-6799; Sutherland, James D/0000-0003-3229-793X; Arruabarrena-Aristorena, Amaia/0000-0002-1636-3944; García, Patricia Zúñiga/0000-0002-6167-4063; Anguita, Juan/0000-0003-2061-7182; Astobiza, Ianire/0000-0002-7142-7066; Castro, Elena/0000-0002-3691-6454; Munoz, Javier/0000-0003-3288-3496; MATO, JOSE/0000-0003-1264-3153; Arreal, Leire/0000-0001-7195-6526; Chantar, Maria Luz Martinez/0000-0002-6446-9911; Cortazar, Ana Rosa/0000-0002-7082-5695; Manning, Brendan/0000-0003-3895-5956; Aransay, Ana M./0000-0002-8271-612X; Farràs, Rosa/0000-0003-4931-1494; Barrio, Rosa/0000-0002-9663-0669; Arruabarrena-Aristorena, Amaia/0000-0002-1636-3944; CABRERA, DIANA/0000-0001-8468-1875; Cendon Florez, Ylenia/0000-0001-7525-7407; Alimonti, Andrea/0000-0002-9362-2313; van Liempd, Sebastiaan/0000-0003-0285-5670; Falcon-Perez, Juan M/0000-0003-3133-0670; Jimenez, Jose/0000-0002-2576-1776; Torrano, Veronica/0000-0002-4252-1977; Piva, Marco/0000-0001-6906-6065; Tomas Cortazar, Julen/0000-0002-0812-0395; Serra, Violeta/0000-0001-6620-1065; Elortza, Felix/0000-0001-8839-5438; Nuciforo, Paolo/0000-0003-1380-0990; Beraza, Naiara/0000-0003-0718-0940; Ximenez-Embun, Pilar/0000-0002-2582-9443; Macarulla, Teresa/0000-0002-5856-4082; Olmos Hidalgo, David/0000-0002-7003-4826	Ramon y Cajal award; Juan de la Cierva; BFU grant [BFU2014-52282-P, BFU2011-25986]; SAF grant (FEDER/EU) [SAF2016-79381-R]; SAF grant from Spanish Ministry of Economy, Industry and Competitiveness (MINECO) [SAF2014-54658-R, SAF2015-66312, SAF 2014-52097R, SAF2015-67538-R, SAF2015-65327R, SAF2011-24967]; European Union [ERC-StG-336343, PoC754627, CIG 660191, 602272, ERC-2014-STG-638891]; Basque Government Department of Health [2016111109, 2015111149]; Department of Education [PI2012/03, IKERTALDE I.T.1106-16, PI2012/42]; PhD grants; AECC; ISCIII [PI10/01484, PI13/00031, PT13/0001, PI15/209, PI13/01714, CP14/00228]; Ramon Areces foundation; Basque Department of Industry, Tourism and Trade (Etortek); FERO Foundation; Fundacion Vasca de Innovacion e Investigacion Sanitarias; BIOEF [BIO15/CA/052]; BBVA Foundation; National Institutes of Health [P01CA087497, R01AT001576]; Fundacion CRIS contra el Cancer; Stewart Rahr Young Investigator Award from Prostate Cancer Foundation; FPU predoctoral fellowship [15/05126]; Catalan Agency AGAUR [2014 SGR 1331]; Medical Research Council [MC_UU_12016/2]; FEDER funds; MRC [MC_UU_12016/2] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R35CA197459, P01CA087497, P30CA008748] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT001576] Funding Source: NIH RePORTER	Ramon y Cajal award(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); BFU grant; SAF grant (FEDER/EU); SAF grant from Spanish Ministry of Economy, Industry and Competitiveness (MINECO); European Union(European Commission); Basque Government Department of Health(Basque Government); Department of Education(US Department of Education); PhD grants; AECC; ISCIII(Instituto de Salud Carlos III); Ramon Areces foundation; Basque Department of Industry, Tourism and Trade (Etortek); FERO Foundation; Fundacion Vasca de Innovacion e Investigacion Sanitarias; BIOEF; BBVA Foundation(BBVA Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion CRIS contra el Cancer; Stewart Rahr Young Investigator Award from Prostate Cancer Foundation; FPU predoctoral fellowship(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Catalan Agency AGAUR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FEDER funds(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Sonenberg for providing 4EBP1- and 4EBP2-targeting shRNAs, D. Alessi for discussions and technical advice, A.M. Cuervo and E. Arias-Perez for technical advice, the Basque biobank for research (BIOEF) for critical support with human specimens and Novartis for providing SAM486A. Funding: Ramon y Cajal award (to A.C., A.E., J.M., D.O.), Juan de la Cierva (to E.C., A.C.-M.), BFU grant (to R.B.: BFU2014-52282-P and BFU2011-25986), SAF grant (to A.C.: SAF2016-79381-R, FEDER/EU; M.L.M.-C.: SAF2014-54658-R; to J.M. F.-P.: SAF2015-66312; to J.M.M: SAF 2014-52097R; to A. E.: SAF2015-67538-R; to J.A.: SAF2015-65327R; to G.T.: SAF2011-24967) from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO); European Union (to A. C.: ERC-StG-336343, PoC754627; to A.C.-M.: CIG 660191; to J.A.: 602272; to A. E.: ERC-2014-STG-638891); Basque Government Department of Health (to V.T.: 2016111109; to J.M. F.-P: 2015111149), Department of Education (to A. C.: PI2012/03 and IKERTALDE I.T.1106-16; to R.B.: PI2012/42; to M.L.M.-C.: 2013) and PhD grants (to A. A.-A. and L.V.-J.); AECC (to V.T.: 2016 JP Bizkaia; to N. M.-M.: 2011 JP Bizkaia; to M.L.M.-C.); ISCIII (to A. C.: PI10/01484, PI13/00031; to J.M.: Proteored PR.B.2 and grant PT13/0001; to R.F.: PI15/209; to V.S.: PI13/01714, CP14/00228); Ramon Areces foundation (to J.M. F.-P.); Basque Department of Industry, Tourism and Trade (Etortek) (to A.C.); FERO Foundation (to A. C., V.S.); Fundacion Vasca de Innovacion e Investigacion Sanitarias, BIOEF (to V.T.: BIO15/CA/052); BBVA Foundation (to A. C.; P.N. team); National Institutes of Health (to C. C.-C. and M.C.: P01CA087497; to J.M.M.: R01AT001576); Fundacion CRIS contra el Cancer (to D.O. team); 2014 Stewart Rahr Young Investigator Award from the Prostate Cancer Foundation (to D.O.); FPU predoctoral fellowship (to Y.C.: 15/05126); Catalan Agency AGAUR (to V.S.: 2014 SGR 1331); Medical Research Council (to R. Bago, D. Alessi laboratory: grant number MC_UU_12016/2). The activity of CIBERONC was co-funded with FEDER funds.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Eskens FALM, 2000, CLIN CANCER RES, V6, P1736; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Fumagalli S, 2012, GENE DEV, V26, P1028, DOI 10.1101/gad.189951.112; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang ZB, 2015, FUTURE ONCOL, V11, P1687, DOI 10.2217/fon.15.70; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Marjon K, 2016, CELL REP, V15, P574, DOI 10.1016/j.celrep.2016.03.043; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Motameni ART, 2004, INFECT IMMUN, V72, P3638, DOI 10.1128/IAI.72.6.3638-3642.2004; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Origanti S, 2012, BIOCHEM J, V442, P199, DOI 10.1042/BJ20111464; Ouyang DY, 2013, AUTOPHAGY, V9, P20, DOI 10.4161/auto.22397; Paridaens R, 2000, BRIT J CANCER, V83, P594, DOI 10.1054/bjoc.2000.1305; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; REGENASS U, 1994, CANCER RES, V54, P3210; Revandkar A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13719; Salazar M, 2015, CELL DEATH DIFFER, V22, P131, DOI 10.1038/cdd.2014.133; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Serra H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8935; Shlomi T, 2014, ANAL CHEM, V86, P1583, DOI 10.1021/ac4032093; Siu LL, 2002, CLIN CANCER RES, V8, P2157; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Torrano V, 2016, NAT CELL BIOL, V18, P645, DOI 10.1038/ncb3357; Ugalde-Olano A, 2015, METHODS, V77-78, P25, DOI 10.1016/j.ymeth.2015.02.005; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xiong HS, 1999, J BIOL CHEM, V274, P35059, DOI 10.1074/jbc.274.49.35059; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	49	100	102	6	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					109	+		10.1038/nature22964	http://dx.doi.org/10.1038/nature22964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658205	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000404839900040
J	Trubiano, JA; Adkinson, NF; Phillips, EJ				Trubiano, Jason A.; Adkinson, N. Franklin; Phillips, Elizabeth Jane			Penicillin Allergy Is Not Necessarily Forever	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CEPHALOSPORINS		[Trubiano, Jason A.] Austin Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Trubiano, Jason A.] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia; [Adkinson, N. Franklin] John Hopkins Asthma & Allergy Ctr, Baltimore, MD USA; [Phillips, Elizabeth Jane] Vanderbilt Univ, Dept Med, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA; [Phillips, Elizabeth Jane] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Vanderbilt University; Murdoch University	Phillips, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Oates Inst Expt Therapeut, 1161 21st Ave S,A-2200 Med Ctr N, Nashville, TN 37232 USA.	elizabeth.j.phillips@vanderbilt.edu		Trubiano, Jason/0000-0002-5111-6367	National Health and Medical Research Council of Australia (NHMRC); Biocryst; Aicuris; National Institutes of Health; NHMRC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Biocryst; Aicuris; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trubiano reports receipt of support from a National Health and Medical Research Council of Australia (NHMRC) postgraduate research scholarship. Dr Adkinson reports being a founding partner in Allerquest. Dr Phillips reports receipt of consultancy fees from Biocryst and Aicuris, grants from the National Institutes of Health and the NHMRC, and royalties from Uptodate. No other disclosures were reported.	Blumenthal KG, 2017, J ALLERG CLIN IMMUNO; Bourke J, 2015, J ALLER CL IMM-PRACT, V3, P365, DOI 10.1016/j.jaip.2014.11.002; Campagna JD, 2012, J EMERG MED, V42, P612, DOI 10.1016/j.jemermed.2011.05.035; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; GADDE J, 1993, JAMA-J AM MED ASSOC, V270, P2456, DOI 10.1001/jama.270.20.2456; Kula B, 2014, CLIN INFECT DIS, V59, P1113, DOI 10.1093/cid/ciu587; Macy E, 2014, J ALLERGY CLIN IMMUN, V133, P790, DOI 10.1016/j.jaci.2013.09.021; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Solensky R, 2002, ARCH INTERN MED, V162, P822, DOI 10.1001/archinte.162.7.822; Trubiano JA, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw153	10	95	95	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					82	83		10.1001/jama.2017.6510	http://dx.doi.org/10.1001/jama.2017.6510			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672303	Green Accepted			2022-12-28	WOS:000404717700017
J	Wysham, C; Bhargava, A; Chaykin, L; de la Rosa, R; Handelsman, Y; Troelsen, LN; Kvist, K; Norwood, P				Wysham, Carol; Bhargava, Anuj; Chaykin, Louis; de la Rosa, Raymond; Handelsman, Yehuda; Troelsen, Lone N.; Kvist, Kajsa; Norwood, Paul			Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes The SWITCH 2 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TO-TARGET TRIAL; NPH INSULIN; GLUCOSE CONTROL; BASAL INSULIN; ASSOCIATION; THERAPY; DETEMIR; PEOPLE; METAANALYSIS; FREQUENCY	IMPORTANCE Hypoglycemia, a serious risk for insulin-treated patients with type 2 diabetes, negatively affects glycemic control. OBJECTIVE To test whether treatment with basal insulin degludec is associated with a lower rate of hypoglycemia compared with insulin glargine U100 in patients with type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, treat-to-target crossover trial including two 32-week treatment periods, each with a 16-week titration period and a 16-week maintenance period. The trial was conducted at 152 US centers between January 2014 and December 2015 in 721 adults with type 2 diabetes and at least 1 hypoglycemia risk factor who were previously treated with basal insulin with or without oral antidiabetic drugs. INTERVENTIONS Patients were randomized 1: 1 to receive once-daily insulin degludec followed by insulin glargine U100(n = 361) or to receive insulin glargine U100 followed by insulin degludec (n = 360) and randomized 1: 1 to morning or evening dosing within each treatment sequence. MAIN OUTCOMES AND MEASURES The primary end point was the rate of overall symptomatic hypoglycemic episodes (severe or blood glucose confirmed [<56mg/dL]) during the maintenance period. Secondary end points were the rate of nocturnal symptomatic hypoglycemic episodes (severe or blood glucose confirmed, occurring between 12: 01 AM and 5: 59 AM) and the proportion of patients with severe hypoglycemia during the maintenance period. RESULTS Of the 721 patients randomized (mean [SD] age, 61.4 [10.5] years; 53.1% male), 580 (80.4%) completed the trial. During the maintenance period, the rates of overall symptomatic hypoglycemia for insulin degludec vs insulin glargine U100 were 185.6 vs 265.4 episodes per 100 patient-years of exposure (PYE) (rate ratio = 0.70 [95% CI, 0.61-0.80]; P <.001; difference, -23.66 episodes/100 PYE [95% CI, -33.98 to -13.33]), and the proportions of patients with hypoglycemic episodes were 22.5% vs 31.6%(difference, -9.1% [95% CI, -13.1% to -5.0%]). The rates of nocturnal symptomatic hypoglycemia with insulin degludec vs insulin glargine U100 were 55.2 vs 93.6 episodes/100 PYE (rate ratio = 0.58 [95% CI, 0.46-0.74]; P <.001; difference, -7.41 episodes/100 PYE [95% CI, -11.98 to -2.85]), and the proportions of patients with hypoglycemic episodes were 9.7% vs 14.7%(difference, -5.1%[95% CI, -8.1% to -2.0%]). The proportions of patients experiencing severe hypoglycemia during the maintenance period were 1.6%(95% CI, 0.6%-2.7%) for insulin degludec vs 2.4%(95% CI, 1.1%-3.7%) for insulin glargine U100 (McNemar P =.35; risk difference, -0.8%[95% CI, -2.2% to 0.5%]). Statistically significant reductions in overall and nocturnal symptomatic hypoglycemia for insulin degludec vs insulin glargine U100 were also seen for the full treatment period. CONCLUSIONS AND RELEVANCE Among patients with type 2 diabetes treated with insulin and with at least 1 hypoglycemia risk factor, 32 weeks' treatment with insulin degludec vs insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemia.	[Wysham, Carol] Univ Washington, Rockwood Clin, Sch Med, Spokane, WA USA; [Bhargava, Anuj] Iowa Diabet & Endocrinol Res Ctr, Des Moines, IA USA; [Chaykin, Louis] Meridien Res, Bradenton, FL USA; [de la Rosa, Raymond] Paducah Endocrinol, Paducah, KY USA; [Handelsman, Yehuda] Metab Inst Amer, Tarzana, CA USA; [Troelsen, Lone N.] Novo Nordisk, Med & Sci, Soborg, Denmark; [Kvist, Kajsa] Novo Nordisk, Biostat Insulin & Diabet Outcomes, Soborg, Denmark; [Norwood, Paul] Valley Res, Fresno, CA USA	University of Washington; Washington State University; Novo Nordisk; Novo Nordisk	Wysham, C (corresponding author), Rockwood Clin, 400 E Fifth Ave,Ste 4N, Spokane, WA 99202 USA.	chwysham@comcast.net	Norwood, Paul/L-6088-2019		Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was supported by Novo Nordisk.	[Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; [Anonymous], 1996, ICH HARM TRIP GUID G; Becker RHA, 2015, DIABETES CARE, V38, P637, DOI 10.2337/dc14-0006; Childs BP, 2005, DIABETES CARE, V28, P1245; Curkendall SM, 2011, J CLIN OUTCOMES MANA, V18, P455; Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x; Frier BM, 2008, DIABETES-METAB RES, V24, P87, DOI 10.1002/dmrr.796; Garber AJ, 2012, LANCET, V379, P1498, DOI 10.1016/S0140-6736(12)60205-0; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Haahr H, 2014, CLIN PHARMACOKINET, V53, P787, DOI 10.1007/s40262-014-0165-y; Hammer Mette, 2009, J Med Econ, V12, P281, DOI 10.3111/13696990903336597; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Leiter LA., 2005, CAN J DIABETES, V29, P186; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Philis-Tsimikas A, 2006, CLIN THER, V28, P1569, DOI 10.1016/j.clinthera.2006.10.020; Ratner RE, 2013, DIABETES OBES METAB, V15, P175, DOI 10.1111/dom.12032; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Sanovi-Aventis, 2015, TOUJ PRESCR INF; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Vora J, 2014, DIABETES THER, V5, P435, DOI 10.1007/s13300-014-0076-9; Yki-Jarvinen H, 2014, DIABETES CARE, V37, P3235, DOI 10.2337/dc14-0990; Zinman B, 2012, DIABETES CARE, V35, P2464, DOI 10.2337/dc12-1205	27	151	156	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					45	56		10.1001/jama.2017.7117	http://dx.doi.org/10.1001/jama.2017.7117			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672317	Green Published, Bronze			2022-12-28	WOS:000404717700014
J	Horton, R				Horton, Richard			Offline: Racism-the pathology we choose to ignore	LANCET			English	Editorial Material												richard.horton@lancet.com							0	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					14	14		10.1016/S0140-6736(17)31746-4	http://dx.doi.org/10.1016/S0140-6736(17)31746-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677545	Bronze			2022-12-28	WOS:000404396300011
J	Buckeridge, J				Buckeridge, John			Taxonomy: swallow the costly medicine	NATURE			English	Letter									[Buckeridge, John] RMIT Univ, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Buckeridge, J (corresponding author), RMIT Univ, Melbourne, Vic, Australia.	john.buckeridge@rmit.edu.au						2017, NATURE, V546, P25	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					600	600		10.1038/546600c	http://dx.doi.org/10.1038/546600c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658218	Bronze			2022-12-28	WOS:000404332000030
J	Martin, CL; Ledbetter, DH				Martin, Christa Lese; Ledbetter, David H.			Chromosomal Microarray Testing for Children With Unexplained Neurodevelopmental Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Martin, Christa Lese; Ledbetter, David H.] Geisinger Hlth Syst, Danville, PA USA	Geisinger Health System	Ledbetter, DH (corresponding author), 100 N Acad Ave,MC 22-01, Danville, PA 17822 USA.	dhledbetter@geisinger.edu			National Institute for Mental Health (NIMH) [R01MH074090]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074090] Funding Source: NIH RePORTER	National Institute for Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funded in part by the National Institute for Mental Health (NIMH; R01MH074090).	Bassett AS, 2011, J PEDIATR-US, V159, P332, DOI 10.1016/j.jpeds.2011.02.039; Fung WLA, 2015, GENET MED, V17, P599, DOI 10.1038/gim.2014.175; Kearney HM, 2011, GENET MED, V13, P676, DOI 10.1097/GIM.0b013e31822272ac; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moeschler JB, 2014, PEDIATRICS, V134, pE903, DOI 10.1542/peds.2014-1839; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Trakadis Y, 2011, DEV MED CHILD NEUROL, V53, P994, DOI 10.1111/j.1469-8749.2011.04080.x	8	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2545	2546		10.1001/jama.2017.7272	http://dx.doi.org/10.1001/jama.2017.7272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28654998	Green Accepted			2022-12-28	WOS:000404106600025
J	Slomski, A				Slomski, Anita			Silk Offers No Relief From Eczema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2476	2476		10.1001/jama.2017.7586	http://dx.doi.org/10.1001/jama.2017.7586			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655012				2022-12-28	WOS:000404106600009
J	Sutter, M; Greber, B; Aussignargues, C; Kerfeld, CA				Sutter, Markus; Greber, Basil; Aussignargues, Clement; Kerfeld, Cheryl A.			Assembly principles and structure of a 6.5-MDa bacterial microcompartment shell	SCIENCE			English	Article							CARBOXYSOME SHELL; ESCHERICHIA-COLI; PROTEIN; ARCHITECTURE; ORGANELLE; TRANSPORT; MODELS	Many bacteria contain primitive organelles composed entirely of protein. These bacterial microcompartments share a common architecture of an enzymatic core encapsulated in a selectively permeable protein shell; prominent examples include the carboxysome for CO2 fixation and catabolic microcompartments found in many pathogenic microbes. The shell sequesters enzymatic reactions from the cytosol, analogous to the lipid-based membrane of eukaryotic organelles. Despite available structural information for single building blocks, the principles of shell assembly have remained elusive. We present the crystal structure of an intact shell from Haliangium ochraceum, revealing the basic principles of bacterial microcompartment shell construction. Given the conservation among shell proteins of all bacterial microcompartments, these principles apply to functionally diverse organelles and can inform the design and engineering of shells with new functionalities.	[Sutter, Markus; Aussignargues, Clement; Kerfeld, Cheryl A.] Michigan State Univ, Michigan State Univ US Dept Energy MSU DOE Plant, E Lansing, MI 48824 USA; [Sutter, Markus; Greber, Basil; Kerfeld, Cheryl A.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Greber, Basil] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Michigan State University	Kerfeld, CA (corresponding author), Michigan State Univ, Michigan State Univ US Dept Energy MSU DOE Plant, E Lansing, MI 48824 USA.; Kerfeld, CA (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Kerfeld, CA (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	ckerfeld@lbl.gov		kerfeld, cheryl/0000-0002-9977-8482; Greber, Basil/0000-0001-9379-7159; Sutter, Markus/0000-0001-6290-4820	National Institutes of Health-National Institute of Allergy and Infectious Diseases [1R01AI114975-01]; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-FG02-91ER20021, DE-AC02-76SF00515]; U.S. DOE, Director, Office of Science, Office of Basic Energy Sciences [DE-AC02-05CH11231]; Swiss National Science Foundation [P300PA_160983]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114975] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE, Director, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health-National Institute of Allergy and Infectious Diseases grant 1R01AI114975-01 and the U.S. DOE, Office of Science, Office of Basic Energy Sciences under contract no. DE-FG02-91ER20021. The Advanced Light Source is supported by the U.S. DOE, Director, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-05CH11231. B.G. was supported by an advanced postdoctoral mobility fellowship from the Swiss National Science Foundation (project P300PA_160983). Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. We thank B. Paasch and J. Zarzycki for their contributions to the BMC-T3 structure determination. We thank E. Nogales for providing access to the electron microscopy facility at University of California, Berkeley, and the Adams lab at Lawrence Berkeley National Lab for use of the crystallization robot. M.S. and C.A.K. are inventors on patent application 62509553 submitted by Berkeley National Laboratory that covers strategies for scaling the shell-protein system described in this work. The cryo-EM map of the complete shell has been deposited at the Electron Microscopy Data Bank (EMDB) with accession code EMD-8747. The x-ray crystallographic coordinates and structure-factor files have been deposited in the Protein Data Bank (PDB) under the following accession numbers: 5V74 (complete shell), 5V75 (BMC-T2), and 5V76 (BMC-T3).	Aussignargues C, 2016, J AM CHEM SOC, V138, P5262, DOI 10.1021/jacs.5b11734; Aussignargues Clement, 2015, Commun Integr Biol, V8, pe1039755, DOI 10.1080/19420889.2015.1039755; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Cai F, 2013, J BIOL CHEM, V288, P16055, DOI 10.1074/jbc.M113.456897; Erbilgin O, 2014, APPL ENVIRON MICROB, V80, P2193, DOI 10.1128/AEM.03887-13; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Liberton M, 2011, PLANT PHYSIOL, V155, P1656, DOI 10.1104/pp.110.165332; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mallette E, 2017, J BIOL CHEM, V292, P1197, DOI 10.1074/jbc.M116.754093; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; Sutter M, 2016, NANO LETT, V16, P1590, DOI 10.1021/acs.nanolett.5b04259; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144	17	115	120	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1293	1297		10.1126/science.aan3289	http://dx.doi.org/10.1126/science.aan3289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642439	Green Accepted			2022-12-28	WOS:000403881700042
J	Stella, S; Alcon, P; Montoya, G				Stella, Stefano; Alcon, Pablo; Montoya, Guillermo			Structure of the Cpf1 endonuclease R-loop complex after target DNA cleavage (vol 546, pg 559, 2017)	NATURE			English	Correction														Alcon, Pablo/0000-0002-7435-3859				Stella S, 2017, NATURE, V546, P559, DOI 10.1038/nature22398	1	0	1	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664								10.1038/nature23300	http://dx.doi.org/10.1038/nature23300			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28678773	Bronze			2022-12-28	WOS:000406358300043
J	Viswanathan, VS; Ryan, MJ; Dhruv, HD; Gill, S; Eichhoff, OM; Seashore-Ludlow, B; Kaffenberger, SD; Eaton, JK; Shimada, K; Aguirre, AJ; Viswanathan, SR; Chattopadhyay, S; Tamayo, P; Yang, WS; Rees, MG; Chen, SX; Boskovic, ZV; Javaid, S; Huang, C; Wu, XY; Tseng, YY; Roider, EM; Gao, D; Cleary, JM; Wolpin, BM; Mesirov, JP; Haber, DA; Engelman, JA; Boehm, JS; Kotz, JD; Hon, CS; Chen, Y; Hahn, WC; Levesque, MP; Doench, JG; Berens, ME; Shamji, AF; Clemons, PA; Stockwell, BR; Schreiber, SL				Viswanathan, Vasanthi S.; Ryan, Matthew J.; Dhruv, Harshil D.; Gill, Shubhroz; Eichhoff, Ossia M.; Seashore-Ludlow, Brinton; Kaffenberger, Samuel D.; Eaton, John K.; Shimada, Kenichi; Aguirre, Andrew J.; Viswanathan, Srinivas R.; Chattopadhyay, Shrikanta; Tamayo, Pablo; Yang, Wan Seok; Rees, Matthew G.; Chen, Sixun; Boskovic, Zarko V.; Javaid, Sarah; Huang, Cherrie; Wu, Xiaoyun; Tseng, Yuen-Yi; Roider, Elisabeth M.; Gao, Dong; Cleary, James M.; Wolpin, Brian M.; Mesirov, Jill P.; Haber, Daniel A.; Engelman, Jeffrey A.; Boehm, Jesse S.; Kotz, Joanne D.; Hon, Cindy S.; Chen, Yu; Hahn, William C.; Levesque, Mitchell P.; Doench, John G.; Berens, Michael E.; Shamji, Alykhan F.; Clemons, Paul A.; Stockwell, Brent R.; Schreiber, Stuart L.			Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN-MELANOMA CELLS; PROSTATE-CANCER; EXPRESSION; INHIBITOR; REVEALS; DEATH; SENSITIVITY; METABOLISM; SIGNATURE	Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer therapies, thereby limiting their effectiveness(1-4). A high-mesenchymal cell state observed in human tumours and cancer cell lines has been associated with resistance to multiple treatment modalities across diverse cancer lineages, but the mechanistic underpinning for this state has remained incompletely understood(1-6). Here we molecularly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and organoids and show that it depends on a druggable lipid-peroxidase pathway that protects against ferroptosis, a nonapoptotic form of cell death induced by the build-up of toxic lipid peroxides(7,8). We show that this cell state is characterized by activity of enzymes that promote the synthesis of polyunsaturated lipids. These lipids are the substrates for lipid peroxidation by lipoxygenase enzymes(8,9). This lipid metabolism creates a dependency on pathways converging on the phospholipid glutathione peroxidase (GPX4), a selenocysteine-containing enzyme that dissipates lipid peroxides and thereby prevents the iron-mediated reactions of peroxides that induce ferroptotic cell death(8). Dependency on GPX4 was found to exist across diverse therapy-resistant states characterized by high expression of ZEB1, including epithelial-mesenchymal transition in epithelial-derived carcinomas, TGF beta-mediated therapy-resistance in melanoma, treatment-induced neuroendocrine transdifferentiation in prostate cancer, and sarcomas, which are fixed in a mesenchymal state owing to their cells of origin. We identify vulnerability to ferroptic cell death induced by inhibition of a lipid peroxidase pathway as a feature of therapy-resistant cancer cells across diverse mesenchymal cell-state contexts.	[Viswanathan, Vasanthi S.; Ryan, Matthew J.; Gill, Shubhroz; Seashore-Ludlow, Brinton; Eaton, John K.; Aguirre, Andrew J.; Viswanathan, Srinivas R.; Chattopadhyay, Shrikanta; Tamayo, Pablo; Rees, Matthew G.; Chen, Sixun; Boskovic, Zarko V.; Huang, Cherrie; Wu, Xiaoyun; Tseng, Yuen-Yi; Mesirov, Jill P.; Boehm, Jesse S.; Kotz, Joanne D.; Hon, Cindy S.; Hahn, William C.; Doench, John G.; Shamji, Alykhan F.; Clemons, Paul A.; Schreiber, Stuart L.] Broad Inst, 415 Main St, Cambridge, MA 02142 USA; [Dhruv, Harshil D.; Berens, Michael E.] Translat Genom Res Inst, Canc & Cell Biol Div, 445 N 5th St, Phoenix, AZ 85004 USA; [Eichhoff, Ossia M.; Roider, Elisabeth M.; Levesque, Mitchell P.] Univ Zurich, Univ Zurich Hosp, Dept Dermatol, Wagistr 14, CH-8952 Zurich, Switzerland; [Kaffenberger, Samuel D.; Gao, Dong; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Shimada, Kenichi] Harvard Med Sch, Lab Syst Pharmacol, 200 Longwood Ave, Boston, MA 02115 USA; [Aguirre, Andrew J.; Viswanathan, Srinivas R.; Cleary, James M.; Wolpin, Brian M.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tamayo, Pablo; Mesirov, Jill P.] Univ Calif San Diego, Sch Med, Moores Canc Ctr, La Jolla, CA 92093 USA; [Tamayo, Pablo; Mesirov, Jill P.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Yang, Wan Seok] St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Javaid, Sarah; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, 149 13th St, Charlestown, MA 02129 USA; [Haber, Daniel A.; Schreiber, Stuart L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Engelman, Jeffrey A.] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, Dept Biol Sci, 550 West 120th St, New York, NY 10027 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Translational Genomics Research Institute; University of Zurich; University Zurich Hospital; Memorial Sloan Kettering Cancer Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Saint John's University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Novartis; Columbia University; Harvard University	Schreiber, SL (corresponding author), Broad Inst, 415 Main St, Cambridge, MA 02142 USA.; Schreiber, SL (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Schreiber, SL (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	stuart_schreiber@harvard.edu	Seashore-Ludlow, Brinton/E-2309-2017; Shimada, Kenichi/AAD-7996-2021; Stockwell, Brent R/AAE-7200-2019; Viswanathan, Srinivas/ABA-6316-2021; Mesirov, Jill/AGF-7626-2022; Boskovic, Zarko/AAF-6750-2019; Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022	Seashore-Ludlow, Brinton/0000-0001-8658-5967; Shimada, Kenichi/0000-0001-8540-9785; Stockwell, Brent R/0000-0002-3532-3868; Viswanathan, Srinivas/0000-0003-1856-3023; Boskovic, Zarko/0000-0001-9376-527X; Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; Gao, Dong/0000-0003-1821-2741; Roider, Elisabeth/0000-0003-0817-1923; Eaton, John/0000-0003-4633-5546; Ryan, Matthew/0000-0002-2760-7609; Berens, Michael/0000-0002-3382-6787; Viswanathan, Vasanthi/0000-0001-9878-3629	National Cancer Institute (Cancer Target Discovery and Development Network) [U01CA176152, U01CA168397, 5R01CA097061, R01CA161061, NCI-CA129933, P30CA008748]; National Institutes of Health [R01GM038627, 5R01GM085081]; Swiss National Fund [310030_149946]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U01CA176152, K08CA218420, U01CA217848, R01CA154480, R01CA129933, U01CA199253, P30CA008748, R01CA193837, R35CA209896, U01CA176058, P50CA092629, R01CA121941, R01CA161061, U01CA168397, R01CA208100, R01CA097061, U24CA194107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081, R01GM038627, R01GM074024] Funding Source: NIH RePORTER	National Cancer Institute (Cancer Target Discovery and Development Network); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Fund(Swiss National Science Foundation (SNSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Hangauer, M. T. McManus, F. McCormick, K. Dutton-Regester, L. V. Kemeny, D. J. Adams and Y. Drier for valuable discussions and L. Hartman for execution of in vivo studies. This project has been supported by grants from the National Cancer Institute (Cancer Target Discovery and Development Network grant U01CA176152 to S.L.S., U01CA168397 to M.E.B., 5R01CA097061 and R01CA161061 to B.R.S., NCI-CA129933 to D.A.H., P30CA008748 to Y.C.), the National Institutes of Health (R01GM038627 to S.L.S., 5R01GM085081 to B.R.S.), the Swiss National Fund (310030_149946, to M.P.L.) and Howard Hughes Medical Institute (D.A.H., S.L.S.).	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bu X, 2016, TRENDS MOL MED, V22, P448, DOI 10.1016/j.molmed.2016.04.008; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chen VW, 2003, CANCER, V97, P2631, DOI 10.1002/cncr.11345; Cheng PF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0594-4; Cohen IJ, 2014, PEDIATR BLOOD CANCER, V61, P7, DOI 10.1002/pbc.24770; Dancik V, 2014, J BIOMOL SCREEN, V19, P771, DOI 10.1177/1087057113520226; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Groger CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051136; Gubelmann C, 2014, ELIFE, V3, DOI 10.7554/eLife.03346; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Mathow D, 2015, EMBO REP, V16, P321, DOI 10.15252/embr.201439333; McKeithen D, 2010, PROSTATE, V70, P982, DOI 10.1002/pros.21132; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; Salt MB, 2014, CANCER DISCOV, V4, P186, DOI 10.1158/2159-8290.CD-13-0520; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Song JG, 2007, CELL RES, V17, P289, DOI 10.1038/cr.2007.25; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Warner GJ, 2000, J BIOL CHEM, V275, P28110; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang PJ, 2015, CELL CYCLE, V14, P481, DOI 10.1080/15384101.2015.1006048; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	35	695	721	19	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					453	+		10.1038/nature23007	http://dx.doi.org/10.1038/nature23007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28678785	Green Accepted			2022-12-28	WOS:000406358300036
J	Sahin, U; Derhovanessian, E; Miller, M; Kloke, BP; Simon, P; Lower, M; Bukur, V; Tadmor, AD; Luxemburger, U; Schrors, B; Omokoko, T; Vormehr, M; Albrecht, C; Paruzynski, A; Kuhn, AN; Buck, J; Heesch, S; Katharina, H; Muller, F; Ortseifer, I; Vogler, I; Godehardt, E; Attig, S; Rae, R; Breitkreuz, A; Tolliver, C; Suchan, M; Martic, G; Hohberger, A; Sorn, P; Diekmann, J; Ciesla, J; Waksmann, O; Burck, AK; Witt, M; Zillgen, M; Rothermel, A; Kasemann, B; Langer, D; Bolte, S; Diken, M; Kreiter, S; Nemecek, R; Gebhardt, C; Grabbe, S; Holler, C; Utikal, J; Huber, C; Loquai, C; Tureci, O				Sahin, Ugur; Derhovanessian, Evelyna; Miller, Matthias; Kloke, Bjoern-Philipp; Simon, Petra; Loewer, Martin; Bukur, Valesca; Tadmor, Arbel D.; Luxemburger, Ulrich; Schroers, Barbara; Omokoko, Tana; Vormehr, Mathias; Albrecht, Christian; Paruzynski, Anna; Kuhn, Andreas N.; Buck, Janina; Heesch, Sandra; Katharina, H.; Mueller, Felicitas; Ortseifer, Inga; Vogler, Isabel; Godehardt, Eva; Attig, Sebastian; Rae, Richard; Breitkreuz, Andrea; Tolliver, Claudia; Suchan, Martin; Martic, Goran; Hohberger, Alexander; Sorn, Patrick; Diekmann, Jan; Ciesla, Janko; Waksmann, Olga; Burck, Alexandra-Kemmer; Witt, Meike; Zillgen, Martina; Rothermel, Andree; Kasemann, Barbara; Langer, David; Bolte, Stefanie; Diken, Mustafa; Kreiter, Sebastian; Nemecek, Romina; Gebhardt, Christoffer; Grabbe, Stephan; Holler, Christoph; Utikal, Jochen; Huber, Christoph; Loquai, Carmen; Tuereci, Oezlem			Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer	NATURE			English	Article							PD-1 BLOCKADE; MASS-SPECTROMETRY; CTLA-4 BLOCKADE; T-CELLS; MUTATIONS; ALIGNMENT; REVEALS; SENSITIVITY; EFFICIENCY; STABILITY	T cells directed against mutant neo-epitopes drive cancer immunity. However, spontaneous immune recognition of mutations is inefficient. We recently introduced the concept of individualized mutanome vaccines and implemented an RNA-based poly-neoepitope approach to mobilize immunity against a spectrum of cancer mutations(1,2). Here we report the first-in-human application of this concept in melanoma. We set up a process comprising comprehensive identification of individual mutations, computational prediction of neo-epitopes, and design and manufacturing of a vaccine unique for each patient. All patients developed T cell responses against multiple vaccine neo-epitopes at up to high single-digit percentages. Vaccine-induced T cell infiltration and neo-epitope-specific killing of autologous tumour cells were shown in post-vaccination resected metastases from two patients. The cumulative rate of metastatic events was highly significantly reduced after the start of vaccination, resulting in a sustained progression-free survival. Two of the five patients with metastatic disease experienced vaccine-related objective responses. One of these patients had a late relapse owing to outgrowth of beta 2-microglobulin-deficient melanoma cells as an acquired resistance mechanism. A third patient developed a complete response to vaccination in combination with PD-1 blockade therapy. Our study demonstrates that individual mutations can be exploited, thereby opening a path to personalized immunotherapy for patients with cancer.	[Sahin, Ugur; Derhovanessian, Evelyna; Miller, Matthias; Kloke, Bjoern-Philipp; Simon, Petra; Bukur, Valesca; Luxemburger, Ulrich; Omokoko, Tana; Vormehr, Mathias; Paruzynski, Anna; Kuhn, Andreas N.; Buck, Janina; Heesch, Sandra; Katharina, H.; Mueller, Felicitas; Ortseifer, Inga; Vogler, Isabel; Godehardt, Eva; Breitkreuz, Andrea; Tolliver, Claudia; Diekmann, Jan; Burck, Alexandra-Kemmer; Witt, Meike; Zillgen, Martina; Langer, David; Bolte, Stefanie; Diken, Mustafa; Kreiter, Sebastian; Huber, Christoph] Biopharmaceut New Technol BioNTech Corp, Goldgrube 12, D-55131 Mainz, Germany; [Sahin, Ugur; Loewer, Martin; Bukur, Valesca; Tadmor, Arbel D.; Schroers, Barbara; Albrecht, Christian; Attig, Sebastian; Rae, Richard; Suchan, Martin; Martic, Goran; Sorn, Patrick; Rothermel, Andree; Kasemann, Barbara; Diken, Mustafa; Kreiter, Sebastian; Huber, Christoph] Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, Freiligrathstr 12, D-55131 Mainz, Germany; [Sahin, Ugur; Vormehr, Mathias; Attig, Sebastian; Hohberger, Alexander; Grabbe, Stephan; Huber, Christoph; Loquai, Carmen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany; [Ciesla, Janko; Waksmann, Olga] EUFETS GmbH, Vollmersbachstr 66, D-55743 Idar Oberstein, Germany; [Nemecek, Romina; Holler, Christoph] Med Univ Vienna, Spitalgasse 23, A-1090 Vienna, Austria; [Gebhardt, Christoffer; Utikal, Jochen] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Gebhardt, Christoffer; Utikal, Jochen] Heidelberg Univ, Univ Med Ctr Mannheim, Theodor Kutzer Ufer 1-3, D-68135 Mannheim, Germany; [Tuereci, Oezlem] CI3 Cluster Individualized Immunointervent eV, Holderlinstr 8, D-55131 Mainz, Germany	BioNTech SE; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Medical University of Vienna; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Sahin, U (corresponding author), Biopharmaceut New Technol BioNTech Corp, Goldgrube 12, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ gGmbH, Univ Med Ctr, TRON Translat Oncol, Freiligrathstr 12, D-55131 Mainz, Germany.; Sahin, U (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	sahin@uni-mainz.de	Grabe, Stephan/AAJ-4578-2021; Loquai, Carmen/AAW-9241-2020; Sahin, Ugur/L-4818-2017; Vormehr, Mathias/AAJ-7808-2021	Grabe, Stephan/0000-0002-6863-8719; Sahin, Ugur/0000-0003-0363-1564; Vormehr, Mathias/0000-0001-7788-3380; Oehm, Petra/0000-0002-1086-2726; Gebhardt, Christoffer/0000-0001-7090-9584; Suchan, Martin/0000-0001-6625-6162; Utikal, Jochen/0000-0001-5316-0241; Schrors, Barbara/0000-0001-9758-250X	CI3 cluster program of the Federal Ministry of Education and Research (BMBF)	CI3 cluster program of the Federal Ministry of Education and Research (BMBF)	We thank J. de Graaf, I. Eichelbronner, L. Leppin, L. Giese and S. Vogler, D. Becker, M. Dorner, J. Grutzner, M. Hossainzadeh, A. Selmi, S. Wessel, C. Ecker, M. Lochschmitt, B. Schmitz, C. Anft, N. Bidmon, H. Schroder, D. Barea Roldan, C. Walter, S. Woll, C. Rohde, O. Renz, F. Bayer, C. Kroner, B. Otte, T. Stricker, M. Drude S. Petri, M. Mechler, L. Hebich, B. Steege, A. Oelbermann, J. Schwarz, C. Britten, J. C. Castle and B. Pless for technical support, project management and advice. We thank A. Tuttenberg for support with a figure. We thank I. Mellman, L. Delamarre and G. Fine for critical reading of the manuscript. We thank K. Sahin for her advice. The study was supported by the CI3 cluster program of the Federal Ministry of Education and Research (BMBF).	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Delamarre L, 2015, SCIENCE, V348, P760, DOI 10.1126/science.aab3465; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; DURSO CM, 1991, J CLIN INVEST, V87, P284, DOI 10.1172/JCI114984; Grudzien-Nogalska Ewa, 2013, Methods Mol Biol, V969, P55, DOI 10.1007/978-1-62703-260-5_4; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kreiter S, 2008, J IMMUNOL, V180, P309, DOI 10.4049/jimmunol.180.1.309; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kreiter S, 2010, CANCER RES, V70, P9031, DOI 10.1158/0008-5472.CAN-10-0699; Kuhn AN, 2010, GENE THER, V17, P961, DOI 10.1038/gt.2010.52; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Omokoko TA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9540975; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Simon P, 2014, CANCER IMMUNOL RES, V2, P1230, DOI 10.1158/2326-6066.CIR-14-0108; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhao Q.-Y., BMC BIOINFORMATI S14, V12, pS2	42	1206	1299	21	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					222	+		10.1038/nature23003	http://dx.doi.org/10.1038/nature23003			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678784				2022-12-28	WOS:000405314500040
J	Gerber, S; Yang, SL; Zhu, D; Soifer, H; Sobota, JA; Rebec, S; Lee, JJ; Jia, T; Moritz, B; Jia, C; Gauthier, A; Li, Y; Leuenberger, D; Zhang, Y; Chaix, L; Li, W; Jang, H; Lee, JS; Yi, M; Dakovski, GL; Song, S; Glownia, JM; Nelson, S; Kim, KW; Chuang, YD; Hussain, Z; Moore, RG; Devereaux, TP; Lee, WS; Kirchmann, PS; Shen, ZX				Gerber, S.; Yang, S. -L.; Zhu, D.; Soifer, H.; Sobota, J. A.; Rebec, S.; Lee, J. J.; Jia, T.; Moritz, B.; Jia, C.; Gauthier, A.; Li, Y.; Leuenberger, D.; Zhang, Y.; Chaix, L.; Li, W.; Jang, H.; Lee, J. -S.; Yi, M.; Dakovski, G. L.; Song, S.; Glownia, J. M.; Nelson, S.; Kim, K. W.; Chuang, Y. -D.; Hussain, Z.; Moore, R. G.; Devereaux, T. P.; Lee, W. -S.; Kirchmann, P. S.; Shen, Z. -X.			Femtosecond electron-phonon lock-in by photoemission and x-ray free-electron laser	SCIENCE			English	Article							IRON PNICTIDES; SUPERCONDUCTIVITY; CHALCOGENIDES; STATES; FILMS; FESE	The interactions that lead to the emergence of superconductivity in iron-based materials remain a subject of debate. It has been suggested that electron-electron correlations enhance electron-phonon coupling in iron selenide (FeSe) and related pnictides, but direct experimental verification has been lacking. Here we show that the electron-phonon coupling strength in FeSe can be quantified by combining two time-domain experiments into a "coherent lock-in" measurement in the terahertz regime. X-ray diffraction tracks the light-induced femtosecond coherent lattice motion at a single phonon frequency, and photoemission monitors the subsequent coherent changes in the electronic band structure. Comparison with theory reveals a strong enhancement of the coupling strength in FeSe owing to correlation effects. Given that the electron-phonon coupling affects superconductivity exponentially, this enhancement highlights the importance of the cooperative interplay between electron-electron and electron-phonon interactions.	[Gerber, S.; Yang, S. -L.; Soifer, H.; Sobota, J. A.; Rebec, S.; Lee, J. J.; Jia, T.; Moritz, B.; Jia, C.; Gauthier, A.; Li, Y.; Leuenberger, D.; Chaix, L.; Li, W.; Moore, R. G.; Devereaux, T. P.; Lee, W. -S.; Kirchmann, P. S.; Shen, Z. -X.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Gerber, S.; Yang, S. -L.; Soifer, H.; Sobota, J. A.; Rebec, S.; Lee, J. J.; Jia, T.; Moritz, B.; Jia, C.; Gauthier, A.; Li, Y.; Leuenberger, D.; Chaix, L.; Li, W.; Moore, R. G.; Devereaux, T. P.; Lee, W. -S.; Kirchmann, P. S.; Shen, Z. -X.] Stanford Univ, Menlo Pk, CA 94025 USA; [Gerber, S.] Paul Scherrer Inst, SwissFEL, CH-5232 Villigen, Switzerland; [Gerber, S.] Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, Switzerland; [Yang, S. -L.; Rebec, S.; Lee, J. J.; Jia, T.; Gauthier, A.; Shen, Z. -X.] Stanford Univ, Dept Phys & Appl Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Zhu, D.; Dakovski, G. L.; Song, S.; Glownia, J. M.; Nelson, S.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Sobota, J. A.; Chuang, Y. -D.; Hussain, Z.] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Zhang, Y.] Peking Univ, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Jang, H.; Lee, J. -S.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Yi, M.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Kim, K. W.] Chungbuk Natl Univ, Dept Phys, Cheongju 28644, South Korea	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Peking University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Berkeley; Chungbuk National University	Lee, WS; Kirchmann, PS; Shen, ZX (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	leews@stanford.edu; kirchman@stanford.edu; zxshen@stanford.edu	Kirchmann, Patrick S/C-1195-2008; Moritz, Brian J/D-7505-2015; Gerber, Simon/A-4566-2012; Hussain, Zahid/HGU-8912-2022; song, sanghoon/AAE-1798-2022; Kim, Kyungwan/A-9242-2012; Moore, Rob/CAG-8039-2022; Soifer, Hadas/G-5522-2010	Kirchmann, Patrick S/0000-0002-4835-0654; Moritz, Brian J/0000-0002-3747-8484; Gerber, Simon/0000-0002-5717-2626; Hussain, Zahid/0000-0003-4989-6496; song, sanghoon/0000-0003-3493-1850; Kim, Kyungwan/0000-0003-3833-5378; Moore, Rob/0000-0002-1608-5411; Soifer, Hadas/0000-0001-8879-0577; Jia, Chunjing/0000-0001-7999-1932; Chaix, Laura/0000-0002-6757-9040; Chuang, Yi-De/0000-0002-2773-3840; Yang, Shuolong/0000-0002-8200-9898; Sobota, Jonathan/0000-0002-8044-1935; devereaux, thomas/0000-0001-8072-9237	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES) [DE-AC02-76SF00515]; DOE-BES Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; Swiss National Science Foundation [P2EZP2_148737, P300P2_151328]; Stanford Graduate Fellowship; Fulbright Scholar Program; National Defense Science and Engineering Graduate Fellowship Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [NRF-2015R1A2A1A10056200]; Office of Science, BES, of the U.S. DOE [DE-AC02-05CH11231]	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); DOE-BES Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stanford Graduate Fellowship(Stanford University); Fulbright Scholar Program; National Defense Science and Engineering Graduate Fellowship Program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; Office of Science, BES, of the U.S. DOE(United States Department of Energy (DOE))	Use of the LCLS, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES) under contract DE-AC02-76SF00515. S.G., S.-L.Y., H.S., J.A.S., S.R., J.J.L., T.J., B.M., C.J., A.G., Y.L., D.L., L.C., W.L., R.G.M., T.P.D., W.-S.L., P.S.K., and Z.-X.S. were supported by the DOE-BES Division of Materials Sciences and Engineering under contract DE-AC02-76SF00515 (to the Stanford Institute for Materials and Energy Sciences). The authors gratefully acknowledge technical assistance at LCLS by D. Stefanescu and R. Fiebich. S.G. and D.L. acknowledge partial support by the Swiss National Science Foundation under fellowships P2EZP2_148737 and P300P2_151328, respectively. S.-L.Y. acknowledges support by the Stanford Graduate Fellowship. H.S. acknowledges support from the Fulbright Scholar Program. A.G. acknowledges support by the National Defense Science and Engineering Graduate Fellowship Program. K.W.K. was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science, ICT and Future Planning (NRF-2015R1A2A1A10056200).; Y.-D.C. and Z.H. were supported by the Director, Office of Science, BES, of the U.S. DOE under contract DE-AC02-05CH11231. Raw data from the time-resolved x-ray scattering experiment are kept at the LCLS. Time-resolved photoemission raw data are kept at the Shen Laboratory of Stanford University.	[Anonymous], 2008, MAT METHODS ARE AVAI; Avigo I, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/9/094003; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Bostedt C, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.015007; Gerber S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8377; Gnezdilov V, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.144508; Grimvall G., 1981, ELECT PHONON INTERAC; Imai T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177005; Johnston DC, 2010, ADV PHYS, V59, P803, DOI 10.1080/00018732.2010.513480; Kim KW, 2012, NAT MATER, V11, P497, DOI [10.1038/nmat3294, 10.1038/NMAT3294]; Kordyuk AA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134513; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Mandal S, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.220502; Margadonna S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064506; Margadonna S, 2008, CHEM COMMUN, P5607, DOI 10.1039/b813076k; McQueen TM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057002; Medvedev S, 2009, NAT MATER, V8, P630, DOI [10.1038/NMAT2491, 10.1038/nmat2491]; Mishchenko AS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036402; Rahn MC, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.180501; Rettig L, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.067402; Rosch O, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.146403; Shimada D, 1998, PHYSICA C, V298, P195, DOI 10.1016/S0921-4534(97)01884-4; Tamai A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097002; Wang QS, 2016, NAT MATER, V15, P159, DOI [10.1038/NMAT4492, 10.1038/nmat4492]; Watson MD, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.155106; Yang LX, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.207001; Yang SL, 2015, NANO LETT, V15, P4150, DOI 10.1021/acs.nanolett.5b01274; Yin ZP, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.021011; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/NMAT3120, 10.1038/nmat3120]; ZEIGER HJ, 1992, PHYS REV B, V45, P768, DOI 10.1103/PhysRevB.45.768	30	126	127	11	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					71	74		10.1126/science.aak9946	http://dx.doi.org/10.1126/science.aak9946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684521	Green Accepted			2022-12-28	WOS:000416909500004
J	Clapham, PJ				Clapham, Phillip J.			Japan disregards whaling review again	NATURE			English	Letter									[Clapham, Phillip J.] Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Clapham, PJ (corresponding author), Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	phillip.clapham@noaa.gov							0	4	4	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					32	32		10.1038/547032b	http://dx.doi.org/10.1038/547032b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682334	Green Submitted			2022-12-28	WOS:000404839900019
J	Heath, I				Heath, Iona			Information without wisdom	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						Bauman Z., 1992, MORTALITY IMMORTALIT, P130; Bauman Z., 1992, MORTALITY IMMORTALIT, P23; Eliot, 1934, THE ROCK; Heath I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6123; Millenson ML, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3048; Vogt H, 2016, MED HEALTH CARE PHIL, V19, P307, DOI 10.1007/s11019-016-9683-8	6	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2017	358								j3203	10.1136/bmj.j3203	http://dx.doi.org/10.1136/bmj.j3203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DN	28679507				2022-12-28	WOS:000405322200009
J	Bentovim, A				Bentovim, Arnon			Michael R Pokorny OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		POKORNY MR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3218	10.1136/bmj.j3218	http://dx.doi.org/10.1136/bmj.j3218			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676495				2022-12-28	WOS:000405322100005
J	Dyer, C				Dyer, Clare			Law, ethics, and emotion: the Charlie Gard case	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The fight over the treatment of terminally ill baby Charlie Gard has been unprecedented, both legally and in its coverage on social media. His parents' last hope, the European Court of Human Rights, turned them down last week, ruling that the baby should be allowed to die. Clare Dyer looks back at this case and considers where it leaves doctors				claredyer4@gmail.com							0	1	1	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3152	10.1136/bmj.j3152	http://dx.doi.org/10.1136/bmj.j3152			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676496				2022-12-28	WOS:000405322100002
J	Reed, NS; Betz, J; Kendig, N; Korczak, M; Lin, FR				Reed, Nicholas S.; Betz, Joshua; Kendig, Nicole; Korczak, Margaret; Lin, Frank R.			Personal Sound Amplification Products vs a Conventional Hearing Aid for Speech Understanding in Noise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Reed, Nicholas S.; Lin, Frank R.] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Betz, Joshua] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kendig, Nicole; Korczak, Margaret] Towson Univ, Dept Audiol Speech Language Pathol & Deaf Studies, Towson, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; Towson University	Reed, NS (corresponding author), Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Johns Hopkins Ctr Aging & Hlth, 2024 E Monument St,Ste 2-700, Baltimore, MD 21205 USA.	nreed9@jhmi.edu			Eleanor Schwartz Charitable Foundation; National Institutes of Health [NIH R33DC015062, NIH KL2TR001077]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R33DC015062] Funding Source: NIH RePORTER	Eleanor Schwartz Charitable Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded in part by the Eleanor Schwartz Charitable Foundation and supported by grants NIH R33DC015062 (Dr Lin) and NIH KL2TR001077 (Dr Reed) from the National Institutes of Health.	Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; National Academies of Sciences Engineering and Medicine, ENG MED HEAR HLTH CA; Presidents Council of Advisors on Science and Technology, 2015, LETT PRES; Spahr AJ, 2012, EAR HEARING, V33, P112, DOI 10.1097/AUD.0b013e31822c2549; Warren E, 2017, JAMA INTERN MED, V177, P609, DOI 10.1001/jamainternmed.2017.0464	5	42	45	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					89	90		10.1001/jama.2017.6905	http://dx.doi.org/10.1001/jama.2017.6905			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672306	Green Published, Bronze			2022-12-28	WOS:000404717700020
J	Shankaran, S; Laptook, AR; Pappas, A; McDonald, SA; Das, A; Tyson, JE; Poindexter, BB; Schibler, K; Bell, EF; Heyne, RJ; Pedroza, C; Bara, R; Van Meurs, KP; Huitema, CMP; Grisby, C; Devaskar, U; Ehrenkranz, RA; Harmon, HM; Chalak, LF; DeMauro, SB; Garg, M; Hartley-McAndrew, ME; Khan, AM; Walsh, MC; Ambalavanan, N; Brumbaugh, JE; Watterberg, KL; Shepherd, EG; Hamrick, SEG; Barks, J; Cotten, CM; Kilbride, HW; Higgins, RD				Shankaran, Seetha; Laptook, Abbot R.; Pappas, Athina; McDonald, Scott. A.; Das, Abhik; Tyson, Jon E.; Poindexter, Brenda B.; Schibler, Kurt; Bell, Edward F.; Heyne, Roy J.; Pedroza, Claudia; Bara, Rebecca; Van Meurs, Krisa P.; Huitema, Carolyn M. Petrie; Grisby, Cathy; Devaskar, Uday; Ehrenkranz, Richard A.; Harmon, Heidi M.; Chalak, Lina F.; DeMauro, Sara B.; Garg, Meena; Hartley-McAndrew, Michelle E.; Khan, Amir M.; Walsh, Michele C.; Ambalavanan, Namasivayam; Brumbaugh, Jane E.; Watterberg, Kristi L.; Shepherd, Edward G.; Hamrick, Shannon E. G.; Barks, John; Cotten, C. Michael; Kilbride, Howard W.; Higgins, Rosemary D.		Eunice Kennedy Shriver Natl Inst	Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDHOOD OUTCOMES; FETAL SHEEP; HYPOTHERMIA; PROTECTION; ASPHYXIA; INJURY; WHITE	IMPORTANCE Hypothermia for 72 hours at 33.5C for neonatal hypoxic-ischemic encephalopathy reduces death or disability, but rates continue to be high. OBJECTIVE To determine if cooling for 120 hours or to a temperature of 32.0C reduces death or disability at age 18 months in infants with hypoxic-ischemic encephalopathy. DESIGN, SETTING, AND PARTICIPANTS Randomized 2 x 2 factorial clinical trial in neonates (36 weeks' gestation) with hypoxic-ischemic encephalopathy at 18 US centers in the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network between October 2010 and January 2016. INTERVENTIONS A total of 364 neonates were randomly assigned to 4 hypothermia groups: 33.5C for 72 hours (n = 95), 32.0C for 72 hours (n = 90), 33.5C for 120 hours (n = 96), or 32.0C for 120 hours (n = 83). MAIN OUTCOMES AND MEASURES The primary outcomewas death or moderate or severe disability at 18 to 22 months of age adjusted for center and level of encephalopathy. Severe disability included any of Bayley Scales of Infant Development III cognitive score less than 70, Gross Motor Function Classification System (GMFCS) level of 3 to 5, or blindness or hearing loss despite amplification. Moderate disability was defined as a cognitive score of 70 to 84 and either GMFCS level 2, active seizures, or hearing with amplification. RESULTS The trial was stopped for safety and futility in November 2013 after 364 of the planned 726 infants were enrolled. Among 347 infants (95%) with primary outcome data (mean age at follow-up, 20.7 [SD, 3.5] months; 42% female), death or disability occurred in 56 of 176 (31.8%) cooled for 72 hours and 54 of 171 (31.6%) cooled for 120 hours (adjusted risk ratio, 0.92 [95% CI, 0.68-1.25]; adjusted absolute risk difference, -1.0% [95% CI, -10.2% to 8.1%]) and in 59 of 185 (31.9%) cooled to 33.5C and 51 of 162 (31.5%) cooled to 32.0C (adjusted risk ratio, 0.92 [95% CI, 0.68-1.26]; adjusted absolute risk difference, -3.1% [95% CI, -12.3% to 6.1%]). A significant interaction between longer and deeper cooling was observed (P =.048), with primary outcome rates of 29.3% at 33.5C for 72 hours, 34.5% at 32.0C for 72 hours, 34.4% at 33.5C for 120 hours, and 28.2% at 32.0C for 120 hours. CONCLUSIONS AND RELEVANCE Among term neonates with moderate or severe hypoxic-ischemic encephalopathy, cooling for longer than 72 hours, cooling to lower than 33.5C, or both did not reduce death or moderate or severe disability at 18 months of age. However, the trial may be underpowered, and an interaction was found between longer and deeper cooling. These results support the current regimen of cooling for 72 hours at 33.5C.	[Shankaran, Seetha; Pappas, Athina; Bara, Rebecca] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [McDonald, Scott. A.] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Das, Abhik; Huitema, Carolyn M. Petrie] RTI Int, Social Stat & Environm Sci Unit, Rockville, MD USA; [Tyson, Jon E.; Pedroza, Claudia; Khan, Amir M.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Houston, TX 77030 USA; [Poindexter, Brenda B.; Harmon, Heidi M.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Poindexter, Brenda B.; Schibler, Kurt; Grisby, Cathy] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst, Cincinnati, OH 45229 USA; [Bell, Edward F.; Brumbaugh, Jane E.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Heyne, Roy J.; Chalak, Lina F.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX USA; [Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Van Meurs, Krisa P.] Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Devaskar, Uday; Garg, Meena] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [DeMauro, Sara B.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Hartley-McAndrew, Michelle E.] SUNY Buffalo, Dept Pediat, Buffalo, NY USA; [Walsh, Michele C.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Ambalavanan, Namasivayam] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Shepherd, Edward G.] Ohio State Univ, Dept Pediat, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Hamrick, Shannon E. G.] Emory Univ, Sch Med, Dept Pediat, Childrens Hlthcare Atlanta, Atlanta, GA USA; [Barks, John] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Cotten, C. Michael] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Kilbride, Howard W.] Childrens Mercy Hosp, Dept Pediat, Kansas City, MO 64108 USA; [Kilbride, Howard W.] Univ Missouri Kansas City, Sch Med, Kansas City, MO USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	Wayne State University; Brown University; Women & Infants Hospital Rhode Island; Research Triangle Institute; Research Triangle Institute; University of Texas System; University of Texas Health Science Center Houston; Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; Lucile Packard Children's Hospital (LPCH); University of California System; University of California Los Angeles; Yale University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of Alabama System; University of Alabama Birmingham; University of New Mexico; University of New Mexico's Health Sciences Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's Healthcare of Atlanta (CHOA); Emory University; University of Michigan System; University of Michigan; Duke University; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shankaran, S (corresponding author), Childrens Hosp Michigan, 3901 Beaubien Blvd, Detroit, MI 48201 USA.	sshankar@med.wayne.edu	Shah, Birju A./C-4811-2014; Ambalavanan, Namasivayam/AAL-3832-2020; DeMauro, Sara/ABD-6568-2021; Das, Abhik/AAF-1883-2020; Ambalavanan, Namasivayam/AAI-4088-2020; Kilbride, Howard/I-2342-2019	Shah, Birju A./0000-0002-9051-1183; DeMauro, Sara/0000-0003-1647-4000; Das, Abhik/0000-0003-2722-0479; Ambalavanan, Namasivayam/0000-0003-0731-9092; McDonald, Scott/0000-0002-0054-1099; Harmon, Heidi/0000-0003-2413-1278; Pedroza, Claudia/0000-0003-4235-1282; Shankaran, Seetha/0000-0001-5512-9571; Barks, John/0000-0003-1320-905X; Bell, Edward/0000-0002-5568-0889; Huitema, Carolyn/0000-0001-8569-2795	National Institutes of Health; NICHD; National Center for Advancing Translational Sciences; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021385, UG1HD040689, UG1HD087229, UG1HD053109, UG1HD053089, U10HD068244, U10HD021373, UG1HD027880, UG1HD027904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The National Institutes of Health, the NICHD, and the National Center for Advancing Translational Sciences provided grant support for the Neonatal Research Network through cooperative agreements.	Alonso-Alconada D, 2015, STROKE, V46, P275, DOI 10.1161/STROKEAHA.114.007330; Azzopardi D, 2014, NEW ENGL J MED, V371, P140, DOI 10.1056/NEJMoa1315788; Bayley N, 2006, MANUAL BAYLEY SCALES; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Davidson JO, 2016, SCI REP-UK, V6, DOI 10.1038/srep25178; Jacobs S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub2; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Pedroza C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1480-4; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2014, JAMA-J AM MED ASSOC, V312, P2629, DOI 10.1001/jama.2014.16058; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Wood T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23430	13	130	135	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					57	67		10.1001/jama.2017.7218	http://dx.doi.org/10.1001/jama.2017.7218			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672318	Green Accepted, Green Published			2022-12-28	WOS:000404717700015
J	Urquhart, S				Urquhart, Scott			Robert Fischl OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3212	10.1136/bmj.j3212	http://dx.doi.org/10.1136/bmj.j3212			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676481				2022-12-28	WOS:000405322100003
J	Lewis, EB; Vincent, B; Brett, A; Gibson, S; Walsh, RJ				Lewis, Emma-Ben; Vincent, Ben; Brett, Alex; Gibson, Sarah; Walsh, Reubs J.			WHAT YOUR PATIENT IS THINKING I am your trans patient	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Walsh, Reubs J/Q-1752-2016	Walsh, Reubs J/0000-0002-5592-7562					0	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2017	357								j2963	10.1136/bmj.j2963	http://dx.doi.org/10.1136/bmj.j2963			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AZ	28667010	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000404725200003
J	Pandis, N; Chung, B; Scherer, RW; Elbourne, D; Altman, DG				Pandis, Nikolaos; Chung, Bryan; Scherer, Roberta W.; Elbourne, Diana; Altman, Douglas G.			CONSORT 2010 statement: extension checklist for reporting within person randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Evidence shows that the quality of reporting of randomised controlled trials (RCTs) is not optimal. The lack of transparent reporting impedes readers from judging the reliability and validity of trial findings and researchers from extracting information for systematic reviews and results in research waste. The Consolidated Standards of Reporting Trials (CONSORT) statement was developed to improve the reporting of RCTs. Within person trials are used for conditions that can affect two or more body sites, and are a useful and efficient tool because the comparisons between interventions are within people. Such trials are most commonly conducted in ophthalmology, dentistry, and dermatology. The reporting of within person trials has, however, been variable and incomplete, hindering their use in clinical decision making and by future researchers. This document presents the CONSORT extension to within person trials. It aims to facilitate the reporting of these trials. It extends 16 items of the CONSORT 2010 checklist and introduces a modified flowchart and baseline table to enhance transparency. Examples of good reporting and evidence based rationale for CONSORT within person checklist items are provided.	[Pandis, Nikolaos] Univ Bern, Med Fac, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Chung, Bryan] Univ British Columbia, Div Plast Surg, Victoria, BC, Canada; [Scherer, Roberta W.] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol Mailroom E6138, Baltimore, MD USA; [Elbourne, Diana] London Sch Hyg & Trop Med, Dept Med Stat, Healthcare Evaluat, London, England; [Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Stat Med, Oxford OX3 7LD, England	University of Bern; University of British Columbia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Pandis, N (corresponding author), Univ Bern, Med Fac, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	npandis@yahoo.com			MRC [MR/J004871/1] Funding Source: UKRI; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J004871/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Balk E.M, 2012, AHRQ PUBLICATION, V12; Bhattacharya R, 2004, J HAND SURG-BRIT EUR, V29B, P113, DOI 10.1016/j.jhsb.2003.09.001; Bland JM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-264; Bonaparte JP, 2011, CLIN OTOLARYNGOL, V36, P550, DOI 10.1111/j.1749-4486.2011.02403.x; Boutron I, 2017, ANN INTERN MED, V167, P40, DOI 10.7326/M17-0046; Bryant D, 2006, J BONE JOINT SURG AM, V88A, P41, DOI 10.2106/JBJS.E.00272; Cairo F, 2012, J CLIN PERIODONTOL, V39, P81, DOI 10.1111/j.1600-051X.2011.01839.x; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chayet A, 2012, J REFRACT SURG, V28, P112, DOI 10.3928/1081597X-20111219-01; Curtin F, 2002, STAT MED, V21, P2145, DOI 10.1002/sim.1206; Dennis DA, 2013, J ARTHROPLASTY, V28, P429, DOI 10.1016/j.arth.2012.07.019; Ebenbichler GR, 1998, BRIT MED J, V316, P731, DOI 10.1136/bmj.316.7133.731; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ejiri Soichi, 2012, Fukushima J Med Sci, V58, P49; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Esposito M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006697.pub2; Fischer TJ, 2007, ANGLE ORTHOD, V77, P417, DOI 10.2319/0003-3219(2007)077[0417:OTAWCE]2.0.CO;2; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Gonzalez P, 2012, J COSMET DERMATOL-US, V11, P251, DOI 10.1111/jocd.12013; Good WV, 2010, ARCH OPHTHALMOL-CHIC, V128, P663, DOI 10.1001/archophthalmol.2010.72; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Haraji A, 2013, J OROFAC PAIN, V27, P256, DOI 10.11607/jop.1142; Hardy RJ, 2004, CONTROL CLIN TRIALS, V25, P311, DOI 10.1016/j.cct.2004.03.003; Hayashi K, 2014, AM J OPHTHALMOL, V158, P232, DOI 10.1016/j.ajo.2014.04.018; He LM, 2015, JAMA OPHTHALMOL, V133, P51, DOI 10.1001/jamaophthalmol.2014.3876; Helsing P, 2013, BRIT J DERMATOL, V169, P1087, DOI 10.1111/bjd.12507; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hutz WW, 2012, ACTA OPHTHALMOL, V90, P530, DOI 10.1111/j.1755-3768.2010.01984.x; Innes NPT, 2011, J DENT RES, V90, P1405, DOI 10.1177/0022034511422064; Innes Nicola P, 2007, BMC Oral Health, V7, P18, DOI 10.1186/1472-6831-7-18; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Julious S A, 1999, J Biopharm Stat, V9, P241, DOI 10.1081/BIP-100101174; Karakosta A, 2012, AM J OPHTHALMOL, V153, P571, DOI 10.1016/j.ajo.2011.08.032; KATZ J, 1988, OPHTHALMIC SURG LAS, V19, P585; Kearney C, 2012, DERMATOL SURG, V38, P1002, DOI 10.1111/j.1524-4725.2012.02401.x; KLOSOK JK, 1993, J BONE JOINT SURG BR, V75, P825, DOI 10.1302/0301-620X.75B5.8376450; Koletsi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085949; Lai TYY, 2007, OPHTHAL EPIDEMIOL, V14, P390, DOI 10.1080/09286580701344399; Lee CF, 2012, OPHTHALMOLOGY, V119, P869, DOI 10.1016/j.ophtha.2011.09.025; Lesaffre E, 2007, J CLIN PERIODONTOL, V34, P756, DOI 10.1111/j.1600-051X.2007.01118.x; Lesaffre E, 2009, STAT MED, V28, P3470, DOI 10.1002/sim.3634; Leydolt C, 2013, AM J OPHTHALMOL, V156, P375, DOI 10.1016/j.ajo.2013.04.007; Lie SA, 2004, STAT MED, V23, P3227, DOI 10.1002/sim.1905; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Malecaze FJ, 2002, OPHTHALMOLOGY, V109, P1622, DOI 10.1016/S0161-6420(02)01164-8; Martignon S, 2012, J DENT RES, V91, P288, DOI 10.1177/0022034511435328; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Nanavaty MA, 2013, J CATARACT REFR SURG, V39, P705, DOI 10.1016/j.jcrs.2012.12.030; Page MJ, 2013, J CLIN EPIDEMIOL, V66, P524, DOI 10.1016/j.jclinepi.2012.10.010; Pandis N, 2014, J CLIN EPIDEMIOL, V67, P1044, DOI 10.1016/j.jclinepi.2014.04.001; Pandis N, 2014, AM J ORTHOD DENTOFAC, V145, pS152, DOI 10.1016/j.ajodo.2013.12.016; Pandis N, 2013, EUR J ORTHODONT, V35, P783, DOI 10.1093/ejo/cjs108; Pare A, 1575, J LIND LIB; Piaggio G, 2010, JAMA-J AM MED ASSOC, V2012, P2594, DOI DOI 10.1001/JAMA.2012.87802; Piltz J, 2000, AM J OPHTHALMOL, V130, P441, DOI 10.1016/S0002-9394(00)00527-4; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rajak SN, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001137; Rubel DM, 2014, BRIT J DERMATOL, V171, P1164, DOI 10.1111/bjd.13138; Scherer RW, 2012, INVEST OPHTH VIS SCI, V53, P4734; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shamseer L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1793; Smail-Faugeron V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007724; Song BH, 2014, J AM ACAD DERMATOL, V71, P764, DOI 10.1016/j.jaad.2014.05.047; Stedman MR, 2011, INT J EPIDEMIOL, V40, P1732, DOI 10.1093/ije/dyp345; Stender IM, 2000, LANCET, V355, P963, DOI 10.1016/S0140-6736(00)90013-8; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; van Zuuren EJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010334.pub2; Vasavada VA, 2012, AM J OPHTHALMOL, V154, P252, DOI 10.1016/j.ajo.2012.02.021; Waddell KM, 2004, BRIT J OPHTHALMOL, V88, P734, DOI 10.1136/bjo.2003.031187; Wang D, 2006, CLIN TRIALS PRACTICE; Wang MTM, 2015, OPTOMETRY VISION SCI, V92, pE321, DOI 10.1097/OPX.0000000000000601; Watson JM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1092; Weiss R, 2010, DERMATOL SURG, V36, P750, DOI 10.1111/j.1524-4725.2010.01547.x; Welch MN, 2012, OPHTHALMOLOGY, V119, P2048, DOI 10.1016/j.ophtha.2012.05.029; Wheelock Margaret E, 2011, Hand (N Y), V6, P47, DOI 10.1007/s11552-010-9288-2; Wiegell SR, 2012, BRIT J DERMATOL, V166, P1327, DOI 10.1111/j.1365-2133.2012.10833.x; Yu KCY, 2012, ARCH FACIAL PLAST S, V14, P198, DOI 10.1001/archfacial.2011.1142; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	84	119	120	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2017	357								j2835	10.1136/bmj.j2835	http://dx.doi.org/10.1136/bmj.j2835			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AZ	28667088	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000404725200001
J	Esteva, A; Kuprel, B; Novoa, RA; Ko, J; Swetter, SM; Blau, HM; Thrun, S				Esteva, Andre; Kuprel, Brett; Novoa, Roberto A.; Ko, Justin; Swetter, Susan M.; Blau, Helen M.; Thrun, Sebastian			Dermatologist-level classification of skin cancer with deep neural networks (vol 542, pg 115, 2017)	NATURE			English	Correction															Baxter Foundation; California Institute for Regenerative Medicine (CIRM) [TT3-05501, RB5-07469]; US National Institutes of Health (NIH) grants [AG044815, AG009521, NS089533, AR063963, AG020961]; National Institutes of Health (NIH) National Center for Advancing Translational Science Clinical and Translational Science Award [UL1 TR001085]	Baxter Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); US National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) National Center for Advancing Translational Science Clinical and Translational Science Award	In the Acknowledgements section of this Letter, the sentence: "This study was supported by the Baxter Foundation, California Institute for Regenerative Medicine (CIRM) grants TT3-05501 and RB5-07469 and US National Institutes of Health (NIH) grants AG044815, AG009521, NS089533, AR063963 and AG020961 (H.M.B.)" should have read: " This study was supported by funding from the Baxter Foundation to H.M.B." Furthermore, the last line of the Acknowledgements section should have read: " In addition, this work was supported by a National Institutes of Health (NIH) National Center for Advancing Translational Science Clinical and Translational Science Award (UL1 TR001085). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH." The original Letter has been corrected online.	Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056	1	65	71	22	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					686	686		10.1038/nature22985	http://dx.doi.org/10.1038/nature22985			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY8CH	28658222	Bronze			2022-12-28	WOS:000427090000002
J	Xiao, YB; Luo, M; Hayes, RP; Kim, J; Ng, S; Ding, F; Liao, MF; Ke, AL				Xiao, Yibei; Luo, Min; Hayes, Robert P.; Kim, Jonathan; Ng, Sherwin; Ding, Fang; Liao, Maofu; Ke, Ailong			Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System	CELL			English	Article							GUIDED SURVEILLANCE COMPLEX; IMMUNE-SYSTEM; VITRO RECONSTITUTION; CRYSTAL-STRUCTURE; RNA; DNA; CASCADE; DEGRADATION; RECOGNITION; INTERFERENCE	Type I CRISPR systems feature a sequential dsDNA target searching and degradation process, by crRNA-displaying Cascade and nuclease-helicase fusion enzyme Cas3, respectively. Here we present two cryo-EM snapshots of the Thermobifida fusca type I-E Cascade: (1) unwinding 11 bp of dsDNA at the seed-sequence region to scout for sequence complementarity, and (2) further unwinding of the entire protospacer to form a full R-loop. These structures provide the much-needed temporal and spatial resolution to resolve key mechanistic steps leading to Cas3 recruitment. In the early steps, PAM recognition causes severe DNA bending, leading to spontaneous DNA unwinding to form a seed-bubble. The full R-loop formation triggers conformational changes in Cascade, licensing Cas3 to bind. The same process also generates a bulge in the non-target DNA strand, enabling its handover to Cas3 for cleavage. The combination of both negative and positive checkpoints ensures stringent yet efficient target degradation in type I CRISPR-Cas systems.	[Xiao, Yibei; Hayes, Robert P.; Kim, Jonathan; Ng, Sherwin; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA; [Luo, Min; Liao, Maofu] Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA; [Hayes, Robert P.] Merck & Co Inc, 770 Sumneytown Pike, West Point, PA 19486 USA	Cornell University; Harvard University; Harvard Medical School; Merck & Company	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA.; Liao, MF (corresponding author), Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave,SGM 509, Boston, MA 02115 USA.	maofu_liao@hms.harvard.edu; ailong.ke@cornell.edu	Liao, Maofu/AAD-7333-2021; Luo, Min/H-1573-2015	Liao, Maofu/0000-0002-3481-450X; Luo, Min/0000-0002-3493-2282; Ng, Sherwin/0000-0002-4797-1694; Hayes, Robert/0000-0003-4947-4410	National Institutes of Health (NIH) [GM118174, GM116632]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116632, R01GM102543, R35GM118174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) grants GM118174 and GM116632 to A.K. We thank M. Chambers and Z. Li for EM technical support; B. Carragher, C. Potter, and R. Grassucci for initial EM analysis; and I. Finkelstein, I. Price, R. Battaglia, and A. Dolan for discussions. Reprints and permissions information are available at XXXX. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to A.K. (ailong.ke@cornell.edu) or M.L. (maofu_liao@hms.harvard.edu). A. K. dedicates this work to his colleague, Professor David B. Wilson (deceased), in memory of his scientific contribution in exploring the bacterium Thermobifida fusca.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Gorski SA, 2017, NAT REV MOL CELL BIO, V18, P215, DOI 10.1038/nrm.2016.174; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jiang FG, 2015, CURR OPIN STRUC BIOL, V30, P100, DOI 10.1016/j.sbi.2015.02.002; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nishimasu H, 2017, CURR OPIN STRUC BIOL, V43, P68, DOI 10.1016/j.sbi.2016.11.013; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Rutkauskas M., 2015, CELL REP; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	55	89	93	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					48	+		10.1016/j.cell.2017.06.012	http://dx.doi.org/10.1016/j.cell.2017.06.012			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666122	Green Accepted, Bronze			2022-12-28	WOS:000404358500009
J	Keusch, GT; McAdam, KPWJ				Keusch, Gerald T.; McAdam, Keith P. W. J.			Clinical trials during epidemics	LANCET			English	Editorial Material							OUTBREAK; LIBERIA		[Keusch, Gerald T.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA; [McAdam, Keith P. W. J.] London Sch Hyg & Trop Med, London, England	Boston University; University of London; London School of Hygiene & Tropical Medicine	Keusch, GT (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA.	keusch@bu.edu		/0000-0001-5724-2965				Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Doe-Anderson J, 2016, CONT CLIN TRIAL COMM, V4, P68, DOI 10.1016/j.conctc.2016.06.008; Kennedy SB, 2016, CLIN TRIALS, V13, P49, DOI 10.1177/1740774515621037; Lang T, 2015, NATURE, V524, P29, DOI 10.1038/524029a; US National Academies of Sciences Engineering and Medicine, 2017, COMM CLIN TRIALS DUR; WHO Regional Office for Africa, 2014, EB HAEM FEV GUIN; Wilkinson S, 2016, USING MEDIA COMMUNIC; World Health Organization, 2014, 1 M IHR EM COMM 2014	8	12	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2455	2457						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28656892				2022-12-28	WOS:000403901800011
J	de Waal, F				de Waal, Frans			Behave The Biology of Humans at Our Best and Worst	SCIENCE			English	Book Review									[de Waal, Frans] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Emory University	de Waal, F (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	dewaal@emory.edu						Sapolsky Robert M., 2017, BEHAVE BIOL HUMANS O	1	2	2	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1239	1240		10.1126/science.aan4208	http://dx.doi.org/10.1126/science.aan4208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642400				2022-12-28	WOS:000403881700023
J	Woolhandler, S; Himmelstein, DU				Woolhandler, Steffie; Himmelstein, David U.			The Relationship of Health Insurance and Mortality: Is Lack of Insurance Deadly?	ANNALS OF INTERNAL MEDICINE			English	Article							UNIVERSAL HEALTH; UNINSURED ADULTS; NATIONAL-HEALTH; UNITED-STATES; COVERAGE; CARE; MEDICARE; HYPERTENSION; ACCESS; IMPACT	About 28 million Americans are currently uninsured, and millions more could lose coverage under policy reforms proposed in Congress. At the same time, a growing number of policy leaders have called for going beyond the Patient Protection and Affordable Care Act to a single-payer national health insurance system that would cover every American. These policy debates lend particular salience to studies evaluating the health effects of insurance coverage. In 2002, an Institute of Medicine review concluded that lack of insurance increases mortality, but several rel-evant studies have appeared since that time. This article summarizes current evidence concerning the relationship of insurance and mortality. The evidence strengthens confidence in the Institute of Medicine's conclusion that health insurance saves lives: The odds of dying among the insured relative to the uninsured is 0.71 to 0.97.	CUNY Hunter Coll, Sch Urban Publ Hlth, New York, NY 10021 USA; Harvard Med Sch, Boston, MA USA; [Woolhandler, Steffie; Himmelstein, David U.] 255 West 90th St, New York, NY 10024 USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Harvard Medical School	Himmelstein, DU (corresponding author), 255 West 90th St, New York, NY 10024 USA.	dhimmels@hunter.cuny.edu						[Anonymous], HEALTH-LONDON, V8, P289, DOI [10.13031/2013, DOI 10.13031/2013, 10.1787/health-data-en, DOI 10.1787/HEALTH-DATA-EN]; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Baicker K, 2011, NEW ENGL J MED, V365, P683, DOI 10.1056/NEJMp1108222; Baker DW, 2006, MED CARE, V44, P277, DOI 10.1097/01.mlr.0000199696.41480.45; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Black B, 2017, J HLTH EC, DOI [10.1162/AJHE_a_00076, DOI 10.1162/AJHE_]; Card D, 2009, Q J ECON, V124, P597, DOI 10.1162/qjec.2009.124.2.597; Card D, 2008, AM ECON REV, V98, P2242, DOI 10.1257/aer.98.5.2242; Christopher AS, 2016, AM J PUBLIC HEALTH, V106, P63, DOI 10.2105/AJPH.2015.302925; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Currie J, 1996, Q J ECON, V111, P431, DOI 10.2307/2946684; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Egan BM, 2014, HYPERTENSION, V64, P997, DOI 10.1161/HYPERTENSIONAHA.114.04276; FIHN SD, 1988, J GEN INTERN MED, V3, P356, DOI 10.1007/BF02595794; Finkelstein A, 2008, J PUBLIC ECON, V92, P1644, DOI 10.1016/j.jpubeco.2007.10.005; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Five-year findings of the hypertension detection and follow-up program, 1979, JAMA-J AM MED ASSOC, V242, P2562; Fox JB, 2014, MMWR-MORBID MORTAL W, V63, P666; FRANKS P, 1993, JAMA-J AM MED ASSOC, V270, P737, DOI 10.1001/jama.270.6.737; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Hadley J, 2006, HEALTH SERV RES, V41, P429, DOI 10.1111/j.1475-6773.2005.00491.x; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Hanratty MJ, 1996, AM ECON REV, V86, P276; Hsu CD, 2017, CANCER-AM CANCER SOC, V123, P3125, DOI 10.1002/cncr.30722; Institute of Medicine, 2002, CAR COV TOO LITTL TO; KASS EH, 1982, BRIT J CLIN PHARMACO, V13, P81; KEELER EB, 1985, JAMA-J AM MED ASSOC, V254, P1926; Kronick R, 2009, HEALTH SERV RES, V44, P1211, DOI 10.1111/j.1475-6773.2009.00973.x; Krugman P, 2017, YOUTUBE VIDEO   0522; Lee YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-225; Levy H, 2008, ANNU REV PUBL HEALTH, V29, P399, DOI 10.1146/annurev.publhealth.28.021406.144042; LICHTENBERG FR, 2002, FRONTIERS HLTH POLIC, V5; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; McWilliams JM, 2007, JAMA-J AM MED ASSOC, V298, P2886, DOI 10.1001/jama.298.24.2886; McWilliams JM, 2009, MILBANK Q, V87, P443, DOI 10.1111/j.1468-0009.2009.00564.x; McWilliams JM, 2004, HEALTH AFFAIR, V23, P223, DOI 10.1377/hlthaff.23.4.223; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Morriss FH, 2013, HEALTH SERV RES, V48, P1232, DOI 10.1111/1475-6773.12042; Newhouse JP, 2003, FREE ALL LESSONS RAN; Polsky D, 2009, HEALTH SERV RES, V44, P926, DOI 10.1111/j.1475-6773.2009.00964.x; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Sommers BD, 2017, AM J HEALTH ECON, V3, P392, DOI 10.1162/ajhe_a_00080; Sommers BD, 2014, ANN INTERN MED, V160, P585, DOI 10.7326/M13-2275; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; SORLIE PD, 1994, ARCH INTERN MED, V154, P2409, DOI 10.1001/archinte.154.21.2409; Stephenson AL, 2017, ANN INTERN MED, V166, P537, DOI 10.7326/M16-0858; Weathers Robert R 2nd, 2010, Soc Secur Bull, V70, P25; Weathers RR, 2012, J HEALTH ECON, V31, P863, DOI 10.1016/j.jhealeco.2012.08.004; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; Wilper AP, 2009, HEALTH AFFAIR, V28, pW1151, DOI 10.1377/hlthaff.28.6.w1151	52	94	94	1	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2017	167	6					424	+		10.7326/M17-1403	http://dx.doi.org/10.7326/M17-1403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FH2YU	28655034				2022-12-28	WOS:000411009900019
J	Kwakkel, G; van Wegen, EEH				Kwakkel, Gert; van Wegen, Erwin E. H.			Family-delivered rehabilitation services at home: is the glass empty?	LANCET			English	Editorial Material							STROKE; TRIAL		[Kwakkel, Gert; van Wegen, Erwin E. H.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam Movement Sci, NL-1081 HV Amsterdam, Netherlands; [Kwakkel, Gert; van Wegen, Erwin E. H.] Amsterdam Neurosci, Amsterdam, Netherlands; [Kwakkel, Gert] Reade, Neurorehabil Res Ctr, Amsterdam, Netherlands; [Kwakkel, Gert] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Northwestern University	Kwakkel, G (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam Movement Sci, NL-1081 HV Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Amsterdam Neurosci, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Reade, Neurorehabil Res Ctr, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	g.kwakkel@vumc.nl		van Wegen, Erwin/0000-0002-7920-9995; Kwakkel, Gert/0000-0002-4041-4043				Alim M, 2016, TRIALS, V17, DOI 10.1186/s13063-015-1129-8; Fearon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000443.pub3; Forster A, 2013, LANCET, V382, P2069, DOI 10.1016/S0140-6736(13)61603-7; Ganjiwale Deepak, 2016, J Family Med Prim Care, V5, P129, DOI 10.4103/2249-4863.184637; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; The ATTEND Collaborative Group, 2017, LANCET; van den Berg M, 2016, STROKE, V47, P1885, DOI 10.1161/STROKEAHA.116.013431; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vloothuis JDM, 2016, COCHRANE DB SYST REV, V12; Wolf SL, 2016, PHYSIOTHERAPY, V102, P1, DOI 10.1016/j.physio.2015.08.007	12	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2017	390	10094					538	539		10.1016/S0140-6736(17)31489-7	http://dx.doi.org/10.1016/S0140-6736(17)31489-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC5BM	28666681				2022-12-28	WOS:000406855800007
J	Jazayeri, A; Rappas, M; Brown, AJH; Kean, J; Errey, JC; Robertson, NJ; Fiez-Vandal, C; Andrews, SP; Congreve, M; Bortolato, A; Mason, JS; Baig, AH; Teobald, I; Dore, AS; Weir, M; Cooke, RM; Marshall, FH				Jazayeri, Ali; Rappas, Mathieu; Brown, Alastair J. H.; Kean, James; Errey, James C.; Robertson, Nathan J.; Fiez-Vandal, Cedric; Andrews, Stephen P.; Congreve, Miles; Bortolato, Andrea; Mason, Jonathan S.; Baig, Asma H.; Teobald, Iryna; Dore, Andrew S.; Weir, Malcolm; Cooke, Robert M.; Marshall, Fiona H.			Crystal structure of the GLP-1 receptor bound to a peptide agonist (vol 546, pg 254, 2017)	NATURE			English	Correction																		Andrews A., 2017, UK patent application, Patent No. [GB1522431.4, 1522431]; Jazayeri A, 2017, NATURE, V546, P254, DOI 10.1038/nature22800; Kodra J. T., 2011, Worldwide patent, Patent No. [WO2011073328, 2011073328]	3	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2017	548	7665								10.1038/nature23311	http://dx.doi.org/10.1038/nature23311			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC4SU	28700581	Bronze			2022-12-28	WOS:000406831700049
J	Althoff, T; Sosic, R; Hicks, JL; King, AC; Delp, SL; Leskovec, J				Althoff, Tim; Sosic, Rok; Hicks, Jennifer L.; King, Abby C.; Delp, Scott L.; Leskovec, Jure			Large-scale physical activity data reveal worldwide activity inequality	NATURE			English	Article							INCOME INEQUALITY; HEALTH; VALIDATION; INACTIVITY; BEHAVIORS; MORTALITY; TRACKING; PROGRESS; SLEEP; STEPS	To be able to curb the global pandemic of physical inactivity(1-7) and the associated 5.3 million deaths per year(2), we need to understand the basic principles that govern physical activity. However, there is a lack of large-scale measurements of physical activity patterns across free-living populations worldwide(1,6). Here we leverage the wide usage of smartphones with built-in accelerometry to measure physical activity at the global scale. We study a dataset consisting of 68 million days of physical activity for 717,527 people, giving us a window into activity in 111 countries across the globe. We find inequality in how activity is distributed within countries and that this inequality is a better predictor of obesity prevalence in the population than average activity volume. Reduced activity in females contributes to a large portion of the observed activity inequality. Aspects of the built environment, such as the walkability of a city, are associated with a smaller gender gap in activity and lower activity inequality. In more walkable cities, activity is greater throughout the day and throughout the week, across age, gender, and body mass index (BMI) groups, with the greatest increases in activity found for females. Our findings have implications for global public health policy and urban planning and highlight the role of activity inequality and the built environment in improving physical activity and health.	[Althoff, Tim; Sosic, Rok; Leskovec, Jure] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Hicks, Jennifer L.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [King, Abby C.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Dept Med, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Leskovec, Jure] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Leskovec, J (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Leskovec, J (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	jure@cs.stanford.edu	King, Abby/AAD-5257-2021	Leskovec, Jure/0000-0002-5411-923X; Hicks, Jennifer/0000-0002-2516-9334; Delp, Scott/0000-0002-9643-7551; King, Abby/0000-0002-7949-8811	National Institutes of Health (NIH) [U54 EB020405]; SAP Stanford Graduate Fellowship; NIH National Center for Simulation in Rehabilitation Research [R24 HD065690, P2C HD065690]; NSF [IIS-1149837]; Stanford Data Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD065690, P2CHD065690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB020405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SAP Stanford Graduate Fellowship; NIH National Center for Simulation in Rehabilitation Research; NSF(National Science Foundation (NSF)); Stanford Data Science Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Further information and data are available at http://activityinequality.stanford.edu. We thank Azumio for donating the data for independent research, and T. Uchida and W. Hamilton for comments and discussions. T.A., R.S., J.L.H., A.C.K., S.L.D. and J.L. were supported by a National Institutes of Health (NIH) grant (U54 EB020405, Mobilize Center, NIH Big Data to Knowledge Center of Excellence). T. A. was supported by the SAP Stanford Graduate Fellowship. J.L.H. and S.L.D. were supported by grants R24 HD065690 and P2C HD065690 (NIH National Center for Simulation in Rehabilitation Research). J.L. and R.S. were supported by NSF grant IIS-1149837 and the Stanford Data Science Initiative. J.L. is a Chan Zuckerberg Biohub investigator.	ALLISON PD, 1978, AM SOCIOL REV, V43, P865, DOI 10.2307/2094626; Anthes E, 2016, NATURE, V532, P20, DOI 10.1038/532020a; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Basner M, 2007, SLEEP, V30, P1085, DOI 10.1093/sleep/30.9.1085; Bassett DR, 2010, MED SCI SPORT EXER, V42, P1819, DOI 10.1249/MSS.0b013e3181dc2e54; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Brown WJ, 2016, LANCET, V388, P1257, DOI 10.1016/S0140-6736(16)30881-9; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Centers for Disease Control and Prevention, 2012, VIT SIGNS MOR PEOPL; Chokshi DA, 2014, SCIENCE, V345, P1243, DOI 10.1126/science.1259809; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; Duncan DT, 2011, INT J ENV RES PUB HE, V8, P4160, DOI 10.3390/ijerph8114160; Efron B., 1994, MONOGRAPHS STAT APPL; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gonzalez MC, 2009, NATURE, V458, DOI 10.1038/nature07850; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hekler EB, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3505; Kawachi I, 1997, SOC SCI MED, V45, P1121, DOI 10.1016/S0277-9536(97)00044-0; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Physical Activity Guidelines Advisory Committee, PHYS ACT GUID REP; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Reis RS, 2016, LANCET, V388, P1337, DOI 10.1016/S0140-6736(16)30728-0; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Servick K, 2015, SCIENCE, V350, P1306, DOI 10.1126/science.350.6266.1306; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; The World Bank, WORLD BANK COUNTR LE; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; UN Secretary General, PREV CONTR NONC DIS; United States Census Bureau (USCB), BAY AR CENS 2010 CEN; US_CB, AM COMMUNITY SURVEY; Van Dyck D, 2015, INT J OBESITY, V39, P199, DOI 10.1038/ijo.2014.115; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; Walch OJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501705; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; World Bank, POP FEM TOT; World Health Organization, GLOB REC PHYS ACT HL; World Health Organization, PREV INS PHYS ACT AD; World Health Organization, OBESITY	45	444	452	25	262	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					336	+		10.1038/nature23018	http://dx.doi.org/10.1038/nature23018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB0OR	28693034	Green Accepted			2022-12-28	WOS:000405844900031
J	Constantino, JN; Kennon-McGill, S; Weichselbaum, C; Marrus, N; Haider, A; Glowinski, AL; Gillespie, S; Klaiman, C; Klin, A; Jones, W				Constantino, John N.; Kennon-McGill, Stefanie; Weichselbaum, Claire; Marrus, Natasha; Haider, Alyzeh; Glowinski, Anne L.; Gillespie, Scott; Klaiman, Cheryl; Klin, Ami; Jones, Warren			Infant viewing of social scenes is under genetic control and is atypical in autism	NATURE			English	Article							FRONTAL EYE FIELD; VISUAL-ATTENTION; GENERAL-POPULATION; SPECTRUM DISORDER; SALIENCE; TRAITS; TODDLERS; BEHAVIOR; SEARCH; ADULTS	Long before infants reach, crawl or walk, they explore the world by looking: they look to learn and to engage(1), giving preferential attention to social stimuli, including faces(2), facelike stimuli(3) and biological motion(4). This capacity-social visual engagement-shapes typical infant development from birth(5) and is pathognomonically impaired in children affected by autism(6). Here we show that variation in viewing of social scenes, including levels of preferential attention and the timing, direction and targeting of individual eye movements, is strongly influenced by genetic factors, with effects directly traceable to the active seeking of social information(7). In a series of eye-tracking experiments conducted with 338 toddlers, including 166 epidemiologically ascertained twins (enrolled by representative sampling from the general population), 88 non-twins with autism and 84 singleton controls, we find high monozygotic twin-twin concordance (0.91) and relatively low dizygotic concordance (0.35). Moreover, the characteristics that are the most highly heritable, preferential attention to eye and mouth regions of the face, are also those that are differentially decreased in children with autism (chi(2) = 64.03, P < 0.0001). These results implicate social visual engagement as a neurodevelopmental endophenotype not only for autism, but also for population-wide variation in social-information seeking(8). In addition, these results reveal a means of human biological niche construction, with phenotypic differences emerging from the interaction of individual genotypes with early life experience(7).	[Constantino, John N.; Kennon-McGill, Stefanie; Weichselbaum, Claire; Marrus, Natasha; Haider, Alyzeh; Glowinski, Anne L.] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Constantino, John N.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Constantino, John N.; Marrus, Natasha] Washington Univ, Intellectual & Dev Disabil Res Ctr, St Louis, MO 63110 USA; [Gillespie, Scott] Emory Univ, Sch Med, Pediat Biostat Core, Atlanta, GA 30307 USA; [Klaiman, Cheryl; Klin, Ami; Jones, Warren] Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA; [Klaiman, Cheryl; Klin, Ami; Jones, Warren] Emory Univ, Sch Med, Div Autism & Related Disabil, Dept Pediat, Atlanta, GA 30329 USA; [Klin, Ami; Jones, Warren] Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30329 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Emory University	Constantino, JN (corresponding author), Washington Univ, Dept Psychiat, St Louis, MO 63110 USA.; Constantino, JN (corresponding author), Washington Univ, Dept Pediat, St Louis, MO 63110 USA.; Constantino, JN (corresponding author), Washington Univ, Intellectual & Dev Disabil Res Ctr, St Louis, MO 63110 USA.; Jones, W (corresponding author), Childrens Healthcare Atlanta, Marcus Autism Ctr, Atlanta, GA 30329 USA.; Jones, W (corresponding author), Emory Univ, Sch Med, Div Autism & Related Disabil, Dept Pediat, Atlanta, GA 30329 USA.; Jones, W (corresponding author), Emory Univ, Ctr Translat Social Neurosci, Atlanta, GA 30329 USA.	constantino@wustl.edu; warren.jones@emory.edu			National Institute of Child Health & Human Development [HD068479, U54 HD087011]; National Institute of Mental Health [MH100019, MH100029]; Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; project entitled Early Quantitative Characterization of Reciprocal Social Behavior; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011, R01HD068479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH100019, K08MH112891, P50MH100029] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Marcus Foundation; Whitehead Foundation; Georgia Research Alliance; project entitled Early Quantitative Characterization of Reciprocal Social Behavior; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the families and children for their participation. Research was supported by grants from the National Institute of Child Health & Human Development, HD068479 (J.N.C.) and U54 HD087011 (Intellectual and Developmental Disabilities Research Center at Washington University, J.N.C., principal investigator); and by the National Institute of Mental Health, MH100019 (N.M.) and MH100029 (A.K., W.J.). Additional support was provided by the Marcus Foundation, the Whitehead Foundation and the Georgia Research Alliance. Epidemiologic ascertainment of twins was made possible by the Missouri Family Register, a joint program of Washington University and the Missouri Department of Health and Senior Services; authorization to access was approved by the MO DHSS Institutional Review Board (S. Ayers, Chair) under auspices of the project entitled Early Quantitative Characterization of Reciprocal Social Behavior. We thank E. Mortenson, S. Sant, T. Gray, Y. Zhang, L. Campbell, L. Malik, A. Khan and E. McGarry for data collection and analysis; A. C. Heath and A. Agrawal for discussions of data analysis and statistics; C. Gunter for helpful comments on the manuscript; C. Drain and D. Hopper for project coordination and data collection; D. Jovanovic and R. Todorovic for contributions to twin family ascertainment; M. Panther for administrative support; and S. Kovar, J. Paredes, and M. Ly for designing and building the eye-tracking laboratory.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BRUCE CJ, 1984, TRENDS NEUROSCI, V7, P436, DOI 10.1016/S0166-2236(84)80149-6; Constantino JN, 2013, MOL PSYCHIATR, V18, P137, DOI 10.1038/mp.2012.9; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Constantino JN, 2000, AM J PSYCHIAT, V157, P2043, DOI 10.1176/appi.ajp.157.12.2043; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Constantino JN, 2016, LANCET NEUROL, V15, P279, DOI 10.1016/S1474-4422(15)00151-9; Constantino JN, 2009, DEV PSYCHOPATHOL, V21, P127, DOI 10.1017/S095457940900008X; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fairchild M. D., 2005, COLOR APPEARANCE MOD; FLEISS JL, 1978, PSYCHOMETRIKA, V43, P259, DOI 10.1007/BF02293867; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Geschwind DH, 2015, LANCET NEUROL, V14, P1109, DOI 10.1016/S1474-4422(15)00044-7; Ghazanfar AA, 2004, NAT REV NEUROSCI, V5, P603, DOI 10.1038/nrn1473; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Giraudeau B, 1996, J CLIN EPIDEMIOL, V49, P1205, DOI 10.1016/0895-4356(96)00053-4; Good P., 2000, PERMUTATION PARAMETR; GOREN CC, 1975, PEDIATRICS, V56, P544; Hanes DP, 2001, J NEUROPHYSIOL, V85, P804, DOI 10.1152/jn.2001.85.2.804; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; JACQUARD A, 1983, BIOMETRICS, V39, P465, DOI 10.2307/2531017; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2003, PHILOS T R SOC B, V358, P345, DOI 10.1098/rstb.2002.1202; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Liben L. S., 2015, HDB CHILD PSYCHOL DE, V2; Locke J.L., 1993, CHILDS PATH SPOKEN L; Lord C., 2002, AUTISM DIAGNOSTIC OB; Magiati I, 2014, CLIN PSYCHOL REV, V34, P73, DOI 10.1016/j.cpr.2013.11.002; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Marr D., 1982, Vision. A computational investigation into the human representation and processing of visual information; Marrus N, 2015, J CHILD PSYCHOL PSYC, V56, P1338, DOI 10.1111/jcpp.12391; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; NEALE MC, 1989, J PERS SOC PSYCHOL, V56, P446, DOI 10.1037/0022-3514.56.3.446; Oppenheim A. V., 1975, DIGITAL SIGNAL PROCE; Oyama S., 2000, EVOLUTIONS EYE SYSTE; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Pearce JM, 2001, ANNU REV PSYCHOL, V52, P111, DOI 10.1146/annurev.psych.52.1.111; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Robinson EB, 2011, ARCH GEN PSYCHIAT, V68, P1113, DOI 10.1001/archgenpsychiatry.2011.119; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.2307/1129703; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHNYDER H, 1985, BRAIN RES, V329, P151, DOI 10.1016/0006-8993(85)90520-7; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Shultz S, 2011, P NATL ACAD SCI USA, V108, P21270, DOI 10.1073/pnas.1109304108; Simion F, 2007, PROG BRAIN RES, V164, P169, DOI 10.1016/S0079-6123(07)64009-6; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Yantis S, 1999, J EXP PSYCHOL HUMAN, V25, P661, DOI 10.1037/0096-1523.25.3.661	62	134	138	5	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					340	+		10.1038/nature22999	http://dx.doi.org/10.1038/nature22999			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FB0OR	28700580	Green Accepted			2022-12-28	WOS:000405844900032
J	Horton, R				Horton, Richard			Offline: Not one day more	LANCET			English	Editorial Material												richard.horton@lancet.com							0	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					110	110		10.1016/S0140-6736(17)31798-1	http://dx.doi.org/10.1016/S0140-6736(17)31798-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28699580	Bronze			2022-12-28	WOS:000404976600014
J	Baumhauer, JF				Baumhauer, Judith F.			Patient-Reported Outcomes - Are They Living Up to Their Potential?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROMIS		[Baumhauer, Judith F.] Univ Rochester, Med Ctr, Dept Orthoped, Rochester, NY 14642 USA	University of Rochester	Baumhauer, JF (corresponding author), Univ Rochester, Med Ctr, Dept Orthoped, Rochester, NY 14642 USA.							Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Ho B, 2016, FOOT ANKLE INT, V37, P911, DOI 10.1177/1071100716665113; Papuga MO, 2014, J ORTHOP RES, V32, P793, DOI 10.1002/jor.22591; Papuga MO, 2017, HLTH SYST BASIN 0412	4	125	128	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					6	9		10.1056/NEJMp1702978	http://dx.doi.org/10.1056/NEJMp1702978			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679102				2022-12-28	WOS:000404730000003
J	Nagano, T; Lubling, Y; Vaarnai, C; Dudley, C; Leung, W; Baran, Y; Cohen, NM; Wingett, S; Fraser, P; Tanay, A				Nagano, Takashi; Lubling, Yaniv; Varnai, Csilla; Dudley, Carmel; Leung, Wing; Baran, Yael; Cohen, Netta Mendelson; Wingett, Steven; Fraser, Peter; Tanay, Amos			Cell-cycle dynamics of chromosomal organization at single-cell resolution	NATURE			English	Article							TOPOLOGICALLY ASSOCIATING DOMAINS; CHROMATIN; PRINCIPLES; REORGANIZATION; COHESIN; GENOME	Chromosomes in proliferating metazoan cells undergo marked structural metamorphoses every cell cycle, alternating between highly condensed mitotic structures that facilitate chromosome segregation, and decondensed interphase structures that accommodate transcription, gene silencing and DNA replication. Here we use single-cell Hi-C (high-resolution chromosome conformation capture) analysis to study chromosome conformations in thousands of individual cells, and discover a continuum of cis-interaction profiles that finely position individual cells along the cell cycle. We show that chromosomal compartments, topological-associated domains (TADs), contact insulation and long-range loops, all defined by bulk Hi-C maps, are governed by distinct cell-cycle dynamics. In particular, DNA replication correlates with a build-up of compartments and a reduction in TAD insulation, while loops are generally stable from G1 to S and G2 phase. Whole-genome three-dimensional structural models reveal a radial architecture of chromosomal compartments with distinct epigenomic signatures. Our single-cell data therefore allow re-interpretation of chromosome conformation maps through the prism of the cell cycle.	[Nagano, Takashi; Varnai, Csilla; Leung, Wing; Wingett, Steven; Fraser, Peter] Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England; [Lubling, Yaniv; Dudley, Carmel; Baran, Yael; Cohen, Netta Mendelson; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Lubling, Yaniv; Dudley, Carmel; Baran, Yael; Cohen, Netta Mendelson; Tanay, Amos] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Fraser, Peter] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Weizmann Institute of Science; Weizmann Institute of Science; State University System of Florida; Florida State University	Vaarnai, C; Fraser, P (corresponding author), Babraham Inst, Nucl Dynam Programme, Cambridge CB22 3AT, England.; Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.; Tanay, A (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel.; Fraser, P (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	csilla.varnai@babraham.ac.uk; peter.fraser@babraham.ac.uk; amos.tanay@weizmann.ac.il	Várnai, Csilla/AAB-6348-2022	Várnai, Csilla/0000-0003-0048-9507; Lubling, Yaniv/0000-0003-3461-9621; Wingett, Steven/0000-0002-2343-0711	National Institutes of Health [1U01HL129971-01]; European Research Council [340152, 309706]; Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL129971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank M. Leeb, A. Wutz and J. Gribnau for haploid and diploid ES cells, and the Babraham Flow Cytometry and Sequencing Facilities for assistance. This work was supported by grants from the National Institutes of Health 4D Nucleome 1U01HL129971-01, European Research Council 340152 and 309706, and the Flight Attendant Medical Research Institute.	Boettiger AN, 2016, NATURE, V529, P418, DOI 10.1038/nature16496; Britton-Davidian J, 2012, HEREDITY, V108, P68, DOI 10.1038/hdy.2011.105; de Wit E, 2015, MOL CELL, V60, P676, DOI 10.1016/j.molcel.2015.09.023; Dileep V, 2015, GENOME RES, V25, P1104, DOI 10.1101/gr.183699.114; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Flyamer IM, 2017, NATURE, V544, P110, DOI 10.1038/nature21711; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Nagano T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0753-7; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Olivares-Chauvet P, 2016, NATURE, V540, P296, DOI 10.1038/nature20158; Paweletz N, 2001, NAT REV MOL CELL BIO, V2, P72, DOI 10.1038/35048077; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Ramani V, 2017, NAT METHODS, V14, P263, DOI [10.1038/NMETH.4155, 10.1038/nmeth.4155]; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Stevens TJ, 2017, NATURE, V544, P59, DOI 10.1038/nature21429; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	23	380	387	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					61	+		10.1038/nature23001	http://dx.doi.org/10.1038/nature23001			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682332	Green Accepted, Green Submitted			2022-12-28	WOS:000404839900031
J	Sengor, AMC; Lom, N				Sengor, A. M. Celal; Lom, Nalan			Stop ruining Turkey's geological heritage	NATURE			English	Letter									[Sengor, A. M. Celal; Lom, Nalan] Istanbul Tech Univ, Istanbul, Turkey	Istanbul Technical University	Sengor, AMC (corresponding author), Istanbul Tech Univ, Istanbul, Turkey.	sengor@itu.edu.tr	lom, nalan/AAE-7164-2020	Lom, Nalan/0000-0002-5553-4937					0	5	5	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					32	32		10.1038/547032d	http://dx.doi.org/10.1038/547032d			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682329	Bronze			2022-12-28	WOS:000404839900021
J	Jha, AK				Jha, Ashish K.			Payment Power to the Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Int Hlth & Hlth Policy, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA	Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Int Hlth & Hlth Policy, Boston, MA 02115 USA.; Jha, AK (corresponding author), Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA.	ajha@hsph.harvard.edu							0	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					18	19		10.1001/jama.2017.7533	http://dx.doi.org/10.1001/jama.2017.7533			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672304				2022-12-28	WOS:000404717700003
J	Vogel, G				Vogel, Gretchen			Europe's top court alarms vaccine experts	SCIENCE			English	News Item																			0	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1320	1320		10.1126/science.356.6345.1320	http://dx.doi.org/10.1126/science.356.6345.1320			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663450				2022-12-28	WOS:000404351500011
J	Wade, L				Wade, Lizzie			Predicting where victims of Mexico's violence are buried	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1317	1318		10.1126/science.356.6345.1317	http://dx.doi.org/10.1126/science.356.6345.1317			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663448				2022-12-28	WOS:000404351500009
J	Duan, HB; Li, JH; Liu, G				Duan, Huabo; Li, Jinhui; Liu, Gang			Growing threat of urban waste dumps	NATURE			English	Letter									[Duan, Huabo] Shenzhen Univ, Shenzhen, Peoples R China; [Li, Jinhui] Tsinghua Univ, Beijing, Peoples R China; [Liu, Gang] Univ Southern Denmark, Odense, Denmark	Shenzhen University; Tsinghua University; University of Southern Denmark	Liu, G (corresponding author), Univ Southern Denmark, Odense, Denmark.	gli@kbm.sdu.dk		Liu, Gang/0000-0002-7613-1985				Bai XM, 2014, NATURE, V509, P158, DOI 10.1038/509158a; Hoornweg D, 2013, NATURE, V502, P615, DOI 10.1038/502615a	2	15	15	6	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					599	599		10.1038/546599b	http://dx.doi.org/10.1038/546599b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658232	Bronze			2022-12-28	WOS:000404332000025
J	Gelebart, AH; Mulder, DJ; Varga, M; Konya, A; Vantomme, G; Meijer, EW; Selinger, RLB; Broer, DJ				Gelebart, Anne Helene; Mulder, Dirk Jan; Varga, Michael; Konya, Andrew; Vantomme, Ghislaine; Meijer, E. W.; Selinger, Robin L. B.; Broer, Dirk J.			Making waves in a photoactive polymer film	NATURE			English	Article							CRYSTAL NETWORK ACTUATORS; SELF-OSCILLATING GEL; PERISTALTIC MOTION; LIGHT; AZOBENZENE; DRIVEN; PHOTOISOMERIZATION; DEVICES	Oscillating materials(1-4) that adapt their shapes in response to external stimuli are of interest for emerging applications in medicine and robotics. For example, liquid-crystal networks can be programmed to undergo stimulus-induced deformations in various geometries, including in response to light(5,6). Azobenzene molecules are often incorporated into liquid-crystal polymer films to make them photoresponsive(7-11); however, in most cases only the bending responses of these films have been studied, and relaxation after photo-isomerization is rather slow. Modifying the core or adding substituents to the azobenzene moiety can lead to marked changes in photophysical and photochemical properties(12-15), providing an opportunity to circumvent the use of a complex set-up that involves multiple light sources, lenses or mirrors. Here, by incorporating azobenzene derivatives with fast cis-to-trans thermal relaxation into liquid-crystal networks, we generate photoactive polymer films that exhibit continuous, directional, macroscopic mechanical waves under constant light illumination, with a feedback loop that is driven by self-shadowing. We explain the mechanism of wave generation using a theoretical model and numerical simulations, which show good qualitative agreement with our experiments. We also demonstrate the potential application of our photoactive films in light-driven locomotion and self-cleaning surfaces, and anticipate further applications in fields such as photomechanical energy harvesting and miniaturized transport.	[Gelebart, Anne Helene; Mulder, Dirk Jan; Broer, Dirk J.] Eindhoven Univ Technol, Lab Funct Organ Mat & Devices SFD, Dept Chem Engn & Chem, Eindhoven, Netherlands; [Gelebart, Anne Helene; Vantomme, Ghislaine; Meijer, E. W.; Broer, Dirk J.] Eindhoven Univ Technol, ICMS, Eindhoven, Netherlands; [Varga, Michael; Konya, Andrew; Selinger, Robin L. B.] Kent State Univ, Inst Liquid Crystal, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA	Eindhoven University of Technology; Eindhoven University of Technology; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Broer, DJ (corresponding author), Eindhoven Univ Technol, Lab Funct Organ Mat & Devices SFD, Dept Chem Engn & Chem, Eindhoven, Netherlands.; Broer, DJ (corresponding author), Eindhoven Univ Technol, ICMS, Eindhoven, Netherlands.; Selinger, RLB (corresponding author), Kent State Univ, Inst Liquid Crystal, Chem Phys Interdisciplinary Program, Kent, OH 44242 USA.	rselinge@kent.edu; D.Broer@tue.nl	Selinger, Robin/M-8955-2017; Broer, Dirk J/J-2614-2014; Mulder, Dirk Jan/AAF-3584-2019; Selinger, Robin/AAC-5339-2019; Meijer, E.W./K-7632-2013	Selinger, Robin/0000-0002-6519-9685; Broer, Dirk J/0000-0001-6136-3276; Mulder, Dirk Jan/0000-0002-9269-4999; Selinger, Robin/0000-0002-6519-9685; Meijer, E.W./0000-0003-4126-7492	Netherlands Organization for Scientific Research (NWO TOP PUNT) [10018944]; European Research Council (Vibrate ERC) [669991]; US National Science Foundation [DMR 1409658, CMMI 1436565]; European Union [607602]; Dutch Polymer Institute (DPI) [776n]; Div Of Civil, Mechanical, & Manufact Inn [1436565] Funding Source: National Science Foundation	Netherlands Organization for Scientific Research (NWO TOP PUNT); European Research Council (Vibrate ERC)(European Research Council (ERC)); US National Science Foundation(National Science Foundation (NSF)); European Union(European Commission); Dutch Polymer Institute (DPI); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported financially by the Netherlands Organization for Scientific Research (NWO; TOP PUNT grant 10018944), the European Research Council (Vibrate ERC, grant 669991), and US National Science Foundation grants DMR 1409658 and CMMI 1436565. A.H.G. acknowledges funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7-2013, grant number 607602. Computing resources provided by the Ohio Supercomputer Center (M.V., A.K., R.L.B.S.) R.L.B.S. acknowledges F. Nazarov for discussions and B. L. Mbanga for his role in developing the Finite Element Method algorithm. The work of D. J. M. forms part of the research programme of the Dutch Polymer Institute (DPI), project 776n.	Bandara HMD, 2012, CHEM SOC REV, V41, P1809, DOI 10.1039/c1cs15179g; BRODE WR, 1952, J AM CHEM SOC, V74, P4641, DOI 10.1021/ja01138a059; Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118; de Haan LT, 2014, ADV FUNCT MATER, V24, P1251, DOI 10.1002/adfm.201302568; Fang GJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2483; Garcia-Amoros J, 2012, BEILSTEIN J ORG CHEM, V8, P1003, DOI 10.3762/bjoc.8.113; Iamsaard S, 2014, NAT CHEM, V6, P229, DOI [10.1038/NCHEM.1859, 10.1038/nchem.1859]; Konya A, 2016, FRONT MATER, V3, DOI 10.3389/fmats.2016.00024; Li MH, 2003, ADV MATER, V15, P569, DOI 10.1002/adma.200304552; Maeda S, 2008, ANGEW CHEM INT EDIT, V47, P6690, DOI 10.1002/anie.200801347; Maeda S, 2007, ADV MATER, V19, P3480, DOI 10.1002/adma.200700625; Martinez A, 2015, OPT EXPRESS, V23, P4591, DOI 10.1364/OE.23.004591; MITA I, 1989, MACROMOLECULES, V22, P558, DOI 10.1021/ma00192a008; Mol GN, 2005, ADV FUNCT MATER, V15, P1155, DOI 10.1002/adfm.200400503; Murase Y, 2009, LANGMUIR, V25, P483, DOI 10.1021/la8029006; Naidek KP, 2014, EUR J INORG CHEM, V2014, P1150, DOI 10.1002/ejic.201301442; Poutanen M, 2016, MACROMOLECULES, V49, P4095, DOI 10.1021/acs.macromol.6b00562; Sawa Y, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022502; Serra F, 2008, MACROMOLECULES, V41, P981, DOI 10.1021/ma702033e; Stumpel JE, 2013, CHEM-EUR J, V19, P10922, DOI 10.1002/chem.201300852; Tabata O, 2002, SENSOR ACTUAT A-PHYS, V95, P234, DOI 10.1016/S0924-4247(01)00731-2; van Oosten CL, 2007, EUR PHYS J E, V23, P329, DOI 10.1140/epje/i2007-10196-1; van Oosten CL, 2009, NAT MATER, V8, P677, DOI [10.1038/NMAT2487, 10.1038/nmat2487]; Vapaavuori J, 2015, J AM CHEM SOC, V137, P13510, DOI 10.1021/jacs.5b06611; White TJ, 2008, SOFT MATTER, V4, P1796, DOI 10.1039/b805434g; Yamada M, 2008, ANGEW CHEM INT EDIT, V47, P4986, DOI 10.1002/anie.200800760; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a	27	551	550	59	876	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					632	+		10.1038/nature22987	http://dx.doi.org/10.1038/nature22987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658225	Green Accepted			2022-12-28	WOS:000404332000043
J	Nirschl, CJ; Suarez-Farinas, M; Izar, B; Prakadan, S; Dannenfelser, R; Tirosh, I; Liu, Y; Zhu, Q; Devi, KSP; Carroll, SL; Chau, D; Rezaee, M; Kim, TG; Huang, RQ; Fuentes-Duculan, J; Song-Zhao, GX; Gulati, N; Lowes, MA; King, SL; Quintana, FJ; Lee, YS; Krueger, JG; Sarin, KY; Yoon, CH; Garraway, L; Regev, A; Shalek, AK; Troyanskaya, O; Anandasabapathy, N				Nirschl, Christopher J.; Suarez-Farinas, Mayte; Izar, Benjamin; Prakadan, Sanjay; Dannenfelser, Ruth; Tirosh, Itay; Liu, Yong; Zhu, Qian; Devi, K. Sanjana P.; Carroll, Shaina L.; Chau, David; Rezaee, Melika; Kim, Tae-Gyun; Huang, Ruiqi; Fuentes-Duculan, Judilyn; Song-Zhao, George X.; Gulati, Nicholas; Lowes, Michelle A.; King, Sandra L.; Quintana, Francisco J.; Lee, Young-suk; Krueger, James G.; Sarin, Kavita Y.; Yoon, Charles H.; Garraway, Levi; Regev, Aviv; Shalek, Alex K.; Troyanskaya, Olga; Anandasabapathy, Niroshana			IFN gamma-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment	CELL			English	Article							MIGRATORY DENDRITIC CELLS; INTERFERON-GAMMA; FUNCTIONAL SPECIALIZATION; EXPRESSION; RESIDENT; CANCER; AUTOIMMUNITY; MACROPHAGES; EXPLORATION; MECHANISMS	Homeostatic programs balance immune protection and self-tolerance. Such mechanisms likely impact autoimmunity and tumor formation, respectively. How homeostasis is maintained and impacts tumor surveillance is unknown. Here, we find that different immune mononuclear phagocytes share a conserved steady-state program during differentiation and entry into healthy tissue. IFN gamma is necessary and sufficient to induce this program, revealing a key instructive role. Remarkably, homeostatic and IFN gamma-dependent programs enrich across primary human tumors, including melanoma, and stratify survival. Single-cell RNA sequencing (RNA-seq) reveals enrichment of homeostatic modules in monocytes and DCs from human metastatic melanoma. Suppressor-of-cytokine-2 (SOCS2) protein, a conserved program transcript, is expressed by mononuclear phagocytes infiltrating primary melanoma and is induced by IFN gamma. SOCS2 limits adaptive anti-tumoral immunity and DC-based priming of T cells in vivo, indicating a critical regulatory role. These findings link immune homeostasis to key determinants of anti-tumoral immunity and escape, revealing co-opting of tissue-specific immune development in the tumor microenvironment.	[Nirschl, Christopher J.; Liu, Yong; Devi, K. Sanjana P.; Chau, David; Kim, Tae-Gyun; Song-Zhao, George X.; King, Sandra L.; Anandasabapathy, Niroshana] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Suarez-Farinas, Mayte] Mt Sinai Sch Med, Dept Dermatol, New York, NY 10029 USA; [Suarez-Farinas, Mayte; Huang, Ruiqi] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Mt Sinai Sch Med, Populat Hlth Sci & Policy, New York, NY 10029 USA; [Izar, Benjamin; Prakadan, Sanjay; Tirosh, Itay; Carroll, Shaina L.; Quintana, Francisco J.; Garraway, Levi; Regev, Aviv; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Izar, Benjamin; Garraway, Levi] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Izar, Benjamin; Garraway, Levi] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02215 USA; [Prakadan, Sanjay; Carroll, Shaina L.; Shalek, Alex K.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Prakadan, Sanjay; Carroll, Shaina L.; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Prakadan, Sanjay; Carroll, Shaina L.; Shalek, Alex K.] Ragon Inst MIT Harvard & MGH, Ragon Inst, Cambridge, MA 02139 USA; [Dannenfelser, Ruth; Zhu, Qian; Lee, Young-suk; Troyanskaya, Olga] Princeton Univ, Dept Comp Sci, Princeton, NJ 08540 USA; [Dannenfelser, Ruth; Zhu, Qian; Lee, Young-suk; Troyanskaya, Olga] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08540 USA; [Rezaee, Melika; Sarin, Kavita Y.] Stanford Univ, Dept Dermatol, Stanford, CA 94305 USA; [Fuentes-Duculan, Judilyn; Gulati, Nicholas; Lowes, Michelle A.; Krueger, James G.] Rockefeller Univ, Lab Investigat Dermatol, New York, NY 10065 USA; [Quintana, Francisco J.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02458 USA; [Yoon, Charles H.] Harvard Med Sch, Dana Farber Canc Inst, Dept Surg Oncol, Boston, MA 02215 USA; [Yoon, Charles H.] Brigham & Womens Hosp, Dept Surg Oncol, Boston, MA 02115 USA; [Garraway, Levi] Ludwig Ctr Harvard, Boston, MA 02215 USA; [Regev, Aviv; Shalek, Alex K.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Regev, Aviv] MIT, Dept Biol, Boston, MA 02142 USA; [Regev, Aviv] MIT, Koch Inst, Boston, MA 02142 USA; [Shalek, Alex K.] Harvard Med Sch, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shalek, Alex K.] Massachusetts Gen Hosp, Dept Immunol, Boston, MA 02115 USA; [Troyanskaya, Olga] Simons Fdn, Simons Ctr Data Anal, New York, NY 10010 USA; [Anandasabapathy, Niroshana] Harvard Canc Ctr, Dana Farber Canc Ctr, Canc Immunol & Melanoma, Boston, MA 02215 USA; [Anandasabapathy, Niroshana] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Princeton University; Princeton University; Stanford University; Rockefeller University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University	Anandasabapathy, N (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA.; Anandasabapathy, N (corresponding author), Harvard Canc Ctr, Dana Farber Canc Ctr, Canc Immunol & Melanoma, Boston, MA 02215 USA.; Anandasabapathy, N (corresponding author), Harvard Stem Cell Inst, Boston, MA 02115 USA.	nanandasabapathy@partners.org	Shalek, Alex/Y-2434-2019; Kangabam, Sanjana P. Devi/N-5874-2019; Quintana, Francisco Javier/AAB-6915-2020; Dannenfelser, Ruth/GPC-8803-2022; Lowes, Michelle A/G-9585-2016	Shalek, Alex/0000-0001-5670-8778; Lowes, Michelle A/0000-0003-4256-478X; Dannenfelser, Ruth/0000-0002-8766-6424; Troyanskaya, Olga/0000-0002-5676-5737; Anandasabapathy, Niroshana/0000-0002-0473-8358; Sarin, Kavita/0000-0001-5363-3053	Dermatology Training Grant [5T32AR007098]; DFCI Wong Family Award for Translational Cancer Research; MSTP Grant [T32GM07739]; MSTP Grant; Beckman Young Investigator Program; NIH New Innovator Award [DP2OD020839]; Melanoma Research Alliance-BWH Department of Dermatology combined grant; Cancer Research Institute; Klarman Family Foundation; National Institute of Arthritis and Musculoskeletal and Skin Disease [R01AR070234, K23 AR063461]; Novartis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098, R01AR070234, K23AR063461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071966, DP2GM119419, T32GM007739] Funding Source: NIH RePORTER	Dermatology Training Grant; DFCI Wong Family Award for Translational Cancer Research; MSTP Grant; MSTP Grant; Beckman Young Investigator Program; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance-BWH Department of Dermatology combined grant; Cancer Research Institute; Klarman Family Foundation; National Institute of Arthritis and Musculoskeletal and Skin Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Novartis(Novartis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Doug Hilton and Warren Alexander generously provided SOCS2<SUP>-/-</SUP> mice. The laboratories of Arlene Sharpe and Charles Drake provided B16-OVA and EL4-OVA tumor lines. We are grateful to Celldex for recombinant Flt3L, Steve Reed and Infectious Disease Research Institute for GLA, and Dev Manoli for critical reading of the manuscript. C.N. was supported by a 5T32AR007098 Dermatology Training Grant. B.I. was supported by the DFCI Wong Family Award for Translational Cancer Research. N.G. was supported by a T32GM07739 MSTP Grant. A.K.S. was supported by the Searle Scholars Program, the Beckman Young Investigator Program, and the NIH New Innovator Award DP2OD020839. N.A., Y.L., and C.N. were supported by the Melanoma Research Alliance-BWH Department of Dermatology combined grant, the Cancer Research Institute, the Klarman Family Foundation, and the National Institute of Arthritis and Musculoskeletal and Skin Disease R01AR070234 and K23 AR063461 (to N.A). A.R. is on the scientific advisory board for ThermoFisher Scientific, Syros Pharmaceuticals, and Driver Group. J.G.K. is a consultant for Biogen. L.G. was a consultant for Foundation Medicine, Novartis, Boehringer Ingelheim, Eli Lilly, an equity holder in Foundation Medicine, and a member of the scientific advisory board at Warp Drive. L.G. also received grant support from Novartis. L.G. is now an employee of Eli Lilly and Company.	Anandasabapathy N, 2014, J EXP MED, V211, P1875, DOI 10.1084/jem.20131397; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Baratin M, 2015, IMMUNITY, V42, P627, DOI 10.1016/j.immuni.2015.03.003; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chung NC, 2015, BIOINFORMATICS, V31, P545, DOI 10.1093/bioinformatics/btu674; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Earl P L, 2001, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0512s13; Elder DE, 2016, PATHOLOGY, V48, P147, DOI 10.1016/j.pathol.2015.12.002; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Harden JL, 2011, J IMMUNOL, V187, P126, DOI 10.4049/jimmunol.1100168; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Iborra S, 2016, IMMUNITY, V45, P847, DOI 10.1016/j.immuni.2016.08.019; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Liu LZ, 2010, NAT MED, V16, P224, DOI 10.1038/nm.2078; Ma DY, 2009, SEMIN IMMUNOL, V21, P265, DOI 10.1016/j.smim.2009.05.010; Martin Stefan F, 2013, Methods Mol Biol, V961, P325, DOI 10.1007/978-1-62703-227-8_21; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; McDavid A, 2013, BIOINFORMATICS, V29, P461, DOI 10.1093/bioinformatics/bts714; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stern RS, 2010, ARCH DERMATOL, V146, P279, DOI 10.1001/archdermatol.2010.4; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Taube J.M., 2015, CLIN CANC RES; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; Waithman J, 2007, J IMMUNOL, V179, P4535, DOI 10.4049/jimmunol.179.7.4535; Wilson NS, 2008, IMMUNOL CELL BIOL, V86, P200, DOI 10.1038/sj.icb.7100125; Yeste A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0612; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zhu Q, 2015, NAT METHODS, V12, P211, DOI [10.1038/NMETH.3249, 10.1038/nmeth.3249]	52	109	115	4	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					127	+		10.1016/j.cell.2017.06.016	http://dx.doi.org/10.1016/j.cell.2017.06.016			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666115	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000404358500015
J	Sarode, D; Asimakopoulos, P; Sim, DW; Syed, MI				Sarode, Deep; Asimakopoulos, Panagiotis; Sim, David W.; Syed, Mohammed Iqbal			10-MINUTE CONSULTATION Aural microsuction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sarode, Deep] Royal Infirm Edinburgh NHS Trust, Dept Otolaryngol & Skull Base Surg, Edinburgh, Midlothian, Scotland; [Asimakopoulos, Panagiotis; Sim, David W.; Syed, Mohammed Iqbal] Royal Infirm Edinburgh NHS Trust, Dept Otolaryngol & Skull Base Surg, Otolaryngol & Skull Base Surg, Edinburgh, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Sarode, D (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Otolaryngol & Skull Base Surg, Edinburgh, Midlothian, Scotland.	deepsarode@hotmail.co.uk	Asimakopoulos, Panagiotis/AAS-9952-2020	Asimakopoulos, Panagiotis/0000-0003-3366-7883				Addams-Williams J, 2010, EUR ARCH OTO-RHINO-L, V267, P1863, DOI 10.1007/s00405-010-1326-8; Clegg AJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14280; Guest JF, 2004, QJM-INT J MED, V97, P477, DOI 10.1093/qjmed/hch082; Prowse SJ, 2014, J LARYNGOL OTOL, V128, P621, DOI 10.1017/S0022215114000796; Roland PS, 2008, OTOLARYNG HEAD NECK, V139, pS1, DOI 10.1016/j.otohns.2008.06.026; Snelling JD, 2009, CLIN OTOLARYNGOL, V34, P21, DOI 10.1111/j.1749-4486.2008.01841.x	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2017	357								j2908	10.1136/bmj.j2908	http://dx.doi.org/10.1136/bmj.j2908			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AY	28663220				2022-12-28	WOS:000404725100004
J	Adler, BL; Albayda, J; Shores, JT; Lee, WPA; Brandacher, G; Bingham, CO				Adler, Brittany L.; Albayda, Jemima; Shores, Jamie T.; Lee, W. P. Andrew; Brandacher, Gerald; Bingham, Clifton O., III			Erosive Rheumatoid Arthritis After Bilateral Hand Transplantation	ANNALS OF INTERNAL MEDICINE			English	Letter							SUSCEPTIBILITY		[Adler, Brittany L.; Albayda, Jemima; Shores, Jamie T.; Lee, W. P. Andrew; Brandacher, Gerald; Bingham, Clifton O., III] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Adler, BL (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.			Adler, Brittany/0000-0001-9912-2435; Brandacher, Gerald/0000-0001-7790-441X; Shores, Jaimie/0000-0002-4272-1389	National Institute of Arthritis and Musculoskeletal and Skin Diseases [P30-AR053503, T32-AR048522]; Department of Defense and Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0032]; University of Pittsburgh Medical Center and Johns Hopkins University School of Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR048522, P30AR053503] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Defense and Armed Forces Institute of Regenerative Medicine; University of Pittsburgh Medical Center and Johns Hopkins University School of Medicine; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By grant P30-AR053503 and T32-AR048522 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, award W81XWH-08-2-0032 from the Department of Defense and Armed Forces Institute of Regenerative Medicine, and the University of Pittsburgh Medical Center and Johns Hopkins University School of Medicine.	Ali Azra Arif I, 2006, J Pak Med Assoc, V56, P452; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Mariaselvam CM, 2016, HLA, V88, P253, DOI 10.1111/tan.12910; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Shores JT, 2015, PLAST RECONSTR SURG, V135, p351E, DOI 10.1097/PRS.0000000000000892	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					216	218		10.7326/L16-0588	http://dx.doi.org/10.7326/L16-0588			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28654973	Green Accepted			2022-12-28	WOS:000406631400018
J	Green, JM; Barratt, MJ; Kinch, M; Gordon, JI				Green, Jonathan M.; Barratt, Michael J.; Kinch, Michael; Gordon, Jeffrey I.			Food and microbiota in the FDA regulatory framework	SCIENCE			English	Editorial Material							GUT MICROBIOTA; DISEASE; METABOLITES; PROBIOTICS; PREBIOTICS; PHYSIOLOGY		[Green, Jonathan M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Green, Jonathan M.] Washington Univ, Inst Publ Hlth, Sch Med, St Louis, MO 63110 USA; [Barratt, Michael J.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63110 USA; [Barratt, Michael J.; Gordon, Jeffrey I.] Washington Univ, Ctr Gut Microbiome & Nutr Res, Sch Med, St Louis, MO 63110 USA; [Kinch, Michael] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci & Syst Biol, Sch Med, St Louis, MO 63110 USA.; Gordon, JI (corresponding author), Washington Univ, Ctr Gut Microbiome & Nutr Res, Sch Med, St Louis, MO 63110 USA.	jgordon@wustl.edu		Green, Jonathan/0000-0002-7449-4387	NIDDK NIH HHS [R01 DK070977, R01 DK030292, P01 DK078669, R37 DK030292] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669, R37DK030292, R01DK070977, R01DK030292] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Brody T, 2016, COMPR REV FOOD SCI F, V15, P92, DOI 10.1111/1541-4337.12172; Center for Food Safety and Applied Nutrition FDA, 2016, FREQ ASK QUEST MED F; Center for Food Safety and Applied Nutrition FDA, 2016, INGR ADD GRAS PACK G; Center for Food Safety and Applied Nutrition FDA, 2016, GUID IND DIET SUPPL; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Gilbert JA, 2016, NATURE, V535, P94, DOI 10.1038/nature18850; Hoffmann DE, 2013, SCIENCE, V342, P314, DOI 10.1126/science.1244656; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kumar H, 2015, CURR OPIN BIOTECH, V32, P99, DOI 10.1016/j.copbio.2014.11.021; Puccio G, 2017, J PEDIATR GASTR NUTR, V64, P624, DOI 10.1097/MPG.0000000000001520; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001	18	19	21	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		39	40		10.1126/science.aan0836	http://dx.doi.org/10.1126/science.aan0836			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684495	Green Accepted			2022-12-28	WOS:000404854100040
J	DeSimone, CV; Graff-Radford, J; El-Harasis, MA; Rabinstein, AA; Asirvatham, SJ; Holmes, DR				DeSimone, Christopher V.; Graff-Radford, Jonathan; El-Harasis, Majd A.; Rabinstein, Alejandro A.; Asirvatham, Samuel J.; Holmes, David R., Jr.			Cerebral amyloid angiopathy and implications for atrial fibrillation management	LANCET			English	Editorial Material							INTRACEREBRAL HEMORRHAGE; MICROBLEEDS; RISK; STROKE		[DeSimone, Christopher V.; Asirvatham, Samuel J.; Holmes, David R., Jr.] Mayo Clin, Coll Med, Dept Cardiovasc Dis, Rochester, MN 55905 USA; [Graff-Radford, Jonathan; Rabinstein, Alejandro A.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN 55905 USA; [El-Harasis, Majd A.] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN 55905 USA; [Asirvatham, Samuel J.] Mayo Clin, Coll Med, Div Pediat & Adolescent Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Holmes, DR (corresponding author), Mayo Clin, Coll Med, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	holmes.david@mayo.edu						Arvanitakis Z, 2011, ANN NEUROL, V69, P320, DOI 10.1002/ana.22112; Charidimou A, 2015, INT J STROKE, V10, P155, DOI 10.1111/ijs.12569; Charidimou A, 2013, NEUROLOGY, V81, P1666, DOI 10.1212/01.wnl.0000435298.80023.7a; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Lovelock CE, 2007, LANCET NEUROL, V6, P487, DOI 10.1016/S1474-4422(07)70107-2; Lovelock CE, 2010, STROKE, V41, P1222, DOI 10.1161/STROKEAHA.109.572594; Morin DP, 2016, MAYO CLIN PROC, V91, P1778, DOI 10.1016/j.mayocp.2016.08.022; Nielsen PB, 2017, JAMA INTERN MED, V177, P563, DOI 10.1001/jamainternmed.2016.9369; O'Donnell MJ, 2016, AM HEART J, V178, P145, DOI 10.1016/j.ahj.2016.03.019; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; van Etten ES, 2016, NEUROLOGY, V87, P1482	15	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					9	11		10.1016/S0140-6736(17)31326-0	http://dx.doi.org/10.1016/S0140-6736(17)31326-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677558				2022-12-28	WOS:000404396300008
J	Woodcock, BA; Bullock, JM; Shore, RF; Heard, MS; Pereira, MG; Redhead, J; Ridding, L; Dean, H; Sleep, D; Henrys, P; Peyton, J; Hulmes, S; Hulmes, L; Sarospataki, M; Saure, C; Edwards, M; Genersch, E; Knabe, S; Pywell, RF				Woodcock, B. A.; Bullock, J. M.; Shore, R. F.; Heard, M. S.; Pereira, M. G.; Redhead, J.; Ridding, L.; Dean, H.; Sleep, D.; Henrys, P.; Peyton, J.; Hulmes, S.; Hulmes, L.; Sarospataki, M.; Saure, C.; Edwards, M.; Genersch, E.; Knaebe, S.; Pywell, R. F.			Country-specific effects of neonicotinoid pesticides on honey bees and wild bees	SCIENCE			English	Article							EXPOSURE; FIELD; IMPACTS; SURVIVAL; RISKS	Neonicotinoid seed dressings have caused concern world-wide. We use large field experiments to assess the effects of neonicotinoid-treated crops on three bee species across three countries (Hungary, Germany, and the United Kingdom). Winter-sown oil-seed rape was grown commercially with either seed coatings containing neonicotinoids (clothianidin or thiamethoxam) or no seed treatment (control). For honey bees, we found both negative (Hungary and United Kingdom) and positive (Germany) effects during crop flowering. In Hungary, negative effects on honey bees (associated with clothianidin) persisted over winter and resulted in smaller colonies in the following spring (24% declines). In wild bees (Bombus terrestris and Osmia bicornis), reproduction was negatively correlated with neonicotinoid residues. These findings point to neonicotinoids causing a reduced capacity of bee species to establish new populations in the year following exposure.	[Woodcock, B. A.; Bullock, J. M.; Heard, M. S.; Redhead, J.; Ridding, L.; Dean, H.; Peyton, J.; Hulmes, S.; Hulmes, L.; Pywell, R. F.] NERC, Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Shore, R. F.; Pereira, M. G.; Sleep, D.; Henrys, P.] NERC, Lancaster Environm Ctr, Ctr Ecol & Hydrol, Lancaster LA1 4AP, England; [Sarospataki, M.] Szent Istvan Univ, H-2103 Godollo, Hungary; [Saure, C.] Heidehof 44, D-14163 Berlin, Germany; [Edwards, M.] Leaside, Carron Lane, Midhurst GU29 9LB, W Sussex, England; [Genersch, E.] Inst Bee Res, D-16540 Hohen Neuendorf, Germany; [Knaebe, S.] Ecotox GmbH, Eurofins, D-75223 Niefern Ooschelbronn, Germany	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Lancaster University; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Hungarian University of Agriculture & Life Sciences	Woodcock, BA (corresponding author), NERC, Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England.	bawood@ceh.ac.uk	Pywell, Richard F/E-8738-2010; Bullock, James M/F-9997-2011; Pereira, M. Gloria/K-3024-2012; Shore, Richard/A-2638-2012; Woodcock, Ben/F-9199-2010; Redhead, John/E-6750-2012; Ridding, Lucy/AAH-5881-2020; Henrys, Peter/K-3321-2012	Pywell, Richard F/0000-0001-6431-9959; Pereira, M. Gloria/0000-0003-3740-0019; Shore, Richard/0000-0002-9337-8883; Woodcock, Ben/0000-0003-0300-9951; Redhead, John/0000-0002-2233-3848; Ridding, Lucy/0000-0003-3141-8795; Genersch, Elke/0000-0001-7906-4530; Henrys, Peter/0000-0003-4758-1482; Dean, Hannah/0000-0002-9602-7202	NERC CEH National Capability funding [NEC05829]	NERC CEH National Capability funding	Data are in supplementary materials. Funded by Syngenta Ltd. and Bayer CropScience (P. Campbell, M. Miles, C. Maus, D. Holah, M. Coulson). Wild pollinator work supported by NERC CEH National Capability funding (NEC05829). Thanks to K. Jaekel, P. Fisher, M. Nowakowski, R. Hails, P. Scrimshaw, N. Mitschunas, P. Nuttall, M. McCracken, S. Ball, J. Webb, B. Sutherland, R. Freckleton, T. Tscharntke, J. Memmott, K. Norris, B. Raffa, and D. Vaskor.	Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Budge GE, 2015, SCI REP-UK, V5, DOI 10.1038/srep12574; Cresswell JE, 2012, ZOOLOGY, V115, P365, DOI 10.1016/j.zool.2012.05.003; Cutler GC, 2014, ECOTOXICOLOGY, V23, P1755, DOI 10.1007/s10646-014-1340-5; Cutler GC, 2014, PEERJ, V2, DOI 10.7717/peerj.652; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; FERA, 2013, NEON PEST BEES; Goulson D, 2015, PEERJ, V3, DOI 10.7717/peerj.854; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Jones A, 2014, PEST MANAG SCI, V70, P1780, DOI 10.1002/ps.3836; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sandrock C, 2014, AGR FOREST ENTOMOL, V16, P119, DOI 10.1111/afe.12041; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Woodcock BA, 2016, J APPL ECOL, V53, P1358, DOI 10.1111/1365-2664.12676; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459	23	379	394	19	454	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1393	+		10.1126/science.aaa1190	http://dx.doi.org/10.1126/science.aaa1190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663502	Green Accepted			2022-12-28	WOS:000404351500040
J	Bellono, NW; Bayrer, JR; Leitch, DB; Castro, J; Zhang, CC; O'Donnell, TA; Brierley, SM; Ingraham, HA; Julius, D				Bellono, Nicholas W.; Bayrer, James R.; Leitch, Duncan B.; Castro, Joel; Zhang, Chuchu; O'Donnell, Tracey A.; Brierley, Stuart M.; Ingraham, Holly A.; Julius, David			Enterochromaffin Cells Are Gut Chemosensors that Couple to Sensory Neural Pathways	CELL			English	Article							CHAIN FATTY-ACIDS; UNION-OF-PHARMACOLOGY; GATED ION-CHANNEL; ENTEROENDOCRINE CELLS; 5-HT RELEASE; IN-VITRO; SEROTONIN; RECEPTOR; 5-HYDROXYTRYPTAMINE; EXPRESSION	Dietary, microbial, and inflammatory factors modulate the gut-brain axis and influence physiological processes ranging from metabolism to cognition. The gut epithelium is a principal site for detecting such agents, but precisely how it communicates with neural elements is poorly understood. Serotonergic entero-chromaffin (EC) cells are proposed to fulfill this role by acting as chemosensors, but understanding how these rare and unique cell types transduce chemosensory information to the nervous system has been hampered by their paucity and inaccessibility to single-cell measurements. Here, we circumvent this limitation by exploiting cultured intestinal organoids together with single-cell measurements to elucidate intrinsic biophysical, pharmacological, and genetic properties of EC cells. We show that EC cells express specific chemosensory receptors, are electrically excitable, and modulate serotonin-sensitive primary afferent nerve fibers via synaptic connections, enabling them to detect and transduce environmental, metabolic, and homeostatic information from the gut directly to the nervous system.	[Bellono, Nicholas W.; Leitch, Duncan B.; Zhang, Chuchu; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bayrer, James R.] Univ Calif San Francisco, Div Gastroenterol, Dept Pediat, San Francisco, CA 94143 USA; [Bayrer, James R.; Ingraham, Holly A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Castro, Joel; O'Donnell, Tracey A.; Brierley, Stuart M.] Flinders Univ S Australia, Visceral Pain Grp, Bedford Pk, SA 5042, Australia; [Castro, Joel; O'Donnell, Tracey A.; Brierley, Stuart M.] Univ Adelaide, Ctr Nutr & Gastrointestinal Dis, SAHMRI, Discipline Med, North Terrace, Adelaide, SA 5000, Australia	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.; Ingraham, HA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	holly.ingraham@ucsf.edu; david.julius@ucsf.edu	Leitch, Duncan/AAU-6744-2020	Zhang, Chuchu/0000-0001-9234-6073; Brierley, Stuart/0000-0002-2527-2905; Leitch, Duncan/0000-0002-8513-888X; Castro, Joel/0000-0002-5781-2224	NIH Institutional Research Service Award [T32HL007731]; Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; Simons Foundation Postdoctoral Fellowship [61-1559]; NIH [R01 NS081115, R01 NS055299, R01 DK099722, K12 HD072222, K08 DK106577]; American Diabetes Association [714MI08]; National Health and Medical Research Council of Australia [APP1083480]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099722, R03DK121061, K08DK106577, R01DK063592, P30DK098722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081115, R01NS055299] Funding Source: NIH RePORTER	NIH Institutional Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); Simons Foundation Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Poblete and H. Escusa for technical assistance, S. Elmes for help with FACS, M. Fischbach for helpful discussion, and R. Nicoll for critical reading of the manuscript. This work was supported by a NIH Institutional Research Service Award to the UCSF CVRI (T32HL007731 to N.W.B.), a Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (N.W.B.), a Simons Foundation Postdoctoral Fellowship to the Jane Coffin Childs Memorial Fund 61-1559 to D.B.L., grants from the NIH (R01 NS081115 and R01 NS055299 to D. J., R01 DK099722 to H. A. I., and K12 HD072222 and K08 DK106577 to J.R.B.), the American Diabetes Association (714MI08 to H. A. I.), and the National Health and Medical Research Council of Australia (APP1083480 to S.M.B.). S.M.B. is a NHMRC R. D. Wright Biomedical Research Fellow (APP1126378).	AIKEN KD, 1992, DEV DYNAM, V194, P303, DOI 10.1002/aja.1001940406; Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Bertrand PP, 2008, AM J PHYSIOL-GASTR L, V295, pG1228, DOI 10.1152/ajpgi.90375.2008; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Brierley SM, 2009, GASTROENTEROLOGY, V137, P2084, DOI 10.1053/j.gastro.2009.07.048; Buffalo V., 2011, SCYTHE VERY SIMPLE A; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chial HJ, 2003, CLIN GASTROENTEROL H, V1, P211, DOI 10.1053/jcgh.2003.50031; Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072; Diwakarla S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13101; Doihara H, 2009, MOL CELL BIOCHEM, V331, P239, DOI 10.1007/s11010-009-0165-7; Emery EC, 2015, DIABETES, V64, P1202, DOI 10.2337/db14-0737; Engelstoft MS, 2015, MOL ENDOCRINOL, V29, P1658, DOI 10.1210/me.2015-1106; Everest P, 2007, GUT, V56, P1037, DOI 10.1136/gut.2006.117150; Farup PG, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0446-z; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gershon MD, 2013, CURR OPIN ENDOCRINOL, V20, P14, DOI 10.1097/MED.0b013e32835bc703; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Hagbom M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002115; HEITZ P, 1976, HISTOCHEMISTRY, V49, P343, DOI 10.1007/BF00496138; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Joshi N., 2011, SICKLE WINDOWED ADPT; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HJ, 2004, GUT, V53, P829, DOI 10.1136/gut.2003.030882; Kim MS, 2001, GASTROENTEROLOGY, V121, P1400, DOI 10.1053/gast.2001.29567; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Nozawa K, 2009, P NATL ACAD SCI USA, V106, P3408, DOI 10.1073/pnas.0805323106; Ohman L, 2015, NAT REV GASTRO HEPAT, V12, P36, DOI 10.1038/nrgastro.2014.200; Priori D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129501; RACKE K, 1993, N-S ARCH PHARMACOL, V347, P1; Raghupathi R, 2013, J PHYSIOL-LONDON, V591, P5959, DOI 10.1113/jphysiol.2013.259796; Rogers GJ, 2011, J PHYSIOL-LONDON, V589, P1081, DOI 10.1113/jphysiol.2010.198069; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; TANAKA K, 1966, P NATL ACAD SCI USA, V56, P236, DOI 10.1073/pnas.56.1.236; TECOTT L, 1995, MOL CELL NEUROSCI, V6, P43, DOI 10.1006/mcne.1995.1005; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Treem WR, 1996, J PEDIATR GASTR NUTR, V23, P280, DOI 10.1097/00005176-199610000-00013; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wang F, 2017, J PHYSIOL-LONDON, V595, P79, DOI 10.1113/JP272718; Westlund KN, 2014, NEUROSCIENCE, V262, P165, DOI 10.1016/j.neuroscience.2013.12.043; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Winston JH, 2010, GASTROENTEROLOGY, V138, P294, DOI 10.1053/j.gastro.2009.09.054; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120	61	359	380	19	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1								10.1016/j.cell.2017.05.034	http://dx.doi.org/10.1016/j.cell.2017.05.034			30	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28648659	Bronze, Green Accepted			2022-12-28	WOS:000404358500019
J	Brown, NJL; Albers, CJ; Ritchie, SJ				Brown, Nicholas J. L.; Albers, Casper J.; Ritchie, Stuart J.			Contesting the evidence for limited human lifespan	NATURE			English	Letter									[Brown, Nicholas J. L.] Univ Groningen, Univ Med Ctr, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Albers, Casper J.] Univ Groningen, Heymans Inst Psychol Res, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Ritchie, Stuart J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland	University of Groningen; University of Groningen; University of Edinburgh	Brown, NJL (corresponding author), Univ Groningen, Univ Med Ctr, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	nick.brown@free.fr	Brown, Nicholas/F-2238-2017	Brown, Nicholas/0000-0003-1579-0730; Albers, Casper/0000-0002-9213-6743				de Haan L Ferreira A, 2006, SPRING S OPERAT RES, VSpringer, DOI 10.1007/0-387-34471-3; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Fisher RA, 1928, P CAMB PHILOS SOC, V24, P180, DOI 10.1017/S0305004100015681	3	13	15	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E6	E7		10.1038/nature22784	http://dx.doi.org/10.1038/nature22784			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658214	Green Accepted, Green Published			2022-12-28	WOS:000404332000001
J	Dong, X; Milholland, B; Vijg, J				Dong, Xiao; Milholland, Brandon; Vijg, Jan			Questionable evidence for a limit to human lifespan Reply	NATURE			English	Letter									[Dong, Xiao; Milholland, Brandon; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.; Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA.	jan.vijg@einstein.yu.edu						Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Lenart A, 2017, NATURE, V546, pE13, DOI 10.1038/nature22790	2	2	2	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E14	E15		10.1038/nature22791	http://dx.doi.org/10.1038/nature22791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658219				2022-12-28	WOS:000404332000008
J	Lee, DYD; Prindle, A; Liu, JT; Suel, GM				Lee, Dong-yeon D.; Prindle, Arthur; Liu, Jintao; Suel, Gurol M.			SnapShot: Electrochemical Communication in Biofilms	CELL			English	Editorial Material							EXTRACELLULAR ELECTRON-TRANSFER; NANOWIRES; BACTERIA		[Lee, Dong-yeon D.; Prindle, Arthur; Liu, Jintao] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Suel, Gurol M.] Univ Calif San Diego, San Diego Ctr Syst Biol, La Jolla, CA 92093 USA; [Suel, Gurol M.] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Lee, DYD (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.		Liu, Jintao/P-9232-2018	Liu, Jintao/0000-0002-6710-2605				Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; Humphries J, 2017, CELL, V168, P200, DOI 10.1016/j.cell.2016.12.014; Liu JT, 2017, SCIENCE, V356, P638, DOI 10.1126/science.aah4204; Malvankar NS, 2011, NAT NANOTECHNOL, V6, P573, DOI [10.1038/nnano.2011.119, 10.1038/NNANO.2011.119]; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Pfeffer C, 2012, NATURE, V491, P218, DOI 10.1038/nature11586; Prindle A, 2015, NATURE, V527, P59, DOI 10.1038/nature15709; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661	10	31	33	7	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1								10.1016/j.cell.2017.06.026	http://dx.doi.org/10.1016/j.cell.2017.06.026			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666120	Bronze			2022-12-28	WOS:000404358500021
J	Stadler, LKJ; Farooqi, IS				Stadler, Lukas K. J.; Farooqi, I. Sadaf			A New Drug Target for Type 2 Diabetes	CELL			English	Editorial Material								Genetic studies can identify novel therapeutic targets for common complex diseases. In this issue of Cell, Rusu et al. demonstrate that a cluster of genetic variants associated with an increased risk of type 2 diabetes affect the function of a monocarboxylate transporter involved in nutrient flux and hepatic lipid metabolism.	[Stadler, Lukas K. J.; Farooqi, I. Sadaf] Univ Cambridge, Metab Res Labs, Cambridge, England; [Stadler, Lukas K. J.; Farooqi, I. Sadaf] Addenbrookes Hosp, Inst Metab Sci, Wellcome Trust MRC, NIHR Cambridge Biomed Res Ctr, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Farooqi, IS (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge, England.	isf20@cam.ac.uk	Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	O'Rahilly, Stephen/0000-0003-2199-4449; Farooqi, Sadaf/0000-0001-7609-3504; Stadler, Lukas/0000-0002-7028-4390	Medical Research Council [MC_UU_12012/5] Funding Source: Medline; MRC [MC_UU_12012/5] Funding Source: UKRI; Medical Research Council [MC_UU_12012/5/B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Rusu V, 2017, CELL, V170, P199, DOI 10.1016/j.cell.2017.06.011; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	10	22	22	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					12	14		10.1016/j.cell.2017.06.024	http://dx.doi.org/10.1016/j.cell.2017.06.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666114	Bronze			2022-12-28	WOS:000404358500005
J	Slomski, A				Slomski, Anita			Neonatal Abstinence Syndrome Better Treated With Buprenorphine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2476	2476		10.1001/jama.2017.7054	http://dx.doi.org/10.1001/jama.2017.7054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655009				2022-12-28	WOS:000404106600006
J	Horton, R				Horton, Richard			Offline: A unique opportunity for WHO	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2017	389	10088					2458	2458						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY3VF	28656893	Bronze			2022-12-28	WOS:000403901800012
J	VanderWeele, TJ; Ding, P				VanderWeele, Tyler J.; Ding, Peng			Sensitivity Analysis in Observational Research: Introducing the E-Value	ANNALS OF INTERNAL MEDICINE			English	Article							BIAS; CANCER	Sensitivity analysis is useful in assessing how robust an association is to potential unmeasured or uncontrolled confounding. This article introduces a new measure called the "E-value," which is related to the evidence for causality in observational studies that are potentially subject to confounding. The E-value is defined as the minimum strength of association, on the risk ratio scale, that an unmeasured confounder would need to have with both the treatment and the outcome to fully explain away a specific treatment-outcome association, conditional on the measured covariates. A large E-value implies that considerable unmeasured confounding would be needed to explain away an effect estimate. A small E-value implies little unmeasured confounding would be needed to explain away an effect estimate. The authors propose that in all observational studies intended to produce evidence for causality, the E-value be reported or some other sensitivity analysis be used. They suggest calculating the E-value for both the observed association estimate (after adjustments for measured confounders) and the limit of the confidence interval closest to the null. If this were to become standard practice, the ability of the scientific community to assess evidence from observational studies would improve considerably, and ultimately, science would be strengthened.	[VanderWeele, Tyler J.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Ding, Peng] Univ Calif Berkeley, 425 Evans Hall, Berkeley, CA 94720 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley	VanderWeele, TJ (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	tvanderw@hsph.harvard.edu			National Institutes of Health [ES017876]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By National Institutes of Health grant ES017876.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Borenstein M., 2009, INTRO METAANALYSIS, P45, DOI DOI 10.1002/9780470743386.CH7; BROSS IDJ, 1966, J CHRON DIS, V19, P637, DOI 10.1016/0021-9681(66)90062-2; BROSS IDJ, 1967, J CHRON DIS, V20, P487, DOI 10.1016/0021-9681(67)90080-X; Brumback BA, 2004, STAT MED, V23, P749, DOI 10.1002/sim.1657; Chiba Y, 2011, AM J EPIDEMIOL, V173, P745, DOI 10.1093/aje/kwq418; CORNFIELD J, 1959, J NATL CANCER I, V22, P173; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Gilbert PB, 2003, BIOMETRICS, V59, P531, DOI 10.1111/1541-0420.00063; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Greenland S, 2011, JURIMETRICS, V51, P11329; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Greenland S, 2011, PREV MED, V53, P225, DOI 10.1016/j.ypmed.2011.08.010; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Hernan MA., 2016, CAUSAL INFERENCE; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Huang TH, 2015, AM J EPIDEMIOL, V182, P868, DOI 10.1093/aje/kwv130; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P496; Imbens GW, 2003, AM ECON REV, V93, P126, DOI 10.1257/000282803321946921; Ip S, 2007, 290020022 TUFTS NEW, V07-E007; Lash, 2008, MODERN EPIDEMIOLOGY, P345; Lash TL., 2009, APPL QUANTITATIVE BI; Lee WC, 2011, STAT MED, V30, P1007, DOI 10.1002/sim.4151; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McCandless LC, 2007, STAT MED, V26, P2331, DOI 10.1002/sim.2711; Moorman PG, 2008, AM J EPIDEMIOL, V167, P1059, DOI 10.1093/aje/kwn006; Pagano M., 2000, PRINCIPLES BIOSTATIS, V2nd edition; Robins J.M., 2000, STAT MODELS EPIDEMIO, P1, DOI DOI 10.1007/978-1-4612-1284-3_; Rosenbaum P.R, 2002, OBSERVATIONAL STUDIE, P105, DOI DOI 10.1007/978-1-4757-3692-2_4; Rosenbaum PR, 2010, J AM STAT ASSOC, V105, P692, DOI 10.1198/jasa.2010.tm09570; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; ROSENBAUM PR, 1991, ANN INTERN MED, V115, P901, DOI 10.7326/0003-4819-115-11-901; Rosenbaum PR, 2010, DESIGN OBSERVATIONAL, P269; Rosner B., 2010, FUNDAMENTALS BIOSTAT; SCHLESSELMAN JJ, 1978, AM J EPIDEMIOL, V108, P3; Stang A, 2010, EUR J EPIDEMIOL, V25, P225, DOI 10.1007/s10654-010-9440-x; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; VanderWeele TJ., 2017, EPIDEMIOLOG IN PRESS; VanderWeele TJ, 2015, EXPLANATION CAUSAL I, P66; VanderWeele TJ, 2011, SOCIOL METHOD RES, V40, P240, DOI 10.1177/0049124111404821; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; VICTORA CG, 1987, LANCET, V2, P319; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108	47	1805	1810	21	92	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					268	+		10.7326/M16-2607	http://dx.doi.org/10.7326/M16-2607			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28693043	Green Submitted			2022-12-28	WOS:000407797500015
J	Stone, RM; Mandrekar, SJ; Sanford, BL; Laumann, K; Geyer, S; Bloomfield, CD; Thiede, C; Prior, TW; Dohner, K; Marcucci, G; Lo-Coco, F; Klisovic, RB; Wei, A; Sierra, J; Sanz, MA; Brandwein, JM; de Witte, T; Niederwieser, D; Appelbaum, FR; Medeiros, BC; Tallman, MS; Krauter, J; Schlenk, RF; Ganser, A; Serve, H; Ehninger, G; Amadori, S; Larson, RA; Dohner, H				Stone, R. M.; Mandrekar, S. J.; Sanford, B. L.; Laumann, K.; Geyer, S.; Bloomfield, C. D.; Thiede, C.; Prior, T. W.; Doehner, K.; Marcucci, G.; Lo-Coco, F.; Klisovic, R. B.; Wei, A.; Sierra, J.; Sanz, M. A.; Brandwein, J. M.; de Witte, T.; Niederwieser, D.; Appelbaum, F. R.; Medeiros, B. C.; Tallman, M. S.; Krauter, J.; Schlenk, R. F.; Ganser, A.; Serve, H.; Ehninger, G.; Amadori, S.; Larson, R. A.; Doehner, H.			Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; TYROSINE KINASE INHIBITOR; PHASE-I; FAVORABLE PROGNOSIS; WILD-TYPE; SORAFENIB; YOUNGER; TRIAL; DISTINCT	BACKGROUND Patients with acute myeloid leukemia (AML) and a FLT3 mutation have poor outcomes. We conducted a phase 3 trial to determine whether the addition of midostaurin - an oral multitargeted kinase inhibitor that is active in patients with a FLT3 mutation - to standard chemotherapy would prolong overall survival in this population. METHODS We screened 3277 patients, 18 to 59 years of age, who had newly diagnosed AML for FLT3 mutations. Patients were randomly assigned to receive standard chemotherapy (induction therapy with daunorubicin and cytarabine and consolidation therapy with high-dose cytarabine) plus either midostaurin or placebo; those who were in remission after consolidation therapy entered a maintenance phase in which they received either midostaurin or placebo. Randomization was stratified according to subtype of FLT3 mutation: point mutation in the tyrosine kinase domain (TKD) or internal tandem duplication (ITD) mutation with either a high ratio (> 0.7) or a low ratio (0.05 to 0.7) of mutant to wild-type alleles (ITD [high] and ITD [low], respectively). Allogeneic transplantation was allowed. The primary end point was overall survival. RESULTS A total of 717 patients underwent randomization; 360 were assigned to the midostaurin group, and 357 to the placebo group. The FLT3 subtype was ITD (high) in 214 patients, ITD (low) in 341 patients, and TKD in 162 patients. The treatment groups were well balanced with respect to age, race, FLT3 subtype, cytogenetic risk, and blood counts but not with respect to sex (51.7% in the midostaurin group vs. 59.4% in the placebo group were women, P = 0.04). Overall survival was significantly longer in the midostaurin group than in the placebo group (hazard ratio for death, 0.78; one-sided P = 0.009), as was event-free survival (hazard ratio for event or death, 0.78; one-sided P = 0.002). In both the primary analysis and an analysis in which data for patients who underwent transplantation were censored, the benefit of midostaurin was consistent across all FLT3 subtypes. The rate of severe adverse events was similar in the two groups. CONCLUSIONS The addition of the multitargeted kinase inhibitor midostaurin to standard chemotherapy significantly prolonged overall and event-free survival among patients with AML and a FLT3 mutation. (Funded by the National Cancer Institute and Novartis; ClinicalTrials.gov number, NCT00651261.)	[Stone, R. M.] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave,D-2053, Boston, MA 02115 USA; [Mandrekar, S. J.; Laumann, K.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Mandrekar, S. J.; Laumann, K.; Geyer, S.] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA; [Sanford, B. L.] Duke Univ, Alliance Stat & Data Ctr, Durham, NC USA; [Geyer, S.; Bloomfield, C. D.; Prior, T. W.; Marcucci, G.; Klisovic, R. B.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Thiede, C.; Ehninger, G.] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany; [Doehner, K.; Schlenk, R. F.; Doehner, H.] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany; [Niederwieser, D.] Univ Leipzig, Hematol & Oncol, Leipzig, Germany; [Krauter, J.; Ganser, A.] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Serve, H.] Goethe Univ Hosp Frankfurt, Dept Med 2, Hematol Oncol, Frankfurt, Germany; [Lo-Coco, F.; Amadori, S.] Univ Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Wei, A.] Alfred Hosp, Dept Clin Haematol, Melbourne, Vic, Australia; [Wei, A.] Monash Univ, Melbourne, Vic, Australia; [Sierra, J.] Autonomous Univ Barcelona, Dept Hematol, Hosp Santa Creu & St Pau, Barcelona, Spain; [Sanz, M. A.] Univ Valencia, Dept Med, Dept Hematol, Hosp Univ Fe, Valencia, Spain; [Brandwein, J. M.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada; [de Witte, T.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Studies, Nijmegen, Netherlands; [Appelbaum, F. R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Medeiros, B. C.] Stanford Univ, Stanford Comprehens Canc Ctr, Div Hematol Oncol, Stanford, CA 94305 USA; [Tallman, M. S.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA; [Tallman, M. S.] Weill Cornell Med Coll, New York, NY USA; [Larson, R. A.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; Mayo Clinic; Duke University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ulm University; Leipzig University; Hannover Medical School; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Rome Tor Vergata; Florey Institute of Neuroscience & Mental Health; Monash University; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Valencia; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Radboud University Nijmegen; Fred Hutchinson Cancer Center; Stanford University; Memorial Sloan Kettering Cancer Center; Cornell University; University of Chicago	Stone, RM (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,D-2053, Boston, MA 02115 USA.	richard_stone@dfci.harvard.edu	Sanz, Miguel A./F-7485-2018; de Witte, T.J.M./L-4762-2015; Schlenk, Richard/AAG-3218-2019; Döhner, Hartmut/C-8933-2016	Sanz, Miguel A./0000-0003-1489-1177; Döhner, Hartmut/0000-0003-2116-5536; Wei, Andrew/0000-0002-7514-3298; Medeiros, Bruno/0000-0001-6972-8137; Thiede, Christian/0000-0003-1241-2048	National Cancer Institute; Novartis; NATIONAL CANCER INSTITUTE [U10CA180867, P30CA016058, U10CA180850, U10CA180882, U10CA180861, U10CA180791, U10CA180821, U10CA180888, U10CA031946, U10CA180820, U10CA180836, U10CA032291, U10CA077651, U10CA041287, U10CA077658, U10CA033601] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute and Novartis; ClinicalTrials.gov number, NCT00651261.	Chen YB, 2014, BIOL BLOOD MARROW TR, V20, P2042, DOI 10.1016/j.bbmt.2014.09.007; Cortes JE, 2013, J CLIN ONCOL, V31, P3681, DOI 10.1200/JCO.2013.48.8783; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Gotlib J, 2016, NEW ENGL J MED, V374, P2530, DOI 10.1056/NEJMoa1513098; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mead AJ, 2007, BLOOD, V110, P1262, DOI 10.1182/blood-2006-04-015826; Metzelder S, 2009, BLOOD, V113, P6567, DOI 10.1182/blood-2009-03-208298; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Perl AE, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1069.1069; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Rollig C, 2015, LANCET ONCOL, V16, P1691, DOI 10.1016/S1470-2045(15)00362-9; Schlenk R, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.322.322; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Schnittger S, 2005, BLOOD, V106, P3733, DOI 10.1182/blood-2005-06-2248; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Stone RM, 2017, NEW ENGL J MED, V377, P454, DOI 10.1056/NEJMoa1614359; Stone RM, 2012, LEUKEMIA, V26, P2061, DOI 10.1038/leu.2012.115; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thol F, 2015, BLOOD, V126, P319, DOI 10.1182/blood-2014-10-551911; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Whitman SP, 2001, CANCER RES, V61, P7233; Whitman SP, 2008, BLOOD, V111, P1552, DOI 10.1182/blood-2007-08-107946	30	1128	1149	9	107	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					454	464		10.1056/NEJMoa1614359	http://dx.doi.org/10.1056/NEJMoa1614359			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3NW	28644114	Green Accepted, Bronze			2022-12-28	WOS:000406747100007
J	Moniz, T; Lingard, L; Watling, C				Moniz, Tracy; Lingard, Lorelei; Watling, Chris			Stories Doctors Tell	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moniz, Tracy] Mt St Vincent Univ, Dept Commun Studies, Halifax, NS, Canada; [Lingard, Lorelei; Watling, Chris] Western Univ, Schulich Sch Med & Dent, Ctr Educ Res & Innovat, London, ON, Canada	Mount Saint Vincent University; Western University (University of Western Ontario)	Moniz, T (corresponding author), Mt St Vincent Univ, Dept Commun Studies, Halifax, NS, Canada.	tracy.moniz@msvu.ca	Moniz, Tracy/AAG-6787-2021					Bleakley A, 2005, MED EDUC, V39, P534, DOI 10.1111/j.1365-2929.2005.02126.x; Bockow Tamara, 2011, Ann Intern Med, V155, P273, DOI 10.7326/0003-4819-155-4-201108160-00015; Bruner J. S., 1990, ACTS MEANING; Cui W, 2014, 2014 CAN C MED ED OT; Hartzband P, 2011, NEW ENGL J MED, V365, P1372, DOI 10.1056/NEJMp1107278; Neumann M, 2011, ACAD MED, V86, P996, DOI 10.1097/ACM.0b013e318221e615; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7	8	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					124	125		10.1001/jama.2017.5518	http://dx.doi.org/10.1001/jama.2017.5518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697257				2022-12-28	WOS:000405190800011
J	Furlan, A; Dyachuk, V; Kastriti, ME; Calvo-Enrique, L; Abdo, H; Hadjab, S; Chontorotzea, T; Akkuratova, N; Usoskin, D; Kamenev, D; Petersen, J; Sunadome, K; Memic, F; Marklund, U; Fried, K; Topilko, P; Lallemend, F; Kharchenko, PV; Ernfors, P; Adameyko, I				Furlan, Alessandro; Dyachuk, Vyacheslav; Kastriti, Maria Eleni; Calvo-Enrique, Laura; Abdo, Hind; Hadjab, Saida; Chontorotzea, Tatiana; Akkuratova, Natalia; Usoskin, Dmitry; Kamenev, Dmitry; Petersen, Julian; Sunadome, Kazunori; Memic, Fatima; Marklund, Ulrika; Fried, Kaj; Topilko, Piotr; Lallemend, Francois; Kharchenko, Peter V.; Ernfors, Patrik; Adameyko, Igor			Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla	SCIENCE			English	Article							ENTERIC NERVOUS-SYSTEM; NEURAL CREST; STEM-CELLS; CHROMAFFIN CELLS; PARASYMPATHETIC NEURONS; SYMPATHETIC NEURONS; SCHWANN-CELLS; DIFFERENTIATION; RECEPTOR; ORIGIN	Adrenaline is a fundamental circulating hormone for bodily responses to internal and external stressors. Chromaffin cells of the adrenal medulla (AM) represent the main neuroendocrine adrenergic component and are believed to differentiate from neural crest cells. We demonstrate that large numbers of chromaffin cells arise from peripheral glial stem cells, termed Schwann cell precursors (SCPs). SCPs migrate along the visceral motor nerve to the vicinity of the forming adrenal gland, where they detach from the nerve and form postsynaptic neuroendocrine chromaffin cells. An intricate molecular logic drives two sequential phases of gene expression, one unique for a distinct transient cellular state and another for cell type specification. Subsequently, these programs down-regulate SCP-gene and up-regulate chromaffin cell-gene networks. The AM forms through limited cell expansion and requires the recruitment of numerous SCPs. Thus, peripheral nerves serve as a stem cell niche for neuroendocrine system development.	[Furlan, Alessandro; Calvo-Enrique, Laura; Abdo, Hind; Usoskin, Dmitry; Memic, Fatima; Marklund, Ulrika; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Unit Mol Neurobiol, S-17177 Stockholm, Sweden; [Dyachuk, Vyacheslav; Hadjab, Saida; Kamenev, Dmitry; Fried, Kaj; Lallemend, Francois] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok 690041, Russia; [Dyachuk, Vyacheslav] ITMO Univ, Dept Nanophoton & Metamat, St Petersburg 197101, Russia; [Kastriti, Maria Eleni; Chontorotzea, Tatiana; Petersen, Julian; Sunadome, Kazunori; Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Akkuratova, Natalia] Skolkovo Inst Sci & Technol, Moscow 143005, Russia; [Akkuratova, Natalia] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia; [Petersen, Julian; Adameyko, Igor] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Topilko, Piotr] Ecole Normale Super, CNRS UMR 8197, Inst Biol Ecole Normale Super, INSERM U1024, 46 Rue Ulm, F-75005 Paris, France; [Kharchenko, Peter V.] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; ITMO University; Karolinska Institutet; Skolkovo Institute of Science & Technology; Saint Petersburg State University; Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Harvard University; Harvard Medical School	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Unit Mol Neurobiol, S-17177 Stockholm, Sweden.; Adameyko, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.; Adameyko, I (corresponding author), Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria.	patrik.ernfors@ki.se; igor.adameyko@ki.se	Furlan, Alessandro/AAM-4680-2021; Akkuratova, Natalia/X-2743-2018; Petersen, Julian/ABE-6060-2021; Dyachuk, Vyacheslav/U-9115-2019; Marklund, Ulrika/I-8814-2012; Calvo, Laura/GWQ-8682-2022; Kamenev, Dmitrii/AAE-4786-2019	Furlan, Alessandro/0000-0001-5149-6331; Akkuratova, Natalia/0000-0001-6733-8119; Petersen, Julian/0000-0002-7444-0610; Dyachuk, Vyacheslav/0000-0001-8100-7367; Marklund, Ulrika/0000-0003-1426-1271; Kamenev, Dmitrii/0000-0002-4399-9737; Calvo Enrique, Laura/0000-0002-9428-3974; Adameyko, Igor/0000-0001-5471-0356; Dr. Chontorotzea, Tatiana/0000-0002-6134-1365; Ernfors, Patrik/0000-0002-1140-3986; Kastriti, Maria Eleni/0000-0002-0563-7399; Abdo, Hind/0000-0002-6910-9165	Swedish Research Council; Bertil Hallsten Research Foundation; ERC Consolidator grant; Ake Wiberg Foundation; Swedish Cancer Foundation; Soderberg Foundation; ERC advanced grant (PainCells); NSF CAREER award [NSF-14-532]; National Heart, Lung, and Blood Institute [NIH 1R01HL131768]; Russian Science Foundation (RSF) [16-15-10273]; VR [2015-03387]; StratNeuro; Russian Foundation for Basic Research [16-04-01243]; RSF [17-74-20037]; VR Foundation; KI Foundation; Ragnar Soderberg Foundation; Wallenberg Foundation; VR International Postdoc Fellowship; Stipend for Young Scientists [Ccoproduct -2890.2016.4]; Russian Science Foundation [16-15-10273] Funding Source: Russian Science Foundation; Direct For Biological Sciences [1452964] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131768] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; ERC Consolidator grant(European Research Council (ERC)); Ake Wiberg Foundation; Swedish Cancer Foundation; Soderberg Foundation; ERC advanced grant (PainCells); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); VR(Swedish Research Council); StratNeuro; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF)); VR Foundation; KI Foundation; Ragnar Soderberg Foundation; Wallenberg Foundation(European Commission); VR International Postdoc Fellowship; Stipend for Young Scientists; Russian Science Foundation(Russian Science Foundation (RSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	I. A. was supported by Swedish Research Council, Bertil Hallsten Research Foundation, ERC Consolidator grant, and Ake Wiberg Foundation. P.E. was supported by the Swedish Research Council, Knut and Alice Wallenberg Foundation, Swedish Cancer and Soderberg Foundations, and ERC advanced grant (PainCells). P.V.K. was supported by NSF CAREER award (NSF-14-532) and NIH 1R01HL131768 from the National Heart, Lung, and Blood Institute. N.A. was supported from the Russian Science Foundation (RSF) grant no. 16-15-10273. V.D. was supported by VR (2015-03387), StratNeuro, Russian Foundation for Basic Research (16-04-01243), Stipend for Young Scientists # C coproduct-2890.2016.4, and RSF (17-74-20037). F.L. and S.H. were supported by VR, KI, Ragnar Soderberg, and Wallenberg Foundations. J.P. was supported by VR International Postdoc Fellowship. A Deo lumen, ab amicis auxilium. We thank The Eukaryotic Single Cell Genomics facility at SciLifeLab and K. Wallenberg and S. Picelli for their invaluable support. We also thank J. Hjerling-Leffler and A. M. Manchado for reagents and mice. We also thank Karolinska Institutet FACS facility at CMB, more specifically J. Avila-Carino and B. Pannagel, for their help. We are grateful to U. Suter for sharing Plp1CreERT2 mice that we used in collaboration with U. Suter's laboratory and K. Meletis for sharing ChatCre mice. We acknowledge V. Pachnis for providing Sox10CreERT2 mouse strain. Plp1CreERT2 and Sox10CreERT2 strains are available from U. Suter (ETH Zurich) and V. Pachnis (The Francis Crick Institute) laboratories correspondingly under material transfer agreements with their institutions. We are also grateful to O. Kharchenko for help with illustrations. Finally, we thank J. F. Brunet, C. Kalcheim, and H. Rohrer for critical discussions during recent years. Supplementary materials contain additional data. RNA sequencing results are available at Gene Expression Omnibus (GEO) under accession number GSE99933 (www.ncbi.nlm.nih.gov/geo/info/datasets.html) and are available online through the interactive interface (for E13.5, see http://pklab.med.harvard.edu/cgi-bin/R/rook/nc.SS2_16_250-2/index.html; for E12.5, see http://pklab.med.harvard.edu/cgi-bin/R/rook/nc.SS2_16_249-2/index.html).	Adameyko I, 2014, CELL CYCLE, V13, P2805, DOI 10.4161/15384101.2014.959854; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Allmendinger A, 2003, MECH DEVELOP, V120, P299, DOI 10.1016/S0925-4773(02)00455-0; Apostolova G, 2009, AUTON NEUROSCI-BASIC, V151, P30, DOI 10.1016/j.autneu.2009.08.012; APPEL NM, 1988, J NEUROSCI, V8, P1767; Chan WH, 2016, DEV NEUROBIOL, V76, P137, DOI 10.1002/dneu.22304; DUN NJ, 1993, NEUROSCI LETT, V158, P51, DOI 10.1016/0304-3940(93)90610-W; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Ernsberger U, 2005, CELL TISSUE RES, V319, P1, DOI 10.1007/s00441-004-0996-1; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Furlan A, 2013, EMBO J, V32, P1613, DOI 10.1038/emboj.2013.85; Gonsalvez DG, 2013, J NEUROSCI, V33, P5969, DOI 10.1523/JNEUROSCI.4350-12.2013; Green SA, 2017, NATURE, V544, P88, DOI 10.1038/nature21679; Gresset A, 2015, STEM CELL REP, V5, P278, DOI 10.1016/j.stemcr.2015.06.005; Gut P, 2005, DEVELOPMENT, V132, P4611, DOI 10.1242/dev.02052; Huber K, 2002, DEVELOPMENT, V129, P4729; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696; Jackson CM, 1919, AM J ANAT, V25, P221; Jessen KR, 2008, GLIA, V56, P1479, DOI 10.1002/glia.20779; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Kaukua N, 2014, NATURE, V513, P551, DOI 10.1038/nature13536; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Krispin S, 2010, DEVELOPMENT, V137, P585, DOI 10.1242/dev.041509; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Reiprich S, 2008, MOL BIOL CELL, V19, P1575, DOI 10.1091/mbc.E07-08-0782; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Saito D, 2012, SCIENCE, V336, P1578, DOI 10.1126/science.1222369; Shtukmaster S, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-12; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Szabo PM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-48; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; Uesaka T, 2015, J NEUROSCI, V35, P9879, DOI 10.1523/JNEUROSCI.1239-15.2015; YIP JW, 1986, J NEUROSCI, V6, P3465	38	154	155	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					46	+	eaal3753	10.1126/science.aal3753	http://dx.doi.org/10.1126/science.aal3753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU5NQ	28684471	Green Accepted			2022-12-28	WOS:000423900600001
J	Sokol, J				Sokol, Joshua			Machines that make sense of the sky	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		26	26		10.1126/science.357.6346.26	http://dx.doi.org/10.1126/science.357.6346.26			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684486				2022-12-28	WOS:000404854100019
J	Callaway, E				Callaway, Ewen			THE TRICKIEST FAMILY TREE IN BIOLOGY	NATURE			English	News Item							LINEAGE											Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Ju YS, 2017, NATURE, V543, P714, DOI 10.1038/nature21703; Junker J. P., 2017, PREPRINT; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Leung M. L., 2017, GENOME RES; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Schmidt ST, 2017, ACS SYNTH BIOL, V6, P936, DOI 10.1021/acssynbio.6b00309; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4	11	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					20	22		10.1038/547020a	http://dx.doi.org/10.1038/547020a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682346	Bronze			2022-12-28	WOS:000404839900014
J	Etzioni, O				Etzioni, Oren			AI zooms in on highly influential citations	NATURE			English	Letter									[Etzioni, Oren] Allen Inst Artificial Intelligence, Seattle, WA 98103 USA		Etzioni, O (corresponding author), Allen Inst Artificial Intelligence, Seattle, WA 98103 USA.	orene@allenai.org							0	3	3	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					32	32		10.1038/547032a	http://dx.doi.org/10.1038/547032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682336	Bronze			2022-12-28	WOS:000404839900018
J	Lee, JR; Raymond, B; Bracegirdle, TJ; Chades, I; Fuller, RA; Shaw, JD; Terauds, A				Lee, Jasmine R.; Raymond, Ben; Bracegirdle, Thomas J.; Chades, Iadine; Fuller, Richard A.; Shaw, Justine D.; Terauds, Aleks			Climate change drives expansion of Antarctic ice-free habitat	NATURE			English	Article							BIOLOGICAL INVASIONS; PENINSULA; SEA; SURFACE; MODEL; SHELF; SHEET; SNOW; RISK; MELT	Antarctic terrestrial biodiversity occurs almost exclusively in ice-free areas that cover less than 1% of the continent. Climate change will alter the extent and configuration of ice-free areas, yet the distribution and severity of these effects remain unclear. Here we quantify the impact of twenty-first century climate change on ice-free areas under two Intergovernmental Panel on Climate Change (IPCC) climate forcing scenarios using temperature-index melt modelling. Under the strongest forcing scenario, ice-free areas could expand by over 17,000 km(2) by the end of the century, close to a 25% increase. Most of this expansion will occur in the Antarctic Peninsula, where a threefold increase in ice-free area could drastically change the availability and connectivity of biodiversity habitat. Isolated ice-free areas will coalesce, and while the effects on biodiversity are uncertain, we hypothesize that they could eventually lead to increasing regional-scale biotic homogenization, the extinction of less-competitive species and the spread of invasive species.	[Lee, Jasmine R.; Fuller, Richard A.; Shaw, Justine D.] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia; [Lee, Jasmine R.; Chades, Iadine] CSIRO, Dutton Pk, Qld 4102, Australia; [Raymond, Ben; Terauds, Aleks] Dept Environm & Energy, Australian Antarctic Div, 203 Channel Highway, Kingston, Tas 7050, Australia; [Raymond, Ben] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Private Bag 80, Hobart, Tas 7001, Australia; [Raymond, Ben] Univ Tasmania, Inst Marine & Antarctic, Private Bag 129, Hobart, Tas 7000, Australia; [Bracegirdle, Thomas J.] British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England; [Chades, Iadine; Shaw, Justine D.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld 4072, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of Tasmania; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Queensland	Lee, JR (corresponding author), Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, Brisbane, Qld 4072, Australia.; Lee, JR (corresponding author), CSIRO, Dutton Pk, Qld 4102, Australia.	jasmine.lee1@uqconnect.edu.au	Bracegirdle, Tom/AAD-6060-2020; Fuller, Richard/B-7971-2008; Chades, iadine/A-4052-2011	Fuller, Richard/0000-0001-9468-9678; Chades, iadine/0000-0002-7442-2850; Shaw, Justine/0000-0002-9603-2271; Lee, Jasmine/0000-0003-3847-1679; Terauds, Aleks/0000-0001-7804-6648	Holsworth Wildlife Research Endowment - Equity Trustees Charitable Foundation; Australian Antarctic Science Program [4296, 4297]; Ecological Society of Australia; CSIRO; Australian Research Council Future Fellowship; Polar Science for Planet Earth programme of the British Antarctic Survey; SCAR (Scientific Committee for Antarctic Research) AntClim21 (Antarctic Climate in the 21st Century) SRP (Scientific Research Programme); Natural Environment Research Council [bas0100032] Funding Source: researchfish	Holsworth Wildlife Research Endowment - Equity Trustees Charitable Foundation; Australian Antarctic Science Program; Ecological Society of Australia; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council Future Fellowship(Australian Research Council); Polar Science for Planet Earth programme of the British Antarctic Survey; SCAR (Scientific Committee for Antarctic Research) AntClim21 (Antarctic Climate in the 21st Century) SRP (Scientific Research Programme); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was supported by the Holsworth Wildlife Research Endowment - Equity Trustees Charitable Foundation, the Australian Antarctic Science Program (projects 4296 and 4297) and the Ecological Society of Australia. I.C. was supported by a CSIRO Julius Career award, and R.A.F. by an Australian Research Council Future Fellowship. The contribution of T.J.B. was funded as part of the Polar Science for Planet Earth programme of the British Antarctic Survey with additional support from the SCAR (Scientific Committee for Antarctic Research) AntClim21 (Antarctic Climate in the 21st Century) SRP (Scientific Research Programme). We thank J. Rhodes, S. Robinson, A. Fraser, M. Stafford Smith and A. Richardson for discussions and valuable feedback on this project. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups for producing and making available their model output (listed in Supplementary Table 5 of this paper). For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. We thank the National Centre for Atmospheric Research, the University Corporation for Atmospheric Research and the Byrd Polar and Climate Research Center who are responsible for AMPS and the European Centre for Medium-Range Weather Forecasts who are responsible for the ERA-interim reanalysis data. The Antarctic coastline spatial layer used in the figures was downloaded from the Antarctic Digital Database (ADD Version 7; http://www.add.scar.org).	[Anonymous], 2017, NATURE, V547, P53; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Barrand NE, 2013, J GEOPHYS RES-EARTH, V118, P315, DOI 10.1029/2012JF002559; Bracegirdle TJ, 2012, CLIM DYNAM, V39, P2805, DOI 10.1007/s00382-012-1330-3; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Braithwaite RJ, 2007, ANN GLACIOL-SER, V46, P297, DOI 10.3189/172756407782871206; Burton-Johnson A, 2016, CRYOSPHERE, V10, P1665, DOI 10.5194/tc-10-1665-2016; Chown SL, 2007, PHILOS T R SOC B, V362, P2307, DOI 10.1098/rstb.2006.1949; Chown SL, 2015, NATURE, V522, P427, DOI 10.1038/nature14505; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Collins GE, 2016, POLAR BIOL, V39, P379, DOI 10.1007/s00300-015-1788-7; Convey P., 2013, REFERENCE MODULE LIF, V1, P179, DOI DOI 10.1016/B978-0-12-809633-8.02182-8; Convey P, 2007, SCIENCE, V317, P1877, DOI 10.1126/science.1147261; Convey P, 2014, ECOL MONOGR, V84, P203, DOI 10.1890/12-2216.1; Convey P, 2010, POLAR SCI, V4, P135, DOI 10.1016/j.polar.2010.03.003; Convey P, 2009, QUATERNARY SCI REV, V28, P3035, DOI 10.1016/j.quascirev.2009.08.015; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; De Smet WH, 2008, POLAR BIOL, V31, P595, DOI 10.1007/s00300-007-0393-9; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Ebnet AF, 2005, ANN GLACIOL-SER, V40, P76, DOI 10.3189/172756405781813519; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fraser CI, 2014, P NATL ACAD SCI USA, V111, P5634, DOI 10.1073/pnas.1321437111; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Golledge NR, 2010, GEOGR ANN A, V92A, P111, DOI 10.1111/j.1468-0459.2010.00381.x; Guidetti R, 2014, POLAR BIOL, V37, P1221, DOI 10.1007/s00300-014-1514-x; Hawes TC, 2015, J BIOGEOGR, V42, P207, DOI 10.1111/jbi.12450; Hawkins E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050087; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hock R, 2003, J HYDROL, V282, P104, DOI 10.1016/S0022-1694(03)00257-9; Hock R, 2005, PROG PHYS GEOG, V29, P362, DOI 10.1191/0309133305pp453ra; Hock R, 1999, J GLACIOL, V45, P101, DOI 10.3189/S0022143000003087; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Hogg ID, 2006, SOIL BIOL BIOCHEM, V38, P3035, DOI 10.1016/j.soilbio.2006.04.026; Hosking JS, 2016, GEOPHYS RES LETT, V43, P367, DOI 10.1002/2015GL067143; Hughes KA, 2015, BIODIVERS CONSERV, V24, P1031, DOI 10.1007/s10531-015-0896-6; IPCC, 2013, CLIMATE CHANGE 2022; Kennicutt MC, 2015, ANTARCT SCI, V27, P3, DOI 10.1017/S0954102014000674; Kumar L, 1997, INT J GEOGR INF SCI, V11, P475, DOI 10.1080/136588197242266; Ligtenberg SRM, 2013, CLIM DYNAM, V41, P867, DOI 10.1007/s00382-013-1749-1; McGeoch MA, 2015, GLOBAL ENVIRON CHANG, V32, P108, DOI 10.1016/j.gloenvcha.2014.12.012; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Molina-Montenegro MA, 2012, CONSERV BIOL, V26, P717, DOI 10.1111/j.1523-1739.2012.01865.x; Mulvaney R, 2012, NATURE, V489, P141, DOI 10.1038/nature11391; Olech M, 2011, ANTARCT SCI, V23, P153, DOI 10.1017/S0954102010000982; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Powers JG, 2003, B AM METEOROL SOC, V84, P1533, DOI 10.1175/BAMS-84-11-1533; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; R Development Core Team, 2009, R LANG ENV STAT COMP; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Robinson SA, 2003, GLOBAL CHANGE BIOL, V9, P1681, DOI 10.1046/j.1365-2486.2003.00693.x; Robinson SA, 2015, GLOBAL CHANGE BIOL, V21, P515, DOI 10.1111/gcb.12739; Rott H, 2002, ANN GLACIOL-SER, V34, P277, DOI 10.3189/172756402781817716; Rubidge EM, 2012, NAT CLIM CHANGE, V2, P285, DOI 10.1038/NCLIMATE1415; Shaw JD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001888; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Sutherland WJ, 2015, TRENDS ECOL EVOL, V30, P17, DOI 10.1016/j.tree.2014.11.002; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Terauds A, 2016, DIVERS DISTRIB, V22, P836, DOI 10.1111/ddi.12453; Terauds A, 2012, DIVERS DISTRIB, V18, P726, DOI 10.1111/j.1472-4642.2012.00925.x; Thaker M, 2011, ECOLOGY, V92, P398, DOI 10.1890/10-0126.1; Turner J, 2016, NATURE, V535, P411, DOI 10.1038/nature18645; UNFCCC, 2015, C PART UN FRAM CONV; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; van Lipzig NPM, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004701; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Velasco-Castrillon A, 2014, POLAR BIOL, V37, P1517, DOI 10.1007/s00300-014-1544-4	69	187	191	9	155	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					49	+		10.1038/nature22996	http://dx.doi.org/10.1038/nature22996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658207	Green Accepted			2022-12-28	WOS:000404839900029
J	Voelker, R				Voelker, Rebecca			Precision Approach in Cancer Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					20	20		10.1001/jama.2017.7641	http://dx.doi.org/10.1001/jama.2017.7641			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672300				2022-12-28	WOS:000404717700005
J	Chu, HP; Cifuentes-Rojas, C; Kesner, B; Aeby, E; Lee, HG; Wei, CY; Oh, HJ; Boukhali, M; Haas, W; Lee, JT				Chu, Hsueh-Ping; Cifuentes-Rojas, Catherine; Kesner, Barry; Aeby, Eric; Lee, Hun-Goo; Wei, Chunyao; Oh, Hyun Jung; Boukhali, Myriam; Haas, Wilhelm; Lee, Jeannie T.			TERRA RNA Antagonizes ATRX and Protects Telomeres	CELL			English	Article							REPEAT-CONTAINING RNA; BINDING; TRANSCRIPTION; EXPRESSION; CANCER; LENGTH; YEAST; IDENTIFICATION; INACTIVATION; RECRUITMENT	Through an integration of genomic and proteomic approaches to advance understanding of long non-coding RNAs, we investigate the function of the telomeric transcript, TERRA. By identifying thousands of TERRA target sites in the mouse genome, we demonstrate that TERRA can bind both in cis to telomeres and in trans to genic targets. We then define a large network of interacting proteins, including epigenetic factors, telomeric proteins, and the RNA helicase, ATRX. TERRA and ATRX share hundreds of target genes and are functionally antagonistic at these loci: whereas TERRA activates, ATRX represses gene expression. At telomeres, TERRA competes with telomeric DNA for ATRX binding, suppresses ATRX localization, and ensures telomeric stability. Depleting TERRA increases telomerase activity and induces telomeric pathologies, including formation of telomere-induced DNA damage foci and loss or duplication of telomeric sequences. We conclude that TERRA functions as an epigenomic modulator in trans and as an essential regulator of telomeres in cis.	[Chu, Hsueh-Ping; Cifuentes-Rojas, Catherine; Kesner, Barry; Aeby, Eric; Lee, Hun-Goo; Wei, Chunyao; Oh, Hyun Jung; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02114 USA; [Chu, Hsueh-Ping; Cifuentes-Rojas, Catherine; Kesner, Barry; Aeby, Eric; Lee, Hun-Goo; Wei, Chunyao; Oh, Hyun Jung; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Chu, Hsueh-Ping; Cifuentes-Rojas, Catherine; Kesner, Barry; Aeby, Eric; Lee, Hun-Goo; Wei, Chunyao; Oh, Hyun Jung; Lee, Jeannie T.] Harvard Med Sch, Dept Genet, Boston, MA 02114 USA; [Boukhali, Myriam; Haas, Wilhelm] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Boukhali, Myriam; Haas, Wilhelm] Harvard Med Sch, Dept Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.; Lee, JT (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Lee, JT (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu		Chu, Hsueh-Ping Catherine/0000-0002-0281-0942	NIH [R01-GM58839, K99-GM115868]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058839, R01GM058839, K99GM115868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the lab for valuable discussions and feedback. We also thank C.-S. Wu for advising on IPA software and T. de Lange for discussion. This work is supported by grants from the NIH to J.T.L. (R01-GM58839), and to C.C.R. (K99-GM115868). J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2015, TRENDS CELL BIOL, V25, P29, DOI 10.1016/j.tcb.2014.08.007; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Barthel FP, 2017, NAT GENET, V49, P349, DOI 10.1038/ng.3781; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Chen LY, 2013, GENE DEV, V27, P2099, DOI 10.1101/gad.222893.113; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Cifuentes-Rojas C, 2014, MOL CELL, V55, P171, DOI 10.1016/j.molcel.2014.05.009; Clynes D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8538; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Deng Z, 2012, EMBO J, V31, P4165, DOI 10.1038/emboj.2012.266; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Doksani Y, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016576; Edwards A, 2016, METHODS MOL BIOL, V1394, P1, DOI 10.1007/978-1-4939-3341-9_1; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fei Q, 2015, GENOME RES, V25, P1325, DOI 10.1101/gr.177576.114; Grolimund L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3848; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kung JT, 2015, MOL CELL, V57, P361, DOI 10.1016/j.molcel.2014.12.006; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Le PN, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00091; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; de Silanes IL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5723; de Silanes IL, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1032; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maicher A, 2012, NUCLEIC ACIDS RES, V40, P6649, DOI 10.1093/nar/gks358; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Moravec M, 2016, EMBO REP, V17, P999, DOI 10.15252/embr.201541708; Pfeiffer V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002747; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Rippe K, 2015, NAT STRUCT MOL BIOL, V22, P853, DOI 10.1038/nsmb.3078; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Scheibe M, 2013, GENOME RES, V23, P2149, DOI 10.1101/gr.151878.112; Schmidt JC, 2016, CELL, V166, P1188, DOI 10.1016/j.cell.2016.07.033; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Webb CJ, 2016, RNA BIOL, V13, P683, DOI 10.1080/15476286.2016.1191725; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; Yu TY, 2014, P NATL ACAD SCI USA, V111, P3377, DOI 10.1073/pnas.1307415111; Zhang LF, 2009, GENETICS, V182, P685, DOI 10.1534/genetics.109.103093; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	61	133	141	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					86	+		10.1016/j.cell.2017.06.017	http://dx.doi.org/10.1016/j.cell.2017.06.017			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666128	Green Accepted, Bronze			2022-12-28	WOS:000404358500012
J	Daum, RS; Miller, LG; Immergluck, L; Fritz, S; Creech, CB; Young, D; Kumar, N; Downing, M; Pettibone, S; Hoagland, R; Eells, SJ; Boyle, MG; Parker, TC; Chambers, HF				Daum, Robert S.; Miller, Loren G.; Immergluck, Lilly; Fritz, Stephanie; Creech, C. Buddy; Young, David; Kumar, Neha; Downing, Michele; Pettibone, Stephanie; Hoagland, Rebecca; Eells, Samantha J.; Boyle, Mary G.; Parker, Trisha Chan; Chambers, Henry F.		DMID 07-0051 Team	A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAPHYLOCOCCUS-AUREUS INFECTIONS; SOFT-TISSUE INFECTIONS; TRIMETHOPRIM-SULFAMETHOXAZOLE; PRACTICE GUIDELINES; DISEASES SOCIETY; MANAGEMENT; CHILDREN; RISK	BACKGROUND Uncomplicated skin abscesses are common, yet the appropriate management of the condition in the era of community-associated methicillin-resistant Staphylococcus aureus (MRSA) is unclear. METHODS We conducted a multicenter, prospective, double-blind trial involving outpatient adults and children. Patients were stratified according to the presence of a surgically drainable abscess, abscess size, the number of sites of skin infection, and the presence of non-purulent cellulitis. Participants with a skin abscess 5 cm or smaller in diameter were enrolled. After abscess incision and drainage, participants were randomly assigned to receive clindamycin, trimethoprim-sulfamethoxazole (TMP-SMX), or placebo for 10 days. The primary outcome was clinical cure 7 to 10 days after the end of treatment. RESULTS We enrolled 786 participants: 505 (64.2%) were adults and 281 (35.8%) were children. A total of 448 (57.0%) of the participants were male. S. aureus was isolated from 527 participants (67.0%), and MRSA was isolated from 388 (49.4%). Ten days after therapy in the intention-to-treat population, the cure rate among participants in the clindamycin group was similar to that in the TMP-SMX group (221 of 266 participants [83.1%] and 215 of 263 participants [81.7%], respectively; P = 0.73), and the cure rate in each active-treatment group was higher than that in the placebo group (177 of 257 participants [68.9%], P<0.001 for both comparisons). The results in the population of patients who could be evaluated were similar. This beneficial effect was restricted to participants with S. aureus infection. Among the participants who were initially cured, new infections at 1 month of follow-up were less common in the clindamycin group (15 of 221, 6.8%) than in the TMP-SMX group (29 of 215 [13.5%], P = 0.03) or the placebo group (22 of 177 [12.4%], P = 0.06). Adverse events were more frequent with clindamycin (58 of 265 [21.9%]) than with TMP-SMX (29 of 261 [11.1%]) or placebo (32 of 255 [12.5%]); all adverse events resolved without sequelae. One participant who received TMP-SMX had a hypersensitivity reaction. CONCLUSIONS As compared with incision and drainage alone, clindamycin or TMP-SMX in conjunction with incision and drainage improves short-term outcomes in patients who have a simple abscess. This benefit must be weighed against the known side-effect profile of these antimicrobials. (Funded by the National Institutes of Health; ClinicalTrials.gov number, NCT00730028.)	[Daum, Robert S.; Kumar, Neha] Univ Chicago Hosp, Chicago, IL 60637 USA; [Miller, Loren G.; Eells, Samantha J.] Harbor UCLA Med Ctr, Los Angeles, CA USA; [Miller, Loren G.; Eells, Samantha J.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Los Angeles, CA USA; [Young, David; Downing, Michele; Chambers, Henry F.] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA USA; [Immergluck, Lilly; Parker, Trisha Chan] Morehouse Sch Med, Atlanta, GA 30310 USA; [Immergluck, Lilly; Parker, Trisha Chan] Emory Univ, Grady Mem Hosp, Atlanta, GA 30322 USA; [Immergluck, Lilly; Parker, Trisha Chan] Childrens Healthcare Atlanta, Atlanta, GA USA; [Fritz, Stephanie; Boyle, Mary G.] Washington Univ, Sch Medicine, Barnes Jewish Hosp, St Louis, MO USA; [Fritz, Stephanie; Boyle, Mary G.] St Louis Childrens Hosp, St Louis, MO 63178 USA; [Creech, C. Buddy] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Creech, C. Buddy] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Pettibone, Stephanie] EMMES Corp, Rockville, MD USA; [Hoagland, Rebecca] Cota Enterprises, Meriden, KS USA	University of Chicago; University of Illinois System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Morehouse School of Medicine; Emory University; Children's Healthcare of Atlanta (CHOA); Barnes-Jewish Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Emmes Corporation	Daum, RS (corresponding author), Univ Maryland, Sch Med, Dept Med, 655 W Baltimore St, Baltimore, MD 21201 USA.	rsdaum@gmail.com	Rodriguez, Renee/GYR-1896-2022	Creech, Clarence/0000-0002-8276-9053; Rodriguez, Robert/0000-0003-1354-1773; Self, Wesley/0000-0002-9300-3045	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700031C]; National Center for Research Resources [UL1RR033176, UL1TR000124]; Pfizer; Dynavax; Theravance; Merck; Gilead Sciences; Achaogen; Abbott; Cepheid; Tetraphase; GlaxoSmithKline; Genentech; AstraZeneca; Allergan; Cempra; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS024338] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Pfizer(Pfizer); Dynavax; Theravance; Merck(Merck & Company); Gilead Sciences(Gilead Sciences); Achaogen; Abbott(Abbott Laboratories); Cepheid; Tetraphase; GlaxoSmithKline(GlaxoSmithKline); Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Allergan(AbbVieAllergan); Cempra; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by a contract from the National Institute of Allergy and Infectious Diseases (NIAID) (HHSN272200700031C to Dr. Chambers) and the National Center for Research Resources (UL1RR033176, now at the National Center for Advancing Translational Sciences, UL1TR000124).; Dr. Daum reports receiving fees for serving on an advisory board from Pfizer and Dynavax and grant support from Theravance and Merck; Dr. Miller, receiving grant support from Gilead Sciences, Achaogen, Merck, Abbott, and Cepheid and consulting fees from Tetraphase; Dr. Creech, receiving grant support from Pfizer, grant support and consulting fees from GlaxoSmithKline, and consulting fees from Theravance; and Dr. Chambers, previously holding stock in Merck and receiving grant support and fees for serving on an advisory board from Genentech and fees for serving on an advisory board from AstraZeneca, Pfizer, Cubist (now Merck), Theravance, Allergan, and Cempra. No other potential conflict of interest relevant to this article was reported.	CLSI, 2015, CLSI DOCUMENT M07 A1, V10th; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Fitch MT, 2007, NEW ENGL J MED, V357, pE20, DOI 10.1056/NEJMvcm071319; Holmes L, 2016, J PEDIATR-US, V169, P128, DOI 10.1016/j.jpeds.2015.10.044; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Lipsky BA, 2010, INFECT CONT HOSP EP, V31, P828, DOI 10.1086/654007; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Miller LG, 2015, NEW ENGL J MED, V372, P1093, DOI 10.1056/NEJMoa1403789; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Sitali L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0935-7; Stevens DL, 2014, CLIN INFECT DIS, V59, pE10, DOI [10.1093/cid/ciu296, 10.1093/cid/ciu444]	15	100	104	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2545	2555		10.1056/NEJMoa1607033	http://dx.doi.org/10.1056/NEJMoa1607033			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657870	Green Accepted, Bronze			2022-12-28	WOS:000404259200008
J	Mortimer, R; Owens, E; Howlett, DC				Mortimer, Rebecca; Owens, Emma; Howlett, David C.			SPOT DIAGNOSIS An unusual case of aphasia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mortimer, Rebecca] East Sussex Healthcare Trust, Eastbourne Dist Gen Hosp, Emergency Dept, Eastbourne, England; [Owens, Emma; Howlett, David C.] East Sussex Healthcare Trust, Eastbourne Dist Gen Hosp, Eastbourne, England		Mortimer, R (corresponding author), East Sussex Healthcare Trust, Eastbourne Dist Gen Hosp, Emergency Dept, Eastbourne, England.	rmortimer1@nhs.net						Dabdoub Carlos B, 2015, Surg Neurol Int, V6, P155, DOI 10.4103/2152-7806.166195; Michel SJ, 2004, RADIOLOGY, V232, P449, DOI 10.1148/radiol.2322021556; Schirmer CM, 2010, NEUROCRIT CARE, V13, P152, DOI 10.1007/s12028-010-9363-0	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2017	357								j2792	10.1136/bmj.j2792	http://dx.doi.org/10.1136/bmj.j2792			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AY	28663278				2022-12-28	WOS:000404725100002
J	Roake, CM; Artandi, SE				Roake, Caitlin M.; Artandi, Steven E.			Approaching TERRA Firma: Genomic Functions of Telomeric Noncoding RNA	CELL			English	Editorial Material							DNA HYBRIDS; SENESCENCE; CELLS	Functions of the telomeric repeat-containing RNA (TERRA), the long noncoding RNA (lncRNA) transcribed from telomeres, have eluded researchers. In this issue of Cell, Graf el al. and Chu et al. uncover new regulatory roles for TERRA at the telomere and at distant genomic sites.	[Roake, Caitlin M.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Roake, Caitlin M.; Artandi, Steven E.] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA; [Artandi, Steven E.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	sartandi@stanford.edu			NATIONAL CANCER INSTITUTE [R35CA197563] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA197563] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Graf M, 2017, CELL, V170, P72, DOI 10.1016/j.cell.2017.06.006; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Rippe K, 2015, NAT STRUCT MOL BIOL, V22, P853, DOI 10.1038/nsmb.3078; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Yu TY, 2014, P NATL ACAD SCI USA, V111, P3377, DOI 10.1073/pnas.1307415111	10	9	10	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					8	9		10.1016/j.cell.2017.06.020	http://dx.doi.org/10.1016/j.cell.2017.06.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666127	Bronze			2022-12-28	WOS:000404358500003
J	Slomski, A				Slomski, Anita			Pill Reminders Don't Improve Adherence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2476	2476		10.1001/jama.2017.7588	http://dx.doi.org/10.1001/jama.2017.7588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655013				2022-12-28	WOS:000404106600037
J	Malcolm, P; Galle, S; De Clercq, D				Malcolm, Philippe; Galle, Samuel; De Clercq, Dirk			Fast exoskeleton optimization	SCIENCE			English	Editorial Material							HUMAN WALKING; COST		[Malcolm, Philippe] Univ Nebraska, Ctr Res Human Movement Variabil, Dept Biomech, Omaha, NE 68182 USA; [Galle, Samuel; De Clercq, Dirk] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium	University of Nebraska System; Ghent University	Malcolm, P (corresponding author), Univ Nebraska, Ctr Res Human Movement Variabil, Dept Biomech, Omaha, NE 68182 USA.	pmalcolm@unomaha.edu		Galle, Samuel/0000-0002-1928-7764	NIH [P20GM109090]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank our colleagues for editorial suggestions. This work was supported by NIH (P20GM109090).	Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Jackson RW, 2015, J APPL PHYSIOL, V119, P541, DOI 10.1152/japplphysiol.01133.2014; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; Mooney LM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-80; Norris JA, 2007, GAIT POSTURE, V25, P620, DOI 10.1016/j.gaitpost.2006.07.002; Orendurff MS, 2008, J REHABIL RES DEV, V45, P1077, DOI 10.1682/JRRD.2007.11.0197; Patton JL, 2006, EXP BRAIN RES, V168, P368, DOI 10.1007/s00221-005-0097-8; Quinlivan BT, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aah4416; Schmidt R. A., 2013, MOTOR LEARNING PERFO; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054	11	6	6	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1230	1231		10.1126/science.aan5367	http://dx.doi.org/10.1126/science.aan5367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642394	Green Accepted			2022-12-28	WOS:000403881700017
J	David, JG				David, Jennie G.			The Chair Grant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[David, Jennie G.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA	Drexel University	David, JG (corresponding author), Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					108	109		10.1056/NEJMp1704381	http://dx.doi.org/10.1056/NEJMp1704381			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA2PC	28700838				2022-12-28	WOS:000405282300004
J	Fitzpatrick, AWP; Falcon, B; He, S; Murzin, AG; Murshudov, G; Garringer, HJ; Crowther, RA; Ghetti, B; Goedert, M; Scheres, SHW				Fitzpatrick, Anthony W. P.; Falcon, Benjamin; He, Shaoda; Murzin, Alexey G.; Murshudov, Garib; Garringer, Holly J.; Crowther, R. Anthony; Ghetti, Bernardino; Goedert, Michel; Scheres, Sjors H. W.			Cryo-EM structures of tau filaments from Alzheimer's disease	NATURE			English	Article							PAIRED HELICAL FILAMENTS; ATOMIC-RESOLUTION STRUCTURE; AMYLOID FIBRILS; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; RECOMBINANT-TAU; BETA STRUCTURE; FINE-STRUCTURE; PROTEIN-TAU; IN-VITRO	Alzheimer's disease is the most common neurodegenerative disease, and there are no mechanism-based therapies. The disease is defined by the presence of abundant neurofibrillary lesions and neuritic plaques in the cerebral cortex. Neurofibrillary lesions comprise paired helical and straight tau filaments, whereas tau filaments with different morphologies characterize other neurodegenerative diseases. No high-resolution structures of tau filaments are available. Here we present cryo-electron microscopy (cryo-EM) maps at 3.4-3.5 angstrom resolution and corresponding atomic models of paired helical and straight filaments from the brain of an individual with Alzheimer's disease. Filament cores are made of two identical protofilaments comprising residues 306-378 of tau protein, which adopt a combined cross-beta/beta-helix structure and define the seed for tau aggregation. Paired helical and straight filaments differ in their inter-protofilament packing, showing that they are ultrastructural polymorphs. These findings demonstrate that cryo-EM allows atomic characterization of amyloid filaments from patient-derived material, and pave the way for investigation of a range of neurodegenerative diseases.	[Fitzpatrick, Anthony W. P.; Falcon, Benjamin; He, Shaoda; Murzin, Alexey G.; Murshudov, Garib; Crowther, R. Anthony; Goedert, Michel; Scheres, Sjors H. W.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Garringer, Holly J.; Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	MRC Laboratory Molecular Biology; Indiana University System; Indiana University Bloomington	Goedert, M; Scheres, SHW (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk; scheres@mrc-lmb.cam.ac.uk	Scheres, Sjors H.W./AAY-2265-2021	Scheres, Sjors H.W./0000-0002-0462-6540; Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618	UK Medical Research Council [MC_UP_A025_1012, MC_U105184291, MC_UP_A025_1013]; European Union; US National Institutes of Health [P30-AG010133]; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER; Medical Research Council [MC_EX_MR/N027892/1, MC_UP_A025_1012, MC_UP_A025_1013, G0600724] Funding Source: researchfish; MRC [G0600724, MC_UP_A025_1012, MC_EX_MR/N027892/1, MC_UP_A025_1013] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology and Laboratory Medicine, Indiana University School of Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These findings mark the culmination of a conversation at the MRC Laboratory of Molecular Biology 34 years ago between A. Klug, the late M. Roth and R.A.C. about the structural analysis of Alzheimer filaments. We thank the patient's family for donating brain tissue; M. R. Farlow for clinical evaluation; F. Epperson, R. M. Richardson and U. Kuederli for human brain collection and analysis; P. Davies, M. Hasegawa and M. Novak for antibodies MC-1, TauC4 and MN423, respectively; H. Zhou for use of the Titan Krios at UCLA EICN; S. Chen, C. Savva and G. Cannone for support with electron microscopy at the MRC Laboratory of Molecular Biology; T. Darling and J. Grimmett for help with computing; and M. Skehel for support with mass spectrometry. M. G. is an Honorary Professor in the Department of Clinical Neurosciences of the University of Cambridge. This work was supported by the UK Medical Research Council (MC_UP_A025_1012 to G. M., MC_U105184291 to M. G. and MC_UP_A025_1013 to S.H.W.S.), the European Union (Marie Curie International Outgoing Fellowship to A.W.P.F., Joint Programme-Neurodegeneration Research to M. G. and B.F., and Horizon 2020 IMPRiND to M. G. and A.W.P.F.), the US National Institutes of Health (grant P30-AG010133 to B.G.) and the Department of Pathology and Laboratory Medicine, Indiana University School of Medicine (to B.G.).	Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Bibow S, 2011, ANGEW CHEM INT EDIT, V50, P11520, DOI 10.1002/anie.201105493; Braak H, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023630; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; CRICK FHC, 1955, NATURE, V176, P780, DOI 10.1038/176780a0; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Dan A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-54; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hayashi S, 2002, ANN NEUROL, V51, P525, DOI 10.1002/ana.10163; He SD, 2017, J STRUCT BIOL, V198, P163, DOI 10.1016/j.jsb.2017.02.003; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Iverson TM, 2000, BIOCHEMISTRY-US, V39, P9222, DOI 10.1021/bi000204s; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kolb HC, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023721; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; McEwan WA, 2017, P NATL ACAD SCI USA, V114, P574, DOI 10.1073/pnas.1607215114; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Spina S, 2008, BRAIN, V131, P72, DOI 10.1093/brain/awm280; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; TERRY RD, 1963, J NEUROPATH EXP NEUR, V22, P629, DOI 10.1097/00005072-196310000-00005; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; Xie C, 2015, J NEUROCHEM, V135, P19, DOI 10.1111/jnc.13228; YAGISHITA S, 1981, ACTA NEUROPATHOL, V54, P239, DOI 10.1007/BF00687747; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	57	980	993	14	493	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					185	+		10.1038/nature23002	http://dx.doi.org/10.1038/nature23002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678775	Green Accepted, Green Submitted			2022-12-28	WOS:000405314500032
J	Voelker, R				Voelker, Rebecca			Expanded Cystic Fibrosis Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					20	20		10.1001/jama.2017.7643	http://dx.doi.org/10.1001/jama.2017.7643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672301				2022-12-28	WOS:000404717700006
J	Blundon, JA; Roy, NC; Teubner, BJW; Yu, J; Eom, TY; Sample, KJ; Pani, A; Smeyne, RJ; Han, SB; Kerekes, RA; Rose, DC; Hackett, TA; Vuppala, PK; Freeman, BB; Zakharenko, SS				Blundon, Jay A.; Roy, Noah C.; Teubner, Brett J. W.; Yu, Jing; Eom, Tae-Yeon; Sample, K. Jake; Pani, Amar; Smeyne, Richard J.; Han, Seung Baek; Kerekes, Ryan A.; Rose, Derek C.; Hackett, Troy A.; Vuppala, Pradeep K.; Freeman, Burgess B., III; Zakharenko, Stanislav S.			Restoring auditory cortex plasticity in adult mice by restricting thalamic adenosine signaling	SCIENCE			English	Article							VAGUS NERVE-STIMULATION; LONG-TERM POTENTIATION; CRITICAL PERIOD; SYNAPTIC PLASTICITY; REPRESENTATION; MEMORY	Circuits in the auditory cortex are highly susceptible to acoustic influences during an early postnatal critical period. The auditory cortex selectively expands neural representations of enriched acoustic stimuli, a process important for human language acquisition. Adults lack this plasticity. Here we show in the murine auditory cortex that juvenile plasticity can be reestablished in adulthood if acoustic stimuli are pairedwith disruption of ecto-5'-nucleotidase-dependent adenosine production or A(1)-adenosine receptor signaling in the auditory thalamus. This plasticity occurs at the level of cortical maps and individual neurons in the auditory cortex of awake adult mice and is associated with long-term improvement of tone-discrimination abilities. We conclude that, in adult mice, disrupting adenosine signaling in the thalamus rejuvenates plasticity in the auditory cortex and improves auditory perception.	[Blundon, Jay A.; Roy, Noah C.; Teubner, Brett J. W.; Yu, Jing; Eom, Tae-Yeon; Sample, K. Jake; Pani, Amar; Smeyne, Richard J.; Han, Seung Baek; Zakharenko, Stanislav S.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kerekes, Ryan A.; Rose, Derek C.] Oak Ridge Natl Lab, Elect & Elect Syst Res Div, Oak Ridge, TN 37831 USA; [Hackett, Troy A.] Vanderbilt Univ, Sch Med, Dept Hearing & Speech Sci, Nashville, TN 37232 USA; [Vuppala, Pradeep K.; Freeman, Burgess B., III] St Jude Childrens Res Hosp, Preclin Pharmacokinet Shared Resource, 332 N Lauderdale St, Memphis, TN 38105 USA; [Pani, Amar] Univ Tennessee, Ctr Hlth Sci, 855 Monroe Ave, Memphis, TN 38163 USA; [Smeyne, Richard J.] Thomas Jefferson Univ, 233 South 10th St,Bluemle Hall,Room 208, Philadelphia, PA 19107 USA; [Vuppala, Pradeep K.] KinderPharm, 100 Arrandale Blvd,Suite 101, Exton, PA 19341 USA	St Jude Children's Research Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; Vanderbilt University; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Jefferson University	Zakharenko, SS (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	stanislav.zakharenko@stjude.org	Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X; Han, Seung Baek/0000-0002-9798-0679; Kerekes, Ryan/0000-0001-7199-811X; Smeyne, Richard/0000-0002-8459-5472	NIH [DC012833, MH097742, DC015388]; American Lebanese Syrian Associated Charities (ALSAC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC015388, R01DC012833] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants DC012833, MH097742 (S.S.Z.), and DC015388 (T.A.H.), and by American Lebanese Syrian Associated Charities (ALSAC) (S.S.Z.). The funding sources had no role in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript. We thank the Vector Core Laboratories (St. Jude Children's Research Hospital and University of Tennessee Health Science Center) and J. Westmoreland for assistance in producing AAVs and lentiviruses; F. Du for assistance in generating Adora1<SUP>fl/fl</SUP> mice and pharmacokinetic studies; J. Min and A. Mayasundari for help with FR194921; A. Onar-Thomas for statistical assistance; A. Uptain and K. Anderson for assistance with imaging experiments and viral injections in vivo; and V. Shanker and A. McArthur for editing the manuscript. The supplementary materials contain additional data. S.S.Z. and J.A.B. are inventors on patent application PCT/US2016/018377 submitted by St. Jude Children's Research Hospital, which covers the subject of improved learning through inhibition of adenosine signaling in the thalamus.	Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Blundon JA, 2013, NEUROSCIENTIST, V19, P465, DOI 10.1177/1073858413482983; Blundon JA, 2011, J NEUROSCI, V31, P16012, DOI 10.1523/JNEUROSCI.3281-11.2011; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Dawson J, 2016, STROKE, V47, P143, DOI 10.1161/STROKEAHA.115.010477; De Ridder D, 2014, NEUROMODULATION, V17, P170, DOI 10.1111/ner.12127; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Dorrn AL, 2010, NATURE, V465, P932, DOI 10.1038/nature09119; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fredholm BB, 2017, MOL ASPECTS MED, V55, P20, DOI 10.1016/j.mam.2016.11.011; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Froemke RC, 2015, CURR OPIN NEUROBIOL, V35, P185, DOI 10.1016/j.conb.2015.10.003; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hubener M, 2014, CELL, V159, P727, DOI 10.1016/j.cell.2014.10.035; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Lindemann L, 2011, J PHARMACOL EXP THER, V339, P474, DOI 10.1124/jpet.111.185660; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P2701, DOI 10.1162/jocn.2010.21585; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Moreno S, 2006, PSYCHOPHYSIOLOGY, V43, P287, DOI 10.1111/j.1469-8986.2006.00401.x; Oberlaender M, 2012, NEURON, V74, P648, DOI 10.1016/j.neuron.2012.03.022; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Schreiner CE, 2014, CURR OPIN NEUROBIOL, V24, P143, DOI 10.1016/j.conb.2013.11.009; Street SE, 2013, J NEUROSCI, V33, P11314, DOI 10.1523/JNEUROSCI.0133-13.2013; Takesian AE, 2013, PROG BRAIN RES, V207, P3, DOI 10.1016/B978-0-444-63327-9.00001-1; Tallal P, 2002, DEV PSYCHOPATHOL, V14, P559, DOI 10.1017/S0954579402003097; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	36	30	30	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1352	+		10.1126/science.aaf4612	http://dx.doi.org/10.1126/science.aaf4612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663494	Green Accepted, Green Submitted			2022-12-28	WOS:000404351500030
J	Comita, LS				Comita, Liza S.			How latitude affects biotic interactions	SCIENCE			English	Editorial Material							NEGATIVE DENSITY-DEPENDENCE; TROPICAL FORESTS; DIVERSITY		[Comita, Liza S.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Panama City, Panama	Yale University; Smithsonian Institution; Smithsonian Tropical Research Institute	Comita, LS (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.; Comita, LS (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	liza.comita@yale.edu	yasin, jeshima k K/H-2912-2018	yasin, jeshima k K/0000-0003-4932-3866				Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Coley PD, 2014, SCIENCE, V343, P35, DOI 10.1126/science.1248110; Comita LS, 2014, J ECOL, V102, P845, DOI 10.1111/1365-2745.12232; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; LaManna JA, 2017, SCIENCE, V356, P1389, DOI 10.1126/science.aam5678; Marden JH, 2017, MOL ECOL, V26, P2498, DOI 10.1111/mec.13999; Moles AT, 2016, BIOTROPICA, V48, P141, DOI 10.1111/btp.12281; Roslin T, 2017, SCIENCE, V356, P742, DOI 10.1126/science.aaj1631; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Zhu K, 2015, ECOLOGY, V96, P2319, DOI 10.1890/14-1780.1	14	18	18	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1328	1329		10.1126/science.aan6356	http://dx.doi.org/10.1126/science.aan6356			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663453				2022-12-28	WOS:000404351500014
J	Yang, WS; Park, BW; Jung, EH; Jeon, NJ; Kim, YC; Lee, DU; Shin, SS; Seo, J; Kim, EK; Noh, JH; Seok, SI				Yang, Woon Seok; Park, Byung-Wook; Jung, Eui Hyuk; Jeon, Nam Joong; Kim, Young Chan; Lee, Dong Uk; Shin, Seong Sik; Seo, Jangwon; Kim, Eun Kyu; Noh, Jun Hong; Seok, Sang Il			Iodide management in formamidinium-lead-halide-based perovskite layers for efficient solar cells	SCIENCE			English	Article							CARRIER DYNAMICS; THIN-FILMS; PERFORMANCE; PASSIVATION; QUALITY	The formation of a dense and uniform thin layer on the substrates is crucial for the fabrication of high-performance perovskite solar cells (PSCs) containing formamidinium with multiple cations and mixed halide anions. The concentration of defect states, which reduce a cell's performance by decreasing the open-circuit voltage and short-circuit current density, needs to be as low as possible. We show that the introduction of additional iodide ions into the organic cation solution, which are used to form the perovskite layers through an intramolecular exchanging process, decreases the concentration of deep-level defects. The defect-engineered thin perovskite layers enable the fabrication of PSCs with a certified power conversion efficiency of 22.1% in small cells and 19.7% in 1-square-centimeter cells.	[Yang, Woon Seok; Park, Byung-Wook; Seok, Sang Il] Ulsan Natl Inst Sci & Technol, Sch Nat Sci, Perovtron Res Ctr, 50 UNIST Gil, Ulsan 44919, South Korea; [Yang, Woon Seok; Park, Byung-Wook; Seok, Sang Il] Ulsan Natl Inst Sci & Technol, Sch Energy & Chem Engn, 50 UNIST Gil, Ulsan 44919, South Korea; [Jung, Eui Hyuk; Jeon, Nam Joong; Kim, Young Chan; Shin, Seong Sik; Seo, Jangwon; Noh, Jun Hong; Seok, Sang Il] Korea Res Inst Chem Technol, Div Adv Mat, 141 Gajeong Ro, Daejeon 34114, South Korea; [Lee, Dong Uk] SK Hynix Inc, NAND Prod Engn Grp, Icheon 17336, South Korea; [Kim, Eun Kyu] Hanyang Univ, Dept Phys, Seoul 04763, South Korea; [Kim, Eun Kyu] Hanyang Univ, Quantum Funct Res Lab, Seoul 04763, South Korea; [Noh, Jun Hong] Korea Univ, Sch Civil Environm & Architectural Engn, Seoul 136713, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Korea Research Institute of Chemical Technology (KRICT); SK Group; SK Hynix; Hanyang University; Hanyang University; Korea University	Seok, SI (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Nat Sci, Perovtron Res Ctr, 50 UNIST Gil, Ulsan 44919, South Korea.; Seok, SI (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Energy & Chem Engn, 50 UNIST Gil, Ulsan 44919, South Korea.; Noh, JH; Seok, SI (corresponding author), Korea Res Inst Chem Technol, Div Adv Mat, 141 Gajeong Ro, Daejeon 34114, South Korea.; Kim, EK (corresponding author), Hanyang Univ, Dept Phys, Seoul 04763, South Korea.; Kim, EK (corresponding author), Hanyang Univ, Quantum Funct Res Lab, Seoul 04763, South Korea.; Noh, JH (corresponding author), Korea Univ, Sch Civil Environm & Architectural Engn, Seoul 136713, South Korea.	ek-kim@hanyang.ac.kr; junhnoh@korea.ac.kr; seoksi@unist.ac.kr	Jung, Eui Hyuk/AAI-3867-2021; Noh, Jun Hong/A-7769-2010; Seok, Sang Il/R-2778-2016; Lee, Dong Uk/E-7291-2013	Noh, Jun Hong/0000-0002-1143-5822; Seok, Sang Il/0000-0001-9976-6628; Lee, Dong Uk/0000-0003-4921-0386; Jung, Eui Hyuk/0000-0002-2833-522X	Global Frontier R&D (Research and Development) Program of the Center for Multiscale Energy System through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technology) and Future Planning [NRF-2011-0031565, NRF-2016M3A6A7945503]; Climate Change Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technology) and Future Planning [NRF-2015M1A2A2056542]; Ulsan National Institute of Science and Technology (UNIST) [1.170003.01]; Korea Research Institute of Chemical Technology (KRICT) [KK1702-A01]; Ministry of Education, Science, and Technology; Pohang University of Science and Technology; UNIST-Central Research Facilities Center; Basic Science Research Program [NRF-2015R1A6A3A04058164]	Global Frontier R&D (Research and Development) Program of the Center for Multiscale Energy System through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technology) and Future Planning(National Research Foundation of Korea); Climate Change Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT (Information and Communication Technology) and Future Planning(National Research Foundation of Korea); Ulsan National Institute of Science and Technology (UNIST); Korea Research Institute of Chemical Technology (KRICT); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Pohang University of Science and Technology; UNIST-Central Research Facilities Center; Basic Science Research Program	This work was supported by the Global Frontier R&D (Research and Development) Program of the Center for Multiscale Energy System (NRF-2011-0031565 and NRF-2016M3A6A7945503) and the Climate Change Program (NRF-2015M1A2A2056542) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT (Information and Communication Technology) and Future Planning. This work was also supported by a brand project (1.170003.01) of the Ulsan National Institute of Science and Technology (UNIST) and internal project (no. KK1702-A01) of the Korea Research Institute of Chemical Technology (KRICT). The GIWAXS experiment at the PLS-II 6D UNIST-Pohang Accelerator Laboratory beamline was supported in part by the Ministry of Education, Science, and Technology; Pohang University of Science and Technology; and UNIST-Central Research Facilities Center. We thank Tae Joo Shin for the indexing of 2D GIWAXS patterns. N.J.J. acknowledges financial support from the Basic Science Research Program (NRF-2015R1A6A3A04058164). All results are reported in the main text and supplementary materials. W.S.Y., J.H.N., J.S., and S.I.S. are inventors on patent application (KR 10-2016-0097290) submitted by both UNIST and KRICT that covers the preparation of perovskite films.	Ball JM, 2016, NAT ENERGY, V1, P1, DOI [10.1038/NENERGY.2016.149, 10.1038/nenergy.2016.149]; Bi DQ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501170; Buin A, 2015, CHEM MATER, V27, P4405, DOI 10.1021/acs.chemmater.5b01909; Buin A, 2014, NANO LETT, V14, P6281, DOI 10.1021/nl502612m; Cao J, 2016, J AM CHEM SOC, V138, P9919, DOI 10.1021/jacs.6b04924; Chen Q, 2014, NANO LETT, V14, P4158, DOI 10.1021/nl501838y; De Marco N, 2016, NANO LETT, V16, P1009, DOI 10.1021/acs.nanolett.5b04060; Edri E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4461; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Gardner JM, 2009, J AM CHEM SOC, V131, P16206, DOI 10.1021/ja905021c; Han QF, 2016, ADV MATER, V28, P2253, DOI 10.1002/adma.201505002; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Heo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30554; Herz LM, 2016, ANNU REV PHYS CHEM, V67, P65, DOI 10.1146/annurev-physchem-040215-112222; Jacobsson TJ, 2016, J AM CHEM SOC, V138, P10331, DOI 10.1021/jacs.6b06320; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/NMAT4014, 10.1038/nmat4014]; Jiang Q, 2017, NAT ENERGY, V2, P1, DOI [10.1038/nenergy.2016.177, 10.1038/NENERGY.2016.177]; MANGLIK A, 1980, REACT KINET CATAL L, V15, P467; Noel NK, 2014, ACS NANO, V8, P9815, DOI 10.1021/nn5036476; Noh JH, 2015, MRS BULL, V40, P648, DOI 10.1557/mrs.2015.168; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j; Shin SS, 2017, SCIENCE, V356, P167, DOI 10.1126/science.aam6620; Stewart RJ, 2016, J PHYS CHEM C, V120, P12392, DOI 10.1021/acs.jpcc.6b03472; Stewart RJ, 2016, J PHYS CHEM LETT, V7, P1148, DOI 10.1021/acs.jpclett.6b00366; Stranks SD, 2014, PHYS REV APPL, V2, DOI 10.1103/PhysRevApplied.2.034007; Wang JTW, 2016, ENERG ENVIRON SCI, V9, P2892, DOI 10.1039/c6ee01969b; Wen XM, 2016, J MATER CHEM C, V4, P793, DOI 10.1039/c5tc03109e; Xu J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8081; Yang WS, 2015, SCIENCE, V348, P1234, DOI 10.1126/science.aaa9272; Yin WJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864778; Yun JS, 2015, J PHYS CHEM LETT, V6, P875, DOI 10.1021/acs.jpclett.5b00182; Zhang W, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10030	34	4197	4258	100	2512	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1376	+		10.1126/science.aan2301	http://dx.doi.org/10.1126/science.aan2301			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663498				2022-12-28	WOS:000404351500035
J	Ball, P				Ball, Philip			A WORLD WITHOUT CAUSE AND EFFECT	NATURE			English	News Item																		Chiribella G, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022318; Chiribella G, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.040301; Daki B., 2011, DEEP BEAUTY UNDERSTA, P365, DOI DOI 10.1017/CBO9780511976971.011; Guerin PA, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.100502; Hardy L, 2007, PREPRINT; Hardy L., 2001, PREPRINT; MacLean JPW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15149; Oreshkov O, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2076; Procopio LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8913; Rubino G, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602589	11	4	4	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					590	592		10.1038/546590a	http://dx.doi.org/10.1038/546590a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28661505	Bronze			2022-12-28	WOS:000404332000020
J	Figueres, C; Schellnhuber, HJ; Whiteman, G; Rockstrom, J; Hobley, A; Rahmstorf, S				Figueres, Christiana; Schellnhuber, Hans Joachim; Whiteman, Gail; Rockstrom, Johan; Hobley, Anthony; Rahmstorf, Stefan			Three years to safeguard our climate	NATURE			English	Editorial Material									[Figueres, Christiana] Global Covenant Mayors Climate & Energy, Potsdam, Germany; [Schellnhuber, Hans Joachim; Rahmstorf, Stefan] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Whiteman, Gail] Univ Lancaster, Pentland Ctr Sustainabil Business, Lancaster, England; [Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Hobley, Anthony] Carbon Tracker, London, England	Potsdam Institut fur Klimafolgenforschung; Lancaster University; Stockholm University	Figueres, C (corresponding author), Global Covenant Mayors Climate & Energy, Potsdam, Germany.	cfigueres@mission2020.global	Schellnhuber, Hans Joachim/O-3873-2019; Rahmstorf, Stefan/A-8465-2010; Schellnhuber, Hans Joachim/B-2607-2012	Schellnhuber, Hans Joachim/0000-0001-7453-4935; Rahmstorf, Stefan/0000-0001-6786-7723; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Whiteman, Gail/0000-0002-4152-5538; Rockstrom, Johan/0000-0001-8988-2983				Carbon Tracker, 2017, EXP UN; Climate Action Tracker, 2016, 10 STEPS; European Parliament, 2016, GLOB TRENDS REN EN I; IEA-IRENA, 2017, PERSP EN TRANS; International Energy Agency, 2016, WORLD EN OUTL 2016; IRENA, 2017, IRENA REN EN JOBS AN; Mission 2020, 2017, 2020 CLIMATE TURNING; REN21, 2016, REN 2016 GLOB STAT R; WindEurope, 2017, WIND POW 2016 EUR ST	9	216	219	0	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					593	595		10.1038/546593a	http://dx.doi.org/10.1038/546593a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9QB	28661507	Green Submitted, Bronze			2022-12-28	WOS:000404332000021
J	Pavlovich, M				Pavlovich, Matthew			One (Cell) in a Million	CELL			English	Editorial Material							SINGLE-CELL; HIGH-THROUGHPUT; READOUT											Datlinger P, 2017, NAT METHODS, V14, P297, DOI [10.1038/NMETH.4177, 10.1038/nmeth.4177]; Frieda KL, 2017, NATURE, V541, P107, DOI 10.1038/nature20777; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P11046, DOI 10.1073/pnas.1612826113; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321	7	2	2	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					1	3						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666111	Bronze			2022-12-28	WOS:000404358500001
J	Roberts, RJ				Roberts, Richard J.			An obituary for the impact factor	NATURE			English	Letter									[Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Roberts, RJ (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	roberts@neb.com						Stephan P, 2017, NATURE, V544, P411, DOI 10.1038/544411a; Wouters P, 2017, NATURE, V543, P492, DOI 10.1038/543492a	2	8	8	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					600	600		10.1038/546600e	http://dx.doi.org/10.1038/546600e			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658236	Bronze			2022-12-28	WOS:000404332000032
J	Litwin, MS; Tan, HJ				Litwin, Mark S.; Tan, Hung-Jui			The Diagnosis and Treatment of Prostate Cancer A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; ANDROGEN-DEPRIVATION THERAPY; CONVENTIONALLY FRACTIONATED RADIOTHERAPY; QUALITY-OF-LIFE; ASSISTED RADICAL PROSTATECTOMY; MODULATED RADIATION-THERAPY; EXTERNAL-BEAM RADIOTHERAPY; ACTIVE SURVEILLANCE COHORT; PATIENT-REPORTED OUTCOMES; DOSE-RATE BRACHYTHERAPY	IMPORTANCE Prostate cancer is the most common cancer diagnosis made in men with more than 160 000 new cases each year in the United States. Although it often has an indolent course, prostate cancer remains the third-leading cause of cancer death in men. OBSERVATIONS When prostate cancer is suspected, tissue biopsy remains the standard of care for diagnosis. However, the identification and characterization of the disease have become increasingly precise through improved risk stratification and advances inmagnetic resonance and functional imaging, as well as from the emergence of biomarkers. Multiple management options now exist for men diagnosed with prostate cancer. Active surveillance (the serial monitoring for disease progression with the intent to cure) appears to be safe and has become the preferred approach for men with less-aggressive prostate cancer, particularly those with a prostate-specific antigen level of less than 10 ng/mL and Gleason score 3 + 3 tumors. Surgery and radiation continue to be curative treatments for localized disease but have adverse effects such as urinary symptoms and sexual dysfunction that can negatively affect quality of life. Formetastatic disease, chemotherapy as initial treatment now appears to extend survival compared with androgen deprivation therapy alone. New vaccines, hormonal therapeutics, and bone-targeting agents have demonstrated efficacy in men with metastatic prostate cancer resistant to traditional hormonal therapy. CONCLUSIONS AND RELEVANCE Advances in the diagnosis and treatment of prostate cancer have improved the ability to stratify patients by risk and allowed clinicians to recommend therapy based on cancer prognosis and patient preference. Initial treatment with chemotherapy can improve survival compared with androgen deprivation therapy. Abiraterone, enzalutamide, and other agents can improve outcomes in men with metastatic prostate cancer resistant to traditional hormonal therapy.	[Litwin, Mark S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Litwin, Mark S.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Litwin, Mark S.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; [Tan, Hung-Jui] Univ N Carolina, Dept Urol, Chapel Hill, NC USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill	Litwin, MS (corresponding author), Univ Calif Los Angeles, Dept Urol, 300 Stein Plaza,Third Floor, Los Angeles, CA 90095 USA.	mlitwin@mednet.ucla.edu		Litwin, Mark/0000-0002-2318-344X				Aluwini S, 2016, LANCET ONCOL, V17, P464, DOI 10.1016/S1470-2045(15)00567-7; Aluwini S, 2015, LANCET ONCOL, V16, P274, DOI 10.1016/S1470-2045(14)70482-6; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Barocas DA, 2017, JAMA-J AM MED ASSOC, V317, P1126, DOI 10.1001/jama.2017.1704; Barry MJ, 2015, JAMA-J AM MED ASSOC, V314, P2073, DOI 10.1001/jama.2015.12614; Beckendorf V, 2011, INT J RADIAT ONCOL, V80, P1056, DOI 10.1016/j.ijrobp.2010.03.049; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Bjurlin MA, 2013, J UROLOGY, V189, P2039, DOI 10.1016/j.juro.2013.02.072; Bolla M, 2016, J CLIN ONCOL, V34, P1748, DOI 10.1200/JCO.2015.64.8055; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Bourke L, 2016, EUR UROL, V69, P693, DOI 10.1016/j.eururo.2015.10.047; Bourke L, 2014, EUR UROL, V65, P865, DOI 10.1016/j.eururo.2013.09.040; Bruner DW, 2011, J SEX MED, V8, P1228, DOI 10.1111/j.1743-6109.2010.02164.x; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Chen RC, 2016, J CLIN ONCOL, V34, P2182, DOI 10.1200/JCO.2015.65.7759; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Couper J, 2015, BJU INT, V115, P35, DOI 10.1111/bju.12991; D'Amico AV, 2015, JAMA-J AM MED ASSOC, V314, P1291, DOI 10.1001/jama.2015.8577; Daskivich TJ, 2013, ANN INTERN MED, V158, P709, DOI 10.7326/0003-4819-158-10-201305210-00005; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Dearnaley DP, 2014, LANCET ONCOL, V15, P464, DOI 10.1016/S1470-2045(14)70040-3; Demanes DJ, 2014, BRACHYTHERAPY, V13, P529, DOI 10.1016/j.brachy.2014.03.002; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Eggener SE, 2015, JAMA-J AM MED ASSOC, V314, P825, DOI 10.1001/jama.2015.8033; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Filson CP, 2016, CANCER-AM CANCER SOC, V122, P884, DOI 10.1002/cncr.29874; Filson CP, 2015, CA-CANCER J CLIN, V65, P264, DOI 10.3322/caac.21278; Fizazi K, 2015, LANCET ONCOL, V16, P787, DOI 10.1016/S1470-2045(15)00011-X; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; Godtman RA, 2016, EUR UROL, V70, P760, DOI 10.1016/j.eururo.2016.03.048; Goode PS, 2011, JAMA-J AM MED ASSOC, V305, P151, DOI 10.1001/jama.2010.1972; Gupta A, 2010, BRIT J CANCER, V103, P708, DOI 10.1038/sj.bjc.6605815; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Heemsbergen WD, 2014, RADIOTHER ONCOL, V110, P104, DOI 10.1016/j.radonc.2013.09.026; Hoskin PJ, 2012, RADIOTHER ONCOL, V103, P217, DOI 10.1016/j.radonc.2012.01.007; Hu JC, 2014, J UROLOGY, V192, P385, DOI 10.1016/j.juro.2014.02.005; James ND, 2016, LANCET, V387, P1163, DOI 10.1016/S0140-6736(15)01037-5; James ND, 2016, JAMA ONCOL, V2, P348, DOI 10.1001/jamaoncol.2015.4350; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Klotz L, 2015, J CLIN ONCOL, V33, P272, DOI 10.1200/JCO.2014.55.1192; Knudsen BS, 2016, J MOL DIAGN, V18, P395, DOI 10.1016/j.jmoldx.2015.12.006; Koh H, 2003, J UROLOGY, V170, P1203, DOI 10.1097/01.ju.0000085074.62960.7b; Koontz BF, 2015, EUR UROL, V68, P683, DOI 10.1016/j.eururo.2014.08.009; Lindenberg ML, 2017, JAMA ONCOL, V3, P1415, DOI 10.1001/jamaoncol.2016.5840; Magnan S, 2015, JAMA ONCOL, V1, P1261, DOI 10.1001/jamaoncol.2015.2895; Mason MD, 2015, J CLIN ONCOL, V33, P2143, DOI 10.1200/JCO.2014.57.7510; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mohler JL, 2016, J NATL COMPR CANC NE, V14, P19, DOI 10.6004/jnccn.2016.0004; Nead KT, 2017, JAMA ONCOL, V3, P49, DOI 10.1001/jamaoncol.2016.3662; Nguyen PL, 2015, EUR UROL, V67, P825, DOI 10.1016/j.eururo.2014.07.010; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745; Ohori M, 2004, J UROLOGY, V171, P1844, DOI 10.1097/01.ju.0000121693.05077.3d; Parker C, 2013, NEW ENGL J MED, V369, P213, DOI 10.1056/NEJMoa1213755; Partin AW, 2014, J UROLOGY, V192, P1081, DOI 10.1016/j.juro.2014.04.013; Patel HR, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0022-9; Rosenkrantz AB, 2016, J UROLOGY, V196, P1613, DOI 10.1016/j.juro.2016.06.079; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scattoni V, 2013, J UROLOGY, V190, P496, DOI 10.1016/j.juro.2013.02.3184; Schellhammer PF, 2013, UROLOGY, V81, P1297, DOI 10.1016/j.urology.2013.01.061; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shipley WU, 2017, NEW ENGL J MED, V376, P417, DOI 10.1056/NEJMoa1607529; Siddiqui MM, 2015, JAMA-J AM MED ASSOC, V313, P390, DOI 10.1001/jama.2014.17942; Siddons HM, 2013, PSYCHO-ONCOLOGY, V22, P2186, DOI 10.1002/pon.3273; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Skolarus TA, 2014, CA-CANCER J CLIN, V64, P226, DOI 10.3322/caac.21234; Sommariva S, 2016, EUR UROL, V69, P107, DOI 10.1016/j.eururo.2014.11.038; Stefanopoulou E, 2015, PSYCHO-ONCOLOGY, V24, P1159, DOI 10.1002/pon.3794; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Stephenson AJ, 2009, J CLIN ONCOL, V27, P4300, DOI 10.1200/JCO.2008.18.2501; Sweeney CJ, 2015, NEW ENGL J MED, V373, P737, DOI 10.1056/NEJMoa1503747; Thompson IM, 2013, J UROLOGY, V190, P441, DOI 10.1016/j.juro.2013.05.032; Tosoian JJ, 2015, J CLIN ONCOL, V33, P3379, DOI 10.1200/JCO.2015.62.5764; Valerio M, 2017, EUR UROL, V71, P17, DOI 10.1016/j.eururo.2016.08.044; Viani GA, 2016, CANCER-AM CANCER SOC, V122, P2004, DOI 10.1002/cncr.29983; Violette PD, 2015, CA-CANCER J CLIN, V65, P239, DOI 10.3322/caac.21272; Wallis CJD, 2016, EUR UROL, V70, P21, DOI 10.1016/j.eururo.2015.11.010; Wei JT, 2014, J CLIN ONCOL, V32, P4066, DOI 10.1200/JCO.2013.52.8505; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Welty CJ, 2015, J UROLOGY, V193, P807, DOI 10.1016/j.juro.2014.09.094; Wiegel T, 2014, EUR UROL, V66, P243, DOI 10.1016/j.eururo.2014.03.011; Wilkins A, 2015, LANCET ONCOL, V16, P1605, DOI 10.1016/S1470-2045(15)00280-6; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Woo S, 2017, EUR UROL, V72, P177, DOI 10.1016/j.eururo.2017.01.042; Wootten AC, 2015, EUR UROL, V68, P471, DOI 10.1016/j.eururo.2014.10.024; Wortel RC, 2015, INT J RADIAT ONCOL, V91, P737, DOI 10.1016/j.ijrobp.2014.12.017; Yaxley JW, 2016, LANCET, V388, P1057, DOI 10.1016/S0140-6736(16)30592-X; Yu JB, 2014, J CLIN ONCOL, V32, P1195, DOI 10.1200/JCO.2013.53.8652; Zapatero A, 2015, LANCET ONCOL, V16, P320, DOI 10.1016/S1470-2045(15)70045-8; Zhang AY, 2015, J UROLOGY, V194, P1675, DOI 10.1016/j.juro.2015.07.090	98	650	669	40	193	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2532	2542		10.1001/jama.2017.7248	http://dx.doi.org/10.1001/jama.2017.7248			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655021				2022-12-28	WOS:000404106600023
J	Mancio-Silva, L; Slavic, K; Ruivo, MTG; Grosso, AR; Modrzynska, KK; Vera, IM; Sales-Dias, J; Gomes, AR; MacPherson, CR; Crozet, P; Adamo, M; Baena-Gonzalez, E; Tewari, R; Llinas, M; Billker, O; Mota, MM				Mancio-Silva, Liliana; Slavic, Ksenija; Ruivo, Margarida T. Grilo; Grosso, Ana Rita; Modrzynska, Katarzyna K.; Vera, Iset Medina; Sales-Dias, Joana; Gomes, Ana Rita; MacPherson, Cameron Ross; Crozet, Pierre; Adamo, Mattia; Baena-Gonzalez, Elena; Tewari, Rita; Llinas, Manuel; Billker, Oliver; Mota, Maria M.			Nutrient sensing modulates malaria parasite virulence	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ACTIVATED PROTEIN-KINASE; PLASMODIUM-FALCIPARUM; CALORIE RESTRICTION; CEREBRAL MALARIA; STRUCTURAL BASIS; BLOOD STAGES; YEAST; ANCIENT; BERGHEI	The lifestyle of intracellular pathogens, such as malaria parasites, is intimately connected to that of their host, primarily for nutrient supply. Nutrients act not only as primary sources of energy but also as regulators of gene expression, metabolism and growth, through various signalling networks that enable cells to sense and adapt to varying environmental conditions(1,2). Canonical nutrient-sensing pathways are presumed to be absent from the causative agent of malaria, Plasmodium(3-5), thus raising the question of whether these parasites can sense and cope with fluctuations in host nutrient levels. Here we show that Plasmodium blood-stage parasites actively respond to host dietary calorie alterations through rearrangement of their transcriptome accompanied by substantial adjustment of their multiplication rate. A kinome analysis combined with chemical and genetic approaches identified KIN as a critical regulator that mediates sensing of nutrients and controls a transcriptional response to the host nutritional status. KIN shares homology with SNF1/AMPK alpha, and yeast complementation studies suggest that it is part of a functionally conserved cellular energy-sensing pathway. Overall, these findings reveal a key parasite nutrient-sensing mechanism that is critical for modulating parasite replication and virulence.	[Mancio-Silva, Liliana; Slavic, Ksenija; Ruivo, Margarida T. Grilo; Grosso, Ana Rita; Vera, Iset Medina; Sales-Dias, Joana; Mota, Maria M.] Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal; [Modrzynska, Katarzyna K.; Gomes, Ana Rita; Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [MacPherson, Cameron Ross] Inst Pasteur, F-75724 Paris, France; [Crozet, Pierre; Adamo, Mattia; Baena-Gonzalez, Elena] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Tewari, Rita] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham, England; [Llinas, Manuel] Penn State Univ, Ctr Malaria Res, Dept Chem, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Llinas, Manuel] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA	Universidade de Lisboa; Wellcome Trust Sanger Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Instituto Gulbenkian de Ciencia; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Mota, MM (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, P-1649028 Lisbon, Portugal.	mmota@medicina.ulisboa.pt	Silva, Liliana Mancio/AAB-2192-2020; Mota, Maria/AAF-2048-2019; Baena-González, Elena/AAI-4051-2020; Baena-González, Elena/G-5811-2013; Grosso, Ana Rita/I-6656-2013; Crozet, Pierre/M-4306-2013	Silva, Liliana Mancio/0000-0002-5585-018X; Baena-González, Elena/0000-0001-6598-3579; Baena-González, Elena/0000-0001-6598-3579; Grosso, Ana Rita/0000-0001-6974-4209; MacPherson, Cameron/0000-0002-8945-9736; Crozet, Pierre/0000-0001-5113-2407; Mota, Maria Manuel/0000-0002-2858-1041; Tewari, Rita/0000-0003-3943-1847; Gomes, Ana Rita/0000-0001-7684-8815; Sales Dias, Joana/0000-0001-8768-4166; Adamo, Mattia Carmelo/0000-0003-4946-305X	European Research Council [311502]; Fundacao para a Ciencia e Tecnologia (FCT) [EXCL/IMI-MIC/0056/2012, PTDC/SAU-MET/118199/2010]; European Commission (FP7) [EVIMALAR 242095]; EMBO LTF [ALTF 960-2009]; FCT fellowship [SFRH/BPD/111788/2015]; EMBO [LTF 712-2012]; NIH NRSA [5F32AI104252-03]; Wellcome Trust [098051]; Medical Research Council (MRC) [G0501670]; FCT [SFRH-BPD79255-2011, UID/Multi/04551/2013]; MRC [G0900109, MR/K011782/1]; Burroughs Wellcome Fund; NIH Director's New Innovators award [1DP2OD001315-01]; European Research Council [311502]; Fundacao para a Ciencia e Tecnologia (FCT) [EXCL/IMI-MIC/0056/2012, PTDC/SAU-MET/118199/2010]; European Commission (FP7) [EVIMALAR 242095]; EMBO LTF [ALTF 960-2009]; FCT fellowship [SFRH/BPD/111788/2015]; EMBO [LTF 712-2012]; NIH NRSA [5F32AI104252-03]; Wellcome Trust [098051]; Medical Research Council (MRC) [G0501670]; FCT [SFRH-BPD79255-2011, UID/Multi/04551/2013]; MRC [G0900109, MR/K011782/1]; Burroughs Wellcome Fund; NIH Director's New Innovators award [1DP2OD001315-01]; BBSRC [BB/N017609/1] Funding Source: UKRI; MRC [MR/N023048/1, G0501670] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N017609/1] Funding Source: researchfish; Medical Research Council [MR/N023048/1, MR/K011782/1, G0900109] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI104252] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission (FP7)(European CommissionEuropean Commission Joint Research Centre); EMBO LTF(European Molecular Biology Organization (EMBO)); FCT fellowship(Portuguese Foundation for Science and Technology); EMBO(European Molecular Biology Organization (EMBO)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Director's New Innovators award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission (FP7)(European CommissionEuropean Commission Joint Research Centre); EMBO LTF(European Molecular Biology Organization (EMBO)); FCT fellowship(Portuguese Foundation for Science and Technology); EMBO(European Molecular Biology Organization (EMBO)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Director's New Innovators award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Pena and A. Pamplona for help with animal experiments; S. Marques for help in transfections; A. Parreira for the mosquito preparation; M. Rebelo for help with flow cytometry analysis; A. Waters, T. Hanscheid and F. Enguita for helpful discussions; R. Wall and D. Brady for technical assistance with. kin clones; and Jacobus Pharmaceuticals for the WR99210 compound. The work was supported by European Research Council (311502) and Fundacao para a Ciencia e Tecnologia (FCT) grants (EXCL/IMI-MIC/0056/2012) and (PTDC/SAU-MET/118199/2010) to M. M. M. and L.M.S., respectively. L.M.S., A. R. Go. and M. M. M. were supported by the European Commission (FP7/2007-2013; EVIMALAR 242095). L.M.S. was supported by EMBO LTF (ALTF 960-2009). K.S. was sponsored by FCT fellowship (SFRH/BPD/111788/2015). I.M.V. received EMBO (LTF 712-2012) and NIH NRSA (5F32AI104252-03) fellowships. Work at the Sanger Institute was funded by Wellcome Trust (098051) and Medical Research Council (MRC, G0501670). Work at the Instituto Gulbenkian de Ciencia was funded through FCT grants (SFRH-BPD79255-2011 and UID/Multi/04551/2013). R.T. was supported by MRC grant (G0900109, MR/K011782/1). M.L. was funded through the Burroughs Wellcome Fund and the NIH Director's New Innovators award (1DP2OD001315-01).	Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Boehme U., 2016, COMPLETE AVIAN MALAR; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bracchi V, 1996, MOL BIOCHEM PARASIT, V76, P299, DOI 10.1016/0166-6851(96)02564-9; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Collino S, 2013, METABOLITES, V3, P881, DOI 10.3390/metabo3040881; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Crozet P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00190; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Dorin-Semblat D, 2008, EUKARYOT CELL, V7, P279, DOI 10.1128/EC.00245-07; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Gasch AP, 2003, YEAST STRESS RESPONS; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; HUNT NH, 1993, PARASITOLOGY, V107, P471, DOI 10.1017/S0031182000068049; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lemieux JE, 2009, P NATL ACAD SCI USA, V106, P7559, DOI 10.1073/pnas.0811829106; Liu Y, 2011, EUKARYOT CELL, V10, P313, DOI 10.1128/EC.00291-10; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meidenbauer JJ, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-23; Mejia P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7050; Miranda-Saavedra D, 2012, MICROBES INFECT, V14, P796, DOI 10.1016/j.micinf.2012.04.007; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; MURRAY MJ, 1975, LANCET, V1, P653; Pankevich DE, 2010, J NEUROSCI, V30, P16399, DOI 10.1523/JNEUROSCI.1955-10.2010; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Serfontein J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000803; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017	38	85	85	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					213	+		10.1038/nature23009	http://dx.doi.org/10.1038/nature23009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678779	Green Accepted			2022-12-28	WOS:000405314500038
J	Patnode, CD; Evans, CV; Senger, CA; Redmond, N; Lin, JS				Patnode, Carrie D.; Evans, Corrine V.; Senger, Caitlyn A.; Redmond, Nadia; Lin, Jennifer S.			Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; NUTRITION EDUCATION INTERVENTION; LIFE-STYLE INTERVENTION; INCLUDING PREGNANT-WOMEN; WEIGHT-GAIN PREVENTION; PRIMARY-CARE PRACTICE; HIGH BLOOD-PRESSURE; LONG-TERM EFFICACY; QUALITY-OF-LIFE; BASE-LINE DATA	IMPORTANCE Unhealthful dietary patterns, low levels of physical activity, and high sedentary time increase the risk of cardiovascular disease. OBJECTIVE To systematically review the evidence on the benefits and harms of behavioral counseling for the primary prevention of cardiovascular disease in adults without known cardiovascular risk factors to inform the US Preventive Services Task Force. DATA SOURCES MEDLINE, PubMed, Cochrane Central Register of Controlled Trials, and PsycINFO for studies published in the English language between January 1, 2013, and May 25, 2016, and ongoing surveillance in targeted publications through March 24, 2017. Studies included in the previous review were reevaluated for inclusion. STUDY SELECTION Randomized clinical trials of behavioral interventions targeting improved diet, increased physical activity, decreased sedentary time, or a combination of these among adults without known hypertension, dyslipidemia, diabetes, or impaired fasting glucose. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal and data abstraction by 2 reviewers. MAIN OUTCOMES AND MEASURES Cardiometabolic health and intermediate outcomes, behavioral outcomes, and harms related to interventions. RESULTS Eighty-eight studies (N = 121 190) in 145 publications were included. There was no consistent benefit of the interventions on all-cause or cardiovascular mortality or morbidity (4 trials [n = 51 356]) or health-related quality of life (10 trials [n = 52 423]). There was evidence of small, statistically significant between-group mean differences for systolic blood pressure (-1.26 mmHg [95% CI, -1.77 to -0.75]; 22 trials [n = 57 953]), diastolic blood pressure (-0.49 mmHg [95% CI, -0.82 to -0.16]; 23 trials [n = 58022]), low-density lipoprotein cholesterol level (-2.58 mg/dL [95% CI, -4.30 to -0.85]; 13 trials [n = 5554]), total cholesterol level (-2.85 mg/dL [95% CI, -4.95 to -0.75]; 19 trials [n = 9325]), and body mass index (-0.41 [95% CI, -0.62 to -0.19]; 20 trials [n = 55059]) at 6 to 12 months as well as small-to-modest associations with dietary and physical activity behaviors. There was no evidence of greater incidence of serious adverse events, injuries, or falls in intervention vs control participants. CONCLUSIONS AND RELEVANCE Diet and physical activity behavioral interventions for adults not at high risk for cardiovascular disease result in consistent modest benefits across a variety of important intermediate health outcomes across 6 to 12 months, including blood pressure, low-density lipoprotein and total cholesterol levels, and adiposity, with evidence of a dose-response effect, with higher-intensity interventions conferring greater improvements. There is very limited evidence on longer-term intermediate and health outcomes or on harmful effects of these interventions.	[Patnode, Carrie D.; Evans, Corrine V.; Senger, Caitlyn A.; Redmond, Nadia; Lin, Jennifer S.] Kaiser Permanente, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente	Patnode, CD (corresponding author), Kaiser Permanente Northwest, Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, 3800 N Interstate Ave, Portland, OR 97227 USA.	carrie.d.patnode@kpchr.org			Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services under USPSTF [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services under USPSTF	This research was funded under contract number HHSA-290-2012-00015-I, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Aittasalo M, 2006, PREV MED, V42, P40, DOI 10.1016/j.ypmed.2005.10.003; Albright CL, 2015, WOMEN HEALTH, V55, P1, DOI 10.1080/03630242.2014.972014; Albright CL, 2014, PREV MED, V69, P214, DOI 10.1016/j.ypmed.2014.09.019; Albright CL, 2012, WOMEN HEALTH, V52, P265, DOI 10.1080/03630242.2012.662935; Aldana SG, 2005, J AM DIET ASSOC, V105, P371, DOI 10.1016/j.jada.2004.12.007; Aldana Steven G, 2006, Prev Chronic Dis, V3, pA05; Alexander GL, 2010, AM J PUBLIC HEALTH, V100, P319, DOI 10.2105/AJPH.2008.154468; Allen Peg, 2008, Prev Chronic Dis, V5, pA76; Allison MA, 2016, AM J HYPERTENS, V29, P959, DOI 10.1093/ajh/hpv196; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; [Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; Assaf AR, 2016, J ACAD NUTR DIET, V116, P259, DOI 10.1016/j.jand.2015.07.016; BARON JA, 1990, BRIT J GEN PRACT, V40, P137; Bennett GG, 2013, JAMA INTERN MED, V173, P1770, DOI 10.1001/jamainternmed.2013.9263; Beresford SAA, 1997, AM J PUBLIC HEALTH, V87, P610, DOI 10.2105/AJPH.87.4.610; Berkman N, 2014, AHRQ PUBLICATION, V14-EHC050-EF; Bernstein MA, 2002, J AM DIET ASSOC, V102, P1421, DOI 10.1016/S0002-8223(02)90315-9; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Bickmore TW, 2013, J AM GERIATR SOC, V61, P1676, DOI 10.1111/jgs.12449; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Blumenthal JA, 2010, ARCH INTERN MED, V170, P126, DOI 10.1001/archinternmed.2009.470; Bowen D, 1996, ANN EPIDEMIOL, V6, P507, DOI 10.1016/S1047-2797(96)00072-5; Brekke HK, 2005, DIABETES RES CLIN PR, V70, P225, DOI 10.1016/j.diabres.2005.03.027; Bryan AD, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-139; Burke L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-14; Burke L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-751; Carpenter RA, 2004, J NUTR EDUC BEHAV, V36, P20, DOI 10.1016/S1499-4046(06)60124-3; Carroll JK, 2010, AM J PREV MED, V39, P148, DOI 10.1016/j.amepre.2010.04.005; Castro CM, 2011, HEALTH PSYCHOL, V30, P285, DOI 10.1037/a0021980; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Chou R, 2015, AHRQ PUBLICATION; Clark PG, 2005, J AGING HEALTH, V17, P753, DOI 10.1177/0898264305281105; Clark PG, 2002, HEALTH EDUC RES, V17, P552, DOI 10.1093/her/17.5.552; Coates RJ, 1999, AM J EPIDEMIOL, V149, P1104, DOI 10.1093/oxfordjournals.aje.a009764; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; De Vet E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-11; Delichatsios HK, 2001, AM J HEALTH PROMOT, V15, P215, DOI 10.4278/0890-1171-15.4.215; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dutton GR, 2008, PREV MED, V46, P216, DOI 10.1016/j.ypmed.2007.12.012; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELLEY CR, 2003, BMJ-BRIT MED J, V326, P793, DOI DOI 10.1136/BMJ.326.7393.793; Estabrooks PA, 2011, INT J SPORT EXERC PS, V9, P4, DOI 10.1080/1612197X.2011.563123; Fjeldsoe BS, 2015, ANN BEHAV MED, V49, P487, DOI 10.1007/s12160-014-9675-y; Foley P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-305; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Franko DL, 2008, PREV MED, V47, P369, DOI 10.1016/j.ypmed.2008.06.013; Fries E, 2005, AM J PREV MED, V28, P162, DOI 10.1016/j.amepre.2004.10.017; Gao S, 2015, PREV MED REP, V3, P113; Garcia-Ortiz L, 2010, REV ESP CARDIOL, V63, P1244, DOI 10.1016/S0300-8932(10)70294-3; Gell NM, 2015, J PHYS ACT HEALTH, V12, P756, DOI 10.1123/jpah.2013-0144; Goldstein MG, 1999, ANN BEHAV MED, V21, P40, DOI 10.1007/BF02895032; Grandes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018363; Grandes G, 2009, ARCH INTERN MED, V169, P694, DOI 10.1001/archinternmed.2009.23; Green BB, 2002, AM J PREV MED, V22, P177, DOI 10.1016/S0749-3797(01)00428-7; Greenberger HM, 2010, THESIS; Greene GW, 2008, GERONTOLOGIST, V48, P378, DOI 10.1093/geront/48.3.378; Greenlee H, 2015, J ACAD NUTR DIET, V115, P709, DOI 10.1016/j.jand.2014.11.002; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113; Halbert JA, 2000, MED J AUSTRALIA, V173, P84, DOI 10.5694/j.1326-5377.2000.tb139250.x; Halbert JA, 1999, J AM GERIATR SOC, V47, P477, DOI 10.1111/j.1532-5415.1999.tb07242.x; Hall WD, 2003, ETHNIC DIS, V13, P337; Hargreaves EA, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4288; Harland J, 1999, BRIT MED J, V319, P828, DOI 10.1136/bmj.319.7213.828; Harris T, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001783; Harris T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-5; Hebert Patricia R., 1995, Annals of Epidemiology, V5, P130, DOI 10.1016/1047-2797(94)00057-Z; HELLENIUS ML, 1995, QUAL LIFE RES, V4, P13, DOI 10.1007/BF00434378; HELLENIUS ML, 1993, ATHEROSCLEROSIS, V103, P81, DOI 10.1016/0021-9150(93)90042-S; HERMAN C, 2006, AM PUBL HLTH ASS 134; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hinderliter AL, 2014, AM J HYPERTENS, V27, P734, DOI 10.1093/ajh/hpt183; Hivert MF, 2007, INT J OBESITY, V31, P1262, DOI 10.1038/sj.ijo.0803572; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Jacobs N, 2011, HEALTH EDUC RES, V26, P886, DOI 10.1093/her/cyr046; Jacobs N, 2011, PATIENT EDUC COUNS, V85, P122, DOI 10.1016/j.pec.2010.08.024; Jeffery RW, 1999, AM J PUBLIC HEALTH, V89, P747, DOI 10.2105/AJPH.89.5.747; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Kallings L., 2008, THESIS; Kallings LV, 2009, EUR J CARDIOV PREV R, V16, P80, DOI 10.1097/HJR.0b013e32831e953a; Kattelmann KK, 2014, J NUTR EDUC BEHAV, V46, pS28, DOI 10.1016/j.jneb.2014.08.007; Katz DL, 2008, J EVAL CLIN PRACT, V14, P294, DOI 10.1111/j.1365-2753.2007.00853.x; Kerr DA, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0376-8; Kerr DA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-477; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; King AC, 2007, HEALTH PSYCHOL, V26, P718, DOI 10.1037/0278-6133.26.6.718; King AC, 2013, ANN BEHAV MED, V46, P157, DOI 10.1007/s12160-013-9501-y; Kinmonth AL, 2008, LANCET, V371, P41, DOI 10.1016/S0140-6736(08)60070-7; Kolt GS, 2007, J AM GERIATR SOC, V55, P986, DOI 10.1111/j.1532-5415.2007.01203.x; Krist AH, 2015, AM J PREV MED, V49, pS138, DOI 10.1016/j.amepre.2015.05.009; Kristal AR, 2000, PREV MED, V31, P380, DOI 10.1006/pmed.2000.0711; Kuller LH, 2001, CIRCULATION, V103, P32; Kumanyika SK, 2005, J HUM HYPERTENS, V19, P33, DOI 10.1038/sj.jhh.1001774; KUMANYIKA SK, 1993, HYPERTENSION, V22, P502, DOI 10.1161/01.HYP.22.4.502; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis BA, 2013, ANN BEHAV MED, V45, P203, DOI 10.1007/s12160-012-9439-5; Lin JS, 2014, ANN INTERN MED, V161, P568, DOI 10.7326/M14-0130; Lin JS, 2010, AHRQ PUBLICATION; Lin JS, 2014, 1305179EF1 AG HEALTH; Lutz SF, 1999, J AM DIET ASSOC, V99, P705, DOI 10.1016/S0002-8223(99)00169-8; Magnan RE, 2013, J BEHAV MED, V36, P20, DOI 10.1007/s10865-011-9385-x; Mailey EL, 2014, J BEHAV MED, V37, P343, DOI 10.1007/s10865-013-9492-y; Marcus BH, 2007, CONTEMP CLIN TRIALS, V28, P90, DOI 10.1016/j.cct.2006.04.003; Marcus BH, 2007, HEALTH PSYCHOL, V26, P401, DOI 10.1037/0278-6133.26.4.401; Marcus BH, 2015, AM J PREV MED, V48, P179, DOI 10.1016/j.amepre.2014.08.032; Marcus BH, 2013, AM J PREV MED, V45, P598, DOI 10.1016/j.amepre.2013.07.006; Marsaux CFM, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4660; Marshall AL, 2003, ANN BEHAV MED, V25, P194, DOI 10.1207/S15324796ABM2503_05; Marshall AL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-593; Martinson BC, 2008, PREV MED, V46, P111, DOI 10.1016/j.ypmed.2007.08.007; Martinson BC, 2010, PREV MED, V51, P37, DOI 10.1016/j.ypmed.2010.04.002; McNellis RJ, 2015, AM J PREV MED, V49, pS150, DOI 10.1016/j.amepre.2015.06.002; MEINERT CL, 1989, CONTROL CLIN TRIALS, V10, pS1, DOI 10.1016/0197-2456(89)90040-8; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Mochari-Greenberger H, 2011, J NUTR EDUC BEHAV, V43, P366, DOI 10.1016/j.jneb.2011.01.014; Mosca L, 2008, CIRC-CARDIOVASC QUAL, V1, P98, DOI 10.1161/CIRCOUTCOMES.108.825786; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Napolitano MA, 2006, PREV MED, V43, P447, DOI 10.1016/j.ypmed.2006.06.011; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; Nishigaki M, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/831735; Norris SL, 2000, PREV MED, V30, P513, DOI 10.1006/pmed.2000.0673; O'Neill SM, 2009, AM J PREV MED, V36, P506, DOI 10.1016/j.amepre.2009.03.002; Parekh S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-41; Parekh S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-179; Patnode CD, 2015, ANN INTERN MED, V163, P608, DOI 10.7326/M15-0171; Pekmezi D, 2012, CONTEMP CLIN TRIALS, V33, P1261, DOI 10.1016/j.cct.2012.07.005; Pekmezi DW, 2009, AM J PREV MED, V37, P495, DOI 10.1016/j.amepre.2009.08.023; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pinto BM, 2002, AM J PREV MED, V23, P113, DOI 10.1016/S0749-3797(02)00441-5; Pinto BM, 1998, AM J PREV MED, V15, P95, DOI 10.1016/S0749-3797(98)00043-9; Pinto BM, 2005, AM J PREV MED, V29, P247, DOI 10.1016/j.amepre.2005.06.016; Roderick P, 1997, BRIT J GEN PRACT, V47, P7; Ruffin MT, 2011, ANN FAM MED, V9, P3, DOI 10.1370/afm.1197; Sacerdote C, 2006, INT J EPIDEMIOL, V35, P409, DOI 10.1093/ije/dyi170; Satterfield S, 1991, Ann Epidemiol, V1, P455; SHAH M, 1990, J AM DIET ASSOC, V90, P69; Sherwood Nancy E, 2008, BMC Geriatr, V8, P17, DOI 10.1186/1471-2318-8-17; Simkin-Silverman L R, 1998, Womens Health, V4, P255; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; SIMKINSILVERMAN L, 1995, PREV MED, V24, P509, DOI 10.1006/pmed.1995.1081; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Smith BJ, 2014, DIABETES RES CLIN PR, V106, pE60, DOI 10.1016/j.diabres.2014.09.035; Springvloet L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1707-4; Springvloet L, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3837; Springvloet L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-47; Stewart AL, 2001, J GERONTOL A-BIOL, V56, pM465, DOI 10.1093/gerona/56.8.M465; Stopponi MA, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1086; Taveras EM, 2011, MATERN CHILD HLTH J, V15, P1217, DOI 10.1007/s10995-010-0696-2; Thompson JL, 2008, AM J PREV MED, V34, P192, DOI 10.1016/j.amepre.2007.11.014; Thompson WG, 2014, ARCH GERONTOL GERIAT, V58, P314, DOI 10.1016/j.archger.2014.01.004; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; Tokunaga-Nakawatase Y, 2014, PRIM CARE DIABETES, V8, P207, DOI 10.1016/j.pcd.2014.01.007; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; US Preventive Services Task Force, 2011, US PREV SERV TASK FO; Valve P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1044; Van Hoecke AS, 2014, J PHYS ACT HEALTH, V11, P1492, DOI 10.1123/jpah.2012-0497; Van Hoecke AS, 2014, J AGING PHYS ACTIV, V22, P186, DOI [10.1123/japa.2012-0261, 10.1123/JAPA.2012-0261]; van Stralen MM, 2011, HEALTH PSYCHOL, V30, P442, DOI 10.1037/a0023579; van Stralen MM, 2010, ANN BEHAV MED, V39, P139, DOI 10.1007/s12160-010-9166-8; van Stralen MM, 2009, AM J PREV MED, V37, P405, DOI 10.1016/j.amepre.2009.07.009; Vandelanotte C, 2005, ANN BEHAV MED, V29, P138, DOI 10.1207/s15324796abm2902_8; Vrdoljak D, 2014, ARCH GERONTOL GERIAT, V58, P160, DOI 10.1016/j.archger.2013.08.007; Wadsworth DD, 2010, AM J HEALTH BEHAV, V34, P60; Warner LM, 2016, PSYCHOL HEALTH, V31, P1145, DOI 10.1080/08870446.2016.1185523; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Williams K, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-48	180	126	130	2	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					175	193		10.1001/jama.2017.3303	http://dx.doi.org/10.1001/jama.2017.3303			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA1HS	28697259				2022-12-28	WOS:000405190800019
J	Wiegel, H				Wiegel, Hanne			Rising Tides Climate Refugees in the Twenty-First Century	SCIENCE			English	Book Review									[Wiegel, Hanne] Wageningen Univ & Res Ctr, Environm Policy Grp, NL-6708PB Wageningen, Netherlands	Wageningen University & Research	Wiegel, H (corresponding author), Wageningen Univ & Res Ctr, Environm Policy Grp, NL-6708PB Wageningen, Netherlands.	hanne.wiegel@wur.nl						FROHLICH CHRISTIANE J., 2016, CONT LEVANT, V1, P38, DOI DOI 10.1080/20581831.2016.1149355; Government Office of Science, 2011, FOR MIGR GLOB ENV CH; IPCC, 2014, CONTRIBUTION WORKING; Wennersten J.R., 2017, RISING TIDES CLIMATE	4	1	1	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		41	41		10.1126/science.aan5667	http://dx.doi.org/10.1126/science.aan5667			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684496				2022-12-28	WOS:000404854100041
J	Rosenthal, N				Rosenthal, Nadia			A Guardian of the Heartbeat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONTRIBUTE		[Rosenthal, Nadia] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Rosenthal, Nadia] Imperial Coll London, London, England	Jackson Laboratory; Imperial College London	Rosenthal, N (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.; Rosenthal, N (corresponding author), Imperial Coll London, London, England.			Rosenthal, Nadia/0000-0002-7599-7365				Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001	5	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					84	86		10.1056/NEJMcibr1705327	http://dx.doi.org/10.1056/NEJMcibr1705327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679094	Green Published			2022-12-28	WOS:000404730000015
J	Clausen, J; Fetz, E; Donoghue, J; Ushiba, J; Sprohase, U; Chandler, J; Birbaumer, N; Soekadar, SR				Clausen, Jens; Fetz, Eberhard; Donoghue, John; Ushiba, Junichi; Spoerhase, Ulrike; Chandler, Jennifer; Birbaumer, Niels; Soekadar, Surjo R.			Help, hope, and hype: Ethical dimensions of neuroprosthetics	SCIENCE			English	Editorial Material							LOCKED-IN PATIENT; BRAIN; INTERFACE; SECURITY; ISSUES		[Clausen, Jens; Spoerhase, Ulrike] Univ Educ, D-79085 Freiburg, Germany; [Fetz, Eberhard] Univ Washington, Seattle, WA 98195 USA; [Donoghue, John; Birbaumer, Niels] Wyss Ctr Bio & Neuroengn, CH-1202 Geneva, Switzerland; [Ushiba, Junichi] Keio Univ, Keio Inst Pure & Appl Sci, Yokohama, Kanagawa 2238521, Japan; [Chandler, Jennifer] Univ Ottawa, Ottawa, ON K1N 6N5, Canada; [Birbaumer, Niels] Univ Tubingen, D-72074 Tubingen, Germany; [Soekadar, Surjo R.] Univ Hosp Tubingen, D-72076 Tubingen, Germany	University of Freiburg; University of Washington; University of Washington Seattle; Keio University; University of Ottawa; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Clausen, J (corresponding author), Univ Educ, D-79085 Freiburg, Germany.	jens.clausen@ph-freiburg.de	Soekadar, Surjo/AAA-3801-2020	Soekadar, Surjo/0000-0003-1280-5538; Birbaumer, Niels/0000-0002-6786-5127	Deutsche Forschungsgemeinschaft (DFG); German Ministry of Education and Research (BMBF); European Commission (Horizon 2020, Framework Programme 7) under projects AIDE, LUMINOUS, and BRAINTRAIN; Baden-Wurttemberg Stiftung; Japan Agency for Medical Research and Development [16dm0107033h005, 16he0402255h0004, 16hk0102032h0002]; National Institute of Neuromuscular Diseases and Stroke, NIH [NS-12542]; NSF Engineering Research Center for Sensorimotor Neural Engineering [EEC-1028725]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012542] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission (Horizon 2020, Framework Programme 7) under projects AIDE, LUMINOUS, and BRAINTRAIN; Baden-Wurttemberg Stiftung; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Institute of Neuromuscular Diseases and Stroke, NIH; NSF Engineering Research Center for Sensorimotor Neural Engineering; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.C., S.R.S., and N.B. are supported by the Deutsche Forschungsgemeinschaft (DFG), and the German Ministry of Education and Research (BMBF); S.R.S. and N.B. are supported by the European Commission (Horizon 2020, Framework Programme 7) under projects AIDE, LUMINOUS, and BRAINTRAIN, as well as the Baden-Wurttemberg Stiftung. J.U. is supported by the Japan Agency for Medical Research and Development (16dm0107033h005, 16he0402255h0004, and 16hk0102032h0002). E.F. is supported by the National Institute of Neuromuscular Diseases and Stroke, NIH (NS-12542) and the NSF Engineering Research Center for Sensorimotor Neural Engineering (EEC-1028725).	Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Braitenberg V., 1974, LECT NOTES BIOMATH, P290; Chaudhary U, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.1002593; Clausen J, 2011, CURR OPIN PSYCHIATR, V24, P495, DOI 10.1097/YCO.0b013e32834bb8ca; Clausen J, 2009, NATURE, V457, P1080, DOI 10.1038/4571080a; Denning T, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0985; Downey JE, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0134-9; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; Fischer JM., 1998, RESPONSIBILITY CONTR, DOI 10.1017/CBO9780511814594; Gallegos-Ayala G, 2014, NEUROLOGY, V82, P1930, DOI 10.1212/WNL.0000000000000449; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Kotchoubey B, 2002, NEWS PHYSIOL SCI, V17, P38; Liu J, 2015, NAT NANOTECHNOL, V10, P629, DOI [10.1038/NNANO.2015.115, 10.1038/nnano.2015.115]; Pycroft L, 2016, WORLD NEUROSURG, V92, P454, DOI 10.1016/j.wneu.2016.05.010; Ransford B., 2014, SECURITY PRIVACY IMP, P157, DOI [10.1007/978-1-4614-1674-6_7, DOI 10.1007/978-1-4614-1674-6_7]; Soekadar SR, 2016, SCI ROBOT, V1, DOI 10.1126/scirobotics.aag3296; Ushiba J, 2016, PROG BRAIN RES, V228, P163, DOI 10.1016/bs.pbr.2016.04.020; Vansteensel MJ, 2016, NEW ENGL J MED, V375, P2060, DOI 10.1056/NEJMoa1608085	18	41	41	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1338	1339		10.1126/science.aam7731	http://dx.doi.org/10.1126/science.aam7731			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663460				2022-12-28	WOS:000404351500021
J	Descours, B; Petitjean, G; Lopez-Zaragoza, JL; Bruel, T; Raffel, R; Psomas, C; Reynes, J; Lacabaratz, C; Levy, Y; Schwartz, O; Lelievre, JD; Benkirane, M				Descours, Benjamin; Petitjean, Gael; Lopez-Zaragoza, Jose-Luis; Bruel, Timothee; Raffel, Raoul; Psomas, Christina; Reynes, Jacques; Lacabaratz, Christine; Levy, Yves; Schwartz, Olivier; Lelievre, Jean Daniel; Benkirane, Monsef			CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses (vol 543, pg 564, 2017)	NATURE			English	Correction													Schwartz, Olivier/AAZ-3765-2021; Bruel, Timothée/AAI-4632-2020; , Lelievre/AAB-1398-2020	Schwartz, Olivier/0000-0002-0729-1475; Lacabaratz, Christine/0000-0001-6925-0225				Descours B, 2017, NATURE, V543, P564, DOI 10.1038/nature21710	1	6	7	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					686	686		10.1038/nature22807	http://dx.doi.org/10.1038/nature22807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY8CH	28658234				2022-12-28	WOS:000427090000001
J	Hollingsworth, PM				Hollingsworth, Peter M.			Taxonomy: avoid extra bureaucracy	NATURE			English	Letter									[Hollingsworth, Peter M.] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland		Hollingsworth, PM (corresponding author), Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland.	p.hollingsworth@rbge.ac.uk		Hollingsworth, Peter/0000-0003-0602-0654; Miller, Scott/0000-0002-4138-1378				HEBERT PDN, 2016, PHIL T R SOC, V371; Pringle RM, 2017, NATURE, V546, P91, DOI 10.1038/nature22902; 2017, NATURE, V546, P25	3	9	9	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					600	600		10.1038/546600a	http://dx.doi.org/10.1038/546600a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658246	Bronze			2022-12-28	WOS:000404332000028
J	Hughes, BG; Hekimi, S				Hughes, Bryan G.; Hekimi, Siegfried			Many possible maximum lifespan trajectories	NATURE			English	Letter									[Hughes, Bryan G.; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hughes, BG (corresponding author), McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada.	bryan.hughes@mail.mcgill.ca; siegfried.hekimi@mcgill.ca	Hughes, Bryan/L-4964-2017	Hughes, Bryan/0000-0002-2718-3818				Antero-Jacquemin JD, 2015, J GERONTOL A-BIOL, V70, P944, DOI 10.1093/gerona/glu130; Cournil A, 2010, DEMOGR RES MONOGR, P31, DOI 10.1007/978-3-642-11520-2_2; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793	3	17	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E8	E9		10.1038/nature22786	http://dx.doi.org/10.1038/nature22786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658230				2022-12-28	WOS:000404332000003
J	Simunovic, M; Manneville, JB; Renard, HF; Evergren, E; Raghunathan, K; Bhatia, D; Kenworthy, AK; Voth, GA; Prost, J; McMahon, HT; Johannes, L; Bassereau, P; Callan-Jones, A				Simunovic, Mijo; Manneville, Jean-Baptiste; Renard, Henri-Francois; Evergren, Emma; Raghunathan, Krishnan; Bhatia, Dhiraj; Kenworthy, Anne K.; Voth, Gregory A.; Prost, Jacques; McMahon, Harvey T.; Johannes, Ludger; Bassereau, Patricia; Callan-Jones, Andrew			Friction Mediates Scission of Tubular Membranes Scaffolded by BAR Proteins	CELL			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; DOMAIN-CONTAINING PROTEINS; MOLECULAR MOTORS; CURVATURE GENERATION; ACTIN DYNAMICS; VESICLES; FISSION; AMPHIPHYSIN; ENDOPHILIN; NANOTUBES	Membrane scission is essential for intracellular trafficking. While BAR domain proteins such as endophilin have been reported in dynamin-independent scission of tubular membrane necks, the cutting mechanism has yet to be deciphered. Here, we combine a theoretical model, in vitro, and in vivo experiments revealing how protein scaffolds may cut tubular membranes. We demonstrate that the protein scaffold bound to the underlying tube creates a frictional barrier for lipid diffusion; tube elongation thus builds local membrane tension until the membrane undergoes scission through lysis. We call this mechanism friction-driven scission (FDS). In cells, motors pull tubes, particularly during endocytosis. Through reconstitution, we show that motors not only can pull out and extend protein-scaffolded tubes but also can cut them by FDS. FDS is generic, operating even in the absence of amphipathic helices in the BAR domain, and could in principle apply to any high-friction protein and membrane assembly.	[Simunovic, Mijo; Prost, Jacques; Bassereau, Patricia] PSL Res Univ, CNRS UMR168, Inst Curie, Lab Phys Chim Curie, F-75005 Paris, France; [Simunovic, Mijo; Prost, Jacques; Bassereau, Patricia] UPMC Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Simunovic, Mijo; Voth, Gregory A.] Univ Chicago, James Franck Inst, Dept Chem, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Manneville, Jean-Baptiste] PSL Res Univ, Inst Curie, CNRS UMR144, Subcellular Struct & Cellular Dynam Unit, F-75005 Paris, France; [Renard, Henri-Francois; Bhatia, Dhiraj; Johannes, Ludger] PSL Res Univ, Inst Curie, Chem Biol Membranes & Therapeut Delivery Unit, CNRS UMR3666,INSERM U1143, F-75005 Paris, France; [Evergren, Emma; McMahon, Harvey T.] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Evergren, Emma] Queens Univ Belfast, Ctr Canc Res & Cell Biol, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland; [Raghunathan, Krishnan; Kenworthy, Anne K.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, 718 Light Hall, Nashville, TN 37232 USA; [Prost, Jacques] Natl Univ Singapore, Mechanobiol Inst, Singapore 119077, Singapore; [Callan-Jones, Andrew] CNRS UMR7057, Lab Mat & Syst Complexes, F-75205 Paris, France; [Simunovic, Mijo] Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA; [Renard, Henri-Francois] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain La Neuve, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; University of Chicago; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; MRC Laboratory Molecular Biology; Queens University Belfast; Vanderbilt University; National University of Singapore; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Rockefeller University; Universite Catholique Louvain	Bassereau, P (corresponding author), PSL Res Univ, CNRS UMR168, Inst Curie, Lab Phys Chim Curie, F-75005 Paris, France.; Bassereau, P (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, F-75005 Paris, France.; Callan-Jones, A (corresponding author), CNRS UMR7057, Lab Mat & Syst Complexes, F-75205 Paris, France.	patricia.bassereau@curie.fr; andrew.callan-jones@univ-paris-diderot.fr	Raghunathan, Krishnan/S-4212-2019; Renard, Henri-François/AAL-4905-2020; BHATIA, DHIRAJ/Y-9699-2019; Johannes, Ludger/M-9778-2017; Manneville, Jean-Baptiste/L-5914-2019; Evergren, Emma/X-3677-2019; Johannes, Ludger/W-8593-2019; BHATIA, DHIRAJ/F-4736-2013; Bassereau, Patricia/P-8657-2018	Raghunathan, Krishnan/0000-0003-2228-6313; Renard, Henri-François/0000-0002-2406-2519; Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004; BHATIA, DHIRAJ/0000-0002-1478-6417; Evergren, Emma/0000-0002-0775-2921; Manneville, Jean-Baptiste/0000-0002-8670-3940; Simunovic, Mijo/0000-0001-9394-1552; Bassereau, Patricia/0000-0002-8544-6778; Kenworthy, Anne/0000-0001-6567-9059	National Institute of General Medical Sciences of the National Institutes of Health [R01GM063796]; Agence Nationale pour la Recherche [ANR-11BSV201403, ANR-16-CE23-0005-02]; European Research Council advanced grant [340485]; Medical Research Council UK [U105178795]; NIH [R01 GM106720]; Chateaubriand fellowship through the University of Chicago; France and Chicago Collaborating in the Sciences grant through the University of Chicago; University Paris Diderot; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106720, R01GM063796] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council advanced grant(European Research Council (ERC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chateaubriand fellowship through the University of Chicago; France and Chicago Collaborating in the Sciences grant through the University of Chicago; University Paris Diderot; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Laura Picas and Marta Bally for assistance in membrane sheet and supported bilayer experiments. M.S. and G.A.V. acknowledge the support of the National Institute of General Medical Sciences of the National Institutes of Health (award number R01GM063796). P.B. and L.J. acknowledge the support of the Agence Nationale pour la Recherche (ANR-11BSV201403 to P.B. and ANR-16-CE23-0005-02 to L.J.), L.J. acknowledges the support of the European Research Council advanced grant (project 340485), E.E. and H.T.M. acknowledge the support of the Medical Research Council UK (grant U105178795), and A.K.K. acknowledges the support of the NIH (grant R01 GM106720). M.S. was funded in part by the Chateaubriand fellowship and the France and Chicago Collaborating in the Sciences grant (both through the University of Chicago) and received support from the University Paris Diderot. The P.B. group belongs to the CNRS consortium CellTiss; the P.B., J.P., and L.J. groups belong to Labex CelTisPhyBio (ANR-11-LABX0038) and to Paris Sciences et Lettres (ANR-10-IDEX-0001-02).	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; BERK DA, 1992, BIOPHYS J, V61, P1, DOI 10.1016/S0006-3495(92)81810-6; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Callan-Jones A, 2016, SOFT MATTER, V12, P1791, DOI 10.1039/c5sm02507a; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Campillo C, 2013, BIOPHYS J, V104, P1248, DOI 10.1016/j.bpj.2013.01.051; Chen ZM, 2016, J AM CHEM SOC, V138, P14616, DOI 10.1021/jacs.6b06820; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; Day CA, 2015, TRAFFIC, V16, P572, DOI 10.1111/tra.12269; Derenyi I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.238101; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Dommersnes PG, 2005, EUROPHYS LETT, V70, P271, DOI 10.1209/epl/i2004-10477-9; EVANS E, 1994, CHEM PHYS LIPIDS, V73, P39, DOI 10.1016/0009-3084(94)90173-2; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; Johannes L, 2015, NAT REV MOL CELL BIO, V16, P311, DOI 10.1038/nrm3968; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; KWOK R, 1981, BIOPHYS J, V35, P637, DOI 10.1016/S0006-3495(81)84817-5; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Leduc C, 2010, BBA-BIOMEMBRANES, V1798, P1418, DOI 10.1016/j.bbamem.2009.11.012; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; MERKEL R, 1989, J PHYS-PARIS, V50, P1535, DOI 10.1051/jphys:0198900500120153500; Merrifield CJ, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016733; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pinot M., 2014, LIPID CELL BIOL POLY; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Renard HF, 2015, NATURE, V517, P493, DOI 10.1038/nature14064; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Schmid SL, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022509; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Simunovic M, 2016, P NATL ACAD SCI USA, V113, P11226, DOI 10.1073/pnas.1606943113; Simunovic M, 2013, BIOPHYS J, V105, P711, DOI 10.1016/j.bpj.2013.06.039; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Sorre B, 2012, P NATL ACAD SCI USA, V109, P173, DOI 10.1073/pnas.1103594108; Soykan T, 2016, CURR OPIN NEUROBIOL, V39, P17, DOI 10.1016/j.conb.2016.03.005; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	58	122	122	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1								10.1016/j.cell.2017.05.047	http://dx.doi.org/10.1016/j.cell.2017.05.047			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28648660	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000404358500018
J	Sabia, S; Dugravot, A; Dartigues, JF; Abell, J; Elbaz, A; Kivimaki, M; Singh-Manoux, A				Sabia, Severine; Dugravot, Aline; Dartigues, Jean-Francois; Abell, Jessica; Elbaz, Alexis; Kivimaki, Mika; Singh-Manoux, Archana			Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BRITISH CIVIL-SERVANTS; ALZHEIMERS-DISEASE; OLDER-ADULTS; PUBLIC-HEALTH; INTERVENTION; METAANALYSIS; ASSOCIATION; POPULATION; PREVENTION; EXERCISE	OBJECTIVE To test the hypotheses that physical activity in midlife is not associated with a reduced risk of dementia and that the preclinical phase of dementia is characterised by a decline in physical activity. DESIGN Prospective cohort study with a mean follow-up of 27 years. SETTING Civil service departments in London (Whitehall II study). PARTICIPANTS 10 308 participants aged 35-55 years at study inception (1985-88). Exposures included time spent in mild, moderate to vigorous, and total physical activity assessed seven times between 1985 and 2013 and categorised as "recommended" if duration of moderate to vigorous physical activity was 2.5 hours/week or more. MAIN OUTCOME MEASURES A battery of cognitive tests was administered up to four times from 1997 to 2013, and incident dementia cases (n=329) were identified through linkage to hospital, mental health services, and mortality registers until 2015. Results Mixed effects models showed no association between physical activity and subsequent 15 year cognitive decline. Similarly, Cox regression showed no association between physical activity and risk of dementia over an average 27 year follow-up (hazard ratio in the "recommended" physical activity category 1.00, 95% confidence interval 0.80 to 1.24). For trajectories of hours/week of total, mild, and moderate to vigorous physical activity in people with dementia compared with those without dementia (all others), no differences were observed between 28 and 10 years before diagnosis of dementia. However, physical activity in people with dementia began to decline up to nine years before diagnosis (difference in moderate to vigorous physical activity -0.39 hours/week; P=0.05), and the difference became more pronounced (-1.03 hours/week; P=0.005) at diagnosis. CONCLUSION This study found no evidence of a neuroprotective effect of physical activity. Previous findings showing a lower risk of dementia in physically active people may be attributable to reverse causation-that is, due to a decline in physical activity levels in the preclinical phase of dementia.	[Sabia, Severine; Dugravot, Aline; Abell, Jessica; Elbaz, Alexis; Singh-Manoux, Archana] Univ Paris Saclay, Hop Paul Brousse, Ctr Res Epidemiol & Populat Hlth, INSERM,U1018, Paris, France; [Sabia, Severine; Abell, Jessica; Kivimaki, Mika; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Dartigues, Jean-Francois] Univ Bordeaux, INSERM, U1219, Bordeaux, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Sabia, S (corresponding author), Univ Paris Saclay, Hop Paul Brousse, Ctr Res Epidemiol & Populat Hlth, INSERM,U1018, Paris, France.; Sabia, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	severine.sabia@inserm.fr	Sabia, Séverine/G-2966-2017; Elbaz, Alexis/F-8952-2017; Singh-Manoux, Archana/F-6804-2013; DARTIGUES, Jean François/T-4513-2019	Sabia, Séverine/0000-0003-3109-9720; Elbaz, Alexis/0000-0001-9724-5490; Singh-Manoux, Archana/0000-0002-1244-5037; Rose, George/0000-0002-9598-6372; Dugravot, Aline/0000-0002-4546-0970; Kivimaki, Mika/0000-0002-4699-5627	US National Institutes on Aging [R01AG013196, R01AG034454]; UK Medical Research Council [MRC K013351]; British Heart Foundation [RG/13/2/30098]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	US National Institutes on Aging; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Whitehall II study is supported by grants from the US National Institutes on Aging (R01AG013196; R01AG034454), the UK Medical Research Council (MRC K013351), and the British Heart Foundation (RG/13/2/30098). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; Baumgart M, 2015, ALZHEIMERS DEMENT, V11, P718, DOI 10.1016/j.jalz.2015.05.016; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bouillon K, 2011, HEART, V97, P923, DOI 10.1136/hrt.2010.216309; British Medical Association, 1995, ALC GUID SENS DRINK; Brown A, 2016, EMERG THEMES EPIDEMI, V13, P1, DOI 10.1186/s12982-016-0053-z; Chang ML, 2010, J GERONTOL A-BIOL, V65, P1369, DOI 10.1093/gerona/glq152; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; de Bruijn RFAG, 2013, EUR J EPIDEMIOL, V28, P277, DOI 10.1007/s10654-013-9773-3; Doyle Y, 2000, BRIT MED J, V321, P563, DOI 10.1136/bmj.321.7260.563; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Hamer M, 2013, OBESITY, V21, pE755, DOI 10.1002/oby.20446; Hamer M, 2012, CIRCULATION, V126, P928, DOI 10.1161/CIRCULATIONAHA.112.103879; Heim A.W., 1970, AH 4 GROUP TEST GEN; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Knopman DS, 2011, ALZHEIMERS DEMENT, V7, P53, DOI 10.1016/j.jalz.2010.11.001; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Morgan GS, 2012, J ALZHEIMERS DIS, V31, P569, DOI 10.3233/JAD-2012-112171; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Ottenbacher AJ, 2014, J AM GERIATR SOC, V62, P1786, DOI 10.1111/jgs.12978; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Prince M, 2015, EPIDEMIOLOGY IMPACT; Prince M, 2009, WORLD ALZHEIMER REPO; Rennie KL, 2003, AM J EPIDEMIOL, V158, P135, DOI 10.1093/aje/kwg120; RICHARDSON MT, 1994, J CLIN EPIDEMIOL, V47, P271, DOI 10.1016/0895-4356(94)90008-6; Savva GM, 2015, AGE AGEING, V44, P642, DOI 10.1093/ageing/afv020; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; Snowden M, 2011, J AM GERIATR SOC, V59, P704, DOI 10.1111/j.1532-5415.2011.03323.x; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Stringhini S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001479; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Tolppanen AM, 2015, ALZHEIMERS DEMENT, V11, P434, DOI 10.1016/j.jalz.2014.01.008; Vercambre MN, 2011, ARCH INTERN MED, V171, P1244, DOI 10.1001/archinternmed.2011.282; Ware JE Jr, 1993, SF 36 HLTH SURVEY MA; Willey JZ, 2014, NEUROEPIDEMIOLOGY, V42, P100, DOI 10.1159/000355975; Wilson RS, 2010, NEUROLOGY, V75, P1070, DOI 10.1212/WNL.0b013e3181f39adc; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; World Health Organization, 2010, Global recommendations on physical activity for health; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Yamada M, 2003, J AM GERIATR SOC, V51, P410, DOI 10.1046/j.1532-5415.2003.51117.x; Young J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005381.pub4	49	184	192	5	105	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2709	10.1136/bmj.j2709	http://dx.doi.org/10.1136/bmj.j2709			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY7YZ	28642251	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000404210800002
J	Busse, R; Blumel, M; Knieps, F; Barnighausen, T				Busse, Reinhard; Bluemel, Miriam; Knieps, Franz; Barnighausen, Till			Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition	LANCET			English	Article							LONG-TERM-CARE; DISEASE MANAGEMENT PROGRAMS; FREE-CHOICE; NETHERLANDS; COUNTRIES; QUALITY; LESSONS	Bismarck's Health Insurance Act of 1883 established the first social health insurance system in the world. The German statutory health insurance system was built on the defining principles of solidarity and self-governance, and these principles have remained at the core of its continuous development for 135 years. A gradual expansion of population and benefits coverage has led to what is, in 2017, universal health coverage with a generous benefits package. Self-governance was initially applied mainly to the payers (the sickness funds) but was extended in 1913 to cover relations between sickness funds and doctors, which in turn led to the right for insured individuals to freely choose their health-care providers. In 1993, the freedom to choose one's sickness fund was formally introduced, and reforms that encourage competition and a strengthened market orientation have gradually gained importance in the past 25 years; these reforms were designed and implemented to protect the principles of solidarity and self-governance. In 2004, self-governance was strengthened through the establishment of the Federal Joint Committee, a major payer-provider structure given the task of defining uniform rules for access to and distribution of health care, benefits coverage, coordination of care across sectors, quality, and efficiency. Under the oversight of the Federal Joint Committee, payer and provider associations have ensured good access to high-quality health care without substantial shortages or waiting times. Self-governance has, however, led to an oversupply of pharmaceutical products, an excess in the number of inpatient cases and hospital stays, and problems with delivering continuity of care across sectoral boundaries. The German health insurance system is not as cost-effective as in some of Germany's neighbouring countries, which, given present expenditure levels, indicates a need to improve efficiency and value for patients.	[Busse, Reinhard; Bluemel, Miriam] Berlin Univ Technol, Dept Hlth Care Management, D-10623 Berlin, Germany; [Busse, Reinhard; Bluemel, Miriam] European Observ Hlth Syst & Policies, Brussels, Belgium; [Knieps, Franz] BKK Dachverband, Berlin, Germany; [Barnighausen, Till] Heidelberg Univ, Heidelberg Inst Publ Hlth, Heidelberg, Germany; [Barnighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Barnighausen, Till] Africa Hlth Res Inst, Kwa Zulu, South Africa	Technical University of Berlin; European Observatory on Health Systems & Policies; Ruprecht Karls University Heidelberg; Harvard University; Harvard T.H. Chan School of Public Health; Africa Health Research Institute	Blumel, M (corresponding author), Berlin Univ Technol, Dept Hlth Care Management, D-10623 Berlin, Germany.	miriam.bluemel@tu-berlin.de	Bärnighausen, Till/Y-2388-2019	Blumel, Miriam/0000-0002-8452-4666	Berlin Centre for Health Economics Research (BerlinHECOR); German Federal Ministry of Education and Research [01EH1604A]	Berlin Centre for Health Economics Research (BerlinHECOR); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded as part of the Berlin Centre for Health Economics Research (BerlinHECOR) by the German Federal Ministry of Education and Research (grant no. 01EH1604A)	Alber J., 1992, GESUNDHEITSWESEN BUN; [Anonymous], 2016, END RECHN GKV 2000 2; [Anonymous], [No title captured]; [Anonymous], 2015, GES DEUTSCHL; [Anonymous], 2015, FALLP KRANK DRG STAT; Auth D, 2012, Z GERONTOL GERIATR, V45, P618, DOI 10.1007/s00391-012-0389-0; Barnighausen T, 2002, SOC SCI MED, V54, P1559, DOI 10.1016/S0277-9536(01)00137-X; Beerheide R., 2017, DTSCH ARZTEBL, V114, pA58; Bismarck O von, 1881, STENOGRAPHISCHE BERI, P1; Blumel M, 2015, INT PROFILES HLTH CA, P69; Bohm K, 2013, HEALTH POLICY, V113, P258, DOI 10.1016/j.healthpol.2013.09.003; Braun B, 1998, MARCHEN KOSTENEXPLOS; Buchner F, 2003, HEALTH POLICY, V65, P21, DOI 10.1016/S0168-8510(02)00114-8; Bundesministerium fur Gesundheit, 2015, GES KRANK MITGL MITV; Bundesministerium fur Gesundheit, 2017, ZAHL FAKT PFLEG; Bundestag Deutscher, 2010, GEST NEUORD ARZN GES; Bundestag Deutscher, 2003, GES MOD GES KRANK; Bundesversicherungsamt, 2015, ZUL STRUKT BEH; Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Busse R., 2016, THESIS; Busse R, 2004, ACCESSING HEALTHCARE, P127; Busse R, 2017, DTSCH GESUNDHEITSSYS, V2; Busse R, 2014, HLTH SYSTEMS TRANSIT; Busse R, 2009, HEALTH AFFAIR, V28, pW294, DOI 10.1377/hlthaff.28.2.w294; Campbell JC, 2010, HEALTH AFFAIR, V29, P87, DOI 10.1377/hlthaff.2009.0548; Deutscher Bundestag, 2015, GES REF STRUKT KRANK; ENTHOVEN AC, 1993, HEALTH AFFAIR, V12, P24, DOI 10.1377/hlthaff.12.suppl_1.24; European health for all databases (HFA-DB), EUR HLTH ALL DAT HFA; European Observatory on Health Systems and Policies, 2016, TRENDS AM MORT SEL C; Evers A., 2003, GLOBALIZATION WELFAR, P55; Fuchs S, 2014, DTSCH ARZTEBL INT, V111, P453, DOI 10.3238/arztebl.2014.0453; Geissler A., 2011, DIAGNOSIS RELATED GR, P243; GKV Spitzenverband, 2017, KRANK; GKV-Spitzenverband, 2017, ANZ KRANK; Gress S, 2002, HEALTH POLICY, V60, P235, DOI 10.1016/S0168-8510(01)00193-2; Gress S., 2002, VIERTELJAHRSHEFTE WI, V71, P490; Hafner H., 1996, J PUBLIC HLTH, V4, P303; Heinzelmann W., 2009, SOZIALHYGIENE ALS GE; Herold-Schmidt H., 1997, GESCH DTSCH ARZTESCH, P43; IAQ, 2019, BEITR GKV ANT GKV AU; Kassenaerztliche Bundesvereinigung, STAT INF BUND; Knieps F, 2015, GESUNDHEITSREFORMEN; Kroneman M., 2016, HLTH SYSTEMS TRANSIT; Kunstmann W, 2002, GESUNDHEITSWESEN, V64, P170, DOI 10.1055/s-2002-22318; Labisch A, 2016, HDB GESUNDHEITSWISSE; Lisac M, 2010, HEALTH ECON POLICY L, V5, P31, DOI 10.1017/S1744133109990144; Luschen G, 1997, SOC SCI MED, V44, P883, DOI 10.1016/S0277-9536(96)00193-1; Marstedt G., 2016, GESUNDHEITSMONITOR 2, P15; Ministry of Health, 2016, HEALTHC DENM OV; Nadash P, 2017, HEALTH POLICY, V121, P588, DOI 10.1016/j.healthpol.2017.03.006; Nolte E, 2012, HEALTH AFFAIR, V31, P2114, DOI 10.1377/hlthaff.2011.0851; Nolte E, 2012, HEALTH ECON POLICY L, V7, P125, DOI 10.1017/S1744133111000338; Nolte Ellen., 2004, DOES HLTH CARE SAVE; Nuscheler R, 2005, HEALTH ECON, V14, P1253, DOI 10.1002/hec.1005; Organisation for Economic Co-Operation and Development, OECD HLTH STAT 2016; Osborn R, 2013, COMMONWEALTH FUND 20; PRIDAN D, 1964, Med Hist, V8, P274; Pross C, 2017, MILBANK Q, V95, P136, DOI 10.1111/1468-0009.12248; Riens B, 2012, ARZTKONTAKTE JAHR 20; Riens B, 2012, DOES HLTH CARE SAVE; Schulz-Nieswandt F., 2006, LIBERALISIERUNG GESU, V53, P47; Schwabe U, 2016, ARZNEIVERORDNUNGS RE, P3; Statistisches Bundesamt, 2017, GES 1995 2015; Statistisches Bundesamt, 2016, GRUNDD KRANK 2015; Stock S, 2015, NEW ENGL J MED, V372, P1781, DOI 10.1056/NEJMp1413625; Tennstedt F., 1976, HDB SOZIALMEDIZIN, P385; Tennstedt F., 1977, SOZIALE SELBSTVERWAL; ter Meulen R, 2016, THEOR MED BIOETH, V37, P517, DOI 10.1007/s11017-016-9387-3; Thiele W., 1974, ARGUMENT, VAS4, P19; Thomson S, 2013, HEALTH POLICY, V109, P209, DOI 10.1016/j.healthpol.2013.01.005; von Stackelberg JM, 2016, ARZNEIVERORDNUNGS RE, P159; Weindling P., HLTH RACE GERMAN POL; Wendt C, 2009, SOC POLICY ADMIN, V43, P70, DOI 10.1111/j.1467-9515.2008.00647.x	73	143	143	4	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					882	897		10.1016/S0140-6736(17)31280-1	http://dx.doi.org/10.1016/S0140-6736(17)31280-1			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28684025	Bronze			2022-12-28	WOS:000408330700026
J	Willink, A; Schoen, C; Davis, K				Willink, Amber; Schoen, Cathy; Davis, Karen			Consideration of Dental, Vision, and Hearing Services to Be Covered Under Medicare	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POLICY; CARE; ADULTS		[Willink, Amber] Johns Hopkins Univ, Dept Hlth Policy & Management, Roger C Lipitz Ctr Integrated Hlth Care, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Schoen, Cathy] New York Acad Med, New York, NY USA; [Davis, Karen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Roger C Lipitz Ctr Integrated Hlth Care, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; New York Academy of Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Willink, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Roger C Lipitz Ctr Integrated Hlth Care, 624 N Broadway,Hampton House 698, Baltimore, MD 21205 USA.	awillin2@jhu.edu			Commonwealth Fund [20160346]	Commonwealth Fund	The research for this article was supported by grant 20160346 from the Commonwealth Fund.	American Dental Association Health Policy Institute, 2016, OR HLTH ANDW BEING U; Campbell BH, 2017, JAMA-J AM MED ASSOC, V317, P1953, DOI 10.1001/jama.2017.0629; Cassel C, 2016, JAMA-J AM MED ASSOC, V315, P553, DOI 10.1001/jama.2016.0044; Lin FR, 2016, JAMA-J AM MED ASSOC, V316, P819, DOI 10.1001/jama.2016.7916; McNeal MH, 2016, HARVARD J LEGIS, V53, P621; Sun BC, 2015, AM J PUBLIC HEALTH, V105, P947, DOI 10.2105/AJPH.2014.302398; Whitson HE, 2014, JAMA-J AM MED ASSOC, V312, P1739, DOI 10.1001/jama.2014.13535; Willink A, 2017, EXPANDED SUPPORT DEN; Willink A, 2016, HEALTH AFFAIR, V35, P2241, DOI 10.1377/hlthaff.2016.0829	9	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					605	606		10.1001/jama.2017.8647	http://dx.doi.org/10.1001/jama.2017.8647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD6CH	28662240				2022-12-28	WOS:000407616000009
J	Wiktor, SZ; Scott, JD				Wiktor, Stefan Z.; Scott, John D.			What is the impact of treatment for hepatitis C virus infection?	LANCET			English	Editorial Material							METAANALYSIS; OUTCOMES		[Wiktor, Stefan Z.] Univ Washington, Sch Med, Dept Global Hlth, Harborview Med Ctr, Seattle, WA 98104 USA; [Wiktor, Stefan Z.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Harborview Med Ctr, Seattle, WA 98104 USA; [Scott, John D.] Univ Washington, Sch Med, Dept Med, Harborview Med Ctr, Seattle, WA 98195 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	Wiktor, SZ (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Harborview Med Ctr, Seattle, WA 98104 USA.; Wiktor, SZ (corresponding author), Univ Washington, Sch Publ Hlth, Dept Global Hlth, Harborview Med Ctr, Seattle, WA 98104 USA.	wiktors@uw.edu	Higgs, Peter/P-7816-2019	Higgs, Peter/0000-0002-5587-5379	Merck; Novartis; Tacere Therapeutics; Bristol-Myers Squibb	Merck(Merck & Company); Novartis(Novartis); Tacere Therapeutics; Bristol-Myers Squibb(Bristol-Myers Squibb)	SZW declares no competing interests. JDS's institution received research funding from Merck for a grant to study long-term outcomes of the HCV drug grazoprevir on which he was the principal investigator; the grant concluded in the past year. JDS receives personal fees from Novartis for serving on the data adjudication committee for canakinumab, a non-HCV medication; has received personal fees from Tacere Therapeutics for serving on the Data Safety and Monitoring Board for a novel HCV drug TT-034 (this study concluded in 2016); and personal fees from Bristol-Myers Squibb for serving on an advisory board in 2015 for therapy of genotype 3 patients with daclatasvir.	American Association for the Study of Liver Diseases Alexandria VA., 2017, REC TEST MAN TREAT H; Boseley S, 2017, GUARDIAN; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Gore C, 2017, LANCET GASTROENTEROL; Jakobsen JC, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012143.pub2, 10.1002/14651858.CD012143.pub3]; Lok A, 2017, AASLD EXPRESSES CONC; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Public Health England, 2017, HEPATITIS C IN ENGLA; Saadoun D, 2017, GASTROENTEROLOGY, V153, P49, DOI [10.1053/j.gastro, 10.1053/j.gastro.2017.03.006]; Simmons B, 2015, CLIN INFECT DIS, V61, P730, DOI 10.1093/cid/civ396; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Terrault NA, 2016, GASTROENTEROLOGY, V151, P1131, DOI 10.1053/j.gastro.2016.08.004; WHO, 2017, WHO PUBLISHES LIST B; WHO, 2016, WHO GLOB HLTH SECT S; World Health Organization, 2017, ESSE MED LIST; Younossi Z, 2014, DIGEST LIVER DIS, V46, pS186, DOI 10.1016/j.dld.2014.09.025	17	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					107	+		10.1016/S0140-6736(17)31762-2	http://dx.doi.org/10.1016/S0140-6736(17)31762-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28699578				2022-12-28	WOS:000404976600012
J	McCarthy, M				McCarthy, Michael			ACCESS TO DRUGS What makes an essential medicine? WHO's new list focuses on antibiotic resistance, adds expensive drugs, and downgrades Tamiflu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mxmc@mac.com						Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545	1	1	1	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2017	358								j3044	10.1136/bmj.j3044	http://dx.doi.org/10.1136/bmj.j3044			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DS	28687536				2022-12-28	WOS:000405322700001
J	Hiam, L				Hiam, Lucinda			Grenfell survivors shouldn't be afraid to go to hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hiam, Lucinda] Doctors Of The World, London, England		Hiam, L (corresponding author), Doctors Of The World, London, England.	LHiam@doctorsoftheworld.org.uk		Hiam, Lucinda/0000-0002-6394-0978					0	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j3292	10.1136/bmj.j3292	http://dx.doi.org/10.1136/bmj.j3292			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DO	28684432				2022-12-28	WOS:000405322300012
J	Juch, JNS; Maas, ET; Ostelo, RJG; Groeneweg, JG; Kallewaard, JW; Koes, B; Verhagen, AP; van Dongen, JM; Huygen, FJPM; van Tulder, M				Juch, Johan N. S.; Maas, Esther T.; Ostelo, RaymondW. J. G.; Groeneweg, J. George; Kallewaard, Jan-Willem; Koes, Bartw.; Verhagen, Arianne P.; van Dongen, Johanna M.; Huygen, Frank J. P. M.; van Tulder, MauritsW.			Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain The Mint Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SACROILIAC JOINT; FACET JOINT; PSYCHOMETRIC PROPERTIES; COST-EFFECTIVENESS; FUNCTIONAL STATUS; HEALTH-STATUS; DISORDERS; NEUROTOMY; DISC	IMPORTANCE Radiofrequency denervation is a commonly used treatment for chronic low back pain, but high-quality evidence for its effectiveness is lacking. OBJECTIVE To evaluate the effectiveness of radiofrequency denervation added to a standardized exercise program for patients with chronic low back pain. DESIGN, SETTING, AND PARTICIPANTS Three pragmatic multicenter, nonblinded randomized clinical trials on the effectiveness of minimal interventional treatments for participants with chronic low back pain (Mint study) were conducted in 16 multidisciplinary pain clinics in the Netherlands. Eligible participants were included between January 1, 2013, and October 24, 2014, and had chronic low back pain, a positive diagnostic block at the facet joints (facet joint trial, 251 participants), sacroiliac joints (sacroiliac joint trial, 228 participants), or a combination of facet joints, sacroiliac joints, or intervertebral disks (combination trial, 202 participants) and were unresponsive to conservative care. INTERVENTIONS All participants received a 3-month standardized exercise program and psychological support if needed. Participants in the intervention group received radiofrequency denervation as well. This is usually a 1-time procedure, but the maximum number of treatments in the trial was 3. MAIN OUTCOMES AND MEASURES The primary outcome was pain intensity (numeric rating scale, 0-10; whereby 0 indicated no pain and 10 indicated worst pain imaginable) measured 3 months after the intervention. The prespecified minimal clinically important difference was defined as 2 points or more. Final follow-up was at 12 months, ending October 2015. RESULTS Among 681 participants who were randomized (mean age, 52.2 years; 421 women [61.8%], mean baseline pain intensity, 7.1), 599 (88%) completed the 3-month follow-up, and 521 (77%) completed the 12-month follow-up. The mean difference in pain intensity between the radiofrequency denervation and control groups at 3 months was -0.18 (95% CI, -0.76 to 0.40) in the facet joint trial; -0.71 (95% CI, -1.35 to -0.06) in the sacroiliac joint trial; and -0.99 (95% CI, -1.73 to -0.25) in the combination trial. CONCLUSIONS AND RELEVANCE In 3 randomized clinical trials of participants with chronic low back pain originating in the facet joints, sacroiliac joints, or a combination of facet joints, sacroiliac joints, or intervertebral disks, radiofrequency denervation combined with a standardized exercise program resulted in either no improvement or no clinically important improvement in chronic low back pain compared with a standardized exercise program alone. The findings do not support the use of radiofrequency denervation to treat chronic low back pain from these sources.	[Juch, Johan N. S.; Groeneweg, J. George; Huygen, Frank J. P. M.] Erasmus Univ, Med Ctr, Dept Anesthesiol, Rotterdam, Netherlands; [Maas, Esther T.; Ostelo, RaymondW. J. G.; van Dongen, Johanna M.; van Tulder, MauritsW.] Vrije Univ, Fac Earth & Life Sci, Dept Hlth Sci, Amsterdam, Netherlands; [Maas, Esther T.; Ostelo, RaymondW. J. G.; van Dongen, Johanna M.; van Tulder, MauritsW.] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Ostelo, RaymondW. J. G.] Vrije Univ, Med Ctr Amsterdam, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Kallewaard, Jan-Willem] Rijnstate Hosp, Dept Anesthesiol, Velp, Netherlands; [Koes, Bartw.; Verhagen, Arianne P.] Erasmus Univ, Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Rijnstate Hospital; Erasmus University Rotterdam; Erasmus MC	Maas, ET (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, 2206 E Mall, Vancouver, BC V6T 1Z3, Canada.	esther.maas@ubc.ca	Kallewaard, Jan/AAD-4467-2022; van Tulder, Maurits/AAB-9785-2022; Koes, Bart/K-4614-2016; Ostelo, Raymond/GSE-2602-2022	van Tulder, Maurits/0000-0002-7589-8471; van Dongen, Johanna Maria/0000-0002-1606-8742; Maas, Esther/0000-0002-2290-9552; Koes, Bart/0000-0002-0450-9969; Ostelo, Raymond/0000-0001-7679-7210; Verhagen, Arianne/0000-0002-6195-0128	Netherlands Organization for Health Research and Development [171202013]; Dutch Society for Anesthesiology; Dutch health insurance companies; ReumaFonds [COI-1] Funding Source: researchfish	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Society for Anesthesiology; Dutch health insurance companies; ReumaFonds	This study was funded by grant 171202013 from the Netherlands Organization for Health Research and Development, by the Dutch Society for Anesthesiology, and the Dutch health insurance companies.	Bogduk N, 1995, J MANIP PHYSIOL THER, V18, P603; BOGDUK N, 2004, PRACTICE GUIDELINES; Bombardier C, 2000, SPINE, V25, P3100, DOI 10.1097/00007632-200012150-00003; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Burnham RS, 2007, REGION ANESTH PAIN M, V32, P12, DOI 10.1016/j.rapm.2006.08.008; Chiarotto A, 2015, EUR SPINE J, V24, P1127, DOI 10.1007/s00586-015-3892-3; Cohen SP, 2008, ANESTHESIOLOGY, V109, P279, DOI 10.1097/ALN.0b013e31817f4c7c; Cohen SP, 2013, NAT REV RHEUMATOL, V9, P101, DOI 10.1038/nrrheum.2012.198; Cosman ER, 2011, PAIN PRACT, V11, P3, DOI 10.1111/j.1533-2500.2010.00400.x; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Ferrante FM, 2001, REGION ANESTH PAIN M, V26, P137, DOI 10.1053/rapm.2001.21739; Gauci CA, 2011, MANUAL RF TECHNIQUES; Hancock MJ, 2007, EUR SPINE J, V16, P1539, DOI 10.1007/s00586-007-0391-1; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Henschke N, 2010, EUR SPINE J, V19, P1425, DOI 10.1007/s00586-010-1411-0; Hoeijenbos M, 2005, HEALTH POLICY, V75, P85, DOI 10.1016/j.healthpol.2005.02.008; Kahan BC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-456; Kallewaard JW, 2010, PAIN PRACT, V10, P560, DOI 10.1111/j.1533-2500.2010.00408.x; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Lousberg R, 1999, BEHAV RES THER, V37, P167, DOI 10.1016/S0005-7967(98)00137-5; Maas ET, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008572.pub2; Maas ET, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-260; Manchikanti L, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0588-2; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Patel N, 2012, PAIN MED, V13, P383, DOI 10.1111/j.1526-4637.2012.01328.x; Schmidt PC, 2014, ANESTH ANALG, V119, P460, DOI 10.1213/ANE.0000000000000282; Szadek KM, 2009, J PAIN, V10, P354, DOI 10.1016/j.jpain.2008.09.014; Twisk JWR, 2006, APPL MULTILEVEL AN P; van der Roer N, 2006, SPINE, V31, P578, DOI 10.1097/01.brs.0000201293.57439.47; van Tilburg CWJ, 2016, CLIN J PAIN, V32, P921, DOI 10.1097/AJP.0000000000000351; Van Zundert J, 2011, EVIDENCE BASED INTER; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	38	135	139	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					68	81		10.1001/jama.2017.7918	http://dx.doi.org/10.1001/jama.2017.7918			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672319	Green Published			2022-12-28	WOS:000404717700016
J	Barnard, A				Barnard, Alan			Affluence Without Abundance The Disappearing World of the Bushmen	SCIENCE			English	Book Review									[Barnard, Alan] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland	University of Edinburgh	Barnard, A (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Edinburgh EH8 9LD, Midlothian, Scotland.							Suzman J., 2017, AFFLUENCE ABUNDANCE	1	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1340	1340		10.1126/science.aan6309	http://dx.doi.org/10.1126/science.aan6309			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663461				2022-12-28	WOS:000404351500022
J	Chen, JH; Asch, SM				Chen, Jonathan H.; Asch, Steven M.			Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BIG DATA		[Chen, Jonathan H.; Asch, Steven M.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Asch, Steven M.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Innovat Implementat Ci2i, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chen, JH (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.			Chen, Jonathan H./0000-0002-4387-8740	NIEHS NIH HHS [K01 ES026837] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES026837] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Chen JH, 2017, INT J MED INFORM, V102, P71, DOI 10.1016/j.ijmedinf.2017.03.006; Escobar GJ, 2016, J HOSP MED, V11, pS18, DOI 10.1002/jhm.2652; Gartner Inc., 2016, ID 3 KEY TRENDS ORG; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181	5	429	441	8	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2507	2509		10.1056/NEJMp1702071	http://dx.doi.org/10.1056/NEJMp1702071			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657867	Green Published, Green Accepted			2022-12-28	WOS:000404259200003
J	Lim, XZ				Lim, XiaoZhi			THE ARCHITECTURE OF STRUCTURED DNA	NATURE			English	Editorial Material							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI											Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Elbaz J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11179; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Liu XW, 2012, NANO LETT, V12, P4254, DOI 10.1021/nl301877k; Praetorius F, 2017, SCIENCE, V355, DOI 10.1126/science.aam5488; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sun W, 2014, SCIENCE, V346, P717, DOI 10.1126/science.1258361; Veneziano R, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4388	12	11	12	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					687	689		10.1038/546687a	http://dx.doi.org/10.1038/546687a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9QB	28658229				2022-12-28	WOS:000404332000055
J	Ndumele, CD; Schpero, WL; Schlesinger, MJ; Trivedi, AN				Ndumele, Chima D.; Schpero, William L.; Schlesinger, Mark J.; Trivedi, Amal N.			Association Between Health Plan Exit From Medicaid Managed Care and Quality of Care, 2006-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARKET	IMPORTANCE State Medicaid programs have increasingly contracted with insurers to provide medical care services for enrollees (Medicaid managed care plans). Insurers that provide these plans can exit Medicaid programs each year, with unclear effects on quality of care and health care experiences. OBJECTIVE To determine the frequency and interstate variation of health plan exit from Medicaid managed care and evaluate the relationship between health plan exit and market-level quality. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort of all comprehensive Medicaid managed care plans (N = 390) during the interval 2006-2014. EXPOSURES Plan exit, defined as the withdrawal of a managed care plan from a state's Medicaid program. MAIN OUTCOMES AND MEASURES Eight measures from the Healthcare Effectiveness Data and Information Set were used to construct 3 composite indicators of quality (preventive care, chronic disease care management, and maternity care). Four measures from the Consumer Assessment of Healthcare Providers and Systems were combined into a composite indicator of patient experience, reflecting the proportion of beneficiaries rating experiences as 8 or above on a 0-to-10-point scale. Outcome data were available for 248 plans (68% of plans operating prior to 2014, representing 78% of beneficiaries). RESULTS Of the 366 comprehensive Medicaid managed care plans operating prior to 2014, 106 exited Medicaid. These exiting plans enrolled 4 848 310 Medicaid beneficiaries, with a mean of 606 039 beneficiaries affected by plan exits annually. Six states had a mean of greater than 10% of Medicaid managed care recipients enrolled in plans that exited, whereas 10 states experienced no plan exits. Plans that exited from a state's Medicaid market performed significantly worse prior to exiting than those that remained in terms of preventive care (57.5% vs 60.4%; difference, 2.9%[95% CI, 0.3% to 5.5%]), maternity care (69.7% vs 73.6%; difference, 3.8% [95% CI, 1.7% to 6.0%]), and patient experience (73.5% vs 74.8%; difference, 1.3%[95% CI, 0.6% to 1.9%]). There was no significant difference between exiting and nonexiting plans for the quality of chronic disease care management (76.2% vs 77.1%; difference, 1.0%[95% CI, -2.1% to 4.0%]). There was also no significant change in overall market performance before and after the exit of a plan: 0.7-percentage point improvement in preventive care quality (95% CI, -4.9 to 6.3); 0.2-percentage point improvement in chronic disease care management quality (95% CI, -5.8 to 6.2); 0.7-percentage point decrease in maternity care quality (95% CI, -6.4 to 5.0]); and a 0.6-percentage point improvement in patient experience ratings (95% CI, -3.9 to 5.1). Medicaid beneficiaries enrolled in exiting plans had access to coverage for a higher-quality plan, with 78% of plans in the same county having higher quality for preventive care, 71.1% for chronic disease management, 65.5% for maternity care, and 80.8% for patient experience. CONCLUSIONS AND RELEVANCE Between 2006 and 2014, health plan exit from the US Medicaid program was frequent. Plans that exited generally had lower quality ratings than those that remained, and the exits were not associated with significant overall changes in quality or patient experience in the plans in the Medicaid market.	[Ndumele, Chima D.; Schpero, William L.; Schlesinger, Mark J.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, 60 Coll St, New Haven, CT 06520 USA; [Trivedi, Amal N.] Brown Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI USA; [Trivedi, Amal N.] Providence VA Med Ctr, Providence, RI USA	Yale University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Ndumele, CD (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, 60 Coll St, New Haven, CT 06520 USA.	chima.ndumele@yale.edu			Health Resources and Services Administration [R40MC28319]; Agency for Healthcare Research and Quality [U18HS016978-08]; National Research Service Award from Agency for Healthcare Research and Quality [T32 HS017589]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016978, T32HS017589] Funding Source: NIH RePORTER	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Research Service Award from Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The conduct of the research was supported by a grant from the Health Resources and Services Administration (R40MC28319). Dr Ndumele acknowledges funding from the Agency for Healthcare Research and Quality (U18HS016978-08). Mr Schpero acknowledges support from a National Research Service Award training grant (T32 HS017589) from the Agency for Healthcare Research and Quality.	Abraham J, 2000, ECON INQ, V38, P385, DOI 10.1093/ei/38.3.385; Agency for Healthcare Research and Quality (AHRQ), 2008, FIELD CAHPS HLTH PLA; Aitken M., 2013, SHIFT FEE SERVICE MA; Bindman AB, 2005, HEALTH SERV RES, V40, P19, DOI 10.1111/j.1475-6773.2005.00340.x; Boscardin CK, 2013, JT COMM J QUAL PATIE, V39, P123, DOI 10.1016/S1553-7250(13)39018-7; Centers for Medicare & Medicaid Services (CMS), 2014, MED MAN CAR ENR REP; Centers for Medicare & Medicaid Services (CMS), 2014, MED MAN CAR ENR PROG; Chernew ME, 2004, HEALTH AFFAIR, V23, P91, DOI 10.1377/hlthaff.23.2.91; CMS, 2016, MED CHIP MAN CAR FIN; Collins S. R., 2012, GAPS HLTH INSURANCE; Financial SNL, 2016, INS RAT PROD FIL; Garfield R, 2014, UNINSURED STARTING L; Ginde AA, 2012, ARCH INTERN MED, V172, P642, DOI 10.1001/archinternmed.2012.34; Halpern R, 2005, HEALTH CARE FINANC R, V26, P105; Iglehart JK, 2011, HEALTH AFFAIR, V30, P1627, DOI 10.1377/hlthaff.2011.0836; Kaiser Family Foundation (KFF), 2016, MED MAN CAR MARK TRA; Keenan C., 2015, FED AGENCY CITES CON; Landon BE, 2004, HEALTH AFFAIR, V23, P245, DOI 10.1377/hlthaff.23.4.245; Landon BE, 1999, JAMA-J AM MED ASSOC, V282, P1769, DOI 10.1001/jama.282.18.1769; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Long SK, 2005, HEALTH AFFAIR, V24, P1084, DOI 10.1377/hlthaff.24.4.1084; Miller RH, 2002, HEALTH AFFAIR, V21, P63, DOI 10.1377/hlthaff.21.4.63; Sommers B., 2013, HLTH AFFAIRS BLOG; Sommers BD, 2014, HEALTH AFFAIR, V33, P887, DOI 10.1377/hlthaff.2014.0005	24	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2524	2531		10.1001/jama.2017.7118	http://dx.doi.org/10.1001/jama.2017.7118			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY6PV	28655014	Green Published, Bronze			2022-12-28	WOS:000404106600022
J	Ackland, GJ; Dunuwille, M; Martinez-Canales, M; Loa, I; Zhang, R; Sinogeikin, S; Cai, WZ; Deemyad, S				Ackland, Graeme J.; Dunuwille, Mihindra; Martinez-Canales, Miguel; Loa, Ingo; Zhang, Rong; Sinogeikin, Stanislav; Cai, Weizhao; Deemyad, Shanti			Quantum and isotope effects in lithium metal	SCIENCE			English	Article							DENSE LITHIUM; LOW-TEMPERATURES; MARTENSITIC-TRANSFORMATION; PHASE-TRANSFORMATION; ELECTRONIC-STRUCTURE; PRESSURE; TRANSITION; CRYSTAL; HYDROGEN; BCC	The crystal structure of elements at zero pressure and temperature is the most fundamental information in condensed matter physics. For decades it has been believed that lithium, the simplest metallic element, has a complicated ground-state crystal structure. Using synchrotron x-ray diffraction in diamond anvil cells and multiscale simulations with density functional theory and molecular dynamics, we show that the previously accepted martensitic ground state is metastable. The actual ground state is face-centered cubic (fcc). We find that isotopes of lithium, under similar thermal paths, exhibit a considerable difference in martensitic transition temperature. Lithium exhibits nuclear quantum mechanical effects, serving as a metallic intermediate between helium, with its quantum effect-dominated structures, and the higher-mass elements. By disentangling the quantum kinetic complexities, we prove that fcc lithium is the ground state, and we synthesize it by decompression.	[Ackland, Graeme J.; Martinez-Canales, Miguel; Loa, Ingo] Univ Edinburgh, Scottish Univ Phys Alliance, Sch Phys & Astron, Edinburgh EH9 3FD, Midlothian, Scotland; [Ackland, Graeme J.; Martinez-Canales, Miguel; Loa, Ingo] Univ Edinburgh, Ctr Sci Extreme Condit, Edinburgh EH9 3FD, Midlothian, Scotland; [Dunuwille, Mihindra; Zhang, Rong; Cai, Weizhao; Deemyad, Shanti] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Sinogeikin, Stanislav] Carnegie Inst Sci, Geophys Lab, HPCAT, Argonne, IL 60439 USA	University of Edinburgh; University of Edinburgh; Utah System of Higher Education; University of Utah; Carnegie Institution for Science	Deemyad, S (corresponding author), Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA.	deemyad@physics.utah.edu	Cai, Weizhao/H-7725-2012; Ackland, Graeme/H-2215-2015	Cai, Weizhao/0000-0001-7805-2108; Ackland, Graeme/0000-0002-1205-7675	DOE-NNSA [DE-NA0001974, DE-NA-0002006]; NSF; DOE Office of Science [DE-AC02-06CH11357]; NSF Division of Materials Research [1351986]; DOE-BES/DMSE [DE-FG02-99ER45775]; EPSRC [K01465X]; ERC; Royal Society; eDIKT initiative; EPSRC [EP/P022790/1, EP/K01465X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/P022790/1, EP/K01465X/1] Funding Source: researchfish; Division Of Materials Research [1351986] Funding Source: National Science Foundation	DOE-NNSA(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); DOE Office of Science(United States Department of Energy (DOE)); NSF Division of Materials Research(National Science Foundation (NSF)); DOE-BES/DMSE; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); eDIKT initiative; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. K. Hinton and M. C. MacLean for assistance in data collection; T. Taylor for assistance in data analysis; S. Tkachev and GSECARS for providing the helium gas loading; J. Smith, C. Kenney-Benson, and R. Ferry in 16-ID-B for experimental support; G. Shen and Y. Meng for providing additional beamtime for final measurements; and D. Fernandez, V. Deshpande, and L. Yang for experimental support on sample purity checks. The experimental work was performed at HPCAT (Sector 16), Advanced Photon Source (APS), Argonne National Laboratory. HPCAT operations are supported by DOE-NNSA under award DE-NA0001974 with partial instrumentation funding by NSF. The APS is a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. Beam time for these experiments was provided by the Carnegie-DOE Alliance Center, which is supported by DOE-NNSA under grant DE-NA-0002006. Research at the University of Utah was supported by NSF Division of Materials Research award 1351986. S. S. acknowledges the support of DOE-BES/DMSE under award DE-FG02-99ER45775. Research at the University of Edinburgh is supported by EPSRC with computing time on EPCC's ARCHER supercomputer (UKCP grant K01465X). G.J.A. was supported by an ERC fellowship "Hecate" and a Royal Society Wolfson fellowship. This work also used resources provided by the Edinburgh Compute and Data Facility [ECDF, www.ecdf.ed.ac.uk; the ECDF is partially supported by the eDIKT initiative (www.edikt.org.uk)]. Experimental data are available in the main text and supplementary materials or are stored in a database on the authors' institution and APS server, which are available from the corresponding author upon reasonable request. Details of computations are available at doi:10.7488/ds/2050.	Ackland GJ, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.054104; Ackland GJ, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/138; ASHCROFT NW, 1989, PHYS REV B, V39, P10552, DOI 10.1103/PhysRevB.39.10552; Babaev E, 2004, NATURE, V431, P666, DOI 10.1038/nature02910; BARRETT CS, 1947, PHYS REV, V72, P245, DOI 10.1103/PhysRev.72.245; BERLINER R, 1986, PHYS REV B, V34, P3586, DOI 10.1103/PhysRevB.34.3586; Bollinger RK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.075503; Bonev SA, 2004, NATURE, V431, P669, DOI 10.1038/nature02968; CEPERLEY DM, 1981, PHYSICA B & C, V108, P875, DOI 10.1016/0378-4363(81)90742-7; Deemyad S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167001; ERNST G, 1986, PHYS REV B, V33, P6465, DOI 10.1103/PhysRevB.33.6465; GOODING RJ, 1988, PHYS REV B, V38, P1695, DOI 10.1103/PhysRevB.38.1695; Gromnitskaya EL, 1999, JETP LETT+, V69, P38, DOI 10.1134/1.567981; Guillaume CL, 2011, NAT PHYS, V7, P211, DOI 10.1038/NPHYS1864; Hanfland M, 2000, NATURE, V408, P174, DOI 10.1038/35041515; Hennig RG, 2005, NAT MATER, V4, P129, DOI 10.1038/nmat1292; Hernandez ER, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.185701; Kogan V. S., 1963, SOV PHYS USP, V5, P951; Lazicki A, 2010, SOLID STATE COMMUN, V150, P625, DOI 10.1016/j.ssc.2009.12.029; Marques M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.095502; MARTIN DL, 1959, PHYSICA, V25, P1193, DOI 10.1016/0031-8914(59)90038-2; Matsuoka T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.144103; Matsuoka T, 2009, NATURE, V458, P186, DOI 10.1038/nature07827; MCCARTHY CM, 1980, PHYS REV B, V22, P574, DOI 10.1103/PhysRevB.22.574; Neaton JB, 1999, NATURE, V400, P141, DOI 10.1038/22067; OVERHAUSER AW, 1984, PHYS REV LETT, V53, P64, DOI 10.1103/PhysRevLett.53.64; Pickard CJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146401; Pinsook U, 2000, PHYS REV B, V62, P5427, DOI 10.1103/PhysRevB.62.5427; Proville L, 2012, NAT MATER, V11, P845, DOI [10.1038/nmat3401, 10.1038/NMAT3401]; Schaeffer AM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9030; Schaeffer AM, 2015, P NATL ACAD SCI USA, V112, P60, DOI 10.1073/pnas.1412638112; Schaeffer AMJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.185702; SCHUCH AF, 1958, PHYS REV, V110, P775, DOI 10.1103/PhysRev.110.775; SCHWARZ W, 1990, PHYS REV LETT, V65, P3144, DOI 10.1103/PhysRevLett.65.3144; SCHWARZ W, 1991, PHYS REV B, V44, P6785, DOI 10.1103/PhysRevB.44.6785; Shimizu K, 2002, NATURE, V419, P597, DOI 10.1038/nature01098; SMITH HG, 1990, PHYS REV B, V41, P1231, DOI 10.1103/PhysRevB.41.1231; SMITH HG, 1987, PHYS REV LETT, V58, P1228, DOI 10.1103/PhysRevLett.58.1228; Souvatzis P, 2009, COMP MATER SCI, V44, P888, DOI 10.1016/j.commatsci.2008.06.016; Stishov S. M., 2001, Physics-Uspekhi, V44, P285, DOI 10.1070/PU2001v044n03ABEH000842; Struzhkin VV, 2002, SCIENCE, V298, P1213, DOI 10.1126/science.1078535; Tamblyn I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.075703; ZDETSIS AD, 1986, PHYS REV B, V34, P7666, DOI 10.1103/PhysRevB.34.7666	43	48	49	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1254	1259		10.1126/science.aal4886	http://dx.doi.org/10.1126/science.aal4886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642431	Green Submitted			2022-12-28	WOS:000403881700033
J	Merritt, M				Merritt, Marilyn			The Evolution of Imagination	SCIENCE			English	Book Review									[Merritt, Marilyn] George Washington Univ, Dept Anthropol, Washington, DC 20052 USA	George Washington University	Merritt, M (corresponding author), George Washington Univ, Dept Anthropol, Washington, DC 20052 USA.	mmerritt@gwu.edu						Asma S, 2017, EVOLUTION IMAGINATIO	1	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1240	1240		10.1126/science.aan4045	http://dx.doi.org/10.1126/science.aan4045			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642401				2022-12-28	WOS:000403881700024
J	Servick, K				Servick, Kelly			Texas signals support for unproven stem cell therapies	SCIENCE			English	News Item																			0	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1219	1219		10.1126/science.356.6344.1219	http://dx.doi.org/10.1126/science.356.6344.1219			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642387				2022-12-28	WOS:000403881700010
J	Kickbusch, I; Franz, C; Holzscheiter, A; Hunger, I; Jahn, A; Kohler, C; Razum, O; Schmidt, JO				Kickbusch, Ilona; Franz, Christian; Holzscheiter, Anna; Hunger, Iris; Jahn, Albrecht; Koehler, Carsten; Razum, Oliver; Schmidt, Jean-Olivier			Germany's expanding role in global health	LANCET			English	Article							FRAMEWORK CONVENTION; TOBACCO CONTROL; REFUGEES; CARE	Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy. Catalysts for this shift have been strong governmental leadership, opportunities through G7 and G20 presidencies, and Germany's involvement in managing the Ebola virus disease outbreak. German global health engagement has four main characteristics that are congruent with the health agenda of the Sustainable Development Goals; it is rooted in human rights, multilateralism, the Bismarck model of social protection, and a link between development and investment on the basis of its own development trajectory after World War 2. The combination of momentum and specific characteristics makes Germany well equipped to become a leader in global health, yet the country needs to accept additional financial responsibility for global health, expand its domestic global health competencies, reduce fragmentation of global health policy making, and solve major incoherencies in its policies both nationally and internationally.	[Kickbusch, Ilona] Grad Inst Int & Dev Studies, CH-1202 Geneva, Switzerland; [Franz, Christian] CPC Analyt, Berlin, Germany; [Holzscheiter, Anna] Free Univ Berlin, Dept Polit & Social Sci, Berlin, Germany; [Holzscheiter, Anna] WZB Berlin Social Sci Ctr, Berlin, Germany; [Hunger, Iris] Robert Koch Inst, Berlin, Germany; [Jahn, Albrecht] Heidelberg Univ, Heidelberg Inst Publ Hlth, Heidelberg, Germany; [Koehler, Carsten] Eberhard Karls Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Razum, Oliver] Bielefeld Univ, Sch Publ Hlth, Bielefeld, Germany; [Schmidt, Jean-Olivier] Deutsch Gesell Int Zusammenarbeit GIZ, Eschborn, Germany	Free University of Berlin; Robert Koch Institute; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; University of Bielefeld	Kickbusch, I (corresponding author), Grad Inst Int & Dev Studies, CH-1202 Geneva, Switzerland.	ilona.kickbusch@graduateinstitute.ch	Zeeb, Hajo/I-2701-2019; Schmidt, Jean-Olivier/I-9510-2019	Zeeb, Hajo/0000-0001-7509-242X; Franz, Christian/0000-0003-1038-5779; Razum, Oliver/0000-0002-1244-7649				Anan K., 2014, GLOBALISATION GERMAN; [Anonymous], 2014, GES ALL MENSCH JED O; [Anonymous], 2017, MARSH AFR NEUE PARTN; [Anonymous], 2017, HLTH SEC SMALL BUGS; [Anonymous], 2017, 1811063 BUND TAB TAB; Auswartiges Amt, 2016, GLOB GES; B20 Health Initiative. Stepping up global health, 2017, STEPP GLOB HLTH RES; Bachrach S, 2004, NEW ENGL J MED, V351, P417, DOI 10.1056/NEJMp048136; Bozorgmehr K, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23445; Bozorgmehr K, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-19; Bundesfinanzministerium, 2017, BUND BESCHL ECKW HAU; Bundesgesundheitsministerium, 2017, TOG TOD HLTH TOM; Bundesministerium fur Bildung und Forschung, 2010, HLTH RES FRAM PROGR; Bundesministerium fur Bildung und Forschung, 2014, AFR STRAT 2014 2018; Bundesministerium fur Bildung und Forschung, 2015, GLOB HLTH FOC RES FU; Bundesministerium fur Bildung und Forschung, 2011, RES FUND CONC NEGL P; Bundesministerium fur Gesundheit, 2013, SHAP GLOB HLTH TAK J; Bundesministerium fur Wirtschaftliche Zusammenarbeit und Entwicklung, 2016, BMZS AFR POL NEW CHA; Busse R, 2017, LANCET; Butler D., 2017, NATURE; Civil2020, 2017, HLTH CIV SOC REC G20; Clift C., 2014, WHATS WHO FINAL REPO; Commission of Experts for Research and Innovation, 2017, 2017EFI COMM EXP RES; Das Gesundheitswesen/ RKI, 2016, GESUNDHEITSWESEN, V78, P795; Deutscher Bundestag, 2013, WHO FRAM CONV TOB CO; Deutscher Bundestag, 2015, 186864 DTSCH BUND; Deutscher Bundestag, 2016, REG 30 MAI; Deutscher Bundestag, 2016, ANTW BUND KLEIN ANFR; Deutscher Bundestag, 2016, 188712 DTSCH BUND; Deutscher Bundestag, 2016, 187510 DTSCH BUND; Deutscher Bundestag, 2015, 184171 DTSCH BUND; Deutscher Bundestag, 2014, 182487 DTSCH BUND; Droge S., 2015, 4 SWP RP; Drugs for Neglected Diseases Initiative, 2012, MED INN NEGL PAT IMP; European Commission, 2010, EU ROL GLOB HLTH; Evidence to Policy Initiative (E2Pi), 2011, GLOB HLTH POL GERM; Federal Foreign Office of Germany, 2014, REV 2014 FRESH LOOK; Federal Government of Germany, 2016, GREAT SOL REF POL; Federal Government of Germany, 2016, GERM G20 PRES BEG; G-finder, 2016, NEGL DIS RES DEV PIV; Garret L., 2016, FOREIGN AFFAIRS; Gauck J., DEUTSCHLANDS ROLLE W; Gebauer T., 2014, C DTSCH PLATF GLOB G; German National Academy of Sciences Leopoldina, 2015, AC NAT AC SCI ENG UN; Global Funding of Innovation for Neglected Diseases, 2013, EM LEAD GERM ROL NEG; Grohe H., 2016, U KLIN BONN NEW 1212; Gruning T, 2012, TOB CONTROL, V21, P30, DOI 10.1136/tc.2010.042093; Huber J, 2008, GLOBAL ENVIRON CHANG, V18, P360, DOI 10.1016/j.gloenvcha.2008.03.004; Huddleston T., 2015, MIGRANT INTEGRATION; International Council on Social Welfare WHO, 2010, SOC PROT FLOOR IN; Ischinger W., 2017, BIG LEAGUE MORE EURO; Ischinger W., 2017, MORE EU FOREIGN SECU; Jacobsen L, 2016, WAS VOM TURKEI DEAL; Jahn T., 2017, HANDELSBLATT GL 0118; Kaffes I, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0814-y; Kickbusch I, 2006, SCAND J PUBLIC HEALT, V34, P561, DOI 10.1080/14034940600973059; Kickbusch I, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6715; Knipper M, 2017, MIPEX HLHT STRAND CO; Krennerich M., 2016, SHIFTING POWER HUMAN; Liu PL, 2014, LANCET, V384, P793, DOI 10.1016/S0140-6736(14)60725-X; Martens J, 2017, GESTIFTETE ENTWICKLU; Meier M, 2016, COMMITMENTS GLOBAL H; Merkel A., 2015, 68 SESS WHO WORLD HL; Merkel A., 2015, COMMUNICATION   0207; MERKEL ANGELA, 2016, COMMUNICATION; Morrison SJ, 2012, END ERA GLOBAL HLTH, P82; Munir K, 2016, HLTH SYSTEMS STRENGT; Munir K, 2016, GERMAN COOPERATIONS; Napoli I, 2016, GLOBAL HLTH ED FOCUS; Pariat M., 2016, CRISIS RESPONSE J, V11, P58; Pence M., 2017, COMMUNICATION   0218; Razum O, 2017, INT J HEALTH POLICY, V6, P349, DOI 10.15171/ijhpm.2016.139; Razum O, 2016, GLOB SOC POLICY, V16, P321, DOI 10.1177/1468018116655267; Ruppel J., 2016, DEUTSCHLANDS BEITRAG; Sachs JD, 2001, MACR HLTH INV HLTH E; Schmidt S., 2015, AUS POLITIK ZEITGESC, V65, P29; ScienceWatch, 2009, MOST CIT I OV 1999 2; Spallek J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-92; Spatz J., 2016, NEW TOBACCO CONTROL; Statistisches Bundesamt, 2016, HLTH EXP FIG; Steinmeier FW, 2016, FOREIGN AFFAIRS; Steinmeier FW, 2015, COMMUNICATION   0319; The Federal Government of Germany, 2015, CHANC PROP CRIS MAN; Trump Garret L., 2017, COUNCIL FOREIGN RELA; VENRO MSF, 2017, G20 GLOB HLTH GLOB R; Volkswagenstiftung, 2016, FREIG FELL 10 MIO AU; WHO, 2016, WHO FIN DIAL 2016 PR; WHO, 2017, CONT FUND EM INC ALL; Yach D, 2014, LANCET, V383, P1771, DOI 10.1016/S0140-6736(13)62155-8; Yamey G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1210	90	29	29	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					898	912		10.1016/S0140-6736(17)31460-5	http://dx.doi.org/10.1016/S0140-6736(17)31460-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28684024	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000408330700027
J	Zellweger, M				Zellweger, Matthieu			Picturing the past and present of health care in Germany	LANCET			English	Editorial Material														Zellweger, Matthieu/0000-0002-0590-3175					0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					837	844		10.1016/S0140-6736(17)31761-0	http://dx.doi.org/10.1016/S0140-6736(17)31761-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28684026	Bronze			2022-12-28	WOS:000408330700013
J	Mason, DJ				Mason, Diana J.			Rethinking Rural Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Mason, Diana J.] CUNY, Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA; [Mason, Diana J.] George Washington Univ, Sch Nursing, Washington, DC 20052 USA	City University of New York (CUNY) System; Hunter College (CUNY); George Washington University	Mason, DJ (corresponding author), CUNY, Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA.; Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Washington, DC 20052 USA.	djmasonrn@gmail.com							0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					114	115		10.1001/jama.2017.7535	http://dx.doi.org/10.1001/jama.2017.7535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697244				2022-12-28	WOS:000405190800002
J	van Dorn, A; Cooney, R				van Dorn, Aaron; Cooney, Rebecca			US Senate unveils ACA repeal bill	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					111	112		10.1016/S0140-6736(17)31760-9	http://dx.doi.org/10.1016/S0140-6736(17)31760-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28669645				2022-12-28	WOS:000404976600015
J	Appenzeller, T				Appenzeller, Tim			THE SCIENTISTS' APPRENTICE	SCIENCE			English	Editorial Material																			0	19	19	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		16	17		10.1126/science.357.6346.16	http://dx.doi.org/10.1126/science.357.6346.16			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684479	Bronze			2022-12-28	WOS:000404854100013
J	Dillon, MR; Kannan, H; Dean, JT; Spelke, ES; Duflo, E				Dillon, Moira R.; Kannan, Harini; Dean, Joshua T.; Spelke, Elizabeth S.; Duflo, Esther			Cognitive science in the field: A preschool intervention durably enhances intuitive but not formal mathematics	SCIENCE			English	Article							CASH TRANSFER PROGRAM; INDIVIDUAL-DIFFERENCES; CHILD-DEVELOPMENT; VISUAL-ATTENTION; MATH PERFORMANCE; NUMBER ACUITY; LOW-INCOME; APPROXIMATE; REPRESENTATIONS; GEOMETRY	Many poor children are underprepared for demanding primary school curricula. Research in cognitive science suggests that school achievement could be improved by preschool pedagogy in which numerate adults engage children's spontaneous, nonsymbolic mathematical concepts. To test this suggestion, we designed and evaluated a game-based preschool curriculum intended to exercise children's emerging skills in number and geometry. In a randomized field experiment with 1540 children (average age 4.9 years) in 214 Indian preschools, 4 months of math game play yielded marked and enduring improvement on the exercised intuitive abilities, relative to no-treatment and active control conditions. Math-trained children also showed immediate gains on symbolic mathematical skills but displayed no advantage in subsequent learning of the language and concepts of school mathematics.	[Dillon, Moira R.; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Kannan, Harini; Duflo, Esther] Abdul Latif Jameel Poverty Act Lab South Asia, New Delhi, India; [Dean, Joshua T.; Duflo, Esther] MIT, Dept Econ, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Dillon, MR; Spelke, ES (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.; Duflo, E (corresponding author), Abdul Latif Jameel Poverty Act Lab South Asia, New Delhi, India.; Duflo, E (corresponding author), MIT, Dept Econ, Cambridge, MA 02139 USA.	mdillon@fas.harvard.edu; spelke@wjh.harvard.edu; eduflo@mit.edu		Dillon, Moira/0000-0002-6689-5316; Dean, Joshua/0000-0001-5751-9100; Spelke, Elizabeth/0000-0002-6925-3618	Union Bank of Switzerland; Optimus Foundation; Harvard University Mind, Brain, and Behavior Initiative; Harvard University Foundations of Human Behavior Program; NSF [DGE-1144152, DGE-1122374]; Division Of Research On Learning [1348140] Funding Source: National Science Foundation	Union Bank of Switzerland; Optimus Foundation; Harvard University Mind, Brain, and Behavior Initiative; Harvard University Foundations of Human Behavior Program; NSF(National Science Foundation (NSF)); Division Of Research On Learning(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	The data and analyses presented in this paper are available at doi:10.7910/DVN/LCLKDT. Supported by grants from the Union Bank of Switzerland and Optimus Foundation to J-PAL South Asia, the Harvard University Mind, Brain, and Behavior Initiative and Harvard University Foundations of Human Behavior Program (E.S.), NSF grant DGE-1144152 (M.D.), and NSF grant DGE-1122374 (J.D.). The project received institutional review board approval from MIT and the Institute for Financial Management and Research (Sri City, India) and is registered in the social science registry (www.socialscienceregistry.org/trials/27/history/15141). We thank C. Cooper, K. Goffin, L. Schiller, and E. Schmidt for assistance in generating game materials; K. Dua, M. Duhon, A. Gupta, and A. Jha for assistance with intervention piloting, implementation, and evaluation; X. Gao and D. Mauer for providing images for the social games; N. Tottenham and C. Nelson for advice on the use of these images; J. Halberda for assistance in generating the images for the numerical games and assessments; Y. Huang for assistance in calibrating the math and social games; B. Reilly for assistance in the design and functioning of the math and social games; and K. Shutts for suggestions on elements of the social games. We thank P. Kakaji, M. Sharma, S. Sharma, Pratham, and the Pratham team of teachers for generously providing us with the opportunity to present these games to their preschool children in the warm and engaging environments that they have created for young learners in India and around the world. Finally, we thank R. Banerji, Pratham CEO, who was initially due to be an investigator, for many inspiring discussions throughout the course of this project.	Andrabi T, 2011, AM ECON J-APPL ECON, V3, P29, DOI 10.1257/app.3.3.29; ASER 2014 (Rural), 2015, ANN STAT ED REP RUR; ASER Centre, 2012, ANN STAT ED REP 2011; Attanasio OP, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5785; Bailey DH, 2014, PSYCHOL SCI, V25, P2017, DOI 10.1177/0956797614547539; Banerjee A.V., 2012, POOR EC RADICAL RETH; Banerji R., 2016, AM EC J APPL EC; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Carey S., 2009, ORIGIN CONCEPTS; Chang SM, 2015, PEDIATRICS, V136, P272, DOI 10.1542/peds.2015-0119; Chen QX, 2014, ACTA PSYCHOL, V148, P163, DOI 10.1016/j.actpsy.2014.01.016; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; CURRIE J, 1995, AM ECON REV, V85, P341; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Hevia MD, 2014, P NATL ACAD SCI USA, V111, P4809, DOI 10.1073/pnas.1323628111; Dehaene S, 2006, SCIENCE, V311, P381, DOI 10.1126/science.1121739; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene Stanislas, 2011, NUMBER SENSE MIND CR, DOI 10.1016/C2010-0-66570-9; DELOACHE JS, 1987, SCIENCE, V238, P1556, DOI 10.1126/science.2446392; Deming D. J., 2015, W21473 NAT BUR EC RE; Deming D, 2009, AM ECON J-APPL ECON, V1, P111, DOI 10.1257/app.1.3.111; Dillon MR, 2015, BRIT J DEV PSYCHOL, V33, P411, DOI 10.1111/bjdp.12118; Dillon MR, 2013, P NATL ACAD SCI USA, V110, P14191, DOI 10.1073/pnas.1312640110; Doherty MJ, 2009, J EXP CHILD PSYCHOL, V104, P296, DOI 10.1016/j.jecp.2009.06.004; Dweck C., 2000, SELF THEORIES THEIR; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2003, DEVELOPMENTAL SCI, V6, P568, DOI 10.1111/1467-7687.00313; Fernald LCH, 2017, DEV PSYCHOL, V53, P222, DOI 10.1037/dev0000185; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Gao XQ, 2009, J EXP CHILD PSYCHOL, V102, P503, DOI 10.1016/j.jecp.2008.11.002; Garces E, 2002, AM ECON REV, V92, P999, DOI 10.1257/00028280260344560; Gelman R., 1978, CHILDS UNDERSTANDING; Gertler P, 2014, SCIENCE, V344, P998, DOI 10.1126/science.1251178; Ginsburg H.P., 2003, TEMA 3 TEST EARLY MA, V3rd ed.; Glewwe P., 2006, HDB EC ED, DOI [10.1016/S1574-0692(06)02016-2, DOI 10.1016/S1574-0692(06)02016-2]; Gliga T, 2012, CHILD DEV, V83, P926, DOI 10.1111/j.1467-8624.2012.01750.x; Griffin S, 1996, MONOGR SOC RES CHILD, V61, P83, DOI 10.1111/j.1540-5834.1996.tb00538.x; Halberda J., 2011, COMPUTER SOFTWARE; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Heckman J. J., 2013, W19656 NAT BUR EC RE; Heckman JJ, 2008, ECON INQ, V46, P289, DOI 10.1111/j.1465-7295.2008.00163.x; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Hurtado N, 2008, DEVELOPMENTAL SCI, V11, pF31, DOI 10.1111/j.1467-7687.2008.00768.x; Huttenlocher J, 1999, PSYCHOL SCI, V10, P393, DOI 10.1111/1467-9280.00175; Hyde DC, 2014, COGNITION, V131, P92, DOI 10.1016/j.cognition.2013.12.007; Izard V, 2011, ATTENTION PERFORM, P319, DOI 10.1016/B978-0-12-385948-8.00019-0; Khanum S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164436; Kline P., 2016, J ECON, V131, P1795; Lauer JE, 2016, PSYCHOL SCI, V27, P1291, DOI 10.1177/0956797616655977; Lourenco SF, 2008, INFANCY, V13, P103, DOI 10.1080/15250000701795572; Martinez S., 2012, PROMISE PRESCHOOL AF, DOI DOI 10.1002/cad.20072; Mix KS, 2016, J EXP PSYCHOL GEN, V145, P1206, DOI 10.1037/xge0000182; Moulson MC, 2015, DEVELOPMENTAL SCI, V18, P298, DOI 10.1111/desc.12217; Muralidharan K., 2016, 22923 NAT BUR EC RES; Muralidharan K., 2017, HDB EC FIELD EXPT, V2, P323, DOI 10.1016/bs.hefe.2016.09.004; Ozler B., 2016, WORLD BANK POLICY RE; Park J, 2016, J EXP CHILD PSYCHOL, V152, P278, DOI 10.1016/j.jecp.2016.07.011; Park J, 2014, COGNITION, V133, P188, DOI 10.1016/j.cognition.2014.06.011; Park J, 2013, PSYCHOL SCI, V24, P2013, DOI 10.1177/0956797613482944; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Scott LS, 2009, PSYCHOL SCI, V20, P676, DOI 10.1111/j.1467-9280.2009.02348.x; Siegler RS, 2009, J EDUC PSYCHOL, V101, P545, DOI 10.1037/a0014239; Siegler RS, 2004, CHILD DEV, V75, P428, DOI 10.1111/j.1467-8624.2004.00684.x; Spelke ES, 2011, ATTENTION PERFORM, P287, DOI 10.1016/B978-0-12-385948-8.00018-9; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; UNESCO, 2015, ED ALL GLOBAL MONITO; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; Uttal DH, 2000, DEVELOPMENTAL SCI, V3, P247, DOI 10.1111/1467-7687.00119; Vagh S, 2010, VALIDATING ASER TEST; Verdine BN, 2014, TRENDS NEUROSCI EDUC, V3, P7, DOI 10.1016/j.tine.2014.02.005; Walker-Andrews A S, 1998, Pediatrics, V102, P1268; Wang JJ, 2016, J EXP CHILD PSYCHOL, V147, P82, DOI 10.1016/j.jecp.2016.03.002; Watts TW, 2018, CHILD DEV, V89, P539, DOI 10.1111/cdev.12713; Winkler-Rhoades N, 2013, DEVELOPMENTAL SCI, V16, P365, DOI 10.1111/desc.12038; World Education Forum, 2015, INCH DECL; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Yoshikawa H, 2015, DEV PSYCHOL, V51, P309, DOI 10.1037/a0038785	80	27	27	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					47	+		10.1126/science.aal4724	http://dx.doi.org/10.1126/science.aal4724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FO5OK	28684518	Green Published			2022-12-28	WOS:000416909500001
J	Faccio, G				Faccio, Greta			Flagging gender bias doesn't always work	NATURE			English	Letter												greta.faccio@gmail.com	Faccio, Greta/B-4815-2013	Faccio, Greta/0000-0003-3655-4235					0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					32	32		10.1038/547032c	http://dx.doi.org/10.1038/547032c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682342	Bronze			2022-12-28	WOS:000404839900020
J	Eberl, F; Gershenzon, J				Eberl, Franziska; Gershenzon, Jonathan			Releasing plant volatiles, as simple as ABC	SCIENCE			English	Editorial Material							LIPIDS; EXPORT		[Eberl, Franziska; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Dept Biochem, D-07745 Jena, Germany	Max Planck Society	Gershenzon, J (corresponding author), Max Planck Inst Chem Ecol, Dept Biochem, D-07745 Jena, Germany.	gershenzon@ice.mpg.de	Eberl, Franziska/AAL-8283-2020; Gershenzon, Jonathan/K-1331-2013	Eberl, Franziska/0000-0003-4097-6975; Gershenzon, Jonathan/0000-0002-1812-1551				Adebesin F, 2017, SCIENCE, V356, P1386, DOI 10.1126/science.aan0826; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dudareva N, 2013, NEW PHYTOL, V198, P16, DOI 10.1111/nph.12145; Junker RR, 2011, J CHEM ECOL, V37, P1323, DOI 10.1007/s10886-011-0043-0; Kessler D, 2010, CURR BIOL, V20, P237, DOI 10.1016/j.cub.2009.11.071; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Widhalm JR, 2015, TRENDS PLANT SCI, V20, P545, DOI 10.1016/j.tplants.2015.06.009	9	2	2	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1334	1335		10.1126/science.aan8291	http://dx.doi.org/10.1126/science.aan8291			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663457				2022-12-28	WOS:000404351500018
J	Graf, M; Bonetti, D; Lockhart, A; Serhal, K; Kellner, V; Maicher, A; Jolivet, P; Teixeira, MT; Luke, B				Graf, Marco; Bonetti, Diego; Lockhart, Arianna; Serhal, Kamar; Kellner, Vanessa; Maicher, Andre; Jolivet, Pascale; Teixeira, Maria Teresa; Luke, Brian			Telomere Length Determines TERRA and R-Loop Regulation through the Cell Cycle	CELL			English	Article							REPEAT-CONTAINING RNA; DNA END-REPLICATION; STRAND BREAK REPAIR; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; SCHIZOSACCHAROMYCES-POMBE; GENOME INTEGRITY; SENESCENCE; HYBRIDS; ELONGATION	Maintenance of a minimal telomere length is essential to prevent cellular senescence. When critically short telomeres arise in the absence of telomerase, they can be repaired by homology-directed repair (HDR) to prevent premature senescence onset. It is unclear why specifically the shortest telomeres are targeted for HDR. We demonstrate that the non-coding RNA TERRA accumulates as HDR-promoting RNA-DNA hybrids (R-loops) preferentially at very short telomeres. The increased level of TERRA and R-loops, exclusively at short telomeres, is due to a local defect in RNA degradation by the Rat1 and RNase H2 nucleases, respectively. Consequently, the coordination of TERRA degradation with telomere replication is altered at shortened telomeres. R-loop persistence at short telomeres contributes to activation of the DNA damage response (DDR) and promotes recruitment of the Rad51 recombinase. Thus, the telomere length-dependent regulation of TERRA and TERRA R-loops is a critical determinant of the rate of replicative senescence.	[Graf, Marco; Bonetti, Diego; Lockhart, Arianna; Kellner, Vanessa; Luke, Brian] Inst Mol Biol, D-55128 Mainz, Germany; [Luke, Brian] Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, D-55099 Mainz, Germany; [Serhal, Kamar; Jolivet, Pascale; Teixeira, Maria Teresa] Univ Paris 06, UPMC, Sorbonne Univ,Inst Biol Phys Chim, UMR8226,Lab Biol Mol & Cellulaire Eucaryotes,CNRS, F-75005 Paris, France; [Maicher, Andre] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Bonetti, Diego] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy	Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; University of Milano-Bicocca	Luke, B (corresponding author), Inst Mol Biol, D-55128 Mainz, Germany.; Luke, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Dev Biol & Neurobiol, Fac Biol, D-55099 Mainz, Germany.	b.luke@imb-mainz.de	Kellner, Vanessa/GWZ-3389-2022; Teixeira, Maria Teresa/A-2100-2011; Kellner, Vanessa/ABB-9789-2020	Kellner, Vanessa/0000-0002-7060-2520; Teixeira, Maria Teresa/0000-0002-9466-7951; Kellner, Vanessa/0000-0002-7060-2520; Bonetti, Diego/0000-0003-4131-8042; Luke, Brian/0000-0002-1648-5511; JOLIVET, Pascale/0000-0002-3896-0598; Maicher, Andre/0000-0002-4593-3678	CancerTelSys in the E:med program of the German Federal Ministry of Education and Research (BMBF) [01ZX1302]; Deutsche Forschungsgemeinschaft (DFG) Heisenberg Program [LU1709/2-1]; German CellNetworks Cluster of Excellence [EXC81]; HBIGS MSc/PhD fellowship; European Research Council [ERC-2010-StG 260906-D-END]; Mairie de Paris (Programme Emergences); Fondation pour la Recherche Medicale [FRM DEQ20160334914]; "Initiative d'Excellence" program from the French State (grant "DYNAMO") [ANR-11-LABX-0011-01]; Lebanese National Council for Scientific Research	CancerTelSys in the E:med program of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG) Heisenberg Program(German Research Foundation (DFG)); German CellNetworks Cluster of Excellence; HBIGS MSc/PhD fellowship; European Research Council(European Research Council (ERC)European Commission); Mairie de Paris (Programme Emergences); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); "Initiative d'Excellence" program from the French State (grant "DYNAMO"); Lebanese National Council for Scientific Research	We thank the Luke and Teixeira lab members and the UMR8226 unit members for support and discussions, the microscopy and media lab core facilities of the IMB, the Chartrand, Foiani, Longhese and the Ulrich Labs for reagents, and Sarah Luke-Glaser for critically reading the manuscript. B.L.'s lab was supported by CancerTelSys (01ZX1302) in the E:med program of the German Federal Ministry of Education and Research (BMBF), the Deutsche Forschungsgemeinschaft (DFG) Heisenberg Program (LU1709/2-1), and by the German CellNetworks Cluster of Excellence (EXC81). A.L. was supported through a DAAD fellowship (57034101). M.G. was supported by an HBIGS MSc/PhD fellowship. M.T.T.'s lab was supported by the European Research Council (ERC-2010-StG 260906-D-END), the Mairie de Paris (Programme Emergences), the Fondation pour la Recherche Medicale (equipe labellisee FRM DEQ20160334914), and the "Initiative d'Excellence" program from the French State (grant "DYNAMO," ANR-11-LABX-0011-01). K.S. was supported by the Lebanese National Council for Scientific Research.	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Arora R, 2015, RNA BIOL, V12, P938, DOI 10.1080/15476286.2015.1065374; Arora R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6220; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Balk B, 2014, RNA BIOL, V11, P95, DOI 10.4161/rna.27798; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Bourgeron T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15326; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chawla R, 2011, EMBO J, V30, P4047, DOI 10.1038/emboj.2011.280; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Clarke DJ, 2001, NAT CELL BIOL, V3, P619, DOI 10.1038/35083009; Cornelio DA, 2017, DNA REPAIR, V52, P110, DOI 10.1016/j.dnarep.2017.02.012; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Epshtein A, 2016, MICROB CELL, V3, P248, DOI 10.15698/mic2016.06.506; Fallet E, 2014, NUCLEIC ACIDS RES, V42, P3648, DOI 10.1093/nar/gkt1328; Feuerhahn S, 2010, FEBS LETT, V584, P3812, DOI 10.1016/j.febslet.2010.07.032; Flynn RL, 2015, SCIENCE, V347, P273, DOI 10.1126/science.1257216; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Houlard M, 2011, CELL CYCLE, V10, P108, DOI 10.4161/cc.10.1.14379; Huang SYN, 2017, EMBO J, V36, P361, DOI 10.15252/embj.201592426; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Hughes T R, 1997, Ciba Found Symp, V211, P41; HUGHES TR, 1997, CIBA F SYMP, V211, P47; HUGHES TR, 1997, CIBA F SYMP, V211, P71; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Kaul Z, 2012, EMBO REP, V13, P52, DOI 10.1038/embor.2011.227; Kim HD, 1999, BIOCHEMISTRY-US, V38, P14697, DOI 10.1021/bi991470c; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Marcand S, 1999, EMBO J, V18, P3509, DOI 10.1093/emboj/18.12.3509; McGee JS, 2010, NAT STRUCT MOL BIOL, V17, P1438, DOI 10.1038/nsmb.1947; Moravec M, 2016, EMBO REP, V17, P999, DOI 10.15252/embr.201541708; Morawska M, 2013, YEAST, V30, P341, DOI 10.1002/yea.2967; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nanavaty V, 2017, NUCLEIC ACIDS RES, V45, P5785, DOI 10.1093/nar/gkx184; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; Pfeiffer V, 2013, EMBO J, V32, P2861, DOI 10.1038/emboj.2013.217; Pfeiffer V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002747; Phillips DD, 2013, J MOL RECOGNIT, V26, P376, DOI 10.1002/jmr.2284; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; Redon S, 2010, NUCLEIC ACIDS RES, V38, P5797, DOI 10.1093/nar/gkq296; Rippe K, 2015, NAT STRUCT MOL BIOL, V22, P853, DOI 10.1038/nsmb.3078; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Sagie S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14015; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Soudet J, 2014, MOL CELL, V53, P954, DOI 10.1016/j.molcel.2014.02.030; Teixeira MT, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00101; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yu TY, 2014, P NATL ACAD SCI USA, V111, P3377, DOI 10.1073/pnas.1307415111	66	145	149	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					72	+		10.1016/j.cell.2017.06.006	http://dx.doi.org/10.1016/j.cell.2017.06.006			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666126	Bronze, Green Published			2022-12-28	WOS:000404358500011
J	Ibrahim, SA				Ibrahim, Said A.			Decision Aids and Elective Joint Replacement - How Knowledge Affects Utilization	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KNEE; HIP		[Ibrahim, Said A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ibrahim, Said A.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Ibrahim, Said A.] Philadelphia VA Med Ctr, Vet Affairs VA Natl Ctr Innovat Hlth Equ Res & Pr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Ibrahim, SA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Ibrahim, SA (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.; Ibrahim, SA (corresponding author), Philadelphia VA Med Ctr, Vet Affairs VA Natl Ctr Innovat Hlth Equ Res & Pr, Philadelphia, PA 19104 USA.							Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Ibrahim SA, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2016.4225; Singh JA, 2014, ANN RHEUM DIS, V73, P2107, DOI 10.1136/annrheumdis-2013-203494; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Vina ER, 2016, CLIN ORTHOP RELAT R, V474, P1755, DOI 10.1007/s11999-016-4834-z	5	7	7	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2509	2511		10.1056/NEJMp1703432	http://dx.doi.org/10.1056/NEJMp1703432			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657869				2022-12-28	WOS:000404259200004
J	Peeters, RP				Peeters, Robin P.			Subclinical Hypothyroidism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMERICAN THYROID ASSOCIATION; PARTICIPANT DATA-ANALYSIS; QUALITY-OF-LIFE; COGNITIVE FUNCTION; FOLLOW-UP; CARDIOVASCULAR HEALTH; SERUM THYROTROPIN; CARDIAC-FUNCTION; CONTROLLED-TRIAL; WHICKHAM SURVEY	A 71-year-old woman reports fatigue and mild depression. She has hypertension and had a myocardial infarction 4 years ago. She has a family history of autoimmune thyroid disease. The physical examination is unremarkable. No thyroid enlargement is present. Laboratory results include normal levels of hemoglobin, creatinine, and calcium and a normal erythrocyte sedimentation rate. The thyrotropin level is 6.9 mIU per liter (reference range, 0.4 to 4.3), whereas the free thyroxine (T-4) level is normal (19 pmol per liter; reference range, 11 to 25). How should she be further evaluated and her symptoms managed?	[Peeters, Robin P.] Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rm D-430,Postbus 2040, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Peeters, RP (corresponding author), Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rm D-430,Postbus 2040, NL-3000 CA Rotterdam, Netherlands.	r.peeters@erasmusmc.nl		Peeters, Robin/0000-0001-7732-9371	IBSA Institut Biochimique; Goodlife Fertility	IBSA Institut Biochimique; Goodlife Fertility	Dr. Peeters reports receiving lecture fees from IBSA Institut Biochimique and Goodlife Fertility. No other potential conflict of interest relevant to this article was reported.	Aghili R, 2012, ARCH MED SCI, V8, P1096, DOI 10.5114/aoms.2012.32423; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; Baldini IM, 1997, PROG NEURO-PSYCHOPH, V21, P925, DOI 10.1016/S0278-5846(97)00089-4; Bano A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38912; Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Blum MR, 2015, JAMA-J AM MED ASSOC, V313, P2055, DOI 10.1001/jama.2015.5161; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Chaker L, 2016, THYROID, V26, P1195, DOI 10.1089/thy.2016.0133; Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438; Chan S, 2015, CLIN ENDOCRINOL, V82, P313, DOI 10.1111/cen.12605; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Correia N, 2009, J CLIN ENDOCR METAB, V94, P3789, DOI 10.1210/jc.2008-2702; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hansen PS, 2004, J CLIN ENDOCR METAB, V89, P2071, DOI 10.1210/jc.2003-031999; Hennessey JV, 2015, J AM GERIATR SOC, V63, P1663, DOI 10.1111/jgs.13532; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Jorde R, 2006, J CLIN ENDOCR METAB, V91, P145, DOI 10.1210/jc.2005-1775; Karmisholt J, 2011, EUR J ENDOCRINOL, V164, P317, DOI 10.1530/EJE-10-1021; Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979; Meier C, 2001, J CLIN ENDOCR METAB, V86, P4860, DOI 10.1210/jc.86.10.4860; Meyerovitch J, 2007, ARCH INTERN MED, V167, P1533, DOI 10.1001/archinte.167.14.1533; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Park YJ, 2010, ARCH GERONTOL GERIAT, V50, pE68, DOI 10.1016/j.archger.2009.05.015; Parle J, 2010, J CLIN ENDOCR METAB, V95, P3623, DOI 10.1210/jc.2009-2571; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2012, ARCH INTERN MED, V172, P811, DOI 10.1001/archinternmed.2012.1159; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Rieben C, 2016, J CLIN ENDOCR METAB, V101, P4945, DOI 10.1210/jc.2016-2129; Roberts LM, 2006, ANN INTERN MED, V145, P573, DOI 10.7326/0003-4819-145-8-200610170-00006; Rodondi N, 2008, J AM COLL CARDIOL, V52, P1152, DOI 10.1016/j.jacc.2008.07.009; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Simonsick EM, 2009, ARCH INTERN MED, V169, P2011, DOI 10.1001/archinternmed.2009.392; Somwaru LL, 2012, J CLIN ENDOCR METAB, V97, P1962, DOI 10.1210/jc.2011-3047; Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696; Stott DJ, 2017, NEW ENGL J MED, V376, P2534, DOI 10.1056/NEJMoa1603825; Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Taylor PN, 2014, JAMA INTERN MED, V174, P32, DOI 10.1001/jamainternmed.2013.11312; van de Ven AC, 2015, THYROID, V25, P629, DOI 10.1089/thy.2014.0574; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; VILLAR HC, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003419.PUB2; Wartofsky L, 2005, J CLIN ENDOCR METAB, V90, P5483, DOI 10.1210/jc.2005-0455; Watt T, 2010, EUR J ENDOCRINOL, V162, P161, DOI 10.1530/EJE-09-0521	49	126	131	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2556	2565		10.1056/NEJMcp1611144	http://dx.doi.org/10.1056/NEJMcp1611144			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657873				2022-12-28	WOS:000404259200009
J	Levin, MD; Chen, TQ; Neubig, ME; Hong, CM; Theulier, CA; Kobylianskii, IJ; Janabi, M; O'Neil, JP; Toste, FD				Levin, Mark D.; Chen, Tiffany Q.; Neubig, Megan E.; Hong, Cynthia M.; Theulier, Cyril A.; Kobylianskii, Ilia J.; Janabi, Mustafa; O'Neil, James P.; Toste, F. Dean			A catalytic fluoride-rebound mechanism for C(sp(3))-CF3 bond formation	SCIENCE			English	Article							FORMING REDUCTIVE ELIMINATION; POSITRON-EMISSION-TOMOGRAPHY; LATE-STAGE; TRIFLUOROMETHYL GROUP; ARYL IODIDES; COMPLEXES; PET; FLUORINATION; GOLD(III); RADIOSYNTHESIS	The biological properties of trifluoromethyl compounds have led to their ubiquity in pharmaceuticals, yet their chemical properties have made their preparation a substantial challenge, necessitating innovative chemical solutions. We report the serendipitous discovery of a borane-catalyzed formal C(sp(3))-CF3 reductive elimination from Au(III) that accesses these compounds by a distinct mechanism proceeding via fluoride abstraction, migratory insertion, and C-F reductive elimination to achieve a net C-C bond construction. The parent bis(trifluoromethyl) Au(III) complexes tolerate a surprising breadth of synthetic protocols, enabling the synthesis of complex organic derivatives without cleavage of the Au-C bond. This feature, combined with the "fluoride-rebound" mechanism, was translated into a protocol for the synthesis of F-18-radiolabeled aliphatic CF3-containing compounds, enabling the preparation of potential tracers for use in positron emission tomography.	[Levin, Mark D.; Chen, Tiffany Q.; Neubig, Megan E.; Hong, Cynthia M.; Theulier, Cyril A.; Kobylianskii, Ilia J.; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Levin, Mark D.; Hong, Cynthia M.; Toste, F. Dean] Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Janabi, Mustafa; O'Neil, James P.] Lawrence Berkeley Natl Lab, Biomed Isotope Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Toste, FD (corresponding author), Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA.; O'Neil, JP (corresponding author), Lawrence Berkeley Natl Lab, Biomed Isotope Lab, Berkeley, CA 94720 USA.	jponeil@lbl.gov; fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198; O'Neil, James/0000-0002-4980-4240; Hong, Cynthia/0000-0002-2563-219X; Levin, Mark/0000-0002-4461-363X; Theulier, Cyril/0000-0003-0376-6557; Chen, Tiffany Q./0000-0001-9096-8856	NSF [DGE 1106400, CHE-0840505]; ARCS Foundation graduate research fellowship; Swiss National Science Foundation; National Institute of General Medical Sciences [R35 GM118190]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118190] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ARCS Foundation graduate research fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NSF grant DGE 1106400 and an ARCS Foundation graduate research fellowship (M.D.L.), a Swiss National Science Foundation postdoctoral fellowship (I.J.K.), and National Institute of General Medical Sciences grant R35 GM118190. DFT studies were conducted at the Molecular Graphics and Computation Facility, funded by NSF grant CHE-0840505. We thank H. Celik, W. Wolf, and L. Sofen for technical assistance; R. Bergman, D. Kaphan, R. Thornbury, M. Winston, Y. Wang, and A. Zhukhovitskiy for helpful discussions; and B. Cwick for facilitating the collaboration that prompted the radiochemical applications of this work. Metrical parameters for the structures of compounds 1a, 1b, 4, 5, 6, 7, 18, S2, and S8 are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC 1537030 to 1537038, respectively, with all other data available in the supplement. M. D. L., J.P.O., and F.D.T. are listed as inventors on a patent application describing Au(III) reagents for radiofluorination, Provisional Application 62/268,842 filed 22 May 2017.	Garcia-Monforte MA, 2012, EUR J INORG CHEM, P4945, DOI 10.1002/ejic.201200620; Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; BARTLETT RR, 1991, AGENTS ACTIONS, V32, P10, DOI 10.1007/BF01983301; Bour JR, 2016, J AM CHEM SOC, V138, P16105, DOI 10.1021/jacs.6b10350; Brooks AF, 2014, CHEM SCI, V5, P4545, DOI 10.1039/c4sc02099e; BROTHERS PJ, 1988, CHEM REV, V88, P1293, DOI 10.1021/cr00089a014; Campbell MG, 2017, NAT CHEM, V9, P1, DOI 10.1038/nchem.2693; Chen EYX, 2000, CHEM REV, V100, P1391, DOI 10.1021/cr980462j; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Choi J, 2011, SCIENCE, V332, P1545, DOI 10.1126/science.1200514; De Vry J, 2004, J PHARMACOL EXP THER, V310, P620, DOI 10.1124/jpet.103.062836; Gil-Rubio J, 2015, DALTON T, V44, P19432, DOI 10.1039/c5dt02023a; Graham TJA, 2014, J AM CHEM SOC, V136, P5291, DOI 10.1021/ja5025645; Harman WD, 1997, CHEM REV, V97, P1953, DOI 10.1021/cr940316n; Hashmi ASK, 2006, EUR J ORG CHEM, V2006, P1387, DOI 10.1002/ejoc.200600009; Herrmann K, 2010, J NUCL MED, V51, DOI 10.2967/jnumed.108.059584; Huang XY, 2014, J AM CHEM SOC, V136, P6842, DOI 10.1021/ja5039819; Huiban M, 2013, NAT CHEM, V5, P941, DOI [10.1038/NCHEM.1756, 10.1038/nchem.1756]; Ivashkin P, 2014, CHEM-EUR J, V20, P9514, DOI 10.1002/chem.201403630; Konovalov AI, 2014, J AM CHEM SOC, V136, P13410, DOI 10.1021/ja507564p; Kumar R, 2015, ANGEW CHEM INT EDIT, V54, P14287, DOI 10.1002/anie.201505533; Laitar DS, 2005, ORGANOMETALLICS, V24, P4503, DOI 10.1021/om050619f; Leclerc MC, 2015, J AM CHEM SOC, V137, P16064, DOI 10.1021/jacs.5b12003; Lee E, 2012, J AM CHEM SOC, V134, P17456, DOI 10.1021/ja3084797; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Liang SH, 2015, AUST J CHEM, V68, P1319, DOI 10.1071/CH15406; Lien VT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/380124; Mankad NP, 2012, CHEM SCI, V3, P72, DOI 10.1039/c1sc00515d; Martinez-Salvador S, 2013, CHEM-EUR J, V19, P14540, DOI 10.1002/chem.201302142; Martinez-Salvador S, 2011, ANGEW CHEM INT EDIT, V50, P6571, DOI 10.1002/anie.201101231; NICHOLAS KM, 1971, TETRAHEDRON LETT, P3475; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; Preshlock S, 2016, CHEM REV, V116, P719, DOI 10.1021/acs.chemrev.5b00493; Rekhroukh F, 2015, ANGEW CHEM INT EDIT, V54, P1266, DOI 10.1002/anie.201409604; Rosillo M, 2007, CHEM SOC REV, V36, P1589, DOI 10.1039/b606665h; Teare H, 2010, ANGEW CHEM INT EDIT, V49, P6821, DOI 10.1002/anie.201002310; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293; van der Born D, 2014, ANGEW CHEM INT EDIT, V53, P11046, DOI 10.1002/anie.201406221; WIEMERS DM, 1986, J AM CHEM SOC, V108, P832, DOI 10.1021/ja00264a043; Winston MS, 2015, J AM CHEM SOC, V137, P7921, DOI 10.1021/jacs.5b04613; Wolf WJ, 2014, NAT CHEM, V6, P159, DOI [10.1038/NCHEM.1822, 10.1038/nchem.1822]; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026	43	64	64	2	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1272	1275		10.1126/science.aan1411	http://dx.doi.org/10.1126/science.aan1411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642435	Green Accepted, Green Submitted			2022-12-28	WOS:000403881700037
J	O'Dowd, A				O'Dowd, Adrian			The only way is up: the "special measures" trust that got back on its feet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com						Care Quality Commission, 2017, DRIV IMPR CAS STUD 8	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2017	357								j2947	10.1136/bmj.j2947	http://dx.doi.org/10.1136/bmj.j2947			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7ZC	28646005				2022-12-28	WOS:000404211100002
J	Ma, GK; Brensinger, CM; Wu, QF; Lewis, JD				Ma, Gene K.; Brensinger, Colleen M.; Wu, Qufei; Lewis, James D.			Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; ECONOMIC BURDEN; HOSPITAL-ONSET; RATES; EPIDEMIOLOGY; MULTICENTER; DISEASE; ADULTS; IMPACT; TERM	Background: Clostridium difficile infection (CDI), the most common health care-associated infection, often recurs. Fecal microbiota transplantation is increasingly used to treat multiply recurrent CDI (mrCDI). Objective: To determine whether the incidence of mrCDI is increasing in proportion to CDI and to identify risk factors for mrCDI. Design: Retrospective cohort study. Setting: United States. Participants: 38 911 718 commercially insured patients in the OptumInsight Clinformatics Database, of whom 45 341 developed CDI. Measurements: Age-and sex-standardized incidence rates for CDI and mrCDI. Results: From 2001 to 2012, the annual incidence of CDI and mrCDI per 1000 person-years increased by 42.7% (from 0.4408 to 0.6289 case) and 188.8% (from 0.0107 to 0.0309 case), respectively. The increase in mrCDI incidence was independent of known risk factors for CDI. Those who developed mrCDI were older (median age, 56.0 vs. 49.0 years; adjusted odds ratio [aOR] per 10-year increase in age, 1.25 [95% CI, 1.21 to 1.29]) and were more likely to be female (63.8% vs. 58.7%; aOR, 1.24 [CI, 1.11 to 1.38]) and to have used antibiotics (72.3% vs. 58.8%; aOR, 1.79 [CI, 1.59 to 2.01]), proton-pump inhibitors (24.6% vs. 18.2%; aOR, 1.14 [CI, 1.01 to 1.29]), or corticosteroids (18.3% vs. 13.7%; aOR, 1.15 [CI, 1.00 to 1.32]) within 90 days of CDI diagnosis. Chronic kidney disease (10.4% vs. 5.6%; aOR, 1.49 [CI, 1.24 to 1.80]) and diagnosis in a nursing home (2.1% vs. 0.6%; aOR, 1.99 [CI, 1.34 to 2.93]) were also associated with increased risk for mrCDI. Limitation: The primary analyses included only commercially insured patients in the United States. Conclusion: Relative to CDI, mrCDI incidence has disproportionately increased, indicating a rising demand for mrCDI therapies.	[Ma, Gene K.; Brensinger, Colleen M.; Wu, Qufei; Lewis, James D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lewis, James D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, 423 Guardian Dr,720 Blockley Hall, Philadelphia, PA 19104 USA; [Ma, Gene K.] Univ Penn, Div Gastroenterol, Dept Med, Perelman Sch Med, 3400 Civ Ctr Blvd,PCAM 7th Floor South Pavil, Philadelphia, PA 19104 USA; [Brensinger, Colleen M.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, 423 Guardian Dr,525 Blockley Hall, Philadelphia, PA 19104 USA; [Wu, Qufei] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, 423 Guardian Dr,509 Blockley Hall, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lewis, JD (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, 423 Guardian Dr,720 Blockley Hall, Philadelphia, PA 19104 USA.	gene.ma@uphs.upenn.edu; cbrensin@uphs.upenn.edu			National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Allergy and Infectious Diseases.	Abou Chakra CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098400; Campbell RJ, 2009, INFECT CONT HOSP EP, V30, P526, DOI 10.1086/597507; Chan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015603; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Deshpande A, 2015, INFECT CONT HOSP EP, V36, P452, DOI 10.1017/ice.2014.88; Drekonja D, 2015, ANN INTERN MED, V162, P630, DOI 10.7326/M14-2693; Dubberke ER, 2008, CLIN INFECT DIS, V46, P497, DOI 10.1086/526530; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Dubberke ER, 2011, CLIN INFECT DIS, V53, P20, DOI 10.1093/cid/cir246; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P1030, DOI 10.1086/656245; Dubberke ER, 2010, INFECT CONT HOSP EP, V31, P262, DOI 10.1086/650447; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Gould CV, 2013, CLIN INFECT DIS, V57, P1304, DOI 10.1093/cid/cit492; Halabi WJ, 2013, J AM COLL SURGEONS, V217, P802, DOI 10.1016/j.jamcollsurg.2013.05.028; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Laffan AM, 2006, J AM GERIATR SOC, V54, P1068, DOI 10.1111/j.1532-5415.2006.00768.x; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Longtin Y, 2013, CLIN INFECT DIS, V56, P67, DOI 10.1093/cid/cis840; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Nanwa N, 2016, INFECT CONT HOSP EP, V37, P1068, DOI 10.1017/ice.2016.122; Olsen MA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1501-7; Petrella LA, 2012, CLIN INFECT DIS, V55, P351, DOI 10.1093/cid/cis430; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Schmiedeskamp M, 2009, INFECT CONT HOSP EP, V30, P1070, DOI 10.1086/606164; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004	29	115	119	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					152	+		10.7326/M16-2733	http://dx.doi.org/10.7326/M16-2733			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28672282				2022-12-28	WOS:000406631400005
J	Miller, TE; Liau, BB; Wallace, LC; Morton, AR; Xie, Q; Dixit, D; Factor, DC; Kim, LJY; Morrow, JJ; Wu, QL; Mack, SC; Hubert, CG; Gillespie, SM; Flavahan, WA; Hoffmann, T; Thummalapalli, R; Hemann, MT; Paddison, PJ; Horbinski, CM; Zuber, J; Scacheri, PC; Bernstein, BE; Tesar, PJ; Rich, JN				Miller, Tyler E.; Liau, Brian B.; Wallace, Lisa C.; Morton, Andrew R.; Xie, Qi; Dixit, Deobrat; Factor, Daniel C.; Kim, Leo J. Y.; Morrow, James J.; Wu, Qiulian; Mack, Stephen C.; Hubert, Christopher G.; Gillespie, Shawn M.; Flavahan, William A.; Hoffmann, Thomas; Thummalapalli, Rohit; Hemann, Michael T.; Paddison, Patrick J.; Horbinski, Craig M.; Zuber, Johannes; Scacheri, Peter C.; Bernstein, Bradley E.; Tesar, Paul J.; Rich, Jeremy N.			Transcription elongation factors represent in vivo cancer dependencies in glioblastoma	NATURE			English	Article							RNA-POLYMERASE-II; CELLS; ENHANCERS; NETWORKS; REVEALS; GENOME; BRD4; SEQ	Glioblastoma is a universally lethal cancer with a median survival time of approximately 15 months(1). Despite substantial efforts to define druggable targets, there are no therapeutic options that notably extend the lifespan of patients with glioblastoma. While previous work has largely focused on in vitro cellular models, here we demonstrate a more physiologically relevant approach to target discovery in glioblastoma. We adapted pooled RNA interference (RNAi) screening technology(2-4) for use in orthotopic patient-derived xenograft models, creating a high-throughput negative-selection screening platform in a functional in vivo tumour microenvironment. Using this approach, we performed parallel in vivo and in vitro screens and discovered that the chromatin and transcriptional regulators needed for cell survival in vivo are non-overlapping with those required in vitro. We identified transcription pause-release and elongation factors as one set of in vivo-specific cancer dependencies, and determined that these factors are necessary for enhancer-mediated transcriptional adaptations that enable cells to survive the tumour microenvironment. Our lead hit, JMJD6, mediates the upregulation of in vivo stress and stimulus response pathways through enhancer-mediated transcriptional pause-release, promoting cell survival specifically in vivo. Targeting JMJD6 or other identified elongation factors extends survival in orthotopic xenograft mouse models, suggesting that targeting transcription elongation machinery may be an effective therapeutic strategy for glioblastoma. More broadly, this study demonstrates the power of in vivo phenotypic screening to identify new classes of 'cancer dependencies' not identified by previous in vitro approaches, and could supply new opportunities for therapeutic intervention.	[Miller, Tyler E.; Wallace, Lisa C.; Morton, Andrew R.; Xie, Qi; Dixit, Deobrat; Kim, Leo J. Y.; Wu, Qiulian; Mack, Stephen C.; Hubert, Christopher G.; Flavahan, William A.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA; [Miller, Tyler E.; Kim, Leo J. Y.; Mack, Stephen C.; Hubert, Christopher G.; Flavahan, William A.; Rich, Jeremy N.] Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44195 USA; [Miller, Tyler E.; Kim, Leo J. Y.; Morrow, James J.] Case Western Reserve Univ, Dept Pathol, Sch Med, Cleveland, OH 44106 USA; [Miller, Tyler E.; Morton, Andrew R.; Factor, Daniel C.; Morrow, James J.; Scacheri, Peter C.; Tesar, Paul J.] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA; [Liau, Brian B.; Gillespie, Shawn M.; Thummalapalli, Rohit; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02114 USA; [Liau, Brian B.; Gillespie, Shawn M.; Thummalapalli, Rohit; Bernstein, Bradley E.] Broad Inst, Epigen Program, Cambridge, MA 02142 USA; [Liau, Brian B.; Gillespie, Shawn M.; Thummalapalli, Rohit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hoffmann, Thomas; Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Hemann, Michael T.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Paddison, Patrick J.] Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; [Horbinski, Craig M.] Northwestern Univ, Feinberg Sch Med, Dept Neurol Surg, Chicago, IL 60611 USA; [Horbinski, Craig M.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60615 USA; [Rich, Jeremy N.] Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92093 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Massachusetts Institute of Technology (MIT); Fred Hutchinson Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Diego	Rich, JN (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Lerner Res Inst, Cleveland, OH 44195 USA.; Rich, JN (corresponding author), Case Western Reserve Univ, Cleveland Clin, Dept Mol Med, Lerner Coll Med, Cleveland, OH 44195 USA.; Tesar, PJ (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA.; Rich, JN (corresponding author), Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92093 USA.	paul.tesar@case.edu; paul.tesar@case.edu; drjeremyrich@gmail.com	Tesar, Paul/GPK-5942-2022; Zuber, Johannes/E-7517-2011; Tesar, Paul J/C-9848-2014; Rich, Jeremy/AAM-1445-2021	Tesar, Paul/0000-0003-1532-3155; Zuber, Johannes/0000-0001-8810-6835; Tesar, Paul J/0000-0003-1532-3155; Morton, Andrew/0000-0002-1234-1676; Gillespie, Shawn/0000-0003-1913-0860; Kim, Leo/0000-0002-1790-9136; Miller, Tyler E/0000-0002-1269-1895; Mack, Stephen C./0000-0001-9620-4742; Dixit, Deobrat/0000-0003-4459-3904; Xie, Qi/0000-0002-2370-2078	Velosano; New York Stem Cell Foundation-Robertson Investigator Award; Goodman family; CIHR; National Institutes of Health [CA183510, GM007250, CA189647, CA154130, CA169117, CA197718, CA171652, NS087913, NS089272]; NATIONAL CANCER INSTITUTE [F32CA189647, F30CA183510, P30CA043703, R01CA169117, R01CA154130, R01CA171652, R35CA197718, F30CA203101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089272, R01NS087913, R01NS103434] Funding Source: NIH RePORTER	Velosano; New York Stem Cell Foundation-Robertson Investigator Award; Goodman family; CIHR(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank the Hemann, Paddison, and Zuber laboratories, along with K. Alazem for technical help with RNAi screening. We thank B. Kristensen and A. M. Rosager for input on histological analysis and A. Saiakhova, E. R. Chan, M. Squatrito and W. Liu for bioinformatic support. Additional support was provided by the Cytometry & Imaging Microscopy and Genomics core facilities of the Case Comprehensive Cancer Center at Cleveland Clinic and Case Western (P30CA043703), respectively. We also thank members of the Rich, Tesar and Scacheri laboratories for input on the project and discussion about the manuscript. This work was supported by Velosano (J.N.R.); New York Stem Cell Foundation-Robertson Investigator Award and philanthropic support from the Goodman family (P.J.T.); CIHR Banting Fellowship (S.C.M.); National Institutes of Health grants CA183510 (T.E.M.); GM007250 (T.E.M., A.R.M., L.J.Y.K., J.J.M.); CA189647 (C.G.H.); CA154130, CA169117, CA197718, CA171652, NS087913 and NS089272 (J.N.R.).	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Gilbert MR, 2014, ACTA NEUROPATHOL, V127, P221, DOI 10.1007/s00401-013-1194-6; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miller TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114433; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Schroder S, 2013, MOL CELL, V52, P314, DOI 10.1016/j.molcel.2013.10.009; Shah S., 2016, CANC IMAGING ARCH; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wan YW, 2016, BIOINFORMATICS, V32, P952, DOI 10.1093/bioinformatics/btv677; Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003; Wu LP, 2014, MOL CELL, V54, P920, DOI 10.1016/j.molcel.2014.04.013; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	39	118	118	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					355	+		10.1038/nature23000	http://dx.doi.org/10.1038/nature23000			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28678782	Green Submitted, Green Accepted			2022-12-28	WOS:000405844900035
J	Ali, SH; Giurco, D; Arndt, N; Nickless, E; Brown, G; Demetriades, A; Durrheim, R; Enriquez, MA; Kinnaird, J; Littleboy, A; Meinert, LD; Oberhansli, R; Salem, J; Schodde, R; Schneider, G; Vidal, O; Yakovleva, N				Ali, Saleem H.; Giurco, Damien; Arndt, Nicholas; Nickless, Edmund; Brown, Graham; Demetriades, Alecos; Durrheim, Ray; Enriquez, Maria Amelia; Kinnaird, Judith; Littleboy, Anna; Meinert, Lawrence D.; Oberhansli, Roland; Salem, Janet; Schodde, Richard; Schneider, Gabi; Vidal, Olivier; Yakovleva, Natalia			Mineral supply for sustainable development requires resource governance (vol 543, pg 367, 2017)	NATURE			English	Correction													Durrheim, Raymond/W-8969-2018; Yakovleva, Natalia/M-1789-2016	Yakovleva, Natalia/0000-0001-5560-3982; Giurco, Damien/0000-0002-1707-9531				Ali SH, 2017, NATURE, V543, P367, DOI 10.1038/nature21359; Northey S, 2014, RESOUR CONSERV RECY, V83, P190, DOI 10.1016/j.resconrec.2013.10.005	2	3	3	4	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					246	246		10.1038/nature22982	http://dx.doi.org/10.1038/nature22982			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28658206	Bronze			2022-12-28	WOS:000405314500045
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Leaving medicine-is the grass always greener?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Kennedy C., 2015, BMJ CAREERS; Rimmer A., 2017, BMJ CAREERS	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 11	2017	358								j3254	10.1136/bmj.j3254	http://dx.doi.org/10.1136/bmj.j3254			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MR	28698306	Bronze, Green Published			2022-12-28	WOS:000405770200001
J	Patorno, E; Glynn, RJ; Levin, R; Lee, MP; Huybrechts, KF				Patorno, Elisabetta; Glynn, Robert J.; Levin, Raisa; Lee, Moa P.; Huybrechts, Krista F.			Benzodiazepines and risk of all cause mortality in adults: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ELIMINATION HALF-LIFE; HYPNOTICS; DRUGS; METAANALYSIS; POPULATION; ANTIDEPRESSANTS; PRESCRIPTIONS; SUICIDALITY; ANXIOLYTICS; FRACTURES	OBJECTIVES To evaluate the risk of all cause mortality associated with initiating compared with not initiating benzodiazepines in adults, and to address potential treatment barriers and confounding related to the use of a non-active comparator group. DESIGN Retrospective cohort study. SETTING Large de-identified US commercial healthcare database (Optum Clinformatics Datamart). PARTICIPANTS 1: 1 high dimensional propensity score matched cohort of benzodiazepine initiators, and randomly selected benzodiazepine non-initiators with a medical visit within 14 days of the start of benzodiazepine treatment (n=1 252 988), between July 2004 and December 2013. To address treatment barriers and confounding, patients were required to have filled one or more prescriptions for any medication in the 90 days and 91-180 days before the index date (ie, the date of starting benzodiazepine treatment for initiators and the date of the selected medical visit for benzodiazepine non-initiators) and the high dimensional propensity score was estimated on the basis of more than 300 covariates. MAIN OUTCOME MEASURE All cause mortality, determined by linkage with the Social Security Administration Death Master File. RESULTS Over a six month follow-up period, 5061 and 4691 deaths occurred among high dimensional propensity score matched benzodiazepine initiators versus non-initiators (9.3 v 9.4 events per 1000 person years; hazard ratio 1.00, 95% confidence interval 0.96 to 1.04). A 4% (95% confidence interval 1% to 8%) to 9% (2% to 7%) increase in mortality risk was observed associated with the start of benzodiazepine treatment for follow-ups of 12 and 48 months and in subgroups of younger patients and patients initiating short acting agents. In secondary analyses comparing 1: 1 high dimensional propensity score matched patients initiating benzodiazepines with an active comparator, ie, patients starting treatment with selective serotonin reuptake inhibitor antidepressants, benzodiazepine use was associated with a 9% (95% confidence interval 3% to 16%) increased risk. CONCLUSIONS This large population based cohort study suggests either no increase or at most a minor increase in risk of all cause mortality associated with benzodiazepine initiation. If a detrimental effect exists, it is likely to be much smaller than previously stated and to have uncertain clinical relevance. Residual confounding likely explains at least part of the small increase in mortality risk observed in selected analyses.	[Patorno, Elisabetta; Glynn, Robert J.; Levin, Raisa; Lee, Moa P.; Huybrechts, Krista F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Patorno, E (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	epatorno@bwh.harvard.edu			Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham; Women's Hospital, Harvard Medical School, Boston, MA; National Institute of Mental Health [K01MH099141]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099141] Funding Source: NIH RePORTER	Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham; Women's Hospital, Harvard Medical School, Boston, MA; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. KFH was supported by a career development grant (K01MH099141) from the National Institute of Mental Health. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bachhuber MA, 2016, AM J PUBLIC HEALTH, V106, P686, DOI 10.2105/AJPH.2016.303061; Belleville G, 2010, CAN J PSYCHIAT, V55, P558, DOI 10.1177/070674371005500904; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Charlson F, 2009, PHARMACOEPIDEM DR S, V18, P93, DOI 10.1002/pds.1694; Cunningham CM, 2010, HEALTH POLICY, V97, P122, DOI 10.1016/j.healthpol.2010.03.008; de Vries OJ, 2013, AGE AGEING, V42, P764, DOI 10.1093/ageing/aft089; Fourrier A, 2001, EUR J CLIN PHARMACOL, V57, P419, DOI 10.1007/s002280100326; Glynn RJ, 2001, EPIDEMIOLOGY, V12, P682, DOI 10.1097/00001648-200111000-00017; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hansen RN, 2015, AM J PUBLIC HEALTH, V105, pE64, DOI 10.2105/AJPH.2015.302723; Hausken AM, 2007, PHARMACOEPIDEM DR S, V16, P913, DOI 10.1002/pds.1417; Hermansen SW, 2009, AM J EPIDEMIOL, V169, P901, DOI 10.1093/aje/kwn404; Hogan David B, 2003, Can J Clin Pharmacol, V10, P72; Huerta C, 2016, PHARMACOEPIDEM DR S, V25, P56, DOI 10.1002/pds.3825; Jaussent I, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-212; Kriegbaum M, 2015, PHARMACOEPIDEM DR S, V24, P779, DOI 10.1002/pds.3745; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Kripke DF, 1998, BIOL PSYCHIAT, V43, P687, DOI 10.1016/S0006-3223(97)00292-8; Madhusoodanan Subramoniam, 2004, Expert Opin Drug Saf, V3, P485, DOI 10.1517/14740338.3.5.485; Mallon L, 2002, J INTERN MED, V251, P207, DOI 10.1046/j.1365-2796.2002.00941.x; Mallon L, 2009, SLEEP MED, V10, P279, DOI 10.1016/j.sleep.2008.12.004; Martin JLR, 2007, J PSYCHOPHARMACOL, V21, P774, DOI 10.1177/0269881107077355; Mihic S, 2011, GOODMAN GILMANS PHAR; Neutel CI, 2015, EUR J CLIN PHARMACOL, V71, P637, DOI 10.1007/s00228-015-1841-z; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Palmaro A, 2015, EUR NEUROPSYCHOPHARM, V25, P1566, DOI 10.1016/j.euroneuro.2015.07.006; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; Requena G, 2016, PHARMACOEPIDEM DR S, V25, P66, DOI 10.1002/pds.3816; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; RUMBLE R, 1992, J AM GERIATR SOC, V40, P787, DOI 10.1111/j.1532-5415.1992.tb01850.x; Schisterman Enrique F, 2004, Popul Health Metr, V2, P2, DOI 10.1186/1478-7954-2-2; Social Security Administration, 2013, SOC SEC DEATH MAST F; Sonnenberg CM, 2012, SOC PSYCH PSYCH EPID, V47, P293, DOI 10.1007/s00127-011-0344-1; Stone M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2880; THOROGOOD M, 1992, LANCET, V340, P1067, DOI 10.1016/0140-6736(92)93081-W; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Uhlenhuth EH, 1999, J CLIN PSYCHOPHARM, V19, p23S, DOI 10.1097/00004714-199912002-00005; VanBalkom AJLM, 1997, J NERV MENT DIS, V185, P510, DOI 10.1097/00005053-199708000-00006; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Vinkers DJ, 2003, JAMA-J AM MED ASSOC, V290, P2942, DOI 10.1001/jama.290.22.2942; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Weich S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1996	47	45	45	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j2941	10.1136/bmj.j2941	http://dx.doi.org/10.1136/bmj.j2941			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA3DO	28684397	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000405322300004
J	Elmore, JG; Barnhill, RL; Elder, DE; Longton, GM; Pepe, MS; Reisch, LM; Carney, PA; Titus, LJ; Nelson, HD; Onega, T; Tosteson, ANA; Weinstock, MA; Knezevich, SR; Piepkorn, MW				Elmore, Joann G.; Barnhill, Raymond L.; Elder, David E.; Longton, Gary M.; Pepe, Margaret S.; Reisch, Lisa M.; Carney, Patricia A.; Titus, Linda J.; Nelson, Heidi D.; Onega, Tracy; Tosteson, Anna N. A.; Weinstock, Martin A.; Knezevich, Stevan R.; Piepkorn, Michael W.			Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CUTANEOUS MALIGNANT-MELANOMA; HISTOPATHOLOGIC DIAGNOSIS; INTEROBSERVER VARIABILITY; PROGNOSTIC PARAMETERS; CLARK LEVEL; NEVI; CLASSIFICATION; DISCORDANCE; RELIABILITY; LESIONS	OBJECTIVE To quantify the accuracy and reproducibility of pathologists' diagnoses of melanocytic skin lesions. DESIGN Observer accuracy and reproducibility study. SETTING 10 US states. PARTICIPANTS Skin biopsy cases (n= 240), grouped into sets of 36 or 48. Pathologists from 10 US states were randomized to independently interpret the same set on two occasions (phases 1 and 2), at least eight months apart. MAIN OUTCOME MEASURES Pathologists' interpretations were condensed into five classes: I (eg, nevus or mild atypia); II (eg, moderate atypia); III (eg, severe atypia or melanoma in situ); IV (eg, pathologic stage T1a (pT1a) early invasive melanoma); and V (eg, >= pT1b invasive melanoma). Reproducibility was assessed by intraobserver and interobserver concordance rates, and accuracy by concordance with three reference diagnoses. RESULTS In phase 1, 187 pathologists completed 8976 independent case interpretations resulting in an average of 10 (SD 4) different diagnostic terms applied to each case. Among pathologists interpreting the same cases in both phases, when pathologists diagnosed a case as class I or class V during phase 1, they gave the same diagnosis in phase 2 for the majority of cases (class I 76.7%; class V 82.6%). However, the intraobserver reproducibility was lower for cases interpreted as class II (35.2%), class III (59.5%), and class IV (63.2%). Average interobserver concordance rates were lower, but with similar trends. Accuracy using a consensus diagnosis of experienced pathologists as reference varied by class: I, 92% (95% confidence interval 90% to 94%); II, 25% (22% to 28%); III, 40% (37% to 44%); IV, 43% (39% to 46%); and V, 72% (69% to 75%). It is estimated that at a population level, 82.8% (81.0% to 84.5%) of melanocytic skin biopsy diagnoses would have their diagnosis verified if reviewed by a consensus reference panel of experienced pathologists, with 8.0% (6.2% to 9.9%) of cases overinterpreted by the initial pathologist and 9.2% (8.8% to 9.6%) underinterpreted. CONCLUSION Diagnoses spanning moderately dysplastic nevi to early stage invasive melanoma were neither reproducible nor accurate in this large study of pathologists in the USA. Efforts to improve clinical practice should include using a standardized classification system, acknowledging uncertainty in pathology reports, and developing tools such as molecular markers to support pathologists' visual assessments.	[Elmore, Joann G.; Reisch, Lisa M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA; [Barnhill, Raymond L.] Univ Paris 05, Fac Med Univ, Inst Curie Inst Hosp, Dept Pathol, Paris, France; [Elder, David E.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Longton, Gary M.; Pepe, Margaret S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Biostat, 1124 Columbia St, Seattle, WA 98104 USA; [Carney, Patricia A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Titus, Linda J.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH USA; [Titus, Linda J.] Norris Cotton Canc Ctr, Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Sch Med, Dept Med Informat, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Sch Med, Dept Clin Epidemiol, Portland, OR 97201 USA; [Nelson, Heidi D.] Oregon Hlth & Sci Univ, Sch Med, Dept Med, Portland, OR 97201 USA; [Nelson, Heidi D.] Providence Hlth & Serv, Providence Canc Ctr, Providence, OR USA; [Onega, Tracy] Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH USA; [Onega, Tracy] Norris Cotton Canc Ctr, Dept Epidemiol, Dept Biomed Data Sci, Lebanon, NH USA; [Tosteson, Anna N. A.] Norris Cotton Canc, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Dept Med, Lebanon, NH USA; [Tosteson, Anna N. A.] Norris Cotton Canc, Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Dept Community & Family Med, Lebanon, NH USA; [Weinstock, Martin A.] Providence VA Med Ctr, Ctr Dermatoepidemiol, Providence, RI USA; [Weinstock, Martin A.] Brown Univ, Dept Dermatol, Providence, RI 02912 USA; [Weinstock, Martin A.] Brown Univ, Dept Epidemiol, Providence, RI 02912 USA; [Knezevich, Stevan R.] Pathol Associates Inc, Clovis, CA USA; [Piepkorn, Michael W.] Univ Washington, Sch Med, Dept Med, Div Dermatol, Seattle, WA 98195 USA; [Piepkorn, Michael W.] Dermatopathol Northwest, Bellevue, WA USA	University of Washington; University of Washington Seattle; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; University of Pennsylvania; Pennsylvania Medicine; Fred Hutchinson Cancer Center; Oregon Health & Science University; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; University of Washington; University of Washington Seattle	Elmore, JG (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98104 USA.	jelmore@uw.edu			National Cancer Institute [R01 CA151306, R01 CA201376, K05 CA104699]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA151306, R01 CA201376 and K05 CA104699). The funding agency had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	American Medical Association, 2011, PHYS SEC PHYS; [Anonymous], 2015, IMPR DIAGN HLTH CAR; Attanoos RL, 1996, J CLIN PATHOL, V49, P79, DOI 10.1136/jcp.49.1.79; Barnhill RL, 1999, HUM PATHOL, V30, P513, DOI 10.1016/S0046-8177(99)90193-4; Boiko P E, 1994, J Am Board Fam Pract, V7, P371; Braun RP, 2012, DERMATOLOGY, V224, P51, DOI 10.1159/000336886; Brochez L, 2002, J PATHOL, V196, P459, DOI 10.1002/path.1061; Carli P, 1998, EUR J CANCER PREV, V7, P397, DOI 10.1097/00008469-199810000-00005; Carney PA, 2016, J CUTAN PATHOL, V43, P830, DOI 10.1111/cup.12751; Carney PA, 2016, J AM ACAD DERMATOL, V74, P317, DOI 10.1016/j.jaad.2015.09.037; COLLOBY PS, 1991, J PATHOL, V163, P245, DOI 10.1002/path.1711630310; Cook MG, 1996, HISTOPATHOLOGY, V28, P497, DOI 10.1046/j.1365-2559.1996.d01-464.x; Cook MG, 1997, J CLIN PATHOL, V50, P202; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Dalkey NC, 1969, DELPHI METHOD 3 USE; Delbanco T, 2012, ANN INTERN MED, V157, P461, DOI 10.7326/0003-4819-157-7-201210020-00002; DUNCAN LM, 1993, J INVEST DERMATOL, V100, pS318, DOI 10.1111/1523-1747.ep12470215; DURAY PH, 1992, J AM ACAD DERMATOL, V27, P741, DOI 10.1016/0190-9622(92)70248-E; Edge SB., 2010, AJCC CANC STAGING MA; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; ELMORE JG, 1992, J CLIN EPIDEMIOL, V45, P567, DOI 10.1016/0895-4356(92)90128-A; Elmore JG, 2016, ANN INTERN MED, V164, P649, DOI 10.7326/M15-0964; Elmore JG, 2015, JAMA-J AM MED ASSOC, V313, P1122, DOI 10.1001/jama.2015.1405; Eriksson H, 2013, ACTA DERM-VENEREOL, V93, P411, DOI 10.2340/00015555-1517; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; FEINSTEIN AR, 1963, NEW ENGL J MED, V269, P929, DOI 10.1056/NEJM196310312691801; FEINSTEIN AR, 1985, J CHRON DIS, V38, P619, DOI 10.1016/0021-9681(85)90016-5; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; Galloway Malcolm, 2011, Patholog Res Int, V2011, P656079, DOI 10.4061/2011/656079; Gaudi S, 2013, J AM ACAD DERMATOL, V68, P119, DOI 10.1016/j.jaad.2012.06.034; Gerami P, 2014, AM J SURG PATHOL, V38, P934, DOI 10.1097/PAS.0000000000000198; Gordon GH, 2000, PATIENT EDUC COUNS, V40, P59, DOI 10.1016/S0738-3991(99)00069-5; HEENAN PJ, 1984, HISTOPATHOLOGY, V8, P717, DOI 10.1111/j.1365-2559.1984.tb02388.x; Knezevich SR, 2014, J AM ACAD DERMATOL, V71, P1204, DOI 10.1016/j.jaad.2014.07.056; KRIEGER N, 1994, J CLIN EPIDEMIOL, V47, P897, DOI 10.1016/0895-4356(94)90193-7; LOCKANDERSEN J, 1995, SCAND J PLAST RECONS, V29, P141, DOI 10.3109/02844319509034330; Lott JP, 2016, J AM ACAD DERMATOL, V75, P356, DOI 10.1016/j.jaad.2016.04.052; Lott JP, 2015, JAMA DERMATOL, V151, P477, DOI 10.1001/jamadermatol.2014.4362; McCullough BJ, 2012, RADIOLOGY, V262, P941, DOI 10.1148/radiol.11110618; Meyer LJ, 1996, J AM ACAD DERMATOL, V34, P618, DOI 10.1016/S0190-9622(96)80061-2; Murali R, 2009, ANN SURG, V249, P641, DOI 10.1097/SLA.0b013e31819ed973; Niebling MG, 2014, ANN SURG ONCOL, V21, P2245, DOI 10.1245/s10434-014-3682-x; Onega T, 2016, J DIGIT IMAGING, V29, P243, DOI 10.1007/s10278-015-9836-y; Patrawala S, 2016, J AM ACAD DERMATOL, V74, P75, DOI 10.1016/j.jaad.2015.09.008; Piepkorn MW, 2014, J AM ACAD DERMATOL, V70, P131, DOI 10.1016/j.jaad.2013.07.027; PIEPKORN MW, 1994, J AM ACAD DERMATOL, V30, P707, DOI 10.1016/S0190-9622(08)81499-5; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Scolyer RA, 2003, AM J SURG PATHOL, V27, P1571, DOI 10.1097/00000478-200312000-00011; Shain AH, 2016, NAT REV CANCER, V16, P345, DOI 10.1038/nrc.2016.37; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Shoo BA, 2010, J AM ACAD DERMATOL, V62, P751, DOI 10.1016/j.jaad.2009.09.043; Spatz A, 2003, EUR J CANCER, V39, P1861, DOI 10.1016/S0959-8049(03)00325-3; Swerlick RA, 1996, ARCH DERMATOL, V132, P881, DOI 10.1001/archderm.132.8.881; Wechsler J, 2002, ARCH DERMATOL, V138, P625, DOI 10.1001/archderm.138.5.625; Weinstock MA, 1997, ARCH DERMATOL, V133, P953, DOI 10.1001/archderm.133.8.953; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0	56	198	200	3	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2017	357								j2813	10.1136/bmj.j2813	http://dx.doi.org/10.1136/bmj.j2813			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AT	28659278	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000404724400002
J	Qiu, J				Qiu, Jane			East Africa turmoil imperils giraffes	SCIENCE			English	News Item									[Qiu, Jane] Samburu Natl Pk, Kenya, Kenya		Qiu, J (corresponding author), Samburu Natl Pk, Kenya, Kenya.								0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1220	1221		10.1126/science.356.6344.1220	http://dx.doi.org/10.1126/science.356.6344.1220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642388				2022-12-28	WOS:000403881700011
J	Stoddard, MC; Yong, EH; Akkaynak, D; Sheard, C; Tobias, JA; Mahadevan, L				Stoddard, Mary Caswell; Yong, Ee Hou; Akkaynak, Derya; Sheard, Catherine; Tobias, Joseph A.; Mahadevan, L.			Avian egg shape: Form, function, and evolution	SCIENCE			English	Article							BIRDS EGGS; DINOSAUR; ADAPTATIONS; MODELS	Avian egg shape is generally explained as an adaptation to life history, yet we currently lack a global synthesis of how egg-shape differences arise and evolve. Here, we apply morphometric, mechanistic, and macroevolutionary analyses to the egg shapes of 1400 bird species. We characterize egg-shape diversity in terms of two biologically relevant variables, asymmetry and ellipticity, allowing us to quantify the observed morphologies in a two-dimensional morphospace. We then propose a simple mechanical model that explains the observed egg-shape diversity based on geometric and material properties of the egg membrane. Finally, using phylogenetic models, we show that egg shape correlates with flight ability on broad taxonomic scales, suggesting that adaptations for flight may have been critical drivers of egg-shape variation in birds.	[Stoddard, Mary Caswell] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Yong, Ee Hou] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, Singapore 637371, Singapore; [Akkaynak, Derya] Univ Haifa, Leon S Charney Sch Marine Sci, Dept Marine Technol, Hafia, Israel; [Akkaynak, Derya] Interuniv Inst Marine Sci, Elat, Israel; [Sheard, Catherine] Univ Bristol, Dept Archaeol & Anthropol, 43 Woodland Rd, Bristol BS8 1UU, Avon, England; [Tobias, Joseph A.] Imperial Coll London, Dept Life Sci, Silwood Pk,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Kavli Inst Bionano Sci & Technol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Kavli Inst Bionano Sci & Technol, Dept Phys, Cambridge, MA 02138 USA; [Mahadevan, L.] Harvard Univ, Paulson Sch Engn & Appl Sci, Kavli Inst Bionano Sci & Technol, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Princeton University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Haifa; University of Bristol; Imperial College London; Harvard University; Harvard University; Harvard University	Stoddard, MC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.; Mahadevan, L (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Kavli Inst Bionano Sci & Technol, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.; Mahadevan, L (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Kavli Inst Bionano Sci & Technol, Dept Phys, Cambridge, MA 02138 USA.; Mahadevan, L (corresponding author), Harvard Univ, Paulson Sch Engn & Appl Sci, Kavli Inst Bionano Sci & Technol, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	mstoddard@princeton.edu; lmahadev@g.harvard.edu	Yong, Ee Hou/AAF-2074-2019; Akkaynak, Derya/HGA-1726-2022	Yong, Ee Hou/0000-0002-4583-4071; Sheard, Catherine/0000-0002-8259-1275; Akkaynak, Derya/0000-0002-6269-4795; Tobias, Joseph/0000-0003-2429-6179	Princeton University; L'Oreal USA For Women in Science Fellowship; L'Oreal-UNESCO International Rising Talents Fellowship; Harvard Society of Fellows; Milton Fund; Nanyang Technological University, Singapore [M4081583]; Oxford Clarendon Fund; U.S.-U.K. Fulbright Commission; Natural Environment Research Council [NE/I028068/1]; MacArthur Foundation; Radcliffe Institute; Museum of Vertebrate Zoology, Berkeley - NSF [0646475]; NERC [NE/I028068/1] Funding Source: UKRI	Princeton University(Princeton University); L'Oreal USA For Women in Science Fellowship; L'Oreal-UNESCO International Rising Talents Fellowship; Harvard Society of Fellows; Milton Fund; Nanyang Technological University, Singapore(Nanyang Technological University); Oxford Clarendon Fund; U.S.-U.K. Fulbright Commission; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MacArthur Foundation; Radcliffe Institute; Museum of Vertebrate Zoology, Berkeley - NSF; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	M.C.S. was supported by Princeton University, with additional support from the L'Oreal USA For Women in Science Fellowship, the L'Oreal-UNESCO International Rising Talents Fellowship, the Harvard Society of Fellows, and the Milton Fund. E.H.Y. was supported by Start-Up Grant no. M4081583 from Nanyang Technological University, Singapore. C.S. was supported by the Oxford Clarendon Fund and the U.S.-U.K. Fulbright Commission. Collection of biometric, life history, and environmental data was supported by a Natural Environment Research Council grant (NE/I028068/1) to J.A.T. L.M. was supported by fellowships from the MacArthur Foundation and the Radcliffe Institute. We thank H. Eyster, D. Swindlehurst, and J. Damore for contributing to data collection; C. Cicero and R. Bowie for specimen access, including digitization of the egg collection at the Museum of Vertebrate Zoology, Berkeley (funded by NSF grant 0646475); and the referees for valuable comments. Egg-shape data reported in this paper are included in the supplementary materials. This study was conceived by M.C.S. and L.M. and designed by M.C.S., J.A.T., and L.M.. The digital morphometric analyses and coding were conducted by M.C.S., E.H.Y., and D.A. M.C.S., C.S., and J.A.T. compiled biometric, life history, and environmental data for birds. The phylogenetic comparative analyses were led by C.S. and J.A.T. L.M. linked the projective geometry parameters to the asymmetry-ellipticity morphospace, and L.M. and E.H.Y. constructed and solved the mathematical model for egg shape. M.C.S., J.A.T., and L.M. coordinated the research, and all authors contributed to writing of the manuscript.	Baker DE, 2002, AUK, V119, P1179, DOI 10.1642/0004-8038(2002)119[1179:AGMFDS]2.0.CO;2; BALCH D. A., 1964, BRIT POULTRY SCI, V5, P201, DOI 10.1080/00071666408415533; Barta Z, 1997, FUNCT ECOL, V11, P656, DOI 10.1046/j.1365-2435.1997.00136.x; Birkhead T.R., 2016, MOST PERFECT THING I; Birkhead TR, 2017, IBIS, V159, P255, DOI 10.1111/ibi.12458; BRADFIELD JRG, 1951, J EXP BIOL, V28, P125; Claramunt S, 2012, P ROY SOC B-BIOL SCI, V279, P1567, DOI 10.1098/rspb.2011.1922; Deeming D. C., 2014, SOC OPEN SCI, V1; Evans E.A., 1980, MECH THERMODYNAMICS; Goriely A, 2003, J THEOR BIOL, V222, P211, DOI 10.1016/S0022-5193(03)00029-8; Gosler AG, 2005, ECOL LETT, V8, P1105, DOI 10.1111/j.1461-0248.2005.00816.x; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Hauber ME, 2014, THE BOOK OF EGGS; Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985; Hutchinson JMC, 2000, BIOL J LINN SOC, V70, P161, DOI 10.1111/j.1095-8312.2000.tb00206.x; Iverson J.B., 1991, P87, DOI 10.1017/CBO9780511585739.008; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Lopez-Martinez N, 2012, PALAEONTOLOGY, V55, P325, DOI 10.1111/j.1475-4983.2011.01114.x; Mallock A, 1925, NATURE, V116, P311, DOI 10.1038/116311a0; Mao KM, 2006, ZOOL SCI, V23, P41, DOI 10.2108/zsj.23.41; Okabe J., 1952, REP RES I APPL MECH, V1, P7; Preston F. W., 1953, Auk, V70, P160; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Smart I.H.M., 1991, P101, DOI 10.1017/CBO9780511585739.009; SMITH NG, 1966, IBIS, V108, P68, DOI 10.1111/j.1474-919X.1966.tb07252.x; Thompson D. W., 1917, GROWTH FORM; Zelenitsky Darla K., 2006, Journal of the Paleontological Society of Korea, V22, P209; Zheng XT, 2013, NATURE, V495, P507, DOI 10.1038/nature11985	31	106	110	12	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1249	+		10.1126/science.aaj1945	http://dx.doi.org/10.1126/science.aaj1945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642430	Green Submitted			2022-12-28	WOS:000403881700032
J	Lagergren, J; Smyth, E; Cunningham, D; Lagergren, P				Lagergren, Jesper; Smyth, Elizabeth; Cunningham, David; Lagergren, Pernilla			Oesophageal cancer	LANCET			English	Review							QUALITY-OF-LIFE; SQUAMOUS-CELL CARCINOMA; PHASE-III TRIAL; ADVANCED GASTRIC-CANCER; ENDOSCOPIC RADIOFREQUENCY ABLATION; LONG-LASTING DETERIORATION; SHOWS CLINICALLY RELEVANT; GENOME-WIDE ASSOCIATION; OPEN-LABEL; BARRETTS-ESOPHAGUS	Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary approach. Extensive treatment might be associated with a considerable decline in health-related quality of life and yet still a poor prognosis. In recent decades, prognosis has gradually improved in many countries. Endoscopic procedures have increasingly been used in the treatment of premalignant and early oesophageal tumours. Neoadjuvant therapy with chemotherapy or chemoradiotherapy has supplemented surgery as standard treatment of locally advanced oesophageal cancer. Surgery has become more standardised and centralised. Several therapeutic alternatives are available for palliative treatment. This Seminar aims to provide insights into the current clinical management, ongoing controversies, and future needs in oesophageal cancer.	[Lagergren, Jesper] Kings Coll London, Guys & St Thomas NHS Fdn Trust, Div Canc Studies, London SE1 1UL, England; [Lagergren, Jesper] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden; [Lagergren, Pernilla] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Surg Care Sci, Stockholm, Sweden; [Smyth, Elizabeth; Cunningham, David] Royal Marsden NHS Fdn Trust, Dept Gastrointestinal Oncol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Royal Marsden NHS Foundation Trust	Lagergren, J (corresponding author), Kings Coll London, Guys & St Thomas NHS Fdn Trust, Div Canc Studies, London SE1 1UL, England.	jesper.lagergren@kcl.ac.uk		Cunningham, David/0000-0001-5158-1069	Swedish Research Council [839-2008-7496]; Swedish Cancer Society [CAN 2015/460]; National Institute for Health Research; Institute for Cancer Research Biomedical Research Centre; Karolinska Institutet Distinguished Professor Award [D-02418/2010]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); National Institute for Health Research(National Institute for Health Research (NIHR)); Institute for Cancer Research Biomedical Research Centre; Karolinska Institutet Distinguished Professor Award	This study was funded by grants from the Swedish Research Council (839-2008-7496) and the Swedish Cancer Society (CAN 2015/460). DC and ES received funding from the National Institute for Health Research and Institute for Cancer Research Biomedical Research Centre. JL received the Karolinska Institutet Distinguished Professor Award (D-02418/2010).	Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Al-Batran SE, 2017, AM SOC CLIN ONC ANN; Alderson D, 2015, ASCO ANN M CHIC IL M; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Anandavadivelan P, 2016, NAT REV CLIN ONCOL, V13, P185, DOI 10.1038/nrclinonc.2015.200; Anderegg MCJ, 2016, ANN SURG, V264, P847, DOI 10.1097/SLA.0000000000001767; [Anonymous], 2017, DOSE ESCALATED INTEN; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bancewicz J, 2002, LANCET, V359, P1727; Bang YJ, 2010, LANCET, V376, P1302; Barlow R, 2011, CLIN NUTR, V30, P560, DOI 10.1016/j.clnu.2011.02.006; Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; Benaglia T, 2013, GASTROENTEROLOGY, V144, P62, DOI 10.1053/j.gastro.2012.09.060; Bergman JJGHM, 2011, GASTROINTEST ENDOSC, V74, P1181, DOI 10.1016/j.gie.2011.05.024; Biere SSAY, 2012, LANCET, V379, P1887, DOI 10.1016/S0140-6736(12)60516-9; Blazeby JM, 2005, CANCER-AM CANCER SOC, V103, P1791, DOI 10.1002/cncr.20980; Blazeby JM, 2003, EUR J CANCER, V39, P1384, DOI 10.1016/S0959-8049(03)00270-3; Boniface MM, 2016, CANCER MANAG RES, V8, P39, DOI 10.2147/CMAR.S101169; Bosetti C, 2006, ORAL ONCOL, V42, P957, DOI 10.1016/j.oraloncology.2006.03.007; Bowrey DJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1053-y; Brierley J.D., 2016, TNM CLASSIFICATION M, Veighth; Briez N, 2012, BRIT J SURG, V99, P1547, DOI 10.1002/bjs.8931; Brusselaers N, 2014, GUT, V63, P1393, DOI 10.1136/gutjnl-2013-306074; Buas MF, 2017, GUT, V66, P1739, DOI 10.1136/gutjnl-2016-311622; Carney Adam, 2015, Anesthesiol Clin, V33, P143, DOI 10.1016/j.anclin.2014.11.009; Chadwick G, 2016, BRIT J SURG, V103, P544, DOI 10.1002/bjs.10116; Chan DSY, 2013, BRIT J SURG, V100, P456, DOI 10.1002/bjs.9015; Chen YW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1185-1; Chou I, 2004, J CLIN ONCOL, V22, P2395, DOI 10.1200/JCO.2004.08.154; Conroy T, 2014, LANCET ONCOL, V15, P305, DOI 10.1016/S1470-2045(14)70028-2; Cools-Lartigue J, 2015, ANN SURG ONCOL, V22, P1858, DOI 10.1245/s10434-014-4270-9; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Dai YX, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005048.pub4; Davies AR, 2014, BRIT J SURG, V101, P511, DOI 10.1002/bjs.9456; Davies AR, 2014, J CLIN ONCOL, V32, P2983, DOI 10.1200/JCO.2014.55.9070; Derogar M, 2013, J CLIN ONCOL, V31, P551, DOI 10.1200/JCO.2012.46.1517; Derogar M, 2012, J CLIN ONCOL, V30, P1615, DOI 10.1200/JCO.2011.40.3568; Djarv T, 2010, J CLIN ONCOL, V28, P1666, DOI 10.1200/JCO.2009.23.5143; Djarv T, 2009, J CLIN ONCOL, V27, P1963, DOI 10.1200/JCO.2008.20.5864; Doi T, 2016, GASTR CANC S SAN FRA, P4046; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Ek WE, 2016, INT J CANCER, V138, P1146, DOI 10.1002/ijc.29863; Findlay JM, 2015, BRIT J SURG, V102, P1488, DOI 10.1002/bjs.9905; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Gaur P, 2016, ONCOTARGET, V7, P48644, DOI 10.18632/oncotarget.8777; Gavin AT, 2012, CANCER EPIDEMIOL, V36, P505, DOI 10.1016/j.canep.2012.07.009; Gharahkhani P, 2016, LANCET ONCOL, V17, P1363, DOI 10.1016/S1470-2045(16)30240-6; Guo HM, 2014, WORLD J GASTROENTERO, V20, P5540, DOI 10.3748/wjg.v20.i18.5540; Haidry RJ, 2015, GUT, V64, P1192, DOI 10.1136/gutjnl-2014-308501; Haisley KR, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2743; Hauser C, 2015, DIS ESOPHAGUS, V28, P652, DOI 10.1111/dote.12257; He S, 2015, ENDOSCOPY, V47, P398, DOI 10.1055/s-0034-1391285; Heneghan HM, 2015, ANN SURG, V262, P803, DOI 10.1097/SLA.0000000000001445; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hironaka S, 2013, J CLIN ONCOL, V31, P4438, DOI 10.1200/JCO.2012.48.5805; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Hu YN, 2016, ANN SURG, V263, P719, DOI 10.1097/SLA.0000000000001387; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Jacobs M, 2014, QUAL LIFE RES, V23, P1155, DOI 10.1007/s11136-013-0576-5; Jacobs M, 2014, QUAL LIFE RES, V23, P1097, DOI 10.1007/s11136-013-0545-z; Janjigian YY, 2016, J CLIN ONCOL, V34, P401, DOI 10.1200/JCO.2015.64.2892; Kang JH, 2012, J CLIN ONCOL, V30, P1513, DOI 10.1200/JCO.2011.39.4585; Kidane B, 2017, EUR J CARDIO-THORAC, V51, P148, DOI 10.1093/ejcts/ezw264; Kidane B, 2016, J THORAC CARDIOV SUR, V151, P1571, DOI 10.1016/j.jtcvs.2016.01.052; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Klevebro F, 2016, ANN ONCOL, V27, P660, DOI 10.1093/annonc/mdw010; Kumar S, 2015, ANN SURG, V262, P981, DOI 10.1097/SLA.0000000000001101; Lagarde SM, 2010, ANN THORAC SURG, V89, P1319, DOI 10.1016/j.athoracsur.2009.09.062; Lagergren J, 2016, JAMA SURG, V151, P32, DOI 10.1001/jamasurg.2015.2611; Lagergren J, 2013, CA-CANCER J CLIN, V63, P232, DOI 10.3322/caac.21185; Lagergren J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6280; Lagergren K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138738; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Le Roy B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012876; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Lee RT, 2015, ANN ONCOL, V26, P1838, DOI 10.1093/annonc/mdv207; Liu J, 2013, INT J CANCER, V133, P473, DOI 10.1002/ijc.28024; Lordick F, 2016, ANN ONCOL, V27, pv50, DOI 10.1093/annonc/mdw329; Lordick F, 2007, LANCET ONCOL, V8, P797, DOI 10.1016/S1470-2045(07)70244-9; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Maret-Ouda J, 2016, CANCER PREV RES, V9, P828, DOI 10.1158/1940-6207.CAPR-16-0170; Mariette C, 2015, J AM COLL SURGEONS, V220, P287, DOI 10.1016/j.jamcollsurg.2014.11.028; Mariette C, 2014, J CLIN ONCOL, V32, P2416, DOI 10.1200/JCO.2013.53.6532; Markar S, 2015, J CLIN ONCOL, V33, P3866, DOI 10.1200/JCO.2014.59.9092; Markar SR, 2016, J CLIN ONCOL, V34, P1528, DOI 10.1200/JCO.2015.65.2875; Markar SR, 2016, ANN SURG, V263, P712, DOI 10.1097/SLA.0000000000001325; Markar SR, 2015, LANCET ONCOL, V16, pE23, DOI 10.1016/S1470-2045(14)70419-X; Martin L, 2009, BRIT J SURG, V96, P1308, DOI 10.1002/bjs.6723; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Merkow RP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju133; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Murugaesu N, 2015, CANCER DISCOV, V5, P821, DOI 10.1158/2159-8290.CD-15-0412; Neuhaus H, 2012, ENDOSCOPY, V44, P1105, DOI 10.1055/s-0032-1310155; Njei B, 2016, J GASTROEN HEPATOL, V31, P1141, DOI 10.1111/jgh.13289; No authors listed, 2017, ROMIO FEASIBILITY RA; Ott K, 2003, J CLIN ONCOL, V21, P4604, DOI 10.1200/JCO.2003.06.574; Ott K, 2006, J CLIN ONCOL, V24, P4692, DOI 10.1200/JCO.2006.06.7801; Ozaki A, 2015, NEW ENGL J MED, V373, P1672, DOI 10.1056/NEJMc1510345; Pasquali S, 2017, ANN SURG, V265, P481, DOI 10.1097/SLA.0000000000001905; Pasricha S, 2015, GASTROENTEROLOGY, V149, P890, DOI 10.1053/j.gastro.2015.06.012; Pearson A, 2016, CANCER DISCOV, V6, P838, DOI 10.1158/2159-8290.CD-15-1246; Phillips AW, 2017, ANN SURG, V265, P750, DOI 10.1097/SLA.0000000000001737; Phoa KN, 2014, JAMA-J AM MED ASSOC, V311, P1209, DOI 10.1001/jama.2014.2511; Prabhu A, 2014, AM J GASTROENTEROL, V109, P821, DOI 10.1038/ajg.2014.71; Qu XD, 2013, ANN EPIDEMIOL, V23, P762, DOI 10.1016/j.annepidem.2013.09.003; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rees J, 2015, BRIT J CANCER, V113, P603, DOI 10.1038/bjc.2015.258; Rizk NP, 2010, ANN SURG, V251, P46, DOI 10.1097/SLA.0b013e3181b2f6ee; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rutegard M, 2008, BRIT J SURG, V95, P592, DOI 10.1002/bjs.6021; Schandl A, 2016, EUR J CANCER, V69, P43, DOI 10.1016/j.ejca.2016.09.032; Schandl A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012624; Schmidt HM, 2015, ANN THORAC SURG, V99, P1719, DOI 10.1016/j.athoracsur.2014.11.019; Secrier M, 2016, NAT GENET, V48, P1131, DOI 10.1038/ng.3659; Shah MA, 2015, J CLIN ONCOL, V33, P3874, DOI 10.1200/JCO.2015.60.7465; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shapiro J, 2015, LANCET ONCOL, V16, P1090, DOI 10.1016/S1470-2045(15)00040-6; Shapiro J, 2014, ANN SURG, V260, P807, DOI 10.1097/SLA.0000000000000966; Siewert JR, 1998, BRIT J SURG, V85, P1457; Sjoquist KM, 2011, LANCET ONCOL, V12, P681, DOI 10.1016/S1470-2045(11)70142-5; Spechler SJ, 2014, NEW ENGL J MED, V371, P836, DOI 10.1056/NEJMra1314704; Stahl M, 2005, J CLIN ONCOL, V23, P2310, DOI 10.1200/JCO.2005.00.034; Stahl M, 2009, J CLIN ONCOL, V27, P851, DOI 10.1200/JCO.2008.17.0506; Sun FH, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-78; Sunde B, 2016, DIS ESOPHAGUS, V29, P442, DOI 10.1111/dote.12352; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/S1470-2045(16)30559-9, 10.1016/s1470-2045(16)30559-9]; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Cutsem E, 2015, ANN ONCOL, V26, P149, DOI 10.1093/annonc/mdu496; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; van der Schaaf M, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv043; van der Schaaf M, 2013, ANN SURG ONCOL, V20, P1639, DOI 10.1245/s10434-012-2690-y; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; van Hagen P, 2013, INT J CLIN ONCOL, V18, P214, DOI 10.1007/s10147-011-0362-8; van Heijl M, 2010, ANN SURG ONCOL, V17, P23, DOI 10.1245/s10434-009-0731-y; Van Laethem JL, 2016, DIGEST LIVER DIS, V48, P1283, DOI 10.1016/j.dld.2016.08.112; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Wikman A, 2015, J CLIN ONCOL, V33, P448, DOI 10.1200/JCO.2014.57.1893; Wikman A, 2014, CANCER-AM CANCER SOC, V120, P286, DOI 10.1002/cncr.28308; Wright CD, 2009, J THORAC CARDIOV SUR, V137, P587, DOI 10.1016/j.jtcvs.2008.11.042; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Wu J, 2014, GASTROINTEST ENDOSC, V79, P233, DOI 10.1016/j.gie.2013.08.005; Xie SH, 2016, ONCOTARGET, V7, P38876, DOI 10.18632/oncotarget.9113; Yang ZP, 2013, INT J MED SCI, V10, P825, DOI 10.7150/ijms.5969; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597; Yerokun BA, 2016, ANN THORAC SURG, V102, P416, DOI 10.1016/j.athoracsur.2016.02.078; Yoshida N, 2016, WORLD J SURG, V40, P1910, DOI 10.1007/s00268-016-3549-3; Zafar SY, 2012, LANCET ONCOL, V13, pE77, DOI 10.1016/S1470-2045(11)70215-7; Zeng HM, 2015, INT J CANCER, V136, P1921, DOI 10.1002/ijc.29227; Zhou C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132889; Zhu HD, 2014, LANCET ONCOL, V15, P612, DOI 10.1016/S1470-2045(14)70131-7	158	462	486	5	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 25	2017	390	10110					2383	2396		10.1016/S0140-6736(17)31462-9	http://dx.doi.org/10.1016/S0140-6736(17)31462-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FN6IX	28648400	Green Submitted			2022-12-28	WOS:000416118700024
J	Stein, MB; Craske, MG				Stein, Murray B.; Craske, Michelle G.			Treating Anxiety in 2017 Optimizing Care to Improve Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, Altman Clin Res Inst Bldg,9500 Gilman Dr,MC 0855, La Jolla, CA 92093 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Stein, MB (corresponding author), Univ Calif San Diego, Dept Psychiat, Altman Clin Res Inst Bldg,9500 Gilman Dr,MC 0855, La Jolla, CA 92093 USA.	mstein@ucsd.edu			Actelion; Dart Neuroscience; Janssen; Neurocrine Biosciences; Pfizer; Resilience Therapeutics; Tonix Pharmaceuticals; Turing Pharmaceuticals	Actelion; Dart Neuroscience; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Neurocrine Biosciences; Pfizer(Pfizer); Resilience Therapeutics; Tonix Pharmaceuticals; Turing Pharmaceuticals	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Stein reported receiving consulting fees from Actelion, Dart Neuroscience, Janssen, Neurocrine Biosciences, Pfizer, Resilience Therapeutics, Tonix Pharmaceuticals, and Turing Pharmaceuticals; holding stock options in Oxeia Biopharmaceuticals and Resilience Therapeutics; holding founder shares in Resilience Therapeutics; serving as editor in chief for psychiatry for UpToDate; as editor in chief for Depression and Anxiety; and as deputy editor for Biological Psychiatry. Dr Craske reported no disclosures.	Comer JS, 2011, J CLIN PSYCHIAT, V72, P43, DOI 10.4088/JCP.09m05094blu; Craske MG, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.24, 10.1038/nrdp.2017.100]; Craske MG, 2016, LANCET, V388, P3048, DOI 10.1016/S0140-6736(16)30381-6; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Olthuis JV, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011565.pub2; Rollman BL, 2017, J GEN INTERN MED, V32, P245, DOI 10.1007/s11606-016-3873-1; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092	7	37	39	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					235	236		10.1001/jama.2017.6996	http://dx.doi.org/10.1001/jama.2017.6996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28679009				2022-12-28	WOS:000405775000006
J	Huang, HL; Fang, M; Ostins, LJ; Mirkov, MU; Boucher, G; Anderson, CA; Andersen, V; Leynen, IC; Cortes, A; Crins, F; D'Amato, M; Deffontaine, V; Dmitrieva, J; Docampo, E; Elansary, M; Farh, KKH; Franke, A; Gori, AS; Goyette, P; Halfvarson, J; Haritunians, T; Knight, J; Lawrance, IC; Lees, CW; Louis, E; Mariman, R; Meuwissen, T; Mni, M; Momozawa, Y; Parkes, M; Spain, SL; Theatre, E; Trynka, G; Satsangi, J; van Sommeren, S; Vermeire, S; Xavier, RJ; Weersma, RK; Duerr, RH; Mathew, CG; Rioux, JD; McGovern, DPB; Cho, JH; Georges, M; Daly, MJ; Barrett, JC				Huang, Hailiang; Fang, Ming; Ostins, Luke J.; Mirkov, Masa Umicevic; Boucher, Gabrielle; Anderson, Carl A.; Andersen, Vibeke; Leynen, Isabelle C.; Cortes, Adrian; Crins, Francois; D'Amato, Mauro; Deffontaine, Valerie; Dmitrieva, Julia; Docampo, Elisa; Elansary, Mahmoud; Farh, Kyle Kai-How; Franke, Andre; Gori, Ann-Stephan; Goyette, Philippe; Halfvarson, Jonas; Haritunians, Talin; Knight, Jo; Lawrance, Ian C.; Lees, Charlie W.; Louis, Edouard; Mariman, Rob; Meuwissen, Theo; Mni, Myriam; Momozawa, Yukihide; Parkes, Miles; Spain, Sarah L.; Theatre, Emilie; Trynka, Gosia; Satsangi, Jack; van Sommeren, Suzanne; Vermeire, Severine; Xavier, Ramnik J.; Weersma, Rinse K.; Duerr, Richard H.; Mathew, Christopher G.; Rioux, John D.; McGovern, Dermot P. B.; Cho, Judy H.; Georges, Michel; Daly, Mark J.; Barrett, Jeffrey C.		International Inflammatory Bowel	Fine-mapping inflammatory bowel disease loci to single-variant resolution	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; ILLUMINA MICROARRAY; ULCERATIVE-COLITIS; COMMON VARIANTS; CROHNS-DISEASE; COMPLEX TRAITS; RARE VARIANTS; LOW-FREQUENCY	Inflammatory bowel diseases are chronic gastrointestinal inflammatory disorders that affect millions of people worldwide. Genome-wide association studies have identified 200 inflammatory bowel disease-associated loci, but few have been conclusively resolved to specific functional variants. Here we report fine-mapping of 94 inflammatory bowel disease loci using high-density genotyping in 67,852 individuals. We pinpoint 18 associations to a single causal variant with greater than 95% certainty, and an additional 27 associations to a single variant with greater than 50% certainty. These 45 variants are significantly enriched for protein-coding changes (n = 13), direct disruption of transcription-factor binding sites (n = 3), and tissue-specific epigenetic marks (n = 10), with the last category showing enrichment in specific immune cells among associations stronger in Crohn's disease and in gut mucosa among associations stronger in ulcerative colitis. The results of this study suggest that high-resolution fine-mapping in large samples can convert many discoveries from genome-wide association studies into statistically convincing causal variants, providing a powerful substrate for experimental elucidation of disease mechanisms.	[Huang, Hailiang; Farh, Kyle Kai-How; Daly, Mark J.] Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Huang, Hailiang; Farh, Kyle Kai-How; Louis, Edouard; Xavier, Ramnik J.; Daly, Mark J.] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Fang, Ming; Crins, Francois; Deffontaine, Valerie; Dmitrieva, Julia; Docampo, Elisa; Elansary, Mahmoud; Gori, Ann-Stephan; Louis, Edouard; Mariman, Rob; Mni, Myriam; Momozawa, Yukihide; Theatre, Emilie; Georges, Michel] Univ Liege, Grp Interdisciplinaire Genoproteom Appl GIGA R Re, Unit Med Genom, B-4000 Liege, Belgium; [Fang, Ming; Crins, Francois; Deffontaine, Valerie; Dmitrieva, Julia; Docampo, Elisa; Elansary, Mahmoud; Gori, Ann-Stephan; Louis, Edouard; Mariman, Rob; Mni, Myriam; Momozawa, Yukihide; Theatre, Emilie; Georges, Michel] Univ Liege, WELBIO, B-4000 Liege, Belgium; [Fang, Ming; Crins, Francois; Deffontaine, Valerie; Dmitrieva, Julia; Docampo, Elisa; Elansary, Mahmoud; Gori, Ann-Stephan; Mariman, Rob; Mni, Myriam; Momozawa, Yukihide; Theatre, Emilie; Georges, Michel] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Ostins, Luke J.; Cortes, Adrian] Univ Oxford, Wellcome Trust Ctr Human Genet, Headington OX3 7BN, England; [Ostins, Luke J.] Univ Oxford, Christ Church, St Aldates OX1 1DP, England; [Mirkov, Masa Umicevic; Anderson, Carl A.; Spain, Sarah L.; Trynka, Gosia; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England; [Boucher, Gabrielle; Goyette, Philippe; Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Andersen, Vibeke] Hosp Southern Jutland, IRS Ctr Sonderjylland, Focused Res Unit Mol Diagnost & Clin Res MOK, DK-6200 Abenra, Denmark; [Andersen, Vibeke] Univ Southern Denmark, Inst Mol Med, DK-5000 Odense, Denmark; [Leynen, Isabelle C.; Vermeire, Severine] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Cortes, Adrian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford Ctr Neuroinflammat,Div Clin Neurol, Oxford OX3 9DS, England; [D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; [D'Amato, Mauro] BioDonostia Hlth Res Inst, Dept Gastrointestinal & Liver Dis, San Sebastian 20014, Spain; [D'Amato, Mauro] Basque Fdn Sci, IKERBASQUE, Bilbao 48013, Spain; [Farh, Kyle Kai-How] Illumina, San Diego, CA 92122 USA; [Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, D-24118 Kiel, Germany; [Halfvarson, Jonas] Orebro Univ, Fac Med & Hlth, Dept Gastroenterol, SE-70182 Orebro, Sweden; [Haritunians, Talin; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Knight, Jo] Univ Lancaster, Data Sci Inst, Lancaster LA1 4YG, England; [Knight, Jo] Univ Lancaster, Lancaster Med Sch, Lancaster LA1 4YG, England; [Lawrance, Ian C.] St John God Hosp, Ctr Inflammatory Bowel Dis, Subiaco, WA 6008, Australia; [Lawrance, Ian C.] Univ Western Australia, Sch Med & Pharmacol, Harry Perkins Inst Med Res, Murdoch, WA 6150, Australia; [Lees, Charlie W.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Louis, Edouard] CHU Liege, Div Gastroenterol, B-4000 Liege, Belgium; [Meuwissen, Theo] Norwegian Univ Life Sci, Inst Livestock & Aquacultural Sci, N-1430 As, Norway; [Momozawa, Yukihide] RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Parkes, Miles] Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 0QQ, England; [Spain, Sarah L.] Open Targets, Wellcome Trust Genome Campus, Hinxton CB10 1SD, Cambs, England; [van Sommeren, Suzanne; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [van Sommeren, Suzanne; Weersma, Rinse K.] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Vermeire, Severine] Univ Hosp Gasthuisberg, Div Gastroenterol, B-3000 Leuven, Belgium; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Gastroenterol Unit, Boston, MA 02114 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Mathew, Christopher G.] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Mathew, Christopher G.] Univ Witwatersrand, Sydney Brenner Inst Mol Biosci, ZA-2193 Johannesburg, South Africa; [Rioux, John D.] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Cho, Judy H.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Liege; University of Liege; WELBIO; University of Liege; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Trust Sanger Institute; Universite de Montreal; University of Southern Denmark; KU Leuven; University of Oxford; Karolinska Institutet; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; Illumina; University of Kiel; Orebro University; Cedars Sinai Medical Center; Lancaster University; Lancaster University; St John of God Health Care; Harry Perkins Institute of Medical Research; University of Western Australia; University of Edinburgh; University of Liege; Norwegian University of Life Sciences; RIKEN; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Groningen; University of Groningen; KU Leuven; University Hospital Leuven; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; King's College London; University of Witwatersrand; Universite de Montreal; Yale University	Huang, HL; Daly, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.; Huang, HL; Daly, MJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02141 USA.; Georges, M (corresponding author), Univ Liege, Grp Interdisciplinaire Genoproteom Appl GIGA R Re, Unit Med Genom, B-4000 Liege, Belgium.; Georges, M (corresponding author), Univ Liege, WELBIO, B-4000 Liege, Belgium.; Georges, M (corresponding author), Univ Liege, Fac Vet Med, B-4000 Liege, Belgium.; Barrett, JC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England.	hhuang@atgu.mgh.harvard.edu; michel.georges@ulg.ac.be; mjdaly@atgu.mgh.harvard.edu; barrett@sanger.ac.uk	Daly, Mark J/B-2453-2017; Andersen, Vibeke/I-7932-2012; Lawrance, Ian C/H-5252-2014; D'Amato, Mauro/F-2450-2010; Duerr, Richard H/B-4188-2009; D'Amato, Mauro/B-5050-2019; Franke, Andre/B-2151-2010; Rioux, John D/A-9599-2015; Weersma, Rinse/ABE-3807-2021; Halfvarson, Jonas/AAU-4687-2020; Spain, Sarah/G-1968-2010; Mathew, Christopher George/G-3434-2015	Daly, Mark J/0000-0002-0949-8752; Andersen, Vibeke/0000-0002-0127-2863; D'Amato, Mauro/0000-0003-2743-5197; Duerr, Richard H/0000-0001-6586-3905; D'Amato, Mauro/0000-0003-2743-5197; Franke, Andre/0000-0003-1530-5811; Rioux, John D/0000-0001-7560-8326; Anderson, Carl/0000-0003-1719-7009; Spain, Sarah/0000-0002-7591-8364; Georges, Michel/0000-0003-4124-2375; Mathew, Christopher George/0000-0003-4178-1838; Mariman, Rob/0000-0001-6405-1091; Barrett, Jeffrey/0000-0002-1152-370X; Parkes, Miles/0000-0002-6467-0631; Knight, Joanne/0000-0002-7148-1660; Vermeire, Severine/0000-0001-9942-3019; Lees, Charlie/0000-0002-0732-8215	Helmsley grant [2015PG-IBD001]; Crohn's AMP; Colitis Foundation of America; Wellcome Trust [098051, 098759/Z/12/Z]; Fonds de la Recherche Scientifique-FNRS [WELBIO-CR-2012A-06]; BELSPO-IUAP-P7/43-BeMGI; Federation Wallonie-Bruxelles (ARC IBD@Ulg); Region Wallonne (CIBLES, FEDER); ASHG/Charles J. Epstein Trainee Award; Olle Engkvist Foundation; Swedish Research Council [2010-2976, 2013-3862, 521 2011 2764]; VIDI grant from the Netherlands Organization for Scientific Research [016.136.308]; Canada Research Chair; National Institute of Diabetes and Digestive and Kidney Diseases [DK064869, DK062432]; CIHR from the Canadian Institutes of Health Research [GPG-102170]; Genome Canada [GPH-129341]; Genome Quebec; Crohn's Colitis Canada; Sanford J. Grossman Charitable Trust; Inflammatory Bowel Disease Genetic Research Chair at the University of Pittsburgh [U01DK062420, R01CA141743]; Marie-Curie Fellowship; Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS); Fonds Leon Fredericq fellowships; Orebro University Hospital Research Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre; German Federal Ministry of Education and Research (SysInflame grant) [01ZX1306A]; DFG Excellence Cluster [306]; Foundation for Experimental Medicine (Zurich, Switzerland); European Union [DK062413, AI067068, U54DE023789-01, 305479]; Leona M. and Harry B. Helmsley Charitable Trust;  [P30DK43351];  [U01DK062432];  [R01DK64869];  [DK062429];  [DK062422];  [DK092235];  [DK106593]; NATIONAL CANCER INSTITUTE [R01CA141743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U54DE023789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, U01DK062429, U01DK062432, U01DK062413, R01DK092235, P01DK046763, R01DK064869, U01DK062422, U01DK062420, R01DK106593, U24DK062429] Funding Source: NIH RePORTER; Medical Research Council [G0800759, MR/M00533X/1, G0600329] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M14-5] Funding Source: researchfish; Chief Scientist Office [ETM/137] Funding Source: researchfish; MRC [MR/M00533X/1, G0800759, G0600329] Funding Source: UKRI	Helmsley grant; Crohn's AMP; Colitis Foundation of America; Wellcome Trust(Wellcome TrustEuropean Commission); Fonds de la Recherche Scientifique-FNRS(Fonds de la Recherche Scientifique - FNRS); BELSPO-IUAP-P7/43-BeMGI; Federation Wallonie-Bruxelles (ARC IBD@Ulg); Region Wallonne (CIBLES, FEDER); ASHG/Charles J. Epstein Trainee Award; Olle Engkvist Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); VIDI grant from the Netherlands Organization for Scientific Research; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CIHR from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Genome Quebec; Crohn's Colitis Canada; Sanford J. Grossman Charitable Trust; Inflammatory Bowel Disease Genetic Research Chair at the University of Pittsburgh; Marie-Curie Fellowship(European Commission); Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Leon Fredericq fellowships; Orebro University Hospital Research Foundation; National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); German Federal Ministry of Education and Research (SysInflame grant); DFG Excellence Cluster(German Research Foundation (DFG)); Foundation for Experimental Medicine (Zurich, Switzerland); European Union(European Commission); Leona M. and Harry B. Helmsley Charitable Trust; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Crohn&quot;s and Colitis UK; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Khan and B. Wong for their assistance in designing illustrations, and K. de Lange for comments on the Supplementary Methods. We received support from the following grants. M.J.D. and R.J.X.: P30DK43351, U01DK062432, R01DK64869, Helmsley grant 2015PG-IBD001 and Crohn's & Colitis Foundation of America. G.T., C.A.A. and J.C.B: Wellcome Trust grant 098051. M.G.: Fonds de la Recherche Scientifique-FNRS for the FRFS-WELBIO under grant no. WELBIO-CR-2012A-06 (CAUSIBD), BELSPO-IUAP-P7/43-BeMGI, Federation Wallonie-Bruxelles (ARC IBD@Ulg), and Region Wallonne (CIBLES, FEDER). H.H.: ASHG/Charles J. Epstein Trainee Award. J.L.: Wellcome Trust 098759/Z/12/Z. D.M.: Olle Engkvist Foundation and Swedish Research Council (grants 2010-2976 and 2013-3862). R.K.W.: VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research. J.D.R.: Canada Research Chair, National Institute of Diabetes and Digestive and Kidney Diseases grants DK064869 and DK062432, CIHR GPG-102170 from the Canadian Institutes of Health Research, GPH-129341 from Genome Canada and Genome Quebec, and Crohn's Colitis Canada. J.H.C.: DK062429, DK062422, DK092235, DK106593, and the Sanford J. Grossman Charitable Trust. R.H.D.: Inflammatory Bowel Disease Genetic Research Chair at the University of Pittsburgh, U01DK062420 and R01CA141743. E.D.: Marie-Curie Fellowship. A.-S.G: Fonds de la Recherche Scientifique-FNRS (F.R.S.-FNRS) and Fonds Leon Fredericq fellowships. J.H.: Orebro University Hospital Research Foundation and the Swedish Research Council (grant number 521 2011 2764). C.G.M. and M.P.: National Institute for Health Research (NIHR) Biomedical Research Centre awards to Guy's & St Thomas' NHS Trust/King's College London and to Addenbrooke's Hospital/University of Cambridge School of Clinical Medicine. D.E.: German Federal Ministry of Education and Research (SysInflame grant 01ZX1306A), DFG Excellence Cluster number 306 'Inflammation at Interfaces'. A.F.: Professor of Foundation for Experimental Medicine (Zurich, Switzerland). D.P.B.M.: DK062413, AI067068, U54DE023789-01, 305479 from the European Union, and The Leona M. and Harry B. Helmsley Charitable Trust. Additional acknowledgements for the original data are in the Supplementary Information.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson E., 1999, LAPACK USERS GUIDE; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Cox DR., 1989, ANAL BINARY DATA; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Huang J, 2012, EUR J HUM GENET, V20, P801, DOI 10.1038/ejhg.2012.3; Jostins L., 2012, THESIS; Jostins L, 2016, BIOINFORMATICS, V32, P1898, DOI 10.1093/bioinformatics/btw075; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Madsen P., 2010, P 9 WORLD C GEN APPL, V137; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van de Bunt M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005535; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2012, NATURE, V490, P267, DOI 10.1038/nature11401; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; 2012, NATURE, V491, P56, DOI DOI 10.1038/NATURE11632	60	273	283	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					173	+		10.1038/nature22969	http://dx.doi.org/10.1038/nature22969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28658209	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000405314500030
J	Levine, GN				Levine, Glenn N.			Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; LONG-TERM MORTALITY; ASSOCIATION; VALIDATION; DAPT	IMPORTANCE Early cardiovascular and bleeding events after coronary stenting are associated with high risk of morbidity and mortality. OBJECTIVE To assess the prognosis of cardiovascular and bleeding events occurring beyond 1 year after coronary stenting. DESIGN, SETTING, AND PARTICIPANTS This secondary analysis is derived from data from the Dual Antiplatelet Therapy (DAPT) Study, a multicenter trial involving 220US and international clinical sites from 11 countries. The study dates were August 2009 to May 2014. Individuals who under went coronary stenting and completed 12 months of thienopyridine plus aspirin therapy without ischemic or bleeding events remained on an aspirin regimen and were randomized to continued thienopyridine therapy vs placebo for 18 additional months. Individuals were then followed up for 3 additional months while receiving aspirin therapy alone. The analysis began in August 2015. EXPOSURES Ischemic events (myocardial infarction not related to stent thrombosis, stent thrombosis, and ischemic stroke) and bleeding events (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries [GUSTO] classification moderate or severe bleeding). MAIN OUTCOMES AND MEASURES Ischemic events (myocardial infarction not related to stent thrombosis, stent thrombosis, and ischemic stroke) and bleeding events (GUSTO classification moderate or severe bleeding). Death at 21 months after randomization (33 months after coronary stenting). RESULTS In total, 25 682 individuals older than 18 years with an indication for coronary stenting were enrolled, and 11 648 (mean age, 61.3 years; 25.1% female) were randomized. After randomization, 478 individuals (4.1%) had 502 ischemic events (306 with myocardial infarction, 113 with stent thrombosis, and 83 with ischemic stroke), and 232 individuals(2.0%) had 235 bleeding events (155 with moderate and 80 with severe bleeding). Among individuals with ischemic events, 52(10.9%) died. The annualized mortalityrate after an ischemic event was 27.2(95% CI, 20.3-35.7) per 100 person-years. The cumulative incidence of death after an ischemic event among the total randomized study population was 0.5%(0.3% with myocardial infarction, 0.1% with stent thrombosis, and 0.1% with ischemic stroke). Among individuals with bleeding events, 41 (17.7%) died. The annualized mortality rate after a bleeding event was 21.5 (95% CI, 15.4-29.1) per 100 person-years. The cumulative incidence of death after a bleeding event among the total randomized study population was 0.3%(0.1% with moderate and 0.2% with severe bleeding). CONCLUSIONS AND RELEVANCE In patients treated with dual antiplatelet therapy for at least 1 year after coronary stenting, ischemic events were more frequent than bleeding events, and both events were associated with high risk of mortality.	[Levine, Glenn N.] Baylor Coll Med, Cardiol Sect, 2002 Holcombe Blvd, Houston, TX 77030 USA	Baylor College of Medicine	Levine, GN (corresponding author), Baylor Coll Med, 2002 Holcombe Blvd, Houston, TX 77030 USA.	glevine@bcm.tmc.edu						Baber U, 2016, J AM COLL CARDIOL, V67, P2224, DOI 10.1016/j.jacc.2016.02.064; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Ducroq G, 2015, EUROINTERVENTION, V11, P737, DOI 10.4244/EIJY14M09_11; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Kazi DS, 2015, J AM COLL CARDIOL, V65, P1411, DOI 10.1016/j.jacc.2015.01.047; Koskinas KC, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002053; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Secemsky EA, 2017, JAMA CARDIOL, V2, P478, DOI 10.1001/jamacardio.2017.0063; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					194	195		10.1001/jama.2017.6698	http://dx.doi.org/10.1001/jama.2017.6698			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697242				2022-12-28	WOS:000405190800020
J	Cho, A				Cho, Adrian			AI's early proving ground: the hunt for new particles	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		20	20		10.1126/science.357.6346.20	http://dx.doi.org/10.1126/science.357.6346.20			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684482				2022-12-28	WOS:000404854100015
J	Sprau, PO; Kostin, A; Kreisel, A; Bohmer, AE; Taufour, V; Canfield, PC; Mukherjee, S; Hirschfeld, PJ; Andersen, BM; Davis, JCS				Sprau, P. O.; Kostin, A.; Kreisel, A.; Bohmer, A. E.; Taufour, V.; Canfield, P. C.; Mukherjee, S.; Hirschfeld, P. J.; Andersen, B. M.; Davis, J. C. Seamus			Discovery of orbital-selective Cooper pairing in FeSe	SCIENCE			English	Article							QUASI-PARTICLE INTERFERENCE; IRON CHALCOGENIDES; SUPERCONDUCTIVITY; NEMATICITY; FRUSTRATION; SYMMETRY	The superconductor iron selenide (FeSe) is of intense interest owing to its unusual nonmagnetic nematic state and potential for high-temperature superconductivity. But its Cooper pairing mechanism has not been determined. We used Bogoliubov quasiparticle interference imaging to determine the Fermi surface geometry of the electronic bands surrounding the Gamma = ( 0, 0) and X = (pi/a(Fe), 0) points of FeSe and to measure the corresponding superconducting energy gaps. We show that both gaps are extremely anisotropic but nodeless and that they exhibit gap maxima oriented orthogonally in momentum space. Moreover, by implementing a novel technique, we demonstrate that these gaps have opposite sign with respect to each other. This complex gap configuration reveals the existence of orbital-selective Cooper pairing that, in FeSe, is based preferentially on electrons from the d(yz) orbitals of the iron atoms.	[Sprau, P. O.; Kostin, A.; Davis, J. C. Seamus] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Sprau, P. O.; Kostin, A.; Davis, J. C. Seamus] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Kreisel, A.; Andersen, B. M.] Univ Copenhagen, Niels Bohr Inst, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark; [Kreisel, A.] Univ Leipzig, Inst Theoret Phys, D-04103 Leipzig, Germany; [Bohmer, A. E.; Taufour, V.; Canfield, P. C.] US DOE, Ames Lab, Ames, IA 50011 USA; [Canfield, P. C.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Mukherjee, S.] SUNY Binghamton, Dept Phys, Binghamton, NY 13902 USA; [Hirschfeld, P. J.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA; [Davis, J. C. Seamus] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Davis, J. C. Seamus] Univ Coll Cork, Tyndall Natl Inst, Cork T12 R5C, Ireland; [Taufour, V.] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Mukherjee, S.] Indian Inst Technol, Dept Phys, Madras 600036, Tamil Nadu, India	Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Copenhagen; Niels Bohr Institute; Leipzig University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University System of Florida; University of Florida; University of St Andrews; University College Cork; University of California System; University of California Davis; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Davis, JCS (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.; Davis, JCS (corresponding author), Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.; Davis, JCS (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.; Davis, JCS (corresponding author), Univ Coll Cork, Tyndall Natl Inst, Cork T12 R5C, Ireland.	jcseamusdavis@gmail.com	Kreisel, Andreas/O-2595-2014; Andersen, Brian M./M-4671-2014; Hirschfeld, Peter J/A-6402-2010	Kreisel, Andreas/0000-0003-3028-377X; Andersen, Brian M./0000-0002-9786-7553; Sprau, Peter/0000-0001-8965-5684; Taufour, Valentin/0000-0002-0024-9960; Mukherjee, Shantanu/0000-0002-4927-5131; Davis, J.C.Seamus/0000-0003-3783-1847	Moore Foundation's EPiQS (Emergent Phenomena in Quantum Physics) Initiative [GBMF4544, GBMF4411]; Tyndall National Institute, University College Cork, Cork, Ireland; U.S. Department of Energy (DOE) grant [DE-FG02-05ER46236]; Lundbeckfond Fellowship [A9318]; U.S. DOE, Office of Basic Energy Science, Division of Materials Sciences and Engineering; U.S. DOE by Iowa State University [DE-AC02-07CH11358]; U.S. DOE [DE-2009-BNL-PM015]; EPSRC [EP/I031014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish	Moore Foundation's EPiQS (Emergent Phenomena in Quantum Physics) Initiative; Tyndall National Institute, University College Cork, Cork, Ireland; U.S. Department of Energy (DOE) grant(United States Department of Energy (DOE)); Lundbeckfond Fellowship; U.S. DOE, Office of Basic Energy Science, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. DOE by Iowa State University(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to A. Chubukov, S. D. Edkins, M. H. Hamidian, J. E. Hoffman, E.-A. Kim, S. A. Kivelson, M. Lawler, D.-H. Lee, J.-H. She, and H.-H. Wen for helpful discussions and communications. J.C.S.D. and P.C.C. gratefully acknowledge support from the Moore Foundation's EPiQS (Emergent Phenomena in Quantum Physics) Initiative through grants GBMF4544 and GBMF4411, respectively. J.C.S.D. gratefully acknowledges the hospitality and support of the Tyndall National Institute, University College Cork, Cork, Ireland. P.J.H. acknowledges support from U.S. Department of Energy (DOE) grant DE-FG02-05ER46236. A.Kr. and B.M.A. acknowledge support from a Lundbeckfond Fellowship (grant A9318). Material synthesis and detailed characterization at Ames National Laboratory was supported by the U.S. DOE, Office of Basic Energy Science, Division of Materials Sciences and Engineering; Ames Laboratory is operated for the U.S. DOE by Iowa State University under contract DE-AC02-07CH11358. Experimental studies carried out by the Center for Emergent Superconductivity, an Energy Frontier Research Center, headquartered at Brookhaven National Laboratory, were funded by the U.S. DOE under grant DE-2009-BNL-PM015. The data described in the paper are archived by the Davis research group at Cornell University.	Aichhorn M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064504; Akbari A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224506; Allan MP, 2013, NAT PHYS, V9, P468, DOI [10.1038/nphys2671, 10.1038/NPHYS2671]; Allan MP, 2012, SCIENCE, V336, P563, DOI 10.1126/science.1218726; Arakawa N, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.074704; Bourgeois-Hope P, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.097003; de' Medici L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.177001; Glasbrenner JK, 2015, NAT PHYS, V11, P953, DOI [10.1038/nphys3434, 10.1038/NPHYS3434]; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; Hirschfeld PJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.184513; Hirschfeld PJ, 2016, CR PHYS, V17, P197, DOI 10.1016/j.crhy.2015.10.002; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Huang D, 2016, NANO LETT, V16, P4224, DOI 10.1021/acs.nanolett.6b01163; Jiao L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44024; Khasanov R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.220510; Kreisel A, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.224515; Lee DH, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/11/117405; Li M, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/8/082001; Liu ZK, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.235138; Mukherjee S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.026402; Song CL, 2011, SCIENCE, V332, P1410, DOI 10.1126/science.1202226; Suzuki Y, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.205117; Teknowijoyo S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.064521; Terashima T, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.144517; Wang F, 2015, NAT PHYS, V11, P959, DOI [10.1038/nphys3456, 10.1038/NPHYS3456]; Wang QH, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.020511; Wang QY, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/037402; Wang QS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12182; Wang QS, 2016, NAT MATER, V15, P159, DOI [10.1038/NMAT4492, 10.1038/nmat4492]; Wang Z, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.104522; Watashige T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031022; Watson MD, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.201107; Watson MD, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.155106; Xu HC, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.157003; Yi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8777; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/NMAT3120, 10.1038/nmat3120]; Yu R, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024509; Zhang YY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094528; Zhang ZC, 2015, SCI BULL, V60, P1301, DOI 10.1007/s11434-015-0842-8	40	231	232	18	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					76	+		10.1126/science.aal1575	http://dx.doi.org/10.1126/science.aal1575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684522	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000416909500005
J	Jin, P; Bulkley, D; Guo, YM; Zhang, W; Guo, ZH; Huynh, W; Wu, SP; Meltzer, S; Cheng, T; Jan, LY; Jan, YN; Cheng, YF				Jin, Peng; Bulkley, David; Guo, Yanmeng; Zhang, Wei; Guo, Zhenhao; Huynh, Walter; Wu, Shenping; Meltzer, Shan; Cheng, Tong; Jan, Lily Yeh; Jan, Yuh-Nung; Cheng, Yifan			Electron cryo-microscopy structure of the mechanotransduction channel NOMPC	NATURE			English	Article							TRP CHANNEL; ION-CHANNEL; CRYSTAL-STRUCTURE; ANKYRIN REPEATS; ACTIVATION; VALIDATION; MICROSCOPY; DYNACTIN; FORCE; HELIX	Mechanosensory transduction for senses such as proprioception, touch, balance, acceleration, hearing and pain relies on mechanotransduction channels, which convert mechanical stimuli into electrical signals in specialized sensory cells(1). How force gates mechanotransduction channels is a central question in the field, for which there are two major models. One is the membrane-tension model: force applied to the membrane generates a change in membrane tension that is sufficient to gate the channel, as in the bacterial MscL channel and certain eukaryotic potassium channels(2-5). The other is the tether model: force is transmitted via a tether to gate the channel. The transient receptor potential (TRP) channel NOMPC is important for mechanosensation-related behaviours such as locomotion, touch and sound sensation across different species including Caenorhabditis elegans(6), Drosophila(7-9) and zebrafish(10). NOMPC is the founding member of the TRPN subfamily(11), and is thought to be gated by tethering of its ankyrin repeat domain to microtubules of the cytoskeleton(12-15). Thus, a goal of studying NOMPC is to reveal the underlying mechanism of force-induced gating, which could serve as a paradigm of the tether model. NOMPC fulfils all the criteria that apply to mechanotransduction channels(1,7) and has 29 ankyrin repeats, the largest number among TRP channels. A key question is how the long ankyrin repeat domain is organized as a tether that can trigger channel gating. Here we present a de novo atomic structure of Drosophila NOMPC determined by single-particle electron cryo-microscopy. Structural analysis suggests that the ankyrin repeat domain of NOMPC resembles a helical spring, suggesting its role of linking mechanical displacement of the cytoskeleton to the opening of the channel. The NOMPC architecture underscores the basis of translating mechanical force into an electrical signal within a cell.	[Jin, Peng; Guo, Yanmeng; Zhang, Wei; Guo, Zhenhao; Meltzer, Shan; Cheng, Tong; Jan, Lily Yeh; Jan, Yuh-Nung] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Bulkley, David; Jan, Lily Yeh; Jan, Yuh-Nung; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Zhang, Wei; Wu, Shenping; Cheng, Tong; Jan, Lily Yeh; Jan, Yuh-Nung; Cheng, Yifan] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Huynh, Walter] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Jan, YN; Cheng, YF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Jan, YN; Cheng, YF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	yuhnung.jan@ucsf.edu; ycheng@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Cheng, Yifan/0000-0001-9535-0369; Bulkley, David/0000-0002-2535-904X; Jan, Lily/0000-0003-3938-8498	NIH [R01NS069229, 5R37NS040929, 1R35NS097227, R01GM098672, S10OD020054]; UCSF Program for Breakthrough Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS040929, R01NS069229, R01NS040929, R35NS097227] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020054] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Mackinnon, T. Xiao and W. Wang for advice on protein purification, S. Grunder for sharing construct, and members from laboratories of D. Minor, D. Julius and R. Vale for sharing equipment and reagents. We also thank colleagues in our laboratories for discussions, M. Braunfeld and C. Kennedy for technical support, and Z. Yu and his colleagues at the HHMI Janelia Cryo-EM Facility for help with data acquisition. This work was supported by grants from the NIH (R01NS069229 to L.Y.J., 5R37NS040929, 1R35NS097227 to Y.-N.J., R01GM098672 and S10OD020054 to Y.C.), and by a UCSF Program for Breakthrough Biomedical Research (Y.C.). L.Y.J., Y.-N.J. and Y.C. are Investigators with the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Booth DS, 2011, JOVE-J VIS EXP, DOI 10.3791/3227; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Effertz T, 2011, CURR BIOL, V21, P592, DOI 10.1016/j.cub.2011.02.048; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Li W, 2006, NATURE, V440, P684, DOI 10.1038/nature04538; Liang X, 2013, CURR BIOL, V23, P755, DOI 10.1016/j.cub.2013.03.065; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Saotome K, 2016, NATURE, V534, P506, DOI 10.1038/nature17975; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schroeder CM, 2016, J CELL BIOL, V214, P309, DOI 10.1083/jcb.201604002; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Teng JF, 2015, P NATL ACAD SCI USA, V112, P3386, DOI 10.1073/pnas.1502366112; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	49	127	130	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					118	+		10.1038/nature22981	http://dx.doi.org/10.1038/nature22981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658211	Green Accepted			2022-12-28	WOS:000404839900042
J	Sentilhes, L; Azria, E; Schmitz, T				Sentilhes, Loic; Azria, Elie; Schmitz, Thomas			Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Sentilhes, Loic] Bordeaux Univ Hosp, Bordeaux, France; [Azria, Elie] Paris St Joseph Hosp, Paris, France; [Schmitz, Thomas] Robert Debre Univ Hosp, Paris, France	CHU Bordeaux; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Sentilhes, L (corresponding author), Bordeaux Univ Hosp, Bordeaux, France.	loicsentilhes@hotmail.com	; Poon, Liona C./P-9311-2017	Nicolaides, Kypros/0000-0003-1266-0711; Poon, Liona C./0000-0002-3944-4130; Rolnik, Daniel Lorber/0000-0002-2263-3592; Maclagan, Kate/0000-0003-0686-3053; Molina, Francisca/0000-0001-9190-5654; Azria, Elie/0000-0002-6159-6253				Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMoa1704559, 10.1056/NEJMc1713798]	1	319	334	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 14	2017	377	24					2399	2400		10.1056/NEJMc1713798	http://dx.doi.org/10.1056/NEJMc1713798			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FP8VG	28657417	Green Published, Green Submitted			2022-12-28	WOS:000417923600017
J	Moss, WJ				Moss, William J.			Measles	LANCET			English	Review							DEVELOPING-COUNTRIES; VACCINE HESITANCY; COMMUNITY SIZE; UNITED-STATES; VIRUS RNA; CARE TEST; TRANSMISSION; ELIMINATION; ANTIBODIES; INFECTION	Measles is a highly contagious disease that results from infection with measles virus and is still responsible for more than 100 000 deaths every year, down from more than 2 million deaths annually before the introduction and widespread use of measles vaccine. Measles virus is transmitted by the respiratory route and illness begins with fever, cough, coryza, and conjunctivitis followed by a characteristic rash. Complications of measles affect most organ systems, with pneumonia accounting for most measles-associated morbidity and mortality. The management of patients with measles includes provision of vitamin A. Measles is best prevented through vaccination, and the major reductions in measles incidence and mortality have renewed interest in regional elimination and global eradication. However, urgent efforts are needed to increase stagnating global coverage with two doses of measles vaccine through advocacy, education, and the strengthening of routine immunisation systems. Use of combined measles-rubella vaccines provides an opportunity to eliminate rubella and congenital rubella syndrome. Ongoing research efforts, including the development of point-of-care diagnostics and microneedle patches, will facilitate progress towards measles elimination and eradication.	[Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Moss, William J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Moss, WJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	wmoss1@jhu.edu						AABY P, 1995, SOC SCI MED, V41, P673, DOI 10.1016/0277-9536(95)00038-9; Abt M, 2009, J GEN VIROL, V90, P909, DOI 10.1099/vir.0.008581-0; Akramuzzaman SM, 2000, AM J EPIDEMIOL, V151, P723, DOI 10.1093/oxfordjournals.aje.a010267; ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; ANDERSON R M, 1991; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P205; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P89; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P73; [Anonymous], 1992, Wkly Epidemiol Rec, V67, P357; Barnard Dale L., 2004, Antiviral Chemistry & Chemotherapy, V15, P111; Beaty SM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040109; Bellini WJ, 2003, J INFECT DIS, V187, pS283, DOI 10.1086/368040; BLACK FL, 1966, J THEOR BIOL, V11, P207, DOI 10.1016/0022-5193(66)90161-5; Campbell H, 2007, INT J EPIDEMIOL, V36, P1334, DOI 10.1093/ije/dym207; Choe YJ, 2012, JPN J INFECT DIS, V65, P371, DOI 10.7883/yoken.65.371; Cochi SL, 2014, J INFECT DIS, V210, pS540, DOI 10.1093/infdis/jiu345; Cohen BJ, 2008, VACCINE, V26, P6392, DOI 10.1016/j.vaccine.2008.08.074; Cutts FT, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001404; De Serres G, 2012, CLIN INFECT DIS, V55, P394, DOI 10.1093/cid/cis439; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; de Vries RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004482; de Vries RD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002885; de Vries RD, 2012, CURR OPIN VIROL, V2, P248, DOI 10.1016/j.coviro.2012.03.005; Defay F, 2013, PEDIATRICS, V132, pE1126, DOI 10.1542/peds.2012-3975; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Do VA, 2017, J INFECT DIS, V215, P1188, DOI 10.1093/infdis/jiw512; Durrheim DN, 2014, VACCINE, V32, P6880, DOI 10.1016/j.vaccine.2014.10.061; Edens C, 2015, VACCINE, V33, P4712, DOI 10.1016/j.vaccine.2015.02.074; Edens C, 2013, VACCINE, V31, P3403, DOI 10.1016/j.vaccine.2012.09.062; ENDERS JF, 1959, NEW ENGL J MED, V261, P875, DOI 10.1056/NEJM195910292611801; ENDERS JF, 1954, P SOC EXP BIOL MED, V86, P277, DOI 10.3181/00379727-86-21073; Ferrari MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0141; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Fill MMA, 2016, MMWR-MORBID MORTAL W, V65, P1039, DOI 10.15585/mmwr.mm6538a3; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fitzgerald TL, 2012, COMMUN DIS INTELL, V36, pE277; FOSTER A, 1986, B WORLD HEALTH ORGAN, V64, P619; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Fulton BO, 2015, CELL REP, V11, P1331, DOI 10.1016/j.celrep.2015.04.054; Gans HA, 1998, JAMA-J AM MED ASSOC, V280, P527, DOI 10.1001/jama.280.6.527; Gardy JL, 2015, J INFECT DIS, V212, P1574, DOI 10.1093/infdis/jiv271; GOOD RA, 1956, PEDIATRICS, V18, P109; GRIFFIN DE, 1990, J INFECT DIS, V161, P449, DOI 10.1093/infdis/161.3.449; Griffin DE, 2014, HAND CLINIC, V123, P577, DOI 10.1016/B978-0-444-53488-0.00027-4; Griffin DE, 2010, IMMUNOL REV, V236, P176, DOI 10.1111/j.1600-065X.2010.00925.x; Hardie DR, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-283; Hayford KT, 2013, J VIROL METHODS, V193, P512, DOI 10.1016/j.jviromet.2013.07.014; Helfand RF, 1997, J INFECT DIS, V175, P195, DOI 10.1093/infdis/175.1.195; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Hope K, 2012, WEST PAC SURVEILL RE, V3, P33, DOI [10.5365/WPSAR.2012.3.3.009, 10.5365/wpsar.2012.3.3.009]; Huiming Y, 2005, COCHRANE DB SYST REV, V4; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Jones-Engel L, 2006, AM J PRIMATOL, V68, P868, DOI 10.1002/ajp.20294; Kabra SK, 2013, COCHRANE DB SYST REV, V8; Kandasamy R, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5225; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; KIMURA A, 1975, ARCH VIROL, V47, P295, DOI 10.1007/BF01347970; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Leuridan E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1626; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Ludlow M, 2015, J PATHOL, V235, P253, DOI 10.1002/path.4457; Ludlow M, 2013, J GEN VIROL, V94, P1933, DOI 10.1099/vir.0.054650-0; Maltezou HC, 2013, AM J INFECT CONTROL, V41, P661, DOI 10.1016/j.ajic.2012.09.017; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Meeting of the International Task Force for Disease Eradication, 2015, WEEKLY EPIDEMIOL REC, V91, P61; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662; MORLEY D, 1969, BMJ-BRIT MED J, V1, P297, DOI 10.1136/bmj.1.5639.297; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Moss WJ, 2011, J INFECT DIS, V204, pS47, DOI 10.1093/infdis/jir065; Moss WJ, 2009, PEDIATR INFECT DIS J, V28, P63, DOI 10.1097/INF.0b013e318184eed2; Moss WJ, 1999, CLIN INFECT DIS, V29, P106, DOI 10.1086/520136; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Moss WJ, 2009, IMMUNOLOGICAL BASIS; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Mulders MN, 2016, MMWR-MORBID MORTAL W, V65, P438, DOI 10.15585/mmwr.mm6517a3; Mulders MN, 2001, VACCINE, V19, P2245, DOI 10.1016/S0264-410X(00)00453-9; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nambulli S, 2016, CURR OPIN VIROL, V16, P95, DOI 10.1016/j.coviro.2016.01.019; Nkowane, 2016, MEASLES RUBELLA GLOB; Ogbuanu IU, 2014, CLIN INFECT DIS, V58, P1086, DOI 10.1093/cid/ciu037; Orenstein WA, 2016, EXPERT REV VACCINES, V15, P791, DOI 10.1586/14760584.2016.1165614; Ortega-Sanchez IR, 2014, VACCINE, V32, P1311, DOI 10.1016/j.vaccine.2013.10.012; Patel MK, 2016, MMWR-MORBID MORTAL W, V65, P1228, DOI 10.15585/mmwr.mm6544a6; Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081; Permar SR, 2004, J INFECT DIS, V190, P998, DOI 10.1086/422846; Permar SR, 2003, J VIROL, V77, P4396, DOI 10.1128/JVI.77.7.4396-4400.2003; Perry RT, 2015, MMWR-MORBID MORTAL W, V64, P1246, DOI [10.15585/mmwr.6444a4, 10.15585/mmwr.mm6444a4]; Perry Robert T., 2004, Journal of Infectious Diseases, V189, pS4, DOI 10.1086/377712; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Plattet P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040112; Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918; REMINGTON PL, 1985, JAMA-J AM MED ASSOC, V253, P1574, DOI 10.1001/jama.253.11.1574; Riddell MA, 2007, J CLIN VIROL, V39, P312, DOI 10.1016/j.jcv.2007.05.006; Ryon JJ, 2002, CLIN DIAGN LAB IMMUN, V9, P994, DOI 10.1128/CDLI.9.5.994-1003.2002; SARTWELL PE, 1966, AM J EPIDEMIOL, V83, P204, DOI 10.1093/oxfordjournals.aje.a120576; Schuster M, 2015, VACCINE, V33, P4157, DOI 10.1016/j.vaccine.2015.04.035; Shanks GD, 2015, EPIDEMIOL INFECT, V143, P3434, DOI 10.1017/S0950268815000631; Shonhai A, 2015, EPIDEMIOL INFECT, V143, P3442, DOI 10.1017/S0950268815000540; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Singh BK, 2016, J VIROL, V90, P6808, DOI 10.1128/JVI.00266-16; Stevens GA, 2015, LANCET GLOB HEALTH, V3, pE528, DOI 10.1016/S2214-109X(15)00039-X; Sugerman DE, 2010, PEDIATRICS, V125, P747, DOI 10.1542/peds.2009-1653; Tahara M, 2013, J VIROL, V87, P3583, DOI 10.1128/JVI.03029-12; Takahashi S, 2015, SCIENCE, V347, P1240, DOI 10.1126/science.aaa3438; TAMASHIRO VG, 1987, PEDIATR INFECT DIS J, V6, P451, DOI 10.1097/00006454-198705000-00007; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Uzicanin A, 2011, J INFECT DIS, V204, pS564, DOI 10.1093/infdis/jir088; von Pirquet C, 1908, DEUT MED WOCHENSCHR, V34, P1297; Waaijenborg S, 2013, J INFECT DIS, V208, P10, DOI 10.1093/infdis/jit143; Walllinga J, 2005, PLOS MED, V2, P1152, DOI 10.1371/journal.pmed.0020316; Warrener L, 2011, B WORLD HEALTH ORGAN, V89, P675, DOI 10.2471/BLT.11.088427; Wendorf KA, 2017, CLIN INFECT DIS, V65, P226, DOI 10.1093/cid/cix302; Wolfson LJ, 2009, INT J EPIDEMIOL, V38, P192, DOI 10.1093/ije/dyn224; World Health Organization, 2016, WKLY EPIDEMIOL REC, V91, P561; Young MK, 2014, COCHRANE DB SYST REV, V4	121	224	242	6	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2490	2502		10.1016/S0140-6736(17)31463-0	http://dx.doi.org/10.1016/S0140-6736(17)31463-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO6UL	28673424				2022-12-28	WOS:000417003400027
J	Anderson, M				Anderson, Michael			How to beat the traffic	SCIENCE			English	Editorial Material							CONGESTION		[Anderson, Michael] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Anderson, M (corresponding author), Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA.	mlanderson@berkeley.edu		Anderson, Michael/0000-0002-4079-1965				Anderson ML, 2016, J PUBLIC ECON, V142, P1, DOI 10.1016/j.jpubeco.2016.07.005; Anderson ML, 2014, AM ECON REV, V104, P2763, DOI 10.1257/aer.104.9.2763; Central London Congestion Charging, 2007, 5 TRANSP LOND; Davis LW, 2008, J POLIT ECON, V116, P38, DOI 10.1086/529398; Duranton G, 2011, AM ECON REV, V101, P2616, DOI 10.1257/aer.101.6.2616; Greenfield Charlotte, 2015, REUTERS; Hanna R, 2017, SCIENCE, V357, P89, DOI 10.1126/science.aan2747; Lindsey R, 2006, ECON J WATCH, V3, P292; Onishi N, 2009, NY TIMES; Siregar K., 2016, AGENCE FRANCE PRESSE	10	2	2	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		36	37		10.1126/science.aan8177	http://dx.doi.org/10.1126/science.aan8177			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EZ6UL	28684493				2022-12-28	WOS:000404854100038
J	Griffin, DE				Griffin, Diane E.			Why are neurons susceptible to Zika virus?	SCIENCE			English	Editorial Material							HEPATITIS-C VIRUS; PROGENITOR CELLS; TRANSMISSION; REPLICATION; CNS		[Griffin, Diane E.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Griffin, DE (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	dgriffi6@jhmi.edu			NINDS NIH HHS [R01 NS087539] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007; Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243; Colomer-Lluch M, 2016, CURR HIV RES, V14, P175, DOI 10.2174/1570162X14999160224094621; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Schultz KLW, 2015, J VIROL, V89, P48, DOI 10.1128/JVI.02394-14; Song YT, 2006, J VIROL, V80, P11579, DOI 10.1128/JVI.00675-06; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002; Yano M, 2016, INT J DEV NEUROSCI, V55, P124, DOI 10.1016/j.ijdevneu.2016.01.002; Zhou LY, 2016, WORLD J GASTROENTERO, V22, P1477, DOI 10.3748/wjg.v22.i4.1477	12	3	3	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		33	34		10.1126/science.aan8626	http://dx.doi.org/10.1126/science.aan8626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684491				2022-12-28	WOS:000404854100036
J	Maekawa, T; Schulze-Lefert, P				Maekawa, Takaki; Schulze-Lefert, Paul			Caught in the jump	SCIENCE			English	Editorial Material									[Maekawa, Takaki; Schulze-Lefert, Paul] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany	Max Planck Society	Maekawa, T (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany.	maekawa@mpipz.mpg.de; schlef@mpipz.mpg.de	Schulze-Lefert, Paul/B-6707-2011					Dong SM, 2014, SCIENCE, V343, P552, DOI 10.1126/science.1246300; Farman M, 2017, PLANT DIS, V101, P684, DOI 10.1094/PDIS-05-16-0700-RE; Inoue Y, 2017, SCIENCE, V357, P80, DOI 10.1126/science.aam9654; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; Schulze-Lefert P, 2011, TRENDS PLANT SCI, V16, P117, DOI 10.1016/j.tplants.2011.01.001	6	2	2	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		31	32		10.1126/science.aan8287	http://dx.doi.org/10.1126/science.aan8287			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684489				2022-12-28	WOS:000404854100034
J	Frances, A; Carroll, BJ				Frances, Allen; Carroll, Bernard J.			Keith Conners OBITUARIEY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Frances, Allen; Carroll, Bernard J.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA	Duke University	Frances, A (corresponding author), Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.								0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j2253	10.1136/bmj.j2253	http://dx.doi.org/10.1136/bmj.j2253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DO	28684388				2022-12-28	WOS:000405322300001
J	Ahmadi-Abhari, S; Guzman-Castillo, M; Bandosz, P; Shipley, MJ; Muniz-Terrera, G; Singh-Manoux, A; Kivimaki, M; Steptoe, A; Capewell, S; O'Flaherty, M; Brunner, EJ				Ahmadi-Abhari, Sara; Guzman-Castillo, Maria; Bandosz, Piotr; Shipley, Martin J.; Muniz-Terrera, Graciela; Singh-Manoux, Archana; Kivimaki, Mika; Steptoe, Andrew; Capewell, Simon; O'Flaherty, Martin; Brunner, Eric J.			Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: modelling study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; COMPETING RISKS; COHORT PROFILE; UNITED-STATES; POPULATION; FUTURE; OLDER; NONPARTICIPANTS; PARTICIPANTS	OBJECTIVE To forecast dementia prevalence with a dynamic modelling approach that integrates calendar trends in dementia incidence with those for mortality and cardiovascular disease. DESIGN Modelling study. SETTING General adult population of England and Wales. PARTICIPANTS The English Longitudinal Study of Ageing (ELSA) is a representative panel study with six waves of data across 2002-13. Men and women aged 50 or more years, selected randomly, and their cohabiting partners were recruited to the first wave of ELSA (2002-03). 11392 adults participated (response rate 67%). To maintain representativeness, refreshment participants were recruited to the study at subsequent waves. The total analytical sample constituted 17 906 people. Constant objective criteria based on cognitive and functional impairment were used to ascertain dementia cases at each wave. MAIN OUTCOME MEASURES To estimate calendar trends in dementia incidence, correcting for bias due to loss to follow-up of study participants, a joint model of longitudinal and time-to-event data was fitted to ELSA data. To forecast future dementia prevalence, the probabilistic Markov model IMPACT-BAM (IMPACT-Better Ageing Model) was developed. IMPACT-BAM models transitions of the population aged 35 or more years through states of cardiovascular disease, cognitive and functional impairment, and dementia, to death. It enables prediction of dementia prevalence while accounting for the growing pool of susceptible people as a result of increased life expectancy and the competing effects due to changes in mortality, and incidence of cardiovascular disease. RESULTS In ELSA, dementia incidence was estimated at 14.3 per 1000 person years in men and 17.0/1000 person years in women aged 50 or more in 2010. Dementia incidence declined at a relative rate of 2.7% (95% confidence interval 2.4% to 2.9%) for each year during 2002-13. Using IMPACT-BAM, we estimated there were approximately 767 000 (95% uncertainty interval 735 000 to 797 000) people with dementia in England and Wales in 2016. Despite the decrease in incidence and age specific prevalence, the number of people with dementia is projected to increase to 872 000, 1 092 000, and 1 205 000 in 2020, 2030, and 2040, respectively. A sensitivity analysis without the incidence decline gave a much larger projected growth, of more than 1.9 million people with dementia in 2040. CONCLUSIONS Age specific dementia incidence is declining. The number of people with dementia in England and Wales is likely to increase by 57% from 2016 to 2040. This increase is mainly driven by improved life expectancy.	[Ahmadi-Abhari, Sara; Shipley, Martin J.; Singh-Manoux, Archana; Kivimaki, Mika; Steptoe, Andrew; Brunner, Eric J.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Guzman-Castillo, Maria; Bandosz, Piotr; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool, Merseyside, England; [Bandosz, Piotr] Med Univ Gdansk, Dept Prevent & Med Educ, Gdansk, Poland; [Muniz-Terrera, Graciela] Univ Edinburgh, Ctr Dementia Prevent, Edinburgh, Midlothian, Scotland; [Singh-Manoux, Archana] Hop Paul Brousse, Ctr Res Epidemiol & Publ Hlth, INSERM, U1018, Villejuif, France; [Kivimaki, Mika] Univ Helsinki, Clinicum, Fac Med, Helsinki, Finland	University of London; University College London; University of Liverpool; Fahrenheit Universities; Medical University Gdansk; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Helsinki	Ahmadi-Abhari, S (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	s.ahmadi-abhari@ucl.ac.uk	Steptoe, Andrew/Y-2440-2019; Brunner, Eric/H-2114-2011; Singh-Manoux, Archana/F-6804-2013	Brunner, Eric/0000-0002-0595-4474; Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Muniz Terrera, Graciela/0000-0002-4516-0337; Ahmadi-Abhari, Sara/0000-0003-4440-4050	British Heart Foundation [RG/13/2/30098, RG/16/11/32334]; Medical Research Council [K013351]; NordForsk; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [G0900847, MR/K013351/1] Funding Source: UKRI; British Heart Foundation [PG/11/63/29011] Funding Source: researchfish; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [G0900847, MR/K013351/1] Funding Source: researchfish; Stroke Association [TSA2008/05] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG017644] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Stroke Association; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the British Heart Foundation (RG/13/2/30098, RG/16/11/32334). MK was supported by the Medical Research Council (K013351) and NordForsk. The funding sources did not have a role in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, or the preparation, review, approval, or decision to submit the manuscript.	Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; [Anonymous], 2015, DEM DIS FRAILT LAT L; BALDERESCHI M, 1994, NEUROLOGY, V44, P239, DOI 10.1212/WNL.44.2.239; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bennett JE, 2015, LANCET, V386, P163, DOI 10.1016/S0140-6736(15)60296-3; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Binder N, 2015, AM J EPIDEMIOL, V181, P291, DOI 10.1093/aje/kwu475; Brunner EJ, 2017, J GERONTOL A-BIOL, V72, P237, DOI 10.1093/gerona/glw092; Castillo MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099482; Chertkow H, 2007, ALZHEIMERS DEMENT, V3, P266, DOI 10.1016/j.jalz.2007.07.013; Comas-Herrera A, 2007, INT J GERIATR PSYCH, V22, P1037, DOI 10.1002/gps.1830; Dementia UK, 2007, REP PREV COST DEM PR; Doblhammer G, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0146-x; Fitzpatrick AL, 2004, J AM GERIATR SOC, V52, P195, DOI 10.1111/j.1532-5415.2004.52058.x; Gauthier S, 2016, ALZHEIMERS DEMENT, V12, P60, DOI 10.1016/j.jalz.2015.12.003; Grasset L, 2016, ALZHEIMERS DEMENT, V12, P272, DOI 10.1016/j.jalz.2015.11.001; Haller B, 2013, LIFETIME DATA ANAL, V19, P33, DOI 10.1007/s10985-012-9230-8; Hardoon SL, 2012, EUR HEART J, V33, P478, DOI 10.1093/eurheartj/ehr142; Harrison JK, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010772.pub2; Health and Social Care Information Centre, 2012, HLTH SURV ENGL 2011; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Knopman DS, 2014, AM J EPIDEMIOL, V180, P414, DOI 10.1093/aje/kwu103; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Lewis FI, 2017, ALZHEIMERS DEMENT, V13, P38, DOI 10.1016/j.jalz.2016.03.013; Lincoln P, 2014, LANCET, V383, P1805, DOI 10.1016/S0140-6736(14)60758-3; Lobo A, 2007, ACTA PSYCHIAT SCAND, V116, P299, DOI 10.1111/j.1600-0447.2007.01006.x; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; MASUR DM, 1994, NEUROLOGY, V44, P1427, DOI 10.1212/WNL.44.8.1427; Matthews FE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11398; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Mendoza W, 2017, CARDIOL CLIN, V35, P1, DOI 10.1016/j.ccl.2016.08.004; Mindell J, 2012, INT J EPIDEMIOL, V41, P1585, DOI 10.1093/ije/dyr199; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nepal B, 2010, AUSTRALAS J AGEING, V29, P111, DOI 10.1111/j.1741-6612.2010.00392.x; Noale M, 2013, INT PSYCHOGERIATR, V25, P1867, DOI 10.1017/S1041610213001300; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Qiu CX, 2013, NEUROLOGY, V80, P1888, DOI 10.1212/WNL.0b013e318292a2f9; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1, DOI 10.1201/b12208; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Sekita A, 2010, ACTA PSYCHIAT SCAND, V122, P319, DOI 10.1111/j.1600-0447.2010.01587.x; Shah H, 2016, LANCET NEUROL, V15, P1283, DOI 10.1016/S1474-4422(16)30235-6; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Stephan BCM, 2010, NAT REV NEUROL, V6, P318, DOI 10.1038/nrneurol.2010.54; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Wanneveich M, 2016, STAT METHODS MED RES; WELSH KA, 1992, ARCH NEUROL-CHICAGO, V49, P448, DOI 10.1001/archneur.1992.00530290030008; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; Wu YT, 2015, LANCET NEUROL, V15, P10; Wu YT, 2014, INT J GERIATR PSYCH, V29, P1212, DOI 10.1002/gps.4148	56	126	128	2	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2017	358								j2856	10.1136/bmj.j2856	http://dx.doi.org/10.1136/bmj.j2856			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FA3DN	28679494	Green Published, hybrid			2022-12-28	WOS:000405322200002
J	Abramowicz, M; Zuccotti, G; Pflomm, JM				Abramowicz, Mark; Zuccotti, Gianna; Pflomm, Jean-Marie			Anaphylaxis and Insect Stings and Bites (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 59, issue 1520, 2017)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint							ADULTS						Pflomm, Jean-Marie/HDO-0765-2022					[Anonymous], 2017, MED LETT DRUGS THER, V59, P33; Anshien M, 2019, AM J THER, V26, pE110, DOI 10.1097/MJT.0000000000000541; Casale TB, 2014, NEW ENGL J MED, V370, P1432, DOI 10.1056/NEJMcp1302681; Edwards ES, 2012, J ALLERGY CLIN IMMUN, V129, pAB179, DOI 10.1016/j.jaci.2011.12.234; Golden DBK, 2015, J ALLER CL IMM-PRACT, V3, P331, DOI 10.1016/j.jaip.2015.01.020; Lee S, 2017, J ALLERGY CLIN IMMUN, V139, P182, DOI 10.1016/j.jaci.2016.04.029; Lieberman P, 2015, CLIN EXP ALLERGY, V45, P1288, DOI 10.1111/cea.12520; Lieberman P, 2015, ANN ALLERG ASTHMA IM, V115, P341, DOI 10.1016/j.anai.2015.07.019; McNeil MM, 2016, J ALLERGY CLIN IMMUN, V137, P868, DOI 10.1016/j.jaci.2015.07.048; Sicherer SH, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4006; 2017, MED LETT DRUGS THERA, V59	11	1	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					86	87		10.1001/jama.2017.6470	http://dx.doi.org/10.1001/jama.2017.6470			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672315				2022-12-28	WOS:000404717700019
J	Desplan, C; Plachta, N; Monteiro, A; Guillemin, K; Briscoe, J				Desplan, Claude; Plachta, Nicolas; Monteiro, Antonia; Guillemin, Karen; Briscoe, James			What Is the Future of Developmental Biology?	CELL			English	Editorial Material									[Desplan, Claude] NYU, New York, NY 10003 USA; [Plachta, Nicolas] Inst Mol & Cell Biol, A STAR, Singapore, Singapore; [Monteiro, Antonia] Natl Univ Singapore, Singapore, Singapore; [Guillemin, Karen] Univ Oregon, CIFAR, Eugene, OR 97403 USA; [Briscoe, James] Francis Crick Inst, London, England	New York University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; University of Oregon; Francis Crick Institute	Desplan, C (corresponding author), NYU, New York, NY 10003 USA.		Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X					0	3	3	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					6	7						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666124	Bronze			2022-12-28	WOS:000404358500002
J	Funk, VA; Herendeen, P; Knapp, S				Funk, Vicki A.; Herendeen, Patrick; Knapp, Sandra			Taxonomy: naming algae, fungi, plants	NATURE			English	Letter									[Funk, Vicki A.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Herendeen, Patrick] Chicago Bot Garden, Glencoe, IL USA; [Knapp, Sandra] Nat Hist Museum, London, England	Smithsonian Institution; Smithsonian National Museum of Natural History; Natural History Museum London	Knapp, S (corresponding author), Nat Hist Museum, London, England.	s.knapp@nhm.ac.uk	Herendeen, Patrick S/F-3032-2010	Herendeen, Patrick S/0000-0003-2657-8671				2017, NATURE, V546, P25	1	4	5	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					599	599		10.1038/546599c	http://dx.doi.org/10.1038/546599c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658217	Bronze			2022-12-28	WOS:000404332000026
J	Rozing, MP; Kirkwood, TBL; Westendorp, RGJ				Rozing, Maarten P.; Kirkwood, Thomas B. L.; Westendorp, Rudi G. J.			Is there evidence for a limit to human lifespan?	NATURE			English	Letter							ERRORS		[Rozing, Maarten P.; Kirkwood, Thomas B. L.; Westendorp, Rudi G. J.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Rozing, Maarten P.; Westendorp, Rudi G. J.] Univ Copenhagen, Sect Social Med, Dept Publ Hlth, Copenhagen, Denmark; [Kirkwood, Thomas B. L.] Univ Copenhagen, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Rozing, MP (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.; Rozing, MP (corresponding author), Univ Copenhagen, Sect Social Med, Dept Publ Hlth, Copenhagen, Denmark.	mroz@sund.ku.dk	Rozing, Maarten/AHC-7454-2022					Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; HOPKINS B, 1973, J EXP EDUC, V41, P31, DOI 10.1080/00220973.1973.11011423; KAISER HF, 1960, PSYCHOL REV, V67, P160, DOI 10.1037/h0047595; KIMBALL AW, 1957, J AM STAT ASSOC, V52, P133, DOI 10.2307/2280840; Kowald A, 2016, AGING CELL, V15, P986, DOI 10.1111/acel.12510	5	19	19	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E11	E12		10.1038/nature22788	http://dx.doi.org/10.1038/nature22788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658235				2022-12-28	WOS:000404332000005
J	Rusu, V; Hoch, E; Mercader, JM; Tenen, DE; Gymrek, M; Hartigan, CR; DeRan, M; von Grotthuss, M; Fontanillas, P; Spooner, A; Guzman, G; Deik, AA; Pierce, KA; Dennis, C; Clish, CB; Carr, SA; Wagner, BK; Schenone, M; Ng, MCY; Chen, BH; Centeno-Cruz, F; Zerrweck, C; Orozco, L; Altshuler, DM; Schreiber, SL; Florez, JC; Jacobs, SBR; Lander, ES				Rusu, Victor; Hoch, Eitan; Mercader, Josep M.; Tenen, Danielle E.; Gymrek, Melissa; Hartigan, Christina R.; DeRan, Michael; von Grotthuss, Marcin; Fontanillas, Pierre; Spooner, Alexandra; Guzman, Gaelen; Deik, Amy A.; Pierce, Kerry A.; Dennis, Courtney; Clish, Clary B.; Carr, Steven A.; Wagner, Bridget K.; Schenone, Monica; Ng, Maggie C. Y.; Chen, Brian H.; Centeno-Cruz, Federico; Zerrweck, Carlos; Orozco, Lorena; Altshuler, David M.; Schreiber, Stuart L.; Florez, Jose C.; Jacobs, Suzanne B. R.; Lander, Eric S.		MEDIA Consortium; SIGMA T2D Consortium	Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms	CELL			English	Article							INSULIN-RESISTANCE; REDUCING LIPIDS; ASSOCIATION; EXPRESSION; DISEASE; TRANSPORTER; ENRICHMENT; MUTATIONS; PROFILES; EFFICACY	Type 2 diabetes (T2D) affects Latinos at twice the rate seen in populations of European descent. We recently identified a risk haplotype spanning SLC16A11 that explains similar to 20% of the increased T2D prevalence in Mexico. Here, through genetic fine-mapping, we define a set of tightly linked variants likely to contain the causal allele(s). We show that variants on the T2D-associated haplotype have two distinct effects: (1) decreasing SLC16A11 expression in liver and (2) disrupting a key interaction with basigin, thereby reducing cell-surface localization. Both independent mechanisms reduce SLC16A11 function and suggest SLC16A11 is the causal gene at this locus. To gain insight into how SLC16A11 disruption impacts T2D risk, we demonstrate that SLC16A11 is a proton-coupled monocarboxylate transporter and that genetic perturbation of SLC16A11 induces changes in fatty acid and lipid metabolism that are associated with increased T2D risk. Our findings suggest that increasing SLC16A11 function could be therapeutically beneficial for T2D.	[Rusu, Victor] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Rusu, Victor; Hoch, Eitan; Mercader, Josep M.; Gymrek, Melissa; von Grotthuss, Marcin; Fontanillas, Pierre; Spooner, Alexandra; Altshuler, David M.; Florez, Jose C.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hoch, Eitan; Clish, Clary B.; Florez, Jose C.; Jacobs, Suzanne B. R.] Broad Inst Harvard & MIT, Metab Program, Cambridge, MA 02142 USA; [Mercader, Josep M.; Florez, Jose C.; Jacobs, Suzanne B. R.] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Mercader, Josep M.; Florez, Jose C.; Jacobs, Suzanne B. R.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Mercader, Josep M.] Joint BSC CRG IRB Res Program Computat Biol, BSC, Barcelona 08034, Spain; [Tenen, Danielle E.; Hartigan, Christina R.; DeRan, Michael; Guzman, Gaelen; Deik, Amy A.; Pierce, Kerry A.; Dennis, Courtney; Clish, Clary B.; Carr, Steven A.; Wagner, Bridget K.; Schenone, Monica; Ng, Maggie C. Y.; Schreiber, Stuart L.; Lander, Eric S.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Tenen, Danielle E.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02215 USA; [Gymrek, Melissa] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ng, Maggie C. Y.] Wake Forest Sch Med, Ctr Diabet Res, Ctr Genom & Personalized Med Res, Winston Salem, NC 27157 USA; [Chen, Brian H.] NIA, Longitudinal Studies Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Centeno-Cruz, Federico; Orozco, Lorena] Inst Nacl Med Genom, Mexico City, DF, Mexico; [Zerrweck, Carlos] Hosp Gen Tlahuac, Obes Clin, Mexico City 13250, DF, Mexico; [Altshuler, David M.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Altshuler, David M.; Florez, Jose C.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Altshuler, David M.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Rusu, Victor] Jnana Therapeut, Boston, MA 02210 USA; [Gymrek, Melissa] Univ Calif San Diego, Dept Comp Sci & Engn, Dept Med, La Jolla, CA 92093 USA; [Fontanillas, Pierre] 23andMe, Mountain View, CA 94041 USA; [Altshuler, David M.] Vertex Pharmaceut, Boston, MA 02210 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Instituto Nacional de Medicina Genomica; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of California System; University of California San Diego; Vertex Pharmaceuticals	Florez, JC (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA.; Florez, JC (corresponding author), Broad Inst Harvard & MIT, Metab Program, Cambridge, MA 02142 USA.; Florez, JC (corresponding author), Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA.; Florez, JC (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Lander, ES (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Florez, JC (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Lander, ES (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Lander, ES (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	jcflorez@mgh.harvard.edu; lander@broadinstitute.org	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Carr, Steven A./AAH-8366-2019; /S-1190-2019; Singleton, Andrew B/C-3010-2009; Crawford, Dana/O-5578-2019; Altshuler, David M/A-4476-2009; Bielinski, Suzette/A-2238-2009; Loos, Ruth/Q-2862-2016	Clish, Clary B/0000-0001-8259-9245; /0000-0001-7488-250X; Crawford, Dana/0000-0002-6437-6248; Altshuler, David M/0000-0002-7250-4107; Guzman, Gaelen/0000-0002-7696-6034; Rich, Stephen/0000-0003-3872-7793; Gomez Velasco, Donaji Veronica/0000-0001-9648-4932; Couper, David/0000-0002-4313-9235; Almeda-Valdes, Paloma/0000-0002-9701-5879; Orozco, Lorena/0000-0002-5801-9180; Evans, Michele/0000-0002-8546-2831; Munoz-Hernandez, Linda Liliana/0000-0003-2803-4408; Pacheco, Jennifer/0000-0001-8021-5818; Centeno Cruz, Federico/0000-0002-3512-4519; Mercader, Josep M/0000-0001-8494-3660; Bielinski, Suzette/0000-0002-2905-5430; Pankow, James/0000-0001-7076-483X; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160; DeRan, Michael/0000-0003-4760-3928; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Jacobs, Suzanne/0000-0002-8103-1700; Patel, Sanjay/0000-0002-9142-5172; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Shriner, Daniel/0000-0003-1928-5520; Loos, Ruth/0000-0002-8532-5087	NIH [R01 DK066358, UM1HG008895]; Beatriu de Pinos fellowship from the Agency for Management of University and Research [2014 BP-B 00227]; Carlos Slim Foundation in Mexico; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG008895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK066358] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beatriu de Pinos fellowship from the Agency for Management of University and Research; Carlos Slim Foundation in Mexico; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Jason Wright, Jessica Gasser, Jamie Marshall, and Daniel O'Connell for many helpful discussions; Bryan MacDonald for discussions and critical reading of the manuscript; Kasper Lage for guidance on GeNets analysis; Zach Dymek for lab management support; and Lior Friedman and Leslie Gaffney for graphic design input. We also acknowledge the many discussions with the Lander, Schreiber, Altshuler, and Florez laboratories and the Diabetes Research Group at the Broad Institute. The Meta-analysis of Type 2 Diabetes in African Americans (MEDIA) Consortium was partly supported by NIH R01 DK066358 to Donald Bowden. J.M.M. was supported by Beatriu de Pinos fellowship from the Agency for Management of University and Research Grants (2014 BP-B 00227). E.H. is a Klarman Family Foundation fellow. E.S.L. is supported in part by NIH UM1HG008895. This work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Foundation in Mexico. S.L.S. is a cofounder and a scientific advisor to Jnana Therapeutics. V.R. is now an employee of Jnana Therapeutics. E.S.L. has no financial conflict of interest related to work on SLC16A11 or type 2 diabetes.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Flannick J, 2016, NAT REV GENET, V17, P535, DOI 10.1038/nrg.2016.56; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Hara K, 2014, HUM MOL GENET, V23, P239, DOI 10.1093/hmg/ddt399; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hugo SE, 2012, GENE DEV, V26, P282, DOI 10.1101/gad.180968.111; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; Locke JM, 2015, DIABETES, V64, P1484, DOI 10.2337/db14-0957; Manoharan C, 2006, MOL MEMBR BIOL, V23, P486, DOI 10.1080/09687860600841967; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Nauck MA, 2014, DRUG DES DEV THER, V8, P1335, DOI 10.2147/DDDT.S50773; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Ng MCY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004517; Ovens MJ, 2010, BIOCHEM J, V425, P523, DOI 10.1042/BJ20091515; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SEYMOUR CA, 1993, POSTGRAD MED J, V69, P679, DOI 10.1136/pgmj.69.815.679; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Traurig M, 2016, DIABETES, V65, P510, DOI 10.2337/db15-0571; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005; Visser WE, 2009, ENDOCRINOLOGY, V150, P5163, DOI 10.1210/en.2009-0699; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Wajner M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150240; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williams AL, 2014, NATURE, V506, P97, DOI 10.1038/nature12828	59	93	96	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					199	+		10.1016/j.cell.2017.06.011	http://dx.doi.org/10.1016/j.cell.2017.06.011			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666119	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000404358500020
J	Slomski, A				Slomski, Anita			Nocebo Effect May Account for Statin Adverse Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2476	2476		10.1001/jama.2017.7582	http://dx.doi.org/10.1001/jama.2017.7582			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655010				2022-12-28	WOS:000404106600007
J	Purdy, TP; Grutter, KE; Srinivasan, K; Taylor, JM				Purdy, T. P.; Grutter, K. E.; Srinivasan, K.; Taylor, J. M.			Quantum correlations from a room-temperature optomechanical cavity	SCIENCE			English	Article							MECHANICAL OSCILLATOR; SHOT-NOISE; THERMOMETRY; LIGHT	The act of position measurement alters the motion of an object being measured. This quantum measurement backaction is typically much smaller than the thermal motion of a room-temperature object and thus difficult to observe. By shining laser light through a nanomechanical beam, we measure the beam's thermally driven vibrations and perturb its motion with optical force fluctuations at a level dictated by the Heisenberg measurement-disturbance uncertainty relation. We demonstrate a cross-correlation technique to distinguish optically driven motion from thermally driven motion, observing this quantum backaction signature up to room temperature. We use the scale of the quantum correlations, which is determined by fundamental constants, to gauge the size of thermal motion, demonstrating a path toward absolute thermometry with quantum mechanically calibrated ticks.	[Purdy, T. P.; Taylor, J. M.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Grutter, K. E.; Srinivasan, K.] NIST, Ctr Nanoscale Sci & Technol, Gaithersburg, MD 20899 USA; [Taylor, J. M.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Grutter, K. E.] Lab Phys Sci, College Pk, MD 20740 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Purdy, TP (corresponding author), NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA.	thomas.purdy@nist.gov	Taylor, Jacob M/B-7826-2011; Taylor, Jacob/O-1670-2019	Taylor, Jacob M/0000-0003-0493-5594; Taylor, Jacob/0000-0003-0493-5594; Grutter, Karen/0000-0003-1455-6686; Purdy, Thomas/0000-0002-2240-5215				Borkje K, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013818; Brooks DWC, 2012, NATURE, V488, P476, DOI 10.1038/nature11325; Chua SSY, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/18/183001; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Dakin J. P., 1985, OPTICAL FIBER SENSOR; Davanco M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4858975; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; FABRE C, 1994, PHYS REV A, V49, P1337, DOI 10.1103/PhysRevA.49.1337; Fischer J, 2015, METROLOGIA, V52, pS364, DOI 10.1088/0026-1394/52/5/S364; Flowers J, 2004, SCIENCE, V306, P1324, DOI 10.1126/science.1102156; Grutter KE, 2015, IEEE J SEL TOP QUANT, V21, DOI 10.1109/JSTQE.2014.2376966; Han X, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4919113; Heidmann A, 1997, APPL PHYS B-LASERS O, V64, P173, DOI 10.1007/s003400050162; Heisenberg W., 1949, PHYS PRINCIPLES QUAN; Khalili FY, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.033840; Lecocq F, 2015, NAT PHYS, V11, P635, DOI [10.1038/NPHYS3365, 10.1038/nphys3365]; Meenehan SM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041002; Migdall A, 1999, ANAL CHIM ACTA, V380, P311, DOI 10.1016/S0003-2670(98)00685-0; PEKOLA JP, 1994, PHYS REV LETT, V73, P2903, DOI 10.1103/PhysRevLett.73.2903; Purdy TP, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.031802; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Riedinger R, 2016, NATURE, V530, P313, DOI 10.1038/nature16536; Safavi-Naeini AH, 2013, NATURE, V500, P185, DOI 10.1038/nature12307; Safavi-Naeini AH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.033602; Spietz L, 2003, SCIENCE, V300, P1929, DOI 10.1126/science.1084647; Stamper-Kurn DM, 2014, QUANT SCI TECH, P283, DOI 10.1007/978-3-642-55312-7_13; Sudhir V, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011001; Teufel JD, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.013602; Underwood M, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.061801; Verlot P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103601; Verlot P, 2011, CR PHYS, V12, P826, DOI 10.1016/j.crhy.2011.03.008; Weinstein AJ, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041003; Wilson DJ, 2015, NATURE, V524, P325, DOI 10.1038/nature14672; Zink BL, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1848658	36	80	80	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1265	1268		10.1126/science.aag1407	http://dx.doi.org/10.1126/science.aag1407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642433				2022-12-28	WOS:000403881700035
J	Hwang, TJ; Kesselheim, AS; Sarpatwari, A				Hwang, Thomas J.; Kesselheim, Aaron S.; Sarpatwari, Ameet			Value-Based Pricing and State Reform of Prescription Drug Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hwang, Thomas J.; Kesselheim, Aaron S.; Sarpatwari, Ameet] Brigham & Womens Hosp, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hwang, Thomas J.; Kesselheim, Aaron S.; Sarpatwari, Ameet] Harvard Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sarpatwari, A (corresponding author), Harvard Med Sch, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.; Sarpatwari, A (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	asarpatwari@bwh.harvard.edu	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497	Engelberg Foundation; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science	Engelberg Foundation; Laura and John Arnold Foundation; Harvard Program in Therapeutic Science	This work is supported by grants from the Engelberg Foundation, Laura and John Arnold Foundation, and Harvard Program in Therapeutic Science (all from both Drs Kesselheim and Sarpatwari).	Sarpatwari A, 2016, NEW ENGL J MED, V374, P2301, DOI 10.1056/NEJMp1605100	1	24	23	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 15	2017	318	7					609	610		10.1001/jama.2017.8255	http://dx.doi.org/10.1001/jama.2017.8255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD6CH	28692713				2022-12-28	WOS:000407616000011
J	Gottlieb, S; Woodcock, J				Gottlieb, Scott; Woodcock, Janet			Marshaling FDA Benefit-Risk Expertise to Address the Current Opioid Abuse Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gottlieb, Scott; Woodcock, Janet] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	janet.woodcock@fda.hhs.gov						[Anonymous], DISP UN MED WHAT YOU; Lhachimi SK, 2010, AM J PREV MED, V38, P78, DOI 10.1016/j.amepre.2009.08.030; Nelson LS, 2015, JAMA-J AM MED ASSOC, V314, P1453, DOI 10.1001/jama.2015.12397; US Food and Drug Administration, RISK EV MIT STRAT RE; US Food and Drug Administration, FDA IS TAK NEW STEPS; US Food and Drug Administration, STRUCT APPR BEN RISK	6	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					421	422		10.1001/jama.2017.9205	http://dx.doi.org/10.1001/jama.2017.9205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FC2HZ	28687816				2022-12-28	WOS:000406659800009
J	Schuchat, A; Houry, D; Guy, GP				Schuchat, Anne; Houry, Debra; Guy, Gery P., Jr.			New Data on Opioid Use and Prescribing in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OVERDOSE; PRESCRIPTION; DEPENDENCE; ABUSE		[Schuchat, Anne; Houry, Debra; Guy, Gery P., Jr.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop D14, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Schuchat, A (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop D14, Atlanta, GA 30329 USA.	aschuchat@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Centers for Disease Control and Prevention, 2017, OP OV GUID RES CLIN; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625; Guy Jr GP, 2017, MMWR MORB MORTAL WKL, V6; Mercado MC, 2018, PAIN MED, V19, P511, DOI 10.1093/pm/pnx015; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1	8	190	190	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 1	2017	318	5					425	426		10.1001/jama.2017.8913	http://dx.doi.org/10.1001/jama.2017.8913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC2HZ	28687823	Green Accepted			2022-12-28	WOS:000406659800011
J	Lee, DH				Lee, Dung-Hai			Hunting down unconventional superconductors	SCIENCE			English	Editorial Material							FESE		[Lee, Dung-Hai] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lee, Dung-Hai] Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Lee, DH (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Lee, DH (corresponding author), Lawrence Berkeley Natl Labs, Div Mat Sci, Berkeley, CA 94720 USA.	dunghai@berkeley.edu						Gerber S, 2017, SCIENCE, V357, P71, DOI 10.1126/science.aak9946; Kasahara S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12843; Kasahara S, 2014, P NATL ACAD SCI USA, V111, P16309, DOI 10.1073/pnas.1413477111; Lee JJ, 2014, NATURE, V515, P245, DOI 10.1038/nature13894; Song CL, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.157001; Sprau PO, 2017, SCIENCE, V357, P76, DOI 10.1126/science.aal1575	6	6	6	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		32	33		10.1126/science.aan2657	http://dx.doi.org/10.1126/science.aan2657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684490				2022-12-28	WOS:000404854100035
J	Aiello, NM; Brabletz, T; Kang, YB; Nieto, MA; Weinberg, RA; Stanger, BZ				Aiello, Nicole M.; Brabletz, Thomas; Kang, Yibin; Angela Nieto, M.; Weinberg, Robert A.; Stanger, Ben Z.			Upholding a role for EMT in pancreatic cancer metastasis	NATURE			English	Letter									[Aiello, Nicole M.; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; [Aiello, Nicole M.; Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Brabletz, Thomas] FAU Univ Erlangen Nuernberg, Nikolaus Fiebiger Ctr Mol Med, Expt Med 1, D-91054 Erlangen, Germany; [Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Angela Nieto, M.] Inst Neurociencias CSIC UMH, Avda Ramon y Cajal S-N, Alacant 03550, Spain; [Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Erlangen Nuremberg; Princeton University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Stanger, BZ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA.; Stanger, BZ (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	bstanger@exchange.upenn.edu	Nieto, M. Angela/A-6531-2008	Nieto, M. Angela/0000-0002-3538-840X; Kang, Yibin/0000-0002-1626-6730; Aiello, Nicole/0000-0003-1616-5785	NCI NIH HHS [R01 CA169123] Funding Source: Medline; NIDDK NIH HHS [P30 DK050306] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA169123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	3	155	159	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					E7	E8		10.1038/nature22963	http://dx.doi.org/10.1038/nature22963			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682339	Green Accepted, Green Submitted			2022-12-28	WOS:000404839900003
J	Davies, M				Davies, Mark			Five things I wish I'd known at the start of my career as a GP	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mark.davies@bmj.com						GERRARD TJ, 1988, BRIT MED J, V297, P530, DOI 10.1136/bmj.297.6647.530	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2017	357								j3042	10.1136/bmj.j3042	http://dx.doi.org/10.1136/bmj.j3042			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AT	28659277				2022-12-28	WOS:000404724400006
J	Pain, E				Pain, Elisabeth			A top mathematician joins the Macron revolution	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1223	1223		10.1126/science.356.6344.1223	http://dx.doi.org/10.1126/science.356.6344.1223			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642391				2022-12-28	WOS:000403881700014
J	Jih, G; Iglesias, N; Currie, MA; Bhanu, NV; Paulo, JA; Gygi, SP; Garcia, BA; Moazed, D				Jih, Gloria; Iglesias, Nahid; Currie, Mark A.; Bhanu, Natarajan V.; Paulo, Joao A.; Gygi, Steven P.; Garcia, Benjamin A.; Moazed, Danesh			Unique roles for histone H3K9me states in RNAi and heritable silencing of transcription	NATURE			English	Article							DECOY SEARCH STRATEGY; PROTEIN-PHOSPHORYLATION; EPIGENETIC INHERITANCE; PRODUCT SPECIFICITY; HETEROCHROMATIN; CHROMATIN; COMPLEX; RITS; H3; INTERFERENCE	Heterochromatic DNA domains have important roles in the regulation of gene expression and maintenance of genome stability by silencing repetitive DNA elements and transposons. From fission yeast to mammals, heterochromatin assembly at DNA repeats involves the activity of small noncoding RNAs (sRNAs) associated with the RNA interference (RNAi) pathway(1-9). Typically, sRNAs, originating from long noncoding RNAs, guide Argonaute-containing effector complexes to complementary nascent RNAs to initiate histone H3 lysine 9 di- and trimethylation (H3K9me2 and H3K9me3, respectively) and the formation of heterochromatin(10-17). H3K9me is in turn required for the recruitment of RNAi to chromatin to promote the amplification of sRNA(11,15,18). Yet, how heterochromatin formation, which silences transcription, can proceed by a co-transcriptional mechanism that also promotes sRNA generation remains paradoxical. Here, using Clr4, the fission yeast Schizosaccharomyces pombe homologue of mammalian SUV39H H3K9 methyltransferases, we design active-site mutations that block H3K9me3, but allow H3K9me2 catalysis. We show that H3K9me2 defines a functionally distinct heterochromatin state that is sufficient for RNAi-dependent co-transcriptional gene silencing at pericentromeric DNA repeats. Unlike H3K9me3 domains, which are transcriptionally silent, H3K9me2 domains are transcriptionally active, contain modifications associated with euchromatic transcription, and couple RNAi-mediated transcript degradation to the establishment of H3K9me domains. The two H3K9me states recruit reader proteins with different efficiencies, explaining their different downstream silencing functions. Furthermore, the transition from H3K9me2 to H3K9me3 is required for RNAi-independent epigenetic inheritance of H3K9me domains. Our findings demonstrate that H3K9me2 and H3K9me3 define functionally distinct chromatin states and uncover a mechanism for the formation of transcriptionally permissive heterochromatin that is compatible with its broadly conserved role in sRNA-mediated genome defence.	[Jih, Gloria; Iglesias, Nahid; Currie, Mark A.; Paulo, Joao A.; Gygi, Steven P.; Moazed, Danesh] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Jih, Gloria; Iglesias, Nahid; Currie, Mark A.; Moazed, Danesh] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Bhanu, Natarajan V.; Garcia, Benjamin A.] Univ Penn, Dept Biochem & Biophys, Epigenet Program, Perelman Sch Med, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine	Moazed, D (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.; Moazed, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Paulo, Joao/AAO-3981-2020	Paulo, Joao/0000-0002-4291-413X; Iglesias, Nahid/0000-0001-5185-846X	NIH [T32 GM007226, RO1 GM072805, K01 DK098285, RO1 GM110174]; EMBO long-term fellowship; Swiss National Science Foundation; NATIONAL CANCER INSTITUTE [P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110174, R01GM072805, T32GM007226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kalocsay for help with histone MS analysis, R. C. Kunz (Thermo Fisher Scientific Center for Multiplexed Proteomics, Harvard Medical School) for performing the initial TMT/MS, the Nikon Imaging Center at Harvard Medical School for access to confocal microscopes, K. Connolly for help with imaging, C. K. Wong and Z. Moqtaderi for help with Illumina library construction and data processing, R. Yu for Python scripts, D. Holoch for the Swi6 antibody, R. Behrouzi, D. Holoch and G. Shipkovenska for comments on the manuscript, and members of the Moazed laboratory for discussion. This work was supported by an NIH training grant (T32 GM007226) (G.J.), an EMBO long-term fellowship and a Swiss National Science Foundation postdoctoral fellowship (N.I.), NIH RO1 GM072805 (D.M.), K01 DK098285 (J.A.P.), and RO1 GM110174 (B.A.G.). D. M. is a Howard Hughes Medical Institute Investigator.	Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Buckley BA, 2012, NATURE, V489, P447, DOI 10.1038/nature11352; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Holoch D, 2015, NAT STRUCT MOL BIOL, V22, P328, DOI 10.1038/nsmb.2979; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Paulo JA, 2016, J AM SOC MASS SPECTR, V27, P1620, DOI 10.1007/s13361-016-1434-9; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Rangan P, 2011, CURR BIOL, V21, P1373, DOI 10.1016/j.cub.2011.06.057; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sidoli S, 2016, JOVE-J VIS EXP, DOI 10.3791/54112; Sidoli S, 2015, MOL CELL PROTEOMICS, V14, P2420, DOI 10.1074/mcp.O114.046102; Sienski G, 2015, GENE DEV, V29, P2258, DOI 10.1101/gad.271908.115; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wong K. H., 2013, CURR PROTOC MOL BIOL; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Yu Y, 2015, SCIENCE, V350, P339, DOI 10.1126/science.aab0700; Yuan ZF, 2015, MOL CELL PROTEOMICS, V14, P1696, DOI 10.1074/mcp.M114.046011; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	44	61	64	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					463	+		10.1038/nature23267	http://dx.doi.org/10.1038/nature23267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28682306	Green Accepted, Green Submitted			2022-12-28	WOS:000406358300038
J	Mullan, F				Mullan, Fitzhugh			Social Mission in Health Professions Education Beyond Flexner	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mullan, Fitzhugh] George Washington Univ, Milken Inst Publ Hlth, 2175 K St NW,Ste 500, Washington, DC 20017 USA	George Washington University	Mullan, F (corresponding author), George Washington Univ, Dept Hlth Policy & Management, 2175 K St NW,Ste 500, Washington, DC 20017 USA.	fmullan@gwu.edu						[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Beyond Flexner Alliance, WHAT IS SOC MISS; Flexner A., 1910, MEDICAL ED US CANADA; Institute of Medicine National Academies of Sciences Engineering and Medicine, ED HLTH PROF ADDR SO; Mullan F, 2010, ANN INTERN MED, V152, P804, DOI 10.7326/0003-4819-152-12-201006150-00009; Valsangkar B, 2014, ACAD MED, V89, P892, DOI 10.1097/ACM.0000000000000241	6	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					122	123		10.1001/jama.2017.7286	http://dx.doi.org/10.1001/jama.2017.7286			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28654979				2022-12-28	WOS:000405190800010
J	Gibbons, A				Gibbons, Ann			HUMAN EVOLUTION Neandertals mated early with modern humans	SCIENCE			English	News Item																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		14	14		10.1126/science.357.6346.14	http://dx.doi.org/10.1126/science.357.6346.14			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684477				2022-12-28	WOS:000404854100011
J	Normile, D				Normile, Dennis			ENERGY POLICY South Korea's nuclear U-turn draws praise and darts	SCIENCE			English	News Item																			0	4	4	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		15	15		10.1126/science.357.6346.15	http://dx.doi.org/10.1126/science.357.6346.15			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684478				2022-12-28	WOS:000404854100012
J	Barnett, ML; Grabowski, DC; Mehrotra, A				Barnett, Michael L.; Grabowski, David C.; Mehrotra, Ateev			Home-to-Home Time - Measuring What Matters to Patients and Payers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Grabowski, David C.; Mehrotra, Ateev] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Barnett, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.		Mehrotra, Ateev/AAO-8454-2021; Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Mehrotra, Ateev/0000-0003-2223-1582; Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609; Grabowski, David/0000-0003-2915-5770				Centers for Medicare and Medicaid Services, CMS PROGR STAT MED U; Coulam R F, 1991, Health Care Financ Rev Annu Suppl, P45; Guterman S, 1986, Health Care Financ Rev, V7, P97; MORRISEY MA, 1988, HEALTH AFFAIR, V7, P52, DOI 10.1377/hlthaff.7.5.52	4	38	37	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2017	377	1					4	6		10.1056/NEJMp1703423	http://dx.doi.org/10.1056/NEJMp1703423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5CS	28679095				2022-12-28	WOS:000404730000002
J	Wilson, NM				Wilson, Nicholas M.			Arthur Claude Wilson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item									[Wilson, Nicholas M.] Southport Gen Infirm, Southport, Qld, Australia; [Wilson, Nicholas M.] Christiana Hartley Matern Hosp, Southport, Qld, Australia		Wilson, NM (corresponding author), Southport Gen Infirm, Southport, Qld, Australia.; Wilson, NM (corresponding author), Christiana Hartley Matern Hosp, Southport, Qld, Australia.								0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 4	2017	358								j3222	10.1136/bmj.j3222	http://dx.doi.org/10.1136/bmj.j3222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DM	28676477				2022-12-28	WOS:000405322100006
J	Adebesin, F; Widhalm, JR; Boachon, B; Lefevre, F; Pierman, B; Lynch, JH; Alam, I; Junqueira, B; Benke, R; Ray, S; Porter, JA; Yanagisawa, M; Wetzstein, HY; Morgan, JA; Boutry, M; Schuurink, RC; Dudareva, N				Adebesin, Funmilayo; Widhalm, Joshua R.; Boachon, Benoit; Lefevre, Francois; Pierman, Baptiste; Lynch, Joseph H.; Alam, Iftekhar; Junqueira, Bruna; Benke, Ryan; Ray, Shaunak; Porter, Justin A.; Yanagisawa, Makoto; Wetzstein, Hazel Y.; Morgan, John A.; Boutry, Marc; Schuurink, Robert C.; Dudareva, Natalia			Emission of volatile organic compounds from petunia flowers is facilitated by an ABC transporter	SCIENCE			English	Article							PLANT VOLATILES; NICOTIANA-TABACUM; BIOSYNTHESIS; EVOLUTION	Plants synthesize a diversity of volatile molecules that are important for reproduction and defense, serve as practical products for humans, and influence atmospheric chemistry and climate. Despite progress in deciphering plant volatile biosynthesis, their release from the cell has been poorly understood. The default assumption has been that volatiles passively diffuse out of cells. By characterization of a Petunia hybrida adenosine triphosphate-binding cassette (ABC) transporter, PhABCG1, we demonstrate that passage of volatiles across the plasma membrane relies on active transport. PhABCG1 down-regulation by RNA interference results in decreased emission of volatiles, which accumulate to toxic levels in the plasma membrane. This study provides direct proof of a biologically mediated mechanism of volatile emission.	[Adebesin, Funmilayo; Widhalm, Joshua R.; Boachon, Benoit; Lynch, Joseph H.; Benke, Ryan; Morgan, John A.; Dudareva, Natalia] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Widhalm, Joshua R.; Dudareva, Natalia] Purdue Univ, Purdue Ctr Plant Biol, W Lafayette, IN 47907 USA; [Lefevre, Francois; Pierman, Baptiste; Alam, Iftekhar; Junqueira, Bruna; Boutry, Marc] Catholic Univ Louvain, Inst Sci Vie, Croix Sud 4-5,Box L7-04-14, B-1348 Louvain La Neuve, Belgium; [Ray, Shaunak; Morgan, John A.] Purdue Univ, Sch Chem Engn, 480 Stadium Mall Dr, W Lafayette, IN 47907 USA; [Widhalm, Joshua R.; Porter, Justin A.; Wetzstein, Hazel Y.; Dudareva, Natalia] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Yanagisawa, Makoto] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Schuurink, Robert C.] Univ Amsterdam, Dept Plant Physiol, Swammerdam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Alam, Iftekhar] Natl Inst Biotechnol, Plant Biotechnol Div, Dhaka 1349, Bangladesh	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universite Catholique Louvain; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Amsterdam; National Institute of Biotechnology (NIB)	Dudareva, N (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Dudareva, N (corresponding author), Purdue Univ, Purdue Ctr Plant Biol, W Lafayette, IN 47907 USA.; Dudareva, N (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	dudareva@purdue.edu	Widhalm, Joshua R/E-4117-2016; Dudareva, Natalia/S-8710-2017; Morgan, John/B-8609-2018	Widhalm, Joshua R/0000-0002-2703-4740; Dudareva, Natalia/0000-0003-0777-7763; Morgan, John/0000-0002-5326-4988; Alam, Iftekhar/0000-0002-4608-6490; Pierman, Baptiste/0000-0002-4292-7985; BOACHON, Benoit/0000-0002-2362-2238; Yanagisawa, Makoto/0000-0003-1824-2326; Lynch, Joseph/0000-0003-0685-1562	National Science Foundation [IOS-1655438]; Belgian National Fund for Scientific Research; Interuniversity Poles of Attraction Program (Belgium); NSF [MCB-1121893]	National Science Foundation(National Science Foundation (NSF)); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Interuniversity Poles of Attraction Program (Belgium); NSF(National Science Foundation (NSF))	This work was supported by grant IOS-1655438 from the National Science Foundation to J.A.M. and N.D. and in part by grants from the Belgian National Fund for Scientific Research and the Interuniversity Poles of Attraction Program (Belgium). M.Y. was supported by NSF grant MCB-1121893 to D.B. Szymanski. We thank J. Nader for excellent technical help and A. Withrow for assisting with transmission electron microscopy. The supplementary materials contain additional data.	Borghi M, 2017, TRENDS PLANT SCI, V22, P338, DOI 10.1016/j.tplants.2016.12.009; Chen F, 2004, PLANT PHYSIOL, V135, P1956, DOI 10.1104/pp.104.044388; Cinege G, 2009, PLANT MOL BIOL, V69, P593, DOI 10.1007/s11103-008-9441-2; Crouzet J, 2013, PLANT MOL BIOL, V82, P181, DOI 10.1007/s11103-013-0053-0; Cseke L, 1998, MOL BIOL EVOL, V15, P1491, DOI 10.1093/oxfordjournals.molbev.a025876; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Glas JJ, 2012, INT J MOL SCI, V13, P17077, DOI 10.3390/ijms131217077; Kolosova N, 2001, PLANT PHYSIOL, V126, P956, DOI 10.1104/pp.126.3.956; Krasnow M, 2008, J EXP BOT, V59, P849, DOI 10.1093/jxb/erm372; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; McFarlane HE, 2010, PLANT CELL, V22, P3066, DOI 10.1105/tpc.110.077974; Mendanha SA, 2015, BIOPHYS CHEM, V198, P45, DOI 10.1016/j.bpc.2015.02.001; Mercx S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00040; Misztal PK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12064; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Niinemets U, 2002, PLANT PHYSIOL, V130, P1371, DOI 10.1104/pp.009670; Penuelas J, 2004, TRENDS ECOL EVOL, V19, P402, DOI 10.1016/j.tree.2004.06.002; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Pichersky E, 2002, CURR OPIN PLANT BIOL, V5, P237, DOI 10.1016/S1369-5266(02)00251-0; Rolny N, 2011, PLANT PHYSIOL BIOCH, V49, P1220, DOI 10.1016/j.plaphy.2011.06.010; Scalliet G, 2006, PLANT PHYSIOL, V140, P18, DOI 10.1104/pp.105.070961; Schuman MC, 2016, SIGNAL COMMUN PLANTS, P3, DOI 10.1007/978-3-319-33498-1_1; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153; Van Moerkercke A, 2012, J EXP BOT, V63, P3157, DOI 10.1093/jxb/ers034; Verdonk JC, 2005, PLANT CELL, V17, P1612, DOI 10.1105/tpc.104.028837; Verdonk JC, 2003, PHYTOCHEMISTRY, V62, P997, DOI 10.1016/S0031-9422(02)00707-0; Widhalm JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9142; Widhalm JR, 2015, TRENDS PLANT SCI, V20, P545, DOI 10.1016/j.tplants.2015.06.009; Zhao DF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14067	29	132	137	17	178	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1386	1388		10.1126/science.aan0826	http://dx.doi.org/10.1126/science.aan0826			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663500	Green Published			2022-12-28	WOS:000404351500038
J	Pennisi, E				Pennisi, Elizabeth			Drowned wildebeest provide ecological feast	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1217	1218		10.1126/science.356.6344.1217	http://dx.doi.org/10.1126/science.356.6344.1217			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642385				2022-12-28	WOS:000403881700008
J	Oldenburg, J; Mahlangu, JN; Kim, B; Schmitt, C; Callaghan, MU; Young, G; Santagostino, E; Kruse-Jarres, R; Negrier, C; Kessler, C; Valente, N; Asikanius, E; Levy, GG; Windyga, J; Shima, M				Oldenburg, Johannes; Mahlangu, Johnny N.; Kim, Benjamin; Schmitt, Christophe; Callaghan, Michael U.; Young, Guy; Santagostino, Elena; Kruse-Jarres, Rebecca; Negrier, Claude; Kessler, Craig; Valente, Nancy; Asikanius, Elina; Levy, Gallia G.; Windyga, Jerzy; Shima, Midori			Emicizumab Prophylaxis in Hemophilia A with Inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; BISPECIFIC ANTIBODY; UTILITY; EQ-5D	BACKGROUND Emicizumab (ACE910) bridges activated factor IX and factor X to restore the function of activated factor VIII, which is deficient in persons with hemophilia A. This phase 3, multicenter trial assessed once-weekly subcutaneous emicizumab prophylaxis in persons with hemophilia A with factor VIII inhibitors. METHODS We enrolled participants who were 12 years of age or older. Those who had previously received episodic treatment with bypassing agents were randomly assigned in a 2: 1 ratio to emicizumab prophylaxis (group A) or no prophylaxis (group B). The primary end point was the difference in bleeding rates between group A and group B. Participants who had previously received prophylactic treatment with bypassing agents received emicizumab prophylaxis in group C. RESULTS A total of 109 male participants with hemophilia A with inhibitors were enrolled. The annualized bleeding rate was 2.9 events (95% confidence interval [CI], 1.7 to 5.0) among participants who were randomly assigned to emicizumab prophylaxis (group A, 35 participants) versus 23.3 events (95% CI, 12.3 to 43.9) among those assigned to no prophylaxis (group B, 18 participants), representing a significant difference of 87% in favor of emicizumab prophylaxis (P<0.001). A total of 22 participants in group A (63%) had zero bleeding events, as compared with 1 participant (6%) in group B. Among 24 participants in group C who had participated in a noninterventional study, emicizumab prophylaxis resulted in a bleeding rate that was significantly lower by 79% than the rate with previous bypassing-agent prophylaxis (P<0.001). Overall, 198 adverse events were reported in 103 participants receiving emicizumab prophylaxis; the most frequent events were injection- site reactions (in 15% of participants). Thrombotic microangiopathy and thrombosis were reported in 2 participants each (in the primary analysis) who had received multiple infusions of activated prothrombin complex concentrate for breakthrough bleeding. No antidrug antibodies were detected. CONCLUSIONS Emicizumab prophylaxis was associated with a significantly lower rate of bleeding events than no prophylaxis among participants with hemophilia A with inhibitors. (Funded by F. Hoffmann-La Roche and Chugai Pharmaceutical; HAVEN 1 ClinicalTrials. gov number, NCT02622321.)	[Oldenburg, Johannes] Univ Klinikum Bonn, Bonn, Germany; [Mahlangu, Johnny N.] Univ Witwatersrand, Fac Hlth Sci, Haemophilia Comprehens Care Ctr, Johannesburg, South Africa; [Mahlangu, Johnny N.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Kim, Benjamin; Valente, Nancy; Levy, Gallia G.] Genentech Inc, San Francisco, CA 94080 USA; [Young, Guy] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA USA; [Schmitt, Christophe; Asikanius, Elina] F Hoffmann La Roche, Basel, Switzerland; [Callaghan, Michael U.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Santagostino, Elena] Osped Maggiore Policlin, Ist Ricovero & Cura Carattere Sci, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Ca Granda Fdn, Milan, Italy; [Kruse-Jarres, Rebecca] Bloodworks Northwest, Seattle, WA USA; [Negrier, Claude] Univ Claude Bernard, Louis Pradel Cardiol Hosp, Lyon, France; [Kessler, Craig] Georgetown Univ, Med Ctr, Washington, DC 20007 USA; [Windyga, Jerzy] Inst Hematol & Transfus Med, Dept Disorders Hemostasis & Internal Med, Warsaw, Poland; [Shima, Midori] Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan	University of Bonn; University of Witwatersrand; National Health Laboratory Service; Roche Holding; Genentech; Children's Hospital Los Angeles; University of Southern California; Roche Holding; Children's Hospital of Michigan; IRCCS Ca Granda Ospedale Maggiore Policlinico; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Georgetown University; Nara Medical University	Oldenburg, J (corresponding author), Univ Klinikum Bonn, Inst Expt Hematol & Transfus Med, Sigmund Freud Str 25, D-53127 Bonn, Germany.	johannes.oldenburg@ukbonn.de	Windyga, Jerzy/AAC-8830-2020; Oldenburg, Johannes/ABB-7817-2020; Callaghan, Michael/AAH-2059-2019; Mahlangu, Johnny Ndoni/H-7558-2019; Su, VY/V-3450-2019	Windyga, Jerzy/0000-0001-7877-4784; Mahlangu, Johnny Ndoni/0000-0001-5781-7669; Negrier, Claude/0000-0003-3569-0366; Chamouard, Valerie/0000-0002-4443-1609; Oldenburg, Johannes/0000-0002-1585-4100	F. Hoffmann-La Roche; Chugai Pharmaceutical; Genentech; Bayer; Biogen Idec; CSL Behring; Novo Nordisk; Roche; Baxalta; Biotest; Roche/Genentech; Grifols; Biogen; Octapharma; Shire; Sancilio; Global Blood Therapeutics; Kedrion; Sobi; LFB Biotechnologies; Alnylam; Baxalta/Shire; Sanofi; Alexion; Baxter Healthcare; Chugai	F. Hoffmann-La Roche(Hoffmann-La Roche); Chugai Pharmaceutical; Genentech(Roche HoldingGenentech); Bayer(Bayer AG); Biogen Idec(Biogen); CSL Behring; Novo Nordisk(Novo Nordisk); Roche(Roche Holding); Baxalta; Biotest; Roche/Genentech(Roche HoldingGenentech); Grifols; Biogen(Biogen); Octapharma; Shire; Sancilio; Global Blood Therapeutics; Kedrion; Sobi; LFB Biotechnologies; Alnylam; Baxalta/Shire; Sanofi; Alexion; Baxter Healthcare; Chugai	Supported by F. Hoffmann-La Roche and Chugai Pharmaceutical.; Dr. Oldenburg reports receiving fees for serving on an advisory board from Genentech; Dr. Mahlangu, receiving grant support and lecture fees from Bayer, Biogen Idec, CSL Behring, Novo Nordisk, and Roche, fees for protocol review from Baxalta, fees for serving on an advisory board from Amgen, and lecture fees from Biotest; Dr. Schmitt, being employed by Roche; Dr. Callaghan, receiving grant support, lecture fees, and fees for serving on an advisory panel and serving as site principal investigator for Roche/Genentech, receiving grant support, lecture fees, and fees for serving on an advisory panel from Baxalta, receiving fees for serving on an advisory panel from Biogen, Grifols, CSL Behring, Bayer, and Octapharma, lecture fees and fees for serving on an advisory panel from Shire, lecture fees from Novo Nordisk, grant support, fees for serving on an advisory panel, and fees for serving as site principal investigator from Pfizer, and fees for serving as site principal investigator from Sancilio and Global Blood Therapeutics; Dr. Young, receiving honoraria from Alnylam, Biogen, Roche, and Shire, consulting fees from Bayer and Kedrion, and honoraria and consulting fees from Novo Nordisk; Dr. Santagostino, receiving grant support and fees for serving on advisory boards and lecture fees from Pfizer, Bayer, CSL Behring, Novo Nordisk, Grifols, Baxalta, Shire, Biogen Idec, Sobi, Octapharma, Kedrion, and Roche; Dr. Kruse-Jarres, receiving grant support and consulting fees from Pfizer and Roche and consulting fees from Baxalta, Bayer, CSL Behring, and Grifols; Dr. Negrier, receiving grant support and consulting fees and lecture fees from CSL Behring, LFB Biotechnologies, Octapharma, Pfizer, Sobi, Novo Nordisk, Alnylam, and Baxalta/Shire, and consulting fees and lecture fees from Bayer and Roche; Dr. Kessler, receiving fees for serving an advisory board from Genentech; Dr. Valente, being employed by Genentech and holding stock in Roche; Ms. Asikanius, being employed by and owning stock in Roche; Dr. Levy, being employed by Genentech/Roche and holding stock in Roche; Dr. Windyga, receiving grant support and lecture fees from Baxalta, Biogen Idec, Bayer, CSL Behring, Novo Nordisk, Octapharma, Sanofi, Alexion, and Baxter Healthcare; and Dr. Shima, receiving grant support and honoraria from Bayer, Biogen, Chugai, CSL Behring, Novo Nordisk, Baxalta, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Adamkewicz JI, 2017, HAEMOPHILIA, V23, P26; [Anonymous], 1997, Int Dig Health Legis, V48, P231; Blanchette VS, 2014, J THROMB HAEMOST, V12, P1935, DOI 10.1111/jth.12672; Franchini M, 2010, BLOOD TRANSFUS-ITALY, V8, P149, DOI [10.2450/2010-0149-09, 10.2450/2010.0149-09]; Gringeri A, 2003, BLOOD, V102, P2358, DOI 10.1182/blood-2003-03-0941; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; MAHLANGU J, 2016, BLOOD, V128; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; Monahan PE, 2011, AM J PREV MED, V41, pS360, DOI 10.1016/j.amepre.2011.09.017; Morfini M, 2008, HAEMOPHILIA, V14, P20, DOI 10.1111/j.1365-2516.2008.01885.x; Nogami K, 2016, HAEMOPHILIA, V22, P76; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Shima M, 2016, NEW ENGL J MED, V374, P2044, DOI 10.1056/NEJMoa1511769; Uchida N, 2016, BLOOD, V127, P1633, DOI 10.1182/blood-2015-06-650226; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Witmer C, 2013, THER ADV HEMATOL, V4, P59, DOI 10.1177/2040620712464509; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wyrwich KW, 2015, HAEMOPHILIA, V21, P578, DOI 10.1111/hae.12642; Yoneyama K, 2016, CLIN PHARM THER S, V99, pPI	20	553	574	4	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					809	818		10.1056/NEJMoa1703068	http://dx.doi.org/10.1056/NEJMoa1703068			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28691557	Bronze			2022-12-28	WOS:000408626400004
J	Hoschler, K; Zambon, MC				Hoschler, Katja; Zambon, Maria C.			Influenza vaccine: going through a sticky patch	LANCET			English	Editorial Material							IMMUNIZATION PRACTICES; ADVISORY-COMMITTEE; SEASONAL INFLUENZA; MICRONEEDLE PATCH; UNITED-STATES; RECOMMENDATIONS; PREVENTION; POLICIES		[Hoschler, Katja; Zambon, Maria C.] Publ Hlth England, Natl Infect Serv, Virus Reference Dept, Reference Microbiol, London NW9 5HT, England	Public Health England	Hoschler, K (corresponding author), Publ Hlth England, Natl Infect Serv, Virus Reference Dept, Reference Microbiol, London NW9 5HT, England.	katja.hoschler@phe.gov.uk						Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Grohskopf LA, 2014, MMWR-MORBID MORTAL W, V63, P691; Hirobe S, 2015, BIOMATERIALS, V57, P50, DOI 10.1016/j.biomaterials.2015.04.007; Jacoby E, 2015, VACCINE, V33, P4699, DOI 10.1016/j.vaccine.2015.03.062; McGuire A, 2016, EXPERT REV VACCINES, V15, P659, DOI 10.1586/14760584.2016.1138861; Ortiz JR, 2016, VACCINE, V34, P5400, DOI 10.1016/j.vaccine.2016.07.045; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Public Health England, 2013, INFL IMM INF DIS GRE; Public Health England, 2016, SEAS INFL VACC UPT F; ROUPHAEL NG, 2017, LANCET; UK Department of Health, 2016, FLU PLAN WINT 2016 1; WHO, 2011, REP 2 WHO CONS GLOB; World Health Organization, 2016, BARR INFL VACC INT B	13	6	6	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					627	628		10.1016/S0140-6736(17)31364-8	http://dx.doi.org/10.1016/S0140-6736(17)31364-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28666679				2022-12-28	WOS:000407456200004
J	Heintz, C; Doktor, TK; Lanjuin, A; Escoubas, CC; Zhang, Y; Weir, HJ; Dutta, S; Silva-Garcia, CG; Bruun, GH; Morantte, I; Hoxhaj, G; Manning, BD; Andresen, BS; Mair, WB				Heintz, Caroline; Doktor, Thomas K.; Lanjuin, Anne; Escoubas, Caroline C.; Zhang, Yue; Weir, Heather J.; Dutta, Sneha; Silva-Garcia, Carlos Giovanni; Bruun, Gitte H.; Morantte, Ianessa; Hoxhaj, Gerta; Manning, Brendan D.; Andresen, Brage S.; Mair, William B.			Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans (vol 541, pg 102, 2017)	NATURE			English	Correction													Heintz, Caroline/R-3272-2017; Manning, Brendan/ABD-6528-2021; Doktor, Thomas/AAB-2216-2020; Doktor, Thomas K/G-9923-2014	Manning, Brendan/0000-0003-3895-5956; Doktor, Thomas/0000-0002-5315-8325; Doktor, Thomas K/0000-0002-5315-8325; Hoxhaj, Gerta/0000-0001-6179-3583	Villum Fonden [00007292] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Heintz C, 2017, NATURE, V541, P102, DOI 10.1038/nature20789	1	3	3	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					476	476		10.1038/nature23313	http://dx.doi.org/10.1038/nature23313			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28700577	Bronze			2022-12-28	WOS:000406358300041
J	Voelker, R				Voelker, Rebecca			Conception Without HIV Transmission	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					117	117		10.1001/jama.2017.8053	http://dx.doi.org/10.1001/jama.2017.8053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697262				2022-12-28	WOS:000405190800007
J	Voosen, P				Voosen, Paul			CLIMATE CHANGE NASA armada targets thaw in Arctic soil	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		12	13		10.1126/science.357.6346.12	http://dx.doi.org/10.1126/science.357.6346.12			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684476				2022-12-28	WOS:000404854100010
J	Nowogrodzki, A				Nowogrodzki, Anna			THE CELL SEEKER	NATURE			English	News Item							RNA-SEQ; TRANSCRIPTOMICS; EXPRESSION; CIRCUITS; SCREENS											Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054	8	3	4	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					24	26		10.1038/547024a	http://dx.doi.org/10.1038/547024a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682347	Bronze			2022-12-28	WOS:000404839900015
J	Shlush, LI; Mitchell, A; Heisler, L; Abelson, S; Ng, SWK; Trotman-Grant, A; Medeiros, JJF; Rao-Bhatia, A; Jaciw-Zurakowsky, I; Marke, R; McLeod, JL; Doedens, M; Bader, G; Voisin, V; Xu, CJ; McPherson, JD; Hudson, TJ; Wang, JCY; Minden, MD; Dick, JE				Shlush, Liran I.; Mitchell, Amanda; Heisler, Lawrence; Abelson, Sagi; Ng, Stanley W. K.; Trotman-Grant, Aaron; Medeiros, Jessie J. F.; Rao-Bhatia, Abilasha; Jaciw-Zurakowsky, Ivana; Marke, Rene; McLeod, Jessica L.; Doedens, Monica; Bader, Gary; Voisin, Veronique; Xu, ChangJiang; McPherson, John D.; Hudson, Thomas J.; Wang, Jean C. Y.; Minden, Mark D.; Dick, John E.			Tracing the origins of relapse in acute myeloid leukaemia to stem cells	NATURE			English	Article							CLONAL EVOLUTION; SOMATIC MUTATIONS; CHEMOTHERAPY; MICE; TRANSPLANTATION; SENSITIVITY; RESISTANCE; DIAGNOSIS	In acute myeloid leukaemia, long-term survival is poor as most patients relapse despite achieving remission(1). Historically, the failure of therapy has been thought to be due to mutations that produce drug resistance, possibly arising as a consequence of the mutagenic properties of chemotherapy drugs(2). However, other lines of evidence have pointed to the pre-existence of drug-resistant cells(3). For example, deep sequencing of paired diagnosis and relapse acute myeloid leukaemia samples has provided direct evidence that relapse in some cases is generated from minor genetic subclones present at diagnosis that survive chemotherapy(3-5), suggesting that resistant cells are generated by evolutionary processes before treatment(3) and are selected by therapy(6-8). Nevertheless, the mechanisms of therapy failure and capacity for leukaemic regeneration remain obscure, as sequence analysis alone does not provide insight into the cell types that are fated to drive relapse. Although leukaemia stem cells(9,10) have been linked to relapse owing to their dormancy and self-renewal properties(11-13), and leukaemia stem cell gene expression signatures are highly predictive of therapy failure(14,15), experimental studies have been primarily correlative(7) and a role for leukaemia stem cells in acute myeloid leukaemia relapse has not been directly proved. Here, through combined genetic and functional analysis of purified subpopulations and xenografts from paired diagnosis/relapse samples, we identify therapy-resistant cells already present at diagnosis and two major patterns of relapse. In some cases, relapse originated from rare leukaemia stem cells with a haematopoietic stem/progenitor cell phenotype, while in other instances relapse developed from larger subclones of immunophenotypically committed leukaemia cells that retained strong stemness transcriptional signatures. The identification of distinct patterns of relapse should lead to improved methods for disease management and monitoring in acute myeloid leukaemia. Moreover, the shared functional and transcriptional stemness properties that underlie both cellular origins of relapse emphasize the importance of developing new therapeutic approaches that target stemness to prevent relapse.	[Shlush, Liran I.; Mitchell, Amanda; Abelson, Sagi; Ng, Stanley W. K.; Trotman-Grant, Aaron; Medeiros, Jessie J. F.; Rao-Bhatia, Abilasha; Jaciw-Zurakowsky, Ivana; McLeod, Jessica L.; Doedens, Monica; Wang, Jean C. Y.; Minden, Mark D.; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Shlush, Liran I.] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Shlush, Liran I.] Div Hematol, Rambam Healthcare Campus, IL-31096 Haifa, Israel; [Heisler, Lawrence; McPherson, John D.; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Marke, Rene] Radboud Univ Nijmegen, Lab Pediat Oncol, Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Bader, Gary; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bader, Gary; Voisin, Veronique; Xu, ChangJiang] Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Hudson, Thomas J.; Minden, Mark D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Wang, Jean C. Y.; Minden, Mark D.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Wang, Jean C. Y.; Minden, Mark D.] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Weizmann Institute of Science; Rambam Health Care Campus; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Radboud University Nijmegen; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Dick, JE (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.	jdick@uhnresearch.ca	Abelson, Sagi/ABG-3403-2021; Marke, Rene/C-6899-2018; Bader, Gary/C-1176-2009; McPherson, John D/D-2633-2017	Abelson, Sagi/0000-0003-1747-3819; Bader, Gary/0000-0003-0185-8861; McPherson, John D/0000-0001-8049-9347; Dick, John/0000-0002-9527-8317; Rao-Bhatia, Abilasha/0000-0002-6637-4545; Wang, Jean/0000-0001-7543-3917; Heisler, Lawrence/0000-0002-1332-1802	Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada; Ontario Genomics Institute [OGI-047]; Canadian Institutes of Health Research [CSC-105367]; Canadian Cancer Society; Terry Fox Foundation; Canada Research Chair; Benjamin Pearl fellowship from McEwen Centre for Regenerative Medicine; American Society of Hematology; Ontario Ministry of Health and Long Term Care	Ontario Institute for Cancer Research; province of Ontario; Cancer Stem Cell Consortium; Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Benjamin Pearl fellowship from McEwen Centre for Regenerative Medicine; American Society of Hematology; Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was supported by grants from the Ontario Institute for Cancer Research with funds from the province of Ontario, the Cancer Stem Cell Consortium with funding from the Government of Canada through Genome Canada and the Ontario Genomics Institute (OGI-047), and the Canadian Institutes of Health Research (CSC-105367), the Canadian Cancer Society, the Terry Fox Foundation, a Canada Research Chair to J.E.D. L.I.S. was funded by the Benjamin Pearl fellowship from the McEwen Centre for Regenerative Medicine and an American Society of Hematology Scholar Award. This research was funded in part by the Ontario Ministry of Health and Long Term Care, whose views are not expressed here. We thank all the members of the Dick laboratory for comments and P. Zandstra for supporting this work.	Andersson AK, 2015, NAT GENET, V47, P330, DOI 10.1038/ng.3230; Bachas C, 2012, LEUKEMIA, V26, P1313, DOI 10.1038/leu.2011.383; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Costello RT, 2000, CANCER RES, V60, P4403; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gamazon ER, 2013, BLOOD, V121, P4366, DOI 10.1182/blood-2012-10-464149; Garg M, 2015, BLOOD, V126, P2491, DOI 10.1182/blood-2015-05-646240; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; GOLDIE JH, 1984, CANCER RES, V44, P3643; Greaves M, 2015, CANCER DISCOV, V5, P806, DOI 10.1158/2159-8290.CD-15-0439; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Parkin B, 2013, BLOOD, V121, P369, DOI 10.1182/blood-2012-04-427039; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Sarkozy C, 2013, AM J HEMATOL, V88, P758, DOI 10.1002/ajh.23498; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terpstra W, 1996, BLOOD, V88, P1944, DOI 10.1182/blood.V88.6.1944.bloodjournal8861944; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158	32	302	310	7	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					104	+		10.1038/nature22993	http://dx.doi.org/10.1038/nature22993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28658204				2022-12-28	WOS:000404839900039
J	Dossett, EC; Wusirika, L; Burt, V				Dossett, Emily C.; Wusirika, Lavanya; Burt, Vivien			No Perfect Choice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dossett, Emily C.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90033 USA; [Dossett, Emily C.] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Wusirika, Lavanya; Burt, Vivien] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dossett, EC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90033 USA.; Dossett, EC (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA.	edossett@med.usc.edu	Dossett, Emily/GSI-6698-2022					Burt VK, 2016, AM J PSYCHIAT, V173, P208, DOI 10.1176/appi.ajp.2015.15111371; Cohen LS, 2016, AM J PSYCHIAT, V173, P263, DOI 10.1176/appi.ajp.2015.15040506; Robinson GE, 2012, J POPUL THER CLIN PH, V19, pE380; Vigod SN, 2014, BJOG-INT J OBSTET GY, V121, P566, DOI 10.1111/1471-0528.12567	4	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					29	30		10.1001/jama.2017.5523	http://dx.doi.org/10.1001/jama.2017.5523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672322				2022-12-28	WOS:000404717700011
J	Voelker, R				Voelker, Rebecca			A First for Giant Cell Arteritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					20	20		10.1001/jama.2017.7639	http://dx.doi.org/10.1001/jama.2017.7639			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672299				2022-12-28	WOS:000404717700004
J	de Beer, J; Bardoutsos, A; Janssen, F				de Beer, Joop; Bardoutsos, Anastasios; Janssen, Fanny			Maximum human lifespan may increase to 125 years	NATURE			English	Letter									[de Beer, Joop; Janssen, Fanny] Netherlands Interdisciplinary Demog Inst, NL-2511 CV The Hague, Netherlands; [Bardoutsos, Anastasios; Janssen, Fanny] Univ Groningen, Fac Spatial Sci, NL-9747 AD Groningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen	de Beer, J (corresponding author), Netherlands Interdisciplinary Demog Inst, NL-2511 CV The Hague, Netherlands.	beer@nidi.nl	Bardoutsos, Anastasios G/N-2284-2015	Bardoutsos, Anastasios G/0000-0002-8325-5820; Janssen, Fanny/0000-0002-3110-238X				Bebbington M, 2014, SCAND ACTUAR J, V2014, P189, DOI 10.1080/03461238.2012.676562; de Beer J, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0113-1; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Gampe J, 2010, DEMOGR RES MONOGR, P219, DOI 10.1007/978-3-642-11520-2_13; Gompertz B., 1825, PHILOS T R SOC LOND, V115, P513, DOI [10.1098/rstl.1825.0026, DOI 10.1098/RSTL.1825.0026]; Kannisto Vaino., 1994, DEV OLDEST OLD MORTA; Robine Jean-Marie, 2005, Genus, V61, P57; ROBINE JM, 1999, VALIDATION EXCEPTION; Thatcher A. R., 1998, FORCE MORTALITY AGES; Wilmoth JR, 2003, POPUL DEV REV, V29, P239	10	23	28	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E16	E20		10.1038/nature22792	http://dx.doi.org/10.1038/nature22792			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658213	Green Submitted, Green Published			2022-12-28	WOS:000404332000009
J	Dong, X; Milholland, B; Vijg, J				Dong, Xiao; Milholland, Brandon; Vijg, Jan			Maximum human lifespan may increase to 125 years Reply	NATURE			English	Letter									[Dong, Xiao; Milholland, Brandon; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.; Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA.	jan.vijg@einstein.yu.edu						de Beer J, 2017, NATURE, V546, pE16, DOI 10.1038/nature22792; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793	2	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E21	E21		10.1038/nature22793	http://dx.doi.org/10.1038/nature22793			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658215	Bronze			2022-12-28	WOS:000404332000010
J	Hong, JH; Savina, M; Du, J; Devendran, A; Ramakanth, KK; Tian, X; Sim, WS; Mironova, VV; Xu, J				Hong, Jing Han; Savina, Maria; Du, Jing; Devendran, Ajay; Ramakanth, Karthikbabu Kannivadi; Tian, Xin; Sim, Wei Shi; Mironova, Victoria V.; Xu, Jian			A Sacrifice-for-Survival Mechanism Protects Root Stem Cell Niche from Chilling Stress	CELL			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; PLANT COLD-ACCLIMATION; ARABIDOPSIS-THALIANA; DNA-DAMAGE; FREEZING TOLERANCE; AUXIN HOMEOSTASIS; FLORAL DIP; DIFFERENTIATION; GROWTH; PIN	Temperature has a profound influence on plant and animal development, but its effects on stem cell behavior and activity remain poorly understood. Here, we characterize the responses of the Arabidopsis root to chilling (low but above-freezing) temperature. Chilling stress at 4 degrees C leads to DNA damage predominantly in root stem cells and their early descendants. However, only newly generated/differentiating columella stem cell daughters (CSCDs) preferentially die in a programmed manner. Inhibition of the DNA damage response in these CSCDs prevents their death but makes the stem cell niche more vulnerable to chilling stress. Mathematical modeling and experimental validation indicate that CSCD death results in the re-establishment of the auxin maximum in the quiescent center (QC) and the maintenance of functional stem cell niche activity under chilling stress. This mechanism improves the root's ability to withstand the accompanying environmental stresses and to resume growth when optimal temperatures are restored.	[Hong, Jing Han; Du, Jing; Devendran, Ajay; Ramakanth, Karthikbabu Kannivadi; Tian, Xin; Sim, Wei Shi; Xu, Jian] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Hong, Jing Han; Du, Jing; Devendran, Ajay; Ramakanth, Karthikbabu Kannivadi; Tian, Xin; Sim, Wei Shi; Xu, Jian] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117543, Singapore; [Savina, Maria; Mironova, Victoria V.] Inst Cytol & Genet, Novosibirsk 630090, Russia; [Savina, Maria; Mironova, Victoria V.] Novosibirsk State Univ, LCT & EB, Novosibirsk 630090, Russia	National University of Singapore; National University of Singapore; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University	Xu, J (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Xu, J (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117543, Singapore.	dbsxj@nus.edu.sg	Savina, Maria S/O-4135-2017; Xu, Jian/I-2921-2012; Mironova, Victoria/I-5690-2014; KANNIVADI RAMAKANTH, KARTHIKBABU/CAJ-4458-2022	Xu, Jian/0000-0001-6194-6316; Mironova, Victoria/0000-0003-3438-0147; KANNIVADI RAMAKANTH, KARTHIKBABU/0000-0002-5598-9763; Tian, Xin/0000-0003-4705-3719	AcRF Tier 2 grant from the Ministry of Education of Singapore [MOE2014-T2-1-128]; National Research Foundation Singapore under its Competitive Research Programme (CRP) [NRF2010NRF-CRP002-]; President's Graduate Fellowship of National University of Singapore; Russian Federation President Grant for Young Scientists [MK-1297.2017.4];  [0324-2016-0008]	AcRF Tier 2 grant from the Ministry of Education of Singapore(Ministry of Education, Singapore); National Research Foundation Singapore under its Competitive Research Programme (CRP)(National Research Foundation, Singapore); President's Graduate Fellowship of National University of Singapore(National University of Singapore); Russian Federation President Grant for Young Scientists; 	We thank Ben Scheres for critical reading of the manuscript, Hao Yu and Toshiro Ito for helpful discussion, Fedor Kazantsev for technical support with the mathematical model, Yan Tong for technical support with the confocal microscope. Wai Shiu Fred Wong for gamma-H2AX antibody, Li Zeng for TUNEL assay kit, Lieven De Veylder for atm-1, Kiyotaka Okada, Toshiaki Tameshige, and Michael Lenhard for providing CG35ST_SKattB1-2 and 35S::LoxP-Ter-LoxP-VENUS, Jim Haseloff for making available the CSC marker J2341, Yunde Zhao for the yuc8 yuc9 double mutant, and the Nottingham Arabidopsis Stock Centre for providing atr (SALK_054383) and wee1 (SALK_147968C). This work was supported by the AcRF Tier 2 grant (MOE2014-T2-1-128) from the Ministry of Education of Singapore, by the National Research Foundation Singapore under its Competitive Research Programme (CRP Award NRF2010NRF-CRP002-018 to J.X.), by the President's Graduate Fellowship of National University of Singapore (to J.H.H.), by the Russian Federation President Grant for Young Scientists (MK-1297.2017.4) and budget project 0324-2016-0008 (to V.M. and M.S.).	Bandyopadhyay A, 2007, BIOCHEM SOC T, V35, P137, DOI 10.1042/BST0350137; Bennett T, 2014, DEVELOPMENT, V141, P4055, DOI 10.1242/dev.110148; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123499; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Curtis MJ, 2007, DNA REPAIR, V6, P1341, DOI 10.1016/j.dnarep.2007.03.004; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Den Herder G, 2010, TRENDS PLANT SCI, V15, P600, DOI 10.1016/j.tplants.2010.08.009; DOLAN L, 1993, DEVELOPMENT, V119, P71; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Faris JA, 1926, PHYTOPATHOLOGY, V16, P885; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fulcher N, 2009, P NATL ACAD SCI USA, V106, P20984, DOI 10.1073/pnas.0909218106; Furukawa T, 2010, DNA REPAIR, V9, P940, DOI 10.1016/j.dnarep.2010.06.006; Garcia V, 2003, PLANT CELL, V15, P119, DOI 10.1105/tpc.006577; Gewin V, 2010, NATURE, V466, P552, DOI 10.1038/466552a; GILMOUR SJ, 1988, PLANT PHYSIOL, V87, P745, DOI 10.1104/pp.87.3.745; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Hanzawa T, 2013, PLANT CELL, V25, P3424, DOI 10.1105/tpc.113.115881; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hentrich M, 2013, PLANT J, V74, P626, DOI 10.1111/tpj.12152; Heo JO, 2017, CURR OPIN PLANT BIOL, V35, P23, DOI 10.1016/j.pbi.2016.10.007; Heyman J, 2013, SCIENCE, V342, P860, DOI 10.1126/science.1240667; Hincha DK, 2014, METHODS MOL BIOL, V1166, P1, DOI 10.1007/978-1-4939-0844-8_1; HOHL M, 1991, PLANT PHYSIOL, V95, P716, DOI 10.1104/pp.95.3.716; Hong JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00206; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; Ludwig-Muller J, 2015, J PLANT PHYSIOL, V172, P4, DOI 10.1016/j.jplph.2014.01.002; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; MacMillan HA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1483; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Marechal Alexandre, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a012716; Mironova VV, 2012, ANN BOT-LONDON, V110, P349, DOI 10.1093/aob/mcs069; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Mori M, 2014, NAT GEOSCI, V7, P869, DOI 10.1038/NGEO2277; Morishita S., 1997, PATHOPHYSIOLOGY, V4, P213; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Naseenn M, 2015, J EXP BOT, V66, P4885, DOI 10.1093/jxb/erv297; Ning SB, 2002, ELECTROPHORESIS, V23, P2096, DOI 10.1002/1522-2683(200207)23:13&lt;2096::AID-ELPS2096&gt;3.0.CO;2-V; Nishimura T, 2014, PLANT J, V77, P352, DOI 10.1111/tpj.12399; Overland JE, 2016, NAT CLIM CHANGE, V6, P992, DOI 10.1038/NCLIMATE3121; Paciorek T, 2006, NAT PROTOC, V1, P104, DOI 10.1038/nprot.2006.16; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sablowski R, 2004, TRENDS CELL BIOL, V14, P605, DOI 10.1016/j.tcb.2004.09.011; Scheres B, 2007, NAT REV MOL CELL BIO, V8, P345, DOI 10.1038/nrm2164; Scheres Ben, 2002, Arabidopsis Book, V1, pe0101, DOI 10.1199/tab.0101; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shepherd TG, 2016, SCIENCE, V353, P989, DOI 10.1126/science.aag2349; Shibasaki K, 2009, PLANT CELL, V21, P3823, DOI 10.1105/tpc.109.069906; SIMINOVITCH D, 1983, CRYOBIOLOGY, V20, P487, DOI 10.1016/0011-2240(83)90037-8; Slovak R, 2014, PLANT CELL, V26, P2390, DOI 10.1105/tpc.114.124032; Song JQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004030; Steponkus P L, 1979, Basic Life Sci, V14, P235; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Tameshige T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003655; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Uhlken C, 2014, PLANT J, V78, P107, DOI 10.1111/tpj.12455; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Xu J, 2006, SCIENCE, V311, P385, DOI 10.1126/science.1121790; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang YH, 2016, PLANT PHYSIOL, V171, P483, DOI 10.1104/pp.15.01754	73	80	82	8	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1								10.1016/j.cell.2017.06.002	http://dx.doi.org/10.1016/j.cell.2017.06.002			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28648662	Bronze			2022-12-28	WOS:000404358500013
J	Calvin, CM; Batty, GD; Der, G; Brett, CE; Taylor, A; Pattie, A; Cukic, I; Deary, IJ				Calvin, Catherine M.; Batty, G. David; Der, Geoff; Brett, Caroline E.; Taylor, Adele; Pattie, Alison; Cukic, Iva; Deary, Ian J.			Childhood intelligence in relation to major causes of death in 68 year follow-up: prospective population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; MENTAL SURVEY 1932; LOTHIAN BIRTH COHORTS; COGNITIVE-ABILITY; EARLY ADULTHOOD; RISK-FACTORS; MIDDLE-AGE; ABERDEEN CHILDREN; LATER LIFE; SOCIOECONOMIC POSITION	OBJECTIVES To examine the association between intelligence measured in childhood and leading causes of death in men and women over the life course. DESIGN Prospective cohort study based on a whole population of participants born in Scotland in 1936 and linked to mortality data across 68 years of follow-up. SETTING Scotland. PARTICIPANTS 33 536 men and 32 229 women who were participants in the Scottish Mental Survey of 1947 (SMS1947) and who could be linked to cause of death data up to December 2015. MAIN OUTCOME MEASURES Cause specific mortality, including from coronary heart disease, stroke, specific cancer types, respiratory disease, digestive disease, external causes, and dementia. RESULTS Childhood intelligence was inversely associated with all major causes of death. The age and sex adjusted hazard ratios (and 95% confidence intervals) per 1 SD (about 15 points) advantage in intelligence test score were strongest for respiratory disease (0.72, 0.70 to 0.74), coronary heart disease (0.75, 0.73 to 0.77), and stroke (0.76, 0.73 to 0.79). Other notable associations (all P< 0.001) were observed for deaths from injury (0.81, 0.75 to 0.86), smoking related cancers (0.82, 0.80 to 0.84), digestive disease (0.82, 0.79 to 0.86), and dementia (0.84, 0.78 to 0.90). Weak associations were apparent for suicide (0.87, 0.74 to 1.02) and deaths from cancer not related to smoking (0.96, 0.93 to 1.00), and their confidence intervals included unity. There was a suggestion that childhood intelligence was somewhat more strongly related to coronary heart disease, smoking related cancers, respiratory disease, and dementia in women than men (P value for interactions < 0.001, 0.02, < 0.001, and 0.02, respectively). Childhood intelligence was related to selected cancer presentations, including lung (0.75, 0.72 to 0.77), stomach (0.77, 0.69 to 0.85), bladder (0.81, 0.71 to 0.91), oesophageal (0.85, 0.78 to 0.94), liver (0.85, 0.74 to 0.97), colorectal (0.89, 0.83 to 0.95), and haematopoietic (0.91, 0.83 to 0.98). Sensitivity analyses on a representative subsample of the cohort observed only small attenuation of the estimated effect of intelligence (by 10-26%) after adjustment for potential confounders, including three indicators of childhood socioeconomic status. In a replication sample from Scotland, in a similar birth year cohort and follow-up period, smoking and adult socioeconomic status partially attenuated (by 16-58%) the association of intelligence with outcome rates. CONCLUSIONS In a whole national population year of birth cohort followed over the life course from age 11 to age 79, higher scores on a well validated childhood intelligence test were associated with lower risk of mortality ascribed to coronary heart disease and stroke, cancers related to smoking (particularly lung and stomach), respiratory diseases, digestive diseases, injury, and dementia.	[Calvin, Catherine M.; Taylor, Adele; Pattie, Alison; Cukic, Iva; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Calvin, Catherine M.; Batty, G. David; Der, Geoff; Brett, Caroline E.; Cukic, Iva; Deary, Ian J.] Univ Edinburgh, Dept Psychol, CCACE, Edinburgh EH8 9JZ, Midlothian, Scotland; [Calvin, Catherine M.] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Der, Geoff] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow G2 3QB, Lanark, Scotland; [Brett, Caroline E.] Liverpool John Moores Univ, Nat Sci & Psychol, Tom Reilly Bldg, Liverpool L3 3AF, Merseyside, England	University of Edinburgh; University of Edinburgh; University of Oxford; University of London; University College London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; Liverpool John Moores University	Calvin, CM; Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland.; Calvin, CM; Deary, IJ (corresponding author), Univ Edinburgh, Dept Psychol, CCACE, Edinburgh EH8 9JZ, Midlothian, Scotland.; Calvin, CM (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	catherine.calvin@psych.ox.ac.uk; I.Deary@ed.ac.uk	Cukic, Iva/HGE-8252-2022; Batty, GD/Y-4401-2018; Deary, Ian J/C-6297-2009; Brett, Caroline E/AAG-7234-2021	Batty, GD/0000-0003-1822-5753; Deary, Ian J/0000-0002-1733-263X; Brett, Caroline E/0000-0002-5680-2948; Der, Geoff/0000-0002-8677-073X; Cukic, Iva/0000-0002-2010-1648	UK cross council Lifelong Health and Wellbeing Initiative [MRCG100140/1]; cross council Lifelong Health and Wellbeing Initiative [MR/K026992/1]; Dementias Platform UK [MR/L023784/2]; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Medical Research Council [MR/L023784/1, MR/K026992/1, MR/L023784/2, G1001401] Funding Source: researchfish; MRC [MR/L023784/2, G1001401, MR/L023784/1] Funding Source: UKRI	UK cross council Lifelong Health and Wellbeing Initiative; cross council Lifelong Health and Wellbeing Initiative; Dementias Platform UK; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a UK cross council Lifelong Health and Wellbeing Initiative (grant No MRCG100140/1), which included a research fellowship for CMC and IC and research associate position for CEB, and for which IJD was the principal investigator. CMC, CEB, GDB, IC, and IJD are members of the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (grant No MR/K026992/1). Dementias Platform UK (grant No MR/L023784/2) supported CMC's role in the latter stages of the paper. Funding from the Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC) is gratefully acknowledged.	ALLEBECK P, 1988, BRIT MED J, V297, P176, DOI 10.1136/bmj.297.6642.176; Andersson L, 2008, ACTA PSYCHIAT SCAND, V118, P99, DOI 10.1111/j.1600-0447.2008.01171.x; Arden R, 2016, INT J EPIDEMIOL, V45, P178, DOI 10.1093/ije/dyv112; Batty GD, 2008, HEART, V94, P1541, DOI 10.1136/hrt.2008.149567; Batty GD, 2007, ANN ONCOL, V18, P21, DOI 10.1093/annonc/mdl473; Batty GD, 2008, EUR J CARDIOV PREV R, V15, P359, DOI 10.1097/HJR.0b013e3282f738a6; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P997, DOI 10.1136/jech.2006.054494; Batty GD, 2007, J EPIDEMIOL COMMUN H, V61, P241, DOI 10.1136/jech.2006.048215; Batty GD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2506; Batty GD, 2009, PSYCHO-ONCOLOGY, V18, P1122, DOI 10.1002/pon.1521; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2005, PAEDIATR PERINAT EP, V19, P452, DOI 10.1111/j.1365-3016.2005.00671.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brett CE, 2014, LONGITUD LIFE COURSE, V5, P283, DOI 10.14301/llcs.v5i3.266; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Carroll D, 2011, THORAX, V66, P884, DOI 10.1136/thoraxjnl-2011-200104; Christensen GT, 2016, INTELLIGENCE, V59, P64, DOI 10.1016/j.intell.2016.08.001; CORWIN LI, 1982, STROKE, V13, P818, DOI 10.1161/01.STR.13.6.818; Cukic I, 2017, INTELLIGENCE, V63, P45, DOI 10.1016/j.intell.2017.05.002; Deary I. J., 2009, LIFETIME INTELLIGENC, DOI [10.1037/11857-000, DOI 10.1037/11857-000]; Deary IJ, 2008, PSYCHOL SCI, V19, P874, DOI 10.1111/j.1467-9280.2008.02171.x; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2006, NEUROLOGY, V67, P1195, DOI 10.1212/01.wnl.0000238520.06958.6a; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary IJ, 2012, GERONTOLOGY, V58, P545, DOI 10.1159/000341157; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Deary IJ, 2010, INT J EPIDEMIOL, V39, P1362, DOI 10.1093/ije/dyq072; Deary ID, SCOTTISH MENTAL SURV; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2003, RES PERSPECT LONGEV, P153; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Der G, 2009, INTELLIGENCE, V37, P573, DOI 10.1016/j.intell.2008.12.002; Dundas R, 2006, INT J EPIDEMIOL, V35, P458, DOI 10.1093/ije/dyi239; Gale CR, 2008, ARCH GEN PSYCHIAT, V65, P1410, DOI 10.1001/archpsyc.65.12.1410; Gow AJ, 2011, PSYCHOL AGING, V26, P232, DOI 10.1037/a0021072; Gunnell D, 2005, BMJ-BRIT MED J, V330, P167, DOI 10.1136/bmj.38310.473565.8F; Gunnell D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6030; Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3; Hagenaars SP, 2015, MOL PSYCHIATR, V2016, P31120; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Jokela M, 2011, ANN EPIDEMIOL, V21, P489, DOI 10.1016/j.annepidem.2011.01.008; Kajantie E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046841; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P695, DOI 10.1007/s10654-008-9281-z; Leon DA, 2009, INTELLIGENCE, V37, P520, DOI 10.1016/j.intell.2008.11.004; LUBINSKI D, 1992, INTELLIGENCE, V16, P99, DOI 10.1016/0160-2896(92)90027-O; Lubinski D, 2009, INTELLIGENCE, V37, P625, DOI 10.1016/j.intell.2009.09.001; Maxwell J., 1961, LEVEL TREND NATL INT; McGurn B, 2008, NEUROLOGY, V71, P1051, DOI 10.1212/01.wnl.0000319692.20283.10; Meincke RH, 2014, J EPIDEMIOL COMMUN H, V68, P130, DOI 10.1136/jech-2013-202637; Osler M, 2008, J EPIDEMIOL COMMUN H, V62, P23, DOI 10.1136/jech.2006.053330; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; OToole BI, 1995, SUICIDE LIFE-THREAT, V25, P475; R Development Core Team, 2009, R LANG ENV STAT COMP; Redelings MD, 2006, EPIDEMIOLOGY, V17, P100, DOI 10.1097/01.ede.0000187177.96138.c6; Richards M, 2005, PSYCHOSOM MED, V67, P602, DOI 10.1097/01.psy.0000170337.51848.68; Rodu B, 2003, J INTERN MED, V253, P660, DOI 10.1046/j.1365-2796.2003.01143.x; Russ TC, 2017, EPIDEMIOLOGY, V28, P361, DOI 10.1097/EDE.0000000000000626; Russ TC, 2013, BRIT J PSYCHIAT, V203, P10, DOI 10.1192/bjp.bp.112.119479; Sjolund S, 2012, ADDICTION, V107, P89, DOI 10.1111/j.1360-0443.2011.03544.x; Sorberg A, 2013, PSYCHOL MED, V43, P49, DOI 10.1017/S0033291712001043; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Taulbut M, 2008, TOBACCO SMOKING SCOT; Taylor MD, 2003, J EPIDEMIOL COMMUN H, V57, P464, DOI 10.1136/jech.57.6.464; Thomas BM, 1997, AGE AGEING, V26, P401, DOI 10.1093/ageing/26.5.401; Thomson GH, 1949, TREND SCOTTISH INTEL; Vasilopoulos T, 2015, J EPIDEMIOL COMMUN H, V69, P261, DOI 10.1136/jech-2014-204143; Weiss A, 2009, PSYCHOSOM MED, V71, P385, DOI 10.1097/PSY.0b013e318198de78; Wennerstad KM, 2010, J EPIDEMIOL COMMUN H, V64, P908, DOI 10.1136/jech.2008.084020; Wersall JP, 1998, INT J EPIDEMIOL, V27, P20, DOI 10.1093/ije/27.1.20; Whalley LJ, 2000, NEUROLOGY, V55, P1455, DOI 10.1212/WNL.55.10.1455; Wraw C, 2015, INTELLIGENCE, V53, P23, DOI 10.1016/j.intell.2015.08.001	75	71	71	2	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2017	357								j2708	10.1136/bmj.j2708	http://dx.doi.org/10.1136/bmj.j2708			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ5AT	28659274	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000404724400001
J	Schoebel, S; Mi, W; Stein, A; Ovchinnikov, S; Pavlovicz, R; DiMaio, F; Baker, D; Chambers, MG; Su, HY; Li, DS; Rapoport, TA; Liao, MF				Schoebel, Stefan; Mi, Wei; Stein, Alexander; Ovchinnikov, Sergey; Pavlovicz, Ryan; DiMaio, Frank; Baker, David; Chambers, Melissa G.; Su, Huayou; Li, Dongsheng; Rapoport, Tom A.; Liao, Maofu			Cryo-EM structure of the protein-conducting ERAD channel Hrd1 in complex with Hrd3	NATURE			English	Article							ENDOPLASMIC-RETICULUM DEGRADATION; X-RAY-STRUCTURE; UBIQUITIN-LIGASE; WEB SERVER; MEMBRANE-PROTEINS; QUALITY-CONTROL; PREDICTION; ALIGNMENT; TRANSLOCATION; MICROSCOPY	Misfolded endoplasmic reticulum proteins are retro-translocated through the membrane into the cytosol, where they are poly-ubiquitinated, extracted from the membrane, and degraded by the proteasome(1-4)-a pathway termed endoplasmic reticulum-associated protein degradation (ERAD). Proteins with misfolded domains in the endoplasmic reticulum lumen or membrane are discarded through the ERAD-L and ERAD-M pathways, respectively. In Saccharomyces cerevisiae, both pathways require the ubiquitin ligase Hrd1, a multi-spanning membrane protein with a cytosolic RING finger domain(5,6). Hrd1 is the crucial membrane component for retro-translocation(7,8), but it is unclear whether it forms a protein-conducting channel. Here we present a cryo-electron microscopy structure of S. cerevisiae Hrd1 in complex with its endoplasmic reticulum luminal binding partner, Hrd3. Hrd1 forms a dimer within the membrane with one or two Hrd3 molecules associated at its luminal side. Each Hrd1 molecule has eight transmembrane segments, five of which form an aqueous cavity extending from the cytosol almost to the endoplasmic reticulum lumen, while a segment of the neighbouring Hrd1 molecule forms a lateral seal. The aqueous cavity and lateral gate are reminiscent of features of protein-conducting conduits that facilitate polypeptide movement in the opposite direction-from the cytosol into or across membranes(9-11). Our results suggest that Hrd1 forms a retro-translocation channel for the movement of misfolded polypeptides through the endoplasmic reticulum membrane.	[Schoebel, Stefan; Rapoport, Tom A.] Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA; [Schoebel, Stefan; Mi, Wei; Chambers, Melissa G.; Rapoport, Tom A.; Liao, Maofu] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Stein, Alexander] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Ovchinnikov, Sergey; Pavlovicz, Ryan; DiMaio, Frank; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Su, Huayou; Li, Dongsheng] Natl Univ Def Technol, Sch Comp Sci, Natl Lab Parallel & Distributed Proc PDL, Changsha, Hunan, Peoples R China; [Schoebel, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; University of Washington; University of Washington Seattle; National University of Defense Technology - China; University of Gothenburg	Rapoport, TA (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.; Rapoport, TA; Liao, MF (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu; maofu_liao@hms.harvard.edu	Liao, Maofu/AAD-7333-2021; Stein, Alexander/I-4950-2012	Liao, Maofu/0000-0002-3481-450X; Stein, Alexander/0000-0002-2696-0611; Ovchinnikov, Sergey/0000-0003-2774-2744	European Molecular Biology Organization (EMBO LTF) [1437-2012]; European Research Council (ERC) under the Horizon 2020 research and innovation program [677770]; National Key Research and Development Program of China [2016YFB1000101]; NIGMS Award [R01GM052586]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	European Molecular Biology Organization (EMBO LTF); European Research Council (ERC) under the Horizon 2020 research and innovation program(European Research Council (ERC)); National Key Research and Development Program of China; NIGMS Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Yu, R. Huang and C. Hong at the HHMI Janelia Cryo-EM Facility for help in microscope operation and data collection, Z. Li for technical support at our in-house EM facility, and S. Andrei Anghel, for help with experiments, and X. Wu, P. Carvalho and T. Walz for comments on the manuscript. This work was supported by the European Molecular Biology Organization (EMBO LTF #1437-2012) to S. S., by the European Research Council (ERC) under the Horizon 2020 research and innovation program (grant #677770) to A. S., by the National Key Research and Development Program of China (grant #2016YFB1000101) to D.L., and by NIGMS Award R01GM052586 to T. A. R. T. A. R. is a Howard Hughes Medical Institute Investigator.	Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Dalbey RE, 2015, STRUCTURE, V23, P1559, DOI 10.1016/j.str.2015.08.002; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Gemmill RM, 1998, P NATL ACAD SCI USA, V95, P9572, DOI 10.1073/pnas.95.16.9572; Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jeon H., 2016, SCI REP-UK, V6, P1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Lyumkis D, 2013, J STRUCT BIOL, V183, P377, DOI 10.1016/j.jsb.2013.07.005; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mccoy JG, 2015, BBA-GEN SUBJECTS, V1850, P577, DOI 10.1016/j.bbagen.2014.03.013; Mehnert M, 2014, NAT CELL BIOL, V16, P77, DOI 10.1038/ncb2882; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Ru H, 2015, CELL, V163, P1138, DOI 10.1016/j.cell.2015.10.055; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger LLC, 2017, PYMOL MOL GRAPHICS S; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stein A, 2014, CELL, V158, P1375, DOI 10.1016/j.cell.2014.07.050; Su H., 2016, GERELION GPU ENHANCE; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW361, DOI 10.1093/nar/gkw307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	51	105	106	4	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2017	548	7667					352	+		10.1038/nature23314	http://dx.doi.org/10.1038/nature23314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD8AU	28682307	Green Accepted			2022-12-28	WOS:000407748400037
J	Suri, V; Sikka, P				Suri, Vanita; Sikka, Pooja			Oral misoprostol for induction of labour in hypertensive pregnancies	LANCET			English	Editorial Material							FOLEY CATHETER		[Suri, Vanita; Sikka, Pooja] Postgrad Inst Med Educ & Res, Dept Obstet & Gynaecol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Suri, V (corresponding author), Postgrad Inst Med Educ & Res, Dept Obstet & Gynaecol, Chandigarh 160012, India.	surivanita@yahoo.co.in						Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001338.pub2; Alfirevic Z, 2000, COCHRANE DB SYST REV, V2; Dalui R, 2005, ACTA OBSTET GYN SCAN, V84, P362, DOI 10.1111/j.0001-6349.2005.00662.x; HOFMEYR GJ, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000941; Hundley VA, 2013, BJOG-INT J OBSTET GY, V120, P277, DOI 10.1111/1471-0528.12049; Krithika KS, 2008, J OBSTET GYNAECOL, V28, P294, DOI 10.1080/01443610802054972; Mundle S, 2017, LANCET, P31367; Muthyala T, 2016, J CLIN DIAGN RES, V10, pQC1, DOI 10.7860/JCDR/2016/17840.8220; National Institute for Health and Clinical Excellence (NICE), 2008, IND LAB CLIN GUID CG; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; ten Eikelder MLG, 2017, AM J PERINAT, V34, P138, DOI 10.1055/s-0036-1584523; WHO, 2011, WHO REC IND LAB	12	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					630	632		10.1016/S0140-6736(17)31453-8	http://dx.doi.org/10.1016/S0140-6736(17)31453-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FD3TV	28668288				2022-12-28	WOS:000407456200006
J	Mello, MM; Livingston, EH				Mello, Michelle M.; Livingston, Edward H.			The Evolving Story of Overlapping Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Livingston, Edward H.] UT Southwestern Sch Med, Dept Surg, Dallas, TX USA; [Livingston, Edward H.] Northwestern Univ, Evanston, IL USA	Stanford University; Stanford University; Northwestern University	Livingston, EH (corresponding author), 330 N Wabash Ave, Chicago, IL 60611 USA.	edward.livingston@jamanetwork.org		Mello, Michelle/0000-0003-2877-4270				Guan J, J NEUROSURG; Hyder JA, 2017, ANN SURG, V265, P639, DOI 10.1097/SLA.0000000000002084; Kent M, J AM COLL SURGEONS, DOI [10.1016/j.jarncollsurg.2017.01.059, DOI 10.1016/J.JARNCOLLSURG.2017.01.059]; Mello MM, 2016, JAMA-J AM MED ASSOC, V315, P1563, DOI 10.1001/jama.2016.2305; Surgeons ACO, STAT PRINC; US Senate Committee on Finance, 2016, CONC OV SURG ADD MEA; Zhang AL, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.16.00248; Zygourakis CC, J NEUROSURG, DOI [10.3171/20166.6.JNSI6822, DOI 10.3171/20166.6.JNSI6822]; Zygourakis CC, 2017, WORLD NEUROSURG, V100, P658, DOI 10.1016/j.wneu.2017.01.064; Zygourakis CC, 2017, NEUROSURGERY, V80, P257, DOI 10.1093/neuros/nyw067	10	30	30	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 18	2017	318	3					233	234		10.1001/jama.2017.8061	http://dx.doi.org/10.1001/jama.2017.8061			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9OJ	28658474				2022-12-28	WOS:000405775000005
J	Yu, J; Zhou, Z; McEvoy, D; Anderson, CS; Rodgers, A; Perkovic, V; Neal, B				Yu, Jie; Zhou, Zien; McEvoy, Doug; Anderson, Craig S.; Rodgers, Anthony; Perkovic, Vlado; Neal, Bruce			Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; BLOOD-PRESSURE; RESISTANT HYPERTENSION; CPAP THERAPY; HEART; DISEASE; WEIGHT; STROKE; RISK; PREVALENCE	IMPORTANCE Sleep apnea (obstructive and central) is associated with adverse cardiovascular risk factors and increased risks of cardiovascular disease. Positive airway pressure (PAP) provides symptomatic relief, whether delivered continuously (CPAP) or as adaptive servo-ventilation (ASV), but the associations with cardiovascular outcomes and death are unclear. OBJECTIVE To assess the association of PAP vs control with cardiovascular events and death in patients with sleep apnea. DATA SOURCES AND STUDY SELECTION MEDLINE, EMBASE, and the Cochrane Library were systematically searched from inception date to March 2017 for randomized clinical trials that included reporting of major adverse cardiovascular events or deaths. DATA EXTRACTION AND SYNTHESIS Two authors independently extracted data using standardized forms. Summary relative risks (RRs), risk differences (RDs) and 95% CIs were obtained using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES The main outcomes were a composite of acute coronary syndrome (ACS) events, stroke, or vascular death (major adverse cardiovascular events); cause-specific vascular events; and death. RESULTS The analyses included data from 10 trials (9 CPAP; 1 ASV) of patients with sleep apnea (N = 7266; mean age, 60.9 [range, 51.5 to 71.1] years; 5847 [80.5%] men; mean [SD] body mass index, 30.0 [5.2]. Among 356 major adverse cardiovascular events and 613 deaths recorded, there was no significant association of PAP with major adverse cardiovascular events (RR, 0.77 [95% CI, 0.53 to 1.13]; P=.19 and RD, -0.01 [95% CI, -0.03 to 0.01]; P=.23), cardiovascular death (RR, 1.15 [95% CI, 0.88 to 1.50]; P=.30 and RD -0.00 [95% CI, -0.02 to 0.02]; P=.87), or all-cause death (RR, 1.13 [95% CI, 0.99 to 1.29]; P=.08 and RD, 0.00 [95% CI, -0.01 to 0.01]; P=.51). The same was true for ACS, stroke, and heart failure. There was no evidence of different associations for CPAP vs ASV (all P value homogeneity >.24), and meta-regressions identified no associations of PAP with outcomes for different levels of apnea severity, follow-up duration, or adherence to PAP (all P values >.13). CONCLUSIONS AND RELEVANCE The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea. Although there are other benefits of treatment with PAP for sleep apnea, these findings do not support treatment with PAP with a goal of prevention of these outcomes.	[Yu, Jie] Peking Univ Third Hosp, Key Lab Cardiovasc Mol Biol & Regulatory Pept, Key Lab Mol Cardiovasc Sci, Minist Hlth,Minist Educ,Dept Cardiol, Beijing, Peoples R China; [Yu, Jie; Zhou, Zien; Anderson, Craig S.; Rodgers, Anthony; Perkovic, Vlado; Neal, Bruce] UNSW Sydney, Fac Med, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Zhou, Zien] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China; [McEvoy, Doug] Flinders Univ S Australia, Adelaide Inst Sleep Hlth, Adelaide, SA, Australia; [Anderson, Craig S.] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing, Peoples R China; [Anderson, Craig S.] Royal Prince Alfred Hosp, Sydney Hlth Partners, Dept Neurol, Sydney, NSW, Australia; [Neal, Bruce] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Neal, Bruce] Imperial Coll London, Div Epidemiol & Biostat, London, England	Peking University; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; Shanghai Jiao Tong University; Flinders University South Australia; Peking University; University of Sydney; University of Sydney; Imperial College London	Neal, B (corresponding author), UNSW Sydney, Fac Med, George Inst Global Hlth, Sydney, NSW 2050, Australia.	bneal@georgeinstitute.org.au	Perkovic, Vlado/AAY-1933-2021; McEvoy, Doug/ABB-8052-2020; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Rodgers, Anthony/0000-0003-1282-1896; McEvoy, Doug/0000-0002-5759-0094; Zhou, Zien/0000-0001-6543-7113; Neal, Bruce/0000-0002-0490-7465; Anderson, Craig/0000-0002-7248-4863; Yu, Jie/0000-0002-7401-7580	National Health and Medical Research Council (NHMRC) of Australia [APP1052555]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a program grant from the National Health and Medical Research Council (NHMRC) of Australia (APP1052555).	Barbe F, 2012, JAMA-J AM MED ASSOC, V307, P2161, DOI 10.1001/jama.2012.4366; Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; Batool-Anwar S, 2016, J SLEEP RES, V25, P731, DOI 10.1111/jsr.12430; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Bratton DJ, 2015, JAMA-J AM MED ASSOC, V314, P2280, DOI 10.1001/jama.2015.16303; Brown DL, 2013, J STROKE CEREBROVASC, V22, P1216, DOI 10.1016/j.jstrokecerebrovasdis.2011.06.010; Campos-Rodriguez F, 2016, AM J RESP CRIT CARE, V194, P1286, DOI 10.1164/rccm.201602-0265OC; Chirinos JA, 2014, NEW ENGL J MED, V370, P2265, DOI 10.1056/NEJMoa1306187; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cowie MR, 2015, NEW ENGL J MED, V373, P1095, DOI 10.1056/NEJMoa1506459; Craig SE, 2012, THORAX, V67, P1090, DOI 10.1136/thoraxjnl-2012-202178; Drager LF, 2015, THORAX, V70, P258, DOI 10.1136/thoraxjnl-2014-205361; Feng Y, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.5; Gottlieb DJ, 2014, NEW ENGL J MED, V370, P2276, DOI 10.1056/NEJMoa1306766; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Guo J, 2016, SLEEP BREATH, V20, P965, DOI 10.1007/s11325-016-1319-y; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoyos CM, 2015, AM J HYPERTENS, V28, P1222, DOI 10.1093/ajh/hpv023; Huang ZW, 2015, AM J HYPERTENS, V28, P300, DOI 10.1093/ajh/hpu147; Iftikhar IH, 2015, J CLIN SLEEP MED, V11, P475, DOI 10.5664/jcsm.4610; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kushida CA, 2012, SLEEP, V35, P1593, DOI 10.5665/sleep.2226; Lacasse Y, 2002, THORAX, V57, P483, DOI 10.1136/thorax.57.6.483; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418; Martinez-Ceron E, 2016, AM J RESP CRIT CARE, V194, P476, DOI 10.1164/rccm.201510-1942OC; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; McMillan A, 2014, LANCET RESP MED, V2, P804, DOI 10.1016/S2213-2600(14)70172-9; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Minnerup J, 2012, STROKE, V43, P1137, DOI 10.1161/STROKEAHA.111.637611; Pack AI, 2009, PROG CARDIOVASC DIS, V51, P434, DOI 10.1016/j.pcad.2009.01.002; Parra O, 2011, EUR RESPIR J, V37, P1128, DOI 10.1183/09031936.00034410; Parra O, 2015, J SLEEP RES, V24, P47, DOI 10.1111/jsr.12181; Pataka A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0385-z; Peker Y, 2016, AM J RESP CRIT CARE, V194, P613, DOI 10.1164/rccm.201601-0088OC; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, JAMA-J AM MED ASSOC, V284, P3015, DOI 10.1001/jama.284.23.3015; Peter B, 2011, PRINCIPLES PRACTICE, P1233; Phillips CL, 2012, THORAX, V67, P639, DOI 10.1136/thoraxjnl-2011-200874; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Povitz M, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001762; Qaseem A, 2013, ANN INTERN MED, V159, P471, DOI 10.7326/00030003-4819-159-7-201310010-00704; Quan SF, 1997, SLEEP, V20, P1077; Quan SF, 2013, J CLIN SLEEP MED, V9, P989, DOI 10.5664/jcsm.3064; Ryan CM, 2011, STROKE, V42, P1062, DOI 10.1161/STROKEAHA.110.597468; Schwarz EI, 2015, RESPIROLOGY, V20, P889, DOI 10.1111/resp.12573; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sundstrom J, 2015, ANN INTERN MED, V162, P184, DOI 10.7326/M14-0773; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Woodward M., 2013, EPIDEMIOLOGY STUDY D; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	58	209	220	1	63	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					156	166		10.1001/jama.2017.7967	http://dx.doi.org/10.1001/jama.2017.7967			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697252	Green Published			2022-12-28	WOS:000405190800017
J	Wadge, H; Roy, R; Sripathy, A; Fontana, G; Marti, J; Darzi, A				Wadge, Hester; Roy, Rhia; Sripathy, Arthika; Fontana, Gianluca; Marti, Joachim; Darzi, Ara			How to harness the private sector for universal health coverage	LANCET			English	Editorial Material									[Wadge, Hester; Roy, Rhia; Sripathy, Arthika; Fontana, Gianluca; Marti, Joachim; Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, St Marys Hosp, London W2 1NY, England	Imperial College London	Darzi, A (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, St Marys Hosp, London W2 1NY, England.	a.darzi@imperial.ac.uk	Fontana, Gianluca/AAB-1960-2021	Marti, Joachim/0000-0001-5763-3704	CDC Group	CDC Group	We are all recipients of a grant from CDC Group for a report commissioned by the CDC Group to Imperial College London. We declare no other competing interests.	Atun R, 2013, LANCET, V382, P65, DOI 10.1016/S0140-6736(13)61051-X; International Finance Corporation, 2013, PUBL PRIV PARTN STOR; International Finance Corporation, 2009, IFCS ROL ADD PRIM; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Marriott A, 2009, OXFAM POLICY PRACT, V6, P1; McPake B, 2016, LANCET, V388, P622, DOI 10.1016/S0140-6736(16)00344-5; Montagu D, 2016, LANCET, V388, P613, DOI 10.1016/S0140-6736(16)30242-2; Morgan R, 2016, LANCET, V388, P606, DOI 10.1016/S0140-6736(16)00343-3; Nicholson D, 2015, LANCET, V385, P838, DOI 10.1016/S0140-6736(15)60129-5; Rangan V. K., 2007, Innovations: Technology / Governance / Globalisation, V2, P35, DOI 10.1162/itgg.2007.2.4.35; Tangcharoensathien V, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001726; Wadge H, 2017, EVALUATING IMPACT PR	13	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					E19	E20		10.1016/S0140-6736(17)31718-X	http://dx.doi.org/10.1016/S0140-6736(17)31718-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ8LF	28651883	Green Submitted			2022-12-28	WOS:000404976600001
J	Ahmad, J				Ahmad, Jawad			CLINICAL UPDATES Hepatitis C	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ahmad, Jawad] Mt Sinai Hosp, Div Liver Dis, Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Ahmad, J (corresponding author), Mt Sinai Hosp, Div Liver Dis, Med, New York, NY 10029 USA.	jawad.ahmad@mountsinai.org						Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; American Association for the Study of Liver Diseases-Infectious Diseases Society of American, 2016, REC TEST MAN TREAT H; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Berk DR, 2007, CLIN GASTROENTEROL H, V5, P142, DOI 10.1016/j.cgh.2006.06.010; Calvaruso V, 2010, J VIRAL HEPATITIS, V17, P469, DOI 10.1111/j.1365-2893.2009.01199.x; Centers for Disease Control and Prevention, 2016, SURV VIR HEP US 2014; Centers for Disease Control and Prevention, 2014, SCREEN HEP DOM MED E; Centers for Disease Control and Prevention, 2012, CDC ANN 1 EV NAT HEP; Chiu WC, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.274; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Colombo M, 1999, SEMIN LIVER DIS, V19, P263, DOI 10.1055/s-2007-1007116; Costentin CE, 2011, J HEPATOL, V54, P1123, DOI 10.1016/j.jhep.2010.08.027; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; European Medicines Agency, 2016, PRAC WARNS RISK HEP; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/M16-2575, 10.7326/m16-2575]; Ferri C, 2002, J CLIN PATHOL, V55, P4, DOI 10.1136/jcp.55.1.4; Freedman ND, 2009, HEPATOLOGY, V50, P1360, DOI 10.1002/hep.23162; Friborg J, 2015, INFECT DIS THER, V4, P137, DOI 10.1007/s40121-014-0052-8; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; HAGAN H, 1995, AM J PUBLIC HEALTH, V85, P1531, DOI 10.2105/AJPH.85.11.1531; Hezode C, 2008, GASTROENTEROLOGY, V134, P432, DOI 10.1053/j.gastro.2007.11.039; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Hu KQ, 1999, HEPATOLOGY, V29, P1311, DOI 10.1002/hep.510290424; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Jakobsen JC, 2017, COCHRANE DB SYST REV, V358; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Mahowald MK, 2016, J CORRECT HEALTH CAR, V22, P41, DOI 10.1177/1078345815618384; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Nouroz F, 2015, EGYPTIAN J MED HUMAN, V358, P291, DOI [10.1016/j.ejmhg.2015.05.003, DOI 10.1016/J.EJMHG.2015.05.003]; Pearlman BL, 2006, CLIN INFECT DIS, V42, P82, DOI 10.1086/498512; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Scott JD, 2007, JAMA-J AM MED ASSOC, V297, P724, DOI 10.1001/jama.297.7.724; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; WILSON SE, 1994, OPHTHALMOLOGY, V101, P736; World Health Organization, 2010, WHO BEST PRACT INJ R	42	4	4	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j2861	10.1136/bmj.j2861	http://dx.doi.org/10.1136/bmj.j2861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DO	28684552				2022-12-28	WOS:000405322300003
J	Martin, G; Martin, P; Hankin, C; Darzi, A; Kinross, J				Martin, Guy; Martin, Paul; Hankin, Chris; Darzi, Ara; Kinross, James			Cybersecurity and healthcare: how safe are we?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Martin, Guy] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, 10th Floor QEQM Bldg,Praed St, London W2 1NY, England; [Darzi, Ara] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Inst Global Hlth Innovat, 10th Floor QEQM Bldg,Praed St, London W2 1NY, England; [Kinross, James] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Surg, 10th Floor QEQM Bldg,Praed St, London W2 1NY, England; [Martin, Paul; Hankin, Chris] Imperial Coll London, Inst Secur Sci & Technol, Cent Lib, Level Admin Off 2, South Kensington Campus, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Kinross, J (corresponding author), Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Surg, 10th Floor QEQM Bldg,Praed St, London W2 1NY, England.	j.kinross@imperial.ac.uk		Hankin, Chris/0000-0001-9149-8577; Kinross, James/0000-0002-0427-7643; Martin, Guy/0000-0002-5759-962X				Abelson R, 2015, NY TIMES; [Anonymous], 2016, COMPUT FRAUD SECUR, P3; [Anonymous], 2016, BBC; Center for Strategic and International Studies and McAfee, 2014, GLOB COST CYB EC IMP; Centre for Internet Security, 2017, CRIT SEC CONTR VERS; Cyber Security Intelligence, 2016, EAS HACK TAK HOSP; Evenstad L., 2016, COMPUT WKLY; Finkle J, 2016, SCI AM; Finkle J, 2016, REUTERS; Healthcare Industry Cybersecurity Task Force, 2017, IMPR CYB HEALTHC IND; Her Majesty's Goverment (HMG), 2015, CYB ESS; Information Commissioner's Office, 2017, OV GEN DAT PROT REG; Institute for Critical Infrastructure Technology, 2016, HACK HEALTHC 2016 LE; Institute of Medicine, 2001, CROSSING QUALITY CHA; International Organisation for Standardisation, 2013, 270012013 ISO; KPMG, 2015, HLTH CAR CYB SEC INC; Mai H, 2012, BANKING TECHNOLOGY S; Mansfield-Devine Steve, 2016, Network Security, V2016, P8, DOI 10.1016/S1353-4858(16)30096-4; Mansfield-Devine S, 2016, COMPUT FRAUD SECUR, V358, P4, DOI [10.1016/S1361-3723(16)30097-5., DOI 10.1016/S1361-3723(16)30097-5]; Millman R, 2016, ITPRO 2016; Muncaster P, 2016, NHS TRUST SUSPENDS O; National Cyber Security Centre, 2016, 10 STEPS CYB SEC; National Data Guardian, 2016, REV DAT SEC CONS OPT; National Institute of Standards and Technology, 2014, FRAM IMPR CRIT INFR; Papoutsi C, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0202-2; Parmar A, 2012, MEDCITY NEWS; PriceWaterhouseCoopers, 2016, INS 2020 REAP DIV CY; Scott M, 2017, NY TIMES; Sengupta K., 2017, INDEPENDENT; TrapX Security Inc, 2017, HLTH CAR CYB BREACH; Winton R., 2016, LOS ANGELES TIMES	31	35	36	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j3179	10.1136/bmj.j3179	http://dx.doi.org/10.1136/bmj.j3179			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DO	28684400	Green Published			2022-12-28	WOS:000405322300006
J	Boyce, N; Howe, R; Palmer, J				Boyce, Niall; Howe, Rhiannon; Palmer, Joanna			2017 Wakley Prize Essay competition: clinical truths	LANCET			English	Editorial Material									[Howe, Rhiannon; Palmer, Joanna] The Lancet, London EC2Y 5AS, England; [Boyce, Niall] The Lancet, Psychiat, London EC2Y 5AS, England		Boyce, N (corresponding author), The Lancet, Psychiat, London EC2Y 5AS, England.							Clark G. N., 1964, HIST ROYAL COLL PHYS; Thomas K., 1991, RELIG DECLINE MAGIC, P787	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					12	12		10.1016/S0140-6736(17)31747-6	http://dx.doi.org/10.1016/S0140-6736(17)31747-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677544				2022-12-28	WOS:000404396300009
J	Tsvetkov, N; Samson-Robert, O; Sood, K; Patel, HS; Malena, DA; Gajiwala, PH; Maciukiewicz, P; Fournier, V; Zayed, A				Tsvetkov, N.; Samson-Robert, O.; Sood, K.; Patel, H. S.; Malena, D. A.; Gajiwala, P. H.; Maciukiewicz, P.; Fournier, V.; Zayed, A.			Chronic exposure to neonicotinoids reduces honey bee health near corn crops	SCIENCE			English	Article							PESTICIDE EXPOSURE; INSECTICIDES; ROUTE	Experiments linking neonicotinoids and declining bee health have been criticized for not simulating realistic exposure. Here we quantified the duration and magnitude of neonicotinoid exposure in Canada's corn-growing regions and used these data to design realistic experiments to investigate the effect of such insecticides on honey bees. Colonies near corn were naturally exposed to neonicotinoids for up to 4 months-the majority of the honey bee's active season. Realistic experiments showed that neonicotinoids increased worker mortality and were associated with declines in social immunity and increased queenlessness over time. We also discovered that the acute toxicity of neonicotinoids to honey bees doubles in the presence of a commonly encountered fungicide. Our work demonstrates that field-realistic exposure to neonicotinoids can reduce honey bee health in corn-growing regions.	[Tsvetkov, N.; Sood, K.; Patel, H. S.; Malena, D. A.; Gajiwala, P. H.; Maciukiewicz, P.; Zayed, A.] York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada; [Samson-Robert, O.; Fournier, V.] Univ Laval, Ctr Rech Innovat Vegetaux, 2480 Blvd Hochelaga, Quebec City, PQ G1V 0A6, Canada	York University - Canada; Laval University	Zayed, A (corresponding author), York Univ, Dept Biol, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	zayed@yorku.ca	Zayed, Amro/G-6405-2011; Tsvetkov, Nadejda/ABC-9029-2020	Zayed, Amro/0000-0003-3233-4585; Tsvetkov, Nadejda/0000-0002-4966-9042; Patel, Harshilkumar/0000-0002-2334-184X	Growing Forward 2 (GF2) from the Ontario Ministry of Agriculture, Food and Rural Affairs; New Directions grant from the Ontario Ministry of Agriculture, Food and Rural Affairs [ND2013-2084]	Growing Forward 2 (GF2) from the Ontario Ministry of Agriculture, Food and Rural Affairs; New Directions grant from the Ontario Ministry of Agriculture, Food and Rural Affairs	This project was funded through Growing Forward 2 (GF2) and a New Directions grant (ND2013-2084) from the Ontario Ministry of Agriculture, Food and Rural Affairs to A.Z. and V.F. We thank G. Thompson and the Toronto Beekeeping Cooperative for help in locating unexposed sites, B. Harpur for blinding the experimenters, F. McCune and J. Parent for assistance. Data can be accessed at Dryad Digital Repository at doi:10.5061/dryad.p039j.	Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Carreck NL, 2014, J APICULT RES, V53, P607, DOI 10.3896/IBRA.1.53.5.08; Cleophas TJ., 2012, STAT APPL CLIN STUDI; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Hamel M.-A., 2014, CANADIAN AGR GLANCE; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Pest Management Regulatory Agency (PMRA), 2013, EV CAN BEE MORT 2013; PMRA, 2014, POLL PROT RESP US TR; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Shimanuki H., 2006, ABC XYZ BEE CULTURE, V41; Stewart G., 2013, NEONICOTINOIDS FIELD; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Williams GR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14621; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108	23	270	285	27	358	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1395	+		10.1126/science.aam7470	http://dx.doi.org/10.1126/science.aam7470			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663503	Green Accepted			2022-12-28	WOS:000404351500041
J	Yu, XK; Jih, J; Jiang, JS; Zhou, ZH				Yu, Xuekui; Jih, Jonathan; Jiang, Jiansen; Zhou, Z. Hong			Atomic structure of the human cytomegalovirus capsid with its securing tegument layer of pp150	SCIENCE			English	Article							CRYO ELECTRON-MICROSCOPY; HIGHLY PATHOGENIC SIV; PROTEIN; VIRUS; DNA; SYSTEM; HERPESVIRUSES; VISUALIZATION; PREDICTION; INFECTION	Herpesviruses possess a genome-pressurized capsid. The 235-kilobase genome of human cytomegalovirus (HCMV) is by far the largest of any herpesvirus, yet it has been unclear how its capsid, which is similar in size to those of other herpesviruses, is stabilized. Here we report a HCMV atomic structure consisting of the herpesvirus-conserved capsid proteins MCP, Tri1, Tri2, and SCP and the HCMV-specific tegument protein pp150-totaling similar to 4000 molecules and 62 different conformers. MCPs manifest as a complex of insertions around a bacteriophage HK97 gp5-like domain, which gives rise to three classes of capsid floor-defining interactions; triplexes, composed of two "embracing" Tri2 conformers and a "third-wheeling" Tri1, fasten the capsid floor. HCMV-specific strategies include using hexon channels to accommodate the genome and pp150 helix bundles to secure the capsid via cysteine tetrad-to-SCP interactions. Our structure should inform rational design of countermeasures against HCMV, other herpesviruses, and even HIV/AIDS.	[Yu, Xuekui; Jih, Jonathan; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yu, Xuekui; Jih, Jonathan; Jiang, Jiansen; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Zhou, ZH (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022	Zhou, Hong/0000-0002-8373-4717; Jih, Jonathan/0000-0001-5169-0919	NIH [GM071940, DE025567, AI094386, 1S10RR23057, 1U24GM116792]; NSF [DMR-1548924, DBI-1338135]; University of California-Los Angeles; Div Of Biological Infrastructure [1338135] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of California-Los Angeles(University of California System); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Our research has been supported in part by grants from the NIH (GM071940, DE025567, and AI094386) and NSF (DMR-1548924). We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by the University of California-Los Angeles and by instrumentation grants from NIH (1S10RR23057 and 1U24GM116792) and NSF (DBI-1338135). We thank H. Zhu for providing AD169 HCMV virus stock, X. Zhang and S. Shivakati for assistance with tissue culture, W. H. Hui for assistance with cryoEM data collection, B. K. Zhou for scanning some of the films, and X. Zhang for help with the refinement of atomic models. The cryoEM density map and atomic coordinates of models reported here are deposited in the Electron Microscopy Data Bank and the Protein Data Bank with accession codes EMD-8703 and 5VKU, respectively. Z.H.Z. conceived the project; X.Y. and Z.H.Z. designed the experiments; X.Y. prepared the samples; X.Y., J. Jia., and Z.H.Z. recorded and processed the EM data; J. Jih, X. Y., and Z.H.Z. built the atomic models; J. Jih, X. Y., and Z.H.Z. analyzed and interpreted the models; J. Jih and X. Y. prepared the illustrations and media; Z.H.Z., X. Y., and J. Jih wrote the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler SP, 2005, PEDIATR INFECT DIS J, V24, P1105, DOI 10.1097/00006454-200512000-00016; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ANDERSEN JK, 1993, CELL MOL NEUROBIOL, V13, P503, DOI 10.1007/BF00711459; AuCoin DP, 2006, J VIROL, V80, P8199, DOI 10.1128/JVI.00457-06; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bauer DW, 2013, J AM CHEM SOC, V135, P11216, DOI 10.1021/ja404008r; Baxter MK, 2001, J VIROL, V75, P6865, DOI 10.1128/JVI.75.15.6865-6873.2001; Bhella D, 2000, J MOL BIOL, V295, P155, DOI 10.1006/jmbi.1999.3344; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Conway JF, 2010, J MOL BIOL, V397, P575, DOI 10.1016/j.jmb.2010.01.043; Dai XH, 2015, P NATL ACAD SCI USA, V112, pE649, DOI 10.1073/pnas.1420317112; Dai XH, 2014, J VIROL, V88, P12694, DOI 10.1128/JVI.01509-14; Dai XH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003525; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; DeRosier DJ, 2000, ULTRAMICROSCOPY, V81, P83, DOI 10.1016/S0304-3991(99)00120-5; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evilevitch A, 2003, P NATL ACAD SCI USA, V100, P9292, DOI 10.1073/pnas.1233721100; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; HOOVER DR, 1993, NEW ENGL J MED, V329, P1922, DOI 10.1056/NEJM199312233292604; Huet A, 2016, NAT STRUCT MOL BIOL, V23, P531, DOI 10.1038/nsmb.3212; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kindt J, 2001, P NATL ACAD SCI USA, V98, P13671, DOI 10.1073/pnas.241486298; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lai LL, 2003, J VIROL, V77, P2730, DOI 10.1128/JVI.77.4.2730-2735.2003; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Leong PA, 2010, METHOD ENZYMOL, V482, P369, DOI 10.1016/S0076-6879(10)82015-4; LERNER CW, 1984, MEDICINE, V63, P155, DOI 10.1097/00005792-198405000-00002; Li HT, 2010, METHODS MOL BIOL, V651, P279, DOI 10.1007/978-1-60761-786-0_16; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mocarski E.S., 2001, FIELDS VIROLOGY, V2, P2629; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramanan P, 2013, INFECT CHEMOTHER, V45, P260, DOI 10.3947/ic.2013.45.3.260; Rizzo AA, 2014, STRUCTURE, V22, P830, DOI 10.1016/j.str.2014.04.003; ROOK AH, 1988, REV INFECT DIS, V10, pS460; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sae-Ueng U, 2014, NUCLEIC ACIDS RES, V42, P9096, DOI 10.1093/nar/gku634; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Toropova K, 2011, J VIROL, V85, P7513, DOI 10.1128/JVI.00837-11; van der Bij W, 2001, CLIN INFECT DIS, V33, pS32, DOI 10.1086/320902; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Veesler D, 2013, P NATL ACAD SCI USA, V110, P5504, DOI 10.1073/pnas.1300601110; Wan Y, 2004, 2004 INTERNATIONAL CONFERENCE ON COMMUNICATION, CIRCUITS, AND SYSTEMS, VOLS 1 AND 2, P960, DOI 10.1109/ICCCAS.2004.1346339; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yu XK, 2015, ELIFE, V4, DOI 10.7554/eLife.07901; Yu XK, 2011, J STRUCT BIOL, V174, P451, DOI 10.1016/j.jsb.2011.03.006; Zandi R, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021917; Zhang XF, 2013, ADV ENERGY MATER, V3, P1299, DOI 10.1002/aenm.201300269; Zhang XK, 2010, J STRUCT BIOL, V172, P400, DOI 10.1016/j.jsb.2010.05.006; Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004; Zhou ZH, 2015, AIMS BIOPHYS, V2, P200, DOI 10.3934/biophy.2015.2.200; Zhou ZH, 2011, ADV PROTEIN CHEM STR, V82, P1, DOI 10.1016/B978-0-12-386507-6.00001-4; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	66	73	73	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345							eaam6892	10.1126/science.aam6892	http://dx.doi.org/10.1126/science.aam6892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663444	Green Accepted			2022-12-28	WOS:000404351500028
J	Brunoni, AR; Moffa, AH; Sampaio, B; Borrione, L; Moreno, ML; Fernandes, RA; Veronezi, BP; Nogueira, BS; Aparicio, LVM; Razza, LB; Chamorro, R; Tort, LC; Fraguas, R; Lotufo, PA; Gattaz, WF; Fregni, F; Bensenor, IM				Brunoni, A. R.; Moffa, A. H.; Sampaio-Junior, B.; Borrione, L.; Moreno, M. L.; Fernandes, R. A.; Veronezi, B. P.; Nogueira, B. S.; Aparicio, L. V. M.; Razza, L. B.; Chamorro, R.; Tort, L. C.; Fraguas, R.; Lotufo, P. A.; Gattaz, W. F.; Fregni, F.; Bensenor, I. M.		ELECT-TDCS Investigators	Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIRECT-CURRENT STIMULATION; NON-INFERIORITY; CLINICAL-TRIAL; METAANALYSIS; TDCS; TOLERABILITY; VALIDATION; FLUOXETINE; EFFICACY; EPISODES	BACKGROUND We compared transcranial direct-current stimulation (tDCS) with a selective serotonin-reuptake inhibitor for the treatment of depression. METHODS In a single-center, double-blind, noninferiority trial involving adults with unipolar depression, we randomly assigned patients to receive tDCS plus oral placebo, sham tDCS plus escitalopram, or sham tDCS plus oral placebo. The tDCS was administered in 30-minute, 2-mA prefrontal stimulation sessions for 15 consecutive weekdays, followed by 7 weekly treatments. Escitalopram was given at a dose of 10 mg per day for 3 weeks and 20 mg per day thereafter. The primary outcome measure was the change in the 17-item Hamilton Depression Rating Scale (HDRS-17) score (range, 0 to 52, with higher scores indicating more depression). Noninferiority of tDCS versus escitalopram was defined by a lower boundary of the confidence interval for the difference in the decreased score that was at least 50% of the difference in the scores with placebo versus escitalopram. RESULTS A total of 245 patients underwent randomization, with 91 being assigned to escitalopram, 94 to tDCS, and 60 to placebo. In the intention-to-treat analysis, the mean (+/- SD) decrease in the score from baseline was 11.3 +/- 6.5 points in the escitalopram group, 9.0 +/- 7.1 points in the tDCS group, and 5.8 +/- 7.9 points in the placebo group. The lower boundary of the confidence interval for the difference in the decrease for tDCS versus escitalopram (difference, -2.3 points; 95% confidence interval [CI], -4.3 to -0.4; P = 0.69) was lower than the noninferiority margin of -2.75 (50% of placebo minus escitalopram), so noninferiority could not be claimed. Escitalopram and tDCS were both superior to placebo (difference vs. placebo, 5.5 points [95% CI, 3.1 to 7.8; P<0.001] and 3.2 points [95% CI, 0.7 to 5.5; P = 0.01], respectively). Patients receiving tDCS had higher rates of skin redness, tinnitus, and nervousness than did those in the other two groups, and new-onset mania developed in 2 patients in the tDCS group. Patients receiving escitalopram had more frequent sleepiness and obstipation than did those in the other two groups. CONCLUSIONS In a single-center trial, tDCS for the treatment of depression did not show noninferiority to escitalopram over a 10-week period and was associated with more adverse events. (Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and others; ELECT-TDCS ClinicalTrials.gov number, NCT01894815.)	[Brunoni, A. R.; Sampaio-Junior, B.; Borrione, L.; Aparicio, L. V. M.; Fraguas, R.; Gattaz, W. F.] Univ Sao Paulo, Lab Neurosci LIM 27, Dept & Inst Psychiat, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil; [Brunoni, A. R.; Moffa, A. H.; Sampaio-Junior, B.; Borrione, L.; Moreno, M. L.; Fernandes, R. A.; Veronezi, B. P.; Nogueira, B. S.; Aparicio, L. V. M.; Razza, L. B.; Chamorro, R.; Tort, L. C.; Fraguas, R.; Lotufo, P. A.; Bensenor, I. M.] Univ Sao Paulo, Univ Hosp, Interdisciplinary Ctr Appl Neuromodulat, Sao Paulo, Brazil; [Fregni, F.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Neuromodulat Ctr, Boston, MA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital	Brunoni, AR (corresponding author), Univ Sao Paulo, Interdisciplinary Ctr Appl Neuromodulat, LIM 27, Ave Prof Lineu Prestes 2565,3o Andar, BR-05508000 Sao Paulo, Brazil.; Brunoni, AR (corresponding author), Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, LIM 27, Ave Prof Lineu Prestes 2565,3o Andar, BR-05508000 Sao Paulo, Brazil.	brunoni@usp.br	Moreno, Marina Lopes/AAT-6138-2020; Fraguas, Renerio/AAK-7870-2021; de Matos Moffa, Adriano Henrique/AAA-8600-2019; Borrione, Lucas/ABB-5874-2020; Brunoni, Andre R./H-8394-2012; Razza, Lais/AAD-8636-2020; Bensenor, Isabela Judith Martins/L-3306-2017; Moreno, Marina/ADX-7717-2022; Fraguas, Renerio/M-7643-2015	Moreno, Marina Lopes/0000-0002-4416-9145; Brunoni, Andre R./0000-0002-6310-3571; de Matos Moffa, Adriano Henrique/0000-0002-4365-9046; Boralli Razza, Lais/0000-0002-0071-0921; Fraguas, Renerio/0000-0002-3052-066X; Fregni, Felipe/0000-0001-9359-8643	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), an independent public foundation [2012/20911-5]; state of Sao Paulo; NARSAD Young Investigator from the Brain and Behavior Research Foundation [20493]; FAPESP Young Researcher from the Sao Paulo State Foundation [20911-5]; National Council for Scientific and Technological Development (CNPq) [470904, 30167-PQ2]; Associacao Beneficente Alzira Denise Hertzog da Silva; Brazilian Coordination for the Improvement of Higher Education Personnel; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), an independent public foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); state of Sao Paulo; NARSAD Young Investigator from the Brain and Behavior Research Foundation(NARSAD); FAPESP Young Researcher from the Sao Paulo State Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Associacao Beneficente Alzira Denise Hertzog da Silva; Brazilian Coordination for the Improvement of Higher Education Personnel; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Supported by a grant (2012/20911-5) from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), an independent public foundation, the income of which is provided by the state of Sao Paulo; by grants from the 2013 NARSAD Young Investigator from the Brain and Behavior Research Foundation (20493, to Dr. Brunoni), the 2013 FAPESP Young Researcher from the Sao Paulo State Foundation (20911-5, to Dr. Brunoni), and the National Council for Scientific and Technological Development (CNPq; 470904 and 30167-PQ2, to Dr. Brunoni); by the Associacao Beneficente Alzira Denise Hertzog da Silva (to the LIM27 neuroscience laboratory); and by scholarships from the Brazilian Coordination for the Improvement of Higher Education Personnel (to Drs. Moffa, Moreno, and Nogueira) and from the FAPESP (to Drs. Fernandes and Veronezi).	Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Amsterdam JD, 2010, J CLIN PSYCHOPHARM, V30, P306, DOI 10.1097/JCP.0b013e3181da5300; [Anonymous], 2010, GUID IND INF CLIN TR; Aparicio LVM, 2016, BRAIN STIMUL, V9, P671, DOI 10.1016/j.brs.2016.05.004; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Brunoni AR, 2015, SAO PAULO MED J, V133, P252, DOI 10.1590/1516-3180.2014.00351712; Brunoni AR, 2011, J NEUROPSYCHOPHARMAC, V14, P1133, DOI DOI 10.1017/S1461145710001690; Castillo-Saavedra L, 2016, J PAIN, V17, P14, DOI 10.1016/j.jpain.2015.09.009; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Connolly K Ryan, 2012, J Clin Psychiatry, V73, pe567, DOI 10.4088/JCP.11m07413; Fuentes D., 2000, ESCALAS AVALIA O 150, P363; GAUDRY E, 1975, MULTIVAR BEHAV RES, V10, P331, DOI 10.1207/s15327906mbr1003_6; Guarienti F, 2015, NEUROMODULATION, V18, P261, DOI 10.1111/ner.12230; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; LEVINE J, 1986, PSYCHOPHARMACOL BULL, V22, P343; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Masson SC, 2013, J CLIN EPIDEMIOL, V66, P805, DOI 10.1016/j.jclinepi.2013.01.010; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Meron D, 2015, NEUROSCI BIOBEHAV R, V57, P46, DOI 10.1016/j.neubiorev.2015.07.012; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nutt D, 2008, J PSYCHOPHARMACOL, V22, P409, DOI 10.1177/0269881108091068; Pigeot I, 2003, STAT MED, V22, P883, DOI 10.1002/sim.1450; Rosa MA, 2012, NEUROPSYCHOPHARMACOL, V37, P102, DOI 10.1038/npp.2011.225; Seibt O, 2015, BRAIN STIMUL, V8, P590, DOI 10.1016/j.brs.2015.01.401; Valiengo LCL, 2017, J NEUROL NEUROSUR PS, V88, P170, DOI 10.1136/jnnp-2016-314075; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	33	178	191	8	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2523	2533		10.1056/NEJMoa1612999	http://dx.doi.org/10.1056/NEJMoa1612999			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY8QE	28657871	Green Published, Bronze			2022-12-28	WOS:000404259200006
J	Dijkstra, KDB				Dijkstra, Klaas-Douwe B.			Taxonomy: use the Red List as a registry	NATURE			English	Letter									[Dijkstra, Klaas-Douwe B.] Nat Biodivers Ctr, Leiden, Netherlands	Naturalis Biodiversity Center	Dijkstra, KDB (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.	kd.dijkstra@naturalis.nl						Garnett ST, 2017, NATURE, V546, P25, DOI 10.1038/546025a	1	5	6	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					599	600		10.1038/546599d	http://dx.doi.org/10.1038/546599d			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658243	Bronze			2022-12-28	WOS:000404332000027
J	Martin, J				Martin, James			Let science be a springboard for politics	NATURE			English	Editorial Material									[Martin, James] North Carolina State Univ, Chem, Raleigh, NC 27695 USA; [Martin, James] Wake Cty Board Educ, Raleigh, NC 27601 USA	University of North Carolina; North Carolina State University	Martin, J (corresponding author), North Carolina State Univ, Chem, Raleigh, NC 27695 USA.; Martin, J (corresponding author), Wake Cty Board Educ, Raleigh, NC 27601 USA.	jim_martin@ncsu.edu		Martin, James/0000-0001-7414-2683				2017, NATURE, V544, P259	1	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					577	577		10.1038/546577a	http://dx.doi.org/10.1038/546577a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9QB	28661506				2022-12-28	WOS:000404332000014
J	Olmeda, D; Cerezo-Wallis, D; Riveiro-Falkenbach, E; Pennacchi, PC; Contreras-Alcalde, M; Ibarz, N; Cifdaloz, M; Catena, X; Calvo, TG; Canon, E; Alonso-Curbelo, D; Suarez, J; Osterloh, L; Grana, O; Mulero, F; Megias, D; Canamero, M; Martinez-Torrecuadrada, JL; Mondal, C; Di Martino, J; Lora, D; Martinez-Corral, I; Bravo-Cordero, JJ; Munoz, J; Puig, S; Ortiz-Romero, P; Rodriguez-Peralto, JL; Ortega, S; Soengas, MS				Olmeda, David; Cerezo-Wallis, Daniela; Riveiro-Falkenbach, Erica; Pennacchi, Paula C.; Contreras-Alcalde, Marta; Ibarz, Nuria; Cifdaloz, Metehan; Catena, Xavier; Calvo, Tonantzin G.; Canon, Estela; Alonso-Curbelo, Direna; Suarez, Javier; Osterloh, Lisa; Grana, Osvaldo; Mulero, Francisca; Megias, Diego; Canamero, Marta; Martinez-Torrecuadrada, Jorge L.; Mondal, Chandrani; Di Martino, Julie; Lora, David; Martinez-Corral, Ines; Bravo-Cordero, J. Javier; Munoz, Javier; Puig, Susana; Ortiz-Romero, Pablo; Rodriguez-Peralto, Jose L.; Ortega, Sagrario; Soengas, Maria S.			Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine	NATURE			English	Article							LYMPH-NODE; LYMPHANGIOGENESIS; EXPRESSION; MELANOMA; GENE; MECHANISMS; BIOMARKER; VESSELS; CANCER; MOUSE	Cutaneous melanoma is a type of cancer with an inherent potential for lymph node colonization, which is generally preceded by neolymphangiogenesis(1-3). However, sentinel lymph node removal does not necessarily extend the overall survival of patients with melanoma(4,5). Moreover, lymphatic vessels collapse and become dysfunctional as melanomas progress(6,7). Therefore, it is unclear whether (and how) lymphangiogenesis contributes to visceral metastasis. Soluble and vesicle-associated proteins secreted by tumours and/or their stroma have been proposed to condition pre-metastatic sites in patients with melanoma(8-14). Still, the identities and prognostic value of lymphangiogenic mediators remain unclear(2,14). Moreover, our understanding of lymphangiogenesis (in melanomas and other tumour types) is limited by the paucity of mouse models for live imaging of distal pre-metastatic niches(15). Injectable lymphatic tracers have been developed(7), but their limited diffusion precludes whole-body imaging at visceral sites(16). Vascular endothelial growth factor receptor 3 (VEGFR3) is an attractive 'lymphoreporter' 17 because its expression is strongly downregulated in normal adult lymphatic endothelial cells, but is activated in pathological situations such as inflammation and cancer(17,18). Here, we exploit this inducibility of VEGFR3 to engineer mouse melanoma models for whole-body imaging of metastasis generated by human cells, clinical biopsies or endogenously deregulated oncogenic pathways. This strategy revealed early induction of distal pre-metastatic niches uncoupled from lymphangiogenesis at primary lesions. Analyses of the melanoma secretome and validation in clinical specimens showed that the heparin-binding factor midkine is a systemic inducer of neo-lymphangiogenesis that defines patient prognosis. This role of midkine was linked to a paracrine activation of the mTOR pathway in lymphatic endothelial cells. These data support the use of VEGFR3 reporter mice as a 'MetAlert' discovery platform for drivers and inhibitors of metastasis.	[Olmeda, David; Cerezo-Wallis, Daniela; Pennacchi, Paula C.; Contreras-Alcalde, Marta; Cifdaloz, Metehan; Catena, Xavier; Calvo, Tonantzin G.; Canon, Estela; Alonso-Curbelo, Direna; Suarez, Javier; Osterloh, Lisa; Soengas, Maria S.] Spanish Natl Canc Res Ctr CNIO, Melanoma Lab, Mol Oncol Programme, Madrid 28029, Spain; [Riveiro-Falkenbach, Erica; Rodriguez-Peralto, Jose L.] Univ Complutense Madrid, Inst I 12, Hosp Univ Octubre 12, Med Sch,Dept Pathol, Madrid 28041, Spain; [Ibarz, Nuria; Munoz, Javier] Spanish Natl Canc Res Ctr CNIO, Prote Unit, Biotechnol Programme, Madrid 28029, Spain; [Grana, Osvaldo] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Mulero, Francisca] Spanish Natl Canc Res Ctr CNIO, Mol Imaging Unit, Biotechnol Programme, Madrid 28029, Spain; [Megias, Diego] Spanish Natl Canc Res Ctr CNIO, Confocal Microscopy Unit, Biotechnol Programme, Madrid 28029, Spain; [Canamero, Marta] Spanish Natl Canc Res Ctr CNIO, Histopathol Unit, Biotechnol Programme, Madrid 28029, Spain; [Martinez-Torrecuadrada, Jorge L.] Spanish Natl Canc Res Ctr CNIO, Crystallog & Prot Engn Unit, Biotechnol Programme, Madrid 28029, Spain; [Mondal, Chandrani; Di Martino, Julie; Bravo-Cordero, J. Javier] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Div Hematol & Oncol, Dept Med, New York, NY 10029 USA; [Lora, David] Hosp Univ 12 Octubre, Inst I 12, CIBERESP, Madrid 28041, Spain; [Martinez-Corral, Ines; Ortega, Sagrario] Spanish Natl Canc Res Ctr CNIO, Transgen Mice Unit, Biotechnol Programme, Madrid 28029, Spain; [Puig, Susana] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Melanoma Unit, Dermatol Dept, E-08036 Barcelona, Spain; [Ortiz-Romero, Pablo] Univ Complutense Madrid, Hosp Univ Octubre 12, Inst I 12, Dept Dermatol,Med Sch, Madrid 28041, Spain; [Alonso-Curbelo, Direna] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Cifdaloz, Metehan] Roche Innovat Ctr Munich, Roche Pharma Res & Early Dev, D-82377 Penzberg, Germany; [Martinez-Corral, Ines] Uppsala Univ, Dept Immunol, Genet & Pathol & Rudbeck Lab, S-75185 Uppsala, Sweden	Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid; Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Icahn School of Medicine at Mount Sinai; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Memorial Sloan Kettering Cancer Center; Uppsala University	Soengas, MS (corresponding author), Spanish Natl Canc Res Ctr CNIO, Melanoma Lab, Mol Oncol Programme, Madrid 28029, Spain.	msoengas@cnio.es	/AAI-3238-2021; Puig, Susana/AAB-2091-2020; Soengas, Maria S/H-6455-2015; Mulero, Francisca/R-2387-2019; Munoz, Javier/I-4891-2012; Megías, Diego/L-6008-2014; Olmeda, David/L-4270-2017; Martinez-Corral, Ines/F-1799-2016; di Martino, Julie Sandra/AAD-1430-2020; Catena, Xavier/L-1577-2017; Martinez-Torrecuadrada, Jorge L./AAG-1090-2019; Alonso Curbelo, Direna/AFT-1035-2022; CONTRERAS-ALCALDE, MARTA/L-1551-2017; Pennacchi, Paula/L-2220-2015; Cerezo-Wallis, Daniela/L-1492-2017	Puig, Susana/0000-0003-1337-9745; Soengas, Maria S/0000-0003-0612-6299; Mulero, Francisca/0000-0001-9584-4211; Munoz, Javier/0000-0003-3288-3496; Olmeda, David/0000-0001-5513-5621; Martinez-Corral, Ines/0000-0001-9194-2412; di Martino, Julie Sandra/0000-0002-2163-0736; Catena, Xavier/0000-0001-7885-2447; Alonso Curbelo, Direna/0000-0001-6674-3059; CONTRERAS-ALCALDE, MARTA/0000-0001-6473-9320; Martinez-Torrecuadrada, Jorge Luis/0000-0002-8240-6623; Grana-Castro, Osvaldo/0000-0003-1615-4242; Pennacchi, Paula/0000-0003-0875-0263; Cifdaloz, Metehan/0000-0003-1153-7535; Cerezo-Wallis, Daniela/0000-0002-4265-6898; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Megias, Diego/0000-0003-0755-0518; Bravo-Cordero, Jose Javier/0000-0001-9481-1231	Spanish Ministry of Economy and Innovation [SAF2014-56868-R]; Asociacion Espanola Contra el Cancer (AECC); Worldwide Cancer Research, an Established Investigator Award from Melanoma Research Alliance (MRA); L'Oreal Paris USA-MRA Team Science Award for Woman in Scientific Research; MINECO [SAF2013-45504-R, SAF2013-44866-R]; Ramon y Cajal Programme (MINECO) [RYC-2012-10651]; Spanish Ministry of Health [FIS 2014/1737, 11/02568, FIS 2014/01784, 11/1759]; AMIT Project/CDTI/CENIT Programme (MICINN); NCI [K22CA196750]; TCI Young Scientist Cancer Research Award JJR Fund [P30 CA196521]; ARC Foundation; Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Fundacion La Caixa; Immutrain Marie Sklodowska-Curie ITN Grant;  [PT13/0001]; NATIONAL CANCER INSTITUTE [P30CA196521, K22CA196750] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Innovation(Spanish Government); Asociacion Espanola Contra el Cancer (AECC); Worldwide Cancer Research, an Established Investigator Award from Melanoma Research Alliance (MRA); L'Oreal Paris USA-MRA Team Science Award for Woman in Scientific Research(L'Oreal Group); MINECO(Spanish Government); Ramon y Cajal Programme (MINECO)(Spanish Government); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); AMIT Project/CDTI/CENIT Programme (MICINN)(Ministry of Science and Innovation, Spain (MICINN)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); TCI Young Scientist Cancer Research Award JJR Fund; ARC Foundation(Australian Research Council); Fundacion Cientifica de la Asociacion Espanola Contra el Cancer; Fundacion La Caixa(La Caixa Foundation); Immutrain Marie Sklodowska-Curie ITN Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank colleagues at the CNIO Melanoma Group, particularly A. Tenaglia for technical assistance; J. A. Esteban for critical reading of this manuscript; the i+ 12 Biobank of the Hospital 12 de Octubre for help with histological analyses and for patient biopsies; L. Larue and M. McMahon for Tyr:CreERT2 and inducible Braf<SUP>CA</SUP> mouse strains, respectively; and the Animal Facility Unit and the Histopathology Core of CNIO for assistance. M.S.S. is funded by grants from the Spanish Ministry of Economy and Innovation (project SAF2014-56868-R), the Asociacion Espanola Contra el Cancer (AECC), the Worldwide Cancer Research, an Established Investigator Award from the Melanoma Research Alliance (MRA), and a L'Oreal Paris USA-MRA Team Science Award for Woman in Scientific Research. The CNIO Proteomics Unit belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. N.I. and J. M. are funded by SAF2013-45504-R (MINECO). J. M. is also supported by Ramon y Cajal Programme (MINECO) RYC-2012-10651. J. L. R.-P and P.O.-R are funded by grants FIS 2014/1737, 11/02568 and FIS 2014/01784, 11/1759, respectively, from the Spanish Ministry of Health. F.M. is funded by the AMIT Project/CDTI/CENIT Programme (MICINN), S.O. by SAF2013-44866-R (MINECO), and J. J. B.-C. by an NCI K22CA196750 grant and the TCI Young Scientist Cancer Research Award JJR Fund (P30 CA196521). J.D.M. is the recipient of a postdoctoral fellowship from the ARC Foundation and E.R.-F. from Fundacion Cientifica de la Asociacion Espanola Contra el Cancer. D.C.-W. is the recipient of a predoctoral fellowship from Fundacion La Caixa, and M. C.-A. and X.C. are recipients of the Immutrain Marie Sklodowska-Curie ITN Grant.	Alonso-Curbelo D, 2015, ONCOTARGET, V6, P11848, DOI 10.18632/oncotarget.4055; Choudhuri R, 1997, CANCER RES, V57, P1814; Coelho P, 2016, J CELL BIOCHEM, V117, P1697, DOI 10.1002/jcb.25463; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Das S, 2013, J EXP MED, V210, P1509, DOI 10.1084/jem.20111627; Demirsoy S, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00240; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Eklund L, 2013, MOL ONCOL, V7, P259, DOI 10.1016/j.molonc.2013.02.007; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; Jono Hirofumi, 2010, Cancers (Basel), V2, P624, DOI 10.3390/cancers2020624; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Kishida S, 2014, BRIT J PHARMACOL, V171, P896, DOI 10.1111/bph.12442; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Luo Y, 2012, NEOPLASIA, V14, P228, DOI 10.1593/neo.111570; Marino S, 2002, DEVELOPMENT, V129, P3513; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P811, DOI 10.1111/bph.12571; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Patsialou Antonia, 2013, Intravital, V2, pe25294; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petrova TV, 2008, CANCER CELL, V13, P554, DOI 10.1016/j.ccr.2008.04.022; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Pucci F, 2016, SCIENCE, V352, P242, DOI 10.1126/science.aaf1328; Sevick-Muraca EM, 2014, J CLIN INVEST, V124, P905, DOI 10.1172/JCI71612; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Akkooi ACJ, 2014, NAT REV CLIN ONCOL, V11, P248, DOI 10.1038/nrclinonc.2014.64; Weckbach LT, 2012, AM J PHYSIOL-HEART C, V303, pH429, DOI 10.1152/ajpheart.00934.2011; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182; Yao J, 2015, AM J CANCER RES, V5, P2912; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	44	77	79	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					676	+		10.1038/nature22977	http://dx.doi.org/10.1038/nature22977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658220	Green Accepted, Green Submitted			2022-12-28	WOS:000404332000052
J	Slomski, A				Slomski, Anita			Teens Who Were Breastfed Are Heavier	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2476	2476		10.1001/jama.2017.7584	http://dx.doi.org/10.1001/jama.2017.7584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655011				2022-12-28	WOS:000404106600008
J	Quah, YL; Aggarwal, IM				Quah, Yan Ling; Aggarwal, Ieera Madan			10 MINUTE CONSULTATION Discussing human papilloma virus vaccination	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADOLESCENTS; WOMEN		[Quah, Yan Ling] Singhlth Polyclin, Singapore, Singapore; [Aggarwal, Ieera Madan] KK Womens & Childrens Hosp, Dept Gynaecol Oncol, Singapore, Singapore	KK Women's & Children's Hospital	Aggarwal, IM (corresponding author), KK Womens & Childrens Hosp, Dept Gynaecol Oncol, Singapore, Singapore.	Ieera.aggarwal@singhealth.com.sg						Bruni L, 2015, HUMAN PAPILLOMAVIRUS; Centers for Disease Control and Prevention, 2015, HUM PAP HPV VACC SAF; De Vincenzo R, 2014, INT J WOMENS HEALTH, V6, P999, DOI 10.2147/IJWH.S50365; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; European Medicines Agency, PRAC REC SIGN; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Hanley SJB, 2015, LANCET, V385, P2571, DOI 10.1016/S0140-6736(15)61152-7; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Huygen F, 2015, EBIOMEDICINE, V2, P1114, DOI 10.1016/j.ebiom.2015.07.003; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kamerow D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2060; Kitchener HC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4781; Kreimer AR, 2015, LANCET ONCOL, V16, P775, DOI 10.1016/S1470-2045(15)00047-9; Mariani L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-105; MCCARTHY M, 2014, BMJ-BRIT MED J, V349, P69751, DOI DOI 10.1136/BMJ.G4877; Public Health England, 2014, HUM PAP HPV GREEN BO; Rambout L, 2007, CAN MED ASSOC J, V177, P469, DOI 10.1503/cmaj.070948; Stanley M, 2014, HUM VACC IMMUNOTHER, V10, P2109, DOI 10.4161/hv.29137; Stanley M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4783; Stillo M, 2015, EXPERT OPIN DRUG SAF, V14, P697, DOI 10.1517/14740338.2015.1013532; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; World Health Organization, 2014, WKLY EPIDEMIOL REC, V89, P465, DOI DOI 10.1186/1750-9378-2-15; World Health Organization International Agency for Research on Cancer, 2013, PRIM END POINTS PROP, V7	24	0	0	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2730	10.1136/bmj.j2730	http://dx.doi.org/10.1136/bmj.j2730			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YZ	28642269				2022-12-28	WOS:000404210800003
J	Rodrigues, LC; Paixao, ES				Rodrigues, Laura C.; Paixao, Enny S.			Risk of Zika-related microcephaly: stable or variable?	LANCET			English	Editorial Material							BIRTH-DEFECTS; BRAZIL		[Rodrigues, Laura C.; Paixao, Enny S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	laura.rodrigues@lshtm.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021		European Union's Horizon research and innovation programme under Zika-PLAN [734584]; MRC [MC_PC_15088] Funding Source: UKRI; Medical Research Council [MC_PC_15088] Funding Source: researchfish	European Union's Horizon research and innovation programme under Zika-PLAN; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LCR is partially funded by the European Union's Horizon 2020 research and innovation programme under Zika-PLAN grant agreement number 734584. We declare no competing interests.	Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brazilian Ministry of Health, 2017, INF EP NO6 SEM EP 45; Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309; Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; de Oliveira WK, 2017, LANCET, V390, P861, DOI [10.1016/S0140-6736(17)31368-5, 10.1016/s0140-6736(17)31368-5]; Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Teixeira M.G., 1999, INF EPIDEMIOLOGICO S, V8, P5, DOI [10.5123/S0104-16731999000400002, DOI 10.5123/S0104-16731999000400002]; WHO, SIT REP ZIK VIR MICR	12	7	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					824	826		10.1016/S0140-6736(17)31478-2	http://dx.doi.org/10.1016/S0140-6736(17)31478-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FE6PF	28647174				2022-12-28	WOS:000408330700005
J	Pollack, CV; Reilly, PA; van Ryn, J; Eikelboom, JW; Glund, S; Bernstein, RA; Dubiel, R; Huisman, MV; Hylek, EM; Kam, CW; Kamphuisen, PW; Kreuzer, J; Levy, JH; Royle, G; Sellke, FW; Stangier, J; Steiner, T; Verhamme, P; Wang, BS; Young, L; Weitz, JI				Pollack, Charles V., Jr.; Reilly, Paul A.; van Ryn, Joanne; Eikelboom, John W.; Glund, Stephan; Bernstein, Richard A.; Dubiel, Robert; Huisman, Menno V.; Hylek, Elaine M.; Kam, Chak-Wah; Kamphuisen, Pieter W.; Kreuzer, Joerg; Levy, Jerrold H.; Royle, Gordon; Sellke, Frank W.; Stangier, Joachim; Steiner, Thorsten; Verhamme, Peter; Wang, Bushi; Young, Laura; Weitz, Jeffrey I.			Idarucizumab for Dabigatran Reversal - Full Cohort Analysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; INTRACRANIAL HEMORRHAGE; PLASMA; PHARMACOKINETICS; ANTIDOTE; SAFETY; AGENT	BACKGROUND Idarucizumab, a monoclonal antibody fragment, was developed to reverse the anticoagulant effect of dabigatran. METHODS We performed a multicenter, prospective, open-label study to determine whether 5 g of intravenous idarucizumab would be able to reverse the anticoagulant effect of dabigatran in patients who had uncontrolled bleeding (group A) or were about to undergo an urgent procedure (group B). The primary end point was the maximum percentage reversal of the anticoagulant effect of dabigatran within 4 hours after the administration of idarucizumab, on the basis of the diluted thrombin time or ecarin clotting time. Secondary end points included the restoration of hemostasis and safety measures. RESULTS A total of 503 patients were enrolled: 301 in group A, and 202 in group B. The median maximum percentage reversal of dabigatran was 100% (95% confidence interval, 100 to 100), on the basis of either the diluted thrombin time or the ecarin clotting time. In group A, 137 patients (45.5%) presented with gastrointestinal bleeding and 98 (32.6%) presented with intracranial hemorrhage; among the patients who could be assessed, the median time to the cessation of bleeding was 2.5 hours. In group B, the median time to the initiation of the intended procedure was 1.6 hours; periprocedural hemostasis was assessed as normal in 93.4% of the patients, mildly abnormal in 5.1%, and moderately abnormal in 1.5%. At 90 days, thrombotic events had occurred in 6.3% of the patients in group A and in 7.4% in group B, and the mortality rate was 18.8% and 18.9%, respectively. There were no serious adverse safety signals. CONCLUSIONS In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.)	[Pollack, Charles V., Jr.] Thomas Jefferson Univ, 1020 Walnut St,6th Fl, Philadelphia, PA 19107 USA; [Reilly, Paul A.; Dubiel, Robert; Wang, Bushi] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [van Ryn, Joanne; Glund, Stephan; Wang, Bushi] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany; [Kreuzer, Joerg] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany; [Steiner, Thorsten] Klinikum Frankfurt Hochst, Frankfurt, Germany; [Steiner, Thorsten] Heidelberg Univ Hosp, Heidelberg, Germany; [Eikelboom, John W.; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON, Canada; [Eikelboom, John W.; Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Bernstein, Richard A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Huisman, Menno V.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Kamphuisen, Pieter W.] Tergooi Hosp, Hilversum, Netherlands; [Hylek, Elaine M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Kam, Chak-Wah] Tuen Mun Hosp, Hong Kong, Hong Kong, Peoples R China; [Levy, Jerrold H.] Duke Univ, Sch Med, Durham, NC USA; [Royle, Gordon] Middlemore Hosp, Auckland, New Zealand; [Young, Laura] Univ Auckland, Auckland, New Zealand; [Sellke, Frank W.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Sellke, Frank W.] Rhode Isl Hosp, Providence, RI USA; [Verhamme, Peter] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium	Jefferson University; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Ruprecht Karls University Heidelberg; McMaster University; McMaster University; Northwestern University; Feinberg School of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Boston University; Tuen Mun Hospital; Duke University; University of Auckland; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; KU Leuven	Pollack, CV (corresponding author), Thomas Jefferson Univ, 1020 Walnut St,6th Fl, Philadelphia, PA 19107 USA.	charles.pollack@jefferson.edu	Weitz, Jeffrey/AAD-1929-2019; Steiner, Thorsten/L-2868-2018; Eikelboom, John/AAG-6117-2019	Weitz, Jeffrey/0000-0002-1092-7550; Steiner, Thorsten/0000-0002-5080-8222; Eikelboom, John/0000-0003-4126-1285; Kamphuisen, Pieter/0000-0002-6263-0177	Boehringer Ingelheim; RE-VERSE AD	Boehringer Ingelheim(Boehringer Ingelheim); RE-VERSE AD	Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947.)	Connolly SJ, 2016, NEW ENGL J MED, V375, P2499, DOI 10.1056/NEJMc1613270; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Glund S, 2017, CLIN PHARMACOKINET, V56, P41, DOI 10.1007/s40262-016-0417-0; Glund S, 2015, THROMB HAEMOSTASIS, V113, P943, DOI 10.1160/TH14-12-1080; Goldstein JN, 2015, LANCET, V385, P2077, DOI 10.1016/S0140-6736(14)61685-8; Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309; Heit JA, 2017, BLOOD; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; MedDRA, 2015, INTR GUID MED DRA VE; Mehta KD, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.1177.1177; Pollack CV, 2015, THROMB HAEMOSTASIS, V114, P198, DOI 10.1160/TH15-03-0192; Reilly PA, 2014, J AM COLL CARDIOL, V63, P321, DOI 10.1016/j.jacc.2013.07.104; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schiele F, 2013, BLOOD, V121, P3554, DOI 10.1182/blood-2012-11-468207; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001; Stangier J, 2012, BLOOD COAGUL FIBRIN, V23, P138, DOI 10.1097/MBC.0b013e32834f1b0c; Steiner T, 2016, LANCET NEUROL, V15, P566, DOI 10.1016/S1474-4422(16)00110-1; Vosko MR, 2017, J THROMB THROMBOLYS, V43, P306, DOI 10.1007/s11239-017-1476-2	20	572	591	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2017	377	5					431	441		10.1056/NEJMoa1707278	http://dx.doi.org/10.1056/NEJMoa1707278			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC3NW	28693366	Bronze, Green Published			2022-12-28	WOS:000406747100005
J	Bennett, JS				Bennett, Joel S.			Are Antiplatelet Agents Beneficial in Essential Thrombocythemia? Maybe Yes, Probably No	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; COMPLICATIONS		[Bennett, Joel S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Bennett, JS (corresponding author), Univ Penn, Hematol Oncol Div, Perelman Sch Med, Dept Med, Room 814,BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu						Campbell PJ, 2012, BLOOD, V120, P1409, DOI 10.1182/blood-2012-04-424911; Carobbio A, 2011, BLOOD, V117, P5857, DOI 10.1182/blood-2011-02-339002; Cazzola M, 2014, BLOOD, V123, P3714, DOI 10.1182/blood-2014-03-530865; Chu DK, 2017, ANN INTERN MED, V167, P170, DOI 10.7326/M17-0284; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Papadakis E, 2010, BLOOD REV, V24, P227, DOI 10.1016/j.blre.2010.08.002; Rumi E, 2014, BLOOD, V124, P1062, DOI 10.1182/blood-2014-05-578435; Spivak JL, 2017, NEW ENGL J MED, V376, P2168, DOI 10.1056/NEJMra1406186; Sulai NH, 2012, HEMATOL ONCOL CLIN N, V26, P285, DOI 10.1016/j.hoc.2012.01.003; Tefferi A, 2015, MAYO CLIN PROC, V90, P1283, DOI 10.1016/j.mayocp.2015.05.014	10	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					206	207		10.7326/M17-1378	http://dx.doi.org/10.7326/M17-1378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28654952				2022-12-28	WOS:000406631400013
J	Grossman, DC				Grossman, David C.		US Preventive Services Task Force	Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BLOOD-PRESSURE; INTERVENTIONS; WOMEN	IMPORTANCE Adults who adhere to national guidelines for a healthful diet and physical activity have lower rates of cardiovascular morbidity and mortality than those who do not. All persons, regardless of their risk status for cardiovascular disease (CVD), can gain health benefits from healthy eating behaviors and appropriate physical activity. OBJECTIVE To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention among adults without obesity who do not have cardiovascular risk factors (hypertension, dyslipidemia, abnormal blood glucose levels, or diabetes). EVIDENCE REVIEW The USPSTF reviewed the evidence on whether primary care-relevant counseling interventions to promote a healthful diet, physical activity, or both improve health outcomes, intermediate outcomes associated with CVD, or dietary or physical activity behaviors in adults; interventions to reduce sedentary behaviors; and the harms of behavioral counseling interventions. FINDINGS Counseling interventions result in improvements in healthful behaviors and small but potentially important improvements in intermediate outcomes, including reductions in blood pressure and low-density lipoprotein cholesterol levels and improvements in measures of adiposity. The overall magnitude of benefit related to these interventions is positive but small. The potential harms are at most small, leading the USPSTF to conclude that these interventions have a small net benefit for adults without obesity who do not have CVD risk factors. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends that primary care professionals individualize the decision to offer or refer adults without obesity who do not have hypertension, dyslipidemia, abnormal blood glucose levels, or diabetes to behavioral counseling to promote a healthful diet and physical activity. Existing evidence indicates a positive but small benefit of behavioral counseling for the prevention of CVD in this population. Persons who are interested and ready to make behavioral changes may be most likely to benefit from behavioral counseling. (C recommendation)				chair@uspstf.net	Epling, John W/J-1097-2019	Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997; Davidson, Karina/0000-0002-9162-477X	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, 2012, CLIN PREV SERV REC H; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Center for Disease Control and Prevention/ National Center for Health Statistics, 2015, LEAD CAUS DEATH; Community Preventive Services Task Force, 2014, DIAB COMB DIET PHYS; Ford ES, 2012, PREV MED, V55, P23, DOI 10.1016/j.ypmed.2012.04.016; Hypertension Prevention Trial Research Group, 1990, ARCH INTERN MED, V150, P153, DOI [10.1001/archinte.1990.00390130131021, DOI 10.1001/ARCHINTE.1990.00390130131021]; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; LeBlanc E, 2011, PUBLICATION AGENCY H; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Patnode CD, 2017, JAMA-J AM MED ASSOC, V318, P175, DOI 10.1001/jama.2017.3303; Patnode CD, 2017, AHRC PUBLICATION; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; U.S. Department of Health and Human Services, 2008, ODPHP PUBL; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657	24	75	79	3	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					167	174		10.1001/jama.2017.7171	http://dx.doi.org/10.1001/jama.2017.7171			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697260				2022-12-28	WOS:000405190800018
J	Stafford, N				Stafford, Ned			Jean Holowach Thurston OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						THURSTON JH, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2017	358								j3335	10.1136/bmj.j3335	http://dx.doi.org/10.1136/bmj.j3335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MO	28694252				2022-12-28	WOS:000405769900010
J	Malakoff, D; Mervis, J				Malakoff, David; Mervis, Jeffrey			2018 US BUDGET Lawmakers balk at most Trump cuts	SCIENCE			English	News Item																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		11	12		10.1126/science.357.6346.11	http://dx.doi.org/10.1126/science.357.6346.11			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684475				2022-12-28	WOS:000404854100009
J	Vazire, S				Vazire, Simine			Our obsession with eminence warps research	NATURE			English	Editorial Material									[Vazire, Simine] Univ Calif Davis, Psychol, Davis, CA 95616 USA	University of California System; University of California Davis	Vazire, S (corresponding author), Univ Calif Davis, Psychol, Davis, CA 95616 USA.	svazire@ucdavis.edu		Vazire, Simine/0000-0002-3933-9752					0	11	11	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					7	7		10.1038/547007a	http://dx.doi.org/10.1038/547007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682348	Bronze			2022-12-28	WOS:000404839900007
J	Davies, R				Davies, Rachael			Fiona Loud: the kidney patients' champion	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					21	21		10.1016/S0140-6736(17)31673-2	http://dx.doi.org/10.1016/S0140-6736(17)31673-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677551				2022-12-28	WOS:000404396300015
J	Hsiang, S; Kopp, R; Jina, A; Rising, J; Delgado, M; Mohan, S; Rasmussen, DJ; Muir-Wood, R; Wilson, P; Oppenheimer, M; Larsen, K; Houser, T				Hsiang, Solomon; Kopp, Robert; Jina, Amir; Rising, James; Delgado, Michael; Mohan, Shashank; Rasmussen, D. J.; Muir-Wood, Robert; Wilson, Paul; Oppenheimer, Michael; Larsen, Kate; Houser, Trevor			Estimating economic damage from climate change in the United States	SCIENCE			English	Article							TEMPERATURE; ADAPTATION; WEATHER; MODELS; POLICY; FLUCTUATIONS; PROJECTIONS; MORTALITY; IMPACTS; CMIP5	Estimates of climate change damage are central to the design of climate policies. Here, we develop a flexible architecture for computing damages that integrates climate science, econometric analyses, and process models. We use this approach to construct spatially explicit, probabilistic, and empirically derived estimates of economic damage in the United States from climate change. The combined value of market and nonmarket damage across analyzed sectors-agriculture, crime, coastal storms, energy, human mortality, and labor-increases quadratically in global mean temperature, costing roughly 1.2% of gross domestic product per +1 degrees C on average. Importantly, risk is distributed unequally across locations, generating a large transfer of value northward and westward that increases economic inequality. By the late 21st century, the poorest third of counties are projected to experience damages between 2 and 20% of county income (90% chance) under business-as-usual emissions (Representative Concentration Pathway 8.5).	[Hsiang, Solomon; Rising, James] Univ Calif Berkeley, Goldman Sch Publ Policy, Global Policy Lab, Berkeley, CA 94720 USA; [Hsiang, Solomon] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Kopp, Robert] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ USA; [Kopp, Robert] Rutgers State Univ, Inst Earth Ocean & Atmospher Sci, New Brunswick, NJ USA; [Jina, Amir] Univ Chicago, Dept Econ, Chicago, IL 60637 USA; [Jina, Amir] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA; [Rising, James] Univ Calif Berkeley, Energy Resource Grp, Berkeley, CA 94720 USA; [Delgado, Michael; Mohan, Shashank; Larsen, Kate; Houser, Trevor] Rhodium Grp, New York, NY USA; [Rasmussen, D. J.; Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Muir-Wood, Robert; Wilson, Paul] Risk Management Solut, Newark, CA USA; [Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	University of California System; University of California Berkeley; National Bureau of Economic Research; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Chicago; University of Chicago; University of California System; University of California Berkeley; Princeton University; Princeton University	Hsiang, S (corresponding author), Univ Calif Berkeley, Goldman Sch Publ Policy, Global Policy Lab, Berkeley, CA 94720 USA.; Hsiang, S (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.; Kopp, R (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ USA.; Kopp, R (corresponding author), Rutgers State Univ, Inst Earth Ocean & Atmospher Sci, New Brunswick, NJ USA.	shsiang@berkeley.edu; robert.kopp@rutgers.edu		Oppenheimer, Michael/0000-0002-9708-5914; Rising, James/0000-0001-8514-4748; Kopp, Robert/0000-0003-4016-9428; Delgado, Michael/0000-0002-2414-045X; Rasmussen, D.J./0000-0003-4668-5749	National Science Foundation; U.S. Department of Energy, Skoll Global Threats Fund; Bloomberg Philanthropies; Office of Hank Paulson; Next Generation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Skoll Global Threats Fund(United States Department of Energy (DOE)); Bloomberg Philanthropies; Office of Hank Paulson; Next Generation	This research was funded by grants from the National Science Foundation, the U.S. Department of Energy, Skoll Global Threats Fund, and by a nonpartisan grant awarded jointly by Bloomberg Philanthropies, the Office of Hank Paulson, and Next Generation. The methodology and results presented represent the views of the authors and are fully independent of the granting organizations. We thank M. Auffhammer, M. Meinshausen, K. Emanuel, J. Graff Zivin, O. Deschenes, J. McGrath, L. Lefgren, M. Neidell, M. Ranson, M. Roberts, A. Norris, K. Chadha, A. Dobbin, A. Guerrero, L. Schick, and W. Schlenker for providing data and additional analysis; M. Burke, W. Fisk, N. Stern, W. Nordhaus, T. Broccoli, M. Huber, T. Rutherford, J. Buzan, K. Fisher-Vanden, M. Light, D. Lobell, M. Greenstone, K. Hayhoe, G. Heal, D. Holtz-Eakin, J. Samet, A. Schreiber, W. Schlenker, J. Shapiro, M. Spence, L. Linden, L. Mearns, S. Ringstead, G. Yohe, and seminar participants at Duke, MIT, Stanford, the University of Chicago, and the National Bureau of Economic Research (NBER) for important discussions and advice; and J. Delgado and S. Shevtchenko for invaluable technical assistance. Rhodium Group is a private economic research company that conducts independent research for clients in the public, private, and philanthropic sectors. Risk Management Solutions is a catastrophe risk modeling company that provides hazard modeling services to financial institutions and public agencies. The analysis contained in this research article was conducted independently of any commercial work and was not influenced by clients of either organization. Data and code used in this analysis can be obtained at https://zenodo.org/communities/economic-damage-from-climate-changeusa/. S.H. and R.K. conceived of the study. All authors designed the analysis. R.K. and D.J.R. developed climate projections. A. J. and S.H. gathered and reanalyzed econometric results. J.R. developed the meta-analysis system. S.H., R.K., A. J., J.R., M. D., and T.H. designed the economic projection systems, and J.R. developed it with support from M. D. and A. J. T.H., M. D., and S. M. developed the energy modeling system, with econometric support from A.J. R.M.-W., P.W., S.H., R.K., and T. H. designed the approach for analyzing cyclone losses; P.W. and R.M.-W. conducted modeling; and M. D. and A. J. analyzed results. M. D., S. M., and T. H. implemented general equilibrium modeling; R.K., S. H., A. J., and J.R. contributed to its design; and M. D., A. J., and S. H. analyzed the output. J.R. developed and implemented the approach for analyzing uncertainty. A. J. conducted analysis and construction of aggregate damage functions. R.K., S. H., and A. J. developed and implemented the approach for valuing risk and inequality of damages. S. H.,R.K., A. J., J.R., M. D., D. J.R., K. L., and T. H. designed the figures; D. J.R. and A. J. constructed Fig. 1; M. D. and T. H. constructed Fig. 4; and A. J. constructed Figs. 2, 3, and 5. All authors wrote the manuscript.	Barreca A, 2016, J POLIT ECON, V124, P105, DOI 10.1086/684582; Burke M, 2016, SCIENCE, V352, P292, DOI 10.1126/science.aad9634; Burke M, 2016, AM ECON J-ECON POLIC, V8, P106, DOI 10.1257/pol.20130025; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cai YY, 2015, P NATL ACAD SCI USA, V112, P4606, DOI 10.1073/pnas.1503890112; Carleton TA, 2016, SCIENCE, V353, DOI 10.1126/science.aad9837; Costinot A, 2016, J POLIT ECON, V124, P205, DOI 10.1086/684719; de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Deryugina T., 2014, TECHNICAL REPORT; Deschenes O, 2007, AM ECON REV, V97, P354, DOI 10.1257/aer.97.1.354; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Gollier Christian, 2013, PRICING PLANETS FUTU; Hall TM, 2007, TELLUS A, V59, P486, DOI [10.1111/j.1600-0870.2007.00240.x, 10.1111/J.1600-0870.2007.00240.X]; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Heaton P., 2010, HIDDEN PLAIN SIGHT; Houser T., 2015, ECC RISKS CLIMATE CH; Hsiang S. M., 2011, THESIS; Hsiang S.M., 2014, CAUSAL EFFECT ENV CA; Hsiang S, 2016, ANNU REV RESOUR ECON, V8, P43, DOI 10.1146/annurev-resource-100815-095343; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Interagency Working Group on Social Cost of Carbon, 2010, TECH REP; Jacob B, 2007, J HUM RESOUR, V42, P489, DOI 10.3368/jhr.XLII.3.489; Kopp R. E., 2013, IMP WORLD 2013 C P, P834; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Lemoine D, 2014, AM ECON J-ECON POLIC, V6, P137, DOI 10.1257/pol.6.1.137; McGrath JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014054; NORDHAUS WD, 1993, AM ECON REV, V83, P313; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pindyck RS, 2013, J ECON LIT, V51, P860, DOI 10.1257/jel.51.3.860; Ranson M, 2014, J ENVIRON ECON MANAG, V67, P274, DOI 10.1016/j.jeem.2013.11.008; Rasmussen DJ, 2016, J APPL METEOROL CLIM, V55, P2301, DOI 10.1175/JAMC-D-15-0302.1; Revesz RL, 2014, NATURE, V508, P173, DOI 10.1038/508173a; Rising J. A., 2014, 2458129 SSRN; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; STERN, 2006, STERN REV EC CLIMATE; Stern N, 2013, J ECON LIT, V51, P838, DOI 10.1257/jel.51.3.838; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; U.S. Environmental Protection Agency National Center for Environmental Economics, 2010, TECH REP; United States Energy Information Administration, 2009, NAT EN MOD SYST OV; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren I. R., 1992, Environmental Software, V7, P229, DOI 10.1016/0266-9838(92)90006-P; Weitzman ML, 2007, J ECON LIT, V45, P703, DOI 10.1257/jel.45.3.703; Weitzman ML, 2009, REV ECON STAT, V91, P1, DOI 10.1162/rest.91.1.1; Willoughby HE, 2006, MON WEATHER REV, V134, P1102, DOI 10.1175/MWR3106.1; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	52	388	393	33	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1362	1368		10.1126/science.aal4369	http://dx.doi.org/10.1126/science.aal4369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663496	Green Submitted			2022-12-28	WOS:000404351500032
J	Lisanby, SH				Lisanby, Sarah H.			Noninvasive Brain Stimulation for Depression - The Devil Is in the Dosing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TDCS		[Lisanby, Sarah H.] NIMH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Lisanby, SH (corresponding author), NIMH, Bethesda, MD 20892 USA.		Lisanby, Sarah Hollingsworth/ABE-9003-2020; Lisanby, Sarah Hollingsworth/T-3918-2019	Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002955] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999; Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715; Brunoni AR, 2013, JAMA PSYCHIAT, V70, P383, DOI 10.1001/2013.jamapsychiatry.32; Chew T, 2015, BRAIN STIMUL, V8, P1130, DOI 10.1016/j.brs.2015.07.031; National Academies of Sciences Engineering and Medicine, 2016, P WORKSH; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Puri R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00107	7	21	22	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					2593	2594		10.1056/NEJMe1702492	http://dx.doi.org/10.1056/NEJMe1702492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY8QE	28657865				2022-12-28	WOS:000404259200015
J	Brown, AEC				Brown, Amy E. Caruso			Porous Boundaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brown, Amy E. Caruso] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA; [Brown, Amy E. Caruso] SUNY Upstate Med Univ, Ctr Bioeth & Humanities, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Brown, AEC (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.; Brown, AEC (corresponding author), SUNY Upstate Med Univ, Ctr Bioeth & Humanities, Syracuse, NY 13210 USA.	brownamy@upstate.edu							0	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2487	2488		10.1001/jama.2017.1589	http://dx.doi.org/10.1001/jama.2017.1589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655020				2022-12-28	WOS:000404106600016
J	Harris, JGE				Harris, Jack G. E.			Ambient quantum optomechanics	SCIENCE			English	Editorial Material							CAVITY OPTOMECHANICS; RADIATION; PRESSURE		[Harris, Jack G. E.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Harris, Jack G. E.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Harris, Jack G. E.] Yale Univ, Yale Quantum Inst, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Harris, JGE (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.; Harris, JGE (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.; Harris, JGE (corresponding author), Yale Univ, Yale Quantum Inst, New Haven, CT 06520 USA.	jack.harris@yale.edu	Harris, Jack/AAA-3829-2020					Aspelmeyer M, 2014, REV MOD PHYS, V86, P1391, DOI 10.1103/RevModPhys.86.1391; Cantor G. N., 1987, FIGURAL LITERAL PROB, P124; CAVES CM, 1980, PHYS REV LETT, V45, P75, DOI 10.1103/PhysRevLett.45.75; Einstein A, 1909, PHYS Z, V10, P185; Lebedew P, 1901, ANN PHYS-BERLIN, V6, P433; Maxwell J.C., 1873, TREATISE ELECT MAGNE, VII, P439; Nichols EF, 1903, ASTROPHYS J, V17, P315, DOI 10.1086/141035; Purdy TP, 2017, SCIENCE, V356, P1265, DOI 10.1126/science.aag1407; Purdy TP, 2013, SCIENCE, V339, P801, DOI 10.1126/science.1231282; Schilpp P.A., 1970, A EINSTEIN PHILOS SC, P217; Stamper-Kurn DM, 2014, QUANT SCI TECH, P283, DOI 10.1007/978-3-642-55312-7_13; Stone A.D., 2013, EINSTEIN QUANTUM, P250	12	3	3	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1232	1233		10.1126/science.aan0400	http://dx.doi.org/10.1126/science.aan0400			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642395				2022-12-28	WOS:000403881700018
J	Koppel, N; Rekdal, VM; Balskus, EP				Koppel, Nitzan; Rekdal, Vayu Maini; Balskus, Emily P.			Chemical transformation of xenobiotics by the human gut microbiota	SCIENCE			English	Review							GLYCYL RADICAL ENZYME; CHOLINE TRIMETHYLAMINE-LYASE; HUMAN INTESTINAL MICROBIOTA; CANCER DRUG TOXICITY; BETA-GLUCURONIDASE; CELIAC-DISEASE; DIETARY FIBER; HUMAN HEALTH; AZO DYES; N-OXIDE	The human gut microbiota makes key contributions to the metabolism of ingested compounds (xenobiotics), transforming hundreds of dietary components, industrial chemicals, and pharmaceuticals into metabolites with altered activities, toxicities, and lifetimes within the body. The chemistry of gut microbial xenobiotic metabolism is often distinct from that of host enzymes. Despite their important consequences for human biology, the gut microbes, genes, and enzymes involved in xenobiotic metabolism are poorly understood. Linking these microbial transformations to enzymes and elucidating their biological effects is undoubtedly challenging. However, recent studies demonstrate that integrating traditional and emerging technologies can enable progress toward this goal. Ultimately, a molecular understanding of gut microbial xenobiotic metabolism will guide personalized medicine and nutrition, inform toxicology risk assessment, and improve drug discovery and development.	[Koppel, Nitzan; Rekdal, Vayu Maini; Balskus, Emily P.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA; [Balskus, Emily P.] Broad Inst, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Balskus, EP (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.; Balskus, EP (corresponding author), Broad Inst, Cambridge, MA 02139 USA.	balskus@chemistry.harvard.edu			Smith Family Award for Biomedical Research; Damon Runyon-Rachleff Innovation Award; George W. Merck Fellowship; David and Lucille Packard Foundation; Howard Hughes Medical Institute-Gates Faculty Scholar Award [OPP1158186]; Massachusetts Institute of Technology Center for Microbiome Informatics and Therapeutics; Sloan Research Fellowship; Blavatnik Biomedical Accelerator Award; Takeda; Defense Advanced Research Projects Agency [HR0011-16-2-0013]; NIH [CA208834, 5T32GM007598]; NSF [MCB-1650086, DGE1144152]	Smith Family Award for Biomedical Research; Damon Runyon-Rachleff Innovation Award; George W. Merck Fellowship; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute-Gates Faculty Scholar Award; Massachusetts Institute of Technology Center for Microbiome Informatics and Therapeutics; Sloan Research Fellowship(Alfred P. Sloan Foundation); Blavatnik Biomedical Accelerator Award; Takeda(Takeda Pharmaceutical Company Ltd); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	Human gut microbiota research in the Balskus laboratory has been supported by the Smith Family Award for Biomedical Research, the Damon Runyon-Rachleff Innovation Award, a George W. Merck Fellowship, a Fellowship for Science and Engineering from the David and Lucille Packard Foundation, a Howard Hughes Medical Institute-Gates Faculty Scholar Award (OPP1158186), the Massachusetts Institute of Technology Center for Microbiome Informatics and Therapeutics, a Sloan Research Fellowship, a Blavatnik Biomedical Accelerator Award, Takeda, the Defense Advanced Research Projects Agency (HR0011-16-2-0013), the NIH (CA208834), and the NSF (MCB-1650086). N.K. acknowledges a Graduate Research Fellowship from the NSF (DGE1144152). V.M.R. is funded by an NIH training grant (5T32GM007598). E.P.B. has received honoraria from Procter & Gamble, Cubist (now Merck), Boehringer Ingelheim, New England Biolabs, Eli Lilly, Pfizer, Novartis, and Merck. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	Aron-Wisnewsky J, 2012, NAT REV GASTRO HEPAT, V9, P590, DOI 10.1038/nrgastro.2012.161; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; BERGMARK J, 1972, N-S ARCH PHARMAKOL, V272, P437, DOI 10.1007/BF00501249; Berry D, 2013, P NATL ACAD SCI USA, V110, P4720, DOI 10.1073/pnas.1219247110; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Bodea S, 2016, CELL CHEM BIOL, V23, P1206, DOI 10.1016/j.chembiol.2016.07.020; BOPP BA, 1986, CRC CR REV TOXICOL, V16, P213, DOI 10.3109/10408448609037465; BORZELLECA JF, 1990, FOOD CHEM TOXICOL, V28, P221, DOI 10.1016/0278-6915(90)90034-K; BOS RP, 1986, TOXICOLOGY, V40, P207, DOI 10.1016/0300-483X(86)90080-6; Buckel W, 2006, ANNU REV MICROBIOL, V60, P27, DOI 10.1146/annurev.micro.60.080805.142216; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; CALNE DB, 1971, BRIT MED J, V3, P729, DOI 10.1136/bmj.3.5777.729; Caminero A, 2016, GASTROENTEROLOGY, V151, P670, DOI 10.1053/j.gastro.2016.06.041; Caminero A, 2015, BRIT J NUTR, V114, P1157, DOI 10.1017/S0007114515002767; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; CARTER JH, 1980, BIOCHEM PHARMACOL, V29, P301, DOI 10.1016/0006-2952(80)90504-3; Cho CE, 2017, TRENDS ENDOCRIN MET, V28, P121, DOI 10.1016/j.tem.2016.10.005; Claus SP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.3; Clavel T, 2006, FEMS MICROBIOL ECOL, V55, P471, DOI 10.1111/j.1574-6941.2005.00057.x; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Cooper AJL, 2011, AMINO ACIDS, V41, P7, DOI 10.1007/s00726-010-0552-0; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Cross AJ, 2010, CANCER RES, V70, P2406, DOI 10.1158/0008-5472.CAN-09-3929; DANIELSSON H, 1959, ARCH BIOCHEM BIOPHYS, V83, P482, DOI 10.1016/0003-9861(59)90056-6; Das A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163099; Delomenie C, 2001, J BACTERIOL, V183, P3417, DOI 10.1128/JB.183.11.3417-3427.2001; Devlin AS, 2016, CELL HOST MICROBE, V20, P709, DOI 10.1016/j.chom.2016.10.021; Diaz-Bone RA, 2009, ENVIRON SCI TECHNOL, V43, P5249, DOI 10.1021/es900544c; DOBKIN JF, 1983, SCIENCE, V220, P325; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Ellrott K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000798; Feng R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12155; Fennema D, 2016, DRUG METAB DISPOS, V44, P1839, DOI 10.1124/dmd.116.070615; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Garcia-Villalba R, 2013, J AGR FOOD CHEM, V61, P8797, DOI 10.1021/jf402498b; Gerard P, 2004, FEMS MICROBIOL ECOL, V47, P337, DOI 10.1016/S0168-6496(03)00285-X; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; GOLDIN BR, 1973, J PHARMACOL EXP THER, V186, P160; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; He X, 2013, J AGR FOOD CHEM, V61, P9559, DOI 10.1021/jf4029046; Humblot C, 2007, CARCINOGENESIS, V28, P2419, DOI 10.1093/carcin/bgm170; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Kallemeijn WW, 2014, ADV CARBOHYD CHEM BI, V71, P297, DOI 10.1016/B978-0-12-800128-8.00004-2; Karigar C. S., 2011, Enzyme Research, V2011, P805187, DOI 10.4061/2011/805187; Kassie F, 2001, CARCINOGENESIS, V22, P1721, DOI 10.1093/carcin/22.10.1721; Kim KS, 2014, CHEMOSPHERE, V94, P151, DOI 10.1016/j.chemosphere.2013.09.066; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kolmeder CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029913; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; KRISHNAN R, 1980, AUST J EXP BIOL MED, V58, P639, DOI 10.1038/icb.1980.66; Kumano T, 2016, P NATL ACAD SCI USA, V113, P9087, DOI 10.1073/pnas.1605050113; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lasken RS, 2012, NAT REV MICROBIOL, V10, P631, DOI 10.1038/nrmicro2857; Laue H, 2001, J BACTERIOL, V183, P1727, DOI 10.1128/JB.183.5.1727-1733.2001; LAVRIJSEN K, 1995, DRUG METAB DISPOS, V23, P354; LEE SC, 1995, BIOCHEM PHARMACOL, V49, P1567, DOI 10.1016/0006-2952(95)00093-F; Lehouritis P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14554; Levin BJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai8386; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liebert CA, 1997, APPL ENVIRON MICROB, V63, P1066, DOI 10.1128/AEM.63.3.1066-1076.1997; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; Liu Y, 2006, TOXICOL SCI, V91, P356, DOI 10.1093/toxsci/kfj164; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; MACDONALD IA, 1983, J LIPID RES, V24, P675; Martinez-del Campo A, 2015, MBIO, V6, DOI 10.1128/mBio.00042-15; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; MOERTEL CG, 1982, NEW ENGL J MED, V306, P201, DOI 10.1056/NEJM198201283060403; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; NIIMURA T, 1974, J BIOCHEM-TOKYO, V75, P407, DOI 10.1093/oxfordjournals.jbchem.a130407; Nutt JG, 1996, ANN NEUROL, V39, P561, DOI 10.1002/ana.410390504; Okuda H, 1997, DRUG METAB DISPOS, V25, P270; PEPPERCORN MA, 1972, J PHARMACOL EXP THER, V181, P555; Rafii F, 1995, ENVIRON HEALTH PERSP, V103, P17, DOI 10.2307/3432471; RAFII F, 1990, APPL ENVIRON MICROB, V56, P2146, DOI 10.1128/AEM.56.7.2146-2151.1990; Rafii F, 1997, FOOD CHEM TOXICOL, V35, P897, DOI 10.1016/S0278-6915(97)00060-4; RELMAN AS, 1982, NEW ENGL J MED, V306, P236, DOI 10.1056/NEJM198201283060410; Ren DW, 1996, STEROIDS, V61, P33, DOI 10.1016/0039-128X(95)00173-N; Renwick AG, 2008, FOOD CHEM TOXICOL, V46, pS70, DOI 10.1016/j.fct.2008.05.008; RENWICK AG, 1986, XENOBIOTICA, V16, P1057, DOI 10.3109/00498258609038983; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; ROSSOL I, 1992, J BACTERIOL, V174, P2968, DOI 10.1128/JB.174.9.2968-2977.1992; Rothenberg SE, 2016, TOXICOL LETT, V242, P60, DOI 10.1016/j.toxlet.2015.11.022; Rowland I R, 1980, Dev Toxicol Environ Sci, V8, P79; ROWLAND IR, 1978, XENOBIOTICA, V8, P37, DOI 10.3109/00498257809060381; Ryan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098551; Saitta KS, 2014, XENOBIOTICA, V44, P28, DOI 10.3109/00498254.2013.811314; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Singh Z, 2016, J OCCUP MED TOXICOL, V11, DOI 10.1186/s12995-016-0128-3; Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009; Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17; STRONG HA, 1987, XENOBIOTICA, V17, P685, DOI 10.3109/00498258709043976; STRUGALA GJ, 1986, BIOCHEM PHARMACOL, V35, P2123, DOI 10.1016/0006-2952(86)90580-0; Sutton D, 1997, J PHARMACOL EXP THER, V282, P294; TAKENO S, 1993, TOXICOL APPL PHARM, V121, P233, DOI 10.1006/taap.1993.1150; Tang J, 2015, BRIT J NUTR, V114, P673, DOI 10.1017/S0007114515002329; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Ticak T, 2014, P NATL ACAD SCI USA, V111, pE4668, DOI 10.1073/pnas.1409642111; Tozaki H, 1997, J PHARM PHARMACOL, V49, P164, DOI 10.1111/j.2042-7158.1997.tb06773.x; Ulmer JE, 2014, J BIOL CHEM, V289, P24289, DOI 10.1074/jbc.M114.573303; Valdes L, 2015, FOOD FUNCT, V6, P2424, DOI [10.1039/C5FO00322A, 10.1039/c5fo00322a]; VANHOGEZAND RA, 1992, EUR J CLIN PHARMACOL, V43, P189, DOI 10.1007/BF01740669; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Wang B, 2016, DRUG DELIVERY PRINCI; Wang H, 2014, APPL MICROBIOL BIOT, V98, P3287, DOI 10.1007/s00253-013-5363-2; Wang J, 2015, EUR J PHARM SCI, V78, P31, DOI 10.1016/j.ejps.2015.06.018; Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Withering W., 1785, ACCOUNT FOXGLOVE; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhang K, 2014, PROTEIN EXPRES PURIF, V94, P33, DOI 10.1016/j.pep.2013.10.018; Zheng XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005114	127	425	440	37	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344							eaag2770	10.1126/science.aag2770	http://dx.doi.org/10.1126/science.aag2770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY3OM	28642381	Green Accepted, Green Published			2022-12-28	WOS:000403881700029
J	Perez-Molina, JA; Molina, I				Perez-Molina, Jose A.; Molina, Israel			Chagas disease	LANCET			English	Review							TRYPANOSOMA-CRUZI INFECTION; POLYMERASE-CHAIN-REACTION; LATIN-AMERICAN MIGRANTS; TERM-FOLLOW-UP; HEART-DISEASE; UNITED-STATES; RANDOMIZED-TRIAL; POPULATION PHARMACOKINETICS; CONGENITAL TRANSMISSION; TRANSPLANT RECIPIENTS	Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century. Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke. Even after more than a century, many challenges remain unresolved, since epidemiological control and diagnostic, therapeutic, and prognostic methods must be improved. In particular, the efficacy and tolerability profile of therapeutic agents is far from ideal. Furthermore, the population affected is older and more complex (eg, immunosuppressed patients and patients with cancer). Nevertheless, in recent years, our knowledge of Chagas disease has expanded, and the international networking needed to change the course of this deadly disease during the 21st century has begun.	[Perez-Molina, Jose A.] Hosp Univ Ramon & Cajal, Dept Infect Dis, Natl Referral Ctr Trop Dis, Inst Ramon & Cajal Invest Sanitaria, Madrid, Spain; [Molina, Israel] Hosp Univ Vall dHebron, Dept Infect Dis, Barcelona, Spain; [Molina, Israel] Catalan Inst Hlth, Int Hlth Program, Barcelona, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitari Vall d'Hebron	Perez-Molina, JA (corresponding author), Hosp Univ Ramon & Cajal, Dept Infect Dis, Natl Referral Ctr Trop Dis, Madrid 28034, Spain.	jperezm@salud.madrid.org		Perez-Molina, Jose Antonio/0000-0001-8735-4124; Molina Romero, Israel/0000-0001-6642-7515	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III, Subdireccion General de Redes; Network Biomedical Research on Tropical Diseases (RICET) [RD16/0027/0020]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III, Subdireccion General de Redes; Network Biomedical Research on Tropical Diseases (RICET)	Funding was provided by Ministerio de Economia y Competitividad; Instituto de Salud Carlos III, Subdireccion General de Redes; Network Biomedical Research on Tropical Diseases (RICET) (ref RD16/0027/0020).	de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Altcheh J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002907; Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006; Andrade J.P., 2011, Arq. Bras. Cardiol., V97, P01, DOI 10.1590/S0066-782X2011001600001; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Basile L, 2011, EUROSURVEILLANCE, V16, P14, DOI 10.2807/ese.16.37.19968-en; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bern C, 2012, CURR OPIN INFECT DIS, V25, P450, DOI 10.1097/QCO.0b013e328354f179; Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11; Bern C, 2009, CLIN INFECT DIS, V49, P1667, DOI 10.1086/648070; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Bestetti RB, 2009, J CARD FAIL, V15, P249, DOI 10.1016/j.cardfail.2008.10.023; BITTENCOURT A L, 1975, Revista do Instituto de Medicina Tropical de Sao Paulo, V17, P146; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Bowman NM, 2008, CLIN INFECT DIS, V46, P1822, DOI 10.1086/588299; Braga Julio Cesar Vieira, 2006, Arq. Bras. Cardiol., V86, P297, DOI 10.1590/S0066-782X2006000400010; Brasil PEAA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-337; Brener Z, 2000, TRYPANOSOMA CRUZI DO, P344; Bua J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002476; Bua J, 2012, T ROY SOC TROP MED H, V106, P623, DOI 10.1016/j.trstmh.2012.03.015; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Bustamante JM, 2014, J INFECT DIS, V209, P150, DOI 10.1093/infdis/jit420; Cancado JR, 1999, MEM I OSWALDO CRUZ, V94, P331, DOI 10.1590/S0074-02761999000700064; Cancino-Faure B, 2015, TRANSFUSION, V55, P1249, DOI 10.1111/trf.12989; Cardoso RN, 2014, J CARD FAIL, V20, P931, DOI 10.1016/j.cardfail.2014.09.003; Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI [10.1590/0074-02760140410, 10.1590/0074-02760140405]; Carod-Artal FJ, 2013, STROKE, V44, P2356, DOI 10.1161/STROKEAHA.113.000738; Centers for Disease Control and Prevention National Institutes of Health, 2010, BIOSAFETY MICROBIOLO; Chappuis F, 2010, J CLIN MICROBIOL, V48, P2948, DOI 10.1128/JCM.00774-10; Chatelain E, 2015, DRUG DES DEV THER, V9, P4807, DOI 10.2147/DDDT.S90208; Chin-Hong PV, 2011, AM J TRANSPLANT, V11, P672, DOI 10.1111/j.1600-6143.2011.03444.x; Cicora F, 2014, TRANSPLANTATION, V97, pE3, DOI 10.1097/01.TP.0000437673.86339.82; Conteh L, 2010, LANCET, V375, P239, DOI 10.1016/S0140-6736(09)61422-7; Coura J R, 1985, Mem Inst Oswaldo Cruz, V80, P73, DOI 10.1590/S0074-02761985000100011; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Pinto AYD, 2008, REV SOC BRAS MED TRO, V41, P602; de Oliveira RB, 1998, AM J GASTROENTEROL, V93, P884, DOI 10.1111/j.1572-0241.1998.270_r.x; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; DETORANZO EGD, 1984, ARCH INT PHARMACOD T, V272, P17; Dias J C, 1989, Rev Soc Bras Med Trop, V22, P147, DOI 10.1590/S0037-86821989000300007; Dutra WO, 2014, PARASITE IMMUNOL, V36, P377, DOI 10.1111/pim.12107; ESPINOSA R, 1985, INT J CARDIOL, V8, P45, DOI 10.1016/0167-5273(85)90262-1; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Feliciangeli MD, 2003, TRENDS PARASITOL, V19, P44, DOI 10.1016/S1471-4922(02)00013-2; Ferreira Claudio Santos, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P161, DOI 10.1590/S0036-46652001000300008; Flores-Chavez M, 2010, ENFERM INFEC MICR CL, V28, P284, DOI 10.1016/j.eimc.2009.07.005; Francisco AF, 2015, ANTIMICROB AGENTS CH, V59, P4653, DOI 10.1128/AAC.00520-15; Alvarez MG, 2016, ANTIMICROB AGENTS CH, V60, P833, DOI 10.1128/AAC.00745-15; Gali WL, 2014, EUROPACE, V16, P674, DOI 10.1093/europace/eut422; Garcia-Bournissen F, 2015, ARCH DIS CHILD, V100, P90, DOI 10.1136/archdischild-2014-306358; Garcia-Bournissen F, 2010, ARCH DIS CHILD, V95, P224, DOI 10.1136/adc.2008.157297; Burgos LG, 2012, AM J DERMATOPATH, V34, pE84, DOI 10.1097/DAD.0b013e318257f9e2; Gorgolas M, 2013, PATHOG GLOB HEALTH, V107, P157, DOI 10.1179/2047773213Y.0000000081; GORLA NB, 1989, MUTAT RES, V224, P263, DOI 10.1016/0165-1218(89)90165-1; GORLA NB, 1988, MUTAT RES, V206, P217, DOI 10.1016/0165-1218(88)90163-2; Guiang KMU, 2013, TRANSPL INFECT DIS, V15, pE264, DOI 10.1111/tid.12157; Gurevitz JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002158; Hernandez Salvador, 2016, Open Forum Infect Dis, V3, pofw227, DOI 10.1093/ofid/ofw227; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; Hidron AI, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000688; Holguin A, 2013, CLIN VACCINE IMMUNOL, V20, P1197, DOI 10.1128/CVI.00221-13; Howard EJ, 2014, BJOG-INT J OBSTET GY, V121, P22, DOI 10.1111/1471-0528.12396; Huprikar S, 2013, AM J TRANSPLANT, V13, P2418, DOI 10.1111/ajt.12340; Imaz-Iglesia I, 2015, ACTA TROP, V148, P77, DOI 10.1016/j.actatropica.2015.04.014; Gonzalez-Tome MI, 2013, ENFERM INFEC MICR CL, V31, P535, DOI 10.1016/j.eimc.2012.09.010; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009; Kaplinski M, 2015, CLIN INFECT DIS, V61, P918, DOI 10.1093/cid/civ446; Kun H, 2009, CLIN INFECT DIS, V48, P1534, DOI 10.1086/598931; LARANJA FS, 1956, CIRCULATION, V14, P1035, DOI 10.1161/01.CIR.14.6.1035; Lattes R, 2010, TRANSPL P, V42, P3354, DOI 10.1016/j.transproceed.2010.09.019; Lee BY, 2013, LANCET INFECT DIS, V13, P342, DOI 10.1016/S1473-3099(13)70002-1; LORKE D, 1972, ARZNEI-FORSCHUNG, V22, P1603; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; Machado-de-Assis GF, 2013, MEM I OSWALDO CRUZ, V108, P873, DOI 10.1590/0074-0276130122; Molina I, 2015, ANTIMICROB AGENTS CH, V59, P6125, DOI 10.1128/AAC.04660-14; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005; Pereira FTM, 2014, PACE, V37, P751, DOI 10.1111/pace.12342; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Morillo CA, 2017, J AM COLL CARDIOL, V69, P939, DOI 10.1016/j.jacc.2016.12.023; Murcia L, 2013, CLIN INFECT DIS, V56, P496, DOI 10.1093/cid/cis910; Navarro M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013960; Norman FF, 2013, EMERG INFECT DIS, V19, P1561, DOI 10.3201/eid1910.130203; Nunes MCP, 2009, J NEUROL SCI, V278, P96, DOI 10.1016/j.jns.2008.12.015; Okamoto EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003227; Organizacion Panamericana de la Salud, OP5HDMCD4250G2006; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Perez-Ayala A, 2011, ANN TROP MED PARASIT, V105, P25, DOI 10.1179/136485910X12851868780423; Perez-Molina JA, 2015, LANCET INFECT DIS, V15, P1347, DOI 10.1016/S1473-3099(15)00243-1; Perez-Molina JA, 2014, CURR OPIN INFECT DIS, V27, P9, DOI 10.1097/QCO.0000000000000023; Perez-Molina JA, 2013, ACTA TROP, V127, P101, DOI 10.1016/j.actatropica.2013.04.003; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Pinazo MJ, 2013, ANTIMICROB AGENTS CH, V57, P390, DOI 10.1128/AAC.01401-12; Pinazo MJ, 2010, ANTIMICROB AGENTS CH, V54, P4896, DOI 10.1128/AAC.00537-10; Poveda C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091154; Rassi A, 2000, CLIN CARDIOL, V23, P883, DOI 10.1002/clc.4960231205; Rassi A Jr, 2001, Arq Bras Cardiol, V76, P75; Rassi Anis, 2002, Rev. Soc. Bras. Med. Trop., V35, P547, DOI 10.1590/S0037-86822002000600001; Rassi A, 2007, CIRCULATION, V115, P1101, DOI 10.1161/CIRCULATIONAHA.106.627265; Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Riarte A, 1999, CLIN INFECT DIS, V29, P561, DOI 10.1086/598634; Riera C, 2012, AM J TROP MED HYG, V86, P412, DOI 10.4269/ajtmh.2012.11-0111; Rochitte CE, 2005, J AM COLL CARDIOL, V46, P1553, DOI 10.1016/j.jacc.2005.06.067; Russomando G, 1998, AM J TROP MED HYG, V59, P487, DOI 10.4269/ajtmh.1998.59.487; Sabino EC, 2013, CIRCULATION, V127, P1105, DOI 10.1161/CIRCULATIONAHA.112.123612; Salvador F, 2014, CLIN MICROBIOL INFEC, V20, P706, DOI 10.1111/1469-0691.12443; Salvador F, 2015, AM J TROP MED HYG, V92, P898, DOI 10.4269/ajtmh.14-0546; Salvador F, 2011, LIVER TRANSPLANT, V17, P1304, DOI 10.1002/lt.22346; Salvatella R, 2014, MEM I OSWALDO CRUZ, V109, P122, DOI 10.1590/0074-0276140338; Samuels AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002358; Sanchez-Camargo CL, 2014, J CLIN MICROBIOL, V52, P2506, DOI 10.1128/JCM.00144-14; Sanchez-Montalva A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157597; Sanchez-Montalva A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004416; Sartor P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005336; Scanavacca M I, 1990, Arq Bras Cardiol, V54, P367; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Sica REP, 1995, B SOC PATHOL EXOT, V88, P156; Soy D, 2015, ANTIMICROB AGENTS CH, V59, P3342, DOI 10.1128/AAC.05018-14; Stimpert KK, 2010, EMERG INFECT DIS, V16, P871, DOI 10.3201/eid1605.091440; Streiger Mirtha L., 2004, Rev. Soc. Bras. Med. Trop., V37, P365; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Torrico F, 2013, ASTMH 62 ANN M WASH; Vallejo A, 2016, ACTA TROP, V164, P117, DOI 10.1016/j.actatropica.2016.09.010; Ventura-Garcia L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002410; Viotti RJ, 2004, HEART, V90, P655, DOI 10.1136/hrt.2003.018960; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; WEGNER DHG, 1972, ARZNEI-FORSCHUNG, V22, P1624; WHO, 2010, WHOHTMNTD2010; Yamagata Y, 2006, ADV PARASIT, V61, P129, DOI 10.1016/S0065-308X(05)61004-4; Yun O, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000488; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009; Zulantay I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001959	142	595	610	4	92	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					82	94		10.1016/S0140-6736(17)31612-4	http://dx.doi.org/10.1016/S0140-6736(17)31612-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FR9ZB	28673423				2022-12-28	WOS:000419432300032
J	Lane, R				Lane, Richard			Reinhard Busse: leader in Germany's health-system development	LANCET			English	Biographical-Item																		BUSSE R, PUBLICATION LIST	1	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					836	836		10.1016/S0140-6736(17)31754-3	http://dx.doi.org/10.1016/S0140-6736(17)31754-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28684022	Bronze			2022-12-28	WOS:000408330700012
J	Hua, T; Vemuri, K; Nikas, SP; Laprairie, RB; Wu, Y; Qu, L; Pu, M; Korde, A; Jiang, S; Ho, JH; Han, GW; Ding, K; Li, X; Liu, H; Hanson, MA; Zhao, S; Bohn, LM; Makriyannis, A; Stevens, RC; Liu, ZJ				Hua, Tian; Vemuri, Kiran; Nikas, Spyros P.; Laprairie, Robert B.; Wu, Yiran; Qu, Lu; Pu, Mengchen; Korde, Anisha; Jiang, Shan; Ho, Jo-Hao; Han, Gye Won; Ding, Kang; Li, Xuanxuan; Liu, Haiguang; Hanson, Michael A.; Zhao, Suwen; Bohn, Laura M.; Makriyannis, Alexandros; Stevens, Raymond C.; Liu, Zhi-Jie			Crystal structures of agonist-bound human cannabinoid receptor CB1	NATURE			English	Article							MEMBRANE-PROTEINS; ACCURATE DOCKING; GLIDE; CHEMISTRY	The cannabinoid receptor 1 (CB1) is the principal target of the psychoactive constituent of marijuana, the partial agonist Delta(9)-tetrahydrocannabinol (Delta(9)-THC)(1). Here we report two agonist-bound crystal structures of human CB1 in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841) at 2.80 angstrom and 2.95 angstrom resolution, respectively. The two CB1-agonist complexes reveal important conformational changes in the overall structure, relative to the antagonist-bound state(2), including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G-protein-binding region. In addition, a 'twin toggle switch' of Phe200(3.36) and Trp356(6.48) (superscripts denote Ballesteros-Weinstein numbering(3)) is experimentally observed and appears to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB1 and provide a molecular basis for predicting the binding modes of Delta(9)-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB1 seems to be a common feature among certain class A G-protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.	[Hua, Tian; Wu, Yiran; Qu, Lu; Pu, Mengchen; Ding, Kang; Zhao, Suwen; Stevens, Raymond C.; Liu, Zhi-Jie] ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Hua, Tian; Qu, Lu; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Hua, Tian; Qu, Lu; Ding, Kang] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Vemuri, Kiran; Nikas, Spyros P.; Korde, Anisha; Jiang, Shan; Makriyannis, Alexandros] Northeastern Univ, Dept Pharmaceut Sci, Ctr Drug Discovery, Boston, MA 02115 USA; [Vemuri, Kiran; Nikas, Spyros P.; Korde, Anisha; Jiang, Shan; Makriyannis, Alexandros] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Laprairie, Robert B.; Ho, Jo-Hao; Bohn, Laura M.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Laprairie, Robert B.; Ho, Jo-Hao; Bohn, Laura M.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Han, Gye Won; Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Han, Gye Won; Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Ding, Kang; Zhao, Suwen; Stevens, Raymond C.; Liu, Zhi-Jie] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Li, Xuanxuan; Liu, Haiguang] Beijing Computat Sci Res Ctr, Complex Syst Div, Beijing 100193, Peoples R China; [Hanson, Michael A.] GPCR Consortium, San Marcos, CA 92078 USA	ShanghaiTech University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeastern University; Northeastern University; Scripps Research Institute; Scripps Research Institute; University of Southern California; University of Southern California; ShanghaiTech University; Chinese Academy of Engineering Physics; Beijing Computational Science Research Center (CSRC)	Zhao, S; Liu, ZJ (corresponding author), ShanghaiTech Univ, iHuman Inst, Shanghai 201210, Peoples R China.; Liu, ZJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Makriyannis, A (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Ctr Drug Discovery, Boston, MA 02115 USA.; Makriyannis, A (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.; Bohn, LM (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.; Bohn, LM (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.; Zhao, S; Liu, ZJ (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.	zhaosw@shanghaitech.edu.cn; lbohn@scripps.edu; a.makriyannis@northeastern.edu; liuzhj@shanghaitech.edu.cn	Bohn, Laura M/A-7483-2014; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8673-2022; Liu, Zhi-Jie/A-3946-2012; Korde, Anisha/M-7275-2018; Makriyannis, Alexandros/GRF-1518-2022	Bohn, Laura M/0000-0002-6474-8179; Stevens, Raymond/0000-0002-4522-8725; Han, Gye Won/0000-0003-4107-835X; Liu, Zhi-Jie/0000-0001-7279-2893; Makriyannis, Alexandros/0000-0003-3272-3687; Pu, Mengchen/0000-0001-6282-2454; Zhao, Suwen/0000-0001-5609-434X; liu, haiguang/0000-0001-7324-6632; Ding, Kang/0000-0001-8570-8793; Qu, Lu/0000-0002-5121-2164; Korde, Anisha/0000-0002-2233-4322	NSF of China [31330019]; MOST of China [2014CB910400, 2015CB910104]; NSF of Shanghai [16ZR1448500]; Key R&D Program of China [2016YCF0905902]; NIH [R01DA041435, P01DA009158, R37DA023142]; NSF; Shanghai Municipal Government; ShanghaiTech University; GPCR Consortium; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA045020, R01DA041435, R37DA023142, P01DA009158] Funding Source: NIH RePORTER	NSF of China(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); NSF of Shanghai; Key R&D Program of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Shanghai Municipal Government; ShanghaiTech University; GPCR Consortium; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NSF of China grant 31330019 (Z.-J.L.), the MOST of China grants 2014CB910400 (Z.-J.L.) and 2015CB910104 (Z.-J.L.), NSF of Shanghai 16ZR1448500 grant (S.Z.), Key R&D Program of China grant 2016YCF0905902 (S.Z.), NIH grants R01DA041435 (R.C.S., A.M.), P01DA009158 (A.M., L.M.B.), R37DA023142 (A.M.), NSF grants, Shanghai Municipal Government, ShanghaiTech University and GPCR Consortium. The diffraction data were collected at GM/CA@APS of Argonne National Laboratory, X06SA@SLS of the Paul Scherrer Insitute, and BL41XU@Spring-8 with JASRI proposals 2015B1031 and 2016A2731. We thank M. Wang, C.-Y. Huang, V. Olieric, M. Audet and M.-Y. Lee for their help with data collection, A. Walker for critical review of the manuscript, and F. Sun for high-resolution mass spectrometry analysis.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn KH, 2009, MOL PHARMACOL, V76, P833, DOI 10.1124/mol.109.057356; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; D'Antona AM, 2006, BIOCHEMISTRY-US, V45, P5606, DOI 10.1021/bi060067k; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kulkarni S, 2016, J MED CHEM, V59, P6903, DOI 10.1021/acs.jmedchem.6b00717; LEMBERGER L, 1980, ANNU REV PHARMACOL, V20, P151, DOI 10.1146/annurev.pa.20.040180.001055; LI HL, 1974, ECON BOT, V28, P437; Makriyannis A, 1987, NIDA Res Monogr, V79, P204; Makriyannis A, 2014, J MED CHEM, V57, P3891, DOI 10.1021/jm500220s; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MECHOULAM R, 1988, EXPERIENTIA, V44, P762, DOI 10.1007/BF01959156; Mechoulam R, 2014, NAT REV NEUROSCI, V15, P757, DOI 10.1038/nrn3811; Nikas SP, 2004, AAPS J, V6; Nikas SP, 2007, TETRAHEDRON, V63, P8112, DOI 10.1016/j.tet.2007.06.006; Nikas SP, 2010, J MED CHEM, V53, P6996, DOI 10.1021/jm100641g; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Singh R, 2002, J PEPT RES, V60, P357, DOI 10.1034/j.1399-3011.2002.21065.x; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Tiburu EK, 2009, BIOCHEM BIOPH RES CO, V384, P243, DOI 10.1016/j.bbrc.2009.04.099; Xie XQ, 1996, J BIOL CHEM, V271, P10640, DOI 10.1074/jbc.271.18.10640; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	39	277	279	5	168	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					468	+		10.1038/nature23272	http://dx.doi.org/10.1038/nature23272			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28678776	Green Accepted			2022-12-28	WOS:000406358300039
J	Clauw, DJ				Clauw, Daniel J.			Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome	LANCET			English	Editorial Material							PACE TRIAL; FIBROMYALGIA		[Clauw, Daniel J.] Univ Michigan, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Clauw, DJ (corresponding author), Univ Michigan, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48106 USA.	dclauw@umich.edu						Clark LV, 2017, LANCET; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Dougall D, 2014, J PSYCHOSOM RES, V77, P20, DOI 10.1016/j.jpsychores.2014.04.002; Hauser W, 2010, EUR J PAIN, V14, P5, DOI 10.1016/j.ejpain.2009.01.006; Jones KD, 2009, RHEUM DIS CLIN N AM, V35, P373, DOI 10.1016/j.rdc.2009.05.004; Kindlon T, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5731; Kindlon T, 2010, PSYCHOSOM MED, V72, P506, DOI 10.1097/PSY.0b013e3181e21e43; Kindlon T, 2010, J REHABIL MED, V42, P184, DOI 10.2340/16501977-0493; Larun L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003200.pub4; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; White PD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5963; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2	12	5	5	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2017	390	10092					335	336		10.1016/S0140-6736(17)30577-9	http://dx.doi.org/10.1016/S0140-6736(17)30577-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FB1NU	28648401	hybrid			2022-12-28	WOS:000405911300004
J	Lolicato, M; Arrigoni, C; Mori, T; Sekioka, Y; Bryant, C; Clark, KA; Minor, DL				Lolicato, Marco; Arrigoni, Cristina; Mori, Takahiro; Sekioka, Yoko; Bryant, Clifford; Clark, Kimberly A.; Minor, Daniel L., Jr.			K(2P)2.1 (TREK-1)-activator complexes reveal a cryptic selectivity filter binding site	NATURE			English	Article							CATION-PI INTERACTIONS; CRYSTAL-STRUCTURE; CHANNEL; MECHANISM; TREK-1; ACTIVATION; INHIBITION; MODEL; TRAAK; OVEREXPRESSION	Polymodal thermo- and mechanosensitive two-pore domain potassium (K-2P) channels of the TREK1 subfamily generate 'leak' currents that regulate neuronal excitability, respond to lipids, temperature and mechanical stretch, and influence pain, temperature perception and anaesthetic responses(1-3). These dimeric voltage-gated ion channel (VGIC) superfamily members have a unique topology comprising two pore-forming regions per subunit(4-6). In contrast to other potassium channels, K-2P channels use a selectivity filter 'C-type' gate(7-10) as the principal gating site. Despite recent advances(3,11,12), poor pharmacological profiles of K2P channels limit mechanistic and biological studies. Here we describe a class of small-molecule TREK activators that directly stimulate the C-type gate by acting as molecular wedges that restrict interdomain interface movement behind the selectivity filter. Structures of K(2P)2.1 (also known as TREK-1) alone and with two selective K(2P)2.1 (TREK-1) and K(2P)10.1 (TREK-2) activators-an N-aryl-sulfonamide, ML335, and a thiophene-carboxamide, ML402-define a cryptic binding pocket unlike other ion channel small-molecule binding sites and, together with functional studies, identify a cation-p interaction that controls selectivity. Together, our data reveal a druggable K-2P site that stabilizes the C-type gate 'leak mode' and provide direct evidence for K-2P selectivity filter gating.	[Lolicato, Marco; Arrigoni, Cristina; Clark, Kimberly A.; Minor, Daniel L., Jr.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Mori, Takahiro; Sekioka, Yoko] Ono Pharmaceut Co Ltd, Shimamoto, Osaka 6188585, Japan; [Bryant, Clifford] Univ Calif San Francisco, Small Mol Discovery Ctr, San Francisco, CA 93858 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA; [Minor, Daniel L., Jr.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Ono Pharmaceutical Co Ltd; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA.; Minor, DL (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.; Minor, DL (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.	daniel.minor@ucsf.edu	Arrigoni, Cristina/AAG-8176-2020; Lolicato, Marco/ABC-6878-2020; Lolicato, Marco/AAL-3614-2020	Lolicato, Marco/0000-0002-2022-7961; Lolicato, Marco/0000-0002-2022-7961; Arrigoni, Cristina/0000-0003-1917-1750	American Heart Association [R01-MH093603]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093603] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K.Brejc, S. Capponi, M.Grabe and L. Jan for comments, and A. Renslo for comments and synthesis advice. This work was supported by grants R01-MH093603 to D.L.M., and to M.L. and C.A. from the American Heart Association.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Bagriantsev SN, 2013, ACS CHEM BIOL, V8, P1841, DOI 10.1021/cb400289x; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brohawn SG, 2014, NATURE, V516, P126, DOI 10.1038/nature14013; Brohawn SG, 2013, P NATL ACAD SCI USA, V110, P2129, DOI 10.1073/pnas.1218950110; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chemin J, 2007, PFLUG ARCH EUR J PHY, V455, P97, DOI 10.1007/s00424-007-0250-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Devilliers M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3941; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Honore E, 2002, EMBO J, V21, P2968, DOI 10.1093/emboj/cdf288; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEARNEY PC, 1993, J AM CHEM SOC, V115, P9907, DOI 10.1021/ja00075a006; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Lolicato M, 2014, NEURON, V84, P1198, DOI 10.1016/j.neuron.2014.11.017; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McClenaghan C, 2016, J GEN PHYSIOL, V147, P497, DOI 10.1085/jgp.201611601; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Murbartian J, 2005, J BIOL CHEM, V280, P30175, DOI 10.1074/jbc.M503862200; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Payandeh J, 2015, J MOL BIOL, V427, P3, DOI 10.1016/j.jmb.2014.08.010; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rapp C, 2014, PROTEINS, V82, P1494, DOI 10.1002/prot.24519; Sandoz G, 2009, P NATL ACAD SCI USA, V106, P14628, DOI 10.1073/pnas.0906267106; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Shaya D, 2011, P NATL ACAD SCI USA, V108, P12313, DOI 10.1073/pnas.1106811108; Su ZW, 2016, P NATL ACAD SCI USA, V113, P5748, DOI 10.1073/pnas.1602815113; Tang L, 2016, NATURE, V537, P117, DOI 10.1038/nature19102; Tertyshnikova S, 2005, J PHARMACOL EXP THER, V313, P250, DOI 10.1124/jpet.104.078592; Veale EL, 2014, MOL PHARMACOL, V85, P671, DOI 10.1124/mol.113.091199; Vivier D, 2017, J MED CHEM, V60, P1076, DOI 10.1021/acs.jmedchem.6b01285; Yelshanskaya MV, 2016, NEURON, V91, P1305, DOI 10.1016/j.neuron.2016.08.012; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	51	107	110	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					364	+		10.1038/nature22988	http://dx.doi.org/10.1038/nature22988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28693035	Green Published, Green Accepted			2022-12-28	WOS:000405844900037
J	Linde, K; Brinkhaus, B				Linde, Klaus; Brinkhaus, Benno			Randomized Trials of Chinese Herbal Medicine: A New Extension of the CONSORT Statement	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Linde, Klaus] Tech Univ Munich, Inst Gen Practice, Orleansstr 47, D-81667 Munich, Germany; [Brinkhaus, Benno] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Luisenstr 57, D-10098 Berlin, Germany	Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Linde, K (corresponding author), Tech Univ Munich, Inst Gen Practice, Orleansstr 47, D-81667 Munich, Germany.	klaus.linde@tum.de	Brinkhaus, Benno/AAU-2428-2021	Brinkhaus, Benno/0000-0001-6290-744X; Linde, Klaus/0000-0002-2902-970X				Cheng CW, 2017, ANN INTERN MED, V167, P112, DOI [10.7326/M16-2977, 10.7326/IsTranslatedFrom_M17-2977_2, 10.7326/IsTranslatedFrom_M17-2977_1]; He J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-122; Maciocia G., 2015, FDN CHINESE MED COMP, P1; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Tu YY, 2016, ANGEW CHEM INT EDIT, V55, P10210, DOI 10.1002/anie.201601967; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Wieland LS, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-51; World Health Organization, 2013, WHO TRAD MED STRAT 2; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Yang W, 2013, SCIENCE, V342, P1019, DOI 10.1126/science.1247700	10	7	8	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2017	167	2					133	+		10.7326/M17-1067	http://dx.doi.org/10.7326/M17-1067			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA6SD	28654966				2022-12-28	WOS:000405573400023
J	[Anonymous]				[Anonymous]			Toxic Mushrooms in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 11	2017	318	2					117	117		10.1001/jama.2017.7990	http://dx.doi.org/10.1001/jama.2017.7990			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA1HS	28697261				2022-12-28	WOS:000405190800006
J	Voosen, P				Voosen, Paul			THE AI DETECTIVES	SCIENCE			English	Editorial Material																			0	54	56	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346			SI		22	27		10.1126/science.357.6346.22	http://dx.doi.org/10.1126/science.357.6346.22			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6UL	28684483				2022-12-28	WOS:000404854100016
J	Giladi, A; Amit, I				Giladi, Amir; Amit, Ido			Immunology, one cell at a time	NATURE			English	Editorial Material							RNA-SEQ; HETEROGENEITY; MICROENVIRONMENT; LANDSCAPE		[Giladi, Amir; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Giladi, A (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	amir.goldberg@weizmann.ac.il; ido.amit@weizmann.ac.il						Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2014, CELL, V157, P8, DOI 10.1016/j.cell.2014.02.010; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	16	26	28	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					27	29		10.1038/547027a	http://dx.doi.org/10.1038/547027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682352	Bronze			2022-12-28	WOS:000404839900016
J	Sheldon, T				Sheldon, Tony			INTEGRATED CARE Buurtzorg: the district nurses who want to be superfluous	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												tonysheldon5@cs.com						[Anonymous], 2015, ADDED VALUE BUURTZOR; [Anonymous], 2015, COMMUNICATION; Brodie C., 2017, BUURTZORG DUTCH WORD; Koster NM, 2015, ANAL CLIENT CHARACTE; Maurits EEM, 2016, VERPLEEGKUNDE, V358, P13	5	4	4	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 6	2017	358								j3140	10.1136/bmj.j3140	http://dx.doi.org/10.1136/bmj.j3140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA3DO	28684468				2022-12-28	WOS:000405322300005
J	[Anonymous]				[Anonymous]			Single-cell biology	NATURE			English	Editorial Material																			0	6	6	4	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					19	19		10.1038/547019a	http://dx.doi.org/10.1038/547019a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682344	Bronze			2022-12-28	WOS:000404839900013
J	Barrett, J				Barrett, James			PRACTICE POINTER Gender dysphoria: assessment and management for non-specialists	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Barrett, James] Charing Cross Gender Ident Clin, London, England		Barrett, J (corresponding author), Charing Cross Gender Ident Clin, London, England.	JBarrett2@tavi-port.nhs.uk						De Cuypere G, 2006, SEXOLOGIES, V15, P126, DOI 10.1016/j.sexol.2006.04.002; Flores AR, 2016, MANY ADULTS IDENTITY; Glidden Derek, 2016, Sex Med Rev, V4, P3, DOI 10.1016/j.sxmr.2015.10.003; Marshall E, 2016, INT REV PSYCHIATR, V28, P58, DOI 10.3109/09540261.2015.1073143; Reed B, 2011, GENDER VARIANCE UK P; Robles R, 2016, LANCET PSYCHIAT, V3, P850, DOI 10.1016/S2215-0366(16)30165-1; Royal College of Psychiatrists, 2013, CR181 ROYAL COLL PSY	7	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2017	357								j2866	10.1136/bmj.j2866	http://dx.doi.org/10.1136/bmj.j2866			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AZ	28667001				2022-12-28	WOS:000404725200002
J	Zagorski, M; Tabata, Y; Brandenberg, N; Lutolf, MP; Tkacik, G; Bollenbach, T; Briscoe, J; Kicheva, A				Zagorski, Marcin; Tabata, Yoji; Brandenberg, Nathalie; Lutolf, Matthias P.; Tkacik, Gasper; Bollenbach, Tobias; Briscoe, James; Kicheva, Anna			Decoding of position in the developing neural tube from antiparallel morphogen gradients	SCIENCE			English	Article							SONIC HEDGEHOG; REPRESSOR ACTIVITY; MOTOR-NEURON; INFORMATION; PRECISION; NOTOCHORD; DESIGN; GENES	Like many developing tissues, the vertebrate neural tube is patterned by antiparallel morphogen gradients. To understand how these inputs are interpreted, we measured morphogen signaling and target gene expression in mouse embryos and chick ex vivo assays. From these data, we derived and validated a characteristic decoding map that relates morphogen input to the positional identity of neural progenitors. Analysis of the observed responses indicates that the underlying interpretation strategy minimizes patterning errors in response to the joint input of noisy opposing gradients. We reverse-engineered a transcriptional network that provides a mechanistic basis for the observed cell fate decisions and accounts for the precision and dynamics of pattern formation. Together, our data link opposing gradient dynamics in a growing tissue to precise pattern formation.	[Zagorski, Marcin; Tkacik, Gasper; Bollenbach, Tobias; Kicheva, Anna] IST Austria, A-3400 Klosterneuburg, Austria; [Tabata, Yoji; Brandenberg, Nathalie; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland; [Tabata, Yoji; Brandenberg, Nathalie; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Bollenbach, Tobias] Univ Cologne, Inst Theoret Phys, Cologne, Germany; [Briscoe, James; Kicheva, Anna] Francis Crick Inst, London NW1 1AT, England	Institute of Science & Technology - Austria; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Cologne; Francis Crick Institute	Bollenbach, T; Kicheva, A (corresponding author), IST Austria, A-3400 Klosterneuburg, Austria.; Bollenbach, T (corresponding author), Univ Cologne, Inst Theoret Phys, Cologne, Germany.; Briscoe, J; Kicheva, A (corresponding author), Francis Crick Inst, London NW1 1AT, England.	t.bollenbach@uni-koeln.de; james.briscoe@crick.ac.uk; anna.kicheva@ist.ac.at	Zagórski, Marcin/A-5746-2017; Bollenbach, Tobias/AAK-3206-2020	Bollenbach, Tobias/0000-0003-4398-476X; Tkacik, Gasper/0000-0002-6699-1455; Briscoe, James/0000-0002-1020-5240; Kicheva, Anna/0000-0003-4509-4998; Zagorski, Marcin/0000-0001-7896-7762	IST Austria; Austrian Science Fund [FWF P 28844]; European Research Council under European Union (EU) Horizon 2020 research and innovation program grant [680037]; People Programme (Marie Curie) of the EU Seventh Framework Programme [REA 291734]; Francis Crick Institute; Cancer Research UK [FC001051]; UK Medical Research Council [FC001051]; Wellcome Trust [FC001051, WT098326MA]; ERC [StG_311422]; EU Seventh Framework HEALTH research program PluriMes; Wellcome Trust [098325/Z/12/Z] Funding Source: researchfish; The Francis Crick Institute [10054, 10051] Funding Source: researchfish	IST Austria; Austrian Science Fund(Austrian Science Fund (FWF)); European Research Council under European Union (EU) Horizon 2020 research and innovation program grant; People Programme (Marie Curie) of the EU Seventh Framework Programme; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); EU Seventh Framework HEALTH research program PluriMes; Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	We thank T. Jessell and E. Laufer for antibodies. Supported by IST Austria (M.Z., G.T., T.B., and A.K.); Austrian Science Fund grant FWF P 28844 (G.T.); the European Research Council under European Union (EU) Horizon 2020 research and innovation program grant 680037 (M.Z. and A.K.); People Programme (Marie Curie) of the EU Seventh Framework Programme grant REA 291734 (M.Z.); the Francis Crick Institute, which receives its core funding from Cancer Research UK grant FC001051, UK Medical Research Council grant FC001051, and Wellcome Trust grants FC001051 and WT098326MA (J.B. and A.K.); and ERC grant StG_311422 and the EU Seventh Framework HEALTH research program PluriMes (www.plurimes.eu) (Y.T., N.B., and M.P.L.). Supplement contains additional data.	Alaynick WA, 2011, CELL, V146, P178, DOI 10.1016/j.cell.2011.06.038; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Bollenbach T, 2008, DEVELOPMENT, V135, P1137, DOI 10.1242/dev.012062; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2015, DEVELOPMENT, V142, P3996, DOI 10.1242/dev.129452; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dubuis JO, 2013, P NATL ACAD SCI USA, V110, P16301, DOI 10.1073/pnas.1315642110; Kicheva A, 2014, SCIENCE, V345, P1577, DOI 10.1126/science.1254927; Liem KF, 2000, DEVELOPMENT, V127, P4855; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Moore S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003811; Morishita Y, 2011, BIOPHYS J, V101, P2324, DOI 10.1016/j.bpj.2011.09.048; Morishita Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061905; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Tkacik G, 2016, ANNU REV CONDEN MA P, V7, P89, DOI 10.1146/annurev-conmatphys-031214-014803; Tkacik G, 2015, GENETICS, V199, P39, DOI 10.1534/genetics.114.171850; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916	25	71	71	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1379	1382		10.1126/science.aam5887	http://dx.doi.org/10.1126/science.aam5887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663499	Green Accepted, Green Submitted			2022-12-28	WOS:000404351500036
J	Dong, X; Milholland, B; Vijg, J				Dong, Xiao; Milholland, Brandon; Vijg, Jan			Is there evidence for a limit to human lifespan? Reply	NATURE			English	Letter									[Dong, Xiao; Milholland, Brandon; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.; Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA.	jan.vijg@einstein.yu.edu						[Anonymous], 2016, NATURE, V538; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Rozing MP, 2017, NATURE, V546, pE11, DOI 10.1038/nature22788	3	0	0	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E12	E12		10.1038/nature22789	http://dx.doi.org/10.1038/nature22789			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658233				2022-12-28	WOS:000404332000006
J	Dong, X; Milholland, B; Vijg, J				Dong, Xiao; Milholland, Brandon; Vijg, Jan			Many possible maximum lifespan trajectories Reply	NATURE			English	Letter									[Dong, Xiao; Milholland, Brandon; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.; Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA.	jan.vijg@einstein.yu.edu						ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Antero-Jacquemin JD, 2015, J GERONTOL A-BIOL, V70, P944, DOI 10.1093/gerona/glu130; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Hughes BG, 2017, NATURE, V546, pE8, DOI 10.1038/nature22786	4	1	1	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E9	E10		10.1038/nature22787	http://dx.doi.org/10.1038/nature22787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658240				2022-12-28	WOS:000404332000004
J	Kues, M; Reimer, C; Roztocki, P; Cortes, LR; Sciara, S; Wetzel, B; Zhang, YB; Cino, A; Chu, ST; Little, BE; Moss, DJ; Caspani, L; Azana, J; Morandotti, R				Kues, Michael; Reimer, Christian; Roztocki, Piotr; Cortes, Luis Romero; Sciara, Stefania; Wetzel, Benjamin; Zhang, Yanbing; Cino, Alfonso; Chu, Sai T.; Little, Brent E.; Moss, David J.; Caspani, Lucia; Azana, Jose; Morandotti, Roberto			On-chip generation of high-dimensional entangled quantum states and their coherent control	NATURE			English	Article							SILICON CHIP; PHOTONS; PHASE; COMPUTATION; EVOLUTION; OPTICS	Optical quantum states based on entangled photons are essential for solving questions in fundamental physics and are at the heart of quantum information science(1). Specifically, the realization of high-dimensional states (D-level quantum systems, that is, qudits, with D > 2) and their control are necessary for fundamental investigations of quantum mechanics(2), for increasing the sensitivity of quantum imaging schemes(3), for improving the robustness and key rate of quantum communication protocols(4), for enabling a richer variety of quantum simulations(5), and for achieving more efficient and error-tolerant quantum computation(6). Integrated photonics has recently become a leading platform for the compact, cost-efficient, and stable generation and processing of non-classical optical states(7). However, so far, integrated entangled quantum sources have been limited to qubits (D = 2)(8-11). Here we demonstrate on-chip generation of entangled qudit states, where the photons are created in a coherent superposition of multiple high-purity frequency modes. In particular, we confirm the realization of a quantum system with at least one hundred dimensions, formed by two entangled qudits with D = 10. Furthermore, using state-of-the-art, yet off-the-shelf telecommunications components, we introduce a coherent manipulation platform with which to control frequency-entangled states, capable of performing deterministic high-dimensional gate operations. We validate this platform by measuring Bell inequality violations and performing quantum state tomography. Our work enables the generation and processing of high-dimensional quantum states in a single spatial mode.	[Kues, Michael; Reimer, Christian; Roztocki, Piotr; Cortes, Luis Romero; Sciara, Stefania; Wetzel, Benjamin; Zhang, Yanbing; Azana, Jose; Morandotti, Roberto] Ctr Energie Mat & Telecommun INRS EMT, Inst Natl Rech Sci, 1650 Blvd Lionel Boulet, Varennes, PQ J3X 1S2, Canada; [Kues, Michael] Univ Glasgow, Sch Engn, Rankine Bldg,Oakfield Ave, Glasgow G12 8LT, Lanark, Scotland; [Sciara, Stefania; Cino, Alfonso] Univ Palermo, Dept Energy Informat Engn & Math Models, Palermo, Italy; [Wetzel, Benjamin] Univ Sussex, Sch Math & Phys Sci, Brighton BN1 9RH, E Sussex, England; [Chu, Sai T.] City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China; [Little, Brent E.] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China; [Moss, David J.] Swinburne Univ Technol, Ctr Micro Photon, Hawthorn, Vic 3122, Australia; [Caspani, Lucia] Univ Strathclyde, Inst Photon, Dept Phys, Glasgow G1 1RD, Lanark, Scotland; [Caspani, Lucia] Heriot Watt Univ, Inst Photon & Quantum Sci, Edinburgh EH14 4AS, Midlothian, Scotland; [Morandotti, Roberto] Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China; [Morandotti, Roberto] Natl Res Univ Informat Technol Mech & Opt, St Petersburg, Russia	University of Quebec; Institut national de la recherche scientifique (INRS); University of Glasgow; University of Palermo; University of Sussex; City University of Hong Kong; Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS; State Key Laboratory of Transient Optics & Photonics; Swinburne University of Technology; University of Strathclyde; Heriot Watt University; University of Electronic Science & Technology of China; ITMO University	Kues, M; Morandotti, R (corresponding author), Ctr Energie Mat & Telecommun INRS EMT, Inst Natl Rech Sci, 1650 Blvd Lionel Boulet, Varennes, PQ J3X 1S2, Canada.; Kues, M (corresponding author), Univ Glasgow, Sch Engn, Rankine Bldg,Oakfield Ave, Glasgow G12 8LT, Lanark, Scotland.; Morandotti, R (corresponding author), Univ Elect Sci & Technol China, Inst Fundamental & Frontier Sci, Chengdu 610054, Peoples R China.; Morandotti, R (corresponding author), Natl Res Univ Informat Technol Mech & Opt, St Petersburg, Russia.	morandotti@emt.inrs.ca	Morandotti, Roberto/AAU-4702-2020; Cortés, Luis Romero/H-6185-2018; Caspani, Lucia/C-3777-2009; Morandotti, Roberto/U-6712-2019; Wetzel, Benjamin/E-9386-2016; Chu, Sai T/D-3312-2014	Cortés, Luis Romero/0000-0002-9534-4476; Caspani, Lucia/0000-0003-2711-0448; Wetzel, Benjamin/0000-0002-2691-0307; Chu, Sai T/0000-0001-8263-8507; moss, david/0000-0001-5195-1744; Cino, Alfonso Carmelo/0000-0002-8116-3172; Sciara, Stefania/0000-0002-4740-9343	Natural Sciences and Engineering Research Council of Canada (NSERC); MESI PSR-SIIRI Initiative in Quebec; Canada Research Chair Program; Australian Research Council [DP150104327]; NSERC Vanier Canada; European Union [656607]; CityU APRC programme [9610356]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB24030300]; People Programme (Marie Curie Actions) of the European Union [PIOF-GA-2013-625466]; People Programme (Marie Curie Actions) of the European Union under REA Grant [627478]; Government of the Russian Federation through ITMO Fellowship; 1000 Talents Sichuan Program;  [074-U 01]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); MESI PSR-SIIRI Initiative in Quebec; Canada Research Chair Program(Canada Research Chairs); Australian Research Council(Australian Research Council); NSERC Vanier Canada; European Union(European Commission); CityU APRC programme; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); People Programme (Marie Curie Actions) of the European Union; People Programme (Marie Curie Actions) of the European Union under REA Grant; Government of the Russian Federation through ITMO Fellowship; 1000 Talents Sichuan Program; 	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) through the Steacie, Strategic, Discovery and Acceleration Grants Schemes, by the MESI PSR-SIIRI Initiative in Quebec, by the Canada Research Chair Program and by the Australian Research Council Discovery Projects scheme (DP150104327). C.R. and P.R. acknowledge the support of NSERC Vanier Canada Graduate Scholarships. M.K. acknowledges funding from the European Union's Horizon 2020 Research and Innovation programme under the Marie Sklodowska-Curie grant agreement number 656607. S.T.C. acknowledges support from the CityU APRC programme number 9610356. B.E.L. acknowledges support from the Strategic Priority Research Program of the Chinese Academy of Sciences (grant number XDB24030300). B.W. acknowledges support from the People Programme (Marie Curie Actions) of the European Union's FP7 Programme under REA grant agreement INCIPIT (PIOF-GA-2013-625466). L.C. acknowledges support from the People Programme (Marie Curie Actions) of the European Union's FP7 Programme under REA Grant Agreement number 627478 (THREEPLE). R.M. acknowledges additional support by the Government of the Russian Federation through the ITMO Fellowship and Professorship Program (grant 074-U 01) and from the 1000 Talents Sichuan Program. We thank R. Helsten and M. Islam for technical insights; A. Tavares, T. Hansson and A. Bruhacs for discussions; T. A. Denidni and S. O. Tatu for lending us some of the required experimental equipment; P. Kung from QPS Photronics for help and the use of processing equipment; as well as Quantum Opus and N. Bertone of OptoElectronics Components for their support and for providing us with state-of-the-art photon detection equipment.	Ali-Khan I, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060503; [Anonymous], 2010, NAT PHOTON, V4, P491; Babinec TM, 2010, NAT NANOTECHNOL, V5, P195, DOI [10.1038/NNANO.2010.6, 10.1038/nnano.2010.6]; Barreiro JT, 2011, PROCEDIA COMPUT SCI, V7, P52, DOI 10.1016/j.procs.2011.12.018; Bernhard C, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.032322; Capmany J, 2010, J OPT SOC AM B, V27, pA119, DOI 10.1364/JOSAB.27.00A119; Christ A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033027; Collins D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.040404; Dada AC, 2011, NAT PHYS, V7, P677, DOI [10.1038/nphys1996, 10.1038/NPHYS1996]; Finot C, 2015, OPT LETT, V40, P1422, DOI 10.1364/OL.40.001422; Fortsch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2838; Grassani D, 2015, OPTICA, V2, P88, DOI 10.1364/OPTICA.2.000088; Helt LG, 2010, OPT LETT, V35, P3006, DOI 10.1364/OL.35.003006; Horn RT, 2013, SCI REP-UK, V3, DOI 10.1038/srep02314; Howell JC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.210403; Imany P., 2017, C LAS EL; Ishizawa A, 2013, OPT EXPRESS, V21, P29186, DOI 10.1364/OE.21.029186; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Karpinski M, 2017, NAT PHOTONICS, V11, P53, DOI [10.1038/nphoton.2016.228, 10.1038/NPHOTON.2016.228]; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kumar P, 2009, IEEE J QUANTUM ELECT, V45, P149, DOI 10.1109/JQE.2008.2002673; Kwiat PG, 2001, NATURE, V409, P1014, DOI 10.1038/35059017; Lanyon BP, 2009, NAT PHYS, V5, P134, DOI 10.1038/NPHYS1150; Law CK, 2000, PHYS REV LETT, V84, P5304, DOI 10.1103/PhysRevLett.84.5304; Lloyd S, 2008, SCIENCE, V321, P1463, DOI 10.1126/science.1160627; Lukens JM, 2017, OPTICA, V4, P8, DOI 10.1364/OPTICA.4.000008; Matsuda N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00817; Neeley M, 2009, SCIENCE, V325, P722, DOI 10.1126/science.1173440; Olislager L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013804; Oppenheim A.V., 1997, SIGNALS SYSTEMS; Reimer C, 2016, SCIENCE, V351, P1176, DOI 10.1126/science.aad8532; Schaeff C, 2012, OPT EXPRESS, V20, P16145, DOI 10.1364/OE.20.016145; Silverstone JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8948; Solntsev A. S., 2016, REV PHYS, V2, P19; Tanzilli S, 2012, LASER PHOTONICS REV, V6, P115, DOI 10.1002/lpor.201100010; Thew R, 2004, QUANTUM INF COMPUT, V4, P93; Thew RT, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.012303; Walmsley IA, 2005, SCIENCE, V307, P1733, DOI 10.1126/science.1107451; Xiong C, 2015, OPTICA, V2, P724, DOI 10.1364/OPTICA.2.000724; Xuan Y, 2016, OPTICA, V3, P1171, DOI 10.1364/OPTICA.3.001171; Zhang YW, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501165; Zhou DL, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.062303	45	386	390	17	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					622	+		10.1038/nature22986	http://dx.doi.org/10.1038/nature22986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658228	Green Accepted			2022-12-28	WOS:000404332000041
J	Schorn, AJ; Gutbrod, MJ; LeBlanc, C; Martienssen, R				Schorn, Andrea J.; Gutbrod, Michael J.; LeBlanc, Chantal; Martienssen, Rob			LTR-Retrotransposon Control by tRNA-Derived Small RNAs	CELL			English	Article							EMBRYONIC STEM-CELLS; NOVO DNA METHYLATION; SMALL NONCODING RNAS; ZINC-FINGER PROTEIN; TRANSPOSABLE ELEMENTS; ENDOGENOUS RETROVIRUSES; GENE-EXPRESSION; MAMMALIAN-CELLS; FRAGMENTS TRFS; MOUSE OOCYTES	Transposon reactivation is an inherent danger in cells that lose epigenetic silencing during developmental reprogramming. In the mouse, long terminal repeat (LTR)-retrotransposons, or endogenous retroviruses (ERV), account for most novel insertions and are expressed in the absence of histone H3 lysine 9 trimethylation in preimplantation stem cells. We found abundant 18 nt tRNA-derived small RNA (tRF) in these cells and ubiquitously expressed 22 nt tRFs that include the 30 terminal CCA of mature tRNAs and target the tRNA primer binding site (PBS) essential for ERV reverse transcription. We show that the two most active ERV families, IAP and MusD/ETn, are major targets and are strongly inhibited by tRFs in retrotransposition assays. 22 nt tRFs post-transcriptionally silence coding-competent ERVs, while 18 nt tRFs specifically interfere with reverse transcription and retrotransposon mobility. The PBS offers a unique target to specifically inhibit LTR-retrotransposons, and tRF-targeting is a potentially highly conserved mechanism of small RNA-mediated transposon control.	[Schorn, Andrea J.; Gutbrod, Michael J.; LeBlanc, Chantal; Martienssen, Rob] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [LeBlanc, Chantal; Martienssen, Rob] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Gutbrod, Michael J.; Martienssen, Rob] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [LeBlanc, Chantal] Yale Univ, Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Yale University	Martienssen, R (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.; Martienssen, R (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.; Martienssen, R (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu			NIH [R01GM076396]; Bristol-Myers Squibb fellowship from the Watson School of Biological Sciences; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GMBF3033]; Cancer Center Support Grant [5PP30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014, R01GM076396] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb fellowship from the Watson School of Biological Sciences; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Janet Rossant (Sick Children Hospital, Toronto/Canada) for the mouse trophoblast cell line. The inducible Setdb1 knockout ESC line was a kind gift of Yoichi Shinkai (Kyoto University, Japan). Weare very grateful to Marie Dewannieux and Thierry Heidmann (CNRS-IGR, Villejuif/France) for providing us with the ETn/MusD and IAP retrotransposition reporter plasmids and the Gag MusD antiserum. We thank Wolf Reik, Wendy Dean, and Myriam Hemberger (Babraham Institute, Cambridge/UK) for discussion and for providing us with the Dnmt1 knockout line as well as additional TS cell clones. A.J.S. was supported by NIH grant R01GM076396 to R.M. M.J.G. was supported by a Bristol-Myers Squibb fellowship from the Watson School of Biological Sciences. This work was supported by the Howard Hughes Medical Institute and the Gordon and Betty Moore Foundation (GMBF3033). The authors acknowledge assistance from the Cold Spring Harbor Laboratory Shared Resources, which are funded in part by the Cancer Center Support Grant (5PP30CA045508).	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Chuong EB, 2013, NAT GENET, V45, P325, DOI 10.1038/ng.2553; Cole C, 2009, RNA, V15, P2147, DOI 10.1261/rna.1738409; Couvillion MT, 2010, GENE DEV, V24, P2742, DOI 10.1101/gad.1996210; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Ecco G, 2016, DEV CELL, V36, P611, DOI 10.1016/j.devcel.2016.02.024; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Fadloun A, 2013, NAT STRUCT MOL BIOL, V20, P332, DOI 10.1038/nsmb.2495; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Haussecker D, 2010, RNA, V16, P673, DOI 10.1261/rna.2000810; HEIDMANN O, 1991, CELL, V64, P159, DOI 10.1016/0092-8674(91)90217-M; Hemberger M, 2010, EPIGENETICS-US, V5, P24, DOI 10.4161/epi.5.1.10589; Ito M, 2015, DEVELOPMENT, V142, P2425, DOI 10.1242/dev.121996; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Keam Simon P., 2015, Life-Basel, V5, P1638, DOI 10.3390/life5041638; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; KEENEY JB, 1995, MOL CELL BIOL, V15, P217, DOI 10.1128/MCB.15.1.217; Kraushaar DC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r121; Kumar P, 2016, TRENDS BIOCHEM SCI, V41, P679, DOI 10.1016/j.tibs.2016.05.004; Kumar P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0078-0; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Grice SFJ, 2003, BIOCHEMISTRY-US, V42, P14349, DOI 10.1021/bi030201q; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZH, 2012, NUCLEIC ACIDS RES, V40, P6787, DOI 10.1093/nar/gks307; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Maksakova IA, 2009, MOL CELL BIOL, V29, P2456, DOI 10.1128/MCB.01383-08; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinez G, 2017, NUCLEIC ACIDS RES, V45, P5142, DOI 10.1093/nar/gkx103; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; Molla-Herman A, 2015, EMBO J, V34, P3009, DOI 10.15252/embj.201591006; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Nellaker C, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r45; Ohnishi Y, 2010, NUCLEIC ACIDS RES, V38, P5141, DOI 10.1093/nar/gkq229; PANGANIBAN AT, 1988, SCIENCE, V241, P1064, DOI 10.1126/science.2457948; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raina M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00171; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Rugg-Gunn PJ, 2010, P NATL ACAD SCI USA, V107, P10783, DOI 10.1073/pnas.0914507107; Ruggero K, 2014, J VIROL, V88, P3612, DOI 10.1128/JVI.02823-13; Schorn A., 2011, GENE DEV, V24, P2742, DOI [10.3410/f.8668956.9177054, DOI 10.3410/F.8668956.9177054]; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Sienski G, 2012, CELL, V151, P964, DOI 10.1016/j.cell.2012.10.040; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan XY, 2013, STEM CELL RES, V11, P1045, DOI 10.1016/j.scr.2013.07.006; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf G, 2015, GENE DEV, V29, P538, DOI 10.1101/gad.252767.114; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909	68	195	202	4	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					61	+		10.1016/j.cell.2017.06.013	http://dx.doi.org/10.1016/j.cell.2017.06.013			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666125	Green Accepted, Bronze			2022-12-28	WOS:000404358500010
J	Humphreys, K; Malenka, RC; Knutson, B; MacCoun, RJ				Humphreys, Keith; Malenka, Robert C.; Knutson, Brian; MacCoun, Robert J.			Brains, environments, and policy responses to addiction	SCIENCE			English	Editorial Material							ADOLESCENTS		[Humphreys, Keith] Vet Affairs Hlth Care Syst, Palo Alto, CA 94304 USA; [Malenka, Robert C.; Knutson, Brian; MacCoun, Robert J.] Stanford Univ, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Stanford University	Humphreys, K (corresponding author), Vet Affairs Hlth Care Syst, Palo Alto, CA 94304 USA.	knh@stanford.edu	MacCoun, Robert/N-1765-2019	MacCoun, Robert/0000-0003-0929-4423; Knutson, Brian/0000-0002-7669-426X	Stanford Neurosciences Institute; Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service	Stanford Neurosciences Institute; Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service	The authors are participants in the Neurochoice Initiative funded by the Stanford Neurosciences Institute. K.H. was supported by the Senior Research Career Scientist Award from the Veterans Affairs Health Services Research and Development Service. Some of these ideas were presented by K.H. at the 2016 World Economic Forum and by R.J.M. at the 2016 Neurochoice Symposium. None of the opinions in this article necessarily represent the policy views of any governmental organization for which the authors have worked or have advised.	Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Buchel C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14140; Chan M., 2017, COMMUNICATION   0313; Englund A, 2017, LANCET PSYCHIAT, V4, P643, DOI 10.1016/S2215-0366(17)30075-5; Jensen F. E., 2015, THE TEENAGE BRAIN; Kalant H, 2010, ADDICTION, V105, P780, DOI 10.1111/j.1360-0443.2009.02739.x; Kristjansson AL, 2016, ADDICTION, V111, P645, DOI 10.1111/add.13248; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; MacCoun R, 2008, REV LAW ECON, V4, P695, DOI 10.2202/1555-5879.1226; MacCoun RJ, 2015, NEW ENGL J MED, V372, P989, DOI 10.1056/NEJMp1416014; Morgan D, 2002, NAT NEUROSCI, V5, P169, DOI 10.1038/nn798; PANKSEPP J, 1978, BIOL PSYCHIAT, V13, P607; Plassmann H, 2012, J CONSUM PSYCHOL, V22, P18, DOI 10.1016/j.jcps.2011.11.010; Proctor RN, 2011, GOLDEN HOLOCAUST: ORIGINS OF THE CIGARETTE CATASTROPHE AND THE CASE FOR ABOLITION, P1; U.S. Department of Health and Human Services (HHS), 2016, OFF SURG GEN FAC ADD	15	7	7	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1237	1238		10.1126/science.aan0655	http://dx.doi.org/10.1126/science.aan0655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642399				2022-12-28	WOS:000403881700022
J	Kakui, Y; Uhlmann, F				Kakui, Yasutaka; Uhlmann, Frank			Building chromosomes without bricks	SCIENCE			English	Editorial Material							MITOTIC CHROMOSOME; PROTEIN; FIBERS		[Uhlmann, Frank] Francis Crick Inst, Chromosome Segregat Lab, London NW1 1AT, England	Francis Crick Institute	Uhlmann, F (corresponding author), Francis Crick Inst, Chromosome Segregat Lab, London NW1 1AT, England.	frank.uhlmann@crick.ac.uk	Kakui, Yasu/T-2183-2017	Kakui, Yasu/0000-0003-2066-232X; Uhlmann, Frank/0000-0002-3527-6619	The Francis Crick Institute [10198] Funding Source: researchfish	The Francis Crick Institute		Cheng TMK, 2015, ELIFE, V4, DOI 10.7554/eLife.05565; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Shintomi K, 2017, SCIENCE, V356, P1284, DOI 10.1126/science.aam9702; Shintomi K, 2015, NAT CELL BIOL, V17, P1014, DOI 10.1038/ncb3187; Terekawa T., 2017, BIORXIV; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30	13	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1233	1234		10.1126/science.aan8090	http://dx.doi.org/10.1126/science.aan8090			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642396				2022-12-28	WOS:000403881700019
J	Oteiza, P; Odstrcil, I; Lauder, G; Portugues, R; Engert, F				Oteiza, Pablo; Odstrcil, Iris; Lauder, George; Portugues, Ruben; Engert, Florian			A novel mechanism for mechanosensory-based rheotaxis in larval zebrafish	NATURE			English	Article							POSTERIOR LATERAL-LINE; FLOW; RHEOTROPISM; FISHES	When flying or swimming, animals must adjust their own movement to compensate for displacements induced by the flow of the surrounding air or water(1). These flow-induced displacements can most easily be detected as visual whole-field motion with respect to the animal's frame of reference(2). Despite this, many aquatic animals consistently orient and swim against oncoming flows (a behaviour known as rheotaxis) even in the absence of visual cues(3,4). How animals achieve this task, and its underlying sensory basis, is still unknown. Here we show that, in the absence of visual information, larval zebrafish (Danio rerio) perform rheotaxis by using flow velocity gradients as navigational cues. We present behavioural data that support a novel algorithm based on such local velocity gradients that fish use to avoid getting dragged by flowing water. Specifically, we show that fish use their mechanosensory lateral line to first sense the curl (or vorticity) of the local velocity vector field to detect the presence of flow and, second, to measure its temporal change after swim bouts to deduce flow direction. These results reveal an elegant navigational strategy based on the sensing of flow velocity gradients and provide a comprehensive behavioural algorithm, also applicable for robotic design, that generalizes to a wide range of animal behaviours in moving fluids.	[Oteiza, Pablo; Odstrcil, Iris; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Oteiza, Pablo; Odstrcil, Iris; Engert, Florian] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Oteiza, Pablo; Portugues, Ruben] Max Planck Inst Neurobiol, Sensorimotor Control Res Grp, D-82152 Martinsried, Germany; [Lauder, George] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University; Max Planck Society; Harvard University	Oteiza, P; Engert, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Oteiza, P; Engert, F (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.; Oteiza, P; Portugues, R (corresponding author), Max Planck Inst Neurobiol, Sensorimotor Control Res Grp, D-82152 Martinsried, Germany.	mijaelsmith@googlemail.com; rportugues@neuro.mpg.de; florian@mcb.harvard.edu	Portugues, Ruben/C-3600-2012; Portugues, Ruben/N-4900-2019	Portugues, Ruben/0000-0002-1495-9314; Portugues, Ruben/0000-0002-1495-9314; Odstrcil, Iris/0000-0002-7276-7337	Pew Latin-American Fellowship; BRAIN National Institutes of Health (NIH) [U01NS090449]; NIH Pioneer award; Simons Foundations [SCGB 325207]; Human Frontier Science Program [RGP0033/2014]; Office of Naval Research [N00014-09-1-0352]; Max-Planck-Gesellschaft;  [DP1 NS082121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086601, DP1NS082121, U01NS090449] Funding Source: NIH RePORTER	Pew Latin-American Fellowship; BRAIN National Institutes of Health (NIH); NIH Pioneer award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundations; Human Frontier Science Program(Human Frontier Science Program); Office of Naval Research(Office of Naval Research); Max-Planck-Gesellschaft(Max Planck Society); ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Soucy and J. Greenwood for technical support, and B. Jordan for discussions. We thank M. Baldwin, M. Hasemeyer, and T. Dunn for reading the manuscript, and M. McHenry for advice on the behavioural rig. We also thank M. Grunthal and R. Hellmiss for contributions to figure design, and V. Stih for sharing unpublished data. This work was supported by a Pew Latin-American Fellowship to P.O., BRAIN National Institutes of Health (NIH) grant U01NS090449, NIH Pioneer award, and DP1 NS082121 to F.E., Simons Foundations grant SCGB 325207 and Human Frontier Science Program grant RGP0033/2014 to F.E., and an Office of Naval Research grant N00014-09-1-0352 to G.L., monitored by T. McKenna. R.P. was funded by the Max-Planck-Gesellschaft during part of this work.	ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Barkley D, 2015, NATURE, V526, P550, DOI 10.1038/nature15701; Beck JC, 2004, J NEUROPHYSIOL, V92, P3546, DOI 10.1152/jn.00311.2004; Berg, 2018, RANDOM WALKS BIOL; Budick SA, 2000, J EXP BIOL, V203, P2565; Carlson RL, 2011, J EXP BIOL, V214, P1181, DOI 10.1242/jeb.051938; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; Drucker EG, 1999, J EXP BIOL, V202, P2393; Galilei G., 1967, DIALOGO DUE MASSIMI; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Hildebrand DGC, 2017, NATURE, V545, P345, DOI 10.1038/nature22356; Hofer B, 1908, BER KGL BAYER BIOL V, V1, P115; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Munz H., 1989, P285; Nagiel A, 2008, J NEUROSCI, V28, P8442, DOI 10.1523/JNEUROSCI.2425-08.2008; Olive R, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00014; Olszewski J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036661; Pujol-Marti J, 2012, J NEUROSCI, V32, P2976, DOI 10.1523/JNEUROSCI.5157-11.2012; Ristroph L, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.018102; Schuster Kevin, 2013, Cold Spring Harb Protoc, V2013, P1175, DOI 10.1101/pdb.prot079475; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; Tritton D. J., 1988, PHYS FLUID DYNAMICS, V18-25, P277; Van Trump WJ, 2013, INTEGR COMP BIOL, V53, P799, DOI 10.1093/icb/ict064; von Karman T., 1930, NACHR GES WISS GO MP, V5, P58; Yuan JZ, 2015, P NATL ACAD SCI USA, V112, P3606, DOI 10.1073/pnas.1424962112	28	87	89	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2017	547	7664					445	+		10.1038/nature23014	http://dx.doi.org/10.1038/nature23014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB7ZK	28700578	Green Submitted, Green Accepted			2022-12-28	WOS:000406358300034
J	Morgan, DJ; Wenzel, RP; Bearman, G				Morgan, Daniel J.; Wenzel, Richard P.; Bearman, Gonzalo			Contact Precautions for Endemic MRSA and VRE Time to Retire Legal Mandates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; CARE; ICU; TRANSMISSION; ENTEROCOCCUS; ACQUISITION; INFECTIONS; IMPACT		[Morgan, Daniel J.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 S Pine St,MSTF 334, Baltimore, MD 21201 USA; [Morgan, Daniel J.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Wenzel, Richard P.; Bearman, Gonzalo] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA	University System of Maryland; University of Maryland Baltimore; Virginia Commonwealth University	Morgan, DJ (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, 10 S Pine St,MSTF 334, Baltimore, MD 21201 USA.	dmorgan@som.umaryland.edu	Bearman, Gonzalo/ABB-2443-2020		Department of Veterans Affairs; US Centers for Disease Control and Prevention; National Institutes of Health; Agency for Healthcare Research and Quality; Pfizer; Cardinal Healthcare; BioVigil LLC; Vestagen Textiles	Department of Veterans Affairs(US Department of Veterans Affairs); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Pfizer(Pfizer); Cardinal Healthcare; BioVigil LLC; Vestagen Textiles	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Morgan reported receiving honoraria for editing a journal and book from Springer Inc; travel reimbursement for conferences and board meetings from the Infectious Diseases Society of America, the American Society for Microbiology, the Society for Healthcare Epidemiology of America, and Lown; and grants from the Department of Veterans Affairs, the US Centers for Disease Control and Prevention, the National Institutes of Health, and the Agency for Healthcare Research and Quality. Dr Bearman reported receiving grant support from Pfizer, Cardinal Healthcare, BioVigil LLC, and Vestagen Textiles. No other disclosures were reported.	Edmond MB, 2015, INFECT CONT HOSP EP, V36, P978, DOI 10.1017/ice.2015.99; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Morgan DJ, 2015, INFECT CONT HOSP EP, V36, P1163, DOI 10.1017/ice.2015.156; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Roghmann MC, 2015, INFECT CONT HOSP EP, V36, P1050, DOI 10.1017/ice.2015.119; Shenoy ES, 2016, INFECT CONT HOSP EP, V37, P782, DOI 10.1017/ice.2016.54; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006	9	40	42	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 25	2017	318	4					329	330		10.1001/jama.2017.7419	http://dx.doi.org/10.1001/jama.2017.7419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FB7BS	28654976				2022-12-28	WOS:000406296700008
J	Ye, X; Brabletz, T; Kang, YB; Longmore, GD; Nieto, MA; Stanger, BZ; Yang, J; Weinberg, RA				Ye, Xin; Brabletz, Thomas; Kang, Yibin; Longmore, Gregory D.; Angela Nieto, M.; Stanger, Ben Z.; Yang, Jing; Weinberg, Robert A.			Upholding a role for EMT in breast cancer metastasis	NATURE			English	Letter							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; TUMOR-INITIATING CELLS; E-CADHERIN EXPRESSION; COLONIZATION; REPRESSION		[Ye, Xin; Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Ye, Xin; Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02142 USA; [Brabletz, Thomas] FAU Univ Erlangen Nuernberg, Nikolaus Fiebiger Ctr Mol Med, Expt Med 1, D-91054 Erlangen, Germany; [Kang, Yibin] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Longmore, Gregory D.] Washington Univ, Dept Med, ICCE Inst, St Louis, MO 63110 USA; [Longmore, Gregory D.] Washington Univ, Dept Cell Biol & Physiol, ICCE Inst, St Louis, MO 63110 USA; [Angela Nieto, M.] CSIC, Inst Neurociencias, Alacant, Spain; [Angela Nieto, M.] Univ Miguel Hernandez, Alacant, Spain; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; [Stanger, Ben Z.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Yang, Jing] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, 3855 Hlth Sci Dr,MC0819, La Jolla, CA 92093 USA; [Weinberg, Robert A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Erlangen Nuremberg; Princeton University; Washington University (WUSTL); Washington University (WUSTL); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad Miguel Hernandez de Elche; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu	Nieto, M. Angela/A-6531-2008	Nieto, M. Angela/0000-0002-3538-840X; Kang, Yibin/0000-0002-1626-6730	NCI NIH HHS [R01 CA196205] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA196205] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beerling E, 2016, CELL REP, V14, P2281, DOI 10.1016/j.celrep.2016.02.034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Ni T, 2016, NAT CELL BIOL, V18, P1221, DOI 10.1038/ncb3425; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Xue CS, 2003, CANCER RES, V63, P3386; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	20	205	212	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					E1	E4		10.1038/nature22816	http://dx.doi.org/10.1038/nature22816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682326	Green Accepted			2022-12-28	WOS:000404839900001
J	Lane, W; Bailey, TS; Gerety, G; Gumprecht, J; Philis-Tsimikas, A; Hansen, CT; Nielsen, TSS; Warren, M				Lane, Wendy; Bailey, Timothy S.; Gerety, Gregg; Gumprecht, Janusz; Philis-Tsimikas, Athena; Hansen, Charlotte Thim; Nielsen, Thor S. S.; Warren, Mark			Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes The SWITCH 1 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BASAL-BOLUS TREATMENT; OPEN-LABEL; RISK; ANALOGS; COMPLICATIONS; METAANALYSIS; ASSOCIATION; VARIABILITY; MORTALITY; PHASE-3	IMPORTANCE Hypoglycemia, common in patients with type 1 diabetes, is a major barrier to achieving good glycemic control. Severe hypoglycemia can lead to coma or death. OBJECTIVE To determine whether insulin degludec is noninferior or superior to insulin glargine U100 in reducing the rate of symptomatic hypoglycemic episodes. DESIGN, SETTING, AND PARTICIPANTS Double-blind, randomized, crossover noninferiority trial involving 501 adults with at least 1 hypoglycemia risk factor treated at 84 US and 6 Polish centers (January 2014-January 12, 2016) for two 32-week treatment periods, each with a 16-week titration and a 16-week maintenance period. INTERVENTIONS Patients were randomized 1: 1 to receive once-daily insulin degludec followed by insulin glargine U100(n = 249) or to receive insulin glargine U100 followed by insulin degludec (n = 252) and randomized 1: 1 to morning or evening dosing within each treatment sequence. MAIN OUTCOMES AND MEASURES The primary end point was the rate of overall severe or blood glucose-confirmed (<56mg/dL) symptomatic hypoglycemic episodes during the maintenance period. Secondary end points included the rate of nocturnal symptomatic hypoglycemic episodes and proportion of patients with severe hypoglycemia during the maintenance period. The noninferiority criterion for the primary end point and for the secondary end point of nocturnal hypoglycemia was defined as an upper limit of the 2-sided 95% CI for a rate ratio of 1.10 or lower; if noninferiority was established, 2-sided statistical testing for superiority was conducted. RESULTS Of the 501 patients randomized (mean age, 45.9 years; 53.7% men), 395 (78.8%) completed the trial. During the maintenance period, the rates of overall symptomatic hypoglycemia were 2200.9 episodes per 100 person-years' exposure (PYE) in the insulin degludec group vs 2462.7 episodes per 100 PYE in the insulin glargine U100 group for a rate ratio (RR) of 0.89 (95% CI, 0.85-0.94; P <.001 for noninferiority; P <.001 for superiority; rate difference, -130.31 episodes per 100 PYE; 95% CI, -193.5 to -67.16). The rates of nocturnal symptomatic hypoglycemia were 277.1 per 100 PYE in the insulin degludec group vs 428.6 episodes per 100 PYE in the insulin glargine U100 group, for an RR of 0.64 (95% CI, 0.56-0.73; P <.001 for noninferiority; P <.001 for superiority; rate difference, -61.94 episodes per 100 PYE; 95% CI, -83.85 to -40.03). A lower proportion of patients in the insulin degludec than in the insulin glargine U100 group experienced severe hypoglycemia during the maintenance period (10.3%, 95% CI, 7.3%-13.3% vs 17.1%, 95% CI, 13.4%-20.8%, respectively; McNemar P =.002; risk difference, -6.8%; 95% CI, -10.8% to -2.7%). CONCLUSIONS AND RELEVANCE Among patients with type 1 diabetes and at least 1 risk factor for hypoglycemia, 32 weeks' treatment with insulin degludec vs insulin glargine U100 resulted in a reduced rate of overall symptomatic hypoglycemic episodes.	[Lane, Wendy] Mt Diabet & Endocrine Ctr, 1998 Hendersonville Rd,Bldg 31, Asheville, NC 28803 USA; [Bailey, Timothy S.] AMCR Inst, Escondido, CA USA; [Gerety, Gregg] Albany Med Coll, Albany, NY 12208 USA; [Gumprecht, Janusz] Med Univ Silesia, Zabrze, Poland; [Philis-Tsimikas, Athena] Scripps Whittier Diabet Inst, San Diego, CA USA; [Hansen, Charlotte Thim] Novo Nordisk AS, Med & Sci, Soborg, Denmark; [Nielsen, Thor S. S.] Novo Nordisk AS, Biostat Insulin & Diabet Outcomes, Soborg, Denmark; [Warren, Mark] Phys East PA, Greenville, NC USA; [Warren, Mark] Campbell Univ, Sch Osteopath Med, Lillington, NC USA	Albany Medical College; Medical University Silesia; Novo Nordisk; Novo Nordisk; Campbell University	Lane, W (corresponding author), Mt Diabet & Endocrine Ctr, 1998 Hendersonville Rd,Bldg 31, Asheville, NC 28803 USA.	mountaindiabetes@msn.com		Gumprecht, Janusz/0000-0001-7091-2118; Bailey, Timothy/0000-0003-4178-3462	Novo Nordisk	Novo Nordisk(Novo Nordisk)	This study was funded by Novo Nordisk.	Agesen RM, 2016, DIABETES METAB, V42, P249, DOI 10.1016/j.diabet.2016.03.001; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Bode BW, 2013, DIABETIC MED, V30, P1293, DOI 10.1111/dme.12243; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Childs BP, 2005, DIABETES CARE, V28, P1245; Chow E, 2014, DIABETES, V63, P1738, DOI 10.2337/db13-0468; Frier BM, 2014, NAT REV ENDOCRINOL, V10, P711, DOI 10.1038/nrendo.2014.170; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Heise T, 2012, DIABETES OBES METAB, V14, P944, DOI 10.1111/j.1463-1326.2012.01638.x; Heise T, 2012, DIABETES OBES METAB, V14, P859, DOI 10.1111/j.1463-1326.2012.01627.x; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; Heller S, 2012, LANCET, V379, P1489, DOI 10.1016/S0140-6736(12)60204-9; International Conference on Harmonisation, 1996, ICH HARM TRIP GUID; Jonassen I, 2012, PHARM RES-DORDR, V29, P2104, DOI 10.1007/s11095-012-0739-z; Khunti K, 2016, DIABETES OBES METAB, V18, P907, DOI 10.1111/dom.12689; Leiter LA., 2005, CAN J DIABETES, V29, P186; McCoy RG, 2012, DIABETES CARE, V35, P1897, DOI 10.2337/dc11-2054; Monami M, 2009, DIABETES OBES METAB, V11, P372, DOI 10.1111/j.1463-1326.2008.00976.x; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Pedersen-Bjergaard U, 2014, LANCET DIABETES ENDO, V2, P553, DOI 10.1016/S2213-8587(14)70073-7; Ratner RE, 2013, DIABETES OBES METAB, V15, P175, DOI 10.1111/dom.12032; Seaquist ER, 2013, DIABETES CARE, V36, P1384, DOI 10.2337/dc12-2480; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Ward Alex, 2014, J Med Econ, V17, P176, DOI 10.3111/13696998.2014.882843; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	26	127	128	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					33	44		10.1001/jama.2017.7115	http://dx.doi.org/10.1001/jama.2017.7115			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672316	Green Published			2022-12-28	WOS:000404717700013
J	Reiling, J				Reiling, Jennifer			Celebration of the Fourth of July: A Successful Campaign for Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 4	2017	318	1					97	97		10.1001/jama.2017.5058	http://dx.doi.org/10.1001/jama.2017.5058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ4YF	28672305				2022-12-28	WOS:000404717700029
J	Fraser, B				Fraser, Barbara			IPK-Cuban-US collaboration targets arboviruses	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					18	18		10.1016/S0140-6736(17)31723-3	http://dx.doi.org/10.1016/S0140-6736(17)31723-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677547				2022-12-28	WOS:000404396300013
J	Palmer, J				Palmer, Joanna			Health in focus: 2017 Highlights photography competition is open for submissions	LANCET			English	Editorial Material									[Palmer, Joanna] The Lancet, London EC2Y 5AS, England		Palmer, J (corresponding author), The Lancet, London EC2Y 5AS, England.	joanna.palmer@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2017	390	10089					12	13		10.1016/S0140-6736(17)31745-2	http://dx.doi.org/10.1016/S0140-6736(17)31745-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EZ0LK	28677543				2022-12-28	WOS:000404396300010
J	Andela, N; Morton, DC; Giglio, L; Chen, Y; van der Werf, GR; Kasibhatla, PS; DeFries, RS; Collatz, GJ; Hantson, S; Kloster, S; Bachelet, D; Forrest, M; Lasslop, G; Li, F; Mangeon, S; Melton, JR; Yue, C; Randerson, JT				Andela, N.; Morton, D. C.; Giglio, L.; Chen, Y.; van der Werf, G. R.; Kasibhatla, P. S.; DeFries, R. S.; Collatz, G. J.; Hantson, S.; Kloster, S.; Bachelet, D.; Forrest, M.; Lasslop, G.; Li, F.; Mangeon, S.; Melton, J. R.; Yue, C.; Randerson, J. T.			A human-driven decline in global burned area	SCIENCE			English	Article							FIRE; CLIMATE; BIOMASS; DEFORESTATION; VARIABILITY; ECOSYSTEMS; TRENDS; IMPACT	Fire is an essential Earth system process that alters ecosystem and atmospheric composition. Here we assessed long- term fire trends using multiple satellite data sets. We found that global burned area declined by 24.3 +/- 8.8% over the past 18 years. The estimated decrease in burned area remained robust after adjusting for precipitation variability and was largest in savannas. Agricultural expansion and intensification were primary drivers of declining fire activity. Fewer and smaller fires reduced aerosol concentrations, modified vegetation structure, and increased the magnitude of the terrestrial carbon sink. Fire models were unable to reproduce the pattern and magnitude of observed declines, suggesting that they may overestimate fire emissions in future projections. Using economic and demographic variables, we developed a conceptual model for predicting fire in human-dominated landscapes.	[Andela, N.; Morton, D. C.; Collatz, G. J.] NASA, Biospher Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Andela, N.; Chen, Y.; Randerson, J. T.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Giglio, L.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [van der Werf, G. R.] Vrije Univ Amsterdam, Fac Earth & Life Sci, Amsterdam, Netherlands; [Kasibhatla, P. S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [DeFries, R. S.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Hantson, S.] Karlsruhe Inst Technol, Inst Meteorol & Climate Res, Atmospher Environm Res, D-82467 Garmisch Partenkirchen, Germany; [Kloster, S.; Lasslop, G.] Max Planck Inst Meteorol, Bundesstr 53, D-20164 Hamburg, Germany; [Bachelet, D.] Oregon State Univ, Biol & Ecol Engn, Corvallis, OR 97331 USA; [Forrest, M.] Senckenberg Biodivers & Climate Res Inst BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Li, F.] Chinese Acad Sci, Inst Atmospher Phys, Int Ctr Climate & Environm Sci, Beijing, Peoples R China; [Mangeon, S.] Imperial Coll London, Dept Phys, London, England; [Melton, J. R.] Environm Canada, Climate Res Div, Victoria, BC V8W 2Y2, Canada; [Yue, C.] Univ Paris Saclay, CNRS, Inst Pierre Simon Laplace,Univ Versailles St Quen, Lab Sci Climat & Environm Comissariat Energie A, F-91198 Gif Sur Yvette, France	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Irvine; University System of Maryland; University of Maryland College Park; Vrije Universiteit Amsterdam; Duke University; Columbia University; Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Oregon State University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Imperial College London; Environment & Climate Change Canada; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Andela, N (corresponding author), NASA, Biospher Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.; Andela, N (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	niels.andela@nasa.gov	Li, Fang/AAJ-6404-2020; collatz, george j/D-5381-2012; Chen, Yang/C-6529-2008; Melton, Joe R./H-6803-2019; Hantson, Stijn/H-4785-2019; Morton, Douglas C/D-5044-2012; Randerson, James/Y-2550-2019; van der Werf, Guido/M-8260-2016	Chen, Yang/0000-0002-0993-7081; Melton, Joe R./0000-0002-9414-064X; Hantson, Stijn/0000-0003-4607-9204; Randerson, James/0000-0001-6559-7387; DeFries, Ruth/0000-0002-3332-4621; van der Werf, Guido/0000-0001-9042-8630; Andela, Niels/0000-0002-8241-6143; Giglio, Louis/0000-0001-6312-7955; Lasslop, Gitta/0000-0001-9939-1459	Gordon and Betty Moore Foundation [GBMF3269]; NASA's Interdisciplinary Science and Carbon Monitoring System Programs; Netherlands Organisation for Scientific Research (NWO); EU [603445, 603542]; National Science Foundation of China [41475099]; European Space Agency Fire_CCI project	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA's Interdisciplinary Science and Carbon Monitoring System Programs; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); European Space Agency Fire_CCI project	N.A, Y.C., and J.T.R. received funding from the Gordon and Betty Moore Foundation (grant GBMF3269). D.C.M. was supported by NASA's Interdisciplinary Science and Carbon Monitoring System Programs. G.R.v.d.W. was supported by the Netherlands Organisation for Scientific Research (NWO), S.H. by the EU FP7 projects BACCHUS (grant 603445) and LUC4C (grant 603542), F.L. by the National Science Foundation of China (grant 41475099), and C.Y. by the European Space Agency Fire_CCI project. We thank M.N. Deeter for helpful suggestions on the CO analysis. The authors declare that they have no competing interests. Data used in this study are available at www.globalfiredata.org, https://reverb.echo.nasa.gov/, http://gpcp.umd.edu/, www.fao.org, and http://web.ornl.gov/sci/landscan/ and are described in more detail in the supplementary materials. FireMIP model simulation output is archived with the supporting information, and full data sets are available on request.	Ahlstrom A, 2015, SCIENCE, V348, P895, DOI 10.1126/science.aaa1668; Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Andela N, 2014, NAT CLIM CHANGE, V4, P791, DOI [10.1038/NCLIMATE2313, 10.1038/nclimate2313]; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Archibald S, 2010, GLOBAL ECOL BIOGEOGR, V19, P794, DOI 10.1111/j.1466-8238.2010.00568.x; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Bistinas I, 2014, BIOGEOSCIENCES, V11, P5087, DOI 10.5194/bg-11-5087-2014; Bond WJ, 2016, SCIENCE, V351, P120, DOI 10.1126/science.aad5132; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Chuvieco E, 2010, ADVANCES IN EARTH OBSERVATION OF GLOBAL CHANGE, P187, DOI 10.1007/978-90-481-9085-0_14; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Giglio L, 2009, REMOTE SENS ENVIRON, V113, P408, DOI 10.1016/j.rse.2008.10.006; Hempson GP, 2015, SCIENCE, V350, P1056, DOI 10.1126/science.aac7978; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Le Quere C, 2015, EARTH SYST SCI DATA, V7, P47, DOI 10.5194/essd-7-47-2015; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lin HW, 2014, J GEOPHYS RES-BIOGEO, V119, P645, DOI 10.1002/2013JG002382; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Mollicone D, 2006, NATURE, V440, P436, DOI 10.1038/440436a; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Pyne SJ., 1982, FIRE AM CULTURAL HIS; Rabin SS, 2017, GEOSCI MODEL DEV, V10, P1175, DOI 10.5194/gmd-10-1175-2017; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Randerson JT, 2006, SCIENCE, V314, P1130, DOI 10.1126/science.1132075; Randerson JT, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002128; Rice AL, 2016, P NATL ACAD SCI USA, V113, P10791, DOI 10.1073/pnas.1522923113; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SWETNAM TW, 1990, SCIENCE, V249, P1017, DOI 10.1126/science.249.4972.1017; The United States Census Bureau, HIST EST WORLD POP; van der Werf GR, 2017, EARTH SYST SCI DATA, V9, P697, DOI 10.5194/essd-9-697-2017; van Marle M.J.E., 2017, GEOSCI MODEL DEV, P1, DOI [10.1016/ 10.5194/gmd-2017-32, DOI 10.1016/10.5194/GMD-2017-32]; Ward DS, 2012, ATMOS CHEM PHYS, V12, P10857, DOI 10.5194/acp-12-10857-2012	39	457	468	23	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1356	1361		10.1126/science.aal4108	http://dx.doi.org/10.1126/science.aal4108			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663495	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000404351500031
J	Yamamoto, Y; Yamamoto, S				Yamamoto, Yu; Yamamoto, Sayaka			Achenbach's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yamamoto, Yu; Yamamoto, Sayaka] Jichi Med Univ, Sch Med, Shimotsuke, Japan	Jichi Medical University	Yamamoto, Y (corresponding author), Jichi Med Univ, Sch Med, Shimotsuke, Japan.	u-bou@jichi.ac.jp							0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2017	376	26					E53	E53		10.1056/NEJMicm1610146	http://dx.doi.org/10.1056/NEJMicm1610146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EY8QE	28657879				2022-12-28	WOS:000404259200012
J	Liu, ZS; Liu, Y; Xu, HF; He, LY; Chen, YL; Fu, LX; Li, N; Lu, YH; Su, TS; Sun, JH; Wang, J; Yue, ZH; Zhang, W; Zhao, JP; Zhou, ZY; Wu, JN; Zhou, KH; Ai, YK; Zhou, J; Pang, R; Wang, Y; Qin, ZS; Yan, SY; Li, HJ; Luo, L; Liu, BY				Liu, Zhishun; Liu, Yan; Xu, Huanfang; He, Liyun; Chen, Yuelai; Fu, Lixin; Li, Ning; Lu, Yonghui; Su, Tongsheng; Sun, Jianhua; Wang, Jie; Yue, Zenghui; Zhang, Wei; Zhao, Jiping; Zhou, Zhongyu; Wu, Jiani; Zhou, Kehua; Ai, Yanke; Zhou, Jing; Pang, Ran; Wang, Yang; Qin, Zongshi; Yan, Shiyan; Li, Hongjiao; Luo, Lin; Liu, Baoyan			Effect of Electroacupuncture on Urinary Leakage Among Women With Stress Urinary Incontinence A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOUR PAD TEST; PELVIC FLOOR; PLACEBO NEEDLE; WEIGHING TEST; ICIQ; STIMULATION; MULTICENTER; MUSCLE; TESTS	IMPORTANCE Electroacupuncture involving the lumbosacral region may be effective for women with stress urinary incontinence (SUI), but evidence is limited. OBJECTIVE To assess the effect of electroacupuncture vs sham electroacupuncture for women with SUI. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized clinical trial conducted at 12 hospitals in China and enrolling 504 women with SUI between October 2013 and May 2015, with data collection completed in December 2015. INTERVENTIONS Participants were randomly assigned (1:1) to receive 18 sessions (over 6 weeks) of electroacupuncture involving the lumbosacral region (n = 252) or sham electroacupuncture (n = 252) with no skin penetration on sham acupoints. MAIN OUTCOMES AND MEASURES The primary outcome was change from baseline to week 6 in the amount of urine leakage, measured by the 1-hour pad test. Secondary outcomes included mean 72-hour urinary incontinence episodes measured by a 72-hour bladder diary (72-hour incontinence episodes). RESULTS Among the 504 randomized participants (mean [SD] age, 55.3 [8.4] years), 482 completed the study. Mean urine leakage at baseline was 18.4 g for the electroacupuncture group and 19.1 g for the sham electroacupuncture group. Mean 72-hour incontinence episodes were 7.9 for the electroacupuncture group and 7.7 for the sham electroacupuncture group. At week 6, the electroacupuncture group had greater decrease in mean urine leakage (-9.9 g) than the sham electroacupuncture group (-2.6 g) with a mean difference of 7.4 g (95% CI, 4.8 to 10.0; P < .001). During some time periods, the change in the mean 72-hour incontinence episodes from baseline was greater with electroacupuncture than sham electroacupuncture with between-group differences of 1.0 episode in weeks 1 to 6 (95% CI, 0.2-1.7; P = .01), 2.0 episodes in weeks 15 to 18 (95% CI, 1.3-2.7; P < .001), and 2.1 episodes in weeks 27 to 30 (95% CI, 1.3-2.8; P < .001). The incidence of treatment-related adverse events was 1.6% in the electroacupuncture group and 2.0% in the sham electroacupuncture group, and all events were classified as mild. CONCLUSIONS AND RELEVANCE Among women with stress urinary incontinence, treatment with electroacupuncture involving the lumbosacral region, compared with sham electroacupuncture, resulted in less urine leakage after 6 weeks. Further research is needed to understand long-term efficacy and the mechanism of action of this intervention.	[Liu, Zhishun; Xu, Huanfang; Wu, Jiani; Zhou, Jing; Pang, Ran; Wang, Yang; Qin, Zongshi; Liu, Baoyan] China Acad Chinese Med Sci, Guangan Men Hosp, Beijing, Peoples R China; [Liu, Yan; He, Liyun; Ai, Yanke; Yan, Shiyan; Li, Hongjiao; Luo, Lin] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Xu, Huanfang] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China; [Chen, Yuelai] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Shanghai, Peoples R China; [Fu, Lixin] Tianjin Univ Tradit Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China; [Li, Ning] Sichuan Univ, West China Hosp, Chengdu, Peoples R China; [Lu, Yonghui] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Su, Tongsheng] Shaanxi Prov Hosp Tradit Chinese Med, Xian, Peoples R China; [Sun, Jianhua] Jiangsu Prov Hosp Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China; [Wang, Jie] Shanxi Hosp Integrated Tradit & Western Med, Taiyuan, Peoples R China; [Yue, Zenghui] Hunan Univ Chinese Med, Hengyang Hosp, Hengyang, Peoples R China; [Zhang, Wei] Hunan Univ Chinese Med, Hosp 1, Changsha, Hunan, Peoples R China; [Zhao, Jiping] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing, Peoples R China; [Zhou, Zhongyu] Hubei Prov Hosp Tradit Chinese Med, Wuhan, Peoples R China; [Zhou, Kehua] Daemen Coll, Daemen Coll Phys Therapy Wound Care Clin, Amherst, NY USA	China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Shanghai University of Traditional Chinese Medicine; Tianjin University of Traditional Chinese Medicine; Sichuan University; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Nanjing University of Chinese Medicine; Hunan University of Chinese Medicine; Hunan University of Chinese Medicine; Beijing University of Chinese Medicine	Liu, BY (corresponding author), China Acad Chinese Med Sci, Dept Acupuncture & Moxibust, Guangan Men Hosp, 5 Beixiange St, Beijing 100053, Peoples R China.	baoyanjournal@163.com	Qin, Zongshi/ABE-2821-2021	Qin, Zongshi/0000-0002-8416-3426; Sun, Jianhua/0000-0002-3398-0346; Pang, Ran/0000-0001-7978-7325; Qin, Zongshi/0000-0001-5888-461X	program of "the 12th Five-year" National Science and Technology Pillar Program by Ministry of Science and Technology of the People's Republic of China [2012BAI24B01, 2012BAI24B02]	program of "the 12th Five-year" National Science and Technology Pillar Program by Ministry of Science and Technology of the People's Republic of China	This study was supported and funded by the program of "the 12th Five-year" National Science and Technology Pillar Program (2012BAI24B01; 2012BAI24B02) by the Ministry of Science and Technology of the People's Republic of China.	ABRAMS P, 1988, SCAND J UROL NEPHROL, P5; Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Aksac B, 2003, GYNECOL OBSTET INVES, V56, P23, DOI 10.1159/000072327; Costantini E, 2008, UROL INT, V81, P153, DOI 10.1159/000144053; Cottenden A., 2013, INCONTINENCE 5 INT C, P149; Groutz A, 2000, J UROLOGY, V164, P698, DOI 10.1016/S0022-5347(05)67284-9; Huang L, 2008, NEUROUROL URODYNAM, V27, P522, DOI 10.1002/nau.20546; Karantanis E, 2004, INT UROGYNECOL J, V15, P111, DOI 10.1007/s00192-004-1123-2; Kobashi KC, 2017, SURG TREATMENT FEMAL; Krhut J, 2014, NEUROUROL URODYNAM, V33, P507, DOI 10.1002/nau.22436; Liebergall-Wischnitzer M, 2010, UROLOGY, V76, P1364, DOI 10.1016/j.urology.2010.05.048; Liebergall-Wischnitzer M, 2009, J WOMENS HEALTH, V18, P377, DOI 10.1089/jwh.2008.0950; Lin Alex Tong-Long, 2008, BMC Urol, V8, P2, DOI 10.1186/1471-2490-8-2; Liu BY, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000200; Liu ZS, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-315; LOSE G, 1988, UROLOGY, V32, P78, DOI 10.1016/0090-4295(88)90462-1; LOSE G, 1989, ACTA OBSTET GYN SCAN, V68, P211, DOI 10.3109/00016348909020991; Matharu GS, 2004, EUR UROL, V45, P208, DOI 10.1016/j.eururo.2003.09.006; Mo Q, 2013, BEIJING J TRADIT CHI, V32, P434; Nystrom E, 2015, NEUROUROL URODYNAM, V34, P747, DOI 10.1002/nau.22657; Punter J, COMPLIANCE PAD TESTS; Sari D, 2009, J WOUND OSTOMY CONT, V36, P429, DOI 10.1097/WON.0b013e3181aaf539; Simons AM, 2001, BRIT J OBSTET GYNAEC, V108, P315, DOI 10.1016/S0306-5456(00)00069-3; Sinclair AJ, 2011, OBSTET GYNAECOL, V13, P143, DOI 10.1576/toag.13.3.143.27665; Sjostrom M, 2013, BJU INT, V112, P362, DOI 10.1111/j.1464-410X.2012.11713.x; SMITH ARB, 1989, BRIT J OBSTET GYNAEC, V96, P24, DOI 10.1111/j.1471-0528.1989.tb01571.x; Smither Anna R, 2007, BMC Urol, V7, P2, DOI 10.1186/1471-2490-7-2; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Wang SY, 2012, BJU INT, V110, P1338, DOI 10.1111/j.1464-410X.2012.11029.x; Wang Y., 2013, ADV MATH PHYS, V2013, P7; Xu HF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150821; Yalcin I, 2010, NEUROUROL URODYNAM, V29, P344, DOI 10.1002/nau.20744; Yamanishi T, 1997, J UROLOGY, V158, P2127, DOI 10.1016/S0022-5347(01)68176-X; Yoshimura N, 2012, INT J UROL, V19, P524, DOI 10.1111/j.1442-2042.2012.02976.x; Zhou KH, 2011, J ALTERN COMPLEM MED, V17, P1007, DOI 10.1089/acm.2010.0652	35	169	235	26	162	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2493	2501		10.1001/jama.2017.7220	http://dx.doi.org/10.1001/jama.2017.7220			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28655016	Bronze, Green Published			2022-12-28	WOS:000404106600019
J	Lyon, J				Lyon, Jeff			Effort to Relax School Lunch Guidelines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2475	2475		10.1001/jama.2017.7993	http://dx.doi.org/10.1001/jama.2017.7993			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28654996				2022-12-28	WOS:000404106600005
J	de Oliveira, WK; de Franca, GVA; Carmo, EH; Duncan, BB; Kuchenbecker, RD; Schmidt, MI				de Oliveira, Wanderson Kleber; Araujo de Franca, Giovanny Vinicius; Carmo, Eduardo Hage; Duncan, Bruce Bartholow; Kuchenbecker, Ricardo de Souza; Schmidt, Maria Ines			Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: a surveillance-based analysis	LANCET			English	Article							HISTORY; JANUARY	Background On Nov 11, 2015, the Brazilian Ministry of Health declared a Public Health Emergency of National Concern in response to an increased number of microcephaly cases, possibly related to previous Zika virus outbreaks. We describe the course of the dual epidemics of the Zika virus infection during pregnancy and microcephaly in Brazil up to Nov 12, 2016, the first anniversary of this declaration. Methods We used secondary data for Zika virus and microcephaly cases obtained through the Brazilian Ministry of Health's surveillance systems from Jan 1, 2015, to Nov 12, 2016. We deemed possible Zika virus infections during pregnancy as all suspected cases of Zika virus disease and all initially suspected, but later discarded, cases of dengue and chikungunya fever. We defined confirmed infection-related microcephaly in liveborn infants as the presence of a head circumference of at least 2 SDs below the mean for their age and sex, accompanied by diagnostic imaging consistent with an infectious cause, or laboratory, clinical, or epidemiological results positive for Zika virus or STORCH (infectious agents known to cause congenital infection, mainly syphilis, toxoplasmosis, cytomegalovirus, and herpes simplex virus). We excluded cases of congenital anomalies or death without microcephaly. We analyse the spatial clustering of these diseases in Brazil to obtain the kernel density estimation. Findings Two distinct waves of possible Zika virus infection extended across all Brazilian regions in 2015 and 2016. 1 673 272 notified cases were reported, of which 41 473 (2.5%) were in pregnant women. During this period, 1950 cases of infection-related microcephaly were confirmed. Most cases (1373 [ 70.4%]) occurred in the northeast region after the first wave of Zika virus infection, with peak monthly occurrence estimated at 49.9 cases per 10 000 livebirths. After a major, well documented second wave of Zika virus infection in all regions of Brazil from September, 2015, to September, 2016, occurrence of microcephaly was much lower than that following the first wave of Zika virus infection, reaching epidemic levels in all but the south of Brazil, with estimated monthly peaks varying from 3.2 cases to 15 cases per 10 000 livebirths. Interpretation The distribution of infection-related microcephaly after Zika virus outbreaks has varied across time and Brazilian regions. Reasons for these apparent differences remain to be elucidated.	[de Oliveira, Wanderson Kleber; Araujo de Franca, Giovanny Vinicius; Carmo, Eduardo Hage] Brazilian Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil; [de Oliveira, Wanderson Kleber; Duncan, Bruce Bartholow; Kuchenbecker, Ricardo de Souza; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Postgrad Program Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	de Oliveira, WK (corresponding author), Fundacao Oswaldo Cruz, Ctr Data & Knowledge Integrat Hlth, Goncalo Moniz Inst, Parque Tecnol Bahia, BR-41745715 Salvador, BA, Brazil.	wkoliveira@gmail.com	Kuchenbecker, Ricardo/I-4009-2013; Schmidt, Maria Inês/AGT-5691-2022; amsalu, ribka/G-8780-2019; de França, Giovanny Vinícius Araújo/L-7385-2018; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria/V-3196-2019; Duncan, Bruce B/L-4140-2016; Oliveira, Wanderson/D-7140-2016	Kuchenbecker, Ricardo/0000-0002-4707-3683; de França, Giovanny Vinícius Araújo/0000-0002-7530-2017; Schmidt, Maria Inês/0000-0002-3837-0731; Duncan, Bruce B/0000-0002-7491-2630; Oliveira, Wanderson/0000-0002-9662-1930				Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028; BITHELL JF, 1990, STAT MED, V9, P691, DOI 10.1002/sim.4780090616; BRASIL, 2016, GUIA VIG SAUD; BRASIL, 2016, PORT DEP INF SIST UN; BRASIL, 2016, PORT SECR VIG SAUD M; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776; de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687; Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1; Lopez-Camelo J. S., 2015, ECLAMC FINAL DOCUMEN; Maurice J, 2016, LANCET, V388, P449, DOI 10.1016/S0140-6736(16)31207-7; Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023; Moore CA, 2016, JAMA PEDIAT, V374, P1552; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Pan American Health Organization, GUID SURV ZIK VIR DI; Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899; WHO, 2015, RAP ADV GUID SCREEN; Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X; World Health Organization, 2016, EM HIST ZIK VIR; World Health Organization (WHO), 2016, WHO SIT REP ZIK VIR	29	161	170	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 26	2017	390	10097					861	870		10.1016/S0140-6736(17)31368-5	http://dx.doi.org/10.1016/S0140-6736(17)31368-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE6PF	28647172	Bronze			2022-12-28	WOS:000408330700024
J	Gunter, MJ; Murphy, N; Cross, AJ; Dossus, L; Dartois, L; Fagherazzi, G; Kaaks, R; Kuhn, T; Boeing, H; Aleksandrova, K; Tjonneland, A; Olsen, A; Overvad, K; Larsen, SC; Cornejo, MLR; Agudo, A; Perez, MJS; Altzibar, JM; Navarro, C; Ardanaz, E; Khaw, KT; Butterworth, A; Bradbury, KE; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Palli, D; Grioni, S; Vineis, P; Panico, S; Tumino, R; Bueno-de-Mesquita, B; Siersema, P; Leenders, M; Beulens, JWJ; Uiterwaal, CU; Wallstrom, P; Nilsson, LM; Landberg, R; Weiderpass, E; Skeie, G; Braaten, T; Brennan, P; Licaj, I; Muller, DC; Sinha, R; Wareham, N; Riboli, E				Gunter, Marc J.; Murphy, Neil; Cross, Amanda J.; Dossus, Laure; Dartois, Laureen; Fagherazzi, Guy; Kaaks, Rudolf; Kuehn, Tilman; Boeing, Heiner; Aleksandrova, Krasimira; Tjonneland, Anne; Olsen, Anja; Overvad, Kim; Larsen, Sofus Christian; Redondo Cornejo, Maria Luisa; Agudo, Antonio; Sanchez Perez, Maria Jose; Altzibar, Jone M.; Navarro, Carmen; Ardanaz, Eva; Khaw, Kay-Tee; Butterworth, Adam; Bradbury, Kathryn E.; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Palli, Domenico; Grioni, Sara; Vineis, Paolo; Panico, Salvatore; Tumino, Rosario; Bueno-de-Mesquita, Bas; Siersema, Peter; Leenders, Max; Beulens, Joline W. J.; Uiterwaal, Cuno U.; Wallstrom, Peter; Nilsson, Lena Maria; Landberg, Rikard; Weiderpass, Elisabete; Skeie, Guri; Braaten, Tonje; Brennan, Paul; Licaj, Idlir; Muller, David C.; Sinha, Rashmi; Wareham, Nick; Riboli, Elio			Coffee Drinking and Mortality in 10 European Countries A Multinational Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY HEART-DISEASE; C-REACTIVE PROTEIN; IOWA WOMENS HEALTH; CARDIOVASCULAR-DISEASE; OVARIAN-CANCER; DECAFFEINATED COFFEE; TEA CONSUMPTION; RISK-FACTORS; CAFFEINE; METAANALYSIS	Background: The relationship between coffee consumption and mortality in diverse European populations with variable coffee preparation methods is unclear. Objective: To examine whether coffee consumption is associated with all-cause and cause-specific mortality. Design: Prospective cohort study. Setting: 10 European countries. Participants: 521 330 persons enrolled in EPIC (European Prospective Investigation into Cancer and Nutrition). Measurements: Hazard ratios (HRs) and 95% CIs estimated using multivariable Cox proportional hazards models. The association of coffee consumption with serum biomarkers of liver function, inflammation, and metabolic health was evaluated in the EPIC Biomarkers subcohort (n = 14 800). Results: During a mean follow-up of 16.4 years, 41 693 deaths occurred. Compared with nonconsumers, participants in the highest quartile of coffee consumption had statistically significantly lower all-cause mortality (men: HR, 0.88 [95% CI, 0.82 to 0.95]; P for trend < 0.001; women: HR, 0.93 [CI, 0.87 to 0.98]; P for trend = 0.009). Inverse associations were also observed for digestive disease mortality for men (HR, 0.41 [CI, 0.32 to 0.54]; P for trend < 0.001) and women (HR, 0.60 [CI, 0.46 to 0.78]; P for trend < 0.001). Among women, there was a statistically significant inverse association of coffee drinking with circulatory disease mortality (HR, 0.78 [CI, 0.68 to 0.90]; P for trend < 0.001) and cerebrovascular disease mortality (HR, 0.70 [CI, 0.55 to 0.90]; P for trend = 0.002) and a positive association with ovarian cancer mortality (HR, 1.31 [CI, 1.07 to 1.61]; P for trend = 0.015). In the EPIC Biomarkers subcohort, higher coffee consumption was associated with lower serum alkaline phosphatase; alanine aminotransferase; aspartate aminotransferase; gamma-glutamyltransferase; and, in women, C-reactive protein, lipoprotein(a), and glycated hemoglobin levels. Limitations: Reverse causality may have biased the findings; however, results did not differ after exclusion of participants who died within 8 years of baseline. Coffee-drinking habits were assessed only once. Conclusion: Coffee drinking was associated with reduced risk for death from various causes. This relationship did not vary by country.	[Gunter, Marc J.; Murphy, Neil; Dossus, Laure; Brennan, Paul] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France; [Cross, Amanda J.; Vineis, Paolo; Muller, David C.; Riboli, Elio] Imperial Coll London, Dept Epidemiol & Biostat, St Marys Campus,Norfolk Pl, London W2 1PG, England; [Dartois, Laureen; Fagherazzi, Guy] Inst Gustave Roussy, Espace Maurice Tubiana, Equipe E3N E4N, 114 Rue Edouard Vaillant, F-94800 Villejuif, France; [Kaaks, Rudolf; Kuehn, Tilman] German Canc Res Ctr, Div Canc Epidemiol, Neuenheimer Feld 581, D-69120 Heidelberg, Germany; [Boeing, Heiner; Aleksandrova, Krasimira] German Inst Human Nutr Potsdam Rehbruecke DIfE, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany; [Tjonneland, Anne; Olsen, Anja] Danish Canc Soc Res Ctr, Strand Blvd 49, DK-2100 Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Bartholins 2,Bldg 1260,2-26, DK-8000 Aarhus, Denmark; Bispebjerg & Frederiksberg Hosp, Frederiksberg, Denmark; [Redondo Cornejo, Maria Luisa] Publ Hlth Directorate, Ciriaco Miguel Vigil 9, Oviedo 33006, Spain; [Agudo, Antonio] Catalan Inst Oncol, Unit Nutr & Canc, Canc Epidemiol Res Programme, Av Gran Via Hosp 199-203,Hosp Llobregat, Barcelona 08908, Spain; Andalusian Sch Publ Hlth, Granada, Spain; Basque Reg Hlth Dept, Publ Hlth Div Gipuzkoa, San Sebastian, Spain; Murcia Reg Hlth Council, Murcia, Spain; [Ardanaz, Eva] Navarre Publ Hlth Inst, Epidemiol Prevent & Promot Hlth Serv, Leyre 15, Pamplona 31003, Navarra, Spain; Univ Cambridge, Cambridge, England; MRC Epidemiol Unit, Cambridge, England; [Bradbury, Kathryn E.] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Trichopoulou, Antonia] Hellen Hlth Fdn, Kaisareias 13 & Alexandroupoleos, Athens 11527, Greece; [Lagiou, Pagona] Harvard T H Chan Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave,Kresge Room 901, Boston, MA 02115 USA; [Palli, Domenico] ISPO, Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Via Oblate 2, I-50141 Florence, Italy; [Grioni, Sara] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Via Giacomo Venezian 1, I-20133 Milan, Italy; [Panico, Salvatore] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Corso Umberto I 40, I-80138 Naples, Italy; Civ M P Arezzo Hosp, ASP Ragusa, Ragusa, Italy; Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Siersema, Peter; Leenders, Max] Univ Med Ctr, Dept Gastroenterol & Hepatol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; Malmo Univ Hosp, Malmo, Sweden; Umea Univ, Umea, Sweden; [Landberg, Rikard] Swedish Univ Agr Sci, Dept Food Sci, BioCtr, Almas 8, S-75007 Uppsala, Sweden; Univ Tromso, Arct Univ Norway, Tromso, Norway; [Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,MSC 9776, Bethesda, MD 20892 USA; [Larsen, Sofus Christian] Copenhagen Univ Hosp, Parker Inst, Res Unit Dietary Studies, Nordre Fasanvej 57,Rd 8-Entrance 19, DK-2000 Frederiksberg, Denmark; [Sanchez Perez, Maria Jose] Escuela Andaluza Salud Publ, Cuesta Observ, 4 Campus Univ Cartuja S-N,Apdo Correos 2070-18080, Granada, Spain; [Altzibar, Jone M.] Basque Govt, Publ Hlth Dept Gipuzkoa, Ave Navarra,4-20013 Donostia, San Sebastian, Spain; [Navarro, Carmen] Murcia Hlth Council, Epidemiol & Publ Hlth Dept, Ronda Levante 11, Murcia 3008, Spain; [Khaw, Kay-Tee; Butterworth, Adam] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Worts Causeway, Cambridge CB1 8RN, England; [Tumino, Rosario] Prov Hlth Ragusa, Dept Prevent Med, Tumor Registry, Via Dante 109, I-97100 Ragusa, Italy; [Bueno-de-Mesquita, Bas] RIVM, Antonie Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands; [Bueno-de-Mesquita, Bas] POB 1, NL-3720 BA Bilthoven, Netherlands; [Beulens, Joline W. J.; Uiterwaal, Cuno U.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Univ 100, NL-3584 CG Utrecht, Netherlands; [Wallstrom, Peter] Clin Res Ctr, Dept Off Clin Sci Malmo, Post Box 50332, S-20213 Malmo, Sweden; [Nilsson, Lena Maria] Univ Hosp, Dept Publ Hlth, S-90185 Umea, Sweden; [Nilsson, Lena Maria] Univ Hosp, Clin Med, S-90185 Umea, Sweden; [Weiderpass, Elisabete; Skeie, Guri; Braaten, Tonje; Licaj, Idlir] UiT Norges Arktiske Univ, Fakturaadresse, Postboks 6050 Langnes, N-9037 Tromso, Norway; [Wareham, Nick] Univ Cambridge, Sch Clin Med, Inst Met Sci, MRC Epidemiol Unit, Cambridge Biomed Campus,Box 285, Cambridge CB2 0QQ, England	World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aarhus University; University of Copenhagen; Bispebjerg Hospital; Catalan Institute of Oncology; Escuela Andaluza de Salud Publica; Murcia Regional Health Council; Public Health Institute of Navarra; University of Cambridge; University of Oxford; Harvard University; Harvard T.H. Chan School of Public Health; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II; Civile M.P. Arezzo Hospital; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Lund University; Skane University Hospital; Umea University; Swedish University of Agricultural Sciences; UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Escuela Andaluza de Salud Publica; Basque Government; Murcia Regional Health Council; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Umea University; Umea University; UiT The Arctic University of Tromso; University of Cambridge	Gunter, MJ (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon 08, France.	gunterm@iarc.fr	Siersema, Peter/V-1636-2019; Licaj, Idlir/AAC-2772-2021; Khaw, Kay-Tee/AAZ-3209-2021; Dossus, Laure/AAW-9097-2021; Fagherazzi, Guy/P-3534-2017; Grioni, Sara/K-5320-2016; Fagherazzi, Guy/ABB-2555-2020; Bradbury, Kathryn/I-2132-2019; Muller, David C/V-8207-2017; Gunter, Marc/AAP-8621-2020; Larsen, Sofus Christian/AAO-5894-2020; Weiderpass, Elisabete/AAP-2747-2021; Sánchez, Maria-José/D-1087-2011; Weiderpass, Elisabete/M-4029-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Murphy, Neil/E-1189-2017	Dossus, Laure/0000-0003-2716-5748; Fagherazzi, Guy/0000-0001-5033-5966; Grioni, Sara/0000-0002-5891-8426; Fagherazzi, Guy/0000-0001-5033-5966; Bradbury, Kathryn/0000-0003-3345-7333; Muller, David C/0000-0002-2350-0417; Larsen, Sofus Christian/0000-0002-0838-9378; Weiderpass, Elisabete/0000-0003-2237-0128; Sánchez, Maria-José/0000-0003-4817-0757; Weiderpass, Elisabete/0000-0003-2237-0128; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Beulens, Joline/0000-0002-4181-0937; ALTZIBAR, JONE MIREN/0000-0001-7037-7944; Overvad, Kim/0000-0001-6429-7921; tumino, rosario/0000-0003-2666-414X; Aleksandrova, Krasimira/0000-0002-1275-1827; Butterworth, Adam/0000-0002-6915-9015; Nilsson, Lena Maria/0000-0002-2354-7258; Licaj, Idlir/0000-0003-3389-0735; Gunter, Marc/0000-0001-5472-6761; Rasul, holem/0000-0003-0579-9029; Olsen, Anja/0000-0003-4788-503X; Riboli, Elio/0000-0001-6795-6080; Murphy, Neil/0000-0003-3347-8249; Tjonneland, Anne/0000-0003-4385-2097	European Commission Directorate-General for Health; Consumers and International Agency for Research on Cancer; MRC [MC_UU_12015/1, MR/L003120/1, MR/N003284/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Cancer Research UK [14136, 16491] Funding Source: researchfish; Medical Research Council [MR/N003284/1, MR/L003120/1, G0401527, MC_UU_12015/1, G1000143] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10114, NF-SI-0512-10165] Funding Source: researchfish	European Commission Directorate-General for Health(European CommissionEuropean Commission Joint Research Centre); Consumers and International Agency for Research on Cancer; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	European Commission Directorate-General for Health and Consumers and International Agency for Research on Cancer.	Braem MGM, 2012, AM J CLIN NUTR, V95, P1172, DOI 10.3945/ajcn.111.026393; CASIGLIA E, 1993, EUR J EPIDEMIOL, V9, P293, DOI 10.1007/BF00146266; Corrao G, 2001, ANN EPIDEMIOL, V11, P458, DOI 10.1016/S1047-2797(01)00223-X; Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Freedman ND, 2009, HEPATOLOGY, V50, P1360, DOI 10.1002/hep.23162; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Gressner OA, 2008, J HEPATOL, V49, P758, DOI 10.1016/j.jhep.2008.03.029; Khaw KT, 2006, CURR OPIN LIPIDOL, V17, P637, DOI 10.1097/MOL.0b013e3280106b95; Klatsky AL, 2006, ARCH INTERN MED, V166, P1190, DOI 10.1001/archinte.166.11.1190; Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787; LINDSTED KD, 1992, J CLIN EPIDEMIOL, V45, P733, DOI 10.1016/0895-4356(92)90051-N; Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164; Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243; Lueth NA, 2008, CANCER CAUSE CONTROL, V19, P1365, DOI 10.1007/s10552-008-9208-8; Office for National Statistics, 2017, REV EUR STAND POP 20; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROSENGREN A, 1991, J INTERN MED, V230, P67, DOI 10.1111/j.1365-2796.1991.tb00407.x; Rost NS, 2001, STROKE, V32, P2575, DOI 10.1161/hs1101.098151; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Saab S, 2014, LIVER INT, V34, P495, DOI 10.1111/liv.12304; Shim SG, 2013, J GASTROEN HEPATOL, V28, P1877, DOI 10.1111/jgh.12317; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7; Tanskanen A, 2000, EUR J EPIDEMIOL, V16, P789, DOI 10.1023/A:1007614714579; TVERDAL A, 1990, BRIT MED J, V300, P566, DOI 10.1136/bmj.300.6724.566; Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3; Tworoger SS, 2008, CANCER-AM CANCER SOC, V112, P1169, DOI 10.1002/cncr.23275; van Dam RM, 2006, NUTR METAB CARDIOVAS, V16, P69, DOI 10.1016/j.numecd.2005.10.003; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902; Wedick NM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-93; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481	45	133	134	1	93	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2017	167	4					236	+		10.7326/M16-2945	http://dx.doi.org/10.7326/M16-2945			26	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD8TR	28693038	Green Accepted, Green Submitted			2022-12-28	WOS:000407797500012
J	Rouphael, NG; Paine, M; Mosley, R; Henry, S; McAllister, DV; Kalluri, H; Pewin, W; Frew, PM; Yu, TW; Thornburg, NJ; Kabbani, S; Lai, LL; Vassilieva, EV; Skountzou, I; Compans, RW; Mulligan, MJ; Prausnitz, MR				Rouphael, Nadine G.; Paine, Michele; Mosley, Regina; Henry, Sebastien; McAllister, Devin V.; Kalluri, Haripriya; Pewin, Winston; Frew, Paula M.; Yu, Tianwei; Thornburg, Natalie J.; Kabbani, Sarah; Lai, Lilin; Vassilieva, Elena V.; Skountzou, Ioanna; Compans, Richard W.; Mulligan, Mark J.; Prausnitz, Mark R.		TIV MNP Study Grp	The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial	LANCET			English	Article							IMMUNIZATION; SKIN	Background Microneedle patches provide an alternative to conventional needle-and-syringe immunisation, and potentially offer improved immunogenicity, simplicity, cost-effectiveness, acceptability, and safety. We describe safety, immunogenicity, and acceptability of the first-in-man study on single, dissolvable microneedle patch vaccination against influenza. Methods The TIV-MNP 2015 study was a randomised, partly blinded, placebo-controlled, phase 1, clinical trial at Emory University that enrolled non-pregnant, immunocompetent adults from Atlanta, GA, USA, who were aged 18-49 years, naive to the 2014-15 influenza vaccine, and did not have any significant dermatological disorders. Participants were randomly assigned (1:1:1:1) to four groups and received a single dose of inactivated influenza vaccine (fluvirin: 18 mu g of haemagglutinin per H1N1 vaccine strain, 17 mu g of haemagglutinin per H3N2 vaccine strain, and 15 mu g of haemagglutinin per B vaccine strain) (1) by microneedle patch or (2) by intramuscular injection, or received (3) placebo by microneedle patch, all administered by an unmasked health-care worker; or received a single dose of (4) inactivated influenza vaccine by microneedle patch self-administered by study participants. A research pharmacist prepared the randomisation code using a computer-generated randomisation schedule with a block size of 4. Because of the nature of the study, participants were not masked to the type of vaccination method (ie, microneedle patch vs intramuscular injection). Primary safety outcome measures are the incidence of study product-related serious adverse events within 180 days, grade 3 solicited or unsolicited adverse events within 28 days, and solicited injection site and systemic reactogenicity on the day of study product administration through 7 days after administration, and secondary safety outcomes are new-onset chronic illnesses within 180 days and unsolicited adverse events within 28 days, all analysed by intention to treat. Secondary immunogenicity outcomes are antibody titres at day 28 and percentages of seroconversion and seroprotection, all determined by haemagglutination inhibition antibody assay. Findings Between June 23, 2015, and Sept 25, 2015, 100 participants were enrolled and randomly assigned to a group. There were no treatment-related serious adverse events, no treatment-related unsolicited grade 3 or higher adverse events, and no new-onset chronic illnesses. Among vaccinated groups (vaccine via health-care worker administered microneedle patch or intramuscular injection, or self-administered microneedle patch), overall incidence of solicited adverse events (n=89 vs n=73 vs n=73) and unsolicited adverse events (n=18 vs n=12 vs n=14) were similar. Reactogenicity was mild, transient, and most commonly reported as tenderness (15 [60%] of 25 participants [95% CI 39-79]) and pain (11 [44%] of 25 [24-65]) after intramuscular injection; and as tenderness (33 [66%] of 50 [51-79]), erythema (20 [40%] of 50 [26-55]), and pruritus (41 [82%] of 50 [69-91]) after vaccination by microneedle patch application. The geometric mean titres were similar at day 28 between the microneedle patch administered by a health-care worker versus the intramuscular route for the H1N1 strain (1197 [ 95% CI 855-1675] vs 997 [703-1415]; p=0.5), the H3N2 strain (287 [192-430] vs 223 [160-312]; p=0.4), and the B strain (126 [86-184] vs 94 [73-122]; p=0.06). Similar geometric mean titres were reported in participants who self-administered the microneedle patch (all p>0.05). The seroconversion percentages were significantly higher at day 28 after microneedle patch vaccination compared with placebo (all p<0.0001) and were similar to intramuscular injection (all p>0.01). Interpretation Use of dissolvable microneedle patches for influenza vaccination was well tolerated and generated robust antibody responses.	[Rouphael, Nadine G.; Paine, Michele; Mosley, Regina; Thornburg, Natalie J.; Kabbani, Sarah; Lai, Lilin; Mulligan, Mark J.] Emory Univ, Hope Clin Emory Vaccine Ctr, Sch Med, Dept Med,Div Infect Dis, Atlanta, GA 30322 USA; [Frew, Paula M.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Frew, Paula M.; Yu, Tianwei] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Vassilieva, Elena V.; Skountzou, Ioanna; Compans, Richard W.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Vassilieva, Elena V.; Skountzou, Ioanna; Compans, Richard W.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Henry, Sebastien; McAllister, Devin V.; Kalluri, Haripriya; Pewin, Winston; Prausnitz, Mark R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Emory University; Emory University; Emory University; Rollins School Public Health; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology	Rouphael, NG (corresponding author), Emory Univ, Hope Clin, Emory Vaccine Ctr, 500 Irvin Court,Suite 200, Decatur, GA 30030 USA.	nroupha@emory.edu	Mulligan, Mark/V-9275-2019	Lai, Lilin/0000-0002-9528-6990; Thornburg, Natalie/0000-0003-3523-3616; Prausnitz, Mark/0000-0002-9076-8448; Yu, Tianwei/0000-0003-2502-1628	National Institutes of Health; National Institute of Biomedical Imaging and Bioengineering [U01 EB012495]; National Institute of Allergy and Infectious Diseases [T32 AI074492]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB012495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	National Institutes of Health.; This study was funded by a grant from the National Institute of Biomedical Imaging and Bioengineering (U01 EB012495). SK received funding from a training grant from the National Institute of Allergy and Infectious Diseases (T32 AI074492). MJM received instrumentation support from the Georgia Research Alliance. We would like to acknowledge Olivia Antao, Jaya Arya, Kristy Bachman, Dawn Battle, Mary Bower, Elaine Brock, Yunmi Chung, Diane Choi, Laura Clegg, Justin Colwell, Lyngail Cooper, Ellen DeStefano, Briyana Domjahn, Francine Dyer, Vickie Grimes, Xin Dong Guo, Mari Hart, Melanie Hartsough, Dennis Hannigan, Sarah Lapp, Jamie MacKelfresh, Amy Morris, Melinda Ogilvie, Eileen Osinski, Peter Patriarca, Emily Presmanes, Courtney Purcell, Madison Raese, Bruce Ribner, Marly Richter-Roche, Nayoka Rimann, David Rimland, Jo Ann Sadowski, Lynn Schaich, Jay Schamel, Mark Schwade, Vidisha Singh, Talib Sirajud-Deen, Pamela Turner, Andrea Trementozzi, Tiffany Wilson, Jianguo Xu, and Wells Yang.	Arnou R, 2009, VACCINE, V27, P7304, DOI 10.1016/j.vaccine.2009.10.033; Arya J, 2016, J CONTROL RELEASE, V240, P135, DOI 10.1016/j.jconrel.2015.11.019; Bednarczyk RA, 2015, VACCINE, V33, P1659, DOI 10.1016/j.vaccine.2015.02.033; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; Burgess TH, 2015, VACCINE, V33, P3894, DOI 10.1016/j.vaccine.2015.06.061; Centers for Disease Control and Prevention, SEAS INFL VACC EFF 2; Coleman BL, 2012, VACCINE, V30, P6287, DOI 10.1016/j.vaccine.2012.08.006; Daddona PE, 2011, PHARM RES-DORDR, V28, P159, DOI 10.1007/s11095-010-0192-9; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Hirobe S, 2015, BIOMATERIALS, V57, P50, DOI 10.1016/j.biomaterials.2015.04.007; Hirobe S, 2013, PHARM RES-DORDR, V30, P2664, DOI 10.1007/s11095-013-1092-6; Hung IFN, 2012, VACCINE, V30, P6427, DOI 10.1016/j.vaccine.2012.08.014; Kieninger D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-343; Lee BY, 2015, VACCINE, V33, P4727, DOI 10.1016/j.vaccine.2015.02.076; Marshall S, 2016, HUM VACC IMMUNOTHER, V12, P2975, DOI 10.1080/21645515.2016.1171440; McCrudden MTC, 2015, EXP DERMATOL, V24, P561, DOI 10.1111/exd.12723; Norman JJ, 2014, VACCINE, V32, P1856, DOI 10.1016/j.vaccine.2014.01.076; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pettis RJ, 2012, THER DELIV, V3, P357, DOI 10.4155/TDE.12.13; Prematunge C, 2012, VACCINE, V30, P4733, DOI 10.1016/j.vaccine.2012.05.018; Seqirus Vaccines Limited, INFL VIR VACC FLUV 2; Skountzou I, 2015, CURR TOP MICROBIOL, V386, P343, DOI 10.1007/82_2014_407; Taddio A, 2012, VACCINE, V30, P4807, DOI 10.1016/j.vaccine.2012.05.011; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND TOX GRAD SC; US Food and Drug Administration, 2014, GUID IND CLIN DAT NE; Vassilieva EV, 2015, DRUG DELIV TRANSL RE, V5, P360, DOI 10.1007/s13346-015-0228-0; WILLIAMS MS, 1993, VET MICROBIOL, V37, P253, DOI 10.1016/0378-1135(93)90027-5; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1; World Health Organization, 2011, MAN LAB DIAGN VIR SU	30	219	226	20	147	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					649	658		10.1016/S0140-6736(17)30575-5	http://dx.doi.org/10.1016/S0140-6736(17)30575-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD3TV	28666680	Green Accepted			2022-12-28	WOS:000407456200021
J	Ciabatti, E; Gonzalez-Rueda, A; Mariotti, L; Morgese, F; Tripodi, M				Ciabatti, Ernesto; Gonzalez-Rueda, Ana; Mariotti, Letizia; Morgese, Fabio; Tripodi, Marco			Life-Long Genetic and Functional Access to Neural Circuits Using Self-Inactivating Rabies Virus	CELL			English	Article							DOPAMINE NEURONS; VISUAL-CORTEX; EXPRESSION; STRATEGIES; DISORDERS; MECHANISM; SINGLE; INPUTS	Neural networks are emerging as the fundamental computational unit of the brain and it is becoming progressively clearer that network dysfunction is at the core of a number of psychiatric and neurodegenerative disorders. Yet, our ability to target specific networks for functional or genetic manipulations remains limited. Monosynaptically restricted rabies virus facilitates the anatomical investigation of neural circuits. However, the inherent cytotoxicity of the rabies largely prevents its implementation in long-term functional studies and the genetic manipulation of neural networks. To overcome this limitation, we developed a self-inactivating DG-rabies virus (SiR) that transcriptionally disappears from the infected neurons while leaving permanent genetic access to the traced network. SiR provides a virtually unlimited temporal window for the study of network dynamics and for the genetic and functional manipulation of neural circuits in vivo without adverse effects on neuronal physiology and circuit function.	[Ciabatti, Ernesto; Gonzalez-Rueda, Ana; Mariotti, Letizia; Morgese, Fabio; Tripodi, Marco] MRC, Lab Mol Biol, Div Neurobiol, Cambridge, England	MRC Laboratory Molecular Biology	Tripodi, M (corresponding author), MRC, Lab Mol Biol, Div Neurobiol, Cambridge, England.	mtripodi@mrc-lmb.cam.ac.uk	Tripodi, Marco/AGN-5956-2022	Tripodi, Marco/0000-0002-6827-6690; Gonzalez-Rueda, Ana/0000-0001-8007-4728; Ciabatti, Ernesto/0000-0001-9361-5992	Medical Research Council [MC_UP_1201/2]; European Research Council [STG 677029]; LMB Graduate Scholarship; MRC [MC_UP_1201/2] Funding Source: UKRI; Medical Research Council [1416697] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); LMB Graduate Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Silvia Arber, Gregory Jefferis, Michael Hastings, and Jonathan Wilson for comments on the manuscript. We thank Rick Livesey and Manuel Peter for providing hESCs-derived neurons, Nicolas Alexandre and the Laboratory of Molecular Biology (LMB) workshops for the help with software and hardware development, and members of the Biological Service Group for their support with the in vivo work. This study was supported by the Medical Research Council (MC_UP_1201/2), the European Research Council (STG 677029 to M.T.), and by a LMB Graduate Scholarship awarded to E.C. All data are stored on the LMB server. All materials described in this paper can be obtained for noncommercial purposes after signing a material transfer agreement (MTA) with the MRC.	Andermann ML, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00003; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Buzsaki G, 2015, CURR OPIN NEUROBIOL, V31, pV, DOI 10.1016/j.conb.2015.01.016; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Goldey GJ, 2014, NAT PROTOC, V9, P2515, DOI 10.1038/nprot.2014.165; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Kim EJ, 2016, CELL REP, V15, P692, DOI 10.1016/j.celrep.2016.03.067; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Komarova AV, 2007, NUCLEIC ACIDS RES, V35, P1522, DOI 10.1093/nar/gkl1127; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Osten P, 2013, NAT METHODS, V10, P515, DOI [10.1038/NMETH.2477, 10.1038/nmeth.2477]; Pachitariu M, 2016, BIORXIV; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Roselli F, 2012, CELL, V151, P250, DOI 10.1016/j.cell.2012.09.030; Rubinov M, 2013, TRENDS COGN SCI, V17, P641, DOI 10.1016/j.tics.2013.10.007; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Shockett PE, 1996, P NATL ACAD SCI USA, V93, P5173, DOI 10.1073/pnas.93.11.5173; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Tian J, 2016, NEURON, V91, P1374, DOI 10.1016/j.neuron.2016.08.018; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999	37	60	62	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 13	2017	170	2					382	+		10.1016/j.cell.2017.06.014	http://dx.doi.org/10.1016/j.cell.2017.06.014			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FA5OU	28689641	Green Published, hybrid			2022-12-28	WOS:000405493900016
J	Minarik, M; Stundl, J; Fabian, P; Jandzik, D; Metscher, BD; Psenicka, M; Gela, D; Osorio-Perez, A; Arias-Rodriguez, L; Horacek, I; Cerny, R				Minarik, Martin; Stundl, Jan; Fabian, Peter; Jandzik, David; Metscher, Brian D.; Psenicka, Martin; Gela, David; Osorio-Perez, Adriana; Arias-Rodriguez, Lenin; Horacek, Ivan; Cerny, Robert			Pre-oral gut contributes to facial structures in non-teleost fishes	NATURE			English	Article							ENDODERM FORMATION; VERTEBRATE HEAD; PRIMARY MOUTH; EVOLUTION; ORIGIN; REGION; MORPHOLOGY; ZEBRAFISH; CELLS; GENE	Despite the wide variety of adaptive modifications in the oral and facial regions of vertebrates, their early oropharyngeal development is considered strictly uniform. It involves sequential formation of the mouth and pharyngeal pouches, with ectoderm outlining the outer surface and endoderm the inner surface, as a rule(1,2). At the extreme anterior domain of vertebrate embryos, the ectoderm and endoderm directly juxtapose and initial development of this earliest ecto-endoderm interface, the primary mouth(3), typically involves ectodermal stomodeal invagination that limits the anterior expansion of the foregut endoderm(3,4). Here we present evidence that in embryos of extant non-teleost fishes, oral (stomodeal) formation is preceded by the development of prominent pre-oral gut diverticula (POGD) between the forebrain and roof of the forming mouth. Micro-computed tomography (micro-CT) imaging of bichir, sturgeon and gar embryos revealed that foregut outpocketing at the pre-oral domain begins even before the sequential formation of pharyngeal pouches. The presence of foregut-derived cells in the front of the mouth was further confirmed by in vivo experiments that allowed specific tracing of the early endodermal lining. We show that POGD in sturgeons contribute to the orofacial surface of their larvae, comprising oral teeth, lips, and sensory barbels. To our knowledge, this is the first thorough evidence for endodermal origin of external craniofacial structures in any vertebrate. In bichir and gar embryos, POGD form prominent cranial adhesive organs that are characteristic of the ancient bauplan of free-living chordate larvae. POGD hence seem arguably to be ancestral for all ray-finned fishes, and their topology, pharyngeal-like morphogenesis and gene expression suggest that they are evolutionarily related to the foregut-derived diverticula of early chordate and hemichordate embryos. The formation of POGD might thus represent an ancestral developmental module with deep deuterostome origins.	[Minarik, Martin; Stundl, Jan; Fabian, Peter; Horacek, Ivan; Cerny, Robert] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Stundl, Jan] Natl Museum, Dept Zool, Prague, Czech Republic; [Jandzik, David] Comenius Univ, Dept Zool, Bratislava, Slovakia; [Metscher, Brian D.] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Psenicka, Martin; Gela, David] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Austria; [Osorio-Perez, Adriana; Arias-Rodriguez, Lenin] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Mexico	Charles University Prague; National Museum; Comenius University Bratislava; University of Vienna; Universidad Juarez Autonoma de Tabasco	Cerny, R (corresponding author), Charles Univ Prague, Dept Zool, Prague, Czech Republic.	robert.cerny@natur.cuni.cz	Metscher, Brian/I-1238-2019; Stundl, Jan/AAM-7937-2021; Fabian, Peter/AGE-1467-2022; Cerny, Robert/H-3801-2017; jandzik, david/AAT-5002-2021; Pšenička, Martin/F-7929-2015; Horacek, Ivan/V-9741-2017; Arias Rodriguez, Lenin/AAE-5577-2022; Minařík, Martin/S-3384-2017; Stundl, Jan/Q-5209-2017	Metscher, Brian/0000-0002-6514-4406; Stundl, Jan/0000-0002-3740-3378; Fabian, Peter/0000-0002-1096-6875; Cerny, Robert/0000-0002-0022-0199; jandzik, david/0000-0002-4239-0014; Pšenička, Martin/0000-0002-3808-7856; Horacek, Ivan/0000-0002-8356-5554; Minařík, Martin/0000-0001-6660-0031; Stundl, Jan/0000-0002-3740-3378; ARIAS RODRIGUEZ, LENIN/0000-0002-8025-5569	European Molecular Biology Organization (EMBO); GACR [16-23836S]; Charles University [SVV 260 434 / 2017]; Charles University GA UK [220213, 726516, 1448514]; OeAD Aktion Osterreich-Tschechien scholarship; BMWFW Austria; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/01.0024, LO1205]	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); GACR(Grant Agency of the Czech Republic); Charles University; Charles University GA UK; OeAD Aktion Osterreich-Tschechien scholarship; BMWFW Austria; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	We thank C. V. H. Baker, M. E. Bronner, M. M. Smith, A. S. Tucker, D. M. Medeiros, P. E. Ahlberg, and S. Kuratani and his laboratory members for their helpful comments; and I. C. epic. ka, whose laboratory members initially assisted with the gene cloning procedures. V. Miller and K. Kodejs are acknowledged for their care of bichirs in Prague, and M. Kahanec and M. Rodina for their care of sturgeons in Vodn. any. D.J. thanks C. V. H. Baker for hosting him in her laboratory and the European Molecular Biology Organization (EMBO) for financial support. The study was supported by GACR project 16-23836S (R.C.); Charles University grant SVV 260 434 / 2017 and Charles University GA UK projects 220213 and 726516 (M. M.), and 1448514 (J.S.). M. M. thanks the OeAD Aktion Osterreich-Tschechien scholarship (financed by BMWFW Austria) for financial support during his stay in B.D.M.'s laboratory. M. P. and D. G. thank the Ministry of Education, Youth and Sports of the Czech Republic (projects CENAKVA (CZ.1.05/2.1.00/01.0024), CENAKVA II (LO1205 under the NPU I program)). L.A.R. thanks the SAGARPA-COFUPRO (RGAC-GTOS-2011-027): "Equipamiento para el Fortalecimiento del Nucleo Genetico de pejelagarto en el estado de Tabasco".	Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; Alexander J, 1999, CURR BIOL, V9, P1147, DOI 10.1016/S0960-9822(00)80016-0; Brand M., 2002, ZEBRAFISH; Choe CP, 2015, CURR OPIN GENET DEV, V32, P66, DOI 10.1016/j.gde.2015.02.003; Cooper MS, 2007, J EXP ZOOL PART B, V308B, P591, DOI 10.1002/jez.b.21142; Couly G, 2002, DEVELOPMENT, V129, P1061; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dettlaff T.A., 1993, STURGEON FISHES DEV; Dickinson AJG, 2006, DEV BIOL, V295, P700, DOI 10.1016/j.ydbio.2006.03.054; Diedhiou S., 2009, DEV NONTELEOST FISH; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Godard BG, 2014, BIOL OPEN, V3, P1098, DOI 10.1242/bio.20148037; Graham A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-24; Grevellec A, 2010, SEMIN CELL DEV BIOL, V21, P325, DOI 10.1016/j.semcdb.2010.01.022; Hatschek, 1893, AMPHIOXUS ITS DEV; Janvier P., 1996, EARLY VERTEBRATES; Kerr J.G., 1907, WORK JS BUDGETT; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; Lowe CJ, 2015, NATURE, V520, P456, DOI 10.1038/nature14434; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Nagasawa T, 2016, ZOOL SCI, V33, P272, DOI 10.2108/zs150183; Oisi Y, 2013, NATURE, V493, P175, DOI 10.1038/nature11794; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Quinlan R, 2004, DEVELOPMENT, V131, P593, DOI 10.1242/dev.00950; Retaux Sylvie, 2011, Communicative & Integrative Biology, V4, P75, DOI 10.4161/cib.4.1.13926; Satoh N, 2014, GENESIS, V52, P925, DOI 10.1002/dvg.22831; SEIFERT R, 1993, J ANAT, V183, P75; Sessel A., 1877, ARCH ANATOMIE ENTWIC; Shone V, 2014, J ANAT, V225, P479, DOI 10.1111/joa.12234; Soukup V, 2008, NATURE, V455, P795, DOI 10.1038/nature07304; Soukup V, 2013, J ANAT, V222, P79, DOI 10.1111/j.1469-7580.2012.01540.x; Suda Y, 2009, DEV BIOL, V325, P282, DOI 10.1016/j.ydbio.2008.09.018; Takeuchi M, 2009, DEV BIOL, V332, P90, DOI 10.1016/j.ydbio.2009.05.543; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Yoshida K, 2012, DEV GROWTH DIFFER, V54, P649, DOI 10.1111/j.1440-169X.2012.01366.x; Yu JK, 2002, EVOL DEV, V4, P9, DOI 10.1046/j.1525-142x.2002.01057.x	36	18	19	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					209	+		10.1038/nature23008	http://dx.doi.org/10.1038/nature23008			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678781				2022-12-28	WOS:000405314500037
J	Nishi, M; Kuwayama, Y; Tsuchiya, J; Tsuchiya, T				Nishi, Masayuki; Kuwayama, Yasuhiro; Tsuchiya, Jun; Tsuchiya, Taku			The pyrite-type high-pressure form of FeOOH	NATURE			English	Article							EQUATION-OF-STATE; CORE-MANTLE BOUNDARY; IRON-WATER REACTION; X-RAY-DIFFRACTION; VELOCITY ZONES; DELTA-ALOOH; PHASE; TRANSITION; STABILITY; TRANSPORT	Water transported into Earth's interior by subduction strongly influences dynamics such as volcanism and plate tectonics(1-3). Several recent studies have reported hydrous minerals to be stable at pressure and temperature conditions representative of Earth's deep interior, implying that surface water may be transported as far as the core-mantle boundary(4-8). However, the hydrous mineral goethite, alpha-FeOOH, was recently reported(9) to decompose under the conditions of the middle region of the lower mantle to form FeO2 and release H-2, suggesting the upward migration of hydrogen and large fluctuations in the oxygen distribution within the Earth system. Here we report the stability of FeOOH phases at the pressure and temperature conditions of the deep lower mantle, based on first-principles calculations and in situ X-ray diffraction experiments. In contrast to previous work suggesting the dehydrogenation of FeOOH into FeO2 in the middle of the lower mantle(9), we report the formation of a new FeOOH phase with the pyrite-type framework of FeO6 octahedra, which is much denser than the surrounding mantle and is stable at the conditions of the base of the mantle. Pyrite-type FeOOH may stabilize as a solid solution with other hydrous minerals in deeply subducted slabs, and could form in subducted banded iron formations. Deep-seated pyrite-type FeOOH eventually dissociates into Fe2O3 and releases H2O when subducted slabs are heated at the base of the mantle. This process may cause the incorporation of hydrogen into the outer core by the formation of iron hydride, FeHx, in the reducing environment of the core-mantle boundary.	[Nishi, Masayuki; Kuwayama, Yasuhiro; Tsuchiya, Jun; Tsuchiya, Taku] Ehime Univ, Geodynam Res Ctr, 2-5 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan; [Nishi, Masayuki; Tsuchiya, Jun; Tsuchiya, Taku] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-2-1 IE 1 Ookayama, Tokyo 1528550, Japan; [Kuwayama, Yasuhiro] Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan	Ehime University; Tokyo Institute of Technology; University of Tokyo	Nishi, M; Tsuchiya, J (corresponding author), Ehime Univ, Geodynam Res Ctr, 2-5 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.; Nishi, M; Tsuchiya, J (corresponding author), Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-2-1 IE 1 Ookayama, Tokyo 1528550, Japan.	nishi@sci.ehime-u.ac.jp; junt@ehime-u.ac.jp	Tsuchiya, Jun/A-3138-2014; Tsuchiya, Taku/ABH-1556-2020	Tsuchiya, Jun/0000-0001-9581-5840; Tsuchiya, Taku/0000-0002-6042-3692; Kuwayama, Yasuhiro/0000-0002-0077-3877	MEXT/JSPS KAKENHI [JP15H05469, JP25220712, JP15H05829, JP16H06285, JP26800274, JP26400516, JP26287137, JP15H05834]; MEXT; RIKEN Advanced Institute for Computational Science through the HPCI System Research project [hp160251/hp170220]; Grants-in-Aid for Scientific Research [15H05834] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Advanced Institute for Computational Science through the HPCI System Research project; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Ohishi and N. Hirao for their assistance in the experiments at BL10XU, SPring-8 (proposal numbers 2014B1363 and 2016A1476). We are grateful to T. Irifune for technical supports and discussion. This work was supported by MEXT/JSPS KAKENHI (grant numbers JP15H05469, JP25220712 and JP15H05829 to M.N., JP16H06285 and JP26800274 to Y.K., JP26400516 to J.T., JP26287137 and JP15H05834 to J.T. and T. T.). This research was also supported in part by MEXT as "Exploratory Challenge on Post-K computer" (Frontiers of Basic Science: Challenging the Limits). This research used the computational resources of the K computer provided by the RIKEN Advanced Institute for Computational Science through the HPCI System Research project (Project ID: hp160251/hp170220).	ANDERSON OL, 1989, J APPL PHYS, V65, P1534, DOI 10.1063/1.342969; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Bykova E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10661; Cococcioni M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035105; Dekura H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.045701; Dobson DP, 2005, NATURE, V434, P371, DOI 10.1038/nature03430; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Eberle MA, 2002, PHYS EARTH PLANET IN, V134, P191, DOI 10.1016/S0031-9201(02)00157-7; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; FUKAI Y, 1984, NATURE, V308, P174, DOI 10.1038/308174a0; Fukui H, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009591; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gleason AE, 2013, EARTH PLANET SC LETT, V379, P49, DOI 10.1016/j.epsl.2013.08.012; Holzapfel C, 2005, SCIENCE, V309, P1707, DOI 10.1126/science.1111895; Hu QY, 2017, P NATL ACAD SCI USA, V114, P1498, DOI 10.1073/pnas.1620644114; Hu QY, 2016, NATURE, V534, P241, DOI 10.1038/nature18018; INOUE T, 1994, PHYS EARTH PLANET IN, V85, P237, DOI 10.1016/0031-9201(94)90116-3; KARATO SI, 1986, J GEOPHYS RES-SOLID, V91, P8151, DOI 10.1029/JB091iB08p08151; Kuwayama Y, 2005, SCIENCE, V309, P923, DOI 10.1126/science.1114879; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Morales MA, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.184107; Nishi M, 2015, PHYS EARTH PLANET IN, V245, P52, DOI 10.1016/j.pepi.2015.05.007; Nishi M, 2014, NAT GEOSCI, V7, P224, DOI [10.1038/NGEO2074, 10.1038/ngeo2074]; Nomura R, 2014, SCIENCE, V343, P522, DOI 10.1126/science.1248186; Ohira I, 2014, EARTH PLANET SC LETT, V401, P12, DOI 10.1016/j.epsl.2014.05.059; Ohishi Y, 2008, HIGH PRESSURE RES, V28, P163, DOI 10.1080/08957950802208910; Ohtani E, 2005, PHYS CHEM MINER, V32, P77, DOI 10.1007/s00269-004-0443-6; Otsuka K, 2012, NATURE, V492, P243, DOI 10.1038/nature11663; Pepin CM, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.265504; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Sano A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031718; Sano A, 2008, J MINER PETROL SCI, V103, P152, DOI 10.2465/jmps.071022m; Sano-Furukawa A, 2009, AM MINERAL, V94, P1255, DOI 10.2138/am.2009.3109; Seto Yusuke, 2010, Review of High Pressure Science and Technology, V20, P70, DOI 10.4131/jshpreview.20.269; Terasaki H, 2012, PHYS EARTH PLANET IN, V194, P18, DOI 10.1016/j.pepi.2012.01.002; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Tsuchiya J, 2008, J MINER PETROL SCI, V103, P116, DOI 10.2465/jmps.071022e; Tsuchiya J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15534; Tsuchiya J, 2013, GEOPHYS RES LETT, V40, P4570, DOI 10.1002/grl.50875; Tsuchiya J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.054115; Tsuchiya T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002446; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Walter MJ, 2015, CHEM GEOL, V418, P16, DOI 10.1016/j.chemgeo.2015.05.001; Wang XL, 2015, NAT GEOSCI, V8, P556, DOI [10.1038/NGEO2458, 10.1038/ngeo2458]; Wen LX, 1998, SCIENCE, V279, P1701, DOI 10.1126/science.279.5357.1701; Yokoo M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104114	48	98	103	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2017	547	7662					205	+		10.1038/nature22823	http://dx.doi.org/10.1038/nature22823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA3AX	28678774				2022-12-28	WOS:000405314500036
J	da Costa, BR; Reichenbach, S; Keller, N; Nartey, L; Wandel, S; Juni, P; Trelle, S				da Costa, Bruno R.; Reichenbach, Stephan; Keller, Noah; Nartey, Linda; Wandel, Simon; Juni, Peter; Trelle, Sven			Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis	LANCET			English	Article							CLINICAL-TRIALS; RHEUMATOID-ARTHRITIS; PRIMARY-CARE; INTERVENTIONS; MEDICATIONS; CHONDROITIN; MANAGEMENT; PLACEBO	Background Non-steroidal anti-inflammatory drugs (NSAIDs) are the backbone of osteoarthritis pain management. We aimed to assess the effectiveness of different preparations and doses of NSAIDs on osteoarthritis pain in a network meta-analysis. Methods For this network meta-analysis, we considered randomised trials comparing any of the following interventions: NSAIDs, paracetamol, or placebo, for the treatment of osteoarthritis pain. We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and the reference lists of relevant articles for trials published between Jan 1, 1980, and Feb 24, 2015, with at least 100 patients per group. The prespecified primary and secondary outcomes were pain and physical function, and were extracted in duplicate for up to seven timepoints after the start of treatment. We used an extension of multivariable Bayesian random effects models for mixed multiple treatment comparisons with a random effect at the level of trials. For the primary analysis, a random walk of first order was used to account for multiple follow-up outcome data within a trial. Preparations that used different total daily dose were considered separately in the analysis. To assess a potential dose-response relation, we used preparation-specific covariates assuming linearity on log relative dose. Findings We identified 8973 manuscripts from our search, of which 76 randomised trials with a total of 58 451 patients were included in this analysis. 23 nodes concerning seven different NSAIDs or paracetamol with specific daily dose of administration or placebo were considered. All preparations, irrespective of dose, improved point estimates of pain symptoms when compared with placebo. For six interventions (diclofenac 150 mg/day, etoricoxib 30 mg/day, 60 mg/day, and 90 mg/day, and rofecoxib 25 mg/day and 50 mg/day), the probability that the difference to placebo is at or below a prespecified minimum clinically important effect for pain reduction (effect size [ES] -0.37) was at least 95%. Among maximally approved daily doses, diclofenac 150 mg/day (ES -0.57, 95% credibility interval [CrI] -0.69 to -0.45) and etoricoxib 60 mg/day (ES -0.58, -0.74 to -0.43) had the highest probability to be the best intervention, both with 100% probability to reach the minimum clinically important difference. Treatment effects increased as drug dose increased, but corresponding tests for a linear dose effect were significant only for naproxen (p=0.034). We found no evidence that treatment effects varied over the duration of treatment. Model fit was good, and between-trial heterogeneity and inconsistency were low in all analyses. All trials were deemed to have a low risk of bias for blinding of patients. Effect estimates did not change in sensitivity analyses with two additional statistical models and accounting for methodological quality criteria in meta-regression analysis. Interpretation On the basis of the available data, we see no role for single-agent paracetamol for the treatment of patients with osteoarthritis irrespective of dose. We provide sound evidence that diclofenac 150 mg/day is the most effective NSAID available at present, in terms of improving both pain and function. Nevertheless, in view of the safety profile of these drugs, physicians need to consider our results together with all known safety information when selecting the preparation and dose for individual patients.	[da Costa, Bruno R.; Keller, Noah; Juni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Reichenbach, Stephan; Trelle, Sven] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Nartey, Linda; Trelle, Sven] Univ Bern, CTU Bern, Dept Clin Res, Bern, Switzerland; [Reichenbach, Stephan] Univ Hosp, Dept Rheumatol Immunol & Allergol, Bern, Switzerland; [Reichenbach, Stephan] Univ Bern, Bern, Switzerland; [Wandel, Simon] Cogitars GmbH In Liq, Wangen An Der Aare, Switzerland; [Juni, Peter] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Trelle, S (corresponding author), Univ Bern, CTU Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	sven.trelle@ctu.unibe.ch	Juni, Peter/Q-8700-2016; Trelle, Sven/D-3760-2009	Juni, Peter/0000-0002-5985-0670; Trelle, Sven/0000-0002-8162-8910; , Simon/0000-0002-1442-597X	Swiss National Science Foundation [405340-104762]; Arco Foundation, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Arco Foundation, Switzerland	Swiss National Science Foundation (grant number 405340-104762) and Arco Foundation, Switzerland.	Adebajo A, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-23; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Arboleya LR, 2003, CURR MED RES OPIN, V19, P278, DOI 10.1185/030079903125001712; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Cahir C, 2010, BRIT J CLIN PHARMACO, V69, P543, DOI 10.1111/j.1365-2125.2010.03628.x; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Chou R, 2011, ANALGESICS OSTEOARTH; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Cordero-Ampuero J, 2012, QUAL LIFE RES, V21, P1391, DOI 10.1007/s11136-011-0058-6; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Food and Drug Administration, 1998, GUID IND PROV CLIN E; Gore M, 2012, PAIN PRACT, V12, P550, DOI 10.1111/j.1533-2500.2012.00532.x; Gore M, 2011, CLIN THER, V33, P1914, DOI 10.1016/j.clinthera.2011.10.019; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; JOHNSON AF, 1985, J CHRON DIS, V38, P265, DOI 10.1016/0021-9681(85)90069-4; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Machado GC, EFFICACY SAFETY PARA; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Porcheret M, 2007, RHEUMATOLOGY, V46, P1694, DOI 10.1093/rheumatology/kem232; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rosemann T, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-48; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Tacconelli S, 2004, CURR PHARM DESIGN, V10, P589, DOI 10.2174/1381612043453108; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; van Walsem A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0554-0; Wadman M., NIH MULLS RULES VALI; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675	38	289	314	3	108	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2017	390	10090					E21	E33		10.1016/S0140-6736(17)31744-0	http://dx.doi.org/10.1016/S0140-6736(17)31744-0			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ8LF	28699595				2022-12-28	WOS:000404976600002
J	Robertson, GP; Hamilton, SK; Barham, BL; Dale, BE; Izaurralde, RC; Jackson, RD; Landis, DA; Swinton, SM; Thelen, KD; Tiedje, JM				Robertson, G. Philip; Hamilton, Stephen K.; Barham, Bradford L.; Dale, Bruce E.; Izaurralde, R. Cesar; Jackson, Randall D.; Landis, Douglas A.; Swinton, Scott M.; Thelen, Kurt D.; Tiedje, James M.			Cellulosic biofuel contributions to a sustainable energy future: Choices and outcomes	SCIENCE			English	Review							SOIL MICROBIAL COMMUNITIES; LIFE-CYCLE ASSESSMENT; CROPPING SYSTEMS; BIOENERGY CROPS; NITROUS-OXIDE; UPPER MIDWEST; ENVIRONMENTAL IMPACTS; ECOSYSTEM SERVICES; GREENHOUSE GASES; CARBON-DIOXIDE	Cellulosic crops are projected to provide a large fraction of transportation energy needs by mid-century. However, the anticipated land requirements are substantial, which creates a potential for environmental harm if trade-offs are not sufficiently well understood to create appropriately prescriptive policy. Recent empirical findings show that cellulosic bioenergy concerns related to climate mitigation, biodiversity, reactive nitrogen loss, and crop water use can be addressed with appropriate crop, placement, and management choices. In particular, growing native perennial species on marginal lands not currently farmed provides substantial potential for climate mitigation and other benefits.	[Robertson, G. Philip; Hamilton, Stephen K.] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Robertson, G. Philip; Thelen, Kurt D.; Tiedje, James M.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Robertson, G. Philip; Hamilton, Stephen K.; Dale, Bruce E.; Izaurralde, R. Cesar; Landis, Douglas A.; Swinton, Scott M.; Thelen, Kurt D.; Tiedje, James M.] Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Hamilton, Stephen K.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Barham, Bradford L.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Barham, Bradford L.; Jackson, Randall D.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Dale, Bruce E.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Izaurralde, R. Cesar] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Izaurralde, R. Cesar] Texas A&M Univ, Texas AgriLife Res, Temple, TX 76502 USA; [Jackson, Randall D.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Landis, Douglas A.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Swinton, Scott M.] Michigan State Univ, Dept Agr Food & Resource Econ, E Lansing, MI 48824 USA; [Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; Michigan State University; University System of Maryland; University of Maryland College Park; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University; Michigan State University	Robertson, GP (corresponding author), Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA.; Robertson, GP (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.; Robertson, GP (corresponding author), Michigan State Univ, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	robert30@msu.edu	Izaurralde, Roberto César/E-5257-2019; Hamilton, Stephen K/N-2979-2014; Jackson, Randall/AAE-5573-2022; Landis, Douglas A./L-7991-2019; Robertson, G Philip/H-3885-2011	Hamilton, Stephen K/0000-0002-4702-9017; Robertson, G Philip/0000-0001-9771-9895; Jackson, Randall/0000-0002-8033-1250; Tiedje, James/0000-0002-8992-6218; Izaurralde, Roberto/0000-0002-8797-9500	U.S. Department of Energy Office of Science [DE-FC02-07ER64494]; Office of Energy Efficiency and Renewable Energy [DE-ACO5-76RL01830]; NSF Long-Term Ecological Research program [DEB 1027253]; MSU AgBioResearch; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	U.S. Department of Energy Office of Science(United States Department of Energy (DOE)); Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); NSF Long-Term Ecological Research program(National Science Foundation (NSF)); MSU AgBioResearch; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by U.S. Department of Energy Office of Science grant DE-FC02-07ER64494, Office of Energy Efficiency and Renewable Energy grant DE-ACO5-76RL01830, NSF Long-Term Ecological Research program grant DEB 1027253, and MSU AgBioResearch.	Abraha M, 2015, GCB BIOENERGY, V7, P1344, DOI 10.1111/gcbb.12239; [Anonymous], 2014, GLOBAL BIOENERGY SUP; [Anonymous], 2014, CLIMATE CHANGE 2014; Bandaru V., 2015, SUSTAINABLE BIOFUELS, P299; Bennett AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110676; Bennett AB, 2014, AGR ECOSYST ENVIRON, V193, P1, DOI 10.1016/j.agee.2014.04.016; Cai XM, 2011, ENVIRON SCI TECHNOL, V45, P334, DOI 10.1021/es103338e; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Campbell JE, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035012; Cavigelli MA, 2001, SOIL BIOL BIOCHEM, V33, P297, DOI 10.1016/S0038-0717(00)00141-3; Christian DG, 2002, BIORESOURCE TECHNOL, V83, P115, DOI 10.1016/S0960-8524(01)00201-2; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Daigh AL, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2013.10.0177; Davis MP, 2015, GCB BIOENERGY, V7, P1222, DOI 10.1111/gcbb.12217; Dickson TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135253; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Duran BEL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151919; Egbendewe-Mondzozo A, 2015, APPL ECON PERSPECT P, V37, P602, DOI 10.1093/aepp/ppu044; Eranki PL, 2011, GCB BIOENERGY, V3, P427, DOI 10.1111/j.1757-1707.2011.01096.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Ferchaud F, 2016, BIOENERG RES, V9, P656, DOI 10.1007/s12155-015-9710-2; Feyereisen GW, 2013, AGRON J, V105, P631, DOI 10.2134/agronj2012.0282; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gelfand I, 2011, P NATL ACAD SCI USA, V108, P13864, DOI 10.1073/pnas.1017277108; Georgescu M, 2011, P NATL ACAD SCI USA, V108, P4307, DOI 10.1073/pnas.1008779108; Griffith AP, 2011, AGRON J, V103, P617, DOI 10.2134/agronj2010.0336; Guo J., 2016, 16 INT S MICR EC MON; Hamilton SK, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/6/064015; Hamilton S. K., 2015, AM GEOPH UN FALL M S; Hamilton SK, 2012, FRESHWATER BIOL, V57, P43, DOI 10.1111/j.1365-2427.2011.02685.x; Harrison T, 2013, INSECT SCI, V20, P407, DOI 10.1111/j.1744-7917.2012.01530.x; Heaton E, 2004, BIOMASS BIOENERG, V27, P21, DOI 10.1016/j.biombioe.2003.10.005; Hickman GC, 2010, GCB BIOENERGY, V2, P157, DOI 10.1111/j.1757-1707.2010.01050.x; Hill J., 2013, ENCY BIODIVERSITY, V2nd ed., P627, DOI 10.1016/B978-0-12-384719-5.00365-8; Jach-Smith LC, 2015, AGR ECOSYST ENVIRON, V204, P62, DOI 10.1016/j.agee.2015.02.006; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jasechko S, 2013, NATURE, V496, P347, DOI 10.1038/nature11983; Jesus ED, 2016, GCB BIOENERGY, V8, P481, DOI 10.1111/gcbb.12289; Jungers JM, 2015, AGRON J, V107, P1627, DOI 10.2134/agronj15.0014; Kang S. J., 2013, Journal of Agricultural Science (Toronto), V5, P129; Kim S, 2015, BIOFUEL BIOPROD BIOR, V9, P422, DOI 10.1002/bbb.1554; Kucharik CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068847; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Lark TJ, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/044003; Le PVV, 2011, P NATL ACAD SCI USA, V108, P15085, DOI 10.1073/pnas.1107177108; Lee ZM, 2014, SOIL BIOL BIOCHEM, V69, P282, DOI 10.1016/j.soilbio.2013.11.012; Levine UY, 2011, ISME J, V5, P1683, DOI 10.1038/ismej.2011.40; Liang C, 2016, SOIL BIOL BIOCHEM, V94, P173, DOI 10.1016/j.soilbio.2015.11.020; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Liebman M, 2015, ELEMENTA-SCI ANTHROP, V3, DOI 10.12952/journal.elementa.000041; Liere H, 2015, ECOL APPL, V25, P652, DOI 10.1890/14-0570.1; Luterbacher JS, 2014, SCIENCE, V343, P277, DOI 10.1126/science.1246748; Mao YJ, 2013, ENVIRON MICROBIOL, V15, P928, DOI 10.1111/j.1462-2920.2012.02844.x; McIsaac GF, 2010, J ENVIRON QUAL, V39, P1790, DOI 10.2134/jeq2009.0497; Meehan TD, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/114001; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Meehan TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041728; Meehan TD, 2010, P NATL ACAD SCI USA, V107, P18533, DOI 10.1073/pnas.1008475107; Meier PJ, 2015, ENVIRON SCI TECHNOL, V49, P8277, DOI 10.1021/acs.est.5b01691; Melillo JM, 2009, SCIENCE, V326, P1397, DOI 10.1126/science.1180251; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Mooney DF, 2015, APPL ECON PERSPECT P, V37, P287, DOI 10.1093/aepp/ppu033; Morales M, 2015, RENEW SUST ENERG REV, V42, P1349, DOI 10.1016/j.rser.2014.10.097; National Agricultural Statistics Service, 2016, CROP PROD 2015 SUMM; National Research Council, 2009, LIQ TRANSP FUELS COA; Nikiema P, 2012, BIOMASS BIOENERG, V39, P413, DOI 10.1016/j.biombioe.2012.01.037; Oates LG, 2016, GCB BIOENERGY, V8, P539, DOI 10.1111/gcbb.12268; Oikawa PY, 2015, GCB BIOENERGY, V7, P974, DOI 10.1111/gcbb.12190; Peckham SD, 2011, GCB BIOENERGY, V3, P135, DOI 10.1111/j.1757-1707.2010.01067.x; Pittman SE, 2015, BIOL INVASIONS, V17, P3247, DOI 10.1007/s10530-015-0950-z; Plevin R. J., 2013, ENCY BIODIVERSITY, V2nd, P293; Plevin RJ, 2014, J IND ECOL, V18, P73, DOI 10.1111/jiec.12074; Pugesgaard S, 2015, GCB BIOENERGY, V7, P1136, DOI 10.1111/gcbb.12215; Qin ZC, 2012, GCB BIOENERGY, V4, P277, DOI 10.1111/j.1757-1707.2011.01129.x; Robertson BA, 2011, GCB BIOENERGY, V3, P235, DOI 10.1111/j.1757-1707.2010.01080.x; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Robertson GP, 2014, BIOSCIENCE, V64, P404, DOI 10.1093/biosci/biu037; Robertson GP, 2011, ECOL APPL, V21, P1055, DOI 10.1890/09-0456.1; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Ruan LL, 2017, ECOSYSTEMS, V20, P917, DOI 10.1007/s10021-016-0077-9; Ruan LL, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/6/064007; Ruan LL, 2013, GLOBAL CHANGE BIOL, V19, P2478, DOI 10.1111/gcb.12216; Sanford GR, 2016, AGR ECOSYST ENVIRON, V216, P344, DOI 10.1016/j.agee.2015.10.018; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schulze ED, 2012, GCB BIOENERGY, V4, P611, DOI 10.1111/j.1757-1707.2012.01169.x; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Shcherbak I, 2014, P NATL ACAD SCI USA, V111, P9199, DOI 10.1073/pnas.1322434111; Skevas T, 2016, GCB BIOENERGY, V8, P1162, DOI 10.1111/gcbb.12320; Skevas T, 2016, LAND USE POLICY, V50, P507, DOI 10.1016/j.landusepol.2015.09.027; Smith CM, 2013, J ENVIRON QUAL, V42, P219, DOI 10.2134/jeq2012.0210; Song F, 2011, AM J AGR ECON, V93, P764, DOI 10.1093/ajae/aar018; Swinton S. M., 2016, GCB BIOENERGY, V9, P414, DOI [10.1111/gcbb.12336s10530-015-0950-z, DOI 10.1111/GCBB.12336S10530-015-0950-Z]; Syswerda SP, 2012, AGR ECOSYST ENVIRON, V149, P10, DOI 10.1016/j.agee.2011.12.007; Syswerda SP, 2011, SOIL SCI SOC AM J, V75, P92, DOI 10.2136/sssaj2009.0414; Thomason WE, 2004, J PLANT NUTR, V27, P1199, DOI 10.1081/PLN-120038544; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; US Department of Energy, 2016, 2016 BILL TON REP AD, V1; VanLoocke A, 2012, AGR FOREST METEOROL, V164, P82, DOI 10.1016/j.agrformet.2012.05.016; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Wang Q, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0093-6; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Werling BP, 2011, GCB BIOENERGY, V3, P347, DOI 10.1111/j.1757-1707.2011.01092.x; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Zangerl AR, 2013, INSECT SCI, V20, P671, DOI 10.1111/j.1744-7917.2012.01532.x; Zhang B., 2015, AM SOC MICR 115 GEN; Zhuang QL, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015020	112	254	255	34	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345							eaal2324	10.1126/science.aal2324	http://dx.doi.org/10.1126/science.aal2324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9XE	28663443				2022-12-28	WOS:000404351500027
J	Long, V; Foong, H				Long, Valencia; Foong, Henry			CASE REVIEW A case of generalised papules	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Long, Valencia; Foong, Henry] Natl Skin Ctr, Singapore, Singapore	National Skin Centre	Long, V (corresponding author), Natl Skin Ctr, Singapore, Singapore.	valencialong@gmail.com	Long, Shihuan/N-3027-2015	Long, Shihuan/0000-0002-1346-9903				Bitman LM, 1998, ARCH DERMATOL, V134, P1019, DOI 10.1001/archderm.134.8.1019	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 29	2017	357								j2912	10.1136/bmj.j2912	http://dx.doi.org/10.1136/bmj.j2912			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AY	28663284				2022-12-28	WOS:000404725100005
J	Wan, LL; Dreyfuss, G				Wan, Lili; Dreyfuss, Gideon			Splicing-Correcting Therapy for SMA	CELL			English	Editorial Material									[Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	wan, li/GRY-7634-2022; Dreyfuss, Gideon/D-1218-2013	Dreyfuss, Gideon/0000-0001-8129-8774					0	29	31	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					5	5		10.1016/j.cell.2017.06.028	http://dx.doi.org/10.1016/j.cell.2017.06.028			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FW8TE	28666123	Bronze			2022-12-28	WOS:000425608600001
J	Dave, CV; Kesselheim, AS; Fox, ER; Qiu, PH; Hartzema, A				Dave, Chintan V.; Kesselheim, Aaron S.; Fox, Erin R.; Qiu, Peihua; Hartzema, Abraham			High Generic Drug Prices and Market Competition A Retrospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICATION; INDUSTRY	Background: Prices for some generic drugs have increased in recent years, adversely affecting patients who rely on them. Objective: To determine the association between market competition levels and the change in generic drug prices in the United States. Design: Retrospective cohort study. Setting: Prescription claims from commercial health plans between 2008 and 2013. Measurements: The 5.5 years of data were divided into 11 study periods of 6 months each. The Herfindahl-Hirschman Index (HHI)-calculated by summing the squares of individual manufacturers' market shares, with higher values indicating a less competitive market-and average drug prices were estimated for the generic drugs in each period. The HHI value estimated in the baseline period (first half of 2008) was modeled as a fixed covariate. Models estimated price changes over time by level of competition, adjusting for drug shortages, market size, and dosage forms. Results: From 1.08 billion prescription claims, a cohort of 1120 generic drugs was identified. After adjustment, drugs with quadropoly (HHI value of 2500, indicating relatively high levels of competition), duopoly (HHI value of 5000), near-monopoly (HHI value of 8000), and monopoly (HHI value of 10 000) levels of baseline competition were associated with price changes of -31.7% (95% CI, -34.4% to -28.9%), -11.8% (CI, -18.6% to -4.4%), 20.1% (CI, 5.5% to 36.6%), and 47.4% (CI, 25.4% to 73.2%), respectively, over the study period. Limitation: Study findings may not be generalizable to drugs that became generic after 2008. Conclusion: Market competition levels were associated with a change in generic drug prices. Such measurements may be helpful in identifying older prescription drugs at higher risk for price change in the future.	Univ Florida, Gainesville, FL USA; Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; Univ Utah, Salt Lake City, UT USA; [Dave, Chintan V.] 1225 Ctr Dr HPNP 3226, Gainesville, FL 32611 USA; [Kesselheim, Aaron S.] 1620 Tremont St,Suite 3030, Boston, MA 02120 USA; [Fox, Erin R.] 50 North Med Dr,Room A050, Salt Lake City, UT 84132 USA; [Qiu, Peihua] 2004 Mowry Rd,POB 117450, Gainesville, FL 32611 USA; [Hartzema, Abraham] 1225 Ctr Dr,HPNP 4304, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Utah System of Higher Education; University of Utah	Dave, CV (corresponding author), 1225 Ctr Dr HPNP 3226, Gainesville, FL 32611 USA.	chintandave19@gmail.com	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	Dr. Kesselheim's work is funded by the Laura and John Arnold Foundation, with additional support provided by the Engelberg Foundation and the Harvard Program in Therapeutic Science.	Aitken M, 2014, MED USE SHIFTING COS, P51; Alpern JD, 2014, NEW ENGL J MED, V371, P1859, DOI 10.1056/NEJMp1408376; [Anonymous], 2012, COMMUNICATION   0131; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Fox E, 2009, AM J HEALTH-SYST PH, V66, P798, DOI 10.2146/ajhp080314; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Hershman DL, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju319; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Morton FMS, 1999, RAND J ECON, V30, P421, DOI 10.2307/2556056; Reiffen D, 2005, REV ECON STAT, V87, P37, DOI 10.1162/0034653053327694; Rhoades SA, 1993, FEDERAL RESERVE B, V79, P188; Rockoff Jonathan D., 2015, WALL STREET J; Rosenthal E., 2014, NY TIMES, pA17; Silverman E, 2015, WALL STREET J; The Lancet Oncology, 2015, LANCET ONCOL, V16, P595, DOI DOI 10.1016/S1470-2045; United States Government Accountability Office, 2014, DRUG SHORT PUBL HLTH; US Department of Justice, 2010, HORIZONTAL MERGER GU; Worth Tammy, 2015, Med Econ, V92, P36	19	62	62	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2017	167	3					145	+		10.7326/M16-1432	http://dx.doi.org/10.7326/M16-1432			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1XN	28672324				2022-12-28	WOS:000406631400004
J	Papa, I; Saliba, D; Ponzoni, M; Bustamante, S; Canete, PF; Gonzalez-Figueroa, P; McNamara, HA; Valvo, S; Grimbaldeston, M; Sweet, RA; Vohra, H; Cockburn, IA; Meyer-Hermann, M; Dustin, ML; Doglioni, C; Vinuesa, CG				Papa, Ilenia; Saliba, David; Ponzoni, Maurilio; Bustamante, Sonia; Canete, Pablo F.; Gonzalez-Figueroa, Paula; McNamara, Hayley A.; Valvo, Salvatore; Grimbaldeston, Michele; Sweet, Rebecca A.; Vohra, Harpreet; Cockburn, Ian A.; Meyer-Hermann, Michael; Dustin, Michael L.; Doglioni, Claudio; Vinuesa, Carola G.			T-FH-derived dopamine accelerates productive synapses in germinal centres	NATURE			English	Article							FOLLICULAR HELPER-CELLS; CATECHOLAMINE SYNTHESIS; TYROSINE-HYDROXYLASE; DENSE-CORE; B-CELLS; SELECTION; NOREPINEPHRINE; LYMPHOCYTE; EXPRESSION; MECHANISM	Protective high-affinity antibody responses depend on competitive selection of B cells carrying somatically mutated B-cell receptors by follicular helper T (T-FH) cells in germinal centres. The rapid T-B-cell interactions that occur during this process are reminiscent of neural synaptic transmission pathways. Here we show that a proportion of human T-FH cells contain dense-core granules marked by chromogranin B, which are normally found in neuronal presynaptic terminals storing catecholamines such as dopamine. T-FH cells produce high amounts of dopamine and release it upon cognate interaction with B cells. Dopamine causes rapid translocation of intracellular ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) to the B-cell surface, which enhances accumulation of CD40L and chromogranin B granules at the human T-FH cell synapse and increases the synapse area. Mathematical modelling suggests that faster dopamine-induced T-B-cell interactions increase total germinal centre output and accelerate it by days. Delivery of neurotransmitters across the T-B-cell synapse may be advantageous in the face of infection.	[Papa, Ilenia; Canete, Pablo F.; Gonzalez-Figueroa, Paula; McNamara, Hayley A.; Sweet, Rebecca A.; Cockburn, Ian A.; Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia; [Saliba, David; Valvo, Salvatore; Dustin, Michael L.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Kennedy Inst Rheumatol, Oxford OX3 7LD, England; [Ponzoni, Maurilio; Doglioni, Claudio] IRCCS Sci Inst San Raffaele, Dept Pathol, Ateneo Vita Salute, I-20132 Milan, Italy; [Bustamante, Sonia] Univ New South Wales, Mark Wainwright Analyt Ctr, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Grimbaldeston, Michele] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Grimbaldeston, Michele] SA Pathol, Adelaide, SA 5000, Australia; [Grimbaldeston, Michele] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA; [Vohra, Harpreet] Australian Natl Univ, John Curtin Sch Med Res, Imaging & Cytometry Facil, Canberra, ACT 2601, Australia; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Dept Syst Immunol, D-38124 Braunschweig, Germany; [Meyer-Hermann, Michael] Helmholtz Ctr Infect Res, Braunschweig Integrated Ctr Syst Biol, D-38124 Braunschweig, Germany; [Vinuesa, Carola G.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Shanghai 200085, Peoples R China	Australian National University; John Curtin School of Medical Research; University of Oxford; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of New South Wales Sydney; Centre for Cancer Biology; University of South Australia; SA Pathology; Roche Holding; Genentech; Australian National University; John Curtin School of Medical Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Shanghai Jiao Tong University	Vinuesa, CG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT 2601, Australia.; Vinuesa, CG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Renji Hosp, China Australia Ctr Personalised Immunol, Shanghai 200085, Peoples R China.	carola.vinuesa@anu.edu.au	Canete, Pablo/HGB-5944-2022; Gonzalez-Figueroa, Paula/W-3654-2018; Canete, Pablo F/AAO-5341-2020; Canete, Pablo F/E-3305-2019; Vinuesa, Carola G/B-1108-2010; Dustin, Michael/AAM-4611-2020	Gonzalez-Figueroa, Paula/0000-0001-8270-552X; Canete, Pablo F/0000-0002-6167-4186; Vinuesa, Carola G/0000-0001-9799-0298; Saliba, David/0000-0001-9523-0586; Dustin, Michael/0000-0003-4983-6389; Papa, Ilenia/0000-0003-3167-7623; Bustamante, sonia/0000-0002-5411-2919; Cockburn, Ian/0000-0001-8220-9294; McNamara, Hayley/0000-0001-6347-6215	NIHR Oxford Biomedical Research Centre; Australian National Health and Medical Research Council; Wellcome Trust; European Research Council [AdG670930]; Human Frontier Science Program [RGP0033/2015]	NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank J. Meldolesi for electron microscopy analysis and P. Podini for technical assistance; M. Cook and E. Bartlett for reading the manuscript; R. Cairella for his contribution to preparing histological samples; A. Wilson, A.-M. Hatch, A. Lopez, E. Barry and T. Lambe for assistance with obtaining tonsil samples; and D. Yu for suggestions. We thank the Imaging and Cytometry Facility and the Biomolecular Research Facility at the John Curtin School of Medical Research for technical support. We acknowledge the contribution to this study made by the Oxford Centre for Histopathology Research and the Oxford Radcliffe Biobank, which are supported by the NIHR Oxford Biomedical Research Centre. C.G.V. is supported by fellowship, project, and program grants from the Australian National Health and Medical Research Council. The Wellcome Trust supports M.L.D. and S.V.; European Research Council grant AdG670930 supports M.L.D.; and D.S. Human Frontier Science Program (RGP0033/2015) supports M.M.H., M.L.D., and C.G.V.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Bergquist J, 1998, IMMUNOL TODAY, V19, P562, DOI 10.1016/S0167-5699(98)01367-X; Bergquist J, 1997, ELECTROPHORESIS, V18, P1760, DOI 10.1002/elps.1150181009; Bergquist J, 1998, RAPID COMMUN MASS SP, V12, P683, DOI 10.1002/(SICI)1097-0231(19980615)12:11<683::AID-RCM218>3.3.CO;2-E; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braeuninger A, 1997, P NATL ACAD SCI USA, V94, P9337, DOI 10.1073/pnas.94.17.9337; Brauninger A, 1999, BLOOD, V93, P2679, DOI 10.1182/blood.V93.8.2679.408k05_2679_2687; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Dustin M. L., 2007, CURRENT PROTOCOLS IM; Dustin ML, 2012, SCIENCE, V335, P408, DOI 10.1126/science.1218165; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Hotta R, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01411.x; Kohm AP, 2000, IMMUNOL TODAY, V21, P539, DOI 10.1016/S0167-5699(00)01747-3; Liu D, 2015, NATURE, V517, P214, DOI 10.1038/nature13803; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Marino F, 1999, EXP HEMATOL, V27, P489, DOI 10.1016/S0301-472X(98)00057-5; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meredith EJ, 2006, P NATL ACAD SCI USA, V103, P13485, DOI 10.1073/pnas.0605993103; Meyer-Hermann M, 2001, J THEOR BIOL, V210, P265, DOI 10.1006/jtbi.2001.2297; Meyer-Hermann M, 2014, J IMMUNOL, V193, P5414, DOI 10.4049/jimmunol.1401828; Meyer-Hermann M, 2012, CELL REP, V2, P162, DOI 10.1016/j.celrep.2012.05.010; Musso NR, 1998, J NEUROIMMUNOL, V87, P82, DOI 10.1016/S0165-5728(98)00057-5; Musso NR, 1996, J CLIN ENDOCR METAB, V81, P3553, DOI 10.1210/jc.81.10.3553; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; NIEMEGEERS CJE, 1976, P ROY SOC MED, V69, P3, DOI 10.1177/00359157760690S102; SCHWARZENBRUNNER U, 1990, NEUROSCIENCE, V37, P819, DOI 10.1016/0306-4522(90)90111-G; Shulman Z, 2014, SCIENCE, V345, P1058, DOI 10.1126/science.1257861; Slater EP, 2006, EUR J ENDOCRINOL, V154, P587, DOI 10.1530/eje.1.02116; SMYTHE GA, 1992, CLIN CHEM, V38, P486; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222	43	82	86	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2017	547	7663					318	+		10.1038/nature23013	http://dx.doi.org/10.1038/nature23013			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB0OR	28700579	Green Submitted, Green Accepted			2022-12-28	WOS:000405844900027
J	Gulland, A				Gulland, Anne			Lisa Anson: pharma's new figurehead wants to let light into the industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Hawkes N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j3195; Kmietowicz Z, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3760; Neville S, 2017, FINANCIAL TIMES; Rawal B, 2015, CURR MED RES OPIN, V31, P1431, DOI 10.1185/03007995.2015.1047749; Silverman E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4704	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 10	2017	358								j3303	10.1136/bmj.j3303	http://dx.doi.org/10.1136/bmj.j3303			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA9MO	28694321				2022-12-28	WOS:000405769900008
J	Benalcazar, WA; Bernevig, BA; Hughes, TL				Benalcazar, Wladimir A.; Bernevig, B. Andrei; Hughes, Taylor L.			Quantized electric multipole insulators	SCIENCE			English	Article							WANNIER FUNCTIONS; ENERGY-BANDS; POLARIZATION; SOLIDS; MODEL	The Berry phase provides a modern formulation of electric polarization in crystals. We extend this concept to higher electricmultipole moments and determine the necessary conditions and minimal models for which the quadrupole and octupole moments are topologically quantized electromagnetic observables. Such systems exhibit gapped boundaries that are themselves lower-dimensional topological phases. Furthermore, they host topologically protected corner states carrying fractional charge, exhibiting fractionalization at the boundary of the boundary. To characterize these insulating phases of matter, we introduce a paradigm in which "nested" Wilson loops give rise to topological invariants that have been overlooked. We propose three realistic experimental implementations of this topological behavior that can be immediately tested. Our work opens a venue for the expansion of the classification of topological phases of matter.	[Benalcazar, Wladimir A.; Hughes, Taylor L.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Benalcazar, Wladimir A.; Hughes, Taylor L.] Univ Illinois, Inst Condensed Matter Theory, Urbana, IL 61801 USA; [Bernevig, B. Andrei] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Princeton University	Hughes, TL (corresponding author), Univ Illinois, Dept Phys, Urbana, IL 61801 USA.; Hughes, TL (corresponding author), Univ Illinois, Inst Condensed Matter Theory, Urbana, IL 61801 USA.	hughest@illinois.edu		Bernevig, B Andrei/0000-0001-6337-4024	U.S. National Science Foundation [DMR-1351895]; Sloan Foundation; U.S. Department of Energy [DE-SC0016239]; NSF EAGER grant [DMR-1643312]; Simons Investigator award [ONR - N00014-14-1-0330]; Army Research Office Multidisciplinary University Research Initiative grant [W911NF-12-1-0461]; NSF-Materials Research Science and Engineering Center grant [DMR-1420541]; Packard Foundation; Schmidt Fund for Innovative Research	U.S. National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); U.S. Department of Energy(United States Department of Energy (DOE)); NSF EAGER grant(National Science Foundation (NSF)); Simons Investigator award; Army Research Office Multidisciplinary University Research Initiative grant; NSF-Materials Research Science and Engineering Center grant(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Schmidt Fund for Innovative Research	We thank C. Fang and A. Soluyanov for useful discussions and B. Gadway for useful discussions and for pointing us to (31). W.A.B. and I.L.H. thank the U.S. National Science Foundation under grant DMR-1351895 and the Sloan Foundation for support. B.A.B. acknowledges support from U.S. Department of Energy grant DE-SC0016239, NSF EAGER grant DMR-1643312, Simons Investigator award ONR - N00014-14-1-0330, Army Research Office Multidisciplinary University Research Initiative grant W911NF-12-1-0461, NSF-Materials Research Science and Engineering Center grant DMR-1420541, and the Packard Foundation and Schmidt Fund for Innovative Research.	Aidelsburger M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185301; Alexandradinata A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.205104; Alexandradinata A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021008; Alexandradinata A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155114; Coh S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107603; Essin AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.146805; Fidkowski L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036601; Gadway B, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043606; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; Hughes TL, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245132; Keil R, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.213901; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; KIVELSON S, 1982, PHYS REV B, V26, P4269, DOI 10.1103/PhysRevB.26.4269; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; Meier EJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13986; Meier EJ, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.051602; Miyake H, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185302; Plotnik Y, 2014, NAT MATER, V13, P57, DOI [10.1038/NMAT3783, 10.1038/nmat3783]; Qi XL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.126803; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Raab R.E, 2004, MULTIPOLE THEORY ELE; Rechtsman MC, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.103901; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; Turner AM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.165120; VANDERBILT D, 1993, PHYS REV B, V48, P4442, DOI 10.1103/PhysRevB.48.4442; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang ZJ, 2016, NATURE, V532, P189, DOI 10.1038/nature17410; Yu R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075119; ZAK J, 1989, PHYS REV LETT, V62, P2747, DOI 10.1103/PhysRevLett.62.2747; Zhou YJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.041102	31	901	905	30	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					61	66		10.1126/science.aah6442	http://dx.doi.org/10.1126/science.aah6442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684520	Green Submitted			2022-12-28	WOS:000416909500003
J	Naxerova, K; Reiter, JG; Brachtel, E; Lennerz, JK; van de Wetering, M; Rowan, A; Cai, TX; Clevers, H; Swanton, C; Nowak, MA; Elledge, SJ; Jain, RK				Naxerova, Kamila; Reiter, Johannes G.; Brachtel, Elena; Lennerz, Jochen K.; van de Wetering, Marc; Rowan, Andrew; Cai, Tianxi; Clevers, Hans; Swanton, Charles; Nowak, Martin A.; Elledge, Stephen J.; Jain, Rakesh K.			Origins of lymphatic and distant metastases in human colorectal cancer	SCIENCE			English	Article							PROSTATE-CANCER; COLON-CANCER; SURGICAL-TREATMENT; EVOLUTION; SURVIVAL; DISSEMINATION; PROGRESSION; MECHANISMS; CARCINOMA; PATTERNS	The spread of cancer cells from primary tumors to regional lymph nodes is often associated with reduced survival. One prevailing model to explain this association posits that fatal, distant metastases are seeded by lymph node metastases. This view provides a mechanistic basis for the TNM staging system and is the rationale for surgical resection of tumor-draining lymph nodes. Here we examine the evolutionary relationship between primary tumor, lymph node, and distant metastases in human colorectal cancer. Studying 213 archival biopsy samples from 17 patients, we used somatic variants in hypermutable DNA regions to reconstruct high-confidence phylogenetic trees. We found that in 65% of cases, lymphatic and distant metastases arose from independent subclones in the primary tumor, whereas in 35% of cases they shared common subclonal origin. Therefore, two different lineage relationships between lymphatic and distant metastases exist in colorectal cancer.	[Naxerova, Kamila; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs Tumor Biol, Boston, MA 02114 USA; [Naxerova, Kamila; Brachtel, Elena; Lennerz, Jochen K.; Jain, Rakesh K.] Harvard Med Sch, Boston, MA 02114 USA; [Naxerova, Kamila; Elledge, Stephen J.] Brigham & Womens Hosp, Dept Genet, Div Genet, Boston, MA 02115 USA; [Naxerova, Kamila; Elledge, Stephen J.] Harvard Med Sch, Boston, MA 02115 USA; [Reiter, Johannes G.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Brachtel, Elena; Lennerz, Jochen K.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [van de Wetering, Marc; Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [van de Wetering, Marc; Clevers, Hans] UMC, NL-3584 CT Utrecht, Netherlands; [van de Wetering, Marc; Clevers, Hans] UMC Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands; [Rowan, Andrew; Swanton, Charles] Francis Crick Inst, London NW1 1AT, England; [Cai, Tianxi] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Swanton, Charles] UCL, Canc Inst, London WC1E 6DD, England; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Elledge, Stephen J.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Francis Crick Institute; Harvard University; University of London; University College London; Harvard University; Harvard University; Howard Hughes Medical Institute	Naxerova, K (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Labs Tumor Biol, Boston, MA 02114 USA.; Naxerova, K (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Naxerova, K (corresponding author), Brigham & Womens Hosp, Dept Genet, Div Genet, Boston, MA 02115 USA.; Naxerova, K (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	naxerova.kamila@mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Reiter, Johannes G./Y-4083-2019	Jain, Rakesh K/0000-0001-7571-3548; Reiter, Johannes G./0000-0002-0170-7353; Swanton, Charles/0000-0002-4299-3018; Elledge, Stephen/0000-0001-7923-6283; Naxerova, Kamila/0000-0001-7744-5110	Department of Defense [W81XWH-10-0016, W81XWH-12-1-0362, W81XWH-15-1-0579]; National Human Genome Research Institute [U54 HG007963]; National Cancer Institute [P01-CA080124, R35-CA19//43]; Francis Crick Institute [FC001169]; Austrian Science Fund [J-3996]; National Foundation for Cancer Research; Ludwig Center at Harvard; MRC [MR/P014712/1] Funding Source: UKRI; Cancer Research UK [20466, 19310, 17786] Funding Source: researchfish; Medical Research Council [MR/P014712/1] Funding Source: researchfish; Rosetrees Trust [M231-CD1, M391, M640, M445, M179] Funding Source: researchfish; The Francis Crick Institute [10359, 10485, C60895/A23896, 10174, 10172, A1278, 10467, VEG 108844, C28575/A25223, 10169, 10170] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA080124, R35CA197743] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007963] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Francis Crick Institute; Austrian Science Fund(Austrian Science Fund (FWF)); National Foundation for Cancer Research; Ludwig Center at Harvard; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Nahrendorf, F. Swirski, J. Gerold, and T. Padera for helpful comments and careful review of the manuscript, and N. Sasaki and V. Sasselli for their help with organoid culture. This work was supported by the Department of Defense W81XWH-10-0016 (R.K.J.), W81XWH-12-1-0362 (S.J.E.), and W81XWH-15-1-0579 (K.N.); National Human Genome Research Institute U54 HG007963 (T.C.); National Cancer Institute P01-CA080124 (R.K.J.) and R35-CA19//43 (R.K.J.); Francis Crick Institute FC001169 (C.S.); Austrian Science Fund J-3996 (J.G.R.); National Foundation for Cancer Research (R.K.J.); and Ludwig Center at Harvard (S.J.E. and R.K.J.). The Program for Evolutionary Dynamics is supported in part by a gift from B. Wu and E. Larson. K.N. conceived and designed the study and performed experiments. K.N. and J.G.R. analyzed data. E.B. and J.K.L. reviewed tissue specimens and clinical records. M.v.d.W., A.R., H.C., and C.S. provided DNA samples. K.N., J.G.R., E.B., J.K.L., T.C., C.S., M.A.N., S.J.E., and R.K.J. discussed results and strategy. R.K.J. supervised the study. K.N. wrote the manuscript, which was revised and approved by all authors. Raw polyguanine-profiling data, distance matrices, and phylogenetic trees can be downloaded from https://steelelabs.mgh.harvard.edu/lymphmet and from datadryad.org (http://dx.doi.org/10.5061/dryad.vv53d).	American Cancer Society, TREATM COL CANC STAT; Boyer JC, 2002, HUM MOL GENET, V11, P707, DOI 10.1093/hmg/11.6.707; CADY B, 1984, ARCH SURG-CHICAGO, V119, P1067; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; Engel J, 2012, CANCER METAST REV, V31, P235, DOI 10.1007/s10555-011-9343-7; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GERVASI LA, 1989, J UROLOGY, V142, P332, DOI 10.1016/S0022-5347(17)38748-7; Gervasoni JE, 2007, ANN SURG ONCOL, V14, P2443, DOI 10.1245/s10434-007-9360-5; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; MCBRIDE CM, 1978, SOUTHERN MED J, V71, P1331, DOI 10.1097/00007611-197811000-00005; MCGUIRE WL, 1987, BREAST CANCER RES TR, V10, P5, DOI 10.1007/BF01806129; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Moynihan BGA, 1908, SURG GYNECOL OBSTET, V6, P463; NARUKE T, 1978, J THORAC CARDIOV SUR, V76, P832; Nathanson SD, 2003, CANCER, V98, P413, DOI 10.1002/cncr.11464; Naxerova K, 2014, P NATL ACAD SCI USA, V111, pE1889, DOI 10.1073/pnas.1400179111; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; PATANAPHAN V, 1993, SOUTHERN MED J, V86, P38, DOI 10.1097/00007611-199301000-00009; Reiter JG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14114; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2008, GENETICS, V178, P967, DOI 10.1534/genetics.107.081018; Salk JJ, 2009, P NATL ACAD SCI USA, V106, P20871, DOI 10.1073/pnas.0909428106; Sleeman J, 2009, SEMIN CANCER BIOL, V19, P285, DOI 10.1016/j.semcancer.2009.05.005; Sleeman JP, 2012, CLIN EXP METASTAS, V29, P737, DOI 10.1007/s10585-012-9489-x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Virchow R., 1863, KRANKHAFTEN GESCHWAL; Vogelstein B, 2015, NEW ENGL J MED, V373, P1895, DOI 10.1056/NEJMp1508811; Weinberg RA, 2008, CARCINOGENESIS, V29, P1092, DOI 10.1093/carcin/bgn104; Wong SY, 2006, CELL CYCLE, V5, P812, DOI 10.4161/cc.5.8.2646; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	36	259	273	6	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2017	357	6346					55	60		10.1126/science.aai8515	http://dx.doi.org/10.1126/science.aai8515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO5OK	28684519	Green Submitted, Green Accepted			2022-12-28	WOS:000416909500002
J	Shulaker, MM; Hills, G; Park, RS; Howe, RT; Saraswat, K; Wong, HSP; Mitra, S				Shulaker, Max M.; Hills, Gage; Park, Rebecca S.; Howe, Roger T.; Saraswat, Krishna; Wong, H. -S. Philip; Mitra, Subhasish			Three-dimensional integration of nanotechnologies for computing and data storage on a single chip	NATURE			English	Article							CARBON; CIRCUITS; MOSFETS	The computing demands of future data-intensive applications will greatly exceed the capabilities of current electronics, and are unlikely to be met by isolated improvements in transistors, data storage technologies or integrated circuit architectures alone. Instead, transformative nanosystems, which use new nanotechnologies to simultaneously realize improved devices and new integrated circuit architectures, are required. Here we present a prototype of such a transformative nanosystem. It consists of more than one million resistive random-access memory cells and more than two million carbon-nanotube field-effect transistors-promising new nanotechnologies for use in energy-efficient digital logic circuits(1-3) and for dense data storage(4)-fabricated on vertically stacked layers in a single chip. Unlike conventional integrated circuit architectures, the layered fabrication realizes a three-dimensional integrated circuit architecture with fine-grained and dense vertical connectivity between layers of computing, data storage, and input and output (in this instance, sensing). As a result, our nanosystem can capture massive amounts of data every second, store it directly on-chip, perform in situ processing of the captured data, and produce 'highly processed' information. As a working prototype, our nanosystem senses and classifies ambient gases. Furthermore, because the layers are fabricated on top of silicon logic circuitry, our nanosystem is compatible with existing infrastructure for silicon-based technologies. Such complex nano-electronic systems will be essential for future high-performance and highly energy-efficient electronic systems(5).	[Shulaker, Max M.; Hills, Gage; Park, Rebecca S.; Howe, Roger T.; Saraswat, Krishna; Wong, H. -S. Philip; Mitra, Subhasish] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Shulaker, Max M.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Mitra, Subhasish] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Stanford University; Massachusetts Institute of Technology (MIT); Stanford University	Shulaker, MM (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Shulaker, MM (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	shulaker@mit.edu		Mitra, Subhasish/0000-0002-5572-5194; Howe, Roger/0000-0002-4554-7347	NSF [CNS-1059020]; DARPA [W909MY-16-1-0001]; STARnet SONIC; Stanford SystemX Alliance; Hertz Fellowship; Stanford Graduate Fellowship	NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); STARnet SONIC; Stanford SystemX Alliance; Hertz Fellowship; Stanford Graduate Fellowship(Stanford University)	We acknowledge the support of NSF (CNS-1059020), DARPA (W909MY-16-1-0001), STARnet SONIC, member companies of the Stanford SystemX Alliance, and the Hertz Fellowship and Stanford Graduate Fellowship for M.M.S. We are grateful to C. Gupta for discussions.	Aly MMS, 2015, COMPUTER, V48, P24, DOI 10.1109/MC.2015.376; Batude P., 2011, P INT EL DEV M IEEE, P7; Cao Q, 2008, NATURE, V454, P495, DOI 10.1038/nature07110; Chang L., 2012, IEEE INT EL DEV M IE; DENNARD RH, 1974, IEEE J SOLID-ST CIRC, VSC 9, P256, DOI 10.1109/JSSC.1974.1050511; Frank DJ, 2001, P IEEE, V89, P259, DOI 10.1109/5.915374; Franklin AD, 2012, NANO LETT, V12, P758, DOI 10.1021/nl203701g; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Leduc P, 2008, 2008 INTERNATIONAL SYMPOSIUM ON VLSI TECHNOLOGY, SYSTEMS AND APPLICATIONS (VLSI-TSA), PROCEEDINGS OF TECHNICAL PROGRAM, P76, DOI 10.1109/VTSA.2008.4530806; Liu SF, 2015, CHEM MATER, V27, P3560, DOI 10.1021/acs.chemmater.5b00153; Mayer-Sch?nber V., 2013, BIG DATA REVOLUTION; Patil N, 2009, P IEEE INT EL DEV M, P1, DOI [DOI 10.1109/IEDM.2009.5424295, 10.1109/IEDM.2009.5424295]; Patil N, 2008, S VLSI TECH, P159; Patil N, 2011, IEEE T NANOTECHNOL, V10, P744, DOI 10.1109/TNANO.2010.2076323; Rogers B, 2009, CONF PROC INT SYMP C, P371, DOI 10.1145/1555815.1555801; Shulaker M. M, 2014, EL DEV M IEDM 2014 I, P33; Shulaker M. M., 2015, IEEE INT EL DEV M IE, P32; Shulaker M. M., 2014, 2014 IEEE INT EL DEV, P27; Shulaker MM, 2014, IEEE J SOLID-ST CIRC, V49, P190, DOI 10.1109/JSSC.2013.2282092; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Shulaker MM, 2011, NANO LETT, V11, P1881, DOI 10.1021/nl200063x; Shulaker MM, 2014, ACS NANO, V8, P3434, DOI 10.1021/nn406301r; Staii C, 2005, NANO LETT, V5, P1774, DOI 10.1021/nl051261f; Steinwart I., 2008, SUPPORT VECTOR MACHI; Villa O, 2014, INT CONF HIGH PERFOR, P830, DOI 10.1109/SC.2014.73; Vinet M, 2011, MICROELECTRON ENG, V88, P331, DOI 10.1016/j.mee.2010.10.022; Wei L., 2009, P IEEE INT EL DEV M, P1, DOI DOI 10.1109/IEDM.2009.5424281; Wong HSP, 2015, NAT NANOTECHNOL, V10, P191, DOI 10.1038/nnano.2015.29; Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369; Zhang J, 2012, IEEE T COMPUT AID D, V31, P453, DOI 10.1109/TCAD.2012.2187527	30	391	401	41	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2017	547	7661					74	+		10.1038/nature22994	http://dx.doi.org/10.1038/nature22994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EZ6PM	28682331				2022-12-28	WOS:000404839900033
J	Feinberg, J; Keeshin, S				Feinberg, Judith; Keeshin, Susana			Management of Newly Diagnosed HIV Infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; PRIMARY-CARE GUIDELINES; ANTIRETROVIRAL THERAPY; VIRAL LOAD; MEDICINE ASSOCIATION; DISEASES SOCIETY; ADULTS; RECOMMENDATIONS; TRANSMISSION; PERFORMANCE		[Feinberg, Judith] West Virginia Univ, Morgantown, WV 26506 USA; Univ Utah, Salt Lake City, UT 84112 USA	West Virginia University; Utah System of Higher Education; University of Utah	Feinberg, J (corresponding author), West Virginia Univ, Morgantown, WV 26506 USA.			feinberg, judith/0000-0003-4206-7214	American College of Physicians	American College of Physicians	American College of Physicians.	Aberg JA, 2014, CLIN INFECT DIS, V58, pE1, DOI [10.1093/cid/cit665, 10.1093/cid/cit757]; Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Centers for Disease Control and Prevention, 2014, HIV SURV REP; Centers for Disease Control and Prevention, 2016, DIAGN HIV INF AD AG; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P581; Centers for Disease Control and Prevention (CDC, 2014, LAB TEST DIAGN HIV I; Centers for Disease Control and Prevention (CDC, 2008, MMWR MORBMORTAL WKLY, V59, P1201; Chavez P, 2011, J CLIN VIROL, V52, pS51, DOI 10.1016/j.jcv.2011.09.010; Chou R, 2007, US PREVENTIVE SERVIC; Chou R, 2005, PREVENTIVE SERVICES; Coco A, 2005, ANN FAM MED, V3, P400, DOI 10.1370/afm.376; Cohen M, 2015, 8 IAS C HIV PATH TRE; Cummiskey J., 2008, Morbidity and Mortality Weekly Report, V57, P660; Dominguez K.L., 2016, UPDATED GUIDELINES A; Ford CL, 2007, ANN EPIDEMIOL, V17, P209, DOI 10.1016/j.annepidem.2006.09.006; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hardy WD, 2017, FUNDAMENTALS HIV MED; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Kuhar DT, 2013, INFECT CONT HOSP EP, V34, P875, DOI 10.1086/672271; Lee PK, 2006, J ANTIMICROB CHEMOTH, V57, P803, DOI 10.1093/jac/dkl092; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Nasrullah M, 2013, AIDS, V27, P731, DOI 10.1097/QAD.0b013e32835bc535; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Palella Jr FJ, 1998, NEW ENGL J MED, V338, P853; Smith DK, 2015, MMWR-MORBID MORTAL W, V64, P1291, DOI 10.15585/mmwr.mm6446a4; Thea DM, 1997, AIDS, V11, P437, DOI 10.1097/00002030-199704000-00006; Vidrih JA, 2001, AM J MED, V111, P192, DOI 10.1016/S0002-9343(01)00804-X; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	38	2	2	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2017	167	1					ITC1	ITC14		10.7326/AITC201707040	http://dx.doi.org/10.7326/AITC201707040			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ3DW	28672393				2022-12-28	WOS:000404591600001
J	Cho, A				Cho, Adrian			THE UNBEARABLE LIGHTNESS OF NEUTRINOS	SCIENCE			English	Editorial Material																			0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2017	356	6345					1322	1326		10.1126/science.356.6345.1322	http://dx.doi.org/10.1126/science.356.6345.1322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY9XE	28663452				2022-12-28	WOS:000404351500013
J	Dong, X; Milholland, B; Vijg, J				Dong, Xiao; Milholland, Brandon; Vijg, Jan			Contesting the evidence for limited human lifespan Reply	NATURE			English	Letter									[Dong, Xiao; Milholland, Brandon; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA.; Vijg, J (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10461 USA.	jan.vijg@einstein.yu.edu						ANSCOMBE FJ, 1973, AM STAT, V27, P17, DOI 10.2307/2682899; Brown NJL, 2017, NATURE, V546, pE6, DOI 10.1038/nature22784; Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793; Gbari S., 2017, COMMUNICATION; van Helden P, 2013, EMBO REP, V14, P104, DOI 10.1038/embor.2012.207	5	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2017	546	7660					E7	E7		10.1038/nature22785	http://dx.doi.org/10.1038/nature22785			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY9QB	28658231				2022-12-28	WOS:000404332000002
J	Jung, C; Hawkins, JA; Jones, SK; Xiao, YB; Rybarski, JR; Dillard, KE; Hussmann, J; Saifuddin, FA; Savran, CA; Ellington, AD; Ke, A; Press, WH; Finkelstein, IJ				Jung, Cheulhee; Hawkins, John A.; Jones, Stephen K., Jr.; Xiao, Yibei; Rybarski, James R.; Dillard, Kaylee E.; Hussmann, Jeffrey; Saifuddin, Fatema A.; Savran, Cagri A.; Ellington, Andrew D.; Ke, Ailong; Press, William H.; Finkelstein, Ilya J.			Massively Parallel Biophysical Analysis of CRISPR-Cas Complexes on Next Generation Sequencing Chips	CELL			English	Article							R-LOOP FORMATION; RNA-GUIDED CAS9; SURVEILLANCE COMPLEX; SPACER ACQUISITION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INTERFERENCE; CASCADE; RECOGNITION; SPECIFICITY	CRISPR-Cas nucleoproteins target foreign DNA via base pairing with a crRNA. However, a quantitative description of protein binding and nuclease activation at off-target DNA sequences remains elusive. Here, we describe a chip-hybridized association-mapping platform (CHAMP) that repurposes next-generation sequencing chips to simultaneously measure the interactions between proteins and similar to 10(7) unique DNA sequences. Using CHAMP, we provide the first comprehensive survey of DNA recognition by a type I-E CRISPR-Cas (Cascade) complex and Cas3 nuclease. Analysis of mutated target sequences and human genomic DNA reveal that Cascade recognizes an extended protospacer adjacent motif (PAM). Cascade recognizes DNA with a surprising 3-nt periodicity. The identity of the PAM and the PAM-proximal nucleotides control Cas3 recruitment by releasing the Cse1 subunit. These findings are used to develop a model for the biophysical constraints governing off-target DNA binding. CHAMP provides a framework for high-throughput, quantitative analysis of protein-DNA interactions on synthetic and genomic DNA.	[Jung, Cheulhee; Jones, Stephen K., Jr.; Rybarski, James R.; Dillard, Kaylee E.; Saifuddin, Fatema A.; Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Jung, Cheulhee; Jones, Stephen K., Jr.; Rybarski, James R.; Dillard, Kaylee E.; Saifuddin, Fatema A.; Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Hawkins, John A.; Hussmann, Jeffrey; Press, William H.] Univ Texas Austin, Inst Computat Engn & Sci, Austin, TX 78712 USA; [Xiao, Yibei; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, 253 Biotechnol Bldg, Ithaca, NY 14853 USA; [Savran, Cagri A.] Purdue Univ, Birck Nanotechnol Ctr, Sch Mech Engn, 1205 West State St, W Lafayette, IN 47907 USA; [Ellington, Andrew D.; Finkelstein, Ilya J.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Press, William H.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Press, William H.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Cornell University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Finkelstein, IJ (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Finkelstein, IJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.; Finkelstein, IJ (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ifinkelstein@cm.utexas.edu	Jung, Cheulhee/D-2726-2017	Jung, Cheulhee/0000-0001-7392-5862; Saifuddin, Fatema/0000-0003-4957-3849; Hussmann, Jeffrey/0000-0002-7778-9893; Rybarski, James/0000-0001-9960-1161; Press, William/0000-0003-0771-0841; Jones, Stephen/0000-0001-8387-1917	College of Natural Sciences Catalyst award; CPRIT [R1214]; Welch Foundation [F-1808]; National Science Foundation [1453358]; NIH [F32 AG053051, R01 GM120554]; John Templeton Foundation [UTA16-000194]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM124141, R01GM120554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG053051] Funding Source: NIH RePORTER	College of Natural Sciences Catalyst award; CPRIT; Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to our colleague Scott Hunicke-Smith and members of the Genomic Sequencing and Analysis Facility for valuable insights. We are grateful to members of the Finkelstein laboratory for carefully reading the manuscript. This work was supported by a College of Natural Sciences Catalyst award, CPRIT (R1214 to I.J.F.), the Welch Foundation (F-1808 to I.J.F.), the National Science Foundation (1453358), and the NIH (F32 AG053051 to S.K.J. and R01 GM120554 to I.J.F.). This publication was also made possible through the support of a grant from the John Templeton Foundation (UTA16-000194 to A.D.E). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. I.J.F. is a CPRIT Scholar in Cancer Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Science Foundation.	Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Caliando BJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7989; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edelstein Arthur D, 2014, J Biol Methods, V1; Efron B., 1994, MONOGRAPHS STAT APPL; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Maneewongvatana S., 1999, CTR GEOMETRIC COMPUT, V2, P1; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; O'Geen H, 2015, NUCLEIC ACIDS RES, V43, P3389, DOI 10.1093/nar/gkv137; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2016, P NATL ACAD SCI USA, V113, P7626, DOI 10.1073/pnas.1602639113; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Staals RHJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12853; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Tome JM, 2014, NAT METHODS, V11, P683, DOI [10.1038/NMETH.2970, 10.1038/nmeth.2970]; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Wu Xuebing, 2014, Quant Biol, V2, P59; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	51	59	59	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 29	2017	170	1					35	+		10.1016/j.cell.2017.05.044	http://dx.doi.org/10.1016/j.cell.2017.05.044			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EY9ZV	28666121	Bronze, Green Accepted			2022-12-28	WOS:000404358500008
J	Laing, ST				Laing, Susan T.			High-Intensity Statins Guideline Expectations and Clinical Application	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FORCE 2014 UPDATE; ASSOCIATION		[Laing, Susan T.] Univ Texas McGovern Med Sch, Div Cardiol, Dept Internal Med, Houston, TX 77030 USA		Laing, ST (corresponding author), Univ Texas McGovern Med Sch, 6431 Fannin St,MSB 2-146, Houston, TX 77030 USA.			Laing, Susan/0000-0002-6504-6646				Maki KC, 2014, J CLIN LIPIDOL, V8, pS17, DOI 10.1016/j.jacl.2014.02.012; National Center for Health Statistics, 2016, HLTH US 2015 SPEC FE; Pokharel Y, 2017, JAMA CARDIOL, V2, P361, DOI 10.1001/jamacardio.2016.5922; Rodriguez F, 2017, JAMA CARDIOL, V2, P47, DOI 10.1001/jamacardio.2016.4052; Rojas-Fernandez CH, 2014, J CLIN LIPIDOL, V8, pS5, DOI 10.1016/j.jacl.2014.02.013; Rosenson RS, 2014, J CLIN LIPIDOL, V8, pS58, DOI 10.1016/j.jacl.2014.03.004; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Virani SS, 2016, J CLIN LIPIDOL, V10, P497, DOI 10.1016/j.jacl.2015.11.002; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	9	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 27	2017	317	24					2543	2544		10.1001/jama.2017.5781	http://dx.doi.org/10.1001/jama.2017.5781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY6PV	28654993				2022-12-28	WOS:000404106600024
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Are GPs specialists in life?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				My Health Career, 2017, SPEC LIF CAMP GPS; Royal Australian College of General Practitioners, 2015, GOOD GP CIN ADV	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 26	2017	357								j2903	10.1136/bmj.j2903	http://dx.doi.org/10.1136/bmj.j2903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EZ5AO	28652385	Bronze, Green Published			2022-12-28	WOS:000404723900001
J	Goodwin, SJ				Goodwin, Shikha Jain			My lessons in mentorship	SCIENCE			English	Editorial Material									[Goodwin, Shikha Jain] Univ Minnesota, Minneapolis, MN 55455 USA; [Goodwin, Shikha Jain] Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Goodwin, SJ (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.; Goodwin, SJ (corresponding author), Minneapolis VA Med Ctr, Minneapolis, MN 55417 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1302	1302		10.1126/science.356.6344.1302	http://dx.doi.org/10.1126/science.356.6344.1302			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642441	Bronze			2022-12-28	WOS:000403881700043
J	Gulland, A				Gulland, Anne			Gordon Waddell OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												annecgulland@yahoo.co.uk						WADDELL G, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2017	357								j2938	10.1136/bmj.j2938	http://dx.doi.org/10.1136/bmj.j2938			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7ZC	28646073				2022-12-28	WOS:000404211100001
J	Mann, A				Mann, Adam			TRIAL BALLOONS	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2017	356	6344					1227	1229		10.1126/science.356.6344.1227	http://dx.doi.org/10.1126/science.356.6344.1227			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EY3OM	28642393				2022-12-28	WOS:000403881700016
J	Mortimer, R; Bano, C; Howlett, DC				Mortimer, Rebecca; Bano, Christopher; Howlett, David C.			SPOT DIAGNOSIS An unusual appearance on cranial computed tomography	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mortimer, Rebecca; Howlett, David C.] East Sussex Healthcare NHS Trust, Eastbourne Dist Gen Hosp, Eastbourne, England; [Bano, Christopher] Kings Coll Hosp NHS Trust, Denmark Hill, London, England	King's College Hospital NHS Foundation Trust	Mortimer, R (corresponding author), East Sussex Healthcare NHS Trust, Eastbourne Dist Gen Hosp, Eastbourne, England.	rmortimer1@nhs.net						Cucchiara B, 2004, NEUROCRIT CARE, V1, P371, DOI 10.1385/NCC:1:3:371; McCarron MO, 2014, ANN CLIN BIOCHEM, V51, P629, DOI 10.1177/0004563214552286	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2017	357								j2760	10.1136/bmj.j2760	http://dx.doi.org/10.1136/bmj.j2760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EY7YZ	28642296				2022-12-28	WOS:000404210800005
J	Pasi, KJ; Rangarajan, S; Georgiev, P; Mant, T; Creagh, MD; Lissitchkov, T; Bevan, D; Austin, S; Hay, CR; Hegemann, I; Kazmi, R; Chowdary, P; Gercheva-Kyuchukova, L; Mamonov, V; Timofeeva, M; Soh, CH; Garg, P; Vaishnaw, A; Akinc, A; Sorensen, B; Ragni, MV				Pasi, K. J.; Rangarajan, S.; Georgiev, P.; Mant, T.; Creagh, M. D.; Lissitchkov, T.; Bevan, D.; Austin, S.; Hay, C. R.; Hegemann, I.; Kazmi, R.; Chowdary, P.; Gercheva-Kyuchukova, L.; Mamonov, V.; Timofeeva, M.; Soh, C. -H.; Garg, P.; Vaishnaw, A.; Akinc, A.; Sorensen, B.; Ragni, M. V.			Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONACOG BETA PEGOL; FACTOR-VIII; INHIBITOR DEVELOPMENT; THROMBIN GENERATION; CLINICAL-TRIALS; FACTOR-IX; PROPHYLAXIS; DEFICIENCY; HEMOSTASIS; CHILDREN	BACKGROUND Current hemophilia treatment involves frequent intravenous infusions of clotting factors, which is associated with variable hemostatic protection, a high treatment burden, and a risk of the development of inhibitory alloantibodies. Fitusiran, an investigational RNA interference (RNAi) therapy that targets antithrombin (encoded by SERPINC1), is in development to address these and other limitations. METHODS In this phase 1 dose-escalation study, we enrolled 4 healthy volunteers and 25 participants with moderate or severe hemophilia A or B who did not have inhibitory alloantibodies. Healthy volunteers received a single subcutaneous injection of fitusiran (at a dose of 0.03 mg per kilogram of body weight) or placebo. The participants with hemophilia received three injections of fitusiran administered either once weekly (at a dose of 0.015, 0.045, or 0.075 mg per kilogram) or once monthly (at a dose of 0.225, 0.45, 0.9, or 1.8 mg per kilogram or a fixed dose of 80 mg). The study objectives were to assess the pharmacokinetic and pharmacodynamic characteristics and safety of fitusiran. RESULTS No thromboembolic events were observed during the study. The most common adverse events were mild injection-site reactions. Plasma levels of fitusiran increased in a dose-dependent manner and showed no accumulation with repeated administration. The monthly regimen induced a dose-dependent mean maximum antithrombin reduction of 70 to 89% from baseline. A reduction in the antithrombin level of more than 75% from baseline resulted in median peak thrombin values at the lower end of the range observed in healthy participants. CONCLUSIONS Once-monthly subcutaneous administration of fitusiran resulted in dose-dependent lowering of the antithrombin level and increased thrombin generation in participants with hemophilia A or B who did not have inhibitory alloantibodies. (Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov number, NCT02035605.)	[Pasi, K. J.] Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England; [Mant, T.] NIHR, Biomed Res Ctr, London, England; [Bevan, D.] Kings Coll London, Guys & St Thomas NHS Fdn Trust, London, England; [Austin, S.] St Georges Healthcare NHS Trust Haemophilia Ctr, London, England; [Chowdary, P.] Royal Free Hosp London, London, England; [Rangarajan, S.] Hampshire Hosp NHS Fdn Trust, Haemophilia Haemostasis & Thrombosis Ctr, Basingstoke, Hants, England; [Mant, T.] Quintiles IMS, Reading, Berks, England; [Creagh, M. D.] Royal Cornwall Hosp NHS Trust, Truro, England; [Hay, C. R.] Manchester Royal Infirm, Manchester, Lancs, England; [Kazmi, R.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Georgiev, P.] Univ Multiprofile Hosp Act Treatment Sveti Georgi, Plovdiv, Bulgaria; [Georgiev, P.] Med Univ Plovdiv, Plovdiv, Bulgaria; [Lissitchkov, T.] Univ Hosp Hematol, Sofia, Bulgaria; [Gercheva-Kyuchukova, L.] Univ Hosp St Marina, Dept Hematol, Varna, Bulgaria; [Hegemann, I.] Univ Hosp Zurich, Zurich, Switzerland; [Mamonov, V.] Natl Res Ctr Hematol, Moscow, Russia; [Timofeeva, M.] Res Inst Hematol & Blood Transfus, Kirov, Russia; [Soh, C. -H.; Garg, P.; Vaishnaw, A.; Akinc, A.; Sorensen, B.] Alnylam Pharmaceut, Cambridge, MA USA; [Sorensen, B.] Codiak Biosci, Woburn, MA USA; [Ragni, M. V.] Univ Pittsburgh, Pittsburgh, PA USA; [Ragni, M. V.] Hemophilia Ctr Western Penn, Pittsburgh, PA USA	University of London; Queen Mary University London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; IQVIA; Royal Cornwall Hospital; University of Manchester; University of Southampton; University Hospital Southampton NHS Foundation Trust; Medical University Plovdiv; Medical University Varna; University of Zurich; University Zurich Hospital; Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Kirov Research Institute of Hematology & Blood Transfusiology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pasi, KJ (corresponding author), Royal London Hosp, Haemophilia Ctr, London E1 1BB, England.	k.j.pasi@qmul.ac.uk	Gorodilova, Elena/H-3682-2017; Georgiev, Pencho/AAV-6464-2020; Chowdary, P/I-2623-2012	Gorodilova, Elena/0000-0002-5714-2785; Georgiev, Pencho/0000-0001-5677-6754; Chowdary, P/0000-0002-6690-8586; Laffan, Michael/0000-0002-8268-3268; Rangarajan, Savita/0000-0001-7367-133X; Vettermann, Christian/0000-0003-3794-6441	Alnylam Pharmaceuticals	Alnylam Pharmaceuticals	Funded by Alnylam Pharmaceuticals; ClinicalTrials.gov number, NCT02035605.	Berntorp E, 2003, HAEMOPHILIA, V9, P1, DOI 10.1046/j.1365-2516.9.s1.17.x; Berntorp E, 2012, LANCET, V379, P1447, DOI 10.1016/S0140-6736(11)61139-2; Bolliger D, 2010, THROMB HAEMOSTASIS, V103, P1233, DOI 10.1160/TH09-10-0732; Bolton-Maggs PHB, 2003, LANCET, V361, P1801, DOI 10.1016/S0140-6736(03)13405-8; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; den Uijl IEM, 2011, HAEMOPHILIA, V17, P41, DOI 10.1111/j.1365-2516.2010.02383.x; DiMichele D, 2007, BRIT J HAEMATOL, V138, P305, DOI 10.1111/j.1365-2141.2007.06657.x; Franchini M, 2009, SEMIN THROMB HEMOST, V35, P307, DOI 10.1055/s-0029-1222609; Ghosh K, 2001, HAEMOPHILIA, V7, P9, DOI 10.1046/j.1365-2516.2001.00455.x; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gouw SC, 2013, BLOOD, V121, P4046, DOI 10.1182/blood-2012-09-457036; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Lofqvist T, 1997, J INTERN MED, V241, P395, DOI 10.1046/j.1365-2796.1997.130135000.x; Mahdi AJ, 2015, BRIT J HAEMATOL, V169, P768, DOI 10.1111/bjh.13360; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Negrier C, 2016, HAEMOPHILIA, V22, P507, DOI 10.1111/hae.12902; NEGRIER C, 1993, BLOOD, V81, P690; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; Oh RC, 2011, AM FAM PHYSICIAN, V84, P1003; Peters RT, 2013, J THROMB HAEMOST, V11, P132, DOI 10.1111/jth.12076; Peyvandi F, 2016, J THROMB HAEMOST, V14, P2095, DOI 10.1111/jth.13491; Peyvandi F, 2016, LANCET, V388, P187, DOI 10.1016/S0140-6736(15)01123-X; Ryan SM, 2008, EXPERT OPIN DRUG DEL, V5, P371, DOI [10.1517/17425247.5.4.371, 10.1517/17425247.5.4.371 ]; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shetty S, 2007, BRIT J HAEMATOL, V138, P541, DOI 10.1111/j.1365-2141.2007.06693.x; Skinner MW, 2012, HAEMOPHILIA, V18, P1, DOI 10.1111/j.1365-2516.2012.02822.x; Srivastava A, 2013, HAEMOPHILIA, V19, pE1, DOI 10.1111/j.1365-2516.2012.02909.x; Young G, 2016, HAEMOPHILIA, V22, P25, DOI 10.1111/hae.13028; Young G, 2016, THROMB RES, V141, P69, DOI 10.1016/j.thromres.2016.02.030	32	578	604	13	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2017	377	9					819	828		10.1056/NEJMoa1616569	http://dx.doi.org/10.1056/NEJMoa1616569			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FF0YG	28691885	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000408626400005
J	Brown, RH; Al-Chalabi, A				Brown, Robert H.; Al-Chalabi, Ammar			Amyotrophic Lateral Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; BAC TRANSGENIC MICE; REPEAT EXPANSION; SUPEROXIDE-DISMUTASE; NUCLEOCYTOPLASMIC TRANSPORT; ANTISENSE OLIGONUCLEOTIDE; PATHOLOGICAL FEATURES; HEXANUCLEOTIDE REPEAT; PROGRESSIVE MOTOR		[Brown, Robert H.] Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA; [Al-Chalabi, Ammar] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London, England	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London	Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.	robert.brown@umassmed.edu	Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010	Hardiman, Orla/0000-0003-2610-1291; Turner, Martin/0000-0003-0267-3180; Shaw, Pamela/0000-0002-8925-2567; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Burrell, James/0000-0001-9638-2768; Al-Chalabi, Ammar/0000-0002-4924-7712; Sheu, Chau-Chyun/0000-0002-7979-3749; Kiernan, Matthew/0000-0001-9054-026X; Eisen, Andrew/0000-0002-1447-2725; Vucic, Steve/0000-0002-8323-873X; Chio, Adriano/0000-0001-9579-5341; Hsu, Chung-Yao/0000-0002-9880-5944	Voyager Therapeutics; GlaxoSmithKline; Cytokinetics; Medical Research Council [G0701923] Funding Source: Medline; Medical Research Council [G0600974, MR/L501529/1] Funding Source: Medline; Medical Research Council [MR/L501529/1] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-TALBOT/APR14/926-794] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-DOBSON/APR14/829-791] Funding Source: Medline	Voyager Therapeutics; GlaxoSmithKline(GlaxoSmithKline); Cytokinetics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Motor Neurone Disease Association	Dr. Brown reports holding equity in AviTx, Amylyx Pharmaceuticals, and ImStar Therapeutics, receiving fees for serving on an advisory board from Voyager Therapeutics, negotiating a collaborative agreement with WAVE Biosciences, holding patents and receiving royalties for patents on "Method for the diagnosis of familial amyotrophic lateral sclerosis" (US 5,843,641) and "Mice having a mutant SOD1 encoding transgene" (US 6,723,893), holding a patent for "Compounds and method for the diagnosis, treatment and prevention of cell death" (US 5,849,290), and holding a pending patent for "Use of synthetic microRNA for AAV-mediated silencing of SOD1 in ALS"; and Dr. Al-Chalabi reports receiving consulting fees from GlaxoSmithKline, providing unpaid consulting for Mitsubishi Tanabe Pharma, Treeway, Chronos Therapeutics, and Avanir Pharmaceuticals, receiving consulting fees and serving as principal investigator in an international commercial clinical trial of tirasemtiv in ALS for Cytokinetics, and serving as chief investigator of an international commercial clinical trial of levosimendan in ALS for Orion Pharma. No other potential conflict of interest relevant to this article was reported.	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2016, LANCET NEUROL, V15, P1182, DOI 10.1016/S1474-4422(16)30199-5; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Arcila-Londono X, 2013, HAND CLINIC, V115, P429, DOI 10.1016/B978-0-444-52902-2.00024-2; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Beard JD, 2016, ENVIRON INT, V91, P104, DOI 10.1016/j.envint.2016.02.014; Beghi E, 2011, AMYOTROPH LATERAL SC, V12, P1, DOI 10.3109/17482968.2010.502940; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Calvo A, 2016, J NEUROL NEUROSUR PS, V87, P1229, DOI 10.1136/jnnp-2016-313793; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Conte A, 2012, NEUROMUSCULAR DISORD, V22, P73, DOI 10.1016/j.nmd.2011.08.003; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Diekstra FP, 2014, ANN NEUROL, V76, P120, DOI 10.1002/ana.24198; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fogh I, 2016, JAMA NEUROL, V73, P812, DOI 10.1001/jamaneurol.2016.1114; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Glass JD, 2016, NEUROLOGY, V87, P392, DOI 10.1212/WNL.0000000000002889; Gordon PH, 2006, NEUROLOGY, V66, P647, DOI 10.1212/01.wnl.0000200962.94777.71; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Lacorte E, 2016, NEUROSCI BIOBEHAV R, V66, P61, DOI 10.1016/j.neubiorev.2016.04.007; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Mitchell JC, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0212-4; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson KA, 2015, NEUROTHERAPEUTICS, V12, P376, DOI 10.1007/s13311-015-0341-2; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Pensato V, 2015, J NEUROL, V262, P1376, DOI 10.1007/s00415-015-7739-y; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Peters OM, 2015, J CLIN INVEST, V125, P2548, DOI 10.1172/JCI82693; Philips T, 2014, EXP NEUROL, V262, P111, DOI 10.1016/j.expneurol.2014.05.015; Pottier C, 2016, J NEUROCHEM, V138, P32, DOI 10.1111/jnc.13622; Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rezania K, 2013, NEUROL CLIN, V31, P219, DOI 10.1016/j.ncl.2012.09.014; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Therrien M, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0658-1; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Wang M., 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1016/J.FUE1.2016.07.061; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Winter SM, 2000, J NEUROL, V247, P783, DOI 10.1007/s004150070093; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	86	1253	1292	21	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					162	172		10.1056/NEJMra1603471	http://dx.doi.org/10.1056/NEJMra1603471			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700839	Green Published			2022-12-28	WOS:000405282300010
J	Brown, RH; Al-Chalabi, A				Brown, Robert H., Jr.; Al-Chalabi, Ammar			Amyotrophic Lateral Sclerosis REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Al-Chalabi, Ammar] Kings Coll London, London, England	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London	Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	robert.brown@umassmed.edu	Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010	Hardiman, Orla/0000-0003-2610-1291; Turner, Martin/0000-0003-0267-3180; Shaw, Pamela/0000-0002-8925-2567; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Burrell, James/0000-0001-9638-2768; Al-Chalabi, Ammar/0000-0002-4924-7712; Sheu, Chau-Chyun/0000-0002-7979-3749; Kiernan, Matthew/0000-0001-9054-026X; Eisen, Andrew/0000-0002-1447-2725; Vucic, Steve/0000-0002-8323-873X; Chio, Adriano/0000-0001-9579-5341; Hsu, Chung-Yao/0000-0002-9880-5944	Medical Research Council [G0701923] Funding Source: Medline; Medical Research Council [G0600974, MR/L501529/1] Funding Source: Medline; Medical Research Council [MR/L501529/1] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-TALBOT/APR14/926-794] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-DOBSON/APR14/829-791] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Motor Neurone Disease Association			0	1253	1292	21	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2017	377	16					1602	1602						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LU	28700839				2022-12-28	WOS:000413243900029
